id	sid	tid	token	lemma	pos
dti-2707	1	1	dti	dti	PROPN
dti-2707	1	2	drug	drug	PROPN
dti-2707	1	3	target	target	NOUN
dti-2707	1	4	insights	insight	NOUN
dti-2707	1	5	2024	2024	NUM
dti-2707	1	6	;	;	PUNCT
dti-2707	1	7	18	18	NUM
dti-2707	1	8	:	:	SYM
dti-2707	1	9	30	30	NUM
dti-2707	1	10	-	-	SYM
dti-2707	1	11	46	46	NUM
dti-2707	1	12	issn	issn	PROPN
dti-2707	1	13	1177	1177	NUM
dti-2707	1	14	-	-	SYM
dti-2707	1	15	3928	3928	NUM
dti-2707	1	16	|	|	ADV
dti-2707	1	17	doi	doi	NOUN
dti-2707	1	18	:	:	PUNCT
dti-2707	1	19	10.33393	10.33393	NUM
dti-2707	1	20	/	/	SYM
dti-2707	1	21	dti.2024.2707	dti.2024.2707	NUM
dti-2707	1	22	review	review	NOUN
dti-2707	1	23	drug	drug	NOUN
dti-2707	1	24	target	target	NOUN
dti-2707	1	25	insights	insight	NOUN
dti-2707	1	26	issn	issn	VERB
dti-2707	1	27	1177	1177	NUM
dti-2707	1	28	-	-	SYM
dti-2707	1	29	3928	3928	NUM
dti-2707	1	30	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2707	1	31	©	©	PROPN
dti-2707	1	32	2024	2024	NUM
dti-2707	1	33	the	the	DET
dti-2707	1	34	authors	author	NOUN
dti-2707	1	35	.	.	PUNCT
dti-2707	2	1	this	this	DET
dti-2707	2	2	article	article	NOUN
dti-2707	2	3	is	be	AUX
dti-2707	2	4	published	publish	VERB
dti-2707	2	5	by	by	ADP
dti-2707	2	6	aboutscience	aboutscience	NOUN
dti-2707	2	7	and	and	CCONJ
dti-2707	2	8	licensed	license	VERB
dti-2707	2	9	under	under	ADP
dti-2707	2	10	creative	creative	ADJ
dti-2707	2	11	commons	common	NOUN
dti-2707	2	12	attribution	attribution	NOUN
dti-2707	2	13	-	-	PUNCT
dti-2707	2	14	noncommercial	noncommercial	ADJ
dti-2707	2	15	4.0	4.0	NUM
dti-2707	2	16	international	international	NOUN
dti-2707	2	17	(	(	PUNCT
dti-2707	2	18	cc	cc	NOUN
dti-2707	2	19	by	by	ADP
dti-2707	2	20	-	-	PUNCT
dti-2707	2	21	nc	nc	PROPN
dti-2707	2	22	4.0	4.0	NUM
dti-2707	2	23	)	)	PUNCT
dti-2707	2	24	.	.	PUNCT
dti-2707	3	1	commercial	commercial	ADJ
dti-2707	3	2	use	use	NOUN
dti-2707	3	3	is	be	AUX
dti-2707	3	4	not	not	PART
dti-2707	3	5	permitted	permit	VERB
dti-2707	3	6	and	and	CCONJ
dti-2707	3	7	is	be	AUX
dti-2707	3	8	subject	subject	ADJ
dti-2707	3	9	to	to	ADP
dti-2707	3	10	publisher	publisher	NOUN
dti-2707	3	11	’s	’s	PART
dti-2707	3	12	permissions	permission	NOUN
dti-2707	3	13	.	.	PUNCT
dti-2707	4	1	full	full	ADJ
dti-2707	4	2	information	information	NOUN
dti-2707	4	3	is	be	AUX
dti-2707	4	4	available	available	ADJ
dti-2707	4	5	at	at	ADP
dti-2707	4	6	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2707	4	7	article	article	NOUN
dti-2707	4	8	type	type	NOUN
dti-2707	4	9	:	:	PUNCT
dti-2707	4	10	original	original	ADJ
dti-2707	4	11	research	research	NOUN
dti-2707	4	12	article	article	NOUN
dti-2707	4	13	doi	doi	NOUN
dti-2707	4	14	:	:	PUNCT
dti-2707	4	15	10.33393	10.33393	NUM
dti-2707	4	16	/	/	SYM
dti-2707	4	17	dti.2024.2670	dti.2024.2670	NOUN
dti-2707	4	18	(	(	PUNCT
dti-2707	4	19	link	link	VERB
dti-2707	4	20	to	to	ADP
dti-2707	4	21	https://doi.org/10.33393/	https://doi.org/10.33393/	PROPN
dti-2707	4	22	dti.2024.2670	dti.2024.2670	NOUN
dti-2707	4	23	)	)	PUNCT
dti-2707	4	24	short	short	ADJ
dti-2707	4	25	title	title	NOUN
dti-2707	4	26	:	:	PUNCT
dti-2707	4	27	(	(	PUNCT
dti-2707	4	28	a	a	X
dti-2707	4	29	:	:	PUNCT
dti-2707	4	30	please	please	INTJ
dti-2707	4	31	provide	provide	VERB
dti-2707	4	32	)	)	PUNCT
dti-2707	4	33	molecular	molecular	ADJ
dti-2707	4	34	targets	target	NOUN
dti-2707	4	35	and	and	CCONJ
dti-2707	4	36	therapeutic	therapeutic	ADJ
dti-2707	4	37	potential	potential	NOUN
dti-2707	4	38	of	of	ADP
dti-2707	4	39	baicalein	baicalein	PROPN
dti-2707	4	40	:	:	PUNCT
dti-2707	4	41	a	a	DET
dti-2707	4	42	review	review	NOUN
dti-2707	4	43	kavita	kavita	PROPN
dti-2707	4	44	munjal1	munjal1	PROPN
dti-2707	4	45	,	,	PUNCT
dti-2707	4	46	yash	yash	PROPN
dti-2707	4	47	goel2	goel2	PROPN
dti-2707	4	48	,	,	PUNCT
dti-2707	4	49	vinod	vinod	PROPN
dti-2707	4	50	kumar	kumar	PROPN
dti-2707	4	51	gauttam	gauttam	PROPN
dti-2707	4	52	3	3	NUM
dti-2707	4	53	,	,	PUNCT
dti-2707	4	54	hitesh	hitesh	PROPN
dti-2707	4	55	chopra	chopra	PROPN
dti-2707	4	56	4	4	NUM
dti-2707	4	57	,	,	PUNCT
dti-2707	4	58	madhav	madhav	PROPN
dti-2707	4	59	singla5	singla5	PROPN
dti-2707	4	60	,	,	PUNCT
dti-2707	4	61	smriti	smriti	PROPN
dti-2707	4	62	5	5	NUM
dti-2707	4	63	,	,	PUNCT
dti-2707	4	64	saurabh	saurabh	PROPN
dti-2707	4	65	gupta	gupta	PROPN
dti-2707	4	66	6	6	NUM
dti-2707	4	67	,	,	PUNCT
dti-2707	4	68	rohit	rohit	PROPN
dti-2707	4	69	sharma	sharma	PROPN
dti-2707	4	70	7	7	NUM
dti-2707	4	71	1department	1department	NUM
dti-2707	4	72	of	of	ADP
dti-2707	4	73	pharmacognosy	pharmacognosy	NOUN
dti-2707	4	74	,	,	PUNCT
dti-2707	4	75	amity	amity	NOUN
dti-2707	4	76	institute	institute	NOUN
dti-2707	4	77	of	of	ADP
dti-2707	4	78	pharmacy	pharmacy	NOUN
dti-2707	4	79	,	,	PUNCT
dti-2707	4	80	amity	amity	NOUN
dti-2707	4	81	university	university	PROPN
dti-2707	4	82	,	,	PUNCT
dti-2707	4	83	noida	noida	PROPN
dti-2707	4	84	,	,	PUNCT
dti-2707	5	1	uttar	uttar	PROPN
dti-2707	5	2	pradesh	pradesh	PROPN
dti-2707	5	3	india	india	PROPN
dti-2707	5	4	2department	2department	PROPN
dti-2707	5	5	of	of	ADP
dti-2707	5	6	pharmacy	pharmacy	NOUN
dti-2707	5	7	,	,	PUNCT
dti-2707	5	8	m.m	m.m	PROPN
dti-2707	5	9	.	.	PROPN
dti-2707	5	10	college	college	PROPN
dti-2707	5	11	of	of	ADP
dti-2707	5	12	pharmacy	pharmacy	NOUN
dti-2707	5	13	,	,	PUNCT
dti-2707	5	14	m.m	m.m	PROPN
dti-2707	5	15	.	.	PROPN
dti-2707	5	16	(	(	PUNCT
dti-2707	5	17	deemed	deem	VERB
dti-2707	5	18	to	to	PART
dti-2707	5	19	be	be	AUX
dti-2707	5	20	university	university	NOUN
dti-2707	5	21	)	)	PUNCT
dti-2707	5	22	,	,	PUNCT
dti-2707	5	23	mullana	mullana	PROPN
dti-2707	5	24	,	,	PUNCT
dti-2707	5	25	ambala	ambala	PROPN
dti-2707	5	26	,	,	PUNCT
dti-2707	5	27	haryana	haryana	PROPN
dti-2707	5	28	india	india	PROPN
dti-2707	5	29	3	3	NUM
dti-2707	5	30	#	#	NOUN
dti-2707	5	31	department	department	NOUN
dti-2707	5	32	of	of	ADP
dti-2707	5	33	pharmacognosy	pharmacognosy	NOUN
dti-2707	5	34	,	,	PUNCT
dti-2707	5	35	shiva	shiva	PROPN
dti-2707	5	36	institute	institute	PROPN
dti-2707	5	37	of	of	ADP
dti-2707	5	38	pharmacy	pharmacy	PROPN
dti-2707	5	39	,	,	PUNCT
dti-2707	5	40	bilaspur	bilaspur	PROPN
dti-2707	5	41	,	,	PUNCT
dti-2707	5	42	himachal	himachal	PROPN
dti-2707	5	43	pradesh	pradesh	PROPN
dti-2707	5	44	india	india	PROPN
dti-2707	5	45	4	4	PROPN
dti-2707	5	46	department	department	PROPN
dti-2707	5	47	of	of	ADP
dti-2707	5	48	biosciences	bioscience	NOUN
dti-2707	5	49	,	,	PUNCT
dti-2707	5	50	saveetha	saveetha	PROPN
dti-2707	5	51	school	school	PROPN
dti-2707	5	52	of	of	ADP
dti-2707	5	53	engineering	engineering	PROPN
dti-2707	5	54	,	,	PUNCT
dti-2707	5	55	saveetha	saveetha	PROPN
dti-2707	5	56	institute	institute	PROPN
dti-2707	5	57	of	of	ADP
dti-2707	5	58	medical	medical	ADJ
dti-2707	5	59	and	and	CCONJ
dti-2707	5	60	technical	technical	ADJ
dti-2707	5	61	sciences	science	NOUN
dti-2707	5	62	,	,	PUNCT
dti-2707	5	63	chennai	chennai	PROPN
dti-2707	5	64	,	,	PUNCT
dti-2707	5	65	tamil	tamil	PROPN
dti-2707	5	66	nadu	nadu	PROPN
dti-2707	5	67	india	india	PROPN
dti-2707	6	1	5department	5department	PROPN
dti-2707	6	2	of	of	ADP
dti-2707	6	3	pharmacy	pharmacy	NOUN
dti-2707	6	4	,	,	PUNCT
dti-2707	6	5	chitkara	chitkara	PROPN
dti-2707	6	6	college	college	NOUN
dti-2707	6	7	of	of	ADP
dti-2707	6	8	pharmacy	pharmacy	NOUN
dti-2707	6	9	,	,	PUNCT
dti-2707	6	10	chitkara	chitkara	ADJ
dti-2707	6	11	university	university	NOUN
dti-2707	6	12	,	,	PUNCT
dti-2707	6	13	rajpura	rajpura	NOUN
dti-2707	6	14	,	,	PUNCT
dti-2707	6	15	punjab	punjab	ADJ
dti-2707	6	16	india	india	PROPN
dti-2707	6	17	6department	6department	NUM
dti-2707	6	18	of	of	ADP
dti-2707	6	19	pharmacology	pharmacology	NOUN
dti-2707	6	20	,	,	PUNCT
dti-2707	6	21	chameli	chameli	PROPN
dti-2707	6	22	devi	devi	PROPN
dti-2707	6	23	institute	institute	PROPN
dti-2707	6	24	of	of	ADP
dti-2707	6	25	pharmacy	pharmacy	PROPN
dti-2707	6	26	,	,	PUNCT
dti-2707	6	27	indore	indore	PROPN
dti-2707	6	28	,	,	PUNCT
dti-2707	6	29	madhya	madhya	PROPN
dti-2707	6	30	pradesh	pradesh	PROPN
dti-2707	6	31	india	india	PROPN
dti-2707	6	32	7	7	NUM
dti-2707	6	33	department	department	PROPN
dti-2707	6	34	of	of	ADP
dti-2707	6	35	rasa	rasa	PROPN
dti-2707	6	36	shastra	shastra	PROPN
dti-2707	6	37	and	and	CCONJ
dti-2707	6	38	bhaishajya	bhaishajya	NOUN
dti-2707	6	39	kalpana	kalpana	PROPN
dti-2707	6	40	,	,	PUNCT
dti-2707	6	41	faculty	faculty	NOUN
dti-2707	6	42	of	of	ADP
dti-2707	6	43	ayurveda	ayurveda	PROPN
dti-2707	6	44	,	,	PUNCT
dti-2707	6	45	institute	institute	NOUN
dti-2707	6	46	of	of	ADP
dti-2707	6	47	medical	medical	PROPN
dti-2707	6	48	sciences	sciences	PROPN
dti-2707	6	49	,	,	PUNCT
dti-2707	6	50	banaras	banaras	PROPN
dti-2707	6	51	hindu	hindu	PROPN
dti-2707	6	52	university	university	PROPN
dti-2707	6	53	,	,	PUNCT
dti-2707	6	54	varanasi	varanasi	PROPN
dti-2707	6	55	,	,	PUNCT
dti-2707	6	56	uttar	uttar	PROPN
dti-2707	6	57	pradesh	pradesh	PROPN
dti-2707	6	58	india	india	PROPN
dti-2707	6	59	abstract	abstract	PROPN
dti-2707	6	60	aim	aim	VERB
dti-2707	6	61	:	:	PUNCT
dti-2707	6	62	researchers	researcher	NOUN
dti-2707	6	63	using	use	VERB
dti-2707	6	64	herbs	herb	NOUN
dti-2707	6	65	and	and	CCONJ
dti-2707	6	66	natural	natural	ADJ
dti-2707	6	67	products	product	NOUN
dti-2707	6	68	to	to	PART
dti-2707	6	69	find	find	VERB
dti-2707	6	70	new	new	ADJ
dti-2707	6	71	drugs	drug	NOUN
dti-2707	6	72	often	often	ADV
dti-2707	6	73	prefer	prefer	VERB
dti-2707	6	74	flavonoids	flavonoid	NOUN
dti-2707	6	75	because	because	SCONJ
dti-2707	6	76	of	of	ADP
dti-2707	6	77	their	their	PRON
dti-2707	6	78	potential	potential	NOUN
dti-2707	6	79	as	as	ADP
dti-2707	6	80	antioxidants	antioxidant	NOUN
dti-2707	6	81	and	and	CCONJ
dti-2707	6	82	anti	anti	NOUN
dti-2707	6	83	-	-	NOUN
dti-2707	6	84	inflammatories	inflammatorie	NOUN
dti-2707	6	85	.	.	PUNCT
dti-2707	7	1	the	the	DET
dti-2707	7	2	planned	plan	VERB
dti-2707	7	3	review	review	NOUN
dti-2707	7	4	addressed	address	VERB
dti-2707	7	5	baicalein	baicalein	PROPN
dti-2707	7	6	research	research	NOUN
dti-2707	7	7	findings	finding	NOUN
dti-2707	7	8	in	in	ADP
dti-2707	7	9	detail	detail	NOUN
dti-2707	7	10	.	.	PUNCT
dti-2707	8	1	this	this	DET
dti-2707	8	2	manuscript	manuscript	NOUN
dti-2707	8	3	provides	provide	VERB
dti-2707	8	4	a	a	DET
dti-2707	8	5	complete	complete	ADJ
dti-2707	8	6	review	review	NOUN
dti-2707	8	7	of	of	ADP
dti-2707	8	8	baicalein	baicalein	PROPN
dti-2707	8	9	’s	’s	PART
dti-2707	8	10	potential	potential	ADJ
dti-2707	8	11	pharmacological	pharmacological	ADJ
dti-2707	8	12	effects	effect	NOUN
dti-2707	8	13	along	along	ADP
dti-2707	8	14	with	with	ADP
dti-2707	8	15	several	several	ADJ
dti-2707	8	16	molecular	molecular	ADJ
dti-2707	8	17	targets	target	NOUN
dti-2707	8	18	for	for	ADP
dti-2707	8	19	better	well	ADJ
dti-2707	8	20	understanding	understanding	NOUN
dti-2707	8	21	of	of	ADP
dti-2707	8	22	its	its	PRON
dti-2707	8	23	therapeutic	therapeutic	ADJ
dti-2707	8	24	activities	activity	NOUN
dti-2707	8	25	.	.	PUNCT
dti-2707	9	1	materials	material	NOUN
dti-2707	9	2	and	and	CCONJ
dti-2707	9	3	methods	method	NOUN
dti-2707	9	4	:	:	PUNCT
dti-2707	9	5	we	we	PRON
dti-2707	9	6	targeted	target	VERB
dti-2707	9	7	the	the	DET
dti-2707	9	8	review	review	NOUN
dti-2707	9	9	on	on	ADP
dti-2707	9	10	in	in	ADP
dti-2707	9	11	vitro	vitro	X
dti-2707	9	12	and	and	CCONJ
dti-2707	9	13	in	in	ADP
dti-2707	9	14	vivo	vivo	ADJ
dti-2707	9	15	studies	study	NOUN
dti-2707	9	16	reported	report	VERB
dti-2707	9	17	on	on	ADP
dti-2707	9	18	baicalein	baicalein	PROPN
dti-2707	9	19	.	.	PUNCT
dti-2707	10	1	for	for	ADP
dti-2707	10	2	this	this	PRON
dti-2707	10	3	,	,	PUNCT
dti-2707	10	4	the	the	DET
dti-2707	10	5	literature	literature	NOUN
dti-2707	10	6	is	be	AUX
dti-2707	10	7	gathered	gather	VERB
dti-2707	10	8	from	from	ADP
dti-2707	10	9	the	the	DET
dti-2707	10	10	database	database	NOUN
dti-2707	10	11	available	available	ADJ
dti-2707	10	12	on	on	ADP
dti-2707	10	13	search	search	NOUN
dti-2707	10	14	engines	engine	NOUN
dti-2707	10	15	like	like	ADP
dti-2707	10	16	pubmed	pubmed	PROPN
dti-2707	10	17	,	,	PUNCT
dti-2707	10	18	sciencedirect	sciencedirect	PROPN
dti-2707	10	19	,	,	PUNCT
dti-2707	10	20	scopus	scopus	PROPN
dti-2707	10	21	,	,	PUNCT
dti-2707	10	22	and	and	CCONJ
dti-2707	10	23	google	google	PROPN
dti-2707	10	24	scholar	scholar	NOUN
dti-2707	10	25	up	up	ADV
dti-2707	10	26	to	to	PART
dti-2707	10	27	21	21	NUM
dti-2707	10	28	december	december	PROPN
dti-2707	10	29	2023	2023	NUM
dti-2707	10	30	.	.	PUNCT
dti-2707	11	1	the	the	DET
dti-2707	11	2	keywords	keyword	NOUN
dti-2707	11	3	“	"	PUNCT
dti-2707	11	4	scutellaria	scutellaria	NOUN
dti-2707	11	5	baicalensis	baicalensis	NOUN
dti-2707	11	6	”	"	PUNCT
dti-2707	11	7	,	,	PUNCT
dti-2707	11	8	“	"	PUNCT
dti-2707	11	9	oroxylum	oroxylum	VERB
dti-2707	11	10	indicum	indicum	NOUN
dti-2707	11	11	”	"	PUNCT
dti-2707	11	12	,	,	PUNCT
dti-2707	11	13	“	"	PUNCT
dti-2707	11	14	neuroprotective	neuroprotective	ADJ
dti-2707	11	15	”	"	PUNCT
dti-2707	11	16	,	,	PUNCT
dti-2707	11	17	“	"	PUNCT
dti-2707	11	18	cardioprotective	cardioprotective	ADJ
dti-2707	11	19	”	"	PUNCT
dti-2707	11	20	,	,	PUNCT
dti-2707	11	21	“	"	PUNCT
dti-2707	11	22	toxicity	toxicity	NOUN
dti-2707	11	23	studies	study	NOUN
dti-2707	11	24	”	"	PUNCT
dti-2707	11	25	,	,	PUNCT
dti-2707	11	26	and	and	CCONJ
dti-2707	11	27	“	"	PUNCT
dti-2707	11	28	baicalein	baicalein	PROPN
dti-2707	11	29	”	"	PUNCT
dti-2707	11	30	were	be	AUX
dti-2707	11	31	used	use	VERB
dti-2707	11	32	to	to	PART
dti-2707	11	33	fetch	fetch	VERB
dti-2707	11	34	the	the	DET
dti-2707	11	35	content	content	NOUN
dti-2707	11	36	.	.	PUNCT
dti-2707	12	1	results	result	NOUN
dti-2707	12	2	:	:	PUNCT
dti-2707	12	3	baicalein	baicalein	PROPN
dti-2707	12	4	’s	’s	PART
dti-2707	12	5	molecular	molecular	ADJ
dti-2707	12	6	receptor	receptor	NOUN
dti-2707	12	7	binding	bind	VERB
dti-2707	12	8	approach	approach	NOUN
dti-2707	12	9	has	have	AUX
dti-2707	12	10	shown	show	VERB
dti-2707	12	11	anticancer	anticancer	NOUN
dti-2707	12	12	,	,	PUNCT
dti-2707	12	13	antidiabetic	antidiabetic	ADJ
dti-2707	12	14	,	,	PUNCT
dti-2707	12	15	antimicrobial	antimicrobial	ADJ
dti-2707	12	16	,	,	PUNCT
dti-2707	12	17	antiaging	antiage	VERB
dti-2707	12	18	,	,	PUNCT
dti-2707	12	19	neuroprotective	neuroprotective	ADJ
dti-2707	12	20	,	,	PUNCT
dti-2707	12	21	cardioprotective	cardioprotective	ADJ
dti-2707	12	22	,	,	PUNCT
dti-2707	12	23	respiratory	respiratory	ADJ
dti-2707	12	24	protective	protective	ADJ
dti-2707	12	25	,	,	PUNCT
dti-2707	12	26	gastroprotective	gastroprotective	NOUN
dti-2707	12	27	,	,	PUNCT
dti-2707	12	28	hepatic	hepatic	ADJ
dti-2707	12	29	protective	protective	NOUN
dti-2707	12	30	,	,	PUNCT
dti-2707	12	31	and	and	CCONJ
dti-2707	12	32	renal	renal	ADJ
dti-2707	12	33	protective	protective	ADJ
dti-2707	12	34	effects	effect	NOUN
dti-2707	12	35	.	.	PUNCT
dti-2707	13	1	the	the	DET
dti-2707	13	2	synergistic	synergistic	ADJ
dti-2707	13	3	effects	effect	NOUN
dti-2707	13	4	of	of	ADP
dti-2707	13	5	this	this	DET
dti-2707	13	6	drug	drug	NOUN
dti-2707	13	7	with	with	ADP
dti-2707	13	8	other	other	ADJ
dti-2707	13	9	selective	selective	ADJ
dti-2707	13	10	herbs	herb	NOUN
dti-2707	13	11	are	be	AUX
dti-2707	13	12	also	also	ADV
dti-2707	13	13	contributed	contribute	VERB
dti-2707	13	14	towards	towards	ADP
dti-2707	13	15	significant	significant	ADJ
dti-2707	13	16	therapeutic	therapeutic	ADJ
dti-2707	13	17	potential	potential	NOUN
dti-2707	13	18	.	.	PUNCT
dti-2707	14	1	conclusion	conclusion	NOUN
dti-2707	14	2	:	:	PUNCT
dti-2707	14	3	this	this	DET
dti-2707	14	4	systematic	systematic	ADJ
dti-2707	14	5	review	review	NOUN
dti-2707	14	6	article	article	NOUN
dti-2707	14	7	from	from	ADP
dti-2707	14	8	a	a	DET
dti-2707	14	9	contemporary	contemporary	ADJ
dti-2707	14	10	and	and	CCONJ
dti-2707	14	11	scientific	scientific	ADJ
dti-2707	14	12	perspective	perspective	NOUN
dti-2707	14	13	offers	offer	VERB
dti-2707	14	14	fresh	fresh	ADJ
dti-2707	14	15	insight	insight	NOUN
dti-2707	14	16	into	into	ADP
dti-2707	14	17	s.	s.	PROPN
dti-2707	14	18	baicalensis	baicalensis	PROPN
dti-2707	14	19	,	,	PUNCT
dti-2707	14	20	o.	o.	NOUN
dti-2707	14	21	indicum	indicum	PROPN
dti-2707	14	22	,	,	PUNCT
dti-2707	14	23	and	and	CCONJ
dti-2707	14	24	its	its	PRON
dti-2707	14	25	bioactive	bioactive	PROPN
dti-2707	14	26	component	component	NOUN
dti-2707	14	27	baicalein	baicalein	NOUN
dti-2707	14	28	as	as	ADP
dti-2707	14	29	a	a	DET
dti-2707	14	30	potential	potential	ADJ
dti-2707	14	31	complementary	complementary	ADJ
dti-2707	14	32	medicine	medicine	NOUN
dti-2707	14	33	.	.	PUNCT
dti-2707	15	1	baicalein	baicalein	PROPN
dti-2707	15	2	may	may	AUX
dti-2707	15	3	be	be	AUX
dti-2707	15	4	transformed	transform	VERB
dti-2707	15	5	into	into	ADP
dti-2707	15	6	more	more	ADV
dti-2707	15	7	efficacious	efficacious	ADJ
dti-2707	15	8	and	and	CCONJ
dti-2707	15	9	acceptable	acceptable	ADJ
dti-2707	15	10	evidence	evidence	NOUN
dti-2707	15	11	-	-	PUNCT
dti-2707	15	12	based	base	VERB
dti-2707	15	13	medicine	medicine	NOUN
dti-2707	15	14	.	.	PUNCT
dti-2707	16	1	however	however	ADV
dti-2707	16	2	,	,	PUNCT
dti-2707	16	3	we	we	PRON
dti-2707	16	4	recommend	recommend	VERB
dti-2707	16	5	more	more	ADV
dti-2707	16	6	clinical	clinical	ADJ
dti-2707	16	7	and	and	CCONJ
dti-2707	16	8	mechanistic	mechanistic	ADJ
dti-2707	16	9	approaches	approach	NOUN
dti-2707	16	10	to	to	PART
dti-2707	16	11	confirm	confirm	VERB
dti-2707	16	12	safety	safety	NOUN
dti-2707	16	13	and	and	CCONJ
dti-2707	16	14	efficacy	efficacy	NOUN
dti-2707	16	15	of	of	ADP
dti-2707	16	16	baicalein	baicalein	PROPN
dti-2707	16	17	.	.	PUNCT
dti-2707	17	1	keywords	keyword	NOUN
dti-2707	17	2	:	:	PUNCT
dti-2707	17	3	alzheimer	alzheimer	PROPN
dti-2707	17	4	’s	’s	PROPN
dti-2707	17	5	,	,	PUNCT
dti-2707	17	6	baicalein	baicalein	PROPN
dti-2707	17	7	,	,	PUNCT
dti-2707	17	8	cancer	cancer	NOUN
dti-2707	17	9	,	,	PUNCT
dti-2707	17	10	epilepsy	epilepsy	NOUN
dti-2707	17	11	,	,	PUNCT
dti-2707	17	12	heart	heart	NOUN
dti-2707	17	13	failure	failure	NOUN
dti-2707	17	14	,	,	PUNCT
dti-2707	17	15	hypertension	hypertension	NOUN
dti-2707	17	16	,	,	PUNCT
dti-2707	17	17	parkinson	parkinson	NOUN
dti-2707	17	18	,	,	PUNCT
dti-2707	17	19	stroke	stroke	NOUN
dti-2707	17	20	received	receive	VERB
dti-2707	17	21	:	:	PUNCT
dti-2707	17	22	november	november	PROPN
dti-2707	17	23	6	6	NUM
dti-2707	17	24	,	,	PUNCT
dti-2707	17	25	2023	2023	NUM
dti-2707	17	26	accepted	accept	VERB
dti-2707	17	27	:	:	PUNCT
dti-2707	17	28	january	january	PROPN
dti-2707	17	29	11	11	NUM
dti-2707	17	30	,	,	PUNCT
dti-2707	17	31	2024	2024	NUM
dti-2707	17	32	published	publish	VERB
dti-2707	17	33	online	online	ADV
dti-2707	17	34	:	:	PUNCT
dti-2707	17	35	june	june	PROPN
dti-2707	17	36	6	6	NUM
dti-2707	17	37	,	,	PUNCT
dti-2707	17	38	2024	2024	NUM
dti-2707	17	39	corresponding	correspond	VERB
dti-2707	17	40	author	author	NOUN
dti-2707	17	41	:	:	PUNCT
dti-2707	17	42	rohit	rohit	PROPN
dti-2707	17	43	sharma	sharma	PROPN
dti-2707	17	44	email	email	NOUN
dti-2707	17	45	:	:	PUNCT
dti-2707	17	46	rohitsharma@bhu.ac.in	rohitsharma@bhu.ac.in	PROPN
dti-2707	17	47	hitesh	hitesh	PROPN
dti-2707	17	48	chopra	chopra	PROPN
dti-2707	17	49	email	email	NOUN
dti-2707	17	50	:	:	PUNCT
dti-2707	17	51	chopraontheride@gmail.com	chopraontheride@gmail.com	PROPN
dti-2707	17	52	baicalensis	baicalensis	NOUN
dti-2707	17	53	and	and	CCONJ
dti-2707	17	54	oroxylum	oroxylum	VERB
dti-2707	17	55	indicum	indicum	NOUN
dti-2707	17	56	.	.	PUNCT
dti-2707	18	1	s.	s.	PROPN
dti-2707	18	2	baicalensis	baicalensis	PROPN
dti-2707	18	3	georgi	georgi	PROPN
dti-2707	18	4	,	,	PUNCT
dti-2707	18	5	a	a	DET
dti-2707	18	6	member	member	NOUN
dti-2707	18	7	of	of	ADP
dti-2707	18	8	the	the	DET
dti-2707	18	9	lamiaceae	lamiaceae	PROPN
dti-2707	18	10	family	family	NOUN
dti-2707	18	11	,	,	PUNCT
dti-2707	18	12	stands	stand	VERB
dti-2707	18	13	as	as	ADP
dti-2707	18	14	one	one	NUM
dti-2707	18	15	of	of	ADP
dti-2707	18	16	the	the	DET
dti-2707	18	17	pharmacologically	pharmacologically	ADV
dti-2707	18	18	significant	significant	ADJ
dti-2707	18	19	species	specie	NOUN
dti-2707	18	20	of	of	ADP
dti-2707	18	21	flowering	flower	VERB
dti-2707	18	22	plant	plant	NOUN
dti-2707	18	23	.	.	PUNCT
dti-2707	19	1	the	the	DET
dti-2707	19	2	herbaceous	herbaceous	ADJ
dti-2707	19	3	perennial	perennial	NOUN
dti-2707	19	4	under	under	ADP
dti-2707	19	5	investigation	investigation	NOUN
dti-2707	19	6	exhibits	exhibit	VERB
dti-2707	19	7	distinct	distinct	ADJ
dti-2707	19	8	characteristics	characteristic	NOUN
dti-2707	19	9	that	that	PRON
dti-2707	19	10	contribute	contribute	VERB
dti-2707	19	11	to	to	ADP
dti-2707	19	12	its	its	PRON
dti-2707	19	13	overall	overall	ADJ
dti-2707	19	14	appeal	appeal	NOUN
dti-2707	19	15	.	.	PUNCT
dti-2707	20	1	its	its	PRON
dti-2707	20	2	papery	papery	NOUN
dti-2707	20	3	leaves	leave	NOUN
dti-2707	20	4	,	,	PUNCT
dti-2707	20	5	thick	thick	ADJ
dti-2707	20	6	roots	root	NOUN
dti-2707	20	7	,	,	PUNCT
dti-2707	20	8	and	and	CCONJ
dti-2707	20	9	branching	branch	VERB
dti-2707	20	10	stems	stem	NOUN
dti-2707	20	11	provide	provide	VERB
dti-2707	20	12	a	a	DET
dti-2707	20	13	sturdy	sturdy	ADJ
dti-2707	20	14	foundation	foundation	NOUN
dti-2707	20	15	for	for	ADP
dti-2707	20	16	its	its	PRON
dti-2707	20	17	growth	growth	NOUN
dti-2707	20	18	and	and	CCONJ
dti-2707	20	19	development	development	NOUN
dti-2707	20	20	.	.	PUNCT
dti-2707	21	1	additionally	additionally	ADV
dti-2707	21	2	,	,	PUNCT
dti-2707	21	3	the	the	DET
dti-2707	21	4	vibrant	vibrant	ADJ
dti-2707	21	5	purple	purple	ADJ
dti-2707	21	6	-	-	PUNCT
dti-2707	21	7	red	red	ADJ
dti-2707	21	8	to	to	ADP
dti-2707	21	9	blue	blue	ADJ
dti-2707	21	10	blooms	bloom	NOUN
dti-2707	21	11	add	add	VERB
dti-2707	21	12	a	a	DET
dti-2707	21	13	touch	touch	NOUN
dti-2707	21	14	of	of	ADP
dti-2707	21	15	elegance	elegance	NOUN
dti-2707	21	16	and	and	CCONJ
dti-2707	21	17	beauty	beauty	NOUN
dti-2707	21	18	to	to	ADP
dti-2707	21	19	its	its	PRON
dti-2707	21	20	appearance	appearance	NOUN
dti-2707	21	21	.	.	PUNCT
dti-2707	22	1	the	the	DET
dti-2707	22	2	presence	presence	NOUN
dti-2707	22	3	of	of	ADP
dti-2707	22	4	black	black	ADJ
dti-2707	22	5	-	-	PUNCT
dti-2707	22	6	brown	brown	ADJ
dti-2707	22	7	ovoid	ovoid	ADJ
dti-2707	22	8	nutlets	nutlet	NOUN
dti-2707	22	9	further	far	ADV
dti-2707	22	10	enhance	enhance	VERB
dti-2707	22	11	its	its	PRON
dti-2707	22	12	appearance	appearance	NOUN
dti-2707	22	13	.	.	PUNCT
dti-2707	23	1	traditional	traditional	ADJ
dti-2707	23	2	chinese	chinese	ADJ
dti-2707	23	3	medicine	medicine	NOUN
dti-2707	23	4	has	have	VERB
dti-2707	23	5	a	a	DET
dti-2707	23	6	rich	rich	ADJ
dti-2707	23	7	history	history	NOUN
dti-2707	23	8	of	of	ADP
dti-2707	23	9	utilization	utilization	NOUN
dti-2707	23	10	and	and	CCONJ
dti-2707	23	11	continues	continue	VERB
dti-2707	23	12	to	to	PART
dti-2707	23	13	be	be	AUX
dti-2707	23	14	widely	widely	ADV
dti-2707	23	15	practiced	practice	VERB
dti-2707	23	16	.	.	PUNCT
dti-2707	24	1	the	the	DET
dti-2707	24	2	cultivation	cultivation	NOUN
dti-2707	24	3	of	of	ADP
dti-2707	24	4	this	this	DET
dti-2707	24	5	particular	particular	ADJ
dti-2707	24	6	plant	plant	NOUN
dti-2707	24	7	species	specie	NOUN
dti-2707	24	8	has	have	AUX
dti-2707	24	9	been	be	AUX
dti-2707	24	10	observed	observe	VERB
dti-2707	24	11	in	in	ADP
dti-2707	24	12	various	various	ADJ
dti-2707	24	13	regions	region	NOUN
dti-2707	24	14	,	,	PUNCT
dti-2707	24	15	including	include	VERB
dti-2707	24	16	eastern	eastern	ADJ
dti-2707	24	17	russia	russia	PROPN
dti-2707	24	18	,	,	PUNCT
dti-2707	24	19	japan	japan	PROPN
dti-2707	24	20	,	,	PUNCT
dti-2707	24	21	china	china	PROPN
dti-2707	24	22	,	,	PUNCT
dti-2707	24	23	siberia	siberia	PROPN
dti-2707	24	24	,	,	PUNCT
dti-2707	24	25	mongolia	mongolia	PROPN
dti-2707	24	26	,	,	PUNCT
dti-2707	24	27	and	and	CCONJ
dti-2707	24	28	korea	korea	PROPN
dti-2707	24	29	.	.	PUNCT
dti-2707	25	1	in	in	ADP
dti-2707	25	2	addition	addition	NOUN
dti-2707	25	3	to	to	ADP
dti-2707	25	4	the	the	DET
dti-2707	25	5	well	well	ADV
dti-2707	25	6	-	-	PUNCT
dti-2707	25	7	known	know	VERB
dti-2707	25	8	chinese	chinese	ADJ
dti-2707	25	9	medicinal	medicinal	ADJ
dti-2707	25	10	ingredients	ingredient	NOUN
dti-2707	25	11	,	,	PUNCT
dti-2707	25	12	various	various	ADJ
dti-2707	25	13	scutellaria	scutellaria	NOUN
dti-2707	25	14	species	specie	NOUN
dti-2707	25	15	including	include	VERB
dti-2707	25	16	s.	s.	PROPN
dti-2707	25	17	viscidula	viscidula	PROPN
dti-2707	25	18	,	,	PUNCT
dti-2707	25	19	s.	s.	PROPN
dti-2707	25	20	rehderiana	rehderiana	PROPN
dti-2707	25	21	,	,	PUNCT
dti-2707	25	22	s.	s.	PROPN
dti-2707	25	23	amoena	amoena	PROPN
dti-2707	25	24	,	,	PUNCT
dti-2707	25	25	s.	s.	PROPN
dti-2707	25	26	likiangensis	likiangensis	PROPN
dti-2707	25	27	,	,	PUNCT
dti-2707	25	28	and	and	CCONJ
dti-2707	25	29	s.	s.	PROPN
dti-2707	25	30	hypericifolia	hypericifolia	PROPN
dti-2707	25	31	have	have	AUX
dti-2707	25	32	also	also	ADV
dti-2707	25	33	introduction	introduction	NOUN
dti-2707	25	34	baicalein	baicalein	PROPN
dti-2707	25	35	,	,	PUNCT
dti-2707	25	36	a	a	DET
dti-2707	25	37	flavone	flavone	NOUN
dti-2707	25	38	compound	compound	NOUN
dti-2707	25	39	,	,	PUNCT
dti-2707	25	40	is	be	AUX
dti-2707	25	41	widely	widely	ADV
dti-2707	25	42	recognized	recognize	VERB
dti-2707	25	43	in	in	ADP
dti-2707	25	44	chinese	chinese	ADJ
dti-2707	25	45	traditional	traditional	ADJ
dti-2707	25	46	medicine	medicine	NOUN
dti-2707	25	47	as	as	ADP
dti-2707	25	48	huang	huang	PROPN
dti-2707	25	49	-	-	PUNCT
dti-2707	25	50	qin	qin	PROPN
dti-2707	25	51	or	or	CCONJ
dti-2707	25	52	chinese	chinese	ADJ
dti-2707	25	53	skullcap	skullcap	NOUN
dti-2707	25	54	(	(	PUNCT
dti-2707	25	55	1	1	NUM
dti-2707	25	56	)	)	PUNCT
dti-2707	25	57	.	.	PUNCT
dti-2707	26	1	recent	recent	ADJ
dti-2707	26	2	research	research	NOUN
dti-2707	26	3	has	have	AUX
dti-2707	26	4	revealed	reveal	VERB
dti-2707	26	5	the	the	DET
dti-2707	26	6	therapeutic	therapeutic	ADJ
dti-2707	26	7	significance	significance	NOUN
dti-2707	26	8	and	and	CCONJ
dti-2707	26	9	pharmacological	pharmacological	ADJ
dti-2707	26	10	findings	finding	NOUN
dti-2707	26	11	of	of	ADP
dti-2707	26	12	roots	root	NOUN
dti-2707	26	13	of	of	ADP
dti-2707	26	14	scutellaria	scutellaria	NOUN
dti-2707	26	15	https://doi.org/10.33393/dti.2024.2707	https://doi.org/10.33393/dti.2024.2707	PROPN
dti-2707	26	16	https://doi.org/dti.2022.2522	https://doi.org/dti.2022.2522	PROPN
dti-2707	26	17	https://creativecommons.org/licenses/by-nc/4.0/legalcode	https://creativecommons.org/licenses/by-nc/4.0/legalcode	NOUN
dti-2707	26	18	https://doi.org/10.33393/dti.2024.2670	https://doi.org/10.33393/dti.2024.2670	VERB
dti-2707	26	19	https://doi.org/10.33393/dti.2024.2670	https://doi.org/10.33393/dti.2024.2670	VERB
dti-2707	26	20	https://orcid.org/0000-0002-9796-170x	https://orcid.org/0000-0002-9796-170x	PROPN
dti-2707	26	21	https://orcid.org/0000-0001-8867-7603	https://orcid.org/0000-0001-8867-7603	PROPN
dti-2707	26	22	https://orcid.org/0000-0003-0720-5650	https://orcid.org/0000-0003-0720-5650	PROPN
dti-2707	26	23	https://orcid.org/0000-0002-4783-0293	https://orcid.org/0000-0002-4783-0293	PROPN
dti-2707	26	24	https://orcid.org/0000-0002-3682-3573	https://orcid.org/0000-0002-3682-3573	ADP
dti-2707	26	25	mailto:rohitsharma@bhu.ac.in	mailto:rohitsharma@bhu.ac.in	NOUN
dti-2707	26	26	mailto:chopraontheride@gmail.com	mailto:chopraontheride@gmail.com	NOUN
dti-2707	26	27	munjal	munjal	VERB
dti-2707	26	28	et	et	PROPN
dti-2707	26	29	al	al	PROPN
dti-2707	26	30	drug	drug	PROPN
dti-2707	26	31	target	target	NOUN
dti-2707	26	32	insights	insight	NOUN
dti-2707	26	33	2024	2024	NUM
dti-2707	26	34	;	;	PUNCT
dti-2707	26	35	18	18	NUM
dti-2707	26	36	:	:	SYM
dti-2707	26	37	31	31	NUM
dti-2707	26	38	©	©	ADP
dti-2707	26	39	2024	2024	NUM
dti-2707	26	40	the	the	DET
dti-2707	26	41	authors	author	NOUN
dti-2707	26	42	.	.	PUNCT
dti-2707	27	1	published	publish	VERB
dti-2707	27	2	by	by	ADP
dti-2707	27	3	aboutscience	aboutscience	NOUN
dti-2707	27	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2707	27	5	been	be	AUX
dti-2707	27	6	utilized	utilize	VERB
dti-2707	27	7	as	as	ADP
dti-2707	27	8	huang	huang	PROPN
dti-2707	27	9	-	-	PUNCT
dti-2707	27	10	qin	qin	PROPN
dti-2707	27	11	in	in	ADP
dti-2707	27	12	different	different	ADJ
dti-2707	27	13	regions	region	NOUN
dti-2707	27	14	(	(	PUNCT
dti-2707	27	15	2	2	NUM
dti-2707	27	16	)	)	PUNCT
dti-2707	27	17	.	.	PUNCT
dti-2707	28	1	there	there	PRON
dti-2707	28	2	are	be	VERB
dti-2707	28	3	several	several	ADJ
dti-2707	28	4	ways	way	NOUN
dti-2707	28	5	available	available	ADJ
dti-2707	28	6	for	for	ADP
dti-2707	28	7	extracting	extract	VERB
dti-2707	28	8	baicalein	baicalein	NOUN
dti-2707	28	9	,	,	PUNCT
dti-2707	28	10	as	as	SCONJ
dti-2707	28	11	shown	show	VERB
dti-2707	28	12	in	in	ADP
dti-2707	28	13	table	table	NOUN
dti-2707	28	14	1	1	NUM
dti-2707	28	15	.	.	PUNCT
dti-2707	29	1	the	the	DET
dti-2707	29	2	auxiliary	auxiliary	ADJ
dti-2707	29	3	extraction	extraction	NOUN
dti-2707	29	4	methodology	methodology	NOUN
dti-2707	29	5	achieved	achieve	VERB
dti-2707	29	6	the	the	DET
dti-2707	29	7	maximum	maximum	ADJ
dti-2707	29	8	yield	yield	NOUN
dti-2707	29	9	while	while	SCONJ
dti-2707	29	10	extracting	extract	VERB
dti-2707	29	11	from	from	ADP
dti-2707	29	12	the	the	DET
dti-2707	29	13	roots	root	NOUN
dti-2707	29	14	of	of	ADP
dti-2707	29	15	scutellaria	scutellaria	NOUN
dti-2707	29	16	.	.	PUNCT
dti-2707	30	1	o.	o.	PROPN
dti-2707	30	2	indicum	indicum	PROPN
dti-2707	30	3	,	,	PUNCT
dti-2707	30	4	commonly	commonly	ADV
dti-2707	30	5	referred	refer	VERB
dti-2707	30	6	to	to	ADP
dti-2707	30	7	as	as	ADP
dti-2707	30	8	the	the	DET
dti-2707	30	9	indian	indian	ADJ
dti-2707	30	10	trumpet	trumpet	NOUN
dti-2707	30	11	flower	flower	NOUN
dti-2707	30	12	,	,	PUNCT
dti-2707	30	13	has	have	AUX
dti-2707	30	14	received	receive	VERB
dti-2707	30	15	significant	significant	ADJ
dti-2707	30	16	attention	attention	NOUN
dti-2707	30	17	in	in	ADP
dti-2707	30	18	the	the	DET
dti-2707	30	19	field	field	NOUN
dti-2707	30	20	of	of	ADP
dti-2707	30	21	research	research	NOUN
dti-2707	30	22	.	.	PUNCT
dti-2707	31	1	the	the	DET
dti-2707	31	2	plant	plant	NOUN
dti-2707	31	3	in	in	ADP
dti-2707	31	4	issue	issue	NOUN
dti-2707	31	5	belongs	belong	VERB
dti-2707	31	6	to	to	ADP
dti-2707	31	7	the	the	DET
dti-2707	31	8	bignoniaceae	bignoniaceae	PROPN
dti-2707	31	9	family	family	NOUN
dti-2707	31	10	,	,	PUNCT
dti-2707	31	11	which	which	PRON
dti-2707	31	12	is	be	AUX
dti-2707	31	13	well	well	ADV
dti-2707	31	14	-	-	PUNCT
dti-2707	31	15	known	know	VERB
dti-2707	31	16	for	for	ADP
dti-2707	31	17	its	its	PRON
dti-2707	31	18	therapeutic	therapeutic	ADJ
dti-2707	31	19	qualities	quality	NOUN
dti-2707	31	20	.	.	PUNCT
dti-2707	32	1	the	the	DET
dti-2707	32	2	subject	subject	NOUN
dti-2707	32	3	of	of	ADP
dti-2707	32	4	investigation	investigation	NOUN
dti-2707	32	5	is	be	AUX
dti-2707	32	6	a	a	DET
dti-2707	32	7	compact	compact	ADJ
dti-2707	32	8	to	to	PART
dti-2707	32	9	moderate	moderate	ADJ
dti-2707	32	10	-	-	PUNCT
dti-2707	32	11	sized	sized	ADJ
dti-2707	32	12	deciduous	deciduous	ADJ
dti-2707	32	13	tree	tree	NOUN
dti-2707	32	14	,	,	PUNCT
dti-2707	32	15	characterized	characterize	VERB
dti-2707	32	16	by	by	ADP
dti-2707	32	17	presence	presence	NOUN
dti-2707	32	18	of	of	ADP
dti-2707	32	19	light	light	ADJ
dti-2707	32	20	grayish	grayish	ADJ
dti-2707	32	21	brown	brown	ADJ
dti-2707	32	22	bark	bark	NOUN
dti-2707	32	23	adorned	adorn	VERB
dti-2707	32	24	with	with	ADP
dti-2707	32	25	cory	cory	PROPN
dti-2707	32	26	lenticels	lenticels	PROPN
dti-2707	32	27	.	.	PUNCT
dti-2707	33	1	the	the	DET
dti-2707	33	2	vibrant	vibrant	ADJ
dti-2707	33	3	reddish	reddish	ADJ
dti-2707	33	4	-	-	PUNCT
dti-2707	33	5	purple	purple	ADJ
dti-2707	33	6	blooms	bloom	NOUN
dti-2707	33	7	grow	grow	VERB
dti-2707	33	8	on	on	ADP
dti-2707	33	9	its	its	PRON
dti-2707	33	10	outer	outer	ADJ
dti-2707	33	11	surface	surface	NOUN
dti-2707	33	12	,	,	PUNCT
dti-2707	33	13	while	while	SCONJ
dti-2707	33	14	its	its	PRON
dti-2707	33	15	inner	inner	ADJ
dti-2707	33	16	core	core	NOUN
dti-2707	33	17	exhibited	exhibit	VERB
dti-2707	33	18	the	the	DET
dti-2707	33	19	presence	presence	NOUN
dti-2707	33	20	of	of	ADP
dti-2707	33	21	pinkish	pinkish	ADJ
dti-2707	33	22	yellow	yellow	ADJ
dti-2707	33	23	flowers	flower	NOUN
dti-2707	33	24	.	.	PUNCT
dti-2707	34	1	additionally	additionally	ADV
dti-2707	34	2	,	,	PUNCT
dti-2707	34	3	the	the	DET
dti-2707	34	4	tree	tree	NOUN
dti-2707	34	5	bears	bear	VERB
dti-2707	34	6	distinctive	distinctive	ADJ
dti-2707	34	7	woody	woody	NOUN
dti-2707	34	8	,	,	PUNCT
dti-2707	34	9	winged	wing	VERB
dti-2707	34	10	,	,	PUNCT
dti-2707	34	11	large	large	ADJ
dti-2707	34	12	,	,	PUNCT
dti-2707	34	13	and	and	CCONJ
dti-2707	34	14	flat	flat	ADJ
dti-2707	34	15	fruits	fruit	NOUN
dti-2707	34	16	,	,	PUNCT
dti-2707	34	17	which	which	PRON
dti-2707	34	18	add	add	VERB
dti-2707	34	19	to	to	ADP
dti-2707	34	20	its	its	PRON
dti-2707	34	21	visual	visual	ADJ
dti-2707	34	22	allure	allure	NOUN
dti-2707	34	23	.	.	PUNCT
dti-2707	35	1	furthermore	furthermore	ADV
dti-2707	35	2	,	,	PUNCT
dti-2707	35	3	this	this	DET
dti-2707	35	4	remarkable	remarkable	ADJ
dti-2707	35	5	tree	tree	NOUN
dti-2707	35	6	exhibits	exhibit	VERB
dti-2707	35	7	presence	presence	NOUN
dti-2707	35	8	of	of	ADP
dti-2707	35	9	pinnately	pinnately	ADV
dti-2707	35	10	compound	compound	VERB
dti-2707	35	11	evergreen	evergreen	PROPN
dti-2707	35	12	leaves	leave	NOUN
dti-2707	35	13	,	,	PUNCT
dti-2707	35	14	enhancing	enhance	VERB
dti-2707	35	15	its	its	PRON
dti-2707	35	16	overall	overall	ADJ
dti-2707	35	17	appeal	appeal	NOUN
dti-2707	35	18	.	.	PUNCT
dti-2707	36	1	the	the	DET
dti-2707	36	2	geographical	geographical	ADJ
dti-2707	36	3	distribution	distribution	NOUN
dti-2707	36	4	of	of	ADP
dti-2707	36	5	this	this	DET
dti-2707	36	6	particular	particular	ADJ
dti-2707	36	7	phenomenon	phenomenon	NOUN
dti-2707	36	8	primarily	primarily	ADV
dti-2707	36	9	encompasses	encompass	VERB
dti-2707	36	10	the	the	DET
dti-2707	36	11	countries	country	NOUN
dti-2707	36	12	of	of	ADP
dti-2707	36	13	india	india	PROPN
dti-2707	36	14	,	,	PUNCT
dti-2707	36	15	china	china	PROPN
dti-2707	36	16	,	,	PUNCT
dti-2707	36	17	thailand	thailand	PROPN
dti-2707	36	18	,	,	PUNCT
dti-2707	36	19	sri	sri	PROPN
dti-2707	36	20	lanka	lanka	PROPN
dti-2707	36	21	,	,	PUNCT
dti-2707	36	22	cambodia	cambodia	PROPN
dti-2707	36	23	,	,	PUNCT
dti-2707	36	24	bangladesh	bangladesh	NOUN
dti-2707	36	25	,	,	PUNCT
dti-2707	36	26	and	and	CCONJ
dti-2707	36	27	other	other	ADJ
dti-2707	36	28	nations	nation	NOUN
dti-2707	36	29	within	within	ADP
dti-2707	36	30	the	the	DET
dti-2707	36	31	south	south	ADJ
dti-2707	36	32	asian	asian	ADJ
dti-2707	36	33	region	region	NOUN
dti-2707	36	34	.	.	PUNCT
dti-2707	37	1	baicalin	baicalin	NOUN
dti-2707	37	2	,	,	PUNCT
dti-2707	37	3	also	also	ADV
dti-2707	37	4	known	know	VERB
dti-2707	37	5	as	as	ADP
dti-2707	37	6	baicalein-7	baicalein-7	NOUN
dti-2707	37	7	-	-	NOUN
dti-2707	37	8	o	o	NOUN
dti-2707	37	9	-	-	PUNCT
dti-2707	37	10	β	β	NOUN
dti-2707	37	11	-	-	ADJ
dti-2707	37	12	d	d	ADJ
dti-2707	37	13	-	-	ADJ
dti-2707	37	14	glucuronic	glucuronic	ADJ
dti-2707	37	15	acid	acid	NOUN
dti-2707	37	16	,	,	PUNCT
dti-2707	37	17	undergoes	undergo	VERB
dti-2707	37	18	hydroxylation	hydroxylation	NOUN
dti-2707	37	19	to	to	PART
dti-2707	37	20	yield	yield	VERB
dti-2707	37	21	a	a	DET
dti-2707	37	22	biologically	biologically	ADV
dti-2707	37	23	active	active	ADJ
dti-2707	37	24	aglycone	aglycone	NOUN
dti-2707	37	25	called	call	VERB
dti-2707	37	26	baicalein	baicalein	NOUN
dti-2707	37	27	(	(	PUNCT
dti-2707	37	28	cid	cid	PROPN
dti-2707	37	29	64982	64982	NUM
dti-2707	37	30	)	)	PUNCT
dti-2707	37	31	,	,	PUNCT
dti-2707	37	32	which	which	PRON
dti-2707	37	33	is	be	AUX
dti-2707	37	34	chemically	chemically	ADV
dti-2707	37	35	known	know	VERB
dti-2707	37	36	as	as	ADP
dti-2707	37	37	5,6,7	5,6,7	NOUN
dti-2707	37	38	-	-	NOUN
dti-2707	37	39	trihydroxyflavone	trihydroxyflavone	NOUN
dti-2707	37	40	(	(	PUNCT
dti-2707	37	41	3	3	NUM
dti-2707	37	42	)	)	PUNCT
dti-2707	37	43	.	.	PUNCT
dti-2707	38	1	baicalein	baicalein	PROPN
dti-2707	38	2	,	,	PUNCT
dti-2707	38	3	a	a	DET
dti-2707	38	4	naturally	naturally	ADV
dti-2707	38	5	occurring	occur	VERB
dti-2707	38	6	flavonoid	flavonoid	NOUN
dti-2707	38	7	,	,	PUNCT
dti-2707	38	8	exhibits	exhibit	VERB
dti-2707	38	9	a	a	DET
dti-2707	38	10	chemical	chemical	NOUN
dti-2707	38	11	structure	structure	NOUN
dti-2707	38	12	derived	derive	VERB
dti-2707	38	13	from	from	ADP
dti-2707	38	14	the	the	DET
dti-2707	38	15	fundamental	fundamental	ADJ
dti-2707	38	16	framework	framework	NOUN
dti-2707	38	17	of	of	ADP
dti-2707	38	18	2	2	NUM
dti-2707	38	19	-	-	PUNCT
dti-2707	38	20	phenyl	phenyl	NOUN
dti-2707	38	21	chromen-4	chromen-4	NOUN
dti-2707	38	22	-	-	PUNCT
dti-2707	38	23	one	one	NUM
dti-2707	38	24	(	(	PUNCT
dti-2707	38	25	also	also	ADV
dti-2707	38	26	known	know	VERB
dti-2707	38	27	as	as	ADP
dti-2707	38	28	2	2	NUM
dti-2707	38	29	-	-	PUNCT
dti-2707	38	30	phenyl-1	phenyl-1	NUM
dti-2707	38	31	-	-	PUNCT
dti-2707	38	32	benzopyran-4	benzopyran-4	NOUN
dti-2707	38	33	-	-	PUNCT
dti-2707	38	34	one	one	NUM
dti-2707	38	35	)	)	PUNCT
dti-2707	38	36	.	.	PUNCT
dti-2707	39	1	one	one	NUM
dti-2707	39	2	intriguing	intriguing	ADJ
dti-2707	39	3	aspect	aspect	NOUN
dti-2707	39	4	of	of	ADP
dti-2707	39	5	bodily	bodily	ADJ
dti-2707	39	6	metabolism	metabolism	NOUN
dti-2707	39	7	is	be	AUX
dti-2707	39	8	the	the	DET
dti-2707	39	9	ability	ability	NOUN
dti-2707	39	10	for	for	ADP
dti-2707	39	11	certain	certain	ADJ
dti-2707	39	12	substances	substance	NOUN
dti-2707	39	13	to	to	PART
dti-2707	39	14	undergo	undergo	VERB
dti-2707	39	15	a	a	DET
dti-2707	39	16	transformative	transformative	ADJ
dti-2707	39	17	process	process	NOUN
dti-2707	39	18	,	,	PUNCT
dti-2707	39	19	allowing	allow	VERB
dti-2707	39	20	them	they	PRON
dti-2707	39	21	to	to	PART
dti-2707	39	22	transition	transition	VERB
dti-2707	39	23	into	into	ADP
dti-2707	39	24	different	different	ADJ
dti-2707	39	25	forms	form	NOUN
dti-2707	39	26	.	.	PUNCT
dti-2707	40	1	baicalin	baicalin	NOUN
dti-2707	40	2	,	,	PUNCT
dti-2707	40	3	a	a	DET
dti-2707	40	4	naturally	naturally	ADV
dti-2707	40	5	occurring	occur	VERB
dti-2707	40	6	compound	compound	NOUN
dti-2707	40	7	,	,	PUNCT
dti-2707	40	8	exhibits	exhibit	VERB
dti-2707	40	9	a	a	DET
dti-2707	40	10	unique	unique	ADJ
dti-2707	40	11	molecular	molecular	ADJ
dti-2707	40	12	structure	structure	NOUN
dti-2707	40	13	,	,	PUNCT
dti-2707	40	14	which	which	PRON
dti-2707	40	15	contributes	contribute	VERB
dti-2707	40	16	to	to	ADP
dti-2707	40	17	the	the	DET
dti-2707	40	18	diverse	diverse	ADJ
dti-2707	40	19	biological	biological	ADJ
dti-2707	40	20	activities	activity	NOUN
dti-2707	40	21	and	and	CCONJ
dti-2707	40	22	potential	potential	ADJ
dti-2707	40	23	therapeutic	therapeutic	ADJ
dti-2707	40	24	applications	application	NOUN
dti-2707	40	25	.	.	PUNCT
dti-2707	41	1	understanding	understand	VERB
dti-2707	41	2	the	the	DET
dti-2707	41	3	structural	structural	ADJ
dti-2707	41	4	features	feature	NOUN
dti-2707	41	5	of	of	ADP
dti-2707	41	6	baicalin	baicalin	NOUN
dti-2707	41	7	is	be	AUX
dti-2707	41	8	crucial	crucial	ADJ
dti-2707	41	9	for	for	ADP
dti-2707	41	10	elucidating	elucidate	VERB
dti-2707	41	11	its	its	PRON
dti-2707	41	12	mechanisms	mechanism	NOUN
dti-2707	41	13	of	of	ADP
dti-2707	41	14	action	action	NOUN
dti-2707	41	15	and	and	CCONJ
dti-2707	41	16	exploring	explore	VERB
dti-2707	41	17	its	its	PRON
dti-2707	41	18	potential	potential	NOUN
dti-2707	41	19	in	in	ADP
dti-2707	41	20	various	various	ADJ
dti-2707	41	21	fields	field	NOUN
dti-2707	41	22	of	of	ADP
dti-2707	41	23	research	research	NOUN
dti-2707	41	24	(	(	PUNCT
dti-2707	41	25	1,4	1,4	NUM
dti-2707	41	26	)	)	PUNCT
dti-2707	41	27	.	.	PUNCT
dti-2707	42	1	this	this	DET
dti-2707	42	2	molecule	molecule	NOUN
dti-2707	42	3	demonstrates	demonstrate	VERB
dti-2707	42	4	a	a	DET
dti-2707	42	5	wide	wide	ADJ
dti-2707	42	6	range	range	NOUN
dti-2707	42	7	of	of	ADP
dti-2707	42	8	biological	biological	ADJ
dti-2707	42	9	actions	action	NOUN
dti-2707	42	10	,	,	PUNCT
dti-2707	42	11	including	include	VERB
dti-2707	42	12	significant	significant	ADJ
dti-2707	42	13	domains	domain	NOUN
dti-2707	42	14	such	such	ADJ
dti-2707	42	15	as	as	ADP
dti-2707	42	16	reducing	reduce	VERB
dti-2707	42	17	the	the	DET
dti-2707	42	18	risk	risk	NOUN
dti-2707	42	19	of	of	ADP
dti-2707	42	20	cancer	cancer	NOUN
dti-2707	42	21	,	,	PUNCT
dti-2707	42	22	virus	virus	NOUN
dti-2707	42	23	suppression	suppression	NOUN
dti-2707	42	24	,	,	PUNCT
dti-2707	42	25	diabetic	diabetic	ADJ
dti-2707	42	26	control	control	NOUN
dti-2707	42	27	,	,	PUNCT
dti-2707	42	28	and	and	CCONJ
dti-2707	42	29	mitigation	mitigation	NOUN
dti-2707	42	30	of	of	ADP
dti-2707	42	31	age	age	NOUN
dti-2707	42	32	-	-	PUNCT
dti-2707	42	33	related	relate	VERB
dti-2707	42	34	deterioration	deterioration	NOUN
dti-2707	42	35	.	.	PUNCT
dti-2707	43	1	additionally	additionally	ADV
dti-2707	43	2	,	,	PUNCT
dti-2707	43	3	it	it	PRON
dti-2707	43	4	demonstrates	demonstrate	VERB
dti-2707	43	5	notable	notable	ADJ
dti-2707	43	6	protective	protective	ADJ
dti-2707	43	7	effects	effect	NOUN
dti-2707	43	8	on	on	ADP
dti-2707	43	9	the	the	DET
dti-2707	43	10	neurological	neurological	ADJ
dti-2707	43	11	,	,	PUNCT
dti-2707	43	12	cardiovascular	cardiovascular	ADJ
dti-2707	43	13	,	,	PUNCT
dti-2707	43	14	gastrointestinal	gastrointestinal	ADJ
dti-2707	43	15	(	(	PUNCT
dti-2707	43	16	gi	gi	NOUN
dti-2707	43	17	)	)	PUNCT
dti-2707	43	18	,	,	PUNCT
dti-2707	43	19	hepatic	hepatic	ADJ
dti-2707	43	20	,	,	PUNCT
dti-2707	43	21	respiratory	respiratory	ADJ
dti-2707	43	22	,	,	PUNCT
dti-2707	43	23	and	and	CCONJ
dti-2707	43	24	renal	renal	ADJ
dti-2707	43	25	systems	system	NOUN
dti-2707	43	26	(	(	PUNCT
dti-2707	43	27	5	5	NUM
dti-2707	43	28	)	)	PUNCT
dti-2707	43	29	.	.	PUNCT
dti-2707	44	1	this	this	DET
dti-2707	44	2	comprehensive	comprehensive	ADJ
dti-2707	44	3	review	review	NOUN
dti-2707	44	4	aims	aim	VERB
dti-2707	44	5	to	to	PART
dti-2707	44	6	consolidate	consolidate	VERB
dti-2707	44	7	a	a	DET
dti-2707	44	8	wealth	wealth	NOUN
dti-2707	44	9	of	of	ADP
dti-2707	44	10	information	information	NOUN
dti-2707	44	11	on	on	ADP
dti-2707	44	12	the	the	DET
dti-2707	44	13	diverse	diverse	ADJ
dti-2707	44	14	pharmacological	pharmacological	ADJ
dti-2707	44	15	effects	effect	NOUN
dti-2707	44	16	associated	associate	VERB
dti-2707	44	17	with	with	ADP
dti-2707	44	18	various	various	ADJ
dti-2707	44	19	diseases	disease	NOUN
dti-2707	44	20	,	,	PUNCT
dti-2707	44	21	encompassing	encompass	VERB
dti-2707	44	22	multiple	multiple	ADJ
dti-2707	44	23	pathways	pathway	NOUN
dti-2707	44	24	,	,	PUNCT
dti-2707	44	25	mechanisms	mechanism	NOUN
dti-2707	44	26	of	of	ADP
dti-2707	44	27	action	action	NOUN
dti-2707	44	28	,	,	PUNCT
dti-2707	44	29	and	and	CCONJ
dti-2707	44	30	in	in	ADP
dti-2707	44	31	vitro	vitro	X
dti-2707	44	32	studies	study	NOUN
dti-2707	44	33	(	(	PUNCT
dti-2707	44	34	5	5	NUM
dti-2707	44	35	)	)	PUNCT
dti-2707	44	36	.	.	PUNCT
dti-2707	45	1	this	this	DET
dti-2707	45	2	review	review	NOUN
dti-2707	45	3	further	far	ADV
dti-2707	45	4	highlight	highlight	VERB
dti-2707	45	5	the	the	DET
dti-2707	45	6	attractive	attractive	ADJ
dti-2707	45	7	opportunities	opportunity	NOUN
dti-2707	45	8	for	for	ADP
dti-2707	45	9	baicalein	baicalein	NOUN
dti-2707	45	10	-	-	PUNCT
dti-2707	45	11	associated	associate	VERB
dti-2707	45	12	drug	drug	NOUN
dti-2707	45	13	discovery	discovery	NOUN
dti-2707	45	14	and	and	CCONJ
dti-2707	45	15	research	research	NOUN
dti-2707	45	16	across	across	ADP
dti-2707	45	17	a	a	DET
dti-2707	45	18	range	range	NOUN
dti-2707	45	19	of	of	ADP
dti-2707	45	20	therapeutic	therapeutic	ADJ
dti-2707	45	21	areas	area	NOUN
dti-2707	45	22	.	.	PUNCT
dti-2707	46	1	chemistry	chemistry	NOUN
dti-2707	46	2	of	of	ADP
dti-2707	46	3	baicalein	baicalein	PROPN
dti-2707	46	4	flavonoids	flavonoid	NOUN
dti-2707	46	5	,	,	PUNCT
dti-2707	46	6	a	a	DET
dti-2707	46	7	class	class	NOUN
dti-2707	46	8	of	of	ADP
dti-2707	46	9	polyphenolic	polyphenolic	ADJ
dti-2707	46	10	compounds	compound	NOUN
dti-2707	46	11	,	,	PUNCT
dti-2707	46	12	have	have	AUX
dti-2707	46	13	garnered	garner	VERB
dti-2707	46	14	significant	significant	ADJ
dti-2707	46	15	attention	attention	NOUN
dti-2707	46	16	in	in	ADP
dti-2707	46	17	the	the	DET
dti-2707	46	18	realm	realm	NOUN
dti-2707	46	19	of	of	ADP
dti-2707	46	20	natural	natural	ADJ
dti-2707	46	21	products	product	NOUN
dti-2707	46	22	due	due	ADP
dti-2707	46	23	to	to	ADP
dti-2707	46	24	their	their	PRON
dti-2707	46	25	extensive	extensive	ADJ
dti-2707	46	26	research	research	NOUN
dti-2707	46	27	and	and	CCONJ
dti-2707	46	28	exploration	exploration	NOUN
dti-2707	46	29	(	(	PUNCT
dti-2707	46	30	11	11	NUM
dti-2707	46	31	)	)	PUNCT
dti-2707	46	32	.	.	PUNCT
dti-2707	47	1	one	one	NUM
dti-2707	47	2	of	of	ADP
dti-2707	47	3	the	the	DET
dti-2707	47	4	key	key	ADJ
dti-2707	47	5	structural	structural	ADJ
dti-2707	47	6	components	component	NOUN
dti-2707	47	7	of	of	ADP
dti-2707	47	8	this	this	DET
dti-2707	47	9	compound	compound	NOUN
dti-2707	47	10	was	be	AUX
dti-2707	47	11	produced	produce	VERB
dti-2707	47	12	using	use	VERB
dti-2707	47	13	the	the	DET
dti-2707	47	14	acetate	acetate	NOUN
dti-2707	47	15	route	route	NOUN
dti-2707	47	16	,	,	PUNCT
dti-2707	47	17	leading	lead	VERB
dti-2707	47	18	to	to	ADP
dti-2707	47	19	the	the	DET
dti-2707	47	20	development	development	NOUN
dti-2707	47	21	of	of	ADP
dti-2707	47	22	the	the	DET
dti-2707	47	23	phenolic	phenolic	ADJ
dti-2707	47	24	ring	ring	NOUN
dti-2707	47	25	chromophore	chromophore	NOUN
dti-2707	47	26	(	(	PUNCT
dti-2707	47	27	ring	ring	NOUN
dti-2707	47	28	a	a	PRON
dti-2707	47	29	)	)	PUNCT
dti-2707	47	30	within	within	ADP
dti-2707	47	31	its	its	PRON
dti-2707	47	32	15	15	NUM
dti-2707	47	33	-	-	PUNCT
dti-2707	47	34	carbon	carbon	NOUN
dti-2707	47	35	skeletal	skeletal	ADJ
dti-2707	47	36	framework	framework	NOUN
dti-2707	47	37	(	(	PUNCT
dti-2707	47	38	11	11	NUM
dti-2707	47	39	)	)	PUNCT
dti-2707	47	40	.	.	PUNCT
dti-2707	48	1	one	one	NUM
dti-2707	48	2	of	of	ADP
dti-2707	48	3	the	the	DET
dti-2707	48	4	best	good	ADJ
dti-2707	48	5	examples	example	NOUN
dti-2707	48	6	of	of	ADP
dti-2707	48	7	the	the	DET
dti-2707	48	8	most	most	ADV
dti-2707	48	9	fundamental	fundamental	ADJ
dti-2707	48	10	flavone	flavone	NOUN
dti-2707	48	11	molecule	molecule	NOUN
dti-2707	48	12	is	be	AUX
dti-2707	48	13	chrysin	chrysin	NOUN
dti-2707	48	14	,	,	PUNCT
dti-2707	48	15	which	which	PRON
dti-2707	48	16	has	have	VERB
dti-2707	48	17	the	the	DET
dti-2707	48	18	unique	unique	ADJ
dti-2707	48	19	property	property	NOUN
dti-2707	48	20	of	of	ADP
dti-2707	48	21	retaining	retain	VERB
dti-2707	48	22	the	the	DET
dti-2707	48	23	necessary	necessary	ADJ
dti-2707	48	24	meta	meta	ADV
dti-2707	48	25	-	-	PUNCT
dti-2707	48	26	substituted	substitute	VERB
dti-2707	48	27	hydroxyl	hydroxyl	NOUN
dti-2707	48	28	groups	group	NOUN
dti-2707	48	29	on	on	ADP
dti-2707	48	30	the	the	DET
dti-2707	48	31	a	a	DET
dti-2707	48	32	-	-	PUNCT
dti-2707	48	33	ring	ring	NOUN
dti-2707	48	34	.	.	PUNCT
dti-2707	49	1	the	the	DET
dti-2707	49	2	oh	oh	NUM
dti-2707	49	3	substitution	substitution	NOUN
dti-2707	49	4	at	at	ADP
dti-2707	49	5	chrysin	chrysin	PROPN
dti-2707	49	6	’s	’s	PART
dti-2707	49	7	c-6	c-6	NOUN
dti-2707	49	8	position	position	NOUN
dti-2707	49	9	causes	cause	VERB
dti-2707	49	10	it	it	PRON
dti-2707	49	11	to	to	PART
dti-2707	49	12	change	change	VERB
dti-2707	49	13	into	into	ADP
dti-2707	49	14	the	the	DET
dti-2707	49	15	trihydroxy	trihydroxy	PROPN
dti-2707	49	16	derivative	derivative	ADJ
dti-2707	49	17	baicalein	baicalein	NOUN
dti-2707	49	18	(	(	PUNCT
dti-2707	49	19	12	12	NUM
dti-2707	49	20	)	)	PUNCT
dti-2707	49	21	having	have	VERB
dti-2707	49	22	chemical	chemical	NOUN
dti-2707	49	23	formula	formula	NOUN
dti-2707	49	24	c15h10o5	c15h10o5	PROPN
dti-2707	49	25	.	.	PUNCT
dti-2707	50	1	more	more	ADV
dti-2707	50	2	specifically	specifically	ADV
dti-2707	50	3	,	,	PUNCT
dti-2707	50	4	it	it	PRON
dti-2707	50	5	is	be	AUX
dti-2707	50	6	recognized	recognize	VERB
dti-2707	50	7	as	as	ADP
dti-2707	50	8	5,6,7	5,6,7	NUM
dti-2707	50	9	-	-	PUNCT
dti-2707	50	10	trihydroxy-2	trihydroxy-2	NUM
dti-2707	50	11	-	-	PUNCT
dti-2707	50	12	phenyl-4h	phenyl-4h	NOUN
dti-2707	50	13	-	-	PUNCT
dti-2707	50	14	chromen-4	chromen-4	NOUN
dti-2707	50	15	-	-	PUNCT
dti-2707	50	16	one	one	NUM
dti-2707	50	17	,	,	PUNCT
dti-2707	50	18	as	as	SCONJ
dti-2707	50	19	figure	figure	NOUN
dti-2707	50	20	1	1	NUM
dti-2707	50	21	illustrates	illustrate	NOUN
dti-2707	50	22	.	.	PUNCT
dti-2707	51	1	using	use	VERB
dti-2707	51	2	a	a	DET
dti-2707	51	3	multistep	multistep	ADJ
dti-2707	51	4	synthetic	synthetic	ADJ
dti-2707	51	5	strategy	strategy	NOUN
dti-2707	51	6	,	,	PUNCT
dti-2707	51	7	researchers	researcher	NOUN
dti-2707	51	8	have	have	AUX
dti-2707	51	9	effectively	effectively	ADV
dti-2707	51	10	recreated	recreate	VERB
dti-2707	51	11	the	the	DET
dti-2707	51	12	biosynthetic	biosynthetic	ADJ
dti-2707	51	13	transition	transition	NOUN
dti-2707	51	14	of	of	ADP
dti-2707	51	15	chrysin	chrysin	NOUN
dti-2707	51	16	to	to	PART
dti-2707	51	17	baicalein	baicalein	VERB
dti-2707	51	18	in	in	ADP
dti-2707	51	19	recent	recent	ADJ
dti-2707	51	20	laboratory	laboratory	NOUN
dti-2707	51	21	tests	test	NOUN
dti-2707	51	22	;	;	PUNCT
dti-2707	51	23	1-(2,4,6	1-(2,4,6	NUM
dti-2707	51	24	-	-	SYM
dti-2707	51	25	trihydroxyphenyl)ethanone	trihydroxyphenyl)ethanone	NUM
dti-2707	51	26	and	and	CCONJ
dti-2707	51	27	1	1	NUM
dti-2707	51	28	-	-	PUNCT
dti-2707	51	29	ethyl-3	ethyl-3	NUM
dti-2707	51	30	-	-	PUNCT
dti-2707	51	31	phenyl-1,3	phenyl-1,3	NOUN
dti-2707	51	32	-	-	PUNCT
dti-2707	51	33	propanedione	propanedione	NOUN
dti-2707	51	34	are	be	AUX
dti-2707	51	35	combined	combine	VERB
dti-2707	51	36	in	in	ADP
dti-2707	51	37	the	the	DET
dti-2707	51	38	first	first	ADJ
dti-2707	51	39	synthesis	synthesis	NOUN
dti-2707	51	40	technique	technique	NOUN
dti-2707	51	41	.	.	PUNCT
dti-2707	52	1	chen	chen	PROPN
dti-2707	52	2	et	et	PROPN
dti-2707	52	3	al	al	PROPN
dti-2707	52	4	completed	complete	VERB
dti-2707	52	5	a	a	DET
dti-2707	52	6	pioneering	pioneering	ADJ
dti-2707	52	7	investigation	investigation	NOUN
dti-2707	52	8	that	that	PRON
dti-2707	52	9	revealed	reveal	VERB
dti-2707	52	10	an	an	DET
dti-2707	52	11	amazing	amazing	ADJ
dti-2707	52	12	and	and	CCONJ
dti-2707	52	13	novel	novel	ADJ
dti-2707	52	14	method	method	NOUN
dti-2707	52	15	for	for	ADP
dti-2707	52	16	extracting	extract	VERB
dti-2707	52	17	baicalein	baicalein	NOUN
dti-2707	52	18	from	from	ADP
dti-2707	52	19	3,4,5	3,4,5	NUM
dti-2707	52	20	-	-	NOUN
dti-2707	52	21	trimethoxyphenol	trimethoxyphenol	NOUN
dti-2707	52	22	.	.	PUNCT
dti-2707	53	1	this	this	DET
dti-2707	53	2	approach	approach	NOUN
dti-2707	53	3	,	,	PUNCT
dti-2707	53	4	which	which	PRON
dti-2707	53	5	consists	consist	VERB
dti-2707	53	6	of	of	ADP
dti-2707	53	7	a	a	DET
dti-2707	53	8	brief	brief	ADJ
dti-2707	53	9	fourstep	fourstep	ADJ
dti-2707	53	10	procedure	procedure	NOUN
dti-2707	53	11	,	,	PUNCT
dti-2707	53	12	showed	show	VERB
dti-2707	53	13	promise	promise	NOUN
dti-2707	53	14	for	for	ADP
dti-2707	53	15	a	a	DET
dti-2707	53	16	more	more	ADV
dti-2707	53	17	streamlined	streamlined	ADJ
dti-2707	53	18	and	and	CCONJ
dti-2707	53	19	effective	effective	ADJ
dti-2707	53	20	manufacture	manufacture	NOUN
dti-2707	53	21	of	of	ADP
dti-2707	53	22	baicalein	baicalein	NOUN
dti-2707	53	23	(	(	PUNCT
dti-2707	53	24	13,14	13,14	NUM
dti-2707	53	25	)	)	PUNCT
dti-2707	53	26	.	.	PUNCT
dti-2707	54	1	one	one	NUM
dti-2707	54	2	of	of	ADP
dti-2707	54	3	the	the	DET
dti-2707	54	4	key	key	ADJ
dti-2707	54	5	structural	structural	ADJ
dti-2707	54	6	characteristics	characteristic	NOUN
dti-2707	54	7	that	that	PRON
dti-2707	54	8	distinguishes	distinguish	VERB
dti-2707	54	9	baicalin	baicalin	NOUN
dti-2707	54	10	and	and	CCONJ
dti-2707	54	11	baicalein	baicalein	NOUN
dti-2707	54	12	is	be	AUX
dti-2707	54	13	the	the	DET
dti-2707	54	14	notable	notable	ADJ
dti-2707	54	15	existence	existence	NOUN
dti-2707	54	16	of	of	ADP
dti-2707	54	17	a	a	DET
dti-2707	54	18	di	di	NOUN
dti-2707	54	19	-	-	ADJ
dti-2707	54	20	ortho	ortho	PROPN
dti-2707	55	1	oh	oh	INTJ
dti-2707	55	2	on	on	ADP
dti-2707	55	3	ring	ring	NOUN
dti-2707	55	4	a.	a.	NOUN
dti-2707	55	5	the	the	DET
dti-2707	55	6	remarkable	remarkable	ADJ
dti-2707	55	7	characteristic	characteristic	NOUN
dti-2707	55	8	exhibited	exhibit	VERB
dti-2707	55	9	by	by	ADP
dti-2707	55	10	polyphenolic	polyphenolic	ADJ
dti-2707	55	11	compounds	compound	NOUN
dti-2707	55	12	lies	lie	VERB
dti-2707	55	13	in	in	ADP
dti-2707	55	14	their	their	PRON
dti-2707	55	15	ability	ability	NOUN
dti-2707	55	16	to	to	PART
dti-2707	55	17	serve	serve	VERB
dti-2707	55	18	as	as	ADP
dti-2707	55	19	efficient	efficient	ADJ
dti-2707	55	20	markers	marker	NOUN
dti-2707	55	21	for	for	ADP
dti-2707	55	22	metal	metal	NOUN
dti-2707	55	23	chelation	chelation	NOUN
dti-2707	55	24	,	,	PUNCT
dti-2707	55	25	table	table	NOUN
dti-2707	55	26	1	1	NUM
dti-2707	55	27	several	several	ADJ
dti-2707	55	28	methods	method	NOUN
dti-2707	55	29	for	for	ADP
dti-2707	55	30	extraction	extraction	NOUN
dti-2707	55	31	of	of	ADP
dti-2707	55	32	baicalein	baicalein	NOUN
dti-2707	55	33	s.	s.	PROPN
dti-2707	55	34	no	no	INTJ
dti-2707	55	35	.	.	PUNCT
dti-2707	56	1	species	specie	NOUN
dti-2707	56	2	part	part	NOUN
dti-2707	56	3	of	of	ADP
dti-2707	56	4	the	the	DET
dti-2707	56	5	plant	plant	NOUN
dti-2707	56	6	extraction	extraction	NOUN
dti-2707	56	7	method	method	NOUN
dti-2707	56	8	analytical	analytical	ADJ
dti-2707	56	9	technique	technique	NOUN
dti-2707	56	10	yield	yield	NOUN
dti-2707	56	11	reference	reference	NOUN
dti-2707	56	12	1	1	NUM
dti-2707	56	13	.	.	PUNCT
dti-2707	57	1	oroxylum	oroxylum	VERB
dti-2707	57	2	indicum	indicum	NOUN
dti-2707	57	3	stem	stem	NOUN
dti-2707	57	4	barks	bark	VERB
dti-2707	57	5	solvent	solvent	NOUN
dti-2707	57	6	(	(	PUNCT
dti-2707	57	7	ethanol	ethanol	NOUN
dti-2707	57	8	)	)	PUNCT
dti-2707	57	9	extraction	extraction	NOUN
dti-2707	57	10	(	(	PUNCT
dti-2707	57	11	reflux	reflux	NOUN
dti-2707	57	12	method	method	NOUN
dti-2707	57	13	)	)	PUNCT
dti-2707	57	14	hptlc	hptlc	NOUN
dti-2707	57	15	26.498	26.498	NUM
dti-2707	57	16	mg	mg	PROPN
dti-2707	57	17	/	/	SYM
dti-2707	57	18	g	g	PROPN
dti-2707	57	19	(	(	PUNCT
dti-2707	57	20	6	6	NUM
dti-2707	57	21	)	)	PUNCT
dti-2707	57	22	solvent	solvent	NOUN
dti-2707	57	23	(	(	PUNCT
dti-2707	57	24	acetone	acetone	NOUN
dti-2707	57	25	)	)	PUNCT
dti-2707	57	26	extraction	extraction	NOUN
dti-2707	57	27	(	(	PUNCT
dti-2707	57	28	reflux	reflux	NOUN
dti-2707	57	29	method	method	NOUN
dti-2707	57	30	)	)	PUNCT
dti-2707	57	31	hptlc	hptlc	NOUN
dti-2707	57	32	8.631	8.631	NUM
dti-2707	57	33	mg	mg	PROPN
dti-2707	57	34	/	/	SYM
dti-2707	57	35	g	g	NOUN
dti-2707	57	36	dmso	dmso	ADJ
dti-2707	57	37	extract	extract	NOUN
dti-2707	57	38	(	(	PUNCT
dti-2707	57	39	reflux	reflux	NOUN
dti-2707	57	40	method	method	NOUN
dti-2707	57	41	)	)	PUNCT
dti-2707	57	42	hptlc	hptlc	NOUN
dti-2707	57	43	13.883	13.883	NUM
dti-2707	57	44	mg	mg	PROPN
dti-2707	57	45	/	/	SYM
dti-2707	57	46	g	g	PROPN
dti-2707	57	47	dmf	dmf	PROPN
dti-2707	57	48	extract	extract	NOUN
dti-2707	57	49	(	(	PUNCT
dti-2707	57	50	reflux	reflux	NOUN
dti-2707	57	51	method	method	NOUN
dti-2707	57	52	)	)	PUNCT
dti-2707	57	53	hptlc	hptlc	NOUN
dti-2707	57	54	20.529	20.529	NUM
dti-2707	57	55	mg	mg	NUM
dti-2707	57	56	/	/	SYM
dti-2707	57	57	g	g	NOUN
dti-2707	57	58	seeds	seed	NOUN
dti-2707	57	59	solvent	solvent	NOUN
dti-2707	57	60	(	(	PUNCT
dti-2707	57	61	95	95	NUM
dti-2707	57	62	%	%	NOUN
dti-2707	57	63	ethanol	ethanol	NOUN
dti-2707	57	64	)	)	PUNCT
dti-2707	57	65	extraction	extraction	NOUN
dti-2707	57	66	(	(	PUNCT
dti-2707	57	67	maceration	maceration	NOUN
dti-2707	57	68	method	method	NOUN
dti-2707	57	69	)	)	PUNCT
dti-2707	57	70	hplc	hplc	NOUN
dti-2707	57	71	0.72	0.72	NUM
dti-2707	57	72	%	%	NOUN
dti-2707	57	73	±	±	NUM
dti-2707	57	74	0.00	0.00	NUM
dti-2707	57	75	%	%	NOUN
dti-2707	57	76	w	w	PROPN
dti-2707	57	77	/	/	SYM
dti-2707	57	78	w	w	PROPN
dti-2707	58	1	(	(	PUNCT
dti-2707	58	2	7	7	NUM
dti-2707	58	3	)	)	SYM
dti-2707	58	4	2	2	NUM
dti-2707	58	5	.	.	X
dti-2707	58	6	scutellaria	scutellaria	PROPN
dti-2707	58	7	baicalensis	baicalensis	PROPN
dti-2707	58	8	georgi	georgi	PROPN
dti-2707	58	9	roots	root	NOUN
dti-2707	58	10	solvent	solvent	NOUN
dti-2707	58	11	(	(	PUNCT
dti-2707	58	12	methanol	methanol	NOUN
dti-2707	58	13	)	)	PUNCT
dti-2707	58	14	extraction	extraction	NOUN
dti-2707	58	15	(	(	PUNCT
dti-2707	58	16	maceration	maceration	NOUN
dti-2707	58	17	method	method	NOUN
dti-2707	58	18	)	)	PUNCT
dti-2707	58	19	hplc	hplc	NOUN
dti-2707	58	20	0.5	0.5	NUM
dti-2707	58	21	mg	mg	PROPN
dti-2707	58	22	/	/	SYM
dti-2707	58	23	ml	ml	PROPN
dti-2707	58	24	(	(	PUNCT
dti-2707	58	25	8)	8)	NUM
dti-2707	58	26	auxiliary	auxiliary	ADJ
dti-2707	58	27	extraction	extraction	NOUN
dti-2707	58	28	method	method	NOUN
dti-2707	58	29	hplc	hplc	NOUN
dti-2707	58	30	116.8	116.8	NUM
dti-2707	58	31	mg	mg	PROPN
dti-2707	58	32	/	/	SYM
dti-2707	58	33	g	g	PROPN
dti-2707	58	34	(	(	PUNCT
dti-2707	58	35	9	9	NUM
dti-2707	58	36	)	)	PUNCT
dti-2707	58	37	supercritical	supercritical	ADJ
dti-2707	58	38	fluid	fluid	NOUN
dti-2707	58	39	extraction	extraction	NOUN
dti-2707	58	40	hplc	hplc	NOUN
dti-2707	58	41	-	-	PUNCT
dti-2707	58	42	uv	uv	PROPN
dti-2707	58	43	2.5	2.5	NUM
dti-2707	58	44	-	-	SYM
dti-2707	58	45	80	80	NUM
dti-2707	58	46	µg	µg	NOUN
dti-2707	58	47	/	/	SYM
dti-2707	58	48	ml	ml	NOUN
dti-2707	58	49	(	(	PUNCT
dti-2707	58	50	10	10	NUM
dti-2707	58	51	)	)	PUNCT
dti-2707	58	52	dmf	dmf	PROPN
dti-2707	58	53	=	=	PUNCT
dti-2707	58	54	dimethylformamide	dimethylformamide	NOUN
dti-2707	58	55	;	;	PUNCT
dti-2707	58	56	dmso	dmso	NOUN
dti-2707	58	57	=	=	PROPN
dti-2707	58	58	dimethyl	dimethyl	NOUN
dti-2707	58	59	sulfoxide	sulfoxide	NOUN
dti-2707	58	60	;	;	PUNCT
dti-2707	58	61	hplc	hplc	NOUN
dti-2707	58	62	-	-	PUNCT
dti-2707	58	63	uv	uv	NOUN
dti-2707	58	64	=	=	PUNCT
dti-2707	58	65	high	high	ADJ
dti-2707	58	66	-	-	PUNCT
dti-2707	58	67	performance	performance	NOUN
dti-2707	58	68	liquid	liquid	ADJ
dti-2707	58	69	chromatography	chromatography	NOUN
dti-2707	58	70	ultraviolet	ultraviolet	NOUN
dti-2707	58	71	;	;	PUNCT
dti-2707	58	72	hptlc	hptlc	NOUN
dti-2707	58	73	=	=	SYM
dti-2707	58	74	high	high	ADJ
dti-2707	58	75	-	-	PUNCT
dti-2707	58	76	performance	performance	NOUN
dti-2707	58	77	thin	thin	ADJ
dti-2707	58	78	layer	layer	NOUN
dti-2707	58	79	chromatography	chromatography	NOUN
dti-2707	58	80	.	.	PUNCT
dti-2707	59	1	therapeutic	therapeutic	ADJ
dti-2707	59	2	insights	insight	NOUN
dti-2707	59	3	into	into	ADP
dti-2707	59	4	baicalein32	baicalein32	PROPN
dti-2707	59	5	©	©	PROPN
dti-2707	59	6	2024	2024	NUM
dti-2707	59	7	the	the	DET
dti-2707	59	8	authors	author	NOUN
dti-2707	59	9	.	.	PUNCT
dti-2707	60	1	drug	drug	NOUN
dti-2707	60	2	target	target	NOUN
dti-2707	60	3	insights	insight	NOUN
dti-2707	60	4	issn	issn	VERB
dti-2707	60	5	1177	1177	NUM
dti-2707	60	6	-	-	SYM
dti-2707	60	7	3928	3928	NUM
dti-2707	60	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	VERB
dti-2707	60	9	free	free	ADJ
dti-2707	60	10	radical	radical	ADJ
dti-2707	60	11	scavenging	scavenging	ADJ
dti-2707	60	12	properties	property	NOUN
dti-2707	60	13	,	,	PUNCT
dti-2707	60	14	and	and	CCONJ
dti-2707	60	15	enzyme	enzyme	NOUN
dti-2707	60	16	inhibition	inhibition	NOUN
dti-2707	60	17	.	.	PUNCT
dti-2707	61	1	the	the	DET
dti-2707	61	2	structural	structural	ADJ
dti-2707	61	3	features	feature	NOUN
dti-2707	61	4	of	of	ADP
dti-2707	61	5	baicalein	baicalein	NOUN
dti-2707	61	6	are	be	AUX
dti-2707	61	7	believed	believe	VERB
dti-2707	61	8	to	to	PART
dti-2707	61	9	be	be	AUX
dti-2707	61	10	responsible	responsible	ADJ
dti-2707	61	11	for	for	ADP
dti-2707	61	12	its	its	PRON
dti-2707	61	13	reported	report	VERB
dti-2707	61	14	antioxidant	antioxidant	ADJ
dti-2707	61	15	effects	effect	NOUN
dti-2707	61	16	and	and	CCONJ
dti-2707	61	17	its	its	PRON
dti-2707	61	18	ability	ability	NOUN
dti-2707	61	19	to	to	PART
dti-2707	61	20	chelate	chelate	VERB
dti-2707	61	21	divalent	divalent	ADJ
dti-2707	61	22	metal	metal	NOUN
dti-2707	61	23	ions	ion	NOUN
dti-2707	61	24	(	(	PUNCT
dti-2707	61	25	14	14	NUM
dti-2707	61	26	)	)	PUNCT
dti-2707	61	27	.	.	PUNCT
dti-2707	62	1	anticancer	anticancer	NOUN
dti-2707	62	2	effects	effect	NOUN
dti-2707	62	3	of	of	ADP
dti-2707	62	4	baicalein	baicalein	NOUN
dti-2707	62	5	cancer	cancer	NOUN
dti-2707	62	6	,	,	PUNCT
dti-2707	62	7	uncontrolled	uncontrolled	ADJ
dti-2707	62	8	cell	cell	NOUN
dti-2707	62	9	proliferation	proliferation	NOUN
dti-2707	62	10	,	,	PUNCT
dti-2707	62	11	can	can	AUX
dti-2707	62	12	show	show	VERB
dti-2707	62	13	up	up	ADP
dti-2707	62	14	phenotypically	phenotypically	ADV
dti-2707	62	15	in	in	ADP
dti-2707	62	16	a	a	DET
dti-2707	62	17	number	number	NOUN
dti-2707	62	18	of	of	ADP
dti-2707	62	19	ways	way	NOUN
dti-2707	62	20	,	,	PUNCT
dti-2707	62	21	from	from	ADP
dti-2707	62	22	benign	benign	ADJ
dti-2707	62	23	to	to	ADP
dti-2707	62	24	fatal	fatal	ADJ
dti-2707	62	25	.	.	PUNCT
dti-2707	63	1	there	there	PRON
dti-2707	63	2	are	be	VERB
dti-2707	63	3	numerous	numerous	ADJ
dti-2707	63	4	factors	factor	NOUN
dti-2707	63	5	that	that	PRON
dti-2707	63	6	can	can	AUX
dti-2707	63	7	lead	lead	VERB
dti-2707	63	8	to	to	ADP
dti-2707	63	9	the	the	DET
dti-2707	63	10	development	development	NOUN
dti-2707	63	11	of	of	ADP
dti-2707	63	12	cancer	cancer	NOUN
dti-2707	63	13	,	,	PUNCT
dti-2707	63	14	including	include	VERB
dti-2707	63	15	deoxyribonucleic	deoxyribonucleic	ADJ
dti-2707	63	16	acid	acid	NOUN
dti-2707	63	17	(	(	PUNCT
dti-2707	63	18	dna	dna	NOUN
dti-2707	63	19	)	)	PUNCT
dti-2707	63	20	damage	damage	NOUN
dti-2707	63	21	,	,	PUNCT
dti-2707	63	22	mutations	mutation	NOUN
dti-2707	63	23	in	in	ADP
dti-2707	63	24	the	the	DET
dti-2707	63	25	dna	dna	NOUN
dti-2707	63	26	or	or	CCONJ
dti-2707	63	27	any	any	PRON
dti-2707	63	28	by	by	ADP
dti-2707	63	29	-	-	PUNCT
dti-2707	63	30	products	product	NOUN
dti-2707	63	31	of	of	ADP
dti-2707	63	32	that	that	DET
dti-2707	63	33	dna	dna	NOUN
dti-2707	63	34	,	,	PUNCT
dti-2707	63	35	and	and	CCONJ
dti-2707	63	36	dysfunction	dysfunction	NOUN
dti-2707	63	37	of	of	ADP
dti-2707	63	38	the	the	DET
dti-2707	63	39	regulatory	regulatory	ADJ
dti-2707	63	40	and	and	CCONJ
dti-2707	63	41	repressor	repressor	NOUN
dti-2707	63	42	mechanisms	mechanism	NOUN
dti-2707	63	43	during	during	ADP
dti-2707	63	44	the	the	DET
dti-2707	63	45	cell	cell	NOUN
dti-2707	63	46	cycle	cycle	NOUN
dti-2707	63	47	.	.	PUNCT
dti-2707	64	1	the	the	DET
dti-2707	64	2	four	four	NUM
dti-2707	64	3	phases	phase	NOUN
dti-2707	64	4	of	of	ADP
dti-2707	64	5	the	the	DET
dti-2707	64	6	cell	cell	NOUN
dti-2707	64	7	cycle	cycle	NOUN
dti-2707	64	8	in	in	ADP
dti-2707	64	9	actively	actively	ADV
dti-2707	64	10	dividing	divide	VERB
dti-2707	64	11	eukaryotes	eukaryote	NOUN
dti-2707	64	12	occur	occur	VERB
dti-2707	64	13	in	in	ADP
dti-2707	64	14	the	the	DET
dti-2707	64	15	sequence	sequence	NOUN
dti-2707	64	16	starting	start	VERB
dti-2707	64	17	from	from	ADP
dti-2707	64	18	gap	gap	NOUN
dti-2707	64	19	1	1	NUM
dti-2707	64	20	,	,	PUNCT
dti-2707	64	21	synthesis	synthesis	NOUN
dti-2707	64	22	,	,	PUNCT
dti-2707	64	23	gap	gap	NOUN
dti-2707	64	24	2	2	NUM
dti-2707	64	25	followed	follow	VERB
dti-2707	64	26	by	by	ADP
dti-2707	64	27	mitosis	mitosis	NOUN
dti-2707	64	28	.	.	PUNCT
dti-2707	65	1	while	while	SCONJ
dti-2707	65	2	entering	enter	VERB
dti-2707	65	3	the	the	DET
dti-2707	65	4	next	next	ADJ
dti-2707	65	5	phase	phase	NOUN
dti-2707	65	6	of	of	ADP
dti-2707	65	7	the	the	DET
dti-2707	65	8	cell	cell	NOUN
dti-2707	65	9	cycle	cycle	NOUN
dti-2707	65	10	,	,	PUNCT
dti-2707	65	11	there	there	PRON
dti-2707	65	12	are	be	VERB
dti-2707	65	13	a	a	DET
dti-2707	65	14	number	number	NOUN
dti-2707	65	15	of	of	ADP
dti-2707	65	16	checkpoints	checkpoint	NOUN
dti-2707	65	17	available	available	ADJ
dti-2707	65	18	en	en	ADP
dti-2707	65	19	route	route	NOUN
dti-2707	65	20	to	to	PART
dti-2707	65	21	ensure	ensure	VERB
dti-2707	65	22	that	that	SCONJ
dti-2707	65	23	the	the	DET
dti-2707	65	24	actions	action	NOUN
dti-2707	65	25	at	at	ADP
dti-2707	65	26	each	each	DET
dti-2707	65	27	phase	phase	NOUN
dti-2707	65	28	have	have	AUX
dti-2707	65	29	been	be	AUX
dti-2707	65	30	appropriately	appropriately	ADV
dti-2707	65	31	completed	complete	VERB
dti-2707	65	32	.	.	PUNCT
dti-2707	66	1	phosphorylated	phosphorylate	VERB
dti-2707	66	2	retinoblastoma	retinoblastoma	NOUN
dti-2707	66	3	protein	protein	NOUN
dti-2707	66	4	(	(	PUNCT
dti-2707	66	5	prb	prb	NOUN
dti-2707	66	6	)	)	PUNCT
dti-2707	66	7	,	,	PUNCT
dti-2707	66	8	cyclin	cyclin	NOUN
dti-2707	66	9	subunits	subunit	NOUN
dti-2707	66	10	,	,	PUNCT
dti-2707	66	11	cyclin	cyclin	NOUN
dti-2707	66	12	-	-	PUNCT
dti-2707	66	13	dependent	dependent	ADJ
dti-2707	66	14	kinases	kinase	NOUN
dti-2707	66	15	(	(	PUNCT
dti-2707	66	16	cdks	cdks	NOUN
dti-2707	66	17	)	)	PUNCT
dti-2707	66	18	,	,	PUNCT
dti-2707	66	19	and	and	CCONJ
dti-2707	66	20	cyclin	cyclin	NOUN
dti-2707	66	21	-	-	PUNCT
dti-2707	66	22	dependent	dependent	ADJ
dti-2707	66	23	kinase	kinase	NOUN
dti-2707	66	24	inhibitors	inhibitor	NOUN
dti-2707	66	25	(	(	PUNCT
dti-2707	66	26	cdkis	cdki	NOUN
dti-2707	66	27	)	)	PUNCT
dti-2707	66	28	are	be	AUX
dti-2707	66	29	the	the	DET
dti-2707	66	30	components	component	NOUN
dti-2707	66	31	of	of	ADP
dti-2707	66	32	these	these	DET
dti-2707	66	33	checkpoints	checkpoint	NOUN
dti-2707	66	34	(	(	PUNCT
dti-2707	66	35	15	15	NUM
dti-2707	66	36	)	)	PUNCT
dti-2707	66	37	.	.	PUNCT
dti-2707	67	1	cell	cell	NOUN
dti-2707	67	2	cycle	cycle	NOUN
dti-2707	67	3	arrest	arrest	NOUN
dti-2707	67	4	occurs	occur	VERB
dti-2707	67	5	when	when	SCONJ
dti-2707	67	6	cells	cell	NOUN
dti-2707	67	7	are	be	AUX
dti-2707	67	8	unable	unable	ADJ
dti-2707	67	9	to	to	PART
dti-2707	67	10	pass	pass	VERB
dti-2707	67	11	cell	cell	NOUN
dti-2707	67	12	cycle	cycle	NOUN
dti-2707	67	13	checkpoints	checkpoint	NOUN
dti-2707	67	14	.	.	PUNCT
dti-2707	68	1	cell	cell	NOUN
dti-2707	68	2	death	death	NOUN
dti-2707	68	3	and	and	CCONJ
dti-2707	68	4	growth	growth	NOUN
dti-2707	68	5	inhibition	inhibition	NOUN
dti-2707	68	6	may	may	AUX
dti-2707	68	7	result	result	VERB
dti-2707	68	8	from	from	ADP
dti-2707	68	9	g1	g1	PROPN
dti-2707	68	10	arrest	arrest	NOUN
dti-2707	68	11	.	.	PUNCT
dti-2707	69	1	g2	g2	PROPN
dti-2707	69	2	/	/	SYM
dti-2707	69	3	m	m	PROPN
dti-2707	69	4	arrest	arrest	NOUN
dti-2707	69	5	is	be	AUX
dti-2707	69	6	linked	link	VERB
dti-2707	69	7	to	to	ADP
dti-2707	69	8	increased	increase	VERB
dti-2707	69	9	apoptosis	apoptosis	NOUN
dti-2707	69	10	and	and	CCONJ
dti-2707	69	11	may	may	AUX
dti-2707	69	12	increase	increase	VERB
dti-2707	69	13	the	the	DET
dti-2707	69	14	cytotoxicity	cytotoxicity	NOUN
dti-2707	69	15	of	of	ADP
dti-2707	69	16	chemotherapy	chemotherapy	NOUN
dti-2707	69	17	(	(	PUNCT
dti-2707	69	18	16	16	NUM
dti-2707	69	19	)	)	PUNCT
dti-2707	69	20	.	.	PUNCT
dti-2707	70	1	it	it	PRON
dti-2707	70	2	is	be	AUX
dti-2707	70	3	estimated	estimate	VERB
dti-2707	70	4	that	that	SCONJ
dti-2707	70	5	in	in	ADP
dti-2707	70	6	2024	2024	NUM
dti-2707	70	7	,	,	PUNCT
dti-2707	70	8	around	around	ADP
dti-2707	70	9	2,001,140	2,001,140	NUM
dti-2707	70	10	new	new	ADJ
dti-2707	70	11	cancer	cancer	NOUN
dti-2707	70	12	cases	case	NOUN
dti-2707	70	13	and	and	CCONJ
dti-2707	70	14	611,720	611,720	NUM
dti-2707	70	15	cancer	cancer	NOUN
dti-2707	70	16	deaths	death	NOUN
dti-2707	70	17	are	be	AUX
dti-2707	70	18	projected	project	VERB
dti-2707	70	19	to	to	PART
dti-2707	70	20	occur	occur	VERB
dti-2707	70	21	in	in	ADP
dti-2707	70	22	the	the	DET
dti-2707	70	23	united	united	PROPN
dti-2707	70	24	states	states	PROPN
dti-2707	70	25	.	.	PUNCT
dti-2707	71	1	with	with	ADP
dti-2707	71	2	around	around	ADV
dti-2707	71	3	350	350	NUM
dti-2707	71	4	cases	case	NOUN
dti-2707	71	5	of	of	ADP
dti-2707	71	6	lung	lung	NOUN
dti-2707	71	7	cancer	cancer	NOUN
dti-2707	71	8	fatalities	fatality	NOUN
dti-2707	71	9	every	every	DET
dti-2707	71	10	day	day	NOUN
dti-2707	71	11	,	,	PUNCT
dti-2707	71	12	lung	lung	NOUN
dti-2707	71	13	cancer	cancer	NOUN
dti-2707	71	14	is	be	AUX
dti-2707	71	15	the	the	DET
dti-2707	71	16	most	most	ADV
dti-2707	71	17	common	common	ADJ
dti-2707	71	18	cause	cause	NOUN
dti-2707	71	19	of	of	ADP
dti-2707	71	20	cancerrelated	cancerrelate	VERB
dti-2707	71	21	mortality	mortality	NOUN
dti-2707	71	22	(	(	PUNCT
dti-2707	71	23	17	17	NUM
dti-2707	71	24	)	)	PUNCT
dti-2707	71	25	.	.	PUNCT
dti-2707	72	1	baicalein	baicalein	PROPN
dti-2707	72	2	induces	induce	VERB
dti-2707	72	3	g1	g1	PROPN
dti-2707	72	4	/	/	SYM
dti-2707	72	5	s	s	PART
dti-2707	72	6	arrest	arrest	NOUN
dti-2707	72	7	in	in	ADP
dti-2707	72	8	lung	lung	NOUN
dti-2707	72	9	squamous	squamous	ADJ
dti-2707	72	10	carcinoma	carcinoma	NOUN
dti-2707	72	11	(	(	PUNCT
dti-2707	72	12	ch27	ch27	PROPN
dti-2707	72	13	)	)	PUNCT
dti-2707	72	14	cells	cell	NOUN
dti-2707	72	15	by	by	ADP
dti-2707	72	16	downregulating	downregulating	NOUN
dti-2707	72	17	cdk4	cdk4	PROPN
dti-2707	72	18	and	and	CCONJ
dti-2707	72	19	cyclin	cyclin	NOUN
dti-2707	72	20	d1	d1	PROPN
dti-2707	72	21	,	,	PUNCT
dti-2707	72	22	as	as	ADV
dti-2707	72	23	well	well	ADV
dti-2707	72	24	as	as	ADP
dti-2707	72	25	upregulating	upregulating	ADJ
dti-2707	72	26	cyclin	cyclin	NOUN
dti-2707	72	27	e	e	NOUN
dti-2707	72	28	expression	expression	NOUN
dti-2707	72	29	,	,	PUNCT
dti-2707	72	30	a	a	DET
dti-2707	72	31	crucial	crucial	ADJ
dti-2707	72	32	regulator	regulator	NOUN
dti-2707	72	33	of	of	ADP
dti-2707	72	34	the	the	DET
dti-2707	72	35	g1	g1	PROPN
dti-2707	72	36	/	/	SYM
dti-2707	72	37	s	s	PART
dti-2707	72	38	checkpoint	checkpoint	NOUN
dti-2707	72	39	of	of	ADP
dti-2707	72	40	the	the	DET
dti-2707	72	41	cell	cell	NOUN
dti-2707	72	42	cycle	cycle	NOUN
dti-2707	72	43	(	(	PUNCT
dti-2707	72	44	18	18	NUM
dti-2707	72	45	)	)	PUNCT
dti-2707	72	46	.	.	PUNCT
dti-2707	73	1	global	global	ADJ
dti-2707	73	2	breast	breast	NOUN
dti-2707	73	3	cancer	cancer	NOUN
dti-2707	73	4	rates	rate	NOUN
dti-2707	73	5	are	be	AUX
dti-2707	73	6	rising	rise	VERB
dti-2707	73	7	,	,	PUNCT
dti-2707	73	8	with	with	ADP
dti-2707	73	9	364,000	364,000	NUM
dti-2707	73	10	united	united	PROPN
dti-2707	73	11	states	states	PROPN
dti-2707	73	12	cases	case	NOUN
dti-2707	73	13	anticipated	anticipate	VERB
dti-2707	73	14	by	by	ADP
dti-2707	73	15	2040	2040	NUM
dti-2707	73	16	(	(	PUNCT
dti-2707	73	17	19	19	NUM
dti-2707	73	18	)	)	PUNCT
dti-2707	73	19	.	.	PUNCT
dti-2707	74	1	baicalein	baicalein	PROPN
dti-2707	74	2	inhibited	inhibit	VERB
dti-2707	74	3	17estradiol	17estradiol	NUM
dti-2707	74	4	-	-	PUNCT
dti-2707	74	5	induced	induced	ADJ
dti-2707	74	6	transactivation	transactivation	NOUN
dti-2707	74	7	of	of	ADP
dti-2707	74	8	the	the	DET
dti-2707	74	9	estrogen	estrogen	NOUN
dti-2707	74	10	receptor	receptor	NOUN
dti-2707	74	11	in	in	ADP
dti-2707	74	12	mcf-7	mcf-7	NOUN
dti-2707	74	13	human	human	ADJ
dti-2707	74	14	breast	breast	NOUN
dti-2707	74	15	cancer	cancer	NOUN
dti-2707	74	16	cells	cell	NOUN
dti-2707	74	17	in	in	ADP
dti-2707	74	18	the	the	DET
dti-2707	74	19	s	s	NOUN
dti-2707	74	20	and	and	CCONJ
dti-2707	74	21	g2	g2	PROPN
dti-2707	74	22	/	/	SYM
dti-2707	74	23	m	m	VERB
dti-2707	74	24	stages	stage	NOUN
dti-2707	74	25	(	(	PUNCT
dti-2707	74	26	20	20	NUM
dti-2707	74	27	)	)	PUNCT
dti-2707	74	28	.	.	PUNCT
dti-2707	75	1	eastern	eastern	PROPN
dti-2707	75	2	asia	asia	PROPN
dti-2707	75	3	currently	currently	ADV
dti-2707	75	4	accounts	account	VERB
dti-2707	75	5	for	for	ADP
dti-2707	75	6	more	more	ADJ
dti-2707	75	7	than	than	ADP
dti-2707	75	8	60	60	NUM
dti-2707	75	9	%	%	NOUN
dti-2707	75	10	of	of	ADP
dti-2707	75	11	cases	case	NOUN
dti-2707	75	12	of	of	ADP
dti-2707	75	13	gastric	gastric	ADJ
dti-2707	75	14	cancer	cancer	NOUN
dti-2707	75	15	.	.	PUNCT
dti-2707	76	1	currently	currently	ADV
dti-2707	76	2	,	,	PUNCT
dti-2707	76	3	a	a	DET
dti-2707	76	4	major	major	ADJ
dti-2707	76	5	problem	problem	NOUN
dti-2707	76	6	in	in	ADP
dti-2707	76	7	eastern	eastern	PROPN
dti-2707	76	8	asia	asia	PROPN
dti-2707	76	9	is	be	AUX
dti-2707	76	10	how	how	SCONJ
dti-2707	76	11	to	to	PART
dti-2707	76	12	manage	manage	VERB
dti-2707	76	13	gastric	gastric	ADJ
dti-2707	76	14	cancer	cancer	NOUN
dti-2707	76	15	in	in	ADP
dti-2707	76	16	the	the	DET
dti-2707	76	17	older	old	ADJ
dti-2707	76	18	population	population	NOUN
dti-2707	76	19	.	.	PUNCT
dti-2707	77	1	it	it	PRON
dti-2707	77	2	is	be	AUX
dti-2707	77	3	anticipated	anticipate	VERB
dti-2707	77	4	that	that	SCONJ
dti-2707	77	5	the	the	DET
dti-2707	77	6	total	total	ADJ
dti-2707	77	7	number	number	NOUN
dti-2707	77	8	of	of	ADP
dti-2707	77	9	gastric	gastric	ADJ
dti-2707	77	10	cancer	cancer	NOUN
dti-2707	77	11	cases	case	NOUN
dti-2707	77	12	and	and	CCONJ
dti-2707	77	13	fatalities	fatality	NOUN
dti-2707	77	14	would	would	AUX
dti-2707	77	15	reach	reach	VERB
dti-2707	77	16	its	its	PRON
dti-2707	77	17	peak	peak	NOUN
dti-2707	77	18	soon	soon	ADV
dti-2707	77	19	(	(	PUNCT
dti-2707	77	20	21	21	NUM
dti-2707	77	21	)	)	PUNCT
dti-2707	77	22	.	.	PUNCT
dti-2707	78	1	the	the	DET
dti-2707	78	2	gastric	gastric	ADJ
dti-2707	78	3	cancer	cancer	NOUN
dti-2707	78	4	cell	cell	NOUN
dti-2707	78	5	line	line	NOUN
dti-2707	78	6	sgc-7901	sgc-7901	NOUN
dti-2707	78	7	underwent	undergo	VERB
dti-2707	78	8	a	a	DET
dti-2707	78	9	significant	significant	ADJ
dti-2707	78	10	s	s	NOUN
dti-2707	78	11	-	-	PUNCT
dti-2707	78	12	phase	phase	NOUN
dti-2707	78	13	arrest	arrest	NOUN
dti-2707	78	14	as	as	ADP
dti-2707	78	15	a	a	DET
dti-2707	78	16	result	result	NOUN
dti-2707	78	17	of	of	ADP
dti-2707	78	18	baicalein	baicalein	PROPN
dti-2707	78	19	.	.	PUNCT
dti-2707	79	1	it	it	PRON
dti-2707	79	2	resulted	result	VERB
dti-2707	79	3	in	in	ADP
dti-2707	79	4	sgc-7901	sgc-7901	ADJ
dti-2707	79	5	cells	cell	NOUN
dti-2707	79	6	going	go	VERB
dti-2707	79	7	into	into	ADP
dti-2707	79	8	apoptosis	apoptosis	NOUN
dti-2707	79	9	.	.	PUNCT
dti-2707	80	1	analysis	analysis	NOUN
dti-2707	80	2	of	of	ADP
dti-2707	80	3	protein	protein	NOUN
dti-2707	80	4	expression	expression	NOUN
dti-2707	80	5	levels	level	NOUN
dti-2707	80	6	in	in	ADP
dti-2707	80	7	sgc-7901	sgc-7901	ADJ
dti-2707	80	8	cells	cell	NOUN
dti-2707	80	9	showed	show	VERB
dti-2707	80	10	that	that	SCONJ
dti-2707	80	11	when	when	SCONJ
dti-2707	80	12	baicalein	baicalein	PROPN
dti-2707	80	13	was	be	AUX
dti-2707	80	14	administered	administer	VERB
dti-2707	80	15	,	,	PUNCT
dti-2707	80	16	bcl-2	bcl-2	PUNCT
dti-2707	80	17	was	be	AUX
dti-2707	80	18	downregulated	downregulate	VERB
dti-2707	80	19	and	and	CCONJ
dti-2707	80	20	bax	bax	PROPN
dti-2707	80	21	was	be	AUX
dti-2707	80	22	increased	increase	VERB
dti-2707	80	23	(	(	PUNCT
dti-2707	80	24	22	22	NUM
dti-2707	80	25	)	)	PUNCT
dti-2707	80	26	.	.	PUNCT
dti-2707	81	1	the	the	DET
dti-2707	81	2	third	third	ADJ
dti-2707	81	3	most	most	ADV
dti-2707	81	4	common	common	ADJ
dti-2707	81	5	reason	reason	NOUN
dti-2707	81	6	for	for	ADP
dti-2707	81	7	cancer	cancer	NOUN
dti-2707	81	8	-	-	PUNCT
dti-2707	81	9	related	relate	VERB
dti-2707	81	10	death	death	NOUN
dti-2707	81	11	worldwide	worldwide	ADV
dti-2707	81	12	is	be	AUX
dti-2707	81	13	primary	primary	ADJ
dti-2707	81	14	hepatic	hepatic	ADJ
dti-2707	81	15	cancer	cancer	NOUN
dti-2707	81	16	.	.	PUNCT
dti-2707	82	1	most	most	ADJ
dti-2707	82	2	patients	patient	NOUN
dti-2707	82	3	receive	receive	VERB
dti-2707	82	4	a	a	DET
dti-2707	82	5	bad	bad	ADJ
dti-2707	82	6	prognosis	prognosis	NOUN
dti-2707	82	7	at	at	ADP
dti-2707	82	8	an	an	DET
dti-2707	82	9	advanced	advanced	ADJ
dti-2707	82	10	stage	stage	NOUN
dti-2707	82	11	.	.	PUNCT
dti-2707	83	1	in	in	ADP
dti-2707	83	2	an	an	DET
dti-2707	83	3	in	in	ADP
dti-2707	83	4	vitro	vitro	X
dti-2707	83	5	investigation	investigation	NOUN
dti-2707	83	6	using	use	VERB
dti-2707	83	7	hepatoma	hepatoma	ADJ
dti-2707	83	8	carcinoma	carcinoma	NOUN
dti-2707	83	9	cells	cell	NOUN
dti-2707	83	10	(	(	PUNCT
dti-2707	83	11	hep	hep	NOUN
dti-2707	83	12	g2	g2	PROPN
dti-2707	83	13	and	and	CCONJ
dti-2707	83	14	j2	j2	PROPN
dti-2707	83	15	)	)	PUNCT
dti-2707	83	16	,	,	PUNCT
dti-2707	83	17	baicalein	baicalein	NOUN
dti-2707	83	18	therapy	therapy	NOUN
dti-2707	83	19	resulted	result	VERB
dti-2707	83	20	in	in	ADP
dti-2707	83	21	s	s	NOUN
dti-2707	83	22	-	-	PUNCT
dti-2707	83	23	phase	phase	NOUN
dti-2707	83	24	arrest	arrest	NOUN
dti-2707	83	25	.	.	PUNCT
dti-2707	84	1	some	some	PRON
dti-2707	84	2	of	of	ADP
dti-2707	84	3	the	the	DET
dti-2707	84	4	underlying	underlying	ADJ
dti-2707	84	5	mechanisms	mechanism	NOUN
dti-2707	84	6	include	include	VERB
dti-2707	84	7	early	early	ADJ
dti-2707	84	8	-	-	PUNCT
dti-2707	84	9	stage	stage	NOUN
dti-2707	84	10	dna	dna	NOUN
dti-2707	84	11	damage	damage	NOUN
dti-2707	84	12	,	,	PUNCT
dti-2707	84	13	the	the	DET
dti-2707	84	14	inhibition	inhibition	NOUN
dti-2707	84	15	of	of	ADP
dti-2707	84	16	growth	growth	NOUN
dti-2707	84	17	-	-	PUNCT
dti-2707	84	18	stimulating	stimulate	VERB
dti-2707	84	19	substances	substance	NOUN
dti-2707	84	20	,	,	PUNCT
dti-2707	84	21	and	and	CCONJ
dti-2707	84	22	the	the	DET
dti-2707	84	23	activation	activation	NOUN
dti-2707	84	24	of	of	ADP
dti-2707	84	25	cyclincdkis	cyclincdkis	PROPN
dti-2707	84	26	(	(	PUNCT
dti-2707	84	27	23	23	NUM
dti-2707	84	28	)	)	PUNCT
dti-2707	84	29	.	.	PUNCT
dti-2707	85	1	the	the	DET
dti-2707	85	2	seventh	seventh	ADJ
dti-2707	85	3	most	most	ADV
dti-2707	85	4	common	common	ADJ
dti-2707	85	5	cause	cause	NOUN
dti-2707	85	6	of	of	ADP
dti-2707	85	7	cancer	cancer	NOUN
dti-2707	85	8	-	-	PUNCT
dti-2707	85	9	related	relate	VERB
dti-2707	85	10	fatalities	fatality	NOUN
dti-2707	85	11	worldwide	worldwide	ADV
dti-2707	85	12	is	be	AUX
dti-2707	85	13	pancreatic	pancreatic	ADJ
dti-2707	85	14	cancer	cancer	NOUN
dti-2707	85	15	.	.	PUNCT
dti-2707	86	1	however	however	ADV
dti-2707	86	2	,	,	PUNCT
dti-2707	86	3	many	many	ADJ
dti-2707	86	4	developed	develop	VERB
dti-2707	86	5	nations	nation	NOUN
dti-2707	86	6	suffer	suffer	VERB
dti-2707	86	7	from	from	ADP
dti-2707	86	8	it	it	PRON
dti-2707	86	9	more	more	ADV
dti-2707	86	10	severely	severely	ADV
dti-2707	86	11	.	.	PUNCT
dti-2707	87	1	globally	globally	ADV
dti-2707	87	2	,	,	PUNCT
dti-2707	87	3	there	there	PRON
dti-2707	87	4	were	be	VERB
dti-2707	87	5	458,918	458,918	NUM
dti-2707	87	6	new	new	ADJ
dti-2707	87	7	cases	case	NOUN
dti-2707	87	8	of	of	ADP
dti-2707	87	9	pancreatic	pancreatic	ADJ
dti-2707	87	10	cancer	cancer	NOUN
dti-2707	87	11	recorded	record	VERB
dti-2707	87	12	in	in	ADP
dti-2707	87	13	2018	2018	NUM
dti-2707	87	14	,	,	PUNCT
dti-2707	87	15	and	and	CCONJ
dti-2707	87	16	355,317	355,317	NUM
dti-2707	87	17	additional	additional	ADJ
dti-2707	87	18	instances	instance	NOUN
dti-2707	87	19	are	be	AUX
dti-2707	87	20	expected	expect	VERB
dti-2707	87	21	to	to	PART
dti-2707	87	22	be	be	AUX
dti-2707	87	23	reported	report	VERB
dti-2707	87	24	before	before	ADP
dti-2707	87	25	2040	2040	NUM
dti-2707	87	26	(	(	PUNCT
dti-2707	87	27	24	24	NUM
dti-2707	87	28	)	)	PUNCT
dti-2707	87	29	.	.	PUNCT
dti-2707	88	1	baicalein	baicalein	PROPN
dti-2707	88	2	upregulates	upregulate	VERB
dti-2707	88	3	bax	bax	PROPN
dti-2707	88	4	while	while	SCONJ
dti-2707	88	5	downregulating	downregulating	NOUN
dti-2707	88	6	bcl-2	bcl-2	VERB
dti-2707	88	7	and	and	CCONJ
dti-2707	88	8	mcl-1	mcl-1	ADP
dti-2707	88	9	to	to	PART
dti-2707	88	10	encourage	encourage	VERB
dti-2707	88	11	apoptosis	apoptosis	NOUN
dti-2707	88	12	in	in	ADP
dti-2707	88	13	pancreatic	pancreatic	ADJ
dti-2707	88	14	cancer	cancer	NOUN
dti-2707	88	15	cells	cell	NOUN
dti-2707	88	16	(	(	PUNCT
dti-2707	88	17	25	25	NUM
dti-2707	88	18	)	)	PUNCT
dti-2707	88	19	.	.	PUNCT
dti-2707	89	1	in	in	ADP
dti-2707	89	2	panc-1	panc-1	NOUN
dti-2707	89	3	cells	cell	NOUN
dti-2707	89	4	,	,	PUNCT
dti-2707	89	5	baicalein	baicalein	NOUN
dti-2707	89	6	induced	induce	VERB
dti-2707	89	7	arrest	arrest	NOUN
dti-2707	89	8	of	of	ADP
dti-2707	89	9	g0	g0	PROPN
dti-2707	89	10	/	/	SYM
dti-2707	89	11	g1	g1	PROPN
dti-2707	89	12	phase	phase	NOUN
dti-2707	89	13	when	when	SCONJ
dti-2707	89	14	studied	study	VERB
dti-2707	89	15	in	in	ADP
dti-2707	89	16	vitro	vitro	X
dti-2707	89	17	(	(	PUNCT
dti-2707	89	18	26	26	NUM
dti-2707	89	19	)	)	PUNCT
dti-2707	89	20	.	.	PUNCT
dti-2707	90	1	rising	rise	VERB
dti-2707	90	2	death	death	NOUN
dti-2707	90	3	rates	rate	NOUN
dti-2707	90	4	from	from	ADP
dti-2707	90	5	colorectal	colorectal	ADJ
dti-2707	90	6	cancer	cancer	NOUN
dti-2707	90	7	(	(	PUNCT
dti-2707	90	8	crc	crc	NOUN
dti-2707	90	9	)	)	PUNCT
dti-2707	90	10	are	be	AUX
dti-2707	90	11	a	a	DET
dti-2707	90	12	burden	burden	NOUN
dti-2707	90	13	shared	share	VERB
dti-2707	90	14	by	by	ADP
dti-2707	90	15	developing	develop	VERB
dti-2707	90	16	asian	asian	ADJ
dti-2707	90	17	nations	nation	NOUN
dti-2707	90	18	.	.	PUNCT
dti-2707	91	1	patients	patient	NOUN
dti-2707	91	2	with	with	ADP
dti-2707	91	3	crc	crc	NOUN
dti-2707	91	4	may	may	AUX
dti-2707	91	5	be	be	AUX
dti-2707	91	6	at	at	ADP
dti-2707	91	7	danger	danger	NOUN
dti-2707	91	8	if	if	SCONJ
dti-2707	91	9	they	they	PRON
dti-2707	91	10	are	be	AUX
dti-2707	91	11	underweight	underweight	ADJ
dti-2707	91	12	or	or	CCONJ
dti-2707	91	13	overweight	overweight	ADJ
dti-2707	91	14	(	(	PUNCT
dti-2707	91	15	27	27	NUM
dti-2707	91	16	)	)	PUNCT
dti-2707	91	17	.	.	PUNCT
dti-2707	92	1	in	in	ADP
dti-2707	92	2	hct-116	hct-116	INTJ
dti-2707	92	3	crc	crc	NOUN
dti-2707	92	4	cells	cell	NOUN
dti-2707	92	5	,	,	PUNCT
dti-2707	92	6	baicalein	baicalein	PROPN
dti-2707	92	7	causes	cause	VERB
dti-2707	92	8	a	a	DET
dti-2707	92	9	significant	significant	ADJ
dti-2707	92	10	arrest	arrest	NOUN
dti-2707	92	11	of	of	ADP
dti-2707	92	12	s	s	NOUN
dti-2707	92	13	phase	phase	NOUN
dti-2707	92	14	and	and	CCONJ
dti-2707	92	15	promotes	promote	VERB
dti-2707	92	16	apoptosis	apoptosis	NOUN
dti-2707	92	17	by	by	ADP
dti-2707	92	18	activating	activate	VERB
dti-2707	92	19	caspase	caspase	PROPN
dti-2707	92	20	3	3	NUM
dti-2707	92	21	and	and	CCONJ
dti-2707	92	22	caspase	caspase	PROPN
dti-2707	92	23	9	9	NUM
dti-2707	92	24	(	(	PUNCT
dti-2707	92	25	28	28	NUM
dti-2707	92	26	)	)	PUNCT
dti-2707	92	27	.	.	PUNCT
dti-2707	93	1	the	the	DET
dti-2707	93	2	most	most	ADV
dti-2707	93	3	common	common	ADJ
dti-2707	93	4	form	form	NOUN
dti-2707	93	5	of	of	ADP
dti-2707	93	6	male	male	ADJ
dti-2707	93	7	cancer	cancer	NOUN
dti-2707	93	8	in	in	ADP
dti-2707	93	9	developed	develop	VERB
dti-2707	93	10	nations	nation	NOUN
dti-2707	93	11	is	be	AUX
dti-2707	93	12	prostate	prostate	NOUN
dti-2707	93	13	cancer	cancer	NOUN
dti-2707	93	14	(	(	PUNCT
dti-2707	93	15	pc	pc	NOUN
dti-2707	93	16	)	)	PUNCT
dti-2707	93	17	.	.	PUNCT
dti-2707	94	1	in	in	ADP
dti-2707	94	2	pc	pc	NOUN
dti-2707	94	3	cells	cell	NOUN
dti-2707	94	4	,	,	PUNCT
dti-2707	94	5	baicalein	baicalein	PROPN
dti-2707	94	6	caused	cause	VERB
dti-2707	94	7	g0	g0	PROPN
dti-2707	94	8	/	/	SYM
dti-2707	94	9	g1	g1	PROPN
dti-2707	94	10	arrest	arrest	NOUN
dti-2707	94	11	by	by	ADP
dti-2707	94	12	lower	low	ADJ
dti-2707	94	13	down	down	ADP
dti-2707	94	14	cyclins	cyclin	NOUN
dti-2707	94	15	(	(	PUNCT
dti-2707	94	16	d1	d1	NOUN
dti-2707	94	17	and	and	CCONJ
dti-2707	94	18	d3	d3	PROPN
dti-2707	94	19	)	)	PUNCT
dti-2707	94	20	and	and	CCONJ
dti-2707	94	21	prb	prb	PROPN
dti-2707	94	22	(	(	PUNCT
dti-2707	94	23	29	29	NUM
dti-2707	94	24	)	)	PUNCT
dti-2707	94	25	.	.	PUNCT
dti-2707	95	1	bladder	bladder	NOUN
dti-2707	95	2	cancer	cancer	NOUN
dti-2707	95	3	(	(	PUNCT
dti-2707	95	4	bc	bc	PROPN
dti-2707	95	5	)	)	PUNCT
dti-2707	95	6	ranks	rank	VERB
dti-2707	95	7	in	in	ADP
dti-2707	95	8	the	the	DET
dti-2707	95	9	top	top	ADJ
dti-2707	95	10	10	10	NUM
dti-2707	95	11	most	most	ADV
dti-2707	95	12	common	common	ADJ
dti-2707	95	13	cancers	cancer	NOUN
dti-2707	95	14	globally	globally	ADV
dti-2707	95	15	.	.	PUNCT
dti-2707	96	1	baicalein	baicalein	PROPN
dti-2707	96	2	caused	cause	VERB
dti-2707	96	3	g2	g2	PROPN
dti-2707	96	4	/	/	SYM
dti-2707	96	5	m	m	NOUN
dti-2707	96	6	arrest	arrest	NOUN
dti-2707	96	7	in	in	ADP
dti-2707	96	8	tsgh8301	tsgh8301	PROPN
dti-2707	96	9	and	and	CCONJ
dti-2707	96	10	bftc905	bftc905	PROPN
dti-2707	96	11	bc	bc	PROPN
dti-2707	96	12	cells	cell	NOUN
dti-2707	96	13	by	by	ADP
dti-2707	96	14	altering	alter	VERB
dti-2707	96	15	two	two	NUM
dti-2707	96	16	essential	essential	ADJ
dti-2707	96	17	proteins	protein	NOUN
dti-2707	96	18	(	(	PUNCT
dti-2707	96	19	cyclin	cyclin	NOUN
dti-2707	96	20	b1	b1	NOUN
dti-2707	96	21	and	and	CCONJ
dti-2707	96	22	phospho	phospho	ADJ
dti-2707	96	23	-	-	PUNCT
dti-2707	96	24	cdc2	cdc2	NOUN
dti-2707	96	25	)	)	PUNCT
dti-2707	96	26	required	require	VERB
dti-2707	96	27	to	to	PART
dti-2707	96	28	initiate	initiate	VERB
dti-2707	96	29	the	the	DET
dti-2707	96	30	final	final	ADJ
dti-2707	96	31	stage	stage	NOUN
dti-2707	96	32	of	of	ADP
dti-2707	96	33	cell	cell	NOUN
dti-2707	96	34	cycle	cycle	NOUN
dti-2707	96	35	(	(	PUNCT
dti-2707	96	36	30,31	30,31	NOUN
dti-2707	96	37	)	)	PUNCT
dti-2707	96	38	.	.	PUNCT
dti-2707	97	1	ovarian	ovarian	ADJ
dti-2707	97	2	cancer	cancer	NOUN
dti-2707	97	3	is	be	AUX
dti-2707	97	4	the	the	DET
dti-2707	97	5	seventh	seventh	ADJ
dti-2707	97	6	most	most	ADV
dti-2707	97	7	prevalent	prevalent	ADJ
dti-2707	97	8	malignant	malignant	ADJ
dti-2707	97	9	tumor	tumor	NOUN
dti-2707	97	10	in	in	ADP
dti-2707	97	11	women	woman	NOUN
dti-2707	97	12	,	,	PUNCT
dti-2707	97	13	gravely	gravely	ADV
dti-2707	97	14	endangering	endanger	VERB
dti-2707	97	15	the	the	DET
dti-2707	97	16	reproductive	reproductive	ADJ
dti-2707	97	17	health	health	NOUN
dti-2707	97	18	of	of	ADP
dti-2707	97	19	women	woman	NOUN
dti-2707	97	20	.	.	PUNCT
dti-2707	98	1	it	it	PRON
dti-2707	98	2	has	have	VERB
dti-2707	98	3	a	a	DET
dti-2707	98	4	poor	poor	ADJ
dti-2707	98	5	prognosis	prognosis	NOUN
dti-2707	98	6	,	,	PUNCT
dti-2707	98	7	unknown	unknown	ADJ
dti-2707	98	8	pathophysiology	pathophysiology	NOUN
dti-2707	98	9	,	,	PUNCT
dti-2707	98	10	missed	miss	VERB
dti-2707	98	11	diagnoses	diagnosis	NOUN
dti-2707	98	12	,	,	PUNCT
dti-2707	98	13	and	and	CCONJ
dti-2707	98	14	a	a	DET
dti-2707	98	15	high	high	ADJ
dti-2707	98	16	recurrence	recurrence	NOUN
dti-2707	98	17	rate	rate	NOUN
dti-2707	98	18	(	(	PUNCT
dti-2707	98	19	38	38	NUM
dti-2707	98	20	)	)	PUNCT
dti-2707	98	21	.	.	PUNCT
dti-2707	99	1	it	it	PRON
dti-2707	99	2	only	only	ADV
dti-2707	99	3	affects	affect	VERB
dti-2707	99	4	women	woman	NOUN
dti-2707	99	5	and	and	CCONJ
dti-2707	99	6	has	have	VERB
dti-2707	99	7	a	a	DET
dti-2707	99	8	fatality	fatality	NOUN
dti-2707	99	9	rate	rate	NOUN
dti-2707	99	10	of	of	ADP
dti-2707	99	11	46.2	46.2	NUM
dti-2707	99	12	%	%	NOUN
dti-2707	99	13	after	after	ADP
dti-2707	99	14	5	5	NUM
dti-2707	99	15	years	year	NOUN
dti-2707	99	16	,	,	PUNCT
dti-2707	99	17	making	make	VERB
dti-2707	99	18	it	it	PRON
dti-2707	99	19	unique	unique	ADJ
dti-2707	99	20	to	to	ADP
dti-2707	99	21	the	the	DET
dti-2707	99	22	female	female	ADJ
dti-2707	99	23	population	population	NOUN
dti-2707	99	24	(	(	PUNCT
dti-2707	99	25	38	38	NUM
dti-2707	99	26	)	)	PUNCT
dti-2707	99	27	.	.	PUNCT
dti-2707	100	1	baicalein	baicalein	PROPN
dti-2707	100	2	inhibits	inhibit	VERB
dti-2707	100	3	the	the	DET
dti-2707	100	4	synthesis	synthesis	NOUN
dti-2707	100	5	of	of	ADP
dti-2707	100	6	vascular	vascular	ADJ
dti-2707	100	7	endothelial	endothelial	ADJ
dti-2707	100	8	growth	growth	NOUN
dti-2707	100	9	factor	factor	NOUN
dti-2707	100	10	(	(	PUNCT
dti-2707	100	11	vegf	vegf	PROPN
dti-2707	100	12	)	)	PUNCT
dti-2707	100	13	,	,	PUNCT
dti-2707	100	14	hif-1	hif-1	X
dti-2707	100	15	,	,	PUNCT
dti-2707	100	16	c	c	NOUN
dti-2707	100	17	-	-	PUNCT
dti-2707	100	18	myc	myc	NOUN
dti-2707	100	19	,	,	PUNCT
dti-2707	100	20	and	and	CCONJ
dti-2707	100	21	nuclear	nuclear	ADJ
dti-2707	100	22	factor	factor	NOUN
dti-2707	100	23	kappa	kappa	PROPN
dti-2707	100	24	b	b	PROPN
dti-2707	100	25	(	(	PUNCT
dti-2707	100	26	nf	nf	NOUN
dti-2707	100	27	-	-	PUNCT
dti-2707	100	28	κb	κb	NOUN
dti-2707	100	29	)	)	PUNCT
dti-2707	100	30	in	in	ADP
dti-2707	100	31	the	the	DET
dti-2707	100	32	g1	g1	NOUN
dti-2707	100	33	and	and	CCONJ
dti-2707	100	34	s	s	VERB
dti-2707	100	35	phases	phase	NOUN
dti-2707	100	36	of	of	ADP
dti-2707	100	37	ovarian	ovarian	ADJ
dti-2707	100	38	cancer	cancer	NOUN
dti-2707	100	39	cell	cell	NOUN
dti-2707	100	40	lines	line	NOUN
dti-2707	100	41	(	(	PUNCT
dti-2707	100	42	ovcar-3	ovcar-3	NUM
dti-2707	100	43	and	and	CCONJ
dti-2707	100	44	cp-70	cp-70	NUM
dti-2707	100	45	)	)	PUNCT
dti-2707	100	46	.	.	PUNCT
dti-2707	101	1	it	it	PRON
dti-2707	101	2	inhibited	inhibit	VERB
dti-2707	101	3	the	the	DET
dti-2707	101	4	growth	growth	NOUN
dti-2707	101	5	of	of	ADP
dti-2707	101	6	ovarian	ovarian	ADJ
dti-2707	101	7	cancer	cancer	NOUN
dti-2707	101	8	cells	cell	NOUN
dti-2707	101	9	by	by	ADP
dti-2707	101	10	lowering	lower	VERB
dti-2707	101	11	the	the	DET
dti-2707	101	12	expression	expression	NOUN
dti-2707	101	13	of	of	ADP
dti-2707	101	14	matrix	matrix	NOUN
dti-2707	101	15	metalloproteinase	metalloproteinase	NOUN
dti-2707	101	16	(	(	PUNCT
dti-2707	101	17	mmp)-2	mmp)-2	NOUN
dti-2707	101	18	(	(	PUNCT
dti-2707	101	19	32	32	NUM
dti-2707	101	20	-	-	SYM
dti-2707	101	21	35	35	NUM
dti-2707	101	22	)	)	PUNCT
dti-2707	101	23	.	.	PUNCT
dti-2707	102	1	osteosarcoma	osteosarcoma	ADJ
dti-2707	102	2	(	(	PUNCT
dti-2707	102	3	os	os	NOUN
dti-2707	102	4	)	)	PUNCT
dti-2707	102	5	is	be	AUX
dti-2707	102	6	the	the	DET
dti-2707	102	7	most	most	ADV
dti-2707	102	8	prevalent	prevalent	ADJ
dti-2707	102	9	primary	primary	ADJ
dti-2707	102	10	bone	bone	NOUN
dti-2707	102	11	cancer	cancer	NOUN
dti-2707	102	12	in	in	ADP
dti-2707	102	13	children	child	NOUN
dti-2707	102	14	and	and	CCONJ
dti-2707	102	15	adolescents	adolescent	NOUN
dti-2707	102	16	.	.	PUNCT
dti-2707	103	1	in	in	ADP
dti-2707	103	2	its	its	PRON
dti-2707	103	3	advanced	advanced	ADJ
dti-2707	103	4	stages	stage	NOUN
dti-2707	103	5	,	,	PUNCT
dti-2707	103	6	it	it	PRON
dti-2707	103	7	has	have	VERB
dti-2707	103	8	a	a	DET
dti-2707	103	9	low	low	ADJ
dti-2707	103	10	survival	survival	NOUN
dti-2707	103	11	rate	rate	NOUN
dti-2707	103	12	(	(	PUNCT
dti-2707	103	13	36,37	36,37	NUM
dti-2707	103	14	)	)	PUNCT
dti-2707	103	15	.	.	PUNCT
dti-2707	104	1	baicalein	baicalein	PROPN
dti-2707	104	2	produced	produce	VERB
dti-2707	104	3	intracellular	intracellular	ADJ
dti-2707	104	4	reactive	reactive	ADJ
dti-2707	104	5	oxygen	oxygen	NOUN
dti-2707	104	6	species	specie	NOUN
dti-2707	104	7	(	(	PUNCT
dti-2707	104	8	ros	ros	PROPN
dti-2707	104	9	)	)	PUNCT
dti-2707	104	10	and	and	CCONJ
dti-2707	104	11	activated	activate	VERB
dti-2707	104	12	bnip3	bnip3	NOUN
dti-2707	104	13	to	to	PART
dti-2707	104	14	slow	slow	VERB
dti-2707	104	15	down	down	ADP
dti-2707	104	16	the	the	DET
dti-2707	104	17	development	development	NOUN
dti-2707	104	18	and	and	CCONJ
dti-2707	104	19	hasten	hasten	VERB
dti-2707	104	20	the	the	DET
dti-2707	104	21	apoptosis	apoptosis	NOUN
dti-2707	104	22	of	of	ADP
dti-2707	104	23	mg-63,os	mg-63,os	NOUN
dti-2707	104	24	cells	cell	NOUN
dti-2707	104	25	(	(	PUNCT
dti-2707	104	26	38	38	NUM
dti-2707	104	27	)	)	PUNCT
dti-2707	104	28	.	.	PUNCT
dti-2707	105	1	figure	figure	VERB
dti-2707	105	2	1	1	NUM
dti-2707	105	3	structure	structure	NOUN
dti-2707	105	4	of	of	ADP
dti-2707	105	5	baicalein	baicalein	PROPN
dti-2707	105	6	.	.	PUNCT
dti-2707	106	1	munjal	munjal	PROPN
dti-2707	106	2	et	et	PROPN
dti-2707	106	3	al	al	PROPN
dti-2707	106	4	drug	drug	PROPN
dti-2707	106	5	target	target	NOUN
dti-2707	106	6	insights	insight	NOUN
dti-2707	106	7	2024	2024	NUM
dti-2707	106	8	;	;	PUNCT
dti-2707	106	9	18	18	NUM
dti-2707	106	10	:	:	SYM
dti-2707	106	11	33	33	NUM
dti-2707	106	12	©	©	PROPN
dti-2707	106	13	2024	2024	NUM
dti-2707	106	14	the	the	DET
dti-2707	106	15	authors	author	NOUN
dti-2707	106	16	.	.	PUNCT
dti-2707	107	1	published	publish	VERB
dti-2707	107	2	by	by	ADP
dti-2707	107	3	aboutscience	aboutscience	NOUN
dti-2707	107	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2707	107	5	by	by	ADP
dti-2707	107	6	reducing	reduce	VERB
dti-2707	107	7	the	the	DET
dti-2707	107	8	levels	level	NOUN
dti-2707	107	9	of	of	ADP
dti-2707	107	10	cyclin	cyclin	NOUN
dti-2707	107	11	d1	d1	PROPN
dti-2707	107	12	and	and	CCONJ
dti-2707	107	13	cdk4	cdk4	PROPN
dti-2707	107	14	,	,	PUNCT
dti-2707	107	15	which	which	PRON
dti-2707	107	16	inhibits	inhibit	VERB
dti-2707	107	17	the	the	DET
dti-2707	107	18	advancement	advancement	NOUN
dti-2707	107	19	of	of	ADP
dti-2707	107	20	the	the	DET
dti-2707	107	21	g1	g1	PROPN
dti-2707	107	22	phase	phase	NOUN
dti-2707	107	23	,	,	PUNCT
dti-2707	107	24	it	it	PRON
dti-2707	107	25	slowed	slow	VERB
dti-2707	107	26	the	the	DET
dti-2707	107	27	growth	growth	NOUN
dti-2707	107	28	of	of	ADP
dti-2707	107	29	os	os	NOUN
dti-2707	107	30	cells	cell	NOUN
dti-2707	107	31	.	.	PUNCT
dti-2707	108	1	by	by	ADP
dti-2707	108	2	decreasing	decrease	VERB
dti-2707	108	3	the	the	DET
dti-2707	108	4	levels	level	NOUN
dti-2707	108	5	of	of	ADP
dti-2707	108	6	cyclin	cyclin	NOUN
dti-2707	108	7	d1	d1	PROPN
dti-2707	108	8	and	and	CCONJ
dti-2707	108	9	cdk4	cdk4	NOUN
dti-2707	108	10	,	,	PUNCT
dti-2707	108	11	it	it	PRON
dti-2707	108	12	inhibited	inhibit	VERB
dti-2707	108	13	the	the	DET
dti-2707	108	14	growth	growth	NOUN
dti-2707	108	15	of	of	ADP
dti-2707	108	16	os	os	NOUN
dti-2707	108	17	cells	cell	NOUN
dti-2707	108	18	by	by	ADP
dti-2707	108	19	inhibiting	inhibit	VERB
dti-2707	108	20	cell	cell	NOUN
dti-2707	108	21	cycle	cycle	NOUN
dti-2707	108	22	progression	progression	NOUN
dti-2707	108	23	at	at	ADP
dti-2707	108	24	the	the	DET
dti-2707	108	25	g1	g1	PROPN
dti-2707	108	26	phase	phase	NOUN
dti-2707	108	27	of	of	ADP
dti-2707	108	28	division	division	NOUN
dti-2707	108	29	(	(	PUNCT
dti-2707	108	30	tab	tab	NOUN
dti-2707	108	31	.	.	NOUN
dti-2707	108	32	2	2	NUM
dti-2707	108	33	)	)	PUNCT
dti-2707	108	34	(	(	PUNCT
dti-2707	108	35	39	39	NUM
dti-2707	108	36	)	)	PUNCT
dti-2707	108	37	.	.	PUNCT
dti-2707	109	1	baicalin	baicalin	NOUN
dti-2707	109	2	for	for	ADP
dti-2707	109	3	neuroprotection	neuroprotection	NOUN
dti-2707	109	4	and	and	CCONJ
dti-2707	109	5	cognitive	cognitive	ADJ
dti-2707	109	6	enhancement	enhancement	NOUN
dti-2707	109	7	alzheimer	alzheimer	PROPN
dti-2707	109	8	’s	’s	PART
dti-2707	109	9	disease	disease	NOUN
dti-2707	109	10	is	be	AUX
dti-2707	109	11	responsible	responsible	ADJ
dti-2707	109	12	for	for	ADP
dti-2707	109	13	the	the	DET
dti-2707	109	14	more	more	ADJ
dti-2707	109	15	than	than	ADP
dti-2707	109	16	25	25	NUM
dti-2707	109	17	million	million	NUM
dti-2707	109	18	cases	case	NOUN
dti-2707	109	19	of	of	ADP
dti-2707	109	20	dementia	dementia	NOUN
dti-2707	109	21	that	that	PRON
dti-2707	109	22	exist	exist	VERB
dti-2707	109	23	today	today	NOUN
dti-2707	109	24	.	.	PUNCT
dti-2707	110	1	both	both	PRON
dti-2707	110	2	in	in	ADP
dti-2707	110	3	industrialized	industrialized	ADJ
dti-2707	110	4	and	and	CCONJ
dti-2707	110	5	developing	develop	VERB
dti-2707	110	6	nations	nation	NOUN
dti-2707	110	7	,	,	PUNCT
dti-2707	110	8	alzheimer	alzheimer	PROPN
dti-2707	110	9	’s	’s	PART
dti-2707	110	10	disease	disease	NOUN
dti-2707	110	11	has	have	VERB
dti-2707	110	12	a	a	DET
dti-2707	110	13	substantial	substantial	ADJ
dti-2707	110	14	impact	impact	NOUN
dti-2707	110	15	on	on	ADP
dti-2707	110	16	those	those	PRON
dti-2707	110	17	who	who	PRON
dti-2707	110	18	are	be	AUX
dti-2707	110	19	affected	affect	VERB
dti-2707	110	20	,	,	PUNCT
dti-2707	110	21	the	the	DET
dti-2707	110	22	caregivers	caregiver	NOUN
dti-2707	110	23	,	,	PUNCT
dti-2707	110	24	and	and	CCONJ
dti-2707	110	25	society	society	NOUN
dti-2707	110	26	(	(	PUNCT
dti-2707	110	27	40	40	NUM
dti-2707	110	28	)	)	PUNCT
dti-2707	110	29	.	.	PUNCT
dti-2707	111	1	one	one	NUM
dti-2707	111	2	of	of	ADP
dti-2707	111	3	the	the	DET
dti-2707	111	4	cellular	cellular	ADJ
dti-2707	111	5	disorders	disorder	NOUN
dti-2707	111	6	hypothesized	hypothesize	VERB
dti-2707	111	7	to	to	PART
dti-2707	111	8	be	be	AUX
dti-2707	111	9	responsible	responsible	ADJ
dti-2707	111	10	for	for	ADP
dti-2707	111	11	the	the	DET
dti-2707	111	12	loss	loss	NOUN
dti-2707	111	13	of	of	ADP
dti-2707	111	14	neurons	neuron	NOUN
dti-2707	111	15	in	in	ADP
dti-2707	111	16	alzheimer	alzheimer	PROPN
dti-2707	111	17	’s	’s	PART
dti-2707	111	18	disease	disease	NOUN
dti-2707	111	19	is	be	AUX
dti-2707	111	20	aggregation	aggregation	NOUN
dti-2707	111	21	of	of	ADP
dti-2707	111	22	a𝛽	a𝛽	NOUN
dti-2707	111	23	(	(	PUNCT
dti-2707	111	24	41	41	NUM
dti-2707	111	25	)	)	PUNCT
dti-2707	111	26	.	.	PUNCT
dti-2707	112	1	baicalein	baicalein	PROPN
dti-2707	112	2	exhibits	exhibit	VERB
dti-2707	112	3	neuroprotective	neuroprotective	ADJ
dti-2707	112	4	qualities	quality	NOUN
dti-2707	112	5	against	against	ADP
dti-2707	112	6	amyloid	amyloid	NOUN
dti-2707	112	7	(	(	PUNCT
dti-2707	112	8	an	an	DET
dti-2707	112	9	)	)	PUNCT
dti-2707	112	10	functions	function	NOUN
dti-2707	112	11	by	by	ADP
dti-2707	112	12	preventing	prevent	VERB
dti-2707	112	13	an	an	PRON
dti-2707	112	14	from	from	ADP
dti-2707	112	15	aggregating	aggregate	VERB
dti-2707	112	16	in	in	ADP
dti-2707	112	17	pc12	pc12	PROPN
dti-2707	112	18	neuronal	neuronal	ADJ
dti-2707	112	19	cells	cell	NOUN
dti-2707	112	20	to	to	PART
dti-2707	112	21	cause	cause	VERB
dti-2707	112	22	a𝛽	a𝛽	NOUN
dti-2707	112	23	-induced	-induce	VERB
dti-2707	112	24	cytotoxicity	cytotoxicity	NOUN
dti-2707	112	25	(	(	PUNCT
dti-2707	112	26	42	42	NUM
dti-2707	112	27	)	)	PUNCT
dti-2707	112	28	.	.	PUNCT
dti-2707	113	1	by	by	ADP
dti-2707	113	2	activating	activate	VERB
dti-2707	113	3	gaba	gaba	NOUN
dti-2707	113	4	receptors	receptor	NOUN
dti-2707	113	5	,	,	PUNCT
dti-2707	113	6	baicalein	baicalein	NOUN
dti-2707	113	7	encourages	encourage	VERB
dti-2707	113	8	non	non	ADJ
dti-2707	113	9	-	-	ADJ
dti-2707	113	10	amyloidogenic	amyloidogenic	ADJ
dti-2707	113	11	processing	processing	NOUN
dti-2707	113	12	of	of	ADP
dti-2707	113	13	app	app	PROPN
dti-2707	113	14	,	,	PUNCT
dti-2707	113	15	which	which	PRON
dti-2707	113	16	lowers	lower	VERB
dti-2707	113	17	the	the	DET
dti-2707	113	18	generation	generation	NOUN
dti-2707	113	19	of	of	ADP
dti-2707	113	20	a𝛽	a𝛽	NOUN
dti-2707	113	21	and	and	CCONJ
dti-2707	113	22	enhances	enhance	VERB
dti-2707	113	23	cognitive	cognitive	ADJ
dti-2707	113	24	function	function	NOUN
dti-2707	113	25	(	(	PUNCT
dti-2707	113	26	43	43	NUM
dti-2707	113	27	)	)	PUNCT
dti-2707	113	28	.	.	PUNCT
dti-2707	114	1	baicalein	baicalein	PROPN
dti-2707	114	2	demonstrated	demonstrate	VERB
dti-2707	114	3	a	a	DET
dti-2707	114	4	potent	potent	ADJ
dti-2707	114	5	inhibitory	inhibitory	ADJ
dti-2707	114	6	effect	effect	NOUN
dti-2707	114	7	on	on	ADP
dti-2707	114	8	a𝛽	a𝛽	NOUN
dti-2707	114	9	-induced	-induce	VERB
dti-2707	114	10	cell	cell	NOUN
dti-2707	114	11	death	death	NOUN
dti-2707	114	12	(	(	PUNCT
dti-2707	114	13	43,44	43,44	NOUN
dti-2707	114	14	)	)	PUNCT
dti-2707	114	15	.	.	PUNCT
dti-2707	115	1	the	the	DET
dti-2707	115	2	prevalence	prevalence	NOUN
dti-2707	115	3	of	of	ADP
dti-2707	115	4	parkinson	parkinson	NOUN
dti-2707	115	5	’s	’s	PART
dti-2707	115	6	disease	disease	NOUN
dti-2707	115	7	looks	look	VERB
dti-2707	115	8	to	to	PART
dti-2707	115	9	be	be	AUX
dti-2707	115	10	rising	rise	VERB
dti-2707	115	11	with	with	ADP
dti-2707	115	12	age	age	NOUN
dti-2707	115	13	,	,	PUNCT
dti-2707	115	14	and	and	CCONJ
dti-2707	115	15	it	it	PRON
dti-2707	115	16	is	be	AUX
dti-2707	115	17	a	a	DET
dti-2707	115	18	global	global	ADJ
dti-2707	115	19	concern	concern	NOUN
dti-2707	115	20	.	.	PUNCT
dti-2707	116	1	males	male	NOUN
dti-2707	116	2	are	be	AUX
dti-2707	116	3	affected	affect	VERB
dti-2707	116	4	by	by	ADP
dti-2707	116	5	the	the	DET
dti-2707	116	6	disease	disease	NOUN
dti-2707	116	7	1.5	1.5	NUM
dti-2707	116	8	-	-	SYM
dti-2707	116	9	2	2	NUM
dti-2707	116	10	times	time	NOUN
dti-2707	116	11	more	more	ADV
dti-2707	116	12	frequently	frequently	ADV
dti-2707	116	13	than	than	ADP
dti-2707	116	14	females	female	NOUN
dti-2707	116	15	worldwide	worldwide	ADV
dti-2707	116	16	.	.	PUNCT
dti-2707	117	1	the	the	DET
dti-2707	117	2	prevalence	prevalence	NOUN
dti-2707	117	3	of	of	ADP
dti-2707	117	4	parkinson	parkinson	NOUN
dti-2707	117	5	’s	’s	PART
dti-2707	117	6	disease	disease	NOUN
dti-2707	117	7	appears	appear	VERB
dti-2707	117	8	to	to	PART
dti-2707	117	9	be	be	AUX
dti-2707	117	10	higher	high	ADJ
dti-2707	117	11	in	in	ADP
dti-2707	117	12	western	western	ADJ
dti-2707	117	13	nations	nation	NOUN
dti-2707	117	14	than	than	ADP
dti-2707	117	15	in	in	ADP
dti-2707	117	16	asian	asian	ADJ
dti-2707	117	17	nations	nation	NOUN
dti-2707	117	18	(	(	PUNCT
dti-2707	117	19	45	45	NUM
dti-2707	117	20	)	)	PUNCT
dti-2707	117	21	.	.	PUNCT
dti-2707	118	1	amyloid	amyloid	NOUN
dti-2707	118	2	-	-	PUNCT
dti-2707	118	3	specific	specific	ADJ
dti-2707	118	4	proteins	protein	NOUN
dti-2707	118	5	aggregate	aggregate	VERB
dti-2707	118	6	to	to	PART
dti-2707	118	7	cause	cause	VERB
dti-2707	118	8	parkinson	parkinson	NOUN
dti-2707	118	9	’s	’s	PART
dti-2707	118	10	disease	disease	NOUN
dti-2707	118	11	.	.	PUNCT
dti-2707	119	1	in	in	ADP
dti-2707	119	2	𝛽	𝛽	PRON
dti-2707	119	3	-sheet	-sheet	ADJ
dti-2707	119	4	fibrillar	fibrillar	ADJ
dti-2707	119	5	aggregate	aggregate	NOUN
dti-2707	119	6	,	,	PUNCT
dti-2707	119	7	formed	form	VERB
dti-2707	119	8	by	by	ADP
dti-2707	119	9	several	several	ADJ
dti-2707	119	10	proteins	protein	NOUN
dti-2707	119	11	including	include	VERB
dti-2707	119	12	α	α	NOUN
dti-2707	119	13	-	-	PUNCT
dti-2707	119	14	syn	syn	ADJ
dti-2707	119	15	amyloid	amyloid	NOUN
dti-2707	119	16	proteins	protein	NOUN
dti-2707	119	17	are	be	AUX
dti-2707	119	18	especially	especially	ADV
dti-2707	119	19	prevalent	prevalent	ADJ
dti-2707	119	20	.	.	PUNCT
dti-2707	120	1	the	the	DET
dti-2707	120	2	main	main	ADJ
dti-2707	120	3	constituent	constituent	NOUN
dti-2707	120	4	of	of	ADP
dti-2707	120	5	lewy	lewy	ADJ
dti-2707	120	6	bodies	body	NOUN
dti-2707	120	7	is	be	AUX
dti-2707	120	8	abnormally	abnormally	ADV
dti-2707	120	9	folded	fold	VERB
dti-2707	120	10	aggregates	aggregate	NOUN
dti-2707	120	11	of	of	ADP
dti-2707	120	12	α	α	PROPN
dti-2707	120	13	-	-	PUNCT
dti-2707	120	14	syn	syn	PROPN
dti-2707	120	15	,	,	PUNCT
dti-2707	120	16	which	which	PRON
dti-2707	120	17	manifest	manifest	VERB
dti-2707	120	18	as	as	ADP
dti-2707	120	19	intracellular	intracellular	ADJ
dti-2707	120	20	inclusions	inclusion	NOUN
dti-2707	120	21	in	in	ADP
dti-2707	120	22	nigral	nigral	ADJ
dti-2707	120	23	dopaminergic	dopaminergic	ADJ
dti-2707	120	24	neurons	neuron	NOUN
dti-2707	120	25	in	in	ADP
dti-2707	120	26	the	the	DET
dti-2707	120	27	brains	brain	NOUN
dti-2707	120	28	of	of	ADP
dti-2707	120	29	parkinson	parkinson	NOUN
dti-2707	120	30	’s	’s	PART
dti-2707	120	31	disease	disease	NOUN
dti-2707	120	32	patients	patient	NOUN
dti-2707	120	33	(	(	PUNCT
dti-2707	120	34	46	46	NUM
dti-2707	120	35	)	)	PUNCT
dti-2707	120	36	.	.	PUNCT
dti-2707	121	1	as	as	ADP
dti-2707	121	2	a	a	DET
dti-2707	121	3	result	result	NOUN
dti-2707	121	4	,	,	PUNCT
dti-2707	121	5	α	α	X
dti-2707	121	6	-	-	PUNCT
dti-2707	121	7	syn	syn	NOUN
dti-2707	121	8	represents	represent	VERB
dti-2707	121	9	a	a	DET
dti-2707	121	10	viable	viable	ADJ
dti-2707	121	11	therapeutic	therapeutic	ADJ
dti-2707	121	12	target	target	NOUN
dti-2707	121	13	for	for	ADP
dti-2707	121	14	parkinson	parkinson	NOUN
dti-2707	121	15	’s	’s	PART
dti-2707	121	16	disease	disease	NOUN
dti-2707	121	17	treatment	treatment	NOUN
dti-2707	121	18	to	to	PART
dti-2707	121	19	stop	stop	VERB
dti-2707	121	20	the	the	DET
dti-2707	121	21	disease	disease	NOUN
dti-2707	121	22	growth	growth	NOUN
dti-2707	121	23	and	and	CCONJ
dti-2707	121	24	spread	spread	VERB
dti-2707	121	25	(	(	PUNCT
dti-2707	121	26	47	47	NUM
dti-2707	121	27	)	)	PUNCT
dti-2707	121	28	.	.	PUNCT
dti-2707	122	1	baicalein	baicalein	PROPN
dti-2707	122	2	functions	function	NOUN
dti-2707	122	3	by	by	ADP
dti-2707	122	4	impeding	impede	VERB
dti-2707	122	5	the	the	DET
dti-2707	122	6	aggregation	aggregation	NOUN
dti-2707	122	7	of	of	ADP
dti-2707	122	8	disease	disease	NOUN
dti-2707	122	9	-	-	PUNCT
dti-2707	122	10	specific	specific	ADJ
dti-2707	122	11	α	α	NOUN
dti-2707	122	12	-	-	PUNCT
dti-2707	122	13	syn	syn	ADJ
dti-2707	122	14	protein	protein	NOUN
dti-2707	122	15	.	.	PUNCT
dti-2707	123	1	both	both	DET
dti-2707	123	2	baicalein	baicalein	PROPN
dti-2707	123	3	and	and	CCONJ
dti-2707	123	4	its	its	PRON
dti-2707	123	5	oxidized	oxidized	ADJ
dti-2707	123	6	counterpart	counterpart	NOUN
dti-2707	123	7	prevent	prevent	VERB
dti-2707	123	8	the	the	DET
dti-2707	123	9	production	production	NOUN
dti-2707	123	10	of	of	ADP
dti-2707	123	11	α	α	PROPN
dti-2707	123	12	-	-	PUNCT
dti-2707	123	13	syn	syn	NOUN
dti-2707	123	14	fibrils	fibril	NOUN
dti-2707	123	15	at	at	ADP
dti-2707	123	16	lower	low	ADJ
dti-2707	123	17	micromolar	micromolar	ADJ
dti-2707	123	18	levels	level	NOUN
dti-2707	123	19	.	.	PUNCT
dti-2707	124	1	moreover	moreover	ADV
dti-2707	124	2	,	,	PUNCT
dti-2707	124	3	baicalein	baicalein	PROPN
dti-2707	124	4	demonstrated	demonstrate	VERB
dti-2707	124	5	the	the	DET
dti-2707	124	6	capacity	capacity	NOUN
dti-2707	124	7	to	to	PART
dti-2707	124	8	disintegrate	disintegrate	VERB
dti-2707	124	9	the	the	DET
dti-2707	124	10	preexisting	preexist	VERB
dti-2707	124	11	α	α	NOUN
dti-2707	124	12	-	-	PUNCT
dti-2707	124	13	syn	syn	NOUN
dti-2707	124	14	fibrils	fibril	NOUN
dti-2707	124	15	(	(	PUNCT
dti-2707	124	16	48	48	NUM
dti-2707	124	17	)	)	PUNCT
dti-2707	124	18	.	.	PUNCT
dti-2707	125	1	additionally	additionally	ADV
dti-2707	125	2	,	,	PUNCT
dti-2707	125	3	by	by	ADP
dti-2707	125	4	eliminating	eliminate	VERB
dti-2707	125	5	inos	ino	NOUN
dti-2707	125	6	protein	protein	NOUN
dti-2707	125	7	,	,	PUNCT
dti-2707	125	8	mrna	mrna	PROPN
dti-2707	125	9	,	,	PUNCT
dti-2707	125	10	and	and	CCONJ
dti-2707	125	11	promoter	promoter	NOUN
dti-2707	125	12	activity	activity	NOUN
dti-2707	125	13	in	in	ADP
dti-2707	125	14	endotoxin	endotoxin	NOUN
dti-2707	125	15	/	/	SYM
dti-2707	125	16	cytokine	cytokine	NOUN
dti-2707	125	17	-	-	PUNCT
dti-2707	125	18	induced	induce	VERB
dti-2707	125	19	microglia	microglia	NOUN
dti-2707	125	20	,	,	PUNCT
dti-2707	125	21	baicalein	baicalein	PROPN
dti-2707	125	22	effectively	effectively	ADV
dti-2707	125	23	reduced	reduce	VERB
dti-2707	125	24	no	no	DET
dti-2707	125	25	generation	generation	NOUN
dti-2707	125	26	and	and	CCONJ
dti-2707	125	27	inos	ino	NOUN
dti-2707	125	28	gene	gene	NOUN
dti-2707	125	29	expression	expression	NOUN
dti-2707	125	30	(	(	PUNCT
dti-2707	125	31	49	49	NUM
dti-2707	125	32	)	)	PUNCT
dti-2707	125	33	.	.	PUNCT
dti-2707	126	1	stroke	stroke	NOUN
dti-2707	126	2	ranks	rank	VERB
dti-2707	126	3	second	second	ADV
dti-2707	126	4	globally	globally	ADV
dti-2707	126	5	in	in	ADP
dti-2707	126	6	terms	term	NOUN
dti-2707	126	7	of	of	ADP
dti-2707	126	8	mortality	mortality	NOUN
dti-2707	126	9	and	and	CCONJ
dti-2707	126	10	third	third	ADV
dti-2707	126	11	globally	globally	ADV
dti-2707	126	12	in	in	ADP
dti-2707	126	13	terms	term	NOUN
dti-2707	126	14	of	of	ADP
dti-2707	126	15	disability	disability	NOUN
dti-2707	126	16	,	,	PUNCT
dti-2707	126	17	with	with	ADP
dti-2707	126	18	ischemic	ischemic	ADJ
dti-2707	126	19	heart	heart	NOUN
dti-2707	126	20	disease	disease	NOUN
dti-2707	126	21	coming	come	VERB
dti-2707	126	22	in	in	ADV
dti-2707	126	23	first	first	ADV
dti-2707	126	24	in	in	ADP
dti-2707	126	25	both	both	DET
dti-2707	126	26	categories	category	NOUN
dti-2707	126	27	(	(	PUNCT
dti-2707	126	28	50	50	NUM
dti-2707	126	29	)	)	PUNCT
dti-2707	126	30	.	.	PUNCT
dti-2707	127	1	according	accord	VERB
dti-2707	127	2	to	to	ADP
dti-2707	127	3	the	the	DET
dti-2707	127	4	indian	indian	ADJ
dti-2707	127	5	global	global	ADJ
dti-2707	127	6	burden	burden	NOUN
dti-2707	127	7	of	of	ADP
dti-2707	127	8	disease	disease	NOUN
dti-2707	127	9	study	study	NOUN
dti-2707	127	10	,	,	PUNCT
dti-2707	127	11	which	which	PRON
dti-2707	127	12	was	be	AUX
dti-2707	127	13	conducted	conduct	VERB
dti-2707	127	14	between	between	ADP
dti-2707	127	15	1990	1990	NUM
dti-2707	127	16	and	and	CCONJ
dti-2707	127	17	2019	2019	NUM
dti-2707	127	18	,	,	PUNCT
dti-2707	127	19	stroke	stroke	NOUN
dti-2707	127	20	was	be	AUX
dti-2707	127	21	india	india	PROPN
dti-2707	127	22	’s	’s	PART
dti-2707	127	23	leading	lead	VERB
dti-2707	127	24	cause	cause	NOUN
dti-2707	127	25	of	of	ADP
dti-2707	127	26	both	both	DET
dti-2707	127	27	fatalities	fatality	NOUN
dti-2707	127	28	from	from	ADP
dti-2707	127	29	neurological	neurological	ADJ
dti-2707	127	30	illnesses	illness	NOUN
dti-2707	127	31	and	and	CCONJ
dti-2707	127	32	disability	disability	NOUN
dti-2707	127	33	-	-	PUNCT
dti-2707	127	34	adjusted	adjust	VERB
dti-2707	127	35	life	life	NOUN
dti-2707	127	36	years	year	NOUN
dti-2707	127	37	(	(	PUNCT
dti-2707	127	38	dalys	daly	NOUN
dti-2707	127	39	)	)	PUNCT
dti-2707	127	40	(	(	PUNCT
dti-2707	127	41	51	51	NUM
dti-2707	127	42	)	)	PUNCT
dti-2707	127	43	.	.	PUNCT
dti-2707	128	1	in	in	ADP
dti-2707	128	2	ischemic	ischemic	ADJ
dti-2707	128	3	stroke	stroke	NOUN
dti-2707	128	4	,	,	PUNCT
dti-2707	128	5	table	table	NOUN
dti-2707	128	6	2	2	NUM
dti-2707	128	7	in	in	ADP
dti-2707	128	8	vitro	vitro	X
dti-2707	128	9	studies	study	NOUN
dti-2707	128	10	of	of	ADP
dti-2707	128	11	baicalin	baicalin	NOUN
dti-2707	128	12	/	/	SYM
dti-2707	128	13	baicalein	baicalein	NOUN
dti-2707	128	14	against	against	ADP
dti-2707	128	15	various	various	ADJ
dti-2707	128	16	types	type	NOUN
dti-2707	128	17	of	of	ADP
dti-2707	128	18	cancer	cancer	NOUN
dti-2707	128	19	plant	plant	NOUN
dti-2707	128	20	compound	compound	NOUN
dti-2707	128	21	name	name	NOUN
dti-2707	128	22	of	of	ADP
dti-2707	128	23	cancers	cancer	NOUN
dti-2707	128	24	cell	cell	NOUN
dti-2707	128	25	lines	line	NOUN
dti-2707	128	26	cell	cell	NOUN
dti-2707	128	27	cycle	cycle	NOUN
dti-2707	128	28	phase	phase	NOUN
dti-2707	128	29	arrest	arrest	NOUN
dti-2707	128	30	mechanism	mechanism	NOUN
dti-2707	128	31	references	reference	NOUN
dti-2707	128	32	scutellaria	scutellaria	PROPN
dti-2707	128	33	baicalensis	baicalensis	PROPN
dti-2707	128	34	georgi	georgi	PROPN
dti-2707	128	35	baicalein	baicalein	PROPN
dti-2707	128	36	oroxylum	oroxylum	PROPN
dti-2707	128	37	indicum	indicum	NOUN
dti-2707	128	38	lung	lung	NOUN
dti-2707	128	39	cancer	cancer	NOUN
dti-2707	128	40	ch27	ch27	PROPN
dti-2707	128	41	g1	g1	PROPN
dti-2707	128	42	/	/	SYM
dti-2707	128	43	s	s	PART
dti-2707	128	44	↑sed	↑sed	ADJ
dti-2707	128	45	cyclin	cyclin	NOUN
dti-2707	128	46	e	e	NOUN
dti-2707	128	47	and	and	CCONJ
dti-2707	128	48	↓	↓	PROPN
dti-2707	128	49	sed	sed	ADJ
dti-2707	128	50	levels	level	NOUN
dti-2707	128	51	of	of	ADP
dti-2707	128	52	cdk4	cdk4	PROPN
dti-2707	128	53	and	and	CCONJ
dti-2707	128	54	cyclin	cyclin	NOUN
dti-2707	128	55	d1	d1	PROPN
dti-2707	128	56	(	(	PUNCT
dti-2707	128	57	18	18	NUM
dti-2707	128	58	)	)	PUNCT
dti-2707	128	59	breast	breast	NOUN
dti-2707	128	60	cancer	cancer	NOUN
dti-2707	128	61	mcf-7	mcf-7	PUNCT
dti-2707	128	62	g2	g2	PROPN
dti-2707	128	63	/	/	SYM
dti-2707	128	64	s	s	VERB
dti-2707	128	65	blocked	block	VERB
dti-2707	128	66	17	17	NUM
dti-2707	128	67	-	-	PUNCT
dti-2707	128	68	estradiolinduced	estradiolinduce	VERB
dti-2707	128	69	transactivation	transactivation	NOUN
dti-2707	128	70	of	of	ADP
dti-2707	128	71	the	the	DET
dti-2707	128	72	estrogen	estrogen	NOUN
dti-2707	128	73	receptor	receptor	NOUN
dti-2707	128	74	(	(	PUNCT
dti-2707	128	75	20	20	NUM
dti-2707	128	76	)	)	PUNCT
dti-2707	128	77	gastric	gastric	ADJ
dti-2707	128	78	cancer	cancer	NOUN
dti-2707	128	79	sgc-7901	sgc-7901	NOUN
dti-2707	128	80	s	s	PART
dti-2707	128	81	↓sed	↓se	VERB
dti-2707	128	82	bcl-2	bcl-2	NUM
dti-2707	128	83	and	and	CCONJ
dti-2707	128	84	↑sed	↑sed	ADJ
dti-2707	128	85	bax	bax	PROPN
dti-2707	128	86	(	(	PUNCT
dti-2707	128	87	22	22	NUM
dti-2707	128	88	)	)	PUNCT
dti-2707	128	89	hepatic	hepatic	ADJ
dti-2707	128	90	cancer	cancer	NOUN
dti-2707	128	91	hep	hep	NOUN
dti-2707	128	92	g2	g2	PROPN
dti-2707	128	93	and	and	CCONJ
dti-2707	128	94	hep	hep	NOUN
dti-2707	128	95	j2	j2	PROPN
dti-2707	128	96	s	s	PART
dti-2707	128	97	activation	activation	NOUN
dti-2707	128	98	of	of	ADP
dti-2707	128	99	cdk	cdk	NOUN
dti-2707	128	100	inhibitors	inhibitor	NOUN
dti-2707	128	101	like	like	ADP
dti-2707	128	102	p21	p21	NOUN
dti-2707	128	103	or	or	CCONJ
dti-2707	128	104	p27	p27	PROPN
dti-2707	128	105	(	(	PUNCT
dti-2707	128	106	23	23	NUM
dti-2707	128	107	)	)	PUNCT
dti-2707	128	108	pancreatic	pancreatic	ADJ
dti-2707	128	109	cancer	cancer	NOUN
dti-2707	128	110	panc-1	panc-1	NOUN
dti-2707	128	111	g0	g0	NOUN
dti-2707	128	112	/	/	SYM
dti-2707	128	113	g1	g1	PROPN
dti-2707	129	1	↑sed	↑se	VERB
dti-2707	129	2	bax	bax	PROPN
dti-2707	129	3	and	and	CCONJ
dti-2707	129	4	↓sed	↓sed	ADJ
dti-2707	129	5	bcl2	bcl2	NOUN
dti-2707	129	6	and	and	CCONJ
dti-2707	129	7	mcl-1	mcl-1	X
dti-2707	129	8	(	(	PUNCT
dti-2707	129	9	26	26	NUM
dti-2707	129	10	)	)	PUNCT
dti-2707	129	11	colorectal	colorectal	ADJ
dti-2707	129	12	cancer	cancer	NOUN
dti-2707	129	13	hct-116	hct-116	NOUN
dti-2707	129	14	s	s	PART
dti-2707	129	15	activation	activation	NOUN
dti-2707	129	16	of	of	ADP
dti-2707	129	17	caspase	caspase	PROPN
dti-2707	129	18	3	3	NUM
dti-2707	129	19	and	and	CCONJ
dti-2707	129	20	9	9	NUM
dti-2707	129	21	(	(	PUNCT
dti-2707	129	22	28	28	NUM
dti-2707	129	23	)	)	PUNCT
dti-2707	129	24	prostate	prostate	NOUN
dti-2707	129	25	cancer	cancer	NOUN
dti-2707	129	26	lncap	lncap	NOUN
dti-2707	129	27	g1	g1	PROPN
dti-2707	129	28	/	/	SYM
dti-2707	129	29	s	s	PART
dti-2707	129	30	↓sed	↓se	VERB
dti-2707	129	31	cyclin	cyclin	NOUN
dti-2707	129	32	d1	d1	PROPN
dti-2707	129	33	,	,	PUNCT
dti-2707	129	34	cyclin	cyclin	NOUN
dti-2707	129	35	d3	d3	PROPN
dti-2707	129	36	,	,	PUNCT
dti-2707	129	37	and	and	CCONJ
dti-2707	129	38	prb	prb	VERB
dti-2707	129	39	protein	protein	NOUN
dti-2707	129	40	(	(	PUNCT
dti-2707	129	41	29	29	NUM
dti-2707	129	42	)	)	PUNCT
dti-2707	129	43	bladder	bladder	NOUN
dti-2707	129	44	cancer	cancer	NOUN
dti-2707	129	45	tsgh831	tsgh831	PROPN
dti-2707	129	46	and	and	CCONJ
dti-2707	129	47	bftc905	bftc905	PROPN
dti-2707	129	48	g2	g2	PROPN
dti-2707	129	49	/	/	SYM
dti-2707	129	50	m	m	AUX
dti-2707	129	51	altering	alter	VERB
dti-2707	129	52	cyclin	cyclin	NOUN
dti-2707	129	53	b1	b1	NOUN
dti-2707	129	54	and	and	CCONJ
dti-2707	129	55	phospho	phospho	ADJ
dti-2707	129	56	-	-	PUNCT
dti-2707	129	57	cdc2	cdc2	NOUN
dti-2707	129	58	(	(	PUNCT
dti-2707	129	59	31	31	NUM
dti-2707	129	60	)	)	PUNCT
dti-2707	129	61	ovarian	ovarian	ADJ
dti-2707	129	62	cancer	cancer	NOUN
dti-2707	129	63	ovcar-3	ovcar-3	PROPN
dti-2707	129	64	and	and	CCONJ
dti-2707	129	65	cp-70	cp-70	ADV
dti-2707	129	66	g1	g1	PROPN
dti-2707	129	67	/	/	SYM
dti-2707	129	68	s	s	PART
dti-2707	129	69	↓sed	↓sed	PROPN
dti-2707	129	70	vegf	vegf	PROPN
dti-2707	129	71	,	,	PUNCT
dti-2707	129	72	hif-1	hif-1	X
dti-2707	129	73	,	,	PUNCT
dti-2707	129	74	c	c	NOUN
dti-2707	129	75	-	-	PUNCT
dti-2707	129	76	myc	myc	NOUN
dti-2707	129	77	,	,	PUNCT
dti-2707	129	78	nf	nf	PROPN
dti-2707	129	79	-	-	PUNCT
dti-2707	129	80	kb	kb	NOUN
dti-2707	129	81	,	,	PUNCT
dti-2707	129	82	and	and	CCONJ
dti-2707	129	83	mmp-2	mmp-2	ADV
dti-2707	129	84	(	(	PUNCT
dti-2707	129	85	34	34	NUM
dti-2707	129	86	)	)	PUNCT
dti-2707	129	87	osteosarcoma	osteosarcoma	VERB
dti-2707	129	88	mg-63	mg-63	NOUN
dti-2707	129	89	g1	g1	NOUN
dti-2707	129	90	activating	activate	VERB
dti-2707	129	91	bnip3	bnip3	NOUN
dti-2707	129	92	and	and	CCONJ
dti-2707	129	93	↓sed	↓se	VERB
dti-2707	129	94	cyclin	cyclin	NOUN
dti-2707	129	95	d1	d1	PROPN
dti-2707	129	96	and	and	CCONJ
dti-2707	129	97	cdk4	cdk4	NOUN
dti-2707	129	98	(	(	PUNCT
dti-2707	129	99	39	39	NUM
dti-2707	129	100	)	)	PUNCT
dti-2707	129	101	therapeutic	therapeutic	ADJ
dti-2707	129	102	insights	insight	NOUN
dti-2707	129	103	into	into	ADP
dti-2707	129	104	baicalein34	baicalein34	NOUN
dti-2707	129	105	©	©	ADP
dti-2707	129	106	2024	2024	NUM
dti-2707	129	107	the	the	DET
dti-2707	129	108	authors	author	NOUN
dti-2707	129	109	.	.	PUNCT
dti-2707	130	1	drug	drug	NOUN
dti-2707	130	2	target	target	NOUN
dti-2707	130	3	insights	insight	NOUN
dti-2707	130	4	issn	issn	VERB
dti-2707	130	5	1177	1177	NUM
dti-2707	130	6	-	-	SYM
dti-2707	130	7	3928	3928	NUM
dti-2707	130	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2707	130	9	neuroprotection	neuroprotection	NOUN
dti-2707	130	10	is	be	AUX
dti-2707	130	11	achieved	achieve	VERB
dti-2707	130	12	by	by	ADP
dti-2707	130	13	inhibiting	inhibit	VERB
dti-2707	130	14	inos	ino	NOUN
dti-2707	130	15	activity	activity	NOUN
dti-2707	130	16	or	or	CCONJ
dti-2707	130	17	by	by	ADP
dti-2707	130	18	inos	ino	NOUN
dti-2707	130	19	gene	gene	NOUN
dti-2707	130	20	deletion	deletion	NOUN
dti-2707	130	21	.	.	PUNCT
dti-2707	131	1	neuroexcitotoxic	neuroexcitotoxic	ADJ
dti-2707	131	2	and	and	CCONJ
dti-2707	131	3	ischemic	ischemic	ADJ
dti-2707	131	4	traumas	trauma	NOUN
dti-2707	131	5	cause	cause	VERB
dti-2707	131	6	the	the	DET
dti-2707	131	7	production	production	NOUN
dti-2707	131	8	of	of	ADP
dti-2707	131	9	cox-2	cox-2	NOUN
dti-2707	131	10	.	.	PUNCT
dti-2707	132	1	specific	specific	ADJ
dti-2707	132	2	cox-2	cox-2	ADJ
dti-2707	132	3	inhibitors	inhibitor	NOUN
dti-2707	132	4	reduce	reduce	VERB
dti-2707	132	5	brain	brain	NOUN
dti-2707	132	6	damage	damage	NOUN
dti-2707	132	7	brought	bring	VERB
dti-2707	132	8	on	on	ADP
dti-2707	132	9	by	by	ADP
dti-2707	132	10	localized	localized	ADJ
dti-2707	132	11	ischemia	ischemia	NOUN
dti-2707	132	12	.	.	PUNCT
dti-2707	133	1	the	the	DET
dti-2707	133	2	optimal	optimal	ADJ
dti-2707	133	3	method	method	NOUN
dti-2707	133	4	for	for	ADP
dti-2707	133	5	treating	treat	VERB
dti-2707	133	6	cerebral	cerebral	ADJ
dti-2707	133	7	ischemia	ischemia	NOUN
dti-2707	133	8	-	-	PUNCT
dti-2707	133	9	reperfusion	reperfusion	NOUN
dti-2707	133	10	(	(	PUNCT
dti-2707	133	11	i	i	NOUN
dti-2707	133	12	/	/	SYM
dti-2707	133	13	r	r	NOUN
dti-2707	133	14	)	)	PUNCT
dti-2707	133	15	injury	injury	NOUN
dti-2707	133	16	involves	involve	VERB
dti-2707	133	17	targeting	target	VERB
dti-2707	133	18	the	the	DET
dti-2707	133	19	nf	nf	ADJ
dti-2707	133	20	-	-	PUNCT
dti-2707	133	21	κb	κb	NOUN
dti-2707	133	22	pathway	pathway	NOUN
dti-2707	133	23	,	,	PUNCT
dti-2707	133	24	according	accord	VERB
dti-2707	133	25	to	to	ADP
dti-2707	133	26	numerous	numerous	ADJ
dti-2707	133	27	experts	expert	NOUN
dti-2707	133	28	.	.	PUNCT
dti-2707	134	1	baicalein	baicalein	PROPN
dti-2707	134	2	therapy	therapy	NOUN
dti-2707	134	3	significantly	significantly	ADV
dti-2707	134	4	decreased	decrease	VERB
dti-2707	134	5	the	the	DET
dti-2707	134	6	expression	expression	NOUN
dti-2707	134	7	of	of	ADP
dti-2707	134	8	cox-2	cox-2	NOUN
dti-2707	134	9	and	and	CCONJ
dti-2707	134	10	inos	ino	NOUN
dti-2707	134	11	,	,	PUNCT
dti-2707	134	12	as	as	ADV
dti-2707	134	13	well	well	ADV
dti-2707	134	14	as	as	ADP
dti-2707	134	15	pge2	pge2	NOUN
dti-2707	134	16	and	and	CCONJ
dti-2707	134	17	nf	nf	NOUN
dti-2707	134	18	-	-	PUNCT
dti-2707	134	19	κb	κb	NOUN
dti-2707	134	20	,	,	PUNCT
dti-2707	134	21	indicating	indicate	VERB
dti-2707	134	22	a	a	DET
dti-2707	134	23	protective	protective	ADJ
dti-2707	134	24	effect	effect	NOUN
dti-2707	134	25	against	against	ADP
dti-2707	134	26	cerebral	cerebral	ADJ
dti-2707	134	27	i	i	PROPN
dti-2707	134	28	/	/	SYM
dti-2707	134	29	r	r	NOUN
dti-2707	134	30	injury	injury	NOUN
dti-2707	134	31	.	.	PUNCT
dti-2707	135	1	because	because	SCONJ
dti-2707	135	2	baicalein	baicalein	NOUN
dti-2707	135	3	blocks	block	VERB
dti-2707	135	4	inflammatory	inflammatory	ADJ
dti-2707	135	5	mediators	mediator	NOUN
dti-2707	135	6	including	include	VERB
dti-2707	135	7	lox-1	lox-1	NOUN
dti-2707	135	8	,	,	PUNCT
dti-2707	135	9	cox-2	cox-2	NOUN
dti-2707	135	10	,	,	PUNCT
dti-2707	135	11	pge2	pge2	NOUN
dti-2707	135	12	,	,	PUNCT
dti-2707	135	13	and	and	CCONJ
dti-2707	135	14	nf	nf	X
dti-2707	135	15	-	-	PUNCT
dti-2707	135	16	κb	κb	NOUN
dti-2707	135	17	,	,	PUNCT
dti-2707	135	18	it	it	PRON
dti-2707	135	19	may	may	AUX
dti-2707	135	20	have	have	VERB
dti-2707	135	21	antiinflammatory	antiinflammatory	NOUN
dti-2707	135	22	and	and	CCONJ
dti-2707	135	23	antioxidant	antioxidant	ADJ
dti-2707	135	24	effects	effect	NOUN
dti-2707	135	25	that	that	PRON
dti-2707	135	26	contribute	contribute	VERB
dti-2707	135	27	to	to	ADP
dti-2707	135	28	its	its	PRON
dti-2707	135	29	capacity	capacity	NOUN
dti-2707	135	30	to	to	PART
dti-2707	135	31	prevent	prevent	VERB
dti-2707	135	32	cerebral	cerebral	ADJ
dti-2707	135	33	i	i	NOUN
dti-2707	135	34	/	/	SYM
dti-2707	135	35	r	r	NOUN
dti-2707	135	36	(	(	PUNCT
dti-2707	135	37	52	52	NUM
dti-2707	135	38	)	)	PUNCT
dti-2707	135	39	.	.	PUNCT
dti-2707	136	1	baicalein	baicalein	PROPN
dti-2707	136	2	therapy	therapy	NOUN
dti-2707	136	3	markedly	markedly	ADV
dti-2707	136	4	elevated	elevate	VERB
dti-2707	136	5	nuclear	nuclear	ADJ
dti-2707	136	6	nrf2	nrf2	NOUN
dti-2707	136	7	expression	expression	NOUN
dti-2707	136	8	and	and	CCONJ
dti-2707	136	9	ampk	ampk	NOUN
dti-2707	136	10	phosphorylation	phosphorylation	NOUN
dti-2707	136	11	in	in	ADP
dti-2707	136	12	the	the	DET
dti-2707	136	13	ischemic	ischemic	ADJ
dti-2707	136	14	cerebral	cerebral	ADJ
dti-2707	136	15	cortex	cortex	NOUN
dti-2707	136	16	(	(	PUNCT
dti-2707	136	17	53	53	NUM
dti-2707	136	18	)	)	PUNCT
dti-2707	136	19	.	.	PUNCT
dti-2707	137	1	cell	cell	NOUN
dti-2707	137	2	damage	damage	NOUN
dti-2707	137	3	and	and	CCONJ
dti-2707	137	4	a	a	DET
dti-2707	137	5	rise	rise	NOUN
dti-2707	137	6	in	in	ADP
dti-2707	137	7	oxidative	oxidative	ADJ
dti-2707	137	8	stress	stress	NOUN
dti-2707	137	9	are	be	AUX
dti-2707	137	10	caused	cause	VERB
dti-2707	137	11	by	by	ADP
dti-2707	137	12	an	an	DET
dti-2707	137	13	excess	excess	NOUN
dti-2707	137	14	of	of	ADP
dti-2707	137	15	ros	ros	PROPN
dti-2707	137	16	or	or	CCONJ
dti-2707	137	17	by	by	ADP
dti-2707	137	18	the	the	DET
dti-2707	137	19	malfunctioning	malfunctioning	NOUN
dti-2707	137	20	of	of	ADP
dti-2707	137	21	antioxidant	antioxidant	ADJ
dti-2707	137	22	enzymes	enzyme	NOUN
dti-2707	137	23	.	.	PUNCT
dti-2707	138	1	basic	basic	ADJ
dti-2707	138	2	leucine	leucine	NOUN
dti-2707	138	3	zipper	zipper	NOUN
dti-2707	138	4	transcription	transcription	NOUN
dti-2707	138	5	factor	factor	NOUN
dti-2707	138	6	nrf2	nrf2	PROPN
dti-2707	138	7	controls	control	VERB
dti-2707	138	8	the	the	DET
dti-2707	138	9	expression	expression	NOUN
dti-2707	138	10	of	of	ADP
dti-2707	138	11	the	the	DET
dti-2707	138	12	gene	gene	NOUN
dti-2707	138	13	that	that	PRON
dti-2707	138	14	detoxifies	detoxify	VERB
dti-2707	138	15	ros	ro	NOUN
dti-2707	138	16	as	as	ADV
dti-2707	138	17	well	well	ADV
dti-2707	138	18	as	as	ADP
dti-2707	138	19	the	the	DET
dti-2707	138	20	antioxidant	antioxidant	ADJ
dti-2707	138	21	gene	gene	NOUN
dti-2707	138	22	(	(	PUNCT
dti-2707	138	23	54,55	54,55	NOUN
dti-2707	138	24	)	)	PUNCT
dti-2707	138	25	.	.	PUNCT
dti-2707	139	1	epilepsy	epilepsy	PROPN
dti-2707	139	2	is	be	AUX
dti-2707	139	3	a	a	DET
dti-2707	139	4	chronic	chronic	NOUN
dti-2707	139	5	,	,	PUNCT
dti-2707	139	6	noncommunicable	noncommunicable	ADJ
dti-2707	139	7	brain	brain	NOUN
dti-2707	139	8	illness	illness	NOUN
dti-2707	139	9	that	that	PRON
dti-2707	139	10	affects	affect	VERB
dti-2707	139	11	people	people	NOUN
dti-2707	139	12	of	of	ADP
dti-2707	139	13	all	all	DET
dti-2707	139	14	ages	age	NOUN
dti-2707	139	15	.	.	PUNCT
dti-2707	140	1	one	one	NUM
dti-2707	140	2	of	of	ADP
dti-2707	140	3	the	the	DET
dti-2707	140	4	most	most	ADV
dti-2707	140	5	prevalent	prevalent	ADJ
dti-2707	140	6	neurological	neurological	ADJ
dti-2707	140	7	conditions	condition	NOUN
dti-2707	140	8	,	,	PUNCT
dti-2707	140	9	epilepsy	epilepsy	NOUN
dti-2707	140	10	affects	affect	VERB
dti-2707	140	11	about	about	ADV
dti-2707	140	12	50	50	NUM
dti-2707	140	13	million	million	NUM
dti-2707	140	14	people	people	NOUN
dti-2707	140	15	worldwide	worldwide	ADV
dti-2707	140	16	.	.	PUNCT
dti-2707	141	1	more	more	ADJ
dti-2707	141	2	than	than	ADP
dti-2707	141	3	80	80	NUM
dti-2707	141	4	%	%	NOUN
dti-2707	141	5	of	of	ADP
dti-2707	141	6	people	people	NOUN
dti-2707	141	7	in	in	ADP
dti-2707	141	8	lowand	lowand	ADJ
dti-2707	141	9	middleincome	middleincome	PROPN
dti-2707	141	10	countries	country	NOUN
dti-2707	141	11	have	have	AUX
dti-2707	141	12	epilepsy	epilepsy	VERB
dti-2707	141	13	.	.	PUNCT
dti-2707	142	1	fecl3	fecl3	PROPN
dti-2707	142	2	-	-	PUNCT
dti-2707	142	3	induced	induce	VERB
dti-2707	142	4	post	post	ADJ
dti-2707	142	5	-	-	ADJ
dti-2707	142	6	traumatic	traumatic	ADJ
dti-2707	142	7	epileptic	epileptic	ADJ
dti-2707	142	8	seizures	seizure	NOUN
dti-2707	142	9	are	be	AUX
dti-2707	142	10	a	a	DET
dti-2707	142	11	significant	significant	ADJ
dti-2707	142	12	type	type	NOUN
dti-2707	142	13	of	of	ADP
dti-2707	142	14	acquired	acquire	VERB
dti-2707	142	15	epileptic	epileptic	ADJ
dti-2707	142	16	seizures	seizure	NOUN
dti-2707	142	17	(	(	PUNCT
dti-2707	142	18	56	56	NUM
dti-2707	142	19	)	)	PUNCT
dti-2707	142	20	.	.	PUNCT
dti-2707	143	1	baicalein	baicalein	PROPN
dti-2707	143	2	suppressed	suppress	VERB
dti-2707	143	3	ferroptosis	ferroptosis	NOUN
dti-2707	143	4	associated	associate	VERB
dti-2707	143	5	with	with	ADP
dti-2707	143	6	12/15	12/15	NUM
dti-2707	143	7	-	-	PUNCT
dti-2707	143	8	lox	lox	NOUN
dti-2707	143	9	,	,	PUNCT
dti-2707	143	10	hence	hence	ADV
dti-2707	143	11	lessening	lessen	VERB
dti-2707	143	12	the	the	DET
dti-2707	143	13	severity	severity	NOUN
dti-2707	143	14	of	of	ADP
dti-2707	143	15	post	post	ADJ
dti-2707	143	16	-	-	ADJ
dti-2707	143	17	traumatic	traumatic	ADJ
dti-2707	143	18	epileptic	epileptic	ADJ
dti-2707	143	19	episodes	episode	NOUN
dti-2707	143	20	generated	generate	VERB
dti-2707	143	21	by	by	ADP
dti-2707	143	22	fecl3	fecl3	PROPN
dti-2707	143	23	(	(	PUNCT
dti-2707	143	24	57	57	NUM
dti-2707	143	25	)	)	PUNCT
dti-2707	143	26	.	.	PUNCT
dti-2707	144	1	ht22	ht22	PROPN
dti-2707	144	2	cells	cell	NOUN
dti-2707	144	3	were	be	AUX
dti-2707	144	4	damaged	damage	VERB
dti-2707	144	5	by	by	ADP
dti-2707	144	6	ferroptosis	ferroptosis	NOUN
dti-2707	144	7	,	,	PUNCT
dti-2707	144	8	which	which	PRON
dti-2707	144	9	is	be	AUX
dti-2707	144	10	mitigated	mitigate	VERB
dti-2707	144	11	by	by	ADP
dti-2707	144	12	baicalein	baicalein	NOUN
dti-2707	144	13	may	may	AUX
dti-2707	144	14	be	be	AUX
dti-2707	144	15	due	due	ADJ
dti-2707	144	16	to	to	ADP
dti-2707	144	17	its	its	PRON
dti-2707	144	18	lipid	lipid	NOUN
dti-2707	144	19	peroxidation	peroxidation	NOUN
dti-2707	144	20	inhibitor	inhibitor	NOUN
dti-2707	144	21	(	(	PUNCT
dti-2707	144	22	fig	fig	NOUN
dti-2707	144	23	.	.	NOUN
dti-2707	145	1	2	2	NUM
dti-2707	145	2	)	)	PUNCT
dti-2707	145	3	(	(	PUNCT
dti-2707	145	4	58	58	NUM
dti-2707	145	5	)	)	PUNCT
dti-2707	145	6	.	.	PUNCT
dti-2707	146	1	respiratory	respiratory	ADJ
dti-2707	146	2	protective	protective	ADJ
dti-2707	146	3	action	action	NOUN
dti-2707	146	4	of	of	ADP
dti-2707	146	5	baicalein	baicalein	NOUN
dti-2707	146	6	chronic	chronic	ADJ
dti-2707	146	7	respiratory	respiratory	ADJ
dti-2707	146	8	conditions	condition	NOUN
dti-2707	146	9	are	be	AUX
dti-2707	146	10	among	among	ADP
dti-2707	146	11	the	the	DET
dti-2707	146	12	world	world	NOUN
dti-2707	146	13	’s	’s	PART
dti-2707	146	14	leading	lead	VERB
dti-2707	146	15	causes	cause	NOUN
dti-2707	146	16	of	of	ADP
dti-2707	146	17	morbidity	morbidity	NOUN
dti-2707	146	18	and	and	CCONJ
dti-2707	146	19	mortality	mortality	NOUN
dti-2707	146	20	.	.	PUNCT
dti-2707	147	1	they	they	PRON
dti-2707	147	2	affect	affect	VERB
dti-2707	147	3	the	the	DET
dti-2707	147	4	lung	lung	NOUN
dti-2707	147	5	’s	’s	PART
dti-2707	147	6	airways	airway	NOUN
dti-2707	147	7	and	and	CCONJ
dti-2707	147	8	other	other	ADJ
dti-2707	147	9	structural	structural	ADJ
dti-2707	147	10	components	component	NOUN
dti-2707	147	11	.	.	PUNCT
dti-2707	148	1	asthma	asthma	PROPN
dti-2707	148	2	is	be	AUX
dti-2707	148	3	the	the	DET
dti-2707	148	4	most	most	ADV
dti-2707	148	5	prevalent	prevalent	ADJ
dti-2707	148	6	chronic	chronic	ADJ
dti-2707	148	7	respiratory	respiratory	ADJ
dti-2707	148	8	illnesses	illness	NOUN
dti-2707	148	9	.	.	PUNCT
dti-2707	149	1	there	there	PRON
dti-2707	149	2	are	be	VERB
dti-2707	149	3	already	already	ADV
dti-2707	149	4	approximately	approximately	ADV
dti-2707	149	5	300	300	NUM
dti-2707	149	6	million	million	NUM
dti-2707	149	7	asthmatics	asthmatic	NOUN
dti-2707	149	8	worldwide	worldwide	ADV
dti-2707	149	9	,	,	PUNCT
dti-2707	149	10	and	and	CCONJ
dti-2707	149	11	by	by	ADP
dti-2707	149	12	2025	2025	NUM
dti-2707	149	13	,	,	PUNCT
dti-2707	149	14	that	that	DET
dti-2707	149	15	figure	figure	NOUN
dti-2707	149	16	may	may	AUX
dti-2707	149	17	rise	rise	VERB
dti-2707	149	18	by	by	ADP
dti-2707	149	19	an	an	DET
dti-2707	149	20	additional	additional	ADJ
dti-2707	149	21	100	100	NUM
dti-2707	149	22	million	million	NUM
dti-2707	149	23	.	.	PUNCT
dti-2707	150	1	asthma	asthma	PROPN
dti-2707	150	2	is	be	AUX
dti-2707	150	3	a	a	DET
dti-2707	150	4	long	long	ADJ
dti-2707	150	5	-	-	PUNCT
dti-2707	150	6	term	term	NOUN
dti-2707	150	7	inflammatory	inflammatory	ADJ
dti-2707	150	8	illness	illness	NOUN
dti-2707	150	9	of	of	ADP
dti-2707	150	10	the	the	DET
dti-2707	150	11	airways	airway	NOUN
dti-2707	150	12	characterized	characterize	VERB
dti-2707	150	13	by	by	ADP
dti-2707	150	14	thickening	thickening	NOUN
dti-2707	150	15	of	of	ADP
dti-2707	150	16	the	the	DET
dti-2707	150	17	airway	airway	NOUN
dti-2707	150	18	wall	wall	NOUN
dti-2707	150	19	,	,	PUNCT
dti-2707	150	20	hyper	hyper	NOUN
dti-2707	150	21	-	-	NOUN
dti-2707	150	22	responsiveness	responsiveness	NOUN
dti-2707	150	23	and	and	CCONJ
dti-2707	150	24	remodeling	remodeling	NOUN
dti-2707	150	25	of	of	ADP
dti-2707	150	26	the	the	DET
dti-2707	150	27	airways	airway	NOUN
dti-2707	150	28	,	,	PUNCT
dti-2707	150	29	poor	poor	ADJ
dti-2707	150	30	relaxation	relaxation	NOUN
dti-2707	150	31	,	,	PUNCT
dti-2707	150	32	and	and	CCONJ
dti-2707	150	33	persistent	persistent	ADJ
dti-2707	150	34	blockage	blockage	NOUN
dti-2707	150	35	of	of	ADP
dti-2707	150	36	airflow	airflow	NOUN
dti-2707	150	37	by	by	ADP
dti-2707	150	38	the	the	DET
dti-2707	150	39	smooth	smooth	ADJ
dti-2707	150	40	muscle	muscle	NOUN
dti-2707	150	41	of	of	ADP
dti-2707	150	42	the	the	DET
dti-2707	150	43	airways	airway	NOUN
dti-2707	150	44	(	(	PUNCT
dti-2707	150	45	59	59	NUM
dti-2707	150	46	-	-	SYM
dti-2707	150	47	61	61	NUM
dti-2707	150	48	)	)	PUNCT
dti-2707	150	49	.	.	PUNCT
dti-2707	151	1	hypersecretion	hypersecretion	NOUN
dti-2707	151	2	of	of	ADP
dti-2707	151	3	airway	airway	NOUN
dti-2707	151	4	mucus	mucus	NOUN
dti-2707	151	5	is	be	AUX
dti-2707	151	6	one	one	NUM
dti-2707	151	7	of	of	ADP
dti-2707	151	8	the	the	DET
dti-2707	151	9	key	key	ADJ
dti-2707	151	10	features	feature	NOUN
dti-2707	151	11	of	of	ADP
dti-2707	151	12	asthma	asthma	NOUN
dti-2707	151	13	pathophysiology	pathophysiology	NOUN
dti-2707	151	14	.	.	PUNCT
dti-2707	152	1	baicalein	baicalein	PROPN
dti-2707	152	2	therapy	therapy	NOUN
dti-2707	152	3	showed	show	VERB
dti-2707	152	4	dramatical	dramatical	ADJ
dti-2707	152	5	decrease	decrease	NOUN
dti-2707	152	6	in	in	ADP
dti-2707	152	7	muc5ac	muc5ac	PROPN
dti-2707	152	8	and	and	CCONJ
dti-2707	152	9	muc5b	muc5b	NOUN
dti-2707	152	10	mrna	mrna	NOUN
dti-2707	152	11	expression	expression	NOUN
dti-2707	152	12	levels	level	NOUN
dti-2707	152	13	in	in	ADP
dti-2707	152	14	the	the	DET
dti-2707	152	15	submucosal	submucosal	NOUN
dti-2707	152	16	glands	gland	NOUN
dti-2707	152	17	and	and	CCONJ
dti-2707	152	18	the	the	DET
dti-2707	152	19	epithelium	epithelium	NOUN
dti-2707	152	20	,	,	PUNCT
dti-2707	152	21	respectively	respectively	ADV
dti-2707	152	22	,	,	PUNCT
dti-2707	152	23	which	which	PRON
dti-2707	152	24	were	be	AUX
dti-2707	152	25	significantly	significantly	ADV
dti-2707	152	26	greater	great	ADJ
dti-2707	152	27	in	in	ADP
dti-2707	152	28	asthma	asthma	NOUN
dti-2707	152	29	.	.	PUNCT
dti-2707	153	1	baicalein	baicalein	PROPN
dti-2707	153	2	also	also	ADV
dti-2707	153	3	exhibits	exhibit	VERB
dti-2707	153	4	anti	anti	ADJ
dti-2707	153	5	-	-	ADJ
dti-2707	153	6	asthmatic	asthmatic	ADJ
dti-2707	153	7	properties	property	NOUN
dti-2707	153	8	by	by	ADP
dti-2707	153	9	inhibiting	inhibit	VERB
dti-2707	153	10	tumor	tumor	NOUN
dti-2707	153	11	necrosis	necrosis	NOUN
dti-2707	153	12	factor	factor	NOUN
dti-2707	153	13	(	(	PUNCT
dti-2707	153	14	tnf)-α	tnf)-α	NOUN
dti-2707	153	15	-	-	PUNCT
dti-2707	153	16	induced	induce	VERB
dti-2707	153	17	nf	nf	ADJ
dti-2707	153	18	-	-	PUNCT
dti-2707	153	19	κb	κb	NOUN
dti-2707	153	20	activation	activation	NOUN
dti-2707	153	21	in	in	ADP
dti-2707	153	22	normal	normal	ADJ
dti-2707	153	23	bronchial	bronchial	ADJ
dti-2707	153	24	epithelial	epithelial	NOUN
dti-2707	153	25	(	(	PUNCT
dti-2707	153	26	beas-2b	beas-2b	ADV
dti-2707	153	27	)	)	PUNCT
dti-2707	153	28	cells	cell	NOUN
dti-2707	153	29	(	(	PUNCT
dti-2707	153	30	62	62	NUM
dti-2707	153	31	)	)	PUNCT
dti-2707	153	32	,	,	PUNCT
dti-2707	153	33	which	which	PRON
dti-2707	153	34	was	be	AUX
dti-2707	153	35	mostly	mostly	ADV
dti-2707	153	36	expressed	express	VERB
dti-2707	153	37	by	by	ADP
dti-2707	153	38	downstream	downstream	ADJ
dti-2707	153	39	inos	ino	NOUN
dti-2707	153	40	production	production	NOUN
dti-2707	153	41	,	,	PUNCT
dti-2707	153	42	iκbα	iκbα	ADJ
dti-2707	153	43	phosphorylation	phosphorylation	NOUN
dti-2707	153	44	and	and	CCONJ
dti-2707	153	45	degradation	degradation	NOUN
dti-2707	153	46	,	,	PUNCT
dti-2707	153	47	and	and	CCONJ
dti-2707	153	48	nuclear	nuclear	ADJ
dti-2707	153	49	translocation	translocation	NOUN
dti-2707	153	50	of	of	ADP
dti-2707	153	51	p65	p65	NOUN
dti-2707	153	52	(	(	PUNCT
dti-2707	153	53	63	63	NUM
dti-2707	153	54	)	)	PUNCT
dti-2707	153	55	.	.	PUNCT
dti-2707	154	1	another	another	DET
dti-2707	154	2	structural	structural	ADJ
dti-2707	154	3	change	change	NOUN
dti-2707	154	4	associated	associate	VERB
dti-2707	154	5	with	with	ADP
dti-2707	154	6	asthma	asthma	NOUN
dti-2707	154	7	has	have	AUX
dti-2707	154	8	been	be	AUX
dti-2707	154	9	described	describe	VERB
dti-2707	154	10	as	as	ADP
dti-2707	154	11	increased	increase	VERB
dti-2707	154	12	extracellular	extracellular	ADJ
dti-2707	154	13	matrix	matrix	NOUN
dti-2707	154	14	(	(	PUNCT
dti-2707	154	15	ecm	ecm	PROPN
dti-2707	154	16	)	)	PUNCT
dti-2707	154	17	deposition	deposition	NOUN
dti-2707	154	18	.	.	PUNCT
dti-2707	155	1	the	the	DET
dti-2707	155	2	primary	primary	ADJ
dti-2707	155	3	ecm	ecm	NOUN
dti-2707	155	4	producers	producer	NOUN
dti-2707	155	5	in	in	ADP
dti-2707	155	6	the	the	DET
dti-2707	155	7	lung	lung	NOUN
dti-2707	155	8	are	be	AUX
dti-2707	155	9	myofibroblasts	myofibroblast	NOUN
dti-2707	155	10	and	and	CCONJ
dti-2707	155	11	fibroblasts	fibroblast	NOUN
dti-2707	155	12	.	.	PUNCT
dti-2707	156	1	during	during	ADP
dti-2707	156	2	allergic	allergic	ADJ
dti-2707	156	3	airway	airway	NOUN
dti-2707	156	4	inflammation	inflammation	NOUN
dti-2707	156	5	,	,	PUNCT
dti-2707	156	6	myofibroblasts	myofibroblast	NOUN
dti-2707	156	7	deposit	deposit	VERB
dti-2707	156	8	collagen	collagen	NOUN
dti-2707	156	9	types	type	NOUN
dti-2707	156	10	i	i	PRON
dti-2707	156	11	and	and	CCONJ
dti-2707	156	12	iii	iii	PROPN
dti-2707	156	13	.	.	PUNCT
dti-2707	157	1	ecm	ecm	PROPN
dti-2707	157	2	’s	’s	PART
dti-2707	157	3	constituents	constituent	NOUN
dti-2707	157	4	,	,	PUNCT
dti-2707	157	5	especially	especially	ADV
dti-2707	157	6	collagens	collagen	NOUN
dti-2707	157	7	,	,	PUNCT
dti-2707	157	8	are	be	AUX
dti-2707	157	9	broken	break	VERB
dti-2707	157	10	down	down	ADP
dti-2707	157	11	and	and	CCONJ
dti-2707	157	12	controlled	control	VERB
dti-2707	157	13	by	by	ADP
dti-2707	157	14	mmps	mmp	NOUN
dti-2707	157	15	,	,	PUNCT
dti-2707	157	16	which	which	PRON
dti-2707	157	17	are	be	AUX
dti-2707	157	18	secreted	secrete	VERB
dti-2707	157	19	by	by	ADP
dti-2707	157	20	fibroblasts	fibroblast	NOUN
dti-2707	157	21	.	.	PUNCT
dti-2707	158	1	in	in	ADP
dti-2707	158	2	allergic	allergic	ADJ
dti-2707	158	3	asthma	asthma	NOUN
dti-2707	158	4	,	,	PUNCT
dti-2707	158	5	mmp-9	mmp-9	X
dti-2707	158	6	,	,	PUNCT
dti-2707	158	7	the	the	DET
dti-2707	158	8	main	main	ADJ
dti-2707	158	9	airway	airway	NOUN
dti-2707	158	10	mmp	mmp	PROPN
dti-2707	158	11	,	,	PUNCT
dti-2707	158	12	is	be	AUX
dti-2707	158	13	upregulated	upregulate	VERB
dti-2707	158	14	,	,	PUNCT
dti-2707	158	15	which	which	PRON
dti-2707	158	16	figure	figure	VERB
dti-2707	158	17	2	2	NUM
dti-2707	158	18	baicalein	baicalein	NOUN
dti-2707	158	19	regulating	regulate	VERB
dti-2707	158	20	a	a	DET
dti-2707	158	21	wide	wide	ADJ
dti-2707	158	22	range	range	NOUN
dti-2707	158	23	of	of	ADP
dti-2707	158	24	signaling	signal	VERB
dti-2707	158	25	pathways	pathway	NOUN
dti-2707	158	26	linked	link	VERB
dti-2707	158	27	to	to	ADP
dti-2707	158	28	the	the	DET
dti-2707	158	29	etiology	etiology	NOUN
dti-2707	158	30	of	of	ADP
dti-2707	158	31	multiple	multiple	ADJ
dti-2707	158	32	degenerative	degenerative	ADJ
dti-2707	158	33	conditions	condition	NOUN
dti-2707	158	34	.	.	PUNCT
dti-2707	159	1	munjal	munjal	PROPN
dti-2707	159	2	et	et	PROPN
dti-2707	159	3	al	al	PROPN
dti-2707	159	4	drug	drug	PROPN
dti-2707	159	5	target	target	NOUN
dti-2707	159	6	insights	insight	NOUN
dti-2707	159	7	2024	2024	NUM
dti-2707	159	8	;	;	PUNCT
dti-2707	159	9	18	18	NUM
dti-2707	159	10	:	:	SYM
dti-2707	159	11	35	35	NUM
dti-2707	159	12	©	©	PROPN
dti-2707	159	13	2024	2024	NUM
dti-2707	159	14	the	the	DET
dti-2707	159	15	authors	author	NOUN
dti-2707	159	16	.	.	PUNCT
dti-2707	160	1	published	publish	VERB
dti-2707	160	2	by	by	ADP
dti-2707	160	3	aboutscience	aboutscience	NOUN
dti-2707	160	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2707	160	5	results	result	NOUN
dti-2707	160	6	in	in	ADP
dti-2707	160	7	airway	airway	NOUN
dti-2707	160	8	remodeling	remodeling	NOUN
dti-2707	160	9	(	(	PUNCT
dti-2707	160	10	64	64	NUM
dti-2707	160	11	)	)	PUNCT
dti-2707	160	12	.	.	PUNCT
dti-2707	161	1	according	accord	VERB
dti-2707	161	2	to	to	ADP
dti-2707	161	3	recent	recent	ADJ
dti-2707	161	4	studies	study	NOUN
dti-2707	161	5	,	,	PUNCT
dti-2707	161	6	baicalein	baicalein	PROPN
dti-2707	161	7	administration	administration	PROPN
dti-2707	161	8	reduces	reduce	VERB
dti-2707	161	9	the	the	DET
dti-2707	161	10	ovalbumin	ovalbumin	NOUN
dti-2707	161	11	(	(	PUNCT
dti-2707	161	12	ova)induced	ova)induced	ADJ
dti-2707	161	13	expression	expression	NOUN
dti-2707	161	14	of	of	ADP
dti-2707	161	15	collagen	collagen	NOUN
dti-2707	161	16	i	i	PROPN
dti-2707	161	17	and	and	CCONJ
dti-2707	161	18	mmp-9	mmp-9	VERB
dti-2707	161	19	(	(	PUNCT
dti-2707	161	20	65	65	NUM
dti-2707	161	21	)	)	PUNCT
dti-2707	161	22	.	.	PUNCT
dti-2707	162	1	cardioprotective	cardioprotective	ADJ
dti-2707	162	2	action	action	NOUN
dti-2707	162	3	of	of	ADP
dti-2707	162	4	baicalein	baicalein	NOUN
dti-2707	162	5	globally	globally	ADV
dti-2707	162	6	,	,	PUNCT
dti-2707	162	7	cardiovascular	cardiovascular	ADJ
dti-2707	162	8	disease	disease	NOUN
dti-2707	162	9	(	(	PUNCT
dti-2707	162	10	cvd	cvd	PROPN
dti-2707	162	11	)	)	PUNCT
dti-2707	162	12	is	be	AUX
dti-2707	162	13	one	one	NUM
dti-2707	162	14	of	of	ADP
dti-2707	162	15	the	the	DET
dti-2707	162	16	major	major	ADJ
dti-2707	162	17	causes	cause	NOUN
dti-2707	162	18	of	of	ADP
dti-2707	162	19	morbidity	morbidity	NOUN
dti-2707	162	20	and	and	CCONJ
dti-2707	162	21	motility	motility	NOUN
dti-2707	162	22	.	.	PUNCT
dti-2707	163	1	in	in	ADP
dti-2707	163	2	past	past	ADJ
dti-2707	163	3	few	few	ADJ
dti-2707	163	4	decades	decade	NOUN
dti-2707	163	5	,	,	PUNCT
dti-2707	163	6	changes	change	NOUN
dti-2707	163	7	in	in	ADP
dti-2707	163	8	lifestyle	lifestyle	NOUN
dti-2707	163	9	and	and	CCONJ
dti-2707	163	10	socioeconomic	socioeconomic	ADJ
dti-2707	163	11	conditions	condition	NOUN
dti-2707	163	12	that	that	PRON
dti-2707	163	13	have	have	VERB
dti-2707	163	14	an	an	DET
dti-2707	163	15	impact	impact	NOUN
dti-2707	163	16	on	on	ADP
dti-2707	163	17	the	the	DET
dti-2707	163	18	progression	progression	NOUN
dti-2707	163	19	of	of	ADP
dti-2707	163	20	cvds	cvds	PROPN
dti-2707	163	21	have	have	AUX
dti-2707	163	22	been	be	AUX
dti-2707	163	23	observed	observe	VERB
dti-2707	163	24	.	.	PUNCT
dti-2707	164	1	hypertension	hypertension	NOUN
dti-2707	164	2	is	be	AUX
dti-2707	164	3	a	a	DET
dti-2707	164	4	significant	significant	ADJ
dti-2707	164	5	contributor	contributor	NOUN
dti-2707	164	6	to	to	ADP
dti-2707	164	7	cvd	cvd	PROPN
dti-2707	164	8	and	and	CCONJ
dti-2707	164	9	fatalities	fatality	NOUN
dti-2707	164	10	globally	globally	ADV
dti-2707	164	11	,	,	PUNCT
dti-2707	164	12	particularly	particularly	ADV
dti-2707	164	13	in	in	ADP
dti-2707	164	14	lowand	lowand	ADJ
dti-2707	164	15	middle	middle	ADJ
dti-2707	164	16	-	-	PUNCT
dti-2707	164	17	income	income	NOUN
dti-2707	164	18	nations	nation	NOUN
dti-2707	164	19	.	.	PUNCT
dti-2707	165	1	as	as	ADP
dti-2707	165	2	per	per	ADP
dti-2707	165	3	the	the	DET
dti-2707	165	4	2017	2017	NUM
dti-2707	165	5	guidelines	guideline	NOUN
dti-2707	165	6	from	from	ADP
dti-2707	165	7	the	the	DET
dti-2707	165	8	american	american	PROPN
dti-2707	165	9	college	college	PROPN
dti-2707	165	10	of	of	ADP
dti-2707	165	11	cardiology	cardiology	NOUN
dti-2707	165	12	and	and	CCONJ
dti-2707	165	13	american	american	ADJ
dti-2707	165	14	heart	heart	PROPN
dti-2707	165	15	association	association	PROPN
dti-2707	165	16	,	,	PUNCT
dti-2707	165	17	hypertension	hypertension	NOUN
dti-2707	165	18	is	be	AUX
dti-2707	165	19	defined	define	VERB
dti-2707	165	20	as	as	ADP
dti-2707	165	21	a	a	DET
dti-2707	165	22	systolic	systolic	ADJ
dti-2707	165	23	blood	blood	NOUN
dti-2707	165	24	pressure	pressure	NOUN
dti-2707	165	25	over	over	ADP
dti-2707	165	26	130	130	NUM
dti-2707	165	27	mm	mm	NUM
dti-2707	165	28	hg	hg	NOUN
dti-2707	165	29	or	or	CCONJ
dti-2707	165	30	a	a	DET
dti-2707	165	31	diastolic	diastolic	ADJ
dti-2707	165	32	blood	blood	NOUN
dti-2707	165	33	pressure	pressure	NOUN
dti-2707	165	34	above	above	ADP
dti-2707	165	35	80	80	NUM
dti-2707	165	36	mm	mm	NUM
dti-2707	165	37	hg	hg	NOUN
dti-2707	165	38	(	(	PUNCT
dti-2707	165	39	66	66	NUM
dti-2707	165	40	-	-	SYM
dti-2707	165	41	70	70	NUM
dti-2707	165	42	)	)	PUNCT
dti-2707	165	43	.	.	PUNCT
dti-2707	166	1	baicalin	baicalin	PROPN
dti-2707	166	2	assisted	assist	VERB
dti-2707	166	3	in	in	ADP
dti-2707	166	4	lowering	lower	VERB
dti-2707	166	5	high	high	ADJ
dti-2707	166	6	-	-	PUNCT
dti-2707	166	7	sensitivity	sensitivity	NOUN
dti-2707	166	8	c	c	NOUN
dti-2707	166	9	-	-	PUNCT
dti-2707	166	10	reactive	reactive	ADJ
dti-2707	166	11	protein	protein	NOUN
dti-2707	166	12	(	(	PUNCT
dti-2707	166	13	crp	crp	PROPN
dti-2707	166	14	)	)	PUNCT
dti-2707	166	15	,	,	PUNCT
dti-2707	166	16	interleukin	interleukin	NOUN
dti-2707	166	17	(	(	PUNCT
dti-2707	166	18	il)-6	il)-6	NUM
dti-2707	166	19	,	,	PUNCT
dti-2707	166	20	and	and	CCONJ
dti-2707	166	21	il-1	il-1	ADP
dti-2707	166	22	levels	level	NOUN
dti-2707	166	23	in	in	ADP
dti-2707	166	24	the	the	DET
dti-2707	166	25	serum	serum	NOUN
dti-2707	166	26	,	,	PUNCT
dti-2707	166	27	which	which	PRON
dti-2707	166	28	served	serve	VERB
dti-2707	166	29	to	to	PART
dti-2707	166	30	forcibly	forcibly	ADV
dti-2707	166	31	lower	low	ADJ
dti-2707	166	32	blood	blood	NOUN
dti-2707	166	33	pressure	pressure	NOUN
dti-2707	166	34	(	(	PUNCT
dti-2707	166	35	71	71	NUM
dti-2707	166	36	)	)	PUNCT
dti-2707	166	37	.	.	PUNCT
dti-2707	167	1	baicalin	baicalin	PROPN
dti-2707	167	2	altered	alter	VERB
dti-2707	167	3	the	the	DET
dti-2707	167	4	expression	expression	NOUN
dti-2707	167	5	of	of	ADP
dti-2707	167	6	mir145	mir145	PROPN
dti-2707	167	7	and	and	CCONJ
dti-2707	167	8	increased	increase	VERB
dti-2707	167	9	tnf	tnf	PROPN
dti-2707	167	10	-	-	PUNCT
dti-2707	167	11	α	α	PROPN
dti-2707	167	12	levels	level	NOUN
dti-2707	167	13	in	in	ADP
dti-2707	167	14	human	human	ADJ
dti-2707	167	15	aortic	aortic	ADJ
dti-2707	167	16	endothelial	endothelial	NOUN
dti-2707	167	17	cells	cell	NOUN
dti-2707	167	18	(	(	PUNCT
dti-2707	167	19	haecs	haecs	PROPN
dti-2707	167	20	)	)	PUNCT
dti-2707	167	21	,	,	PUNCT
dti-2707	167	22	thereby	thereby	ADV
dti-2707	167	23	reducing	reduce	VERB
dti-2707	167	24	the	the	DET
dti-2707	167	25	inflammatory	inflammatory	ADJ
dti-2707	167	26	effects	effect	NOUN
dti-2707	167	27	of	of	ADP
dti-2707	167	28	tnf	tnf	PROPN
dti-2707	167	29	-	-	PUNCT
dti-2707	167	30	α	α	PROPN
dti-2707	167	31	(	(	PUNCT
dti-2707	167	32	72	72	NUM
dti-2707	167	33	)	)	PUNCT
dti-2707	167	34	.	.	PUNCT
dti-2707	168	1	angiotensin	angiotensin	PROPN
dti-2707	168	2	ii	ii	PROPN
dti-2707	168	3	(	(	PUNCT
dti-2707	168	4	ang	ang	PROPN
dti-2707	168	5	ii	ii	PROPN
dti-2707	168	6	)	)	PUNCT
dti-2707	168	7	may	may	AUX
dti-2707	168	8	activate	activate	VERB
dti-2707	168	9	apoptosis	apoptosis	NOUN
dti-2707	168	10	-	-	PUNCT
dti-2707	168	11	related	relate	VERB
dti-2707	168	12	proteins	protein	NOUN
dti-2707	168	13	,	,	PUNCT
dti-2707	168	14	encourage	encourage	VERB
dti-2707	168	15	the	the	DET
dti-2707	168	16	production	production	NOUN
dti-2707	168	17	of	of	ADP
dti-2707	168	18	ros	ros	PROPN
dti-2707	168	19	,	,	PUNCT
dti-2707	168	20	and	and	CCONJ
dti-2707	168	21	inhibit	inhibit	VERB
dti-2707	168	22	the	the	DET
dti-2707	168	23	synthesis	synthesis	NOUN
dti-2707	168	24	of	of	ADP
dti-2707	168	25	no	no	NOUN
dti-2707	168	26	,	,	PUNCT
dti-2707	168	27	which	which	PRON
dti-2707	168	28	results	result	VERB
dti-2707	168	29	in	in	ADP
dti-2707	168	30	endothelial	endothelial	ADJ
dti-2707	168	31	dysfunction	dysfunction	NOUN
dti-2707	168	32	that	that	PRON
dti-2707	168	33	may	may	AUX
dti-2707	168	34	lead	lead	VERB
dti-2707	168	35	to	to	ADP
dti-2707	168	36	hypertension	hypertension	NOUN
dti-2707	168	37	.	.	PUNCT
dti-2707	169	1	therefore	therefore	ADV
dti-2707	169	2	,	,	PUNCT
dti-2707	169	3	lowering	lower	VERB
dti-2707	169	4	cell	cell	NOUN
dti-2707	169	5	apoptosis	apoptosis	NOUN
dti-2707	169	6	,	,	PUNCT
dti-2707	169	7	suppressing	suppress	VERB
dti-2707	169	8	oxidative	oxidative	ADJ
dti-2707	169	9	stress	stress	NOUN
dti-2707	169	10	,	,	PUNCT
dti-2707	169	11	and	and	CCONJ
dti-2707	169	12	preventing	prevent	VERB
dti-2707	169	13	ang	ang	PROPN
dti-2707	169	14	ii	ii	ADV
dti-2707	169	15	-	-	PUNCT
dti-2707	169	16	induced	induce	VERB
dti-2707	169	17	endothelial	endothelial	ADJ
dti-2707	169	18	dysfunction	dysfunction	NOUN
dti-2707	169	19	are	be	AUX
dti-2707	169	20	effective	effective	ADJ
dti-2707	169	21	ways	way	NOUN
dti-2707	169	22	to	to	PART
dti-2707	169	23	treat	treat	VERB
dti-2707	169	24	hypertension	hypertension	NOUN
dti-2707	169	25	.	.	PUNCT
dti-2707	170	1	baicalin	baicalin	NOUN
dti-2707	170	2	has	have	AUX
dti-2707	170	3	been	be	AUX
dti-2707	170	4	shown	show	VERB
dti-2707	170	5	in	in	ADP
dti-2707	170	6	a	a	DET
dti-2707	170	7	study	study	NOUN
dti-2707	170	8	utilizing	utilize	VERB
dti-2707	170	9	the	the	DET
dti-2707	170	10	human	human	ADJ
dti-2707	170	11	umbilical	umbilical	ADJ
dti-2707	170	12	vein	vein	ADJ
dti-2707	170	13	endothelial	endothelial	ADJ
dti-2707	170	14	cell	cell	NOUN
dti-2707	170	15	(	(	PUNCT
dti-2707	170	16	huvec	huvec	NOUN
dti-2707	170	17	)	)	PUNCT
dti-2707	170	18	model	model	NOUN
dti-2707	170	19	of	of	ADP
dti-2707	170	20	ang	ang	PROPN
dti-2707	170	21	ii	ii	PROPN
dti-2707	170	22	injury	injury	NOUN
dti-2707	170	23	to	to	PART
dti-2707	170	24	significantly	significantly	ADV
dti-2707	170	25	reduce	reduce	VERB
dti-2707	170	26	oxidative	oxidative	ADJ
dti-2707	170	27	stress	stress	NOUN
dti-2707	170	28	and	and	CCONJ
dti-2707	170	29	endothelial	endothelial	ADJ
dti-2707	170	30	dysfunction	dysfunction	NOUN
dti-2707	170	31	caused	cause	VERB
dti-2707	170	32	by	by	ADP
dti-2707	170	33	ang	ang	PROPN
dti-2707	170	34	ii	ii	PROPN
dti-2707	170	35	.	.	PUNCT
dti-2707	171	1	the	the	DET
dti-2707	171	2	primary	primary	ADJ
dti-2707	171	3	strategies	strategy	NOUN
dti-2707	171	4	employed	employ	VERB
dti-2707	171	5	to	to	PART
dti-2707	171	6	produce	produce	VERB
dti-2707	171	7	these	these	DET
dti-2707	171	8	beneficial	beneficial	ADJ
dti-2707	171	9	effects	effect	NOUN
dti-2707	171	10	include	include	VERB
dti-2707	171	11	modulating	modulate	VERB
dti-2707	171	12	the	the	DET
dti-2707	171	13	expression	expression	NOUN
dti-2707	171	14	of	of	ADP
dti-2707	171	15	bax	bax	PROPN
dti-2707	171	16	,	,	PUNCT
dti-2707	171	17	bcl-2	bcl-2	NOUN
dti-2707	171	18	,	,	PUNCT
dti-2707	171	19	and	and	CCONJ
dti-2707	171	20	cleaved	cleave	VERB
dti-2707	171	21	caspase-3	caspase-3	PROPN
dti-2707	171	22	,	,	PUNCT
dti-2707	171	23	activating	activate	VERB
dti-2707	171	24	the	the	DET
dti-2707	171	25	ace2	ace2	PROPN
dti-2707	171	26	/	/	SYM
dti-2707	171	27	ang-(1	ang-(1	PROPN
dti-2707	171	28	-	-	PUNCT
dti-2707	171	29	7)/mas	7)/mas	PROPN
dti-2707	171	30	axis	axis	NOUN
dti-2707	171	31	,	,	PUNCT
dti-2707	171	32	and	and	CCONJ
dti-2707	171	33	upregulating	upregulate	VERB
dti-2707	171	34	the	the	DET
dti-2707	171	35	pi3k/	pi3k/	PROPN
dti-2707	171	36	akt	akt	PROPN
dti-2707	171	37	/	/	SYM
dti-2707	171	38	enos	enos	PROPN
dti-2707	171	39	pathway	pathway	NOUN
dti-2707	171	40	.	.	PUNCT
dti-2707	172	1	they	they	PRON
dti-2707	172	2	also	also	ADV
dti-2707	172	3	found	find	VERB
dti-2707	172	4	that	that	SCONJ
dti-2707	172	5	baicalin	baicalin	NOUN
dti-2707	172	6	raised	raise	VERB
dti-2707	172	7	no	no	DET
dti-2707	172	8	level	level	NOUN
dti-2707	172	9	and	and	CCONJ
dti-2707	172	10	total	total	ADJ
dti-2707	172	11	antioxidant	antioxidant	ADJ
dti-2707	172	12	capacity	capacity	NOUN
dti-2707	172	13	,	,	PUNCT
dti-2707	172	14	and	and	CCONJ
dti-2707	172	15	decreased	decrease	VERB
dti-2707	172	16	markers	marker	NOUN
dti-2707	172	17	of	of	ADP
dti-2707	172	18	oxidative	oxidative	ADJ
dti-2707	172	19	stress	stress	NOUN
dti-2707	172	20	such	such	ADJ
dti-2707	172	21	as	as	ADP
dti-2707	172	22	malondialdehyde	malondialdehyde	PROPN
dti-2707	172	23	(	(	PUNCT
dti-2707	172	24	mda	mda	PROPN
dti-2707	172	25	)	)	PUNCT
dti-2707	172	26	and	and	CCONJ
dti-2707	172	27	ros	ros	PROPN
dti-2707	172	28	(	(	PUNCT
dti-2707	172	29	73,74	73,74	NOUN
dti-2707	172	30	)	)	PUNCT
dti-2707	172	31	.	.	PUNCT
dti-2707	173	1	it	it	PRON
dti-2707	173	2	was	be	AUX
dti-2707	173	3	also	also	ADV
dti-2707	173	4	shown	show	VERB
dti-2707	173	5	that	that	SCONJ
dti-2707	173	6	the	the	DET
dti-2707	173	7	combination	combination	NOUN
dti-2707	173	8	of	of	ADP
dti-2707	173	9	baicalin	baicalin	NOUN
dti-2707	173	10	and	and	CCONJ
dti-2707	173	11	berberine	berberine	NOUN
dti-2707	173	12	relaxed	relax	VERB
dti-2707	173	13	blood	blood	NOUN
dti-2707	173	14	arteries	artery	NOUN
dti-2707	173	15	by	by	ADP
dti-2707	173	16	acting	act	VERB
dti-2707	173	17	on	on	ADP
dti-2707	173	18	the	the	DET
dti-2707	173	19	voltage	voltage	NOUN
dti-2707	173	20	-	-	PUNCT
dti-2707	173	21	dependent	dependent	ADJ
dti-2707	173	22	ca2	ca2	PROPN
dti-2707	173	23	+	+	PROPN
dti-2707	173	24	channel	channel	NOUN
dti-2707	173	25	(	(	PUNCT
dti-2707	173	26	vdcc	vdcc	NOUN
dti-2707	173	27	)	)	PUNCT
dti-2707	173	28	(	(	PUNCT
dti-2707	173	29	75	75	NUM
dti-2707	173	30	)	)	PUNCT
dti-2707	173	31	.	.	PUNCT
dti-2707	174	1	by	by	ADP
dti-2707	174	2	boosting	boost	VERB
dti-2707	174	3	endogenous	endogenous	ADJ
dti-2707	174	4	no	no	DET
dti-2707	174	5	synthesis	synthesis	NOUN
dti-2707	174	6	,	,	PUNCT
dti-2707	174	7	which	which	PRON
dti-2707	174	8	is	be	AUX
dti-2707	174	9	produced	produce	VERB
dti-2707	174	10	by	by	ADP
dti-2707	174	11	the	the	DET
dti-2707	174	12	enzyme	enzyme	NOUN
dti-2707	174	13	endothelial	endothelial	ADJ
dti-2707	174	14	nitric	nitric	ADJ
dti-2707	174	15	oxide	oxide	NOUN
dti-2707	174	16	synthase	synthase	NOUN
dti-2707	174	17	(	(	PUNCT
dti-2707	174	18	enos	enos	PROPN
dti-2707	174	19	)	)	PUNCT
dti-2707	174	20	,	,	PUNCT
dti-2707	174	21	baicalin	baicalin	NOUN
dti-2707	174	22	may	may	AUX
dti-2707	174	23	also	also	ADV
dti-2707	174	24	lower	lower	VERB
dti-2707	174	25	blood	blood	NOUN
dti-2707	174	26	pressure	pressure	NOUN
dti-2707	174	27	(	(	PUNCT
dti-2707	174	28	76	76	NUM
dti-2707	174	29	)	)	PUNCT
dti-2707	174	30	.	.	PUNCT
dti-2707	175	1	heart	heart	NOUN
dti-2707	175	2	failure	failure	NOUN
dti-2707	175	3	is	be	AUX
dti-2707	175	4	a	a	DET
dti-2707	175	5	complicated	complicated	ADJ
dti-2707	175	6	clinical	clinical	ADJ
dti-2707	175	7	condition	condition	NOUN
dti-2707	175	8	that	that	PRON
dti-2707	175	9	arises	arise	VERB
dti-2707	175	10	when	when	SCONJ
dti-2707	175	11	the	the	DET
dti-2707	175	12	heart	heart	NOUN
dti-2707	175	13	is	be	AUX
dti-2707	175	14	unable	unable	ADJ
dti-2707	175	15	to	to	PART
dti-2707	175	16	pump	pump	VERB
dti-2707	175	17	enough	enough	ADJ
dti-2707	175	18	blood	blood	NOUN
dti-2707	175	19	to	to	PART
dti-2707	175	20	meet	meet	VERB
dti-2707	175	21	the	the	DET
dti-2707	175	22	body	body	NOUN
dti-2707	175	23	’s	’s	PART
dti-2707	175	24	needs	need	NOUN
dti-2707	175	25	.	.	PUNCT
dti-2707	176	1	it	it	PRON
dti-2707	176	2	arises	arise	VERB
dti-2707	176	3	from	from	ADP
dti-2707	176	4	any	any	DET
dti-2707	176	5	ailment	ailment	NOUN
dti-2707	176	6	that	that	PRON
dti-2707	176	7	impacts	impact	VERB
dti-2707	176	8	the	the	DET
dti-2707	176	9	ventricles	ventricle	NOUN
dti-2707	176	10	’	'	PUNCT
dti-2707	176	11	ability	ability	NOUN
dti-2707	176	12	to	to	PART
dti-2707	176	13	fill	fill	VERB
dti-2707	176	14	or	or	CCONJ
dti-2707	176	15	the	the	DET
dti-2707	176	16	blood	blood	NOUN
dti-2707	176	17	’s	’s	PART
dti-2707	176	18	ability	ability	NOUN
dti-2707	176	19	to	to	PART
dti-2707	176	20	be	be	AUX
dti-2707	176	21	ejected	eject	VERB
dti-2707	176	22	into	into	ADP
dti-2707	176	23	the	the	DET
dti-2707	176	24	systemic	systemic	ADJ
dti-2707	176	25	circulation	circulation	NOUN
dti-2707	176	26	(	(	PUNCT
dti-2707	176	27	77	77	NUM
dti-2707	176	28	)	)	PUNCT
dti-2707	176	29	.	.	PUNCT
dti-2707	177	1	baicalin	baicalin	PROPN
dti-2707	177	2	seems	seem	VERB
dti-2707	177	3	to	to	PART
dti-2707	177	4	be	be	AUX
dti-2707	177	5	very	very	ADV
dti-2707	177	6	useful	useful	ADJ
dti-2707	177	7	in	in	ADP
dti-2707	177	8	treatment	treatment	NOUN
dti-2707	177	9	of	of	ADP
dti-2707	177	10	chf	chf	NOUN
dti-2707	177	11	as	as	SCONJ
dti-2707	177	12	it	it	PRON
dti-2707	177	13	has	have	VERB
dti-2707	177	14	an	an	DET
dti-2707	177	15	anti	anti	ADJ
dti-2707	177	16	-	-	ADJ
dti-2707	177	17	fibrosis	fibrosis	ADJ
dti-2707	177	18	property	property	NOUN
dti-2707	177	19	.	.	PUNCT
dti-2707	178	1	baicalin	baicalin	NOUN
dti-2707	178	2	may	may	AUX
dti-2707	178	3	be	be	AUX
dti-2707	178	4	able	able	ADJ
dti-2707	178	5	to	to	PART
dti-2707	178	6	treat	treat	VERB
dti-2707	178	7	myocardial	myocardial	ADJ
dti-2707	178	8	fibrosis	fibrosis	NOUN
dti-2707	178	9	by	by	ADP
dti-2707	178	10	inhibiting	inhibit	VERB
dti-2707	178	11	the	the	DET
dti-2707	178	12	expression	expression	NOUN
dti-2707	178	13	of	of	ADP
dti-2707	178	14	the	the	DET
dti-2707	178	15	fibrosis	fibrosis	NOUN
dti-2707	178	16	genes	gene	NOUN
dti-2707	178	17	(	(	PUNCT
dti-2707	178	18	type	type	NOUN
dti-2707	178	19	i	i	PRON
dti-2707	178	20	and	and	CCONJ
dti-2707	178	21	iii	iii	NUM
dti-2707	178	22	collagen	collagen	NOUN
dti-2707	178	23	)	)	PUNCT
dti-2707	178	24	and	and	CCONJ
dti-2707	178	25	connective	connective	ADJ
dti-2707	178	26	tissue	tissue	NOUN
dti-2707	178	27	growth	growth	NOUN
dti-2707	178	28	factor	factor	NOUN
dti-2707	178	29	(	(	PUNCT
dti-2707	178	30	ctgf	ctgf	NOUN
dti-2707	178	31	)	)	PUNCT
dti-2707	178	32	.	.	PUNCT
dti-2707	179	1	baicalin	baicalin	NOUN
dti-2707	179	2	can	can	AUX
dti-2707	179	3	efficiently	efficiently	ADV
dti-2707	179	4	induce	induce	VERB
dti-2707	179	5	endothelial	endothelial	ADJ
dti-2707	179	6	cell	cell	NOUN
dti-2707	179	7	migration	migration	NOUN
dti-2707	179	8	and	and	CCONJ
dti-2707	179	9	greatly	greatly	ADV
dti-2707	179	10	boost	boost	VERB
dti-2707	179	11	the	the	DET
dti-2707	179	12	expression	expression	NOUN
dti-2707	179	13	of	of	ADP
dti-2707	179	14	vegf	vegf	PROPN
dti-2707	179	15	when	when	SCONJ
dti-2707	179	16	the	the	DET
dti-2707	179	17	concentration	concentration	NOUN
dti-2707	179	18	is	be	AUX
dti-2707	179	19	between	between	ADP
dti-2707	179	20	10	10	NUM
dti-2707	179	21	and	and	CCONJ
dti-2707	179	22	50	50	NUM
dti-2707	179	23	g	g	NOUN
dti-2707	179	24	/	/	SYM
dti-2707	179	25	ml	ml	NOUN
dti-2707	179	26	,	,	PUNCT
dti-2707	179	27	which	which	PRON
dti-2707	179	28	aids	aid	VERB
dti-2707	179	29	in	in	ADP
dti-2707	179	30	promoting	promote	VERB
dti-2707	179	31	angiogenesis	angiogenesis	NOUN
dti-2707	179	32	.	.	PUNCT
dti-2707	180	1	this	this	DET
dti-2707	180	2	outcome	outcome	NOUN
dti-2707	180	3	can	can	AUX
dti-2707	180	4	be	be	AUX
dti-2707	180	5	achieved	achieve	VERB
dti-2707	180	6	by	by	ADP
dti-2707	180	7	over	over	ADV
dti-2707	180	8	-	-	PUNCT
dti-2707	180	9	activating	activate	VERB
dti-2707	180	10	the	the	DET
dti-2707	180	11	err	err	NOUN
dti-2707	180	12	/	/	SYM
dti-2707	180	13	pgc-1a	pgc-1a	NOUN
dti-2707	180	14	pathway	pathway	NOUN
dti-2707	180	15	(	(	PUNCT
dti-2707	180	16	78	78	NUM
dti-2707	180	17	)	)	PUNCT
dti-2707	180	18	.	.	PUNCT
dti-2707	181	1	baicalin	baicalin	PROPN
dti-2707	181	2	also	also	ADV
dti-2707	181	3	decreased	decrease	VERB
dti-2707	181	4	caspase-3	caspase-3	NUM
dti-2707	181	5	and	and	CCONJ
dti-2707	181	6	the	the	DET
dti-2707	181	7	bax	bax	PROPN
dti-2707	181	8	/	/	SYM
dti-2707	181	9	bcl-2	bcl-2	NOUN
dti-2707	181	10	ratio	ratio	NOUN
dti-2707	181	11	,	,	PUNCT
dti-2707	181	12	which	which	PRON
dti-2707	181	13	lowered	lower	VERB
dti-2707	181	14	apoptosis	apoptosis	NOUN
dti-2707	181	15	.	.	PUNCT
dti-2707	182	1	this	this	PRON
dti-2707	182	2	suggests	suggest	VERB
dti-2707	182	3	that	that	SCONJ
dti-2707	182	4	apoptosis	apoptosis	NOUN
dti-2707	182	5	inhibition	inhibition	NOUN
dti-2707	182	6	could	could	AUX
dti-2707	182	7	lessen	lessen	VERB
dti-2707	182	8	adverse	adverse	ADJ
dti-2707	182	9	remodeling	remodeling	NOUN
dti-2707	182	10	and	and	CCONJ
dti-2707	182	11	the	the	DET
dti-2707	182	12	eventual	eventual	ADJ
dti-2707	182	13	development	development	NOUN
dti-2707	182	14	of	of	ADP
dti-2707	182	15	heart	heart	NOUN
dti-2707	182	16	failure	failure	NOUN
dti-2707	182	17	(	(	PUNCT
dti-2707	182	18	79	79	NUM
dti-2707	182	19	)	)	PUNCT
dti-2707	182	20	.	.	PUNCT
dti-2707	183	1	gastroprotective	gastroprotective	NOUN
dti-2707	183	2	activity	activity	NOUN
dti-2707	183	3	of	of	ADP
dti-2707	183	4	baicalein	baicalein	NOUN
dti-2707	183	5	peptic	peptic	ADJ
dti-2707	183	6	ulcer	ulcer	NOUN
dti-2707	183	7	disease	disease	NOUN
dti-2707	183	8	(	(	PUNCT
dti-2707	183	9	pud	pud	NOUN
dti-2707	183	10	)	)	PUNCT
dti-2707	183	11	,	,	PUNCT
dti-2707	183	12	as	as	SCONJ
dti-2707	183	13	determined	determine	VERB
dti-2707	183	14	by	by	ADP
dti-2707	183	15	hospitalization	hospitalization	NOUN
dti-2707	183	16	statistics	statistic	NOUN
dti-2707	183	17	and	and	CCONJ
dti-2707	183	18	diagnosed	diagnose	VERB
dti-2707	183	19	by	by	ADP
dti-2707	183	20	physicians	physician	NOUN
dti-2707	183	21	,	,	PUNCT
dti-2707	183	22	had	have	VERB
dti-2707	183	23	an	an	DET
dti-2707	183	24	incidence	incidence	NOUN
dti-2707	183	25	rate	rate	NOUN
dti-2707	183	26	of	of	ADP
dti-2707	183	27	0.03%-0.17	0.03%-0.17	NOUN
dti-2707	183	28	%	%	NOUN
dti-2707	183	29	and	and	CCONJ
dti-2707	183	30	0.10%-0.19	0.10%-0.19	NOUN
dti-2707	183	31	%	%	NOUN
dti-2707	183	32	per	per	ADP
dti-2707	183	33	year	year	NOUN
dti-2707	183	34	,	,	PUNCT
dti-2707	183	35	respectively	respectively	ADV
dti-2707	183	36	.	.	PUNCT
dti-2707	184	1	although	although	SCONJ
dti-2707	184	2	most	most	ADJ
dti-2707	184	3	research	research	NOUN
dti-2707	184	4	indicated	indicate	VERB
dti-2707	184	5	that	that	SCONJ
dti-2707	184	6	pud	pud	NOUN
dti-2707	184	7	incidence	incidence	NOUN
dti-2707	184	8	or	or	CCONJ
dti-2707	184	9	prevalence	prevalence	NOUN
dti-2707	184	10	had	have	AUX
dti-2707	184	11	decreased	decrease	VERB
dti-2707	184	12	over	over	ADP
dti-2707	184	13	time	time	NOUN
dti-2707	184	14	,	,	PUNCT
dti-2707	184	15	still	still	ADV
dti-2707	184	16	it	it	PRON
dti-2707	184	17	is	be	AUX
dti-2707	184	18	a	a	DET
dti-2707	184	19	serious	serious	ADJ
dti-2707	184	20	and	and	CCONJ
dti-2707	184	21	life	life	NOUN
dti-2707	184	22	-	-	PUNCT
dti-2707	184	23	threatening	threaten	VERB
dti-2707	184	24	disease	disease	NOUN
dti-2707	184	25	(	(	PUNCT
dti-2707	184	26	80	80	NUM
dti-2707	184	27	)	)	PUNCT
dti-2707	184	28	.	.	PUNCT
dti-2707	185	1	acetylsalicylic	acetylsalicylic	PROPN
dti-2707	185	2	acid	acid	PROPN
dti-2707	185	3	(	(	PUNCT
dti-2707	185	4	asa	asa	PROPN
dti-2707	185	5	)	)	PUNCT
dti-2707	185	6	,	,	PUNCT
dti-2707	185	7	helicobacter	helicobacter	NOUN
dti-2707	185	8	pylori	pylori	NOUN
dti-2707	185	9	infection	infection	NOUN
dti-2707	185	10	,	,	PUNCT
dti-2707	185	11	and	and	CCONJ
dti-2707	185	12	non	non	ADJ
dti-2707	185	13	-	-	ADJ
dti-2707	185	14	steroidal	steroidal	ADJ
dti-2707	185	15	anti	anti	ADJ
dti-2707	185	16	inflammatory	inflammatory	ADJ
dti-2707	185	17	drugs	drug	NOUN
dti-2707	185	18	(	(	PUNCT
dti-2707	185	19	nsaids	nsaid	NOUN
dti-2707	185	20	)	)	PUNCT
dti-2707	185	21	are	be	AUX
dti-2707	185	22	the	the	DET
dti-2707	185	23	major	major	ADJ
dti-2707	185	24	causes	cause	NOUN
dti-2707	185	25	of	of	ADP
dti-2707	185	26	pud	pud	NOUN
dti-2707	185	27	.	.	PUNCT
dti-2707	186	1	while	while	SCONJ
dti-2707	186	2	there	there	PRON
dti-2707	186	3	has	have	AUX
dti-2707	186	4	been	be	AUX
dti-2707	186	5	a	a	DET
dti-2707	186	6	significant	significant	ADJ
dti-2707	186	7	improvement	improvement	NOUN
dti-2707	186	8	in	in	ADP
dti-2707	186	9	h.	h.	PROPN
dti-2707	186	10	pylori	pylori	NOUN
dti-2707	186	11	infection	infection	NOUN
dti-2707	186	12	therapy	therapy	NOUN
dti-2707	186	13	recently	recently	ADV
dti-2707	186	14	,	,	PUNCT
dti-2707	186	15	asa	asa	PROPN
dti-2707	186	16	and	and	CCONJ
dti-2707	186	17	nsaid	nsaid	PROPN
dti-2707	186	18	prescriptions	prescription	NOUN
dti-2707	186	19	have	have	AUX
dti-2707	186	20	grown	grow	VERB
dti-2707	186	21	within	within	ADP
dti-2707	186	22	the	the	DET
dti-2707	186	23	same	same	ADJ
dti-2707	186	24	time	time	NOUN
dti-2707	186	25	frame	frame	NOUN
dti-2707	186	26	(	(	PUNCT
dti-2707	186	27	81	81	NUM
dti-2707	186	28	)	)	PUNCT
dti-2707	186	29	.	.	PUNCT
dti-2707	187	1	according	accord	VERB
dti-2707	187	2	to	to	ADP
dti-2707	187	3	reports	report	NOUN
dti-2707	187	4	,	,	PUNCT
dti-2707	187	5	inhibiting	inhibit	VERB
dti-2707	187	6	gastric	gastric	ADJ
dti-2707	187	7	acid	acid	NOUN
dti-2707	187	8	output	output	NOUN
dti-2707	187	9	and	and	CCONJ
dti-2707	187	10	exhibiting	exhibit	VERB
dti-2707	187	11	a	a	DET
dti-2707	187	12	reduction	reduction	NOUN
dti-2707	187	13	in	in	ADP
dti-2707	187	14	gastric	gastric	ADJ
dti-2707	187	15	mucosal	mucosal	NOUN
dti-2707	187	16	damage	damage	NOUN
dti-2707	187	17	are	be	AUX
dti-2707	187	18	both	both	DET
dti-2707	187	19	effects	effect	NOUN
dti-2707	187	20	of	of	ADP
dti-2707	187	21	activating	activate	VERB
dti-2707	187	22	α2	α2	ADJ
dti-2707	187	23	-	-	PUNCT
dti-2707	187	24	adrenergic	adrenergic	NOUN
dti-2707	187	25	receptors	receptor	NOUN
dti-2707	187	26	(	(	PUNCT
dti-2707	187	27	82	82	NUM
dti-2707	187	28	)	)	PUNCT
dti-2707	187	29	.	.	PUNCT
dti-2707	188	1	the	the	DET
dti-2707	188	2	gastroprotective	gastroprotective	NOUN
dti-2707	188	3	properties	property	NOUN
dti-2707	188	4	of	of	ADP
dti-2707	188	5	baicalein	baicalein	NOUN
dti-2707	188	6	may	may	AUX
dti-2707	188	7	be	be	AUX
dti-2707	188	8	mediated	mediate	VERB
dti-2707	188	9	through	through	ADP
dti-2707	188	10	these	these	DET
dti-2707	188	11	receptors	receptor	NOUN
dti-2707	188	12	.	.	PUNCT
dti-2707	189	1	in	in	ADP
dti-2707	189	2	contrast	contrast	NOUN
dti-2707	189	3	to	to	ADP
dti-2707	189	4	the	the	DET
dti-2707	189	5	formation	formation	NOUN
dti-2707	189	6	of	of	ADP
dti-2707	189	7	free	free	ADJ
dti-2707	189	8	radicals	radical	NOUN
dti-2707	189	9	,	,	PUNCT
dti-2707	189	10	glutathione	glutathione	NOUN
dti-2707	189	11	(	(	PUNCT
dti-2707	189	12	gsh	gsh	PROPN
dti-2707	189	13	)	)	PUNCT
dti-2707	189	14	protects	protect	VERB
dti-2707	189	15	the	the	DET
dti-2707	189	16	stomach	stomach	NOUN
dti-2707	189	17	mucosa	mucosa	NOUN
dti-2707	189	18	from	from	ADP
dti-2707	189	19	damage	damage	NOUN
dti-2707	189	20	(	(	PUNCT
dti-2707	189	21	82	82	NUM
dti-2707	189	22	)	)	PUNCT
dti-2707	189	23	.	.	PUNCT
dti-2707	190	1	baicalein	baicalein	PROPN
dti-2707	190	2	was	be	AUX
dti-2707	190	3	found	find	VERB
dti-2707	190	4	to	to	PART
dti-2707	190	5	exert	exert	VERB
dti-2707	190	6	protective	protective	ADJ
dti-2707	190	7	effects	effect	NOUN
dti-2707	190	8	via	via	ADP
dti-2707	190	9	raising	raise	VERB
dti-2707	190	10	the	the	DET
dti-2707	190	11	tissue	tissue	NOUN
dti-2707	190	12	’s	’s	PART
dti-2707	190	13	gsh	gsh	PROPN
dti-2707	190	14	concentration	concentration	NOUN
dti-2707	190	15	,	,	PUNCT
dti-2707	190	16	signaling	signal	VERB
dti-2707	190	17	to	to	ADP
dti-2707	190	18	an	an	DET
dti-2707	190	19	antioxidant	antioxidant	ADJ
dti-2707	190	20	mechanism	mechanism	NOUN
dti-2707	190	21	(	(	PUNCT
dti-2707	190	22	83	83	NUM
dti-2707	190	23	)	)	PUNCT
dti-2707	190	24	.	.	PUNCT
dti-2707	191	1	baicalein	baicalein	PROPN
dti-2707	191	2	exhibited	exhibit	VERB
dti-2707	191	3	cytoprotective	cytoprotective	ADJ
dti-2707	191	4	effects	effect	NOUN
dti-2707	191	5	by	by	ADP
dti-2707	191	6	inducing	induce	VERB
dti-2707	191	7	the	the	DET
dti-2707	191	8	secretion	secretion	NOUN
dti-2707	191	9	of	of	ADP
dti-2707	191	10	more	more	ADJ
dti-2707	191	11	gastric	gastric	ADJ
dti-2707	191	12	mucus	mucus	NOUN
dti-2707	191	13	,	,	PUNCT
dti-2707	191	14	acting	act	VERB
dti-2707	191	15	as	as	ADP
dti-2707	191	16	an	an	DET
dti-2707	191	17	anti	anti	ADJ
dti-2707	191	18	-	-	ADJ
dti-2707	191	19	secretory	secretory	ADJ
dti-2707	191	20	by	by	ADP
dti-2707	191	21	suppressing	suppress	VERB
dti-2707	191	22	hydrogen	hydrogen	NOUN
dti-2707	191	23	-	-	PUNCT
dti-2707	191	24	potassium	potassium	NOUN
dti-2707	191	25	-	-	PUNCT
dti-2707	191	26	atpase	atpase	NOUN
dti-2707	191	27	activity	activity	NOUN
dti-2707	191	28	,	,	PUNCT
dti-2707	191	29	and	and	CCONJ
dti-2707	191	30	acting	act	VERB
dti-2707	191	31	as	as	ADP
dti-2707	191	32	an	an	DET
dti-2707	191	33	antioxidant	antioxidant	NOUN
dti-2707	191	34	by	by	ADP
dti-2707	191	35	raising	raise	VERB
dti-2707	191	36	gsh	gsh	PROPN
dti-2707	191	37	levels	level	NOUN
dti-2707	191	38	(	(	PUNCT
dti-2707	191	39	83	83	NUM
dti-2707	191	40	)	)	PUNCT
dti-2707	191	41	.	.	PUNCT
dti-2707	192	1	by	by	ADP
dti-2707	192	2	raising	raise	VERB
dti-2707	192	3	the	the	DET
dti-2707	192	4	sh	sh	PROPN
dti-2707	192	5	compound	compound	NOUN
dti-2707	192	6	,	,	PUNCT
dti-2707	192	7	which	which	PRON
dti-2707	192	8	naturally	naturally	ADV
dti-2707	192	9	regulates	regulate	VERB
dti-2707	192	10	mucus	mucus	NOUN
dti-2707	192	11	production	production	NOUN
dti-2707	192	12	,	,	PUNCT
dti-2707	192	13	and	and	CCONJ
dti-2707	192	14	the	the	DET
dti-2707	192	15	no	no	DET
dti-2707	192	16	level	level	NOUN
dti-2707	192	17	,	,	PUNCT
dti-2707	192	18	which	which	PRON
dti-2707	192	19	is	be	AUX
dti-2707	192	20	involved	involve	VERB
dti-2707	192	21	in	in	ADP
dti-2707	192	22	maintenance	maintenance	NOUN
dti-2707	192	23	of	of	ADP
dti-2707	192	24	the	the	DET
dti-2707	192	25	integrity	integrity	NOUN
dti-2707	192	26	of	of	ADP
dti-2707	192	27	the	the	DET
dti-2707	192	28	gastric	gastric	ADJ
dti-2707	192	29	mucosa	mucosa	NOUN
dti-2707	192	30	,	,	PUNCT
dti-2707	192	31	and	and	CCONJ
dti-2707	192	32	regulates	regulate	VERB
dti-2707	192	33	the	the	DET
dti-2707	192	34	secretions	secretion	NOUN
dti-2707	192	35	like	like	ADP
dti-2707	192	36	acid	acid	NOUN
dti-2707	192	37	,	,	PUNCT
dti-2707	192	38	alkaline	alkaline	NOUN
dti-2707	192	39	,	,	PUNCT
dti-2707	192	40	mucus	mucus	NOUN
dti-2707	192	41	,	,	PUNCT
dti-2707	192	42	and	and	CCONJ
dti-2707	192	43	blood	blood	NOUN
dti-2707	192	44	flow	flow	NOUN
dti-2707	192	45	in	in	ADP
dti-2707	192	46	gastric	gastric	ADJ
dti-2707	192	47	mucosa	mucosa	NOUN
dti-2707	192	48	,	,	PUNCT
dti-2707	192	49	baicalein	baicalein	PROPN
dti-2707	192	50	demonstrated	demonstrate	VERB
dti-2707	192	51	a	a	DET
dti-2707	192	52	gastroprotective	gastroprotective	ADJ
dti-2707	192	53	effect	effect	NOUN
dti-2707	192	54	against	against	ADP
dti-2707	192	55	lesions	lesion	NOUN
dti-2707	192	56	(	(	PUNCT
dti-2707	192	57	83	83	NUM
dti-2707	192	58	)	)	PUNCT
dti-2707	192	59	.	.	PUNCT
dti-2707	193	1	the	the	DET
dti-2707	193	2	stomach	stomach	NOUN
dti-2707	193	3	mucosa	mucosa	NOUN
dti-2707	193	4	showed	show	VERB
dti-2707	193	5	significant	significant	ADJ
dti-2707	193	6	reductions	reduction	NOUN
dti-2707	193	7	in	in	ADP
dti-2707	193	8	mda	mda	PROPN
dti-2707	193	9	,	,	PUNCT
dti-2707	193	10	il-8	il-8	NOUN
dti-2707	193	11	,	,	PUNCT
dti-2707	193	12	and	and	CCONJ
dti-2707	193	13	tnf	tnf	PROPN
dti-2707	193	14	-	-	PUNCT
dti-2707	193	15	α	α	PROPN
dti-2707	193	16	contents	content	NOUN
dti-2707	193	17	,	,	PUNCT
dti-2707	193	18	as	as	ADV
dti-2707	193	19	well	well	ADV
dti-2707	193	20	as	as	ADP
dti-2707	193	21	increases	increase	NOUN
dti-2707	193	22	in	in	ADP
dti-2707	193	23	superoxide	superoxide	NOUN
dti-2707	193	24	dismutase	dismutase	NOUN
dti-2707	193	25	(	(	PUNCT
dti-2707	193	26	sod	sod	NOUN
dti-2707	193	27	)	)	PUNCT
dti-2707	193	28	activity	activity	NOUN
dti-2707	193	29	and	and	CCONJ
dti-2707	193	30	glutathione	glutathione	NOUN
dti-2707	193	31	peroxidase	peroxidase	NOUN
dti-2707	193	32	(	(	PUNCT
dti-2707	193	33	gpx	gpx	NOUN
dti-2707	193	34	)	)	PUNCT
dti-2707	193	35	level	level	NOUN
dti-2707	193	36	due	due	ADP
dti-2707	193	37	to	to	ADP
dti-2707	193	38	inhibition	inhibition	NOUN
dti-2707	193	39	of	of	ADP
dti-2707	193	40	inflammation	inflammation	NOUN
dti-2707	193	41	and	and	CCONJ
dti-2707	193	42	ros	ros	PROPN
dti-2707	193	43	scavenging	scavenge	VERB
dti-2707	193	44	actions	action	NOUN
dti-2707	193	45	of	of	ADP
dti-2707	193	46	the	the	DET
dti-2707	193	47	baicalein	baicalein	PROPN
dti-2707	193	48	-	-	PUNCT
dti-2707	193	49	zn	zn	PROPN
dti-2707	193	50	complex	complex	NOUN
dti-2707	193	51	(	(	PUNCT
dti-2707	193	52	84	84	NUM
dti-2707	193	53	)	)	PUNCT
dti-2707	193	54	.	.	PUNCT
dti-2707	194	1	hepatoprotective	hepatoprotective	ADJ
dti-2707	194	2	activity	activity	NOUN
dti-2707	194	3	of	of	ADP
dti-2707	194	4	baicalein	baicalein	NOUN
dti-2707	194	5	worldwide	worldwide	ADV
dti-2707	194	6	,	,	PUNCT
dti-2707	194	7	the	the	DET
dti-2707	194	8	prevalence	prevalence	NOUN
dti-2707	194	9	and	and	CCONJ
dti-2707	194	10	incidence	incidence	NOUN
dti-2707	194	11	of	of	ADP
dti-2707	194	12	nonalcoholic	nonalcoholic	NOUN
dti-2707	194	13	fatty	fatty	NOUN
dti-2707	194	14	liver	liver	NOUN
dti-2707	194	15	disease	disease	NOUN
dti-2707	194	16	(	(	PUNCT
dti-2707	194	17	nafld	nafld	ADV
dti-2707	194	18	)	)	PUNCT
dti-2707	194	19	,	,	PUNCT
dti-2707	194	20	the	the	DET
dti-2707	194	21	main	main	ADJ
dti-2707	194	22	cause	cause	NOUN
dti-2707	194	23	of	of	ADP
dti-2707	194	24	liver	liver	NOUN
dti-2707	194	25	-	-	PUNCT
dti-2707	194	26	related	relate	VERB
dti-2707	194	27	morbidity	morbidity	NOUN
dti-2707	194	28	and	and	CCONJ
dti-2707	194	29	mortality	mortality	NOUN
dti-2707	194	30	,	,	PUNCT
dti-2707	194	31	have	have	AUX
dti-2707	194	32	increased	increase	VERB
dti-2707	194	33	as	as	ADP
dti-2707	194	34	a	a	DET
dti-2707	194	35	result	result	NOUN
dti-2707	194	36	of	of	ADP
dti-2707	194	37	the	the	DET
dti-2707	194	38	obesity	obesity	NOUN
dti-2707	194	39	epidemic	epidemic	NOUN
dti-2707	194	40	(	(	PUNCT
dti-2707	194	41	85	85	NUM
dti-2707	194	42	)	)	PUNCT
dti-2707	194	43	.	.	PUNCT
dti-2707	195	1	men	man	NOUN
dti-2707	195	2	and	and	CCONJ
dti-2707	195	3	aging	age	VERB
dti-2707	195	4	both	both	PRON
dti-2707	195	5	increase	increase	VERB
dti-2707	195	6	the	the	DET
dti-2707	195	7	risk	risk	NOUN
dti-2707	195	8	of	of	ADP
dti-2707	195	9	nafld	nafld	ADJ
dti-2707	195	10	and	and	CCONJ
dti-2707	195	11	fibrosis	fibrosis	NOUN
dti-2707	195	12	.	.	PUNCT
dti-2707	196	1	despite	despite	SCONJ
dti-2707	196	2	the	the	DET
dti-2707	196	3	fact	fact	NOUN
dti-2707	196	4	that	that	SCONJ
dti-2707	196	5	obesity	obesity	NOUN
dti-2707	196	6	is	be	AUX
dti-2707	196	7	a	a	DET
dti-2707	196	8	major	major	ADJ
dti-2707	196	9	risk	risk	NOUN
dti-2707	196	10	factor	factor	NOUN
dti-2707	196	11	for	for	ADP
dti-2707	196	12	nafld	nafld	ADV
dti-2707	196	13	,	,	PUNCT
dti-2707	196	14	current	current	ADJ
dti-2707	196	15	studies	study	NOUN
dti-2707	196	16	have	have	AUX
dti-2707	196	17	revealed	reveal	VERB
dti-2707	196	18	that	that	SCONJ
dti-2707	196	19	slim	slim	ADJ
dti-2707	196	20	individuals	individual	NOUN
dti-2707	196	21	can	can	AUX
dti-2707	196	22	also	also	ADV
dti-2707	196	23	develop	develop	VERB
dti-2707	196	24	the	the	DET
dti-2707	196	25	condition	condition	NOUN
dti-2707	196	26	(	(	PUNCT
dti-2707	196	27	86	86	NUM
dti-2707	196	28	)	)	PUNCT
dti-2707	196	29	.	.	PUNCT
dti-2707	197	1	nafld	nafld	PROPN
dti-2707	197	2	is	be	AUX
dti-2707	197	3	defined	define	VERB
dti-2707	197	4	as	as	ADP
dti-2707	197	5	the	the	DET
dti-2707	197	6	condition	condition	NOUN
dti-2707	197	7	in	in	ADP
dti-2707	197	8	which	which	PRON
dti-2707	197	9	5	5	NUM
dti-2707	197	10	%	%	NOUN
dti-2707	197	11	or	or	CCONJ
dti-2707	197	12	more	more	ADJ
dti-2707	197	13	hepatic	hepatic	ADJ
dti-2707	197	14	cells	cell	NOUN
dti-2707	197	15	develop	develop	VERB
dti-2707	197	16	macro	macro	ADJ
dti-2707	197	17	-	-	ADJ
dti-2707	197	18	vesicular	vesicular	ADJ
dti-2707	197	19	steatosis	steatosis	NOUN
dti-2707	197	20	,	,	PUNCT
dti-2707	197	21	when	when	SCONJ
dti-2707	197	22	there	there	PRON
dti-2707	197	23	is	be	VERB
dti-2707	197	24	no	no	DET
dti-2707	197	25	secondary	secondary	ADJ
dti-2707	197	26	etiology	etiology	NOUN
dti-2707	197	27	like	like	ADP
dti-2707	197	28	alcohol	alcohol	NOUN
dti-2707	197	29	or	or	CCONJ
dti-2707	197	30	drugs	drug	NOUN
dti-2707	197	31	(	(	PUNCT
dti-2707	197	32	86	86	NUM
dti-2707	197	33	)	)	PUNCT
dti-2707	197	34	.	.	PUNCT
dti-2707	198	1	an	an	DET
dti-2707	198	2	excessive	excessive	ADJ
dti-2707	198	3	buildup	buildup	NOUN
dti-2707	198	4	of	of	ADP
dti-2707	198	5	lipids	lipid	NOUN
dti-2707	198	6	in	in	ADP
dti-2707	198	7	the	the	DET
dti-2707	198	8	liver	liver	NOUN
dti-2707	198	9	results	result	NOUN
dti-2707	198	10	from	from	ADP
dti-2707	198	11	the	the	DET
dti-2707	198	12	increased	increase	VERB
dti-2707	198	13	hepatic	hepatic	ADJ
dti-2707	198	14	lipogenesis	lipogenesis	NOUN
dti-2707	198	15	and	and	CCONJ
dti-2707	198	16	serum	serum	VERB
dti-2707	198	17	non	non	ADJ
dti-2707	198	18	-	-	ADJ
dti-2707	198	19	esterified	esterify	VERB
dti-2707	198	20	fatty	fatty	NOUN
dti-2707	198	21	acids	acid	NOUN
dti-2707	198	22	,	,	PUNCT
dti-2707	198	23	which	which	PRON
dti-2707	198	24	causes	cause	VERB
dti-2707	198	25	fatty	fatty	ADJ
dti-2707	198	26	liver	liver	NOUN
dti-2707	198	27	,	,	PUNCT
dti-2707	198	28	decreased	decrease	VERB
dti-2707	198	29	liver	liver	NOUN
dti-2707	198	30	function	function	NOUN
dti-2707	198	31	,	,	PUNCT
dti-2707	198	32	and	and	CCONJ
dti-2707	198	33	ultimately	ultimately	ADV
dti-2707	198	34	liver	liver	ADJ
dti-2707	198	35	failure	failure	NOUN
dti-2707	198	36	(	(	PUNCT
dti-2707	198	37	87	87	NUM
dti-2707	198	38	)	)	PUNCT
dti-2707	198	39	.	.	PUNCT
dti-2707	199	1	baicalein	baicalein	PROPN
dti-2707	199	2	has	have	VERB
dti-2707	199	3	several	several	ADJ
dti-2707	199	4	effects	effect	NOUN
dti-2707	199	5	against	against	ADP
dti-2707	199	6	fld	fld	PROPN
dti-2707	199	7	,	,	PUNCT
dti-2707	199	8	suggesting	suggest	VERB
dti-2707	199	9	that	that	SCONJ
dti-2707	199	10	it	it	PRON
dti-2707	199	11	may	may	AUX
dti-2707	199	12	be	be	AUX
dti-2707	199	13	used	use	VERB
dti-2707	199	14	therapeutically	therapeutically	ADV
dti-2707	199	15	.	.	PUNCT
dti-2707	200	1	in	in	ADP
dti-2707	200	2	order	order	NOUN
dti-2707	200	3	to	to	PART
dti-2707	200	4	improve	improve	VERB
dti-2707	200	5	lipid	lipid	ADJ
dti-2707	200	6	metabolism	metabolism	NOUN
dti-2707	200	7	and	and	CCONJ
dti-2707	200	8	reduce	reduce	VERB
dti-2707	200	9	hepatic	hepatic	NOUN
dti-2707	200	10	de	de	X
dti-2707	200	11	novo	novo	NOUN
dti-2707	200	12	lipogenesis	lipogenesis	NOUN
dti-2707	200	13	,	,	PUNCT
dti-2707	200	14	baicalein	baicalein	PROPN
dti-2707	200	15	inhibits	inhibit	VERB
dti-2707	200	16	the	the	DET
dti-2707	200	17	ca2+/cam	ca2+/cam	NOUN
dti-2707	200	18	-	-	PUNCT
dti-2707	200	19	dependent	dependent	ADJ
dti-2707	200	20	protein	protein	NOUN
dti-2707	200	21	kinase	kinase	PROPN
dti-2707	200	22	/	/	SYM
dti-2707	200	23	amp	amp	NOUN
dti-2707	200	24	-	-	PUNCT
dti-2707	200	25	activated	activate	VERB
dti-2707	200	26	protein	protein	NOUN
dti-2707	200	27	kinase	kinase	NOUN
dti-2707	200	28	/	/	SYM
dti-2707	200	29	acetyl	acetyl	NOUN
dti-2707	200	30	-	-	PUNCT
dti-2707	200	31	coa	coa	NOUN
dti-2707	200	32	carboxylase	carboxylase	NOUN
dti-2707	200	33	(	(	PUNCT
dti-2707	200	34	camkk	camkk	NOUN
dti-2707	200	35	/	/	SYM
dti-2707	200	36	ampk	ampk	PROPN
dti-2707	200	37	/	/	SYM
dti-2707	200	38	acc	acc	PROPN
dti-2707	200	39	)	)	PUNCT
dti-2707	200	40	therapeutic	therapeutic	ADJ
dti-2707	200	41	insights	insight	NOUN
dti-2707	200	42	into	into	ADP
dti-2707	200	43	baicalein36	baicalein36	NOUN
dti-2707	200	44	©	©	ADP
dti-2707	200	45	2024	2024	NUM
dti-2707	200	46	the	the	DET
dti-2707	200	47	authors	author	NOUN
dti-2707	200	48	.	.	PUNCT
dti-2707	201	1	drug	drug	NOUN
dti-2707	201	2	target	target	NOUN
dti-2707	201	3	insights	insight	NOUN
dti-2707	201	4	issn	issn	VERB
dti-2707	201	5	1177	1177	NUM
dti-2707	201	6	-	-	SYM
dti-2707	201	7	3928	3928	NUM
dti-2707	201	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2707	201	9	pathway	pathway	NOUN
dti-2707	201	10	(	(	PUNCT
dti-2707	201	11	88	88	NUM
dti-2707	201	12	)	)	PUNCT
dti-2707	201	13	.	.	PUNCT
dti-2707	202	1	baicalein	baicalein	PROPN
dti-2707	202	2	also	also	ADV
dti-2707	202	3	has	have	VERB
dti-2707	202	4	the	the	DET
dti-2707	202	5	capacity	capacity	NOUN
dti-2707	202	6	to	to	PART
dti-2707	202	7	reduce	reduce	VERB
dti-2707	202	8	liver	liver	NOUN
dti-2707	202	9	fibrosis	fibrosis	NOUN
dti-2707	202	10	,	,	PUNCT
dti-2707	202	11	oxidative	oxidative	ADJ
dti-2707	202	12	stress	stress	NOUN
dti-2707	202	13	,	,	PUNCT
dti-2707	202	14	and	and	CCONJ
dti-2707	202	15	systemic	systemic	ADJ
dti-2707	202	16	inflammation	inflammation	NOUN
dti-2707	202	17	in	in	ADP
dti-2707	202	18	fld	fld	PROPN
dti-2707	202	19	.	.	PUNCT
dti-2707	203	1	in	in	ADP
dti-2707	203	2	order	order	NOUN
dti-2707	203	3	to	to	PART
dti-2707	203	4	reverse	reverse	VERB
dti-2707	203	5	fibrosis	fibrosis	NOUN
dti-2707	203	6	,	,	PUNCT
dti-2707	203	7	baicalein	baicalein	PROPN
dti-2707	203	8	consequently	consequently	ADV
dti-2707	203	9	inhibits	inhibit	VERB
dti-2707	203	10	the	the	DET
dti-2707	203	11	synthesis	synthesis	NOUN
dti-2707	203	12	of	of	ADP
dti-2707	203	13	collagen	collagen	NOUN
dti-2707	203	14	(	(	PUNCT
dti-2707	203	15	type	type	NOUN
dti-2707	203	16	i	i	PRON
dti-2707	203	17	and	and	CCONJ
dti-2707	203	18	α-1	α-1	NOUN
dti-2707	203	19	)	)	PUNCT
dti-2707	203	20	chain	chain	NOUN
dti-2707	203	21	and	and	CCONJ
dti-2707	203	22	transforming	transform	VERB
dti-2707	203	23	growth	growth	NOUN
dti-2707	203	24	factor	factor	NOUN
dti-2707	203	25	(	(	PUNCT
dti-2707	203	26	tgf)-β1	tgf)-β1	NOUN
dti-2707	203	27	(	(	PUNCT
dti-2707	203	28	88,89	88,89	NOUN
dti-2707	203	29	)	)	PUNCT
dti-2707	203	30	.	.	PUNCT
dti-2707	204	1	additionally	additionally	ADV
dti-2707	204	2	,	,	PUNCT
dti-2707	204	3	it	it	PRON
dti-2707	204	4	inhibits	inhibit	VERB
dti-2707	204	5	the	the	DET
dti-2707	204	6	tgf-1	tgf-1	NUM
dti-2707	204	7	/	/	SYM
dti-2707	204	8	smad3	smad3	NOUN
dti-2707	204	9	pathway	pathway	NOUN
dti-2707	204	10	in	in	ADP
dti-2707	204	11	vitro	vitro	X
dti-2707	204	12	to	to	PART
dti-2707	204	13	reverse	reverse	VERB
dti-2707	204	14	the	the	DET
dti-2707	204	15	epithelial	epithelial	ADJ
dti-2707	204	16	-	-	PUNCT
dti-2707	204	17	mesenchymal	mesenchymal	NOUN
dti-2707	204	18	transition	transition	NOUN
dti-2707	204	19	and	and	CCONJ
dti-2707	204	20	stop	stop	VERB
dti-2707	204	21	the	the	DET
dti-2707	204	22	progression	progression	NOUN
dti-2707	204	23	of	of	ADP
dti-2707	204	24	liver	liver	NOUN
dti-2707	204	25	fibrosis	fibrosis	NOUN
dti-2707	204	26	(	(	PUNCT
dti-2707	204	27	90	90	NUM
dti-2707	204	28	)	)	PUNCT
dti-2707	204	29	.	.	PUNCT
dti-2707	205	1	baicalein	baicalein	PROPN
dti-2707	205	2	also	also	ADV
dti-2707	205	3	has	have	VERB
dti-2707	205	4	an	an	DET
dti-2707	205	5	indirect	indirect	ADJ
dti-2707	205	6	antioxidant	antioxidant	ADJ
dti-2707	205	7	effect	effect	NOUN
dti-2707	205	8	by	by	ADP
dti-2707	205	9	decreasing	decrease	VERB
dti-2707	205	10	mda	mda	PROPN
dti-2707	205	11	levels	level	NOUN
dti-2707	205	12	while	while	SCONJ
dti-2707	205	13	increasing	increase	VERB
dti-2707	205	14	hepatic	hepatic	ADJ
dti-2707	205	15	gsh	gsh	NOUN
dti-2707	205	16	and	and	CCONJ
dti-2707	205	17	sod	sod	PROPN
dti-2707	205	18	(	(	PUNCT
dti-2707	205	19	91	91	NUM
dti-2707	205	20	)	)	PUNCT
dti-2707	205	21	.	.	PUNCT
dti-2707	206	1	by	by	ADP
dti-2707	206	2	inhibiting	inhibit	VERB
dti-2707	206	3	the	the	DET
dti-2707	206	4	tgf	tgf	PROPN
dti-2707	206	5	-	-	PUNCT
dti-2707	206	6	β	β	NOUN
dti-2707	206	7	/	/	SYM
dti-2707	206	8	smad	smad	PROPN
dti-2707	206	9	pathway	pathway	NOUN
dti-2707	206	10	,	,	PUNCT
dti-2707	206	11	baicalein	baicalein	PROPN
dti-2707	206	12	slowed	slow	VERB
dti-2707	206	13	down	down	ADP
dti-2707	206	14	the	the	DET
dti-2707	206	15	epithelial	epithelial	ADJ
dti-2707	206	16	-	-	PUNCT
dti-2707	206	17	mesenchymal	mesenchymal	NOUN
dti-2707	206	18	transition	transition	NOUN
dti-2707	206	19	.	.	PUNCT
dti-2707	207	1	additionally	additionally	ADV
dti-2707	207	2	,	,	PUNCT
dti-2707	207	3	it	it	PRON
dti-2707	207	4	decreased	decrease	VERB
dti-2707	207	5	high	high	ADJ
dti-2707	207	6	levels	level	NOUN
dti-2707	207	7	of	of	ADP
dti-2707	207	8	inflammatory	inflammatory	ADJ
dti-2707	207	9	factors	factor	NOUN
dti-2707	207	10	such	such	ADJ
dti-2707	207	11	tnf	tnf	PROPN
dti-2707	207	12	-	-	PUNCT
dti-2707	207	13	α	α	PROPN
dti-2707	207	14	,	,	PUNCT
dti-2707	207	15	il-1	il-1	PUNCT
dti-2707	207	16	and	and	CCONJ
dti-2707	207	17	-6	-6	ADV
dti-2707	207	18	,	,	PUNCT
dti-2707	207	19	inhibited	inhibit	VERB
dti-2707	207	20	the	the	DET
dti-2707	207	21	apoptotic	apoptotic	ADJ
dti-2707	207	22	proteins	protein	NOUN
dti-2707	207	23	caspase-3	caspase-3	NUM
dti-2707	207	24	and	and	CCONJ
dti-2707	207	25	-9	-9	ADV
dti-2707	207	26	,	,	PUNCT
dti-2707	207	27	and	and	CCONJ
dti-2707	207	28	b	b	X
dti-2707	207	29	-	-	PUNCT
dti-2707	207	30	cell	cell	NOUN
dti-2707	207	31	lymphoma-2	lymphoma-2	NOUN
dti-2707	207	32	,	,	PUNCT
dti-2707	207	33	and	and	CCONJ
dti-2707	207	34	hindered	hinder	VERB
dti-2707	207	35	the	the	DET
dti-2707	207	36	iκb	iκb	NOUN
dti-2707	207	37	kinase	kinase	PROPN
dti-2707	207	38	/	/	SYM
dti-2707	207	39	iκb/	iκb/	ADJ
dti-2707	207	40	nf	nf	PROPN
dti-2707	207	41	-	-	PUNCT
dti-2707	207	42	κb	κb	NOUN
dti-2707	207	43	pathway	pathway	NOUN
dti-2707	207	44	.	.	PUNCT
dti-2707	208	1	these	these	PRON
dti-2707	208	2	all	all	PRON
dti-2707	208	3	helped	help	VERB
dti-2707	208	4	to	to	PART
dti-2707	208	5	lessen	lessen	VERB
dti-2707	208	6	liver	liver	NOUN
dti-2707	208	7	disorders	disorder	NOUN
dti-2707	208	8	(	(	PUNCT
dti-2707	208	9	92	92	NUM
dti-2707	208	10	)	)	PUNCT
dti-2707	208	11	.	.	PUNCT
dti-2707	209	1	because	because	SCONJ
dti-2707	209	2	of	of	ADP
dti-2707	209	3	its	its	PRON
dti-2707	209	4	inhibitory	inhibitory	ADJ
dti-2707	209	5	influence	influence	NOUN
dti-2707	209	6	on	on	ADP
dti-2707	209	7	the	the	DET
dti-2707	209	8	production	production	NOUN
dti-2707	209	9	of	of	ADP
dti-2707	209	10	p	p	NOUN
dti-2707	209	11	-	-	PUNCT
dti-2707	209	12	p38	p38	NOUN
dti-2707	209	13	,	,	PUNCT
dti-2707	209	14	mapk	mapk	NOUN
dti-2707	209	15	,	,	PUNCT
dti-2707	209	16	p	p	NOUN
dti-2707	209	17	-	-	PUNCT
dti-2707	209	18	creb	creb	NOUN
dti-2707	209	19	,	,	PUNCT
dti-2707	209	20	foxo1	foxo1	NOUN
dti-2707	209	21	,	,	PUNCT
dti-2707	209	22	pgc-1	pgc-1	NOUN
dti-2707	209	23	,	,	PUNCT
dti-2707	209	24	pepck	pepck	NOUN
dti-2707	209	25	,	,	PUNCT
dti-2707	209	26	and	and	CCONJ
dti-2707	209	27	g6pase	g6pase	NOUN
dti-2707	209	28	,	,	PUNCT
dti-2707	209	29	baicalein	baicalein	NOUN
dti-2707	209	30	considerably	considerably	ADV
dti-2707	209	31	reduces	reduce	VERB
dti-2707	209	32	insulin	insulin	NOUN
dti-2707	209	33	concentrations	concentration	NOUN
dti-2707	209	34	brought	bring	VERB
dti-2707	209	35	on	on	ADP
dti-2707	209	36	by	by	ADP
dti-2707	209	37	a	a	DET
dti-2707	209	38	high	high	ADJ
dti-2707	209	39	-	-	PUNCT
dti-2707	209	40	fat	fat	NOUN
dti-2707	209	41	meal	meal	NOUN
dti-2707	209	42	.	.	PUNCT
dti-2707	210	1	thus	thus	ADV
dti-2707	210	2	,	,	PUNCT
dti-2707	210	3	because	because	SCONJ
dti-2707	210	4	of	of	ADP
dti-2707	210	5	its	its	PRON
dti-2707	210	6	numerous	numerous	ADJ
dti-2707	210	7	pharmacological	pharmacological	ADJ
dti-2707	210	8	actions	action	NOUN
dti-2707	210	9	,	,	PUNCT
dti-2707	210	10	baicalein	baicalein	PROPN
dti-2707	210	11	may	may	AUX
dti-2707	210	12	prevent	prevent	VERB
dti-2707	210	13	fld	fld	PROPN
dti-2707	210	14	(	(	PUNCT
dti-2707	210	15	93	93	NUM
dti-2707	210	16	)	)	PUNCT
dti-2707	210	17	.	.	PUNCT
dti-2707	211	1	baicalein	baicalein	PROPN
dti-2707	211	2	action	action	NOUN
dti-2707	211	3	as	as	ADP
dti-2707	211	4	a	a	DET
dti-2707	211	5	renal	renal	ADJ
dti-2707	211	6	protective	protective	ADJ
dti-2707	211	7	agent	agent	NOUN
dti-2707	211	8	chronic	chronic	ADJ
dti-2707	211	9	kidney	kidney	NOUN
dti-2707	211	10	disease	disease	NOUN
dti-2707	211	11	(	(	PUNCT
dti-2707	211	12	ckd	ckd	NOUN
dti-2707	211	13	)	)	PUNCT
dti-2707	211	14	prevalence	prevalence	NOUN
dti-2707	211	15	is	be	AUX
dti-2707	211	16	acknowledged	acknowledge	VERB
dti-2707	211	17	as	as	ADP
dti-2707	211	18	a	a	DET
dti-2707	211	19	major	major	ADJ
dti-2707	211	20	public	public	ADJ
dti-2707	211	21	health	health	NOUN
dti-2707	211	22	concern	concern	NOUN
dti-2707	211	23	on	on	ADP
dti-2707	211	24	a	a	DET
dti-2707	211	25	global	global	ADJ
dti-2707	211	26	scale	scale	NOUN
dti-2707	211	27	.	.	PUNCT
dti-2707	212	1	it	it	PRON
dti-2707	212	2	is	be	AUX
dti-2707	212	3	estimated	estimate	VERB
dti-2707	212	4	that	that	SCONJ
dti-2707	212	5	13.4	13.4	NUM
dti-2707	212	6	%	%	NOUN
dti-2707	212	7	(	(	PUNCT
dti-2707	212	8	11.7%-15.1	11.7%-15.1	NUM
dti-2707	212	9	%	%	NOUN
dti-2707	212	10	)	)	PUNCT
dti-2707	212	11	of	of	ADP
dti-2707	212	12	the	the	DET
dti-2707	212	13	global	global	ADJ
dti-2707	212	14	population	population	NOUN
dti-2707	212	15	has	have	VERB
dti-2707	212	16	kd	kd	PROPN
dti-2707	212	17	and	and	CCONJ
dti-2707	212	18	that	that	SCONJ
dti-2707	212	19	4.902	4.902	NUM
dti-2707	212	20	-	-	SYM
dti-2707	212	21	7.083	7.083	NUM
dti-2707	212	22	million	million	NUM
dti-2707	212	23	have	have	VERB
dti-2707	212	24	end	end	NOUN
dti-2707	212	25	-	-	PUNCT
dti-2707	212	26	stage	stage	NOUN
dti-2707	212	27	kidney	kidney	NOUN
dti-2707	212	28	disease	disease	NOUN
dti-2707	212	29	(	(	PUNCT
dti-2707	212	30	eskd	eskd	PROPN
dti-2707	212	31	)	)	PUNCT
dti-2707	212	32	,	,	PUNCT
dti-2707	212	33	requiring	require	VERB
dti-2707	212	34	renal	renal	ADJ
dti-2707	212	35	replacement	replacement	NOUN
dti-2707	212	36	therapy	therapy	NOUN
dti-2707	212	37	(	(	PUNCT
dti-2707	212	38	94	94	NUM
dti-2707	212	39	)	)	PUNCT
dti-2707	212	40	.	.	PUNCT
dti-2707	213	1	the	the	DET
dti-2707	213	2	incapacity	incapacity	NOUN
dti-2707	213	3	of	of	ADP
dti-2707	213	4	the	the	DET
dti-2707	213	5	kidneys	kidney	NOUN
dti-2707	213	6	to	to	PART
dti-2707	213	7	perform	perform	VERB
dti-2707	213	8	their	their	PRON
dti-2707	213	9	excretory	excretory	NOUN
dti-2707	213	10	duties	duty	NOUN
dti-2707	213	11	,	,	PUNCT
dti-2707	213	12	which	which	PRON
dti-2707	213	13	results	result	VERB
dti-2707	213	14	in	in	ADP
dti-2707	213	15	the	the	DET
dti-2707	213	16	retention	retention	NOUN
dti-2707	213	17	of	of	ADP
dti-2707	213	18	nitrogenous	nitrogenous	ADJ
dti-2707	213	19	waste	waste	NOUN
dti-2707	213	20	products	product	NOUN
dti-2707	213	21	in	in	ADP
dti-2707	213	22	the	the	DET
dti-2707	213	23	blood	blood	NOUN
dti-2707	213	24	,	,	PUNCT
dti-2707	213	25	is	be	AUX
dti-2707	213	26	known	know	VERB
dti-2707	213	27	as	as	ADP
dti-2707	213	28	renal	renal	ADJ
dti-2707	213	29	failure	failure	NOUN
dti-2707	213	30	.	.	PUNCT
dti-2707	214	1	kidney	kidney	NOUN
dti-2707	214	2	failure	failure	NOUN
dti-2707	214	3	comes	come	VERB
dti-2707	214	4	in	in	ADP
dti-2707	214	5	two	two	NUM
dti-2707	214	6	flavors	flavor	NOUN
dti-2707	214	7	:	:	PUNCT
dti-2707	214	8	acute	acute	ADJ
dti-2707	214	9	and	and	CCONJ
dti-2707	214	10	chronic	chronic	ADJ
dti-2707	214	11	(	(	PUNCT
dti-2707	214	12	95	95	NUM
dti-2707	214	13	)	)	PUNCT
dti-2707	214	14	.	.	PUNCT
dti-2707	215	1	one	one	NUM
dti-2707	215	2	of	of	ADP
dti-2707	215	3	the	the	DET
dti-2707	215	4	main	main	ADJ
dti-2707	215	5	causes	cause	NOUN
dti-2707	215	6	of	of	ADP
dti-2707	215	7	renal	renal	ADJ
dti-2707	215	8	failure	failure	NOUN
dti-2707	215	9	is	be	AUX
dti-2707	215	10	diabetes	diabetes	NOUN
dti-2707	215	11	mellitus	mellitus	NOUN
dti-2707	215	12	(	(	PUNCT
dti-2707	215	13	dm	dm	PROPN
dti-2707	215	14	)	)	PUNCT
dti-2707	215	15	,	,	PUNCT
dti-2707	215	16	which	which	PRON
dti-2707	215	17	is	be	AUX
dti-2707	215	18	why	why	SCONJ
dti-2707	215	19	many	many	ADJ
dti-2707	215	20	diabetic	diabetic	ADJ
dti-2707	215	21	individuals	individual	NOUN
dti-2707	215	22	continue	continue	VERB
dti-2707	215	23	to	to	PART
dti-2707	215	24	struggle	struggle	VERB
dti-2707	215	25	with	with	ADP
dti-2707	215	26	diabetic	diabetic	ADJ
dti-2707	215	27	nephropathy	nephropathy	NOUN
dti-2707	215	28	(	(	PUNCT
dti-2707	215	29	dn	dn	NOUN
dti-2707	215	30	)	)	PUNCT
dti-2707	215	31	,	,	PUNCT
dti-2707	215	32	which	which	PRON
dti-2707	215	33	is	be	AUX
dti-2707	215	34	a	a	DET
dti-2707	215	35	serious	serious	ADJ
dti-2707	215	36	condition	condition	NOUN
dti-2707	215	37	(	(	PUNCT
dti-2707	215	38	96	96	NUM
dti-2707	215	39	)	)	PUNCT
dti-2707	215	40	.	.	PUNCT
dti-2707	216	1	patients	patient	NOUN
dti-2707	216	2	with	with	ADP
dti-2707	216	3	dn	dn	NOUN
dti-2707	216	4	typically	typically	ADV
dti-2707	216	5	have	have	VERB
dti-2707	216	6	elevated	elevate	VERB
dti-2707	216	7	urine	urine	NOUN
dti-2707	216	8	microalbumin	microalbumin	NOUN
dti-2707	216	9	,	,	PUNCT
dti-2707	216	10	urine	urine	NOUN
dti-2707	216	11	β2	β2	NOUN
dti-2707	216	12	-	-	PUNCT
dti-2707	216	13	mg	mg	PROPN
dti-2707	216	14	,	,	PUNCT
dti-2707	216	15	and	and	CCONJ
dti-2707	216	16	urinary	urinary	ADJ
dti-2707	216	17	albumin	albumin	ADJ
dti-2707	216	18	excretion	excretion	NOUN
dti-2707	216	19	rate	rate	NOUN
dti-2707	216	20	in	in	ADP
dti-2707	216	21	diabetic	diabetic	NOUN
dti-2707	216	22	neuropathy	neuropathy	ADJ
dti-2707	216	23	.	.	PUNCT
dti-2707	217	1	among	among	ADP
dti-2707	217	2	these	these	PRON
dti-2707	217	3	,	,	PUNCT
dti-2707	217	4	an	an	DET
dti-2707	217	5	increase	increase	NOUN
dti-2707	217	6	in	in	ADP
dti-2707	217	7	urine	urine	NOUN
dti-2707	217	8	microalbumin	microalbumin	NOUN
dti-2707	217	9	and	and	CCONJ
dti-2707	217	10	urinary	urinary	ADJ
dti-2707	217	11	2	2	NUM
dti-2707	217	12	-	-	PUNCT
dti-2707	217	13	mb	mb	NOUN
dti-2707	217	14	indicates	indicate	VERB
dti-2707	217	15	renal	renal	ADJ
dti-2707	217	16	tubular	tubular	ADJ
dti-2707	217	17	injury	injury	NOUN
dti-2707	217	18	,	,	PUNCT
dti-2707	217	19	while	while	SCONJ
dti-2707	217	20	an	an	DET
dti-2707	217	21	increase	increase	NOUN
dti-2707	217	22	in	in	ADP
dti-2707	217	23	uaer	uaer	NOUN
dti-2707	217	24	indicates	indicate	VERB
dti-2707	217	25	glomerular	glomerular	ADJ
dti-2707	217	26	injury	injury	NOUN
dti-2707	217	27	(	(	PUNCT
dti-2707	217	28	97	97	NUM
dti-2707	217	29	)	)	PUNCT
dti-2707	217	30	.	.	PUNCT
dti-2707	218	1	it	it	PRON
dti-2707	218	2	was	be	AUX
dti-2707	218	3	discovered	discover	VERB
dti-2707	218	4	that	that	SCONJ
dti-2707	218	5	baicalin	baicalin	NOUN
dti-2707	218	6	significantly	significantly	ADV
dti-2707	218	7	reduced	reduce	VERB
dti-2707	218	8	the	the	DET
dti-2707	218	9	patient	patient	NOUN
dti-2707	218	10	’s	’s	PART
dti-2707	218	11	urine	urine	NOUN
dti-2707	218	12	2	2	NUM
dti-2707	218	13	-	-	PUNCT
dti-2707	218	14	mg	mg	PROPN
dti-2707	218	15	,	,	PUNCT
dti-2707	218	16	uaer	uaer	NOUN
dti-2707	218	17	,	,	PUNCT
dti-2707	218	18	and	and	CCONJ
dti-2707	218	19	microalbumin	microalbumin	NOUN
dti-2707	218	20	levels	level	NOUN
dti-2707	218	21	.	.	PUNCT
dti-2707	219	1	additionally	additionally	ADV
dti-2707	219	2	,	,	PUNCT
dti-2707	219	3	it	it	PRON
dti-2707	219	4	was	be	AUX
dti-2707	219	5	discovered	discover	VERB
dti-2707	219	6	to	to	PART
dti-2707	219	7	considerably	considerably	ADV
dti-2707	219	8	enhance	enhance	VERB
dti-2707	219	9	the	the	DET
dti-2707	219	10	patient	patient	NOUN
dti-2707	219	11	’s	’s	PART
dti-2707	219	12	quality	quality	NOUN
dti-2707	219	13	of	of	ADP
dti-2707	219	14	life	life	NOUN
dti-2707	219	15	,	,	PUNCT
dti-2707	219	16	reduce	reduce	VERB
dti-2707	219	17	the	the	DET
dti-2707	219	18	rate	rate	NOUN
dti-2707	219	19	at	at	ADP
dti-2707	219	20	which	which	PRON
dti-2707	219	21	dn	dn	NOUN
dti-2707	219	22	progresses	progress	VERB
dti-2707	219	23	,	,	PUNCT
dti-2707	219	24	and	and	CCONJ
dti-2707	219	25	enhance	enhance	VERB
dti-2707	219	26	kidney	kidney	NOUN
dti-2707	219	27	function	function	NOUN
dti-2707	219	28	(	(	PUNCT
dti-2707	219	29	98	98	NUM
dti-2707	219	30	-	-	SYM
dti-2707	219	31	100	100	NUM
dti-2707	219	32	)	)	PUNCT
dti-2707	219	33	.	.	PUNCT
dti-2707	220	1	acute	acute	PROPN
dti-2707	220	2	renal	renal	ADJ
dti-2707	220	3	injury	injury	NOUN
dti-2707	220	4	is	be	AUX
dti-2707	220	5	a	a	DET
dti-2707	220	6	serious	serious	ADJ
dti-2707	220	7	adverse	adverse	ADJ
dti-2707	220	8	effect	effect	NOUN
dti-2707	220	9	of	of	ADP
dti-2707	220	10	the	the	DET
dti-2707	220	11	anticancer	anticancer	NOUN
dti-2707	220	12	drug	drug	NOUN
dti-2707	220	13	cisplatin	cisplatin	NOUN
dti-2707	220	14	.	.	PUNCT
dti-2707	221	1	increased	increase	VERB
dti-2707	221	2	ros	ros	PROPN
dti-2707	221	3	generation	generation	NOUN
dti-2707	221	4	from	from	ADP
dti-2707	221	5	cisplatin	cisplatin	NOUN
dti-2707	221	6	damages	damage	NOUN
dti-2707	221	7	endogenous	endogenous	ADJ
dti-2707	221	8	intracellular	intracellular	ADJ
dti-2707	221	9	targets	target	NOUN
dti-2707	221	10	like	like	ADP
dti-2707	221	11	proteins	protein	NOUN
dti-2707	221	12	,	,	PUNCT
dti-2707	221	13	lipids	lipid	NOUN
dti-2707	221	14	,	,	PUNCT
dti-2707	221	15	and	and	CCONJ
dti-2707	221	16	dna	dna	PROPN
dti-2707	221	17	,	,	PUNCT
dti-2707	221	18	resulting	result	VERB
dti-2707	221	19	in	in	ADP
dti-2707	221	20	cellular	cellular	ADJ
dti-2707	221	21	malfunction	malfunction	NOUN
dti-2707	221	22	and	and	CCONJ
dti-2707	221	23	death	death	NOUN
dti-2707	221	24	(	(	PUNCT
dti-2707	221	25	101	101	NUM
dti-2707	221	26	)	)	PUNCT
dti-2707	221	27	.	.	PUNCT
dti-2707	222	1	additionally	additionally	ADV
dti-2707	222	2	,	,	PUNCT
dti-2707	222	3	the	the	DET
dti-2707	222	4	toxic	toxic	ADJ
dti-2707	222	5	effects	effect	NOUN
dti-2707	222	6	of	of	ADP
dti-2707	222	7	cisplatin	cisplatin	NOUN
dti-2707	222	8	are	be	AUX
dti-2707	222	9	made	make	VERB
dti-2707	222	10	worse	bad	ADJ
dti-2707	222	11	by	by	ADP
dti-2707	222	12	the	the	DET
dti-2707	222	13	activation	activation	NOUN
dti-2707	222	14	of	of	ADP
dti-2707	222	15	various	various	ADJ
dti-2707	222	16	signaling	signal	VERB
dti-2707	222	17	pathways	pathway	NOUN
dti-2707	222	18	,	,	PUNCT
dti-2707	222	19	such	such	ADJ
dti-2707	222	20	as	as	ADP
dti-2707	222	21	mapks	mapks	NOUN
dti-2707	222	22	,	,	PUNCT
dti-2707	222	23	nf	nf	NOUN
dti-2707	222	24	-	-	PUNCT
dti-2707	222	25	κb	κb	NOUN
dti-2707	222	26	,	,	PUNCT
dti-2707	222	27	and	and	CCONJ
dti-2707	222	28	p53	p53	NOUN
dti-2707	222	29	,	,	PUNCT
dti-2707	222	30	by	by	ADP
dti-2707	222	31	cisplatin	cisplatin	NOUN
dti-2707	222	32	-	-	PUNCT
dti-2707	222	33	induced	induce	VERB
dti-2707	222	34	ros	ro	NOUN
dti-2707	222	35	(	(	PUNCT
dti-2707	222	36	114	114	NUM
dti-2707	222	37	)	)	PUNCT
dti-2707	222	38	.	.	PUNCT
dti-2707	223	1	a	a	DET
dti-2707	223	2	key	key	ADJ
dti-2707	223	3	factor	factor	NOUN
dti-2707	223	4	in	in	ADP
dti-2707	223	5	the	the	DET
dti-2707	223	6	pathophysiology	pathophysiology	NOUN
dti-2707	223	7	of	of	ADP
dti-2707	223	8	cisplatin	cisplatin	NOUN
dti-2707	223	9	-	-	PUNCT
dti-2707	223	10	induced	induce	VERB
dti-2707	223	11	kidney	kidney	NOUN
dti-2707	223	12	injury	injury	NOUN
dti-2707	223	13	is	be	AUX
dti-2707	223	14	the	the	DET
dti-2707	223	15	production	production	NOUN
dti-2707	223	16	of	of	ADP
dti-2707	223	17	inos	ino	NOUN
dti-2707	223	18	and	and	CCONJ
dti-2707	223	19	strong	strong	ADJ
dti-2707	223	20	cytotoxic	cytotoxic	ADJ
dti-2707	223	21	peroxynitrite	peroxynitrite	NOUN
dti-2707	223	22	through	through	ADP
dti-2707	223	23	the	the	DET
dti-2707	223	24	interaction	interaction	NOUN
dti-2707	223	25	of	of	ADP
dti-2707	223	26	superoxide	superoxide	NOUN
dti-2707	223	27	radical	radical	ADJ
dti-2707	223	28	and	and	CCONJ
dti-2707	223	29	no	no	DET
dti-2707	223	30	(	(	PUNCT
dti-2707	223	31	102	102	NUM
dti-2707	223	32	)	)	PUNCT
dti-2707	223	33	.	.	PUNCT
dti-2707	224	1	baicalein	baicalein	PROPN
dti-2707	224	2	has	have	AUX
dti-2707	224	3	been	be	AUX
dti-2707	224	4	demonstrated	demonstrate	VERB
dti-2707	224	5	to	to	PART
dti-2707	224	6	have	have	VERB
dti-2707	224	7	a	a	DET
dti-2707	224	8	significant	significant	ADJ
dti-2707	224	9	antioxidant	antioxidant	ADJ
dti-2707	224	10	impact	impact	NOUN
dti-2707	224	11	.	.	PUNCT
dti-2707	225	1	baicalein	baicalein	PROPN
dti-2707	225	2	has	have	AUX
dti-2707	225	3	been	be	AUX
dti-2707	225	4	shown	show	VERB
dti-2707	225	5	to	to	PART
dti-2707	225	6	adequately	adequately	ADV
dti-2707	225	7	remove	remove	VERB
dti-2707	225	8	peroxynitrite	peroxynitrite	ADJ
dti-2707	225	9	anion	anion	NOUN
dti-2707	225	10	radicals	radical	NOUN
dti-2707	225	11	and	and	CCONJ
dti-2707	225	12	inhibit	inhibit	VERB
dti-2707	225	13	peroxynitrite	peroxynitrite	ADV
dti-2707	225	14	-	-	PUNCT
dti-2707	225	15	induced	induce	VERB
dti-2707	225	16	cell	cell	NOUN
dti-2707	225	17	death	death	NOUN
dti-2707	225	18	in	in	ADP
dti-2707	225	19	llc	llc	PROPN
dti-2707	225	20	-	-	PUNCT
dti-2707	225	21	pk1	pk1	NOUN
dti-2707	225	22	cells	cell	NOUN
dti-2707	225	23	.	.	PUNCT
dti-2707	226	1	pretreatment	pretreatment	NOUN
dti-2707	226	2	with	with	ADP
dti-2707	226	3	baicalein	baicalein	PROPN
dti-2707	226	4	significantly	significantly	ADV
dti-2707	226	5	decreased	decrease	VERB
dti-2707	226	6	these	these	DET
dti-2707	226	7	changes	change	NOUN
dti-2707	226	8	.	.	PUNCT
dti-2707	227	1	therefore	therefore	ADV
dti-2707	227	2	,	,	PUNCT
dti-2707	227	3	baicalein	baicalein	PROPN
dti-2707	227	4	’s	’s	PART
dti-2707	227	5	capacity	capacity	NOUN
dti-2707	227	6	to	to	PART
dti-2707	227	7	lessen	lessen	VERB
dti-2707	227	8	cisplatin	cisplatin	NOUN
dti-2707	227	9	-	-	PUNCT
dti-2707	227	10	induced	induce	VERB
dti-2707	227	11	nephrotoxicity	nephrotoxicity	NOUN
dti-2707	227	12	is	be	AUX
dti-2707	227	13	probably	probably	ADV
dti-2707	227	14	due	due	ADJ
dti-2707	227	15	,	,	PUNCT
dti-2707	227	16	at	at	ADP
dti-2707	227	17	least	least	ADJ
dti-2707	227	18	in	in	ADP
dti-2707	227	19	part	part	NOUN
dti-2707	227	20	,	,	PUNCT
dti-2707	227	21	to	to	ADP
dti-2707	227	22	the	the	DET
dti-2707	227	23	attenuation	attenuation	NOUN
dti-2707	227	24	of	of	ADP
dti-2707	227	25	renal	renal	ADJ
dti-2707	227	26	oxidative	oxidative	ADJ
dti-2707	227	27	and/or	and/or	CCONJ
dti-2707	227	28	nitrative	nitrative	ADJ
dti-2707	227	29	stress	stress	NOUN
dti-2707	227	30	(	(	PUNCT
dti-2707	227	31	fig	fig	NOUN
dti-2707	227	32	.	.	PUNCT
dti-2707	228	1	3	3	X
dti-2707	228	2	)	)	PUNCT
dti-2707	228	3	(	(	PUNCT
dti-2707	228	4	102	102	NUM
dti-2707	228	5	)	)	PUNCT
dti-2707	228	6	.	.	PUNCT
dti-2707	229	1	baicalein	baicalein	PROPN
dti-2707	229	2	as	as	ADP
dti-2707	229	3	an	an	DET
dti-2707	229	4	antimicrobial	antimicrobial	ADJ
dti-2707	229	5	agent	agent	NOUN
dti-2707	229	6	across	across	ADP
dti-2707	229	7	the	the	DET
dti-2707	229	8	world	world	NOUN
dti-2707	229	9	,	,	PUNCT
dti-2707	229	10	infectious	infectious	ADJ
dti-2707	229	11	diseases	disease	NOUN
dti-2707	229	12	are	be	AUX
dti-2707	229	13	a	a	DET
dti-2707	229	14	leading	lead	VERB
dti-2707	229	15	source	source	NOUN
dti-2707	229	16	of	of	ADP
dti-2707	229	17	morbidity	morbidity	NOUN
dti-2707	229	18	and	and	CCONJ
dti-2707	229	19	mortality	mortality	NOUN
dti-2707	229	20	(	(	PUNCT
dti-2707	229	21	103	103	NUM
dti-2707	229	22	)	)	PUNCT
dti-2707	229	23	.	.	PUNCT
dti-2707	230	1	the	the	DET
dti-2707	230	2	emergence	emergence	NOUN
dti-2707	230	3	of	of	ADP
dti-2707	230	4	drugresistant	drugresistant	NOUN
dti-2707	230	5	forms	form	NOUN
dti-2707	230	6	of	of	ADP
dti-2707	230	7	bacteria	bacteria	NOUN
dti-2707	230	8	has	have	AUX
dti-2707	230	9	diminished	diminish	VERB
dti-2707	230	10	the	the	DET
dti-2707	230	11	impact	impact	NOUN
dti-2707	230	12	of	of	ADP
dti-2707	230	13	antibiotics	antibiotic	NOUN
dti-2707	230	14	on	on	ADP
dti-2707	230	15	germs	germ	NOUN
dti-2707	230	16	and	and	CCONJ
dti-2707	230	17	resulted	result	VERB
dti-2707	230	18	in	in	ADP
dti-2707	230	19	ongoing	ongoing	ADJ
dti-2707	230	20	difficulties	difficulty	NOUN
dti-2707	230	21	,	,	PUNCT
dti-2707	230	22	despite	despite	SCONJ
dti-2707	230	23	notable	notable	ADJ
dti-2707	230	24	advancements	advancement	NOUN
dti-2707	230	25	in	in	ADP
dti-2707	230	26	the	the	DET
dti-2707	230	27	treatment	treatment	NOUN
dti-2707	230	28	of	of	ADP
dti-2707	230	29	microbial	microbial	ADJ
dti-2707	230	30	infections	infection	NOUN
dti-2707	230	31	(	(	PUNCT
dti-2707	230	32	104	104	NUM
dti-2707	230	33	)	)	PUNCT
dti-2707	230	34	.	.	PUNCT
dti-2707	231	1	combination	combination	NOUN
dti-2707	231	2	therapy	therapy	NOUN
dti-2707	231	3	was	be	AUX
dti-2707	231	4	developed	develop	VERB
dti-2707	231	5	in	in	ADP
dti-2707	231	6	response	response	NOUN
dti-2707	231	7	to	to	ADP
dti-2707	231	8	this	this	DET
dti-2707	231	9	problem	problem	NOUN
dti-2707	231	10	,	,	PUNCT
dti-2707	231	11	and	and	CCONJ
dti-2707	231	12	as	as	ADP
dti-2707	231	13	a	a	DET
dti-2707	231	14	result	result	NOUN
dti-2707	231	15	of	of	ADP
dti-2707	231	16	the	the	DET
dti-2707	231	17	expanding	expand	VERB
dti-2707	231	18	prevalence	prevalence	NOUN
dti-2707	231	19	of	of	ADP
dti-2707	231	20	antibiotic	antibiotic	ADJ
dti-2707	231	21	resistance	resistance	NOUN
dti-2707	231	22	,	,	PUNCT
dti-2707	231	23	it	it	PRON
dti-2707	231	24	has	have	AUX
dti-2707	231	25	improved	improve	VERB
dti-2707	231	26	treatment	treatment	NOUN
dti-2707	231	27	efficacy	efficacy	NOUN
dti-2707	231	28	and	and	CCONJ
dti-2707	231	29	partially	partially	ADV
dti-2707	231	30	reduced	reduce	VERB
dti-2707	231	31	drug	drug	NOUN
dti-2707	231	32	resistance	resistance	NOUN
dti-2707	231	33	.	.	PUNCT
dti-2707	232	1	furthermore	furthermore	ADV
dti-2707	232	2	,	,	PUNCT
dti-2707	232	3	the	the	DET
dti-2707	232	4	bacterial	bacterial	ADJ
dti-2707	232	5	resistance	resistance	NOUN
dti-2707	232	6	to	to	ADP
dti-2707	232	7	antibiotics	antibiotic	NOUN
dti-2707	232	8	has	have	AUX
dti-2707	232	9	motivated	motivate	VERB
dti-2707	232	10	the	the	DET
dti-2707	232	11	creation	creation	NOUN
dti-2707	232	12	of	of	ADP
dti-2707	232	13	innovative	innovative	ADJ
dti-2707	232	14	antibacterial	antibacterial	ADJ
dti-2707	232	15	drugs	drug	NOUN
dti-2707	232	16	for	for	ADP
dti-2707	232	17	the	the	DET
dti-2707	232	18	treatment	treatment	NOUN
dti-2707	232	19	of	of	ADP
dti-2707	232	20	infectious	infectious	ADJ
dti-2707	232	21	figure	figure	NOUN
dti-2707	232	22	3	3	NUM
dti-2707	232	23	the	the	DET
dti-2707	232	24	healing	healing	NOUN
dti-2707	232	25	potential	potential	NOUN
dti-2707	232	26	of	of	ADP
dti-2707	232	27	baicalein	baicalein	NOUN
dti-2707	232	28	by	by	ADP
dti-2707	232	29	modulating	modulate	VERB
dti-2707	232	30	several	several	ADJ
dti-2707	232	31	signaling	signal	VERB
dti-2707	232	32	pathways	pathway	NOUN
dti-2707	232	33	mitigating	mitigate	VERB
dti-2707	232	34	the	the	DET
dti-2707	232	35	symptoms	symptom	NOUN
dti-2707	232	36	of	of	ADP
dti-2707	232	37	certain	certain	ADJ
dti-2707	232	38	illnesses	illness	NOUN
dti-2707	232	39	such	such	ADJ
dti-2707	232	40	as	as	ADP
dti-2707	232	41	cardiac	cardiac	ADJ
dti-2707	232	42	,	,	PUNCT
dti-2707	232	43	renal	renal	ADJ
dti-2707	232	44	,	,	PUNCT
dti-2707	232	45	respiratory	respiratory	ADJ
dti-2707	232	46	,	,	PUNCT
dti-2707	232	47	and	and	CCONJ
dti-2707	232	48	gastric	gastric	NOUN
dti-2707	232	49	.	.	PUNCT
dti-2707	233	1	munjal	munjal	PROPN
dti-2707	233	2	et	et	PROPN
dti-2707	233	3	al	al	PROPN
dti-2707	233	4	drug	drug	PROPN
dti-2707	233	5	target	target	NOUN
dti-2707	233	6	insights	insight	NOUN
dti-2707	233	7	2024	2024	NUM
dti-2707	233	8	;	;	PUNCT
dti-2707	233	9	18	18	NUM
dti-2707	233	10	:	:	SYM
dti-2707	233	11	37	37	NUM
dti-2707	233	12	©	©	PROPN
dti-2707	233	13	2024	2024	NUM
dti-2707	233	14	the	the	DET
dti-2707	233	15	authors	author	NOUN
dti-2707	233	16	.	.	PUNCT
dti-2707	234	1	published	publish	VERB
dti-2707	234	2	by	by	ADP
dti-2707	234	3	aboutscience	aboutscience	NOUN
dti-2707	234	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2707	234	5	disorders	disorder	NOUN
dti-2707	234	6	.	.	PUNCT
dti-2707	235	1	people	people	NOUN
dti-2707	235	2	from	from	ADP
dti-2707	235	3	many	many	ADJ
dti-2707	235	4	cultures	culture	NOUN
dti-2707	235	5	have	have	AUX
dti-2707	235	6	used	use	VERB
dti-2707	235	7	a	a	DET
dti-2707	235	8	variety	variety	NOUN
dti-2707	235	9	of	of	ADP
dti-2707	235	10	herbal	herbal	ADJ
dti-2707	235	11	remedies	remedy	NOUN
dti-2707	235	12	for	for	ADP
dti-2707	235	13	many	many	ADJ
dti-2707	235	14	generations	generation	NOUN
dti-2707	235	15	,	,	PUNCT
dti-2707	235	16	and	and	CCONJ
dti-2707	235	17	some	some	PRON
dti-2707	235	18	of	of	ADP
dti-2707	235	19	these	these	DET
dti-2707	235	20	natural	natural	ADJ
dti-2707	235	21	medicines	medicine	NOUN
dti-2707	235	22	are	be	AUX
dti-2707	235	23	crucial	crucial	ADJ
dti-2707	235	24	for	for	ADP
dti-2707	235	25	the	the	DET
dti-2707	235	26	treatment	treatment	NOUN
dti-2707	235	27	and	and	CCONJ
dti-2707	235	28	prevention	prevention	NOUN
dti-2707	235	29	of	of	ADP
dti-2707	235	30	infectious	infectious	ADJ
dti-2707	235	31	diseases	disease	NOUN
dti-2707	235	32	(	(	PUNCT
dti-2707	235	33	105,106	105,106	NUM
dti-2707	235	34	)	)	PUNCT
dti-2707	235	35	.	.	PUNCT
dti-2707	236	1	baicalein	baicalein	PROPN
dti-2707	236	2	’s	’s	PART
dti-2707	236	3	function	function	NOUN
dti-2707	236	4	as	as	ADP
dti-2707	236	5	an	an	DET
dti-2707	236	6	antibacterial	antibacterial	ADJ
dti-2707	236	7	agent	agent	NOUN
dti-2707	236	8	is	be	AUX
dti-2707	236	9	crucial	crucial	ADJ
dti-2707	236	10	.	.	PUNCT
dti-2707	237	1	baicalin	baicalin	NOUN
dti-2707	237	2	inhibits	inhibit	VERB
dti-2707	237	3	pro	pro	ADJ
dti-2707	237	4	-	-	ADJ
dti-2707	237	5	inflammatory	inflammatory	ADJ
dti-2707	237	6	cytokine	cytokine	NOUN
dti-2707	237	7	release	release	NOUN
dti-2707	237	8	,	,	PUNCT
dti-2707	237	9	mapk	mapk	NOUN
dti-2707	237	10	activation	activation	NOUN
dti-2707	237	11	,	,	PUNCT
dti-2707	237	12	nf	nf	ADJ
dti-2707	237	13	-	-	PUNCT
dti-2707	237	14	κb	κb	NOUN
dti-2707	237	15	pathway	pathway	NOUN
dti-2707	237	16	activation	activation	NOUN
dti-2707	237	17	,	,	PUNCT
dti-2707	237	18	and	and	CCONJ
dti-2707	237	19	nlrp3	nlrp3	NOUN
dti-2707	237	20	to	to	PART
dti-2707	237	21	diminish	diminish	VERB
dti-2707	237	22	inflammation	inflammation	NOUN
dti-2707	237	23	in	in	ADP
dti-2707	237	24	periodontal	periodontal	ADJ
dti-2707	237	25	cells	cell	NOUN
dti-2707	237	26	.	.	PUNCT
dti-2707	238	1	by	by	ADP
dti-2707	238	2	promoting	promote	VERB
dti-2707	238	3	the	the	DET
dti-2707	238	4	expression	expression	NOUN
dti-2707	238	5	of	of	ADP
dti-2707	238	6	interferon	interferon	ADJ
dti-2707	238	7	regulatory	regulatory	ADJ
dti-2707	238	8	factor	factor	NOUN
dti-2707	238	9	(	(	PUNCT
dti-2707	238	10	irf)4	irf)4	PROPN
dti-2707	238	11	and	and	CCONJ
dti-2707	238	12	inhibiting	inhibit	VERB
dti-2707	238	13	the	the	DET
dti-2707	238	14	expression	expression	NOUN
dti-2707	238	15	of	of	ADP
dti-2707	238	16	irf5	irf5	PROPN
dti-2707	238	17	,	,	PUNCT
dti-2707	238	18	baicalin	baicalin	NOUN
dti-2707	238	19	also	also	ADV
dti-2707	238	20	lessens	lessen	VERB
dti-2707	238	21	inflammation	inflammation	NOUN
dti-2707	238	22	by	by	ADP
dti-2707	238	23	regulating	regulate	VERB
dti-2707	238	24	the	the	DET
dti-2707	238	25	transition	transition	NOUN
dti-2707	238	26	of	of	ADP
dti-2707	238	27	m1	m1	PROPN
dti-2707	238	28	to	to	ADP
dti-2707	238	29	m2	m2	PROPN
dti-2707	238	30	macrophages	macrophage	NOUN
dti-2707	238	31	.	.	PUNCT
dti-2707	239	1	baicalin	baicalin	PROPN
dti-2707	239	2	inhibited	inhibit	VERB
dti-2707	239	3	nf	nf	PROPN
dti-2707	239	4	-	-	PUNCT
dti-2707	239	5	κb	κb	NOUN
dti-2707	239	6	and	and	CCONJ
dti-2707	239	7	p38	p38	NOUN
dti-2707	239	8	phosphorylation	phosphorylation	NOUN
dti-2707	239	9	as	as	ADV
dti-2707	239	10	well	well	ADV
dti-2707	239	11	as	as	ADP
dti-2707	239	12	mrna	mrna	NOUN
dti-2707	239	13	expression	expression	NOUN
dti-2707	239	14	,	,	PUNCT
dti-2707	239	15	which	which	PRON
dti-2707	239	16	decreases	decrease	VERB
dti-2707	239	17	pro	pro	ADJ
dti-2707	239	18	-	-	ADJ
dti-2707	239	19	inflammatory	inflammatory	ADJ
dti-2707	239	20	cytokines	cytokine	VERB
dti-2707	239	21	tnf	tnf	PROPN
dti-2707	239	22	-	-	PUNCT
dti-2707	239	23	α	α	PROPN
dti-2707	239	24	,	,	PUNCT
dti-2707	239	25	il	il	PROPN
dti-2707	239	26	-	-	PROPN
dti-2707	239	27	β	β	PROPN
dti-2707	239	28	,	,	PUNCT
dti-2707	239	29	and	and	CCONJ
dti-2707	239	30	il-6	il-6	NOUN
dti-2707	239	31	levels	level	NOUN
dti-2707	239	32	(	(	PUNCT
dti-2707	239	33	107	107	NUM
dti-2707	239	34	)	)	PUNCT
dti-2707	239	35	.	.	PUNCT
dti-2707	240	1	bacterial	bacterial	ADJ
dti-2707	240	2	growth	growth	NOUN
dti-2707	240	3	occurs	occur	VERB
dti-2707	240	4	naturally	naturally	ADV
dti-2707	240	5	as	as	ADP
dti-2707	240	6	biofilms	biofilm	NOUN
dti-2707	240	7	,	,	PUNCT
dti-2707	240	8	which	which	PRON
dti-2707	240	9	are	be	AUX
dti-2707	240	10	abundant	abundant	ADJ
dti-2707	240	11	in	in	ADP
dti-2707	240	12	the	the	DET
dti-2707	240	13	environment	environment	NOUN
dti-2707	240	14	(	(	PUNCT
dti-2707	240	15	108	108	NUM
dti-2707	240	16	)	)	PUNCT
dti-2707	240	17	.	.	PUNCT
dti-2707	241	1	biofilm	biofilm	NOUN
dti-2707	241	2	production	production	NOUN
dti-2707	241	3	leads	lead	VERB
dti-2707	241	4	to	to	ADP
dti-2707	241	5	an	an	DET
dti-2707	241	6	increase	increase	NOUN
dti-2707	241	7	in	in	ADP
dti-2707	241	8	resistance	resistance	NOUN
dti-2707	241	9	to	to	ADP
dti-2707	241	10	antibiotics	antibiotic	NOUN
dti-2707	241	11	and	and	CCONJ
dti-2707	241	12	antimicrobial	antimicrobial	ADJ
dti-2707	241	13	agents	agent	NOUN
dti-2707	241	14	.	.	PUNCT
dti-2707	242	1	quorum	quorum	NOUN
dti-2707	242	2	sensing	sense	VERB
dti-2707	242	3	(	(	PUNCT
dti-2707	242	4	qs	qs	NOUN
dti-2707	242	5	)	)	PUNCT
dti-2707	242	6	,	,	PUNCT
dti-2707	242	7	a	a	DET
dti-2707	242	8	mechanism	mechanism	NOUN
dti-2707	242	9	responsible	responsible	ADJ
dti-2707	242	10	for	for	ADP
dti-2707	242	11	the	the	DET
dti-2707	242	12	intercellular	intercellular	ADJ
dti-2707	242	13	exchanges	exchange	NOUN
dti-2707	242	14	of	of	ADP
dti-2707	242	15	information	information	NOUN
dti-2707	242	16	,	,	PUNCT
dti-2707	242	17	is	be	AUX
dti-2707	242	18	essential	essential	ADJ
dti-2707	242	19	to	to	ADP
dti-2707	242	20	the	the	DET
dti-2707	242	21	production	production	NOUN
dti-2707	242	22	of	of	ADP
dti-2707	242	23	biofilms	biofilm	NOUN
dti-2707	242	24	(	(	PUNCT
dti-2707	242	25	109	109	NUM
dti-2707	242	26	)	)	PUNCT
dti-2707	242	27	.	.	PUNCT
dti-2707	243	1	baicalin	baicalin	NOUN
dti-2707	243	2	suppresses	suppress	VERB
dti-2707	243	3	the	the	DET
dti-2707	243	4	qs	qs	NOUN
dti-2707	243	5	system	system	NOUN
dti-2707	243	6	,	,	PUNCT
dti-2707	243	7	which	which	PRON
dti-2707	243	8	inhibits	inhibit	VERB
dti-2707	243	9	inflammatory	inflammatory	ADJ
dti-2707	243	10	responses	response	NOUN
dti-2707	243	11	.	.	PUNCT
dti-2707	244	1	baicalein	baicalein	PROPN
dti-2707	244	2	has	have	AUX
dti-2707	244	3	been	be	AUX
dti-2707	244	4	shown	show	VERB
dti-2707	244	5	to	to	PART
dti-2707	244	6	have	have	VERB
dti-2707	244	7	antimicrobial	antimicrobial	ADJ
dti-2707	244	8	properties	property	NOUN
dti-2707	244	9	against	against	ADP
dti-2707	244	10	meningococcus	meningococcus	NOUN
dti-2707	244	11	,	,	PUNCT
dti-2707	244	12	staphylococcus	staphylococcus	NOUN
dti-2707	244	13	aureus	aureus	NOUN
dti-2707	244	14	,	,	PUNCT
dti-2707	244	15	corynebacterium	corynebacterium	NOUN
dti-2707	244	16	diphtheriae	diphtheriae	NOUN
dti-2707	244	17	,	,	PUNCT
dti-2707	244	18	pseudomonas	pseudomona	NOUN
dti-2707	244	19	aeruginosa	aeruginosa	NOUN
dti-2707	244	20	,	,	PUNCT
dti-2707	244	21	and	and	CCONJ
dti-2707	244	22	dysentery	dysentery	NOUN
dti-2707	244	23	bacillus	bacillus	NOUN
dti-2707	244	24	.	.	PUNCT
dti-2707	245	1	through	through	ADP
dti-2707	245	2	a	a	DET
dti-2707	245	3	number	number	NOUN
dti-2707	245	4	of	of	ADP
dti-2707	245	5	mechanisms	mechanism	NOUN
dti-2707	245	6	,	,	PUNCT
dti-2707	245	7	such	such	ADJ
dti-2707	245	8	as	as	ADP
dti-2707	245	9	enhancing	enhance	VERB
dti-2707	245	10	the	the	DET
dti-2707	245	11	host	host	NOUN
dti-2707	245	12	immune	immune	ADJ
dti-2707	245	13	system	system	NOUN
dti-2707	245	14	,	,	PUNCT
dti-2707	245	15	preventing	prevent	VERB
dti-2707	245	16	the	the	DET
dti-2707	245	17	formation	formation	NOUN
dti-2707	245	18	of	of	ADP
dti-2707	245	19	biofilms	biofilm	NOUN
dti-2707	245	20	,	,	PUNCT
dti-2707	245	21	lowering	lower	VERB
dti-2707	245	22	antimicrobial	antimicrobial	ADJ
dti-2707	245	23	medicine	medicine	NOUN
dti-2707	245	24	resistance	resistance	NOUN
dti-2707	245	25	,	,	PUNCT
dti-2707	245	26	suppressing	suppress	VERB
dti-2707	245	27	bacterial	bacterial	ADJ
dti-2707	245	28	secretions	secretion	NOUN
dti-2707	245	29	,	,	PUNCT
dti-2707	245	30	and	and	CCONJ
dti-2707	245	31	upsetting	upset	VERB
dti-2707	245	32	microbial	microbial	ADJ
dti-2707	245	33	morphology	morphology	NOUN
dti-2707	245	34	,	,	PUNCT
dti-2707	245	35	baicalin	baicalin	NOUN
dti-2707	245	36	acts	act	NOUN
dti-2707	245	37	as	as	ADP
dti-2707	245	38	a	a	DET
dti-2707	245	39	herbal	herbal	ADJ
dti-2707	245	40	antimicrobial	antimicrobial	ADJ
dti-2707	245	41	agent	agent	NOUN
dti-2707	245	42	against	against	ADP
dti-2707	245	43	several	several	ADJ
dti-2707	245	44	microbial	microbial	ADJ
dti-2707	245	45	infections	infection	NOUN
dti-2707	245	46	(	(	PUNCT
dti-2707	245	47	110	110	NUM
dti-2707	245	48	)	)	PUNCT
dti-2707	245	49	.	.	PUNCT
dti-2707	246	1	baicalin	baicalin	NOUN
dti-2707	246	2	has	have	AUX
dti-2707	246	3	also	also	ADV
dti-2707	246	4	been	be	AUX
dti-2707	246	5	shown	show	VERB
dti-2707	246	6	to	to	PART
dti-2707	246	7	suppress	suppress	VERB
dti-2707	246	8	apoptosis	apoptosis	NOUN
dti-2707	246	9	,	,	PUNCT
dti-2707	246	10	decrease	decrease	VERB
dti-2707	246	11	fas	fas	ADJ
dti-2707	246	12	protein	protein	NOUN
dti-2707	246	13	expression	expression	NOUN
dti-2707	246	14	,	,	PUNCT
dti-2707	246	15	block	block	VERB
dti-2707	246	16	the	the	DET
dti-2707	246	17	caspase-8	caspase-8	NOUN
dti-2707	246	18	pathway	pathway	NOUN
dti-2707	246	19	,	,	PUNCT
dti-2707	246	20	and	and	CCONJ
dti-2707	246	21	decrease	decrease	VERB
dti-2707	246	22	bax	bax	NOUN
dti-2707	246	23	protein	protein	NOUN
dti-2707	246	24	production	production	NOUN
dti-2707	246	25	.	.	PUNCT
dti-2707	247	1	these	these	DET
dti-2707	247	2	actions	action	NOUN
dti-2707	247	3	are	be	AUX
dti-2707	247	4	all	all	PRON
dti-2707	247	5	thought	think	VERB
dti-2707	247	6	to	to	PART
dti-2707	247	7	contribute	contribute	VERB
dti-2707	247	8	to	to	ADP
dti-2707	247	9	its	its	PRON
dti-2707	247	10	antiviral	antiviral	ADJ
dti-2707	247	11	efficacy	efficacy	NOUN
dti-2707	247	12	(	(	PUNCT
dti-2707	247	13	111	111	NUM
dti-2707	247	14	)	)	PUNCT
dti-2707	247	15	.	.	PUNCT
dti-2707	248	1	baicalin	baicalin	NOUN
dti-2707	248	2	lowers	lower	VERB
dti-2707	248	3	the	the	DET
dti-2707	248	4	raised	raise	VERB
dti-2707	248	5	levels	level	NOUN
dti-2707	248	6	of	of	ADP
dti-2707	248	7	hepatic	hepatic	ADJ
dti-2707	248	8	markers	marker	NOUN
dti-2707	248	9	alanine	alanine	NOUN
dti-2707	248	10	transaminase	transaminase	NOUN
dti-2707	248	11	(	(	PUNCT
dti-2707	248	12	alt	alt	PROPN
dti-2707	248	13	)	)	PUNCT
dti-2707	248	14	,	,	PUNCT
dti-2707	248	15	aspartate	aspartate	NOUN
dti-2707	248	16	aminotransferase	aminotransferase	NOUN
dti-2707	248	17	(	(	PUNCT
dti-2707	248	18	ast	ast	NOUN
dti-2707	248	19	)	)	PUNCT
dti-2707	248	20	,	,	PUNCT
dti-2707	248	21	and	and	CCONJ
dti-2707	248	22	total	total	ADJ
dti-2707	248	23	bilirubin	bilirubin	NOUN
dti-2707	248	24	along	along	ADP
dti-2707	248	25	with	with	ADP
dti-2707	248	26	hepatitis	hepatitis	PROPN
dti-2707	248	27	b	b	PROPN
dti-2707	248	28	virus	virus	NOUN
dti-2707	248	29	(	(	PUNCT
dti-2707	248	30	hbv)-dna	hbv)-dna	PROPN
dti-2707	248	31	in	in	ADP
dti-2707	248	32	patients	patient	NOUN
dti-2707	248	33	with	with	ADP
dti-2707	248	34	chronic	chronic	ADJ
dti-2707	248	35	hepatitis	hepatitis	PROPN
dti-2707	248	36	b.	b.	PROPN
dti-2707	249	1	it	it	PRON
dti-2707	249	2	can	can	AUX
dti-2707	249	3	also	also	ADV
dti-2707	249	4	be	be	AUX
dti-2707	249	5	used	use	VERB
dti-2707	249	6	in	in	ADP
dti-2707	249	7	conjunction	conjunction	NOUN
dti-2707	249	8	with	with	ADP
dti-2707	249	9	other	other	ADJ
dti-2707	249	10	medications	medication	NOUN
dti-2707	249	11	to	to	PART
dti-2707	249	12	treat	treat	VERB
dti-2707	249	13	viral	viral	ADJ
dti-2707	249	14	infections	infection	NOUN
dti-2707	249	15	in	in	ADP
dti-2707	249	16	patients	patient	NOUN
dti-2707	249	17	with	with	ADP
dti-2707	249	18	an	an	DET
dti-2707	249	19	h1n1	h1n1	NOUN
dti-2707	249	20	influenza	influenza	NOUN
dti-2707	249	21	infection	infection	NOUN
dti-2707	249	22	.	.	PUNCT
dti-2707	250	1	baicalin	baicalin	NOUN
dti-2707	250	2	regulates	regulate	VERB
dti-2707	250	3	the	the	DET
dti-2707	250	4	numbers	number	NOUN
dti-2707	250	5	of	of	ADP
dti-2707	250	6	t	t	PROPN
dti-2707	250	7	-	-	PUNCT
dti-2707	250	8	lymphocyte	lymphocyte	ADJ
dti-2707	250	9	subsets	subset	NOUN
dti-2707	250	10	and	and	CCONJ
dti-2707	250	11	upregulates	upregulate	VERB
dti-2707	250	12	cd3	cd3	VERB
dti-2707	250	13	+	+	PROPN
dti-2707	250	14	,	,	PUNCT
dti-2707	250	15	cd4+/cd8	cd4+/cd8	NOUN
dti-2707	250	16	+	+	NOUN
dti-2707	250	17	,	,	PUNCT
dti-2707	250	18	and	and	CCONJ
dti-2707	250	19	other	other	ADJ
dti-2707	250	20	positive	positive	ADJ
dti-2707	250	21	lymphocyte	lymphocyte	ADJ
dti-2707	250	22	subsets	subset	NOUN
dti-2707	250	23	(	(	PUNCT
dti-2707	250	24	112	112	NUM
dti-2707	250	25	)	)	PUNCT
dti-2707	250	26	.	.	PUNCT
dti-2707	251	1	invasive	invasive	ADJ
dti-2707	251	2	fungal	fungal	ADJ
dti-2707	251	3	infections	infection	NOUN
dti-2707	251	4	increase	increase	VERB
dti-2707	251	5	morbidity	morbidity	NOUN
dti-2707	251	6	and	and	CCONJ
dti-2707	251	7	death	death	NOUN
dti-2707	251	8	of	of	ADP
dti-2707	251	9	patients	patient	NOUN
dti-2707	251	10	who	who	PRON
dti-2707	251	11	have	have	VERB
dti-2707	251	12	impaired	impair	VERB
dti-2707	251	13	immune	immune	ADJ
dti-2707	251	14	systems	system	NOUN
dti-2707	251	15	(	(	PUNCT
dti-2707	251	16	113	113	NUM
dti-2707	251	17	)	)	PUNCT
dti-2707	251	18	.	.	PUNCT
dti-2707	252	1	currently	currently	ADV
dti-2707	252	2	,	,	PUNCT
dti-2707	252	3	polyenes	polyene	NOUN
dti-2707	252	4	,	,	PUNCT
dti-2707	252	5	echinocandins	echinocandin	NOUN
dti-2707	252	6	,	,	PUNCT
dti-2707	252	7	and	and	CCONJ
dti-2707	252	8	azoles	azole	NOUN
dti-2707	252	9	are	be	AUX
dti-2707	252	10	the	the	DET
dti-2707	252	11	three	three	NUM
dti-2707	252	12	primary	primary	ADJ
dti-2707	252	13	classes	class	NOUN
dti-2707	252	14	of	of	ADP
dti-2707	252	15	frontline	frontline	NOUN
dti-2707	252	16	clinical	clinical	ADJ
dti-2707	252	17	antifungal	antifungal	ADJ
dti-2707	252	18	agents	agent	NOUN
dti-2707	252	19	used	use	VERB
dti-2707	252	20	to	to	PART
dti-2707	252	21	treat	treat	VERB
dti-2707	252	22	such	such	ADJ
dti-2707	252	23	infections	infection	NOUN
dti-2707	252	24	(	(	PUNCT
dti-2707	252	25	114	114	NUM
dti-2707	252	26	)	)	PUNCT
dti-2707	252	27	.	.	PUNCT
dti-2707	253	1	however	however	ADV
dti-2707	253	2	,	,	PUNCT
dti-2707	253	3	each	each	PRON
dti-2707	253	4	of	of	ADP
dti-2707	253	5	these	these	DET
dti-2707	253	6	groups	group	NOUN
dti-2707	253	7	has	have	VERB
dti-2707	253	8	drawbacks	drawback	NOUN
dti-2707	253	9	that	that	PRON
dti-2707	253	10	may	may	AUX
dti-2707	253	11	restrict	restrict	VERB
dti-2707	253	12	their	their	PRON
dti-2707	253	13	clinical	clinical	ADJ
dti-2707	253	14	use	use	NOUN
dti-2707	253	15	for	for	ADP
dti-2707	253	16	the	the	DET
dti-2707	253	17	management	management	NOUN
dti-2707	253	18	of	of	ADP
dti-2707	253	19	invasive	invasive	ADJ
dti-2707	253	20	fungal	fungal	ADJ
dti-2707	253	21	infections	infection	NOUN
dti-2707	253	22	,	,	PUNCT
dti-2707	253	23	and	and	CCONJ
dti-2707	253	24	it	it	PRON
dti-2707	253	25	is	be	AUX
dti-2707	253	26	urgently	urgently	ADV
dti-2707	253	27	necessary	necessary	ADJ
dti-2707	253	28	to	to	PART
dti-2707	253	29	identify	identify	VERB
dti-2707	253	30	new	new	ADJ
dti-2707	253	31	antifungal	antifungal	ADJ
dti-2707	253	32	medicines	medicine	NOUN
dti-2707	253	33	that	that	PRON
dti-2707	253	34	target	target	VERB
dti-2707	253	35	novel	novel	NOUN
dti-2707	253	36	targets	target	NOUN
dti-2707	253	37	.	.	PUNCT
dti-2707	254	1	baicalein	baicalein	PROPN
dti-2707	254	2	has	have	AUX
dti-2707	254	3	demonstrated	demonstrate	VERB
dti-2707	254	4	potential	potential	ADJ
dti-2707	254	5	antifungal	antifungal	ADJ
dti-2707	254	6	activity	activity	NOUN
dti-2707	254	7	.	.	PUNCT
dti-2707	255	1	it	it	PRON
dti-2707	255	2	significantly	significantly	ADV
dti-2707	255	3	inhibits	inhibit	VERB
dti-2707	255	4	the	the	DET
dti-2707	255	5	growth	growth	NOUN
dti-2707	255	6	of	of	ADP
dti-2707	255	7	aspergillus	aspergillus	NOUN
dti-2707	255	8	fumigatus	fumigatus	NOUN
dti-2707	255	9	,	,	PUNCT
dti-2707	255	10	cryptococcus	cryptococcus	PROPN
dti-2707	255	11	neoformans	neoforman	NOUN
dti-2707	255	12	,	,	PUNCT
dti-2707	255	13	and	and	CCONJ
dti-2707	255	14	candida	candida	PROPN
dti-2707	255	15	species	specie	NOUN
dti-2707	255	16	.	.	PUNCT
dti-2707	256	1	because	because	SCONJ
dti-2707	256	2	it	it	PRON
dti-2707	256	3	targets	target	VERB
dti-2707	256	4	eno1	eno1	NOUN
dti-2707	256	5	,	,	PUNCT
dti-2707	256	6	be	be	AUX
dti-2707	256	7	(	(	PUNCT
dti-2707	256	8	baicalein	baicalein	PROPN
dti-2707	256	9	)	)	PUNCT
dti-2707	256	10	has	have	VERB
dti-2707	256	11	anti	anti	ADJ
dti-2707	256	12	-	-	ADJ
dti-2707	256	13	c.	c.	ADJ
dti-2707	256	14	albicans	albican	NOUN
dti-2707	256	15	action	action	NOUN
dti-2707	256	16	via	via	ADP
dti-2707	256	17	preventing	prevent	VERB
dti-2707	256	18	glycolysis	glycolysis	NOUN
dti-2707	256	19	.	.	PUNCT
dti-2707	257	1	be	be	AUX
dti-2707	257	2	(	(	PUNCT
dti-2707	257	3	baicalein	baicalein	PROPN
dti-2707	257	4	)	)	PUNCT
dti-2707	257	5	has	have	VERB
dti-2707	257	6	a	a	DET
dti-2707	257	7	substantial	substantial	ADJ
dti-2707	257	8	inhibitory	inhibitory	ADJ
dti-2707	257	9	effect	effect	NOUN
dti-2707	257	10	on	on	ADP
dti-2707	257	11	caeno1	caeno1	PROPN
dti-2707	257	12	’s	’s	PART
dti-2707	257	13	enolase	enolase	NOUN
dti-2707	257	14	activity	activity	NOUN
dti-2707	257	15	(	(	PUNCT
dti-2707	257	16	115	115	NUM
dti-2707	257	17	)	)	PUNCT
dti-2707	257	18	.	.	PUNCT
dti-2707	258	1	baicalein	baicalein	PROPN
dti-2707	258	2	inhibits	inhibit	VERB
dti-2707	258	3	tslp	tslp	VERB
dti-2707	258	4	/	/	SYM
dti-2707	258	5	tslpr	tslpr	NOUN
dti-2707	258	6	pathway	pathway	NOUN
dti-2707	258	7	activity	activity	NOUN
dti-2707	258	8	,	,	PUNCT
dti-2707	258	9	which	which	PRON
dti-2707	258	10	suppresses	suppress	VERB
dti-2707	258	11	inflammatory	inflammatory	ADJ
dti-2707	258	12	response	response	NOUN
dti-2707	258	13	and	and	CCONJ
dti-2707	258	14	protects	protect	VERB
dti-2707	258	15	against	against	ADP
dti-2707	258	16	a.	a.	NOUN
dti-2707	258	17	fumigatus	fumigatus	NOUN
dti-2707	258	18	keratitis	keratitis	NOUN
dti-2707	258	19	by	by	ADP
dti-2707	258	20	preventing	prevent	VERB
dti-2707	258	21	fungal	fungal	ADJ
dti-2707	258	22	growth	growth	NOUN
dti-2707	258	23	,	,	PUNCT
dti-2707	258	24	biofilm	biofilm	NOUN
dti-2707	258	25	formation	formation	NOUN
dti-2707	258	26	,	,	PUNCT
dti-2707	258	27	and	and	CCONJ
dti-2707	258	28	adhesion	adhesion	NOUN
dti-2707	258	29	(	(	PUNCT
dti-2707	258	30	tab	tab	NOUN
dti-2707	258	31	.	.	NOUN
dti-2707	259	1	3	3	NUM
dti-2707	259	2	)	)	PUNCT
dti-2707	259	3	(	(	PUNCT
dti-2707	259	4	116,117	116,117	NUM
dti-2707	259	5	)	)	PUNCT
dti-2707	259	6	.	.	PUNCT
dti-2707	260	1	antidiabetic	antidiabetic	ADJ
dti-2707	260	2	property	property	NOUN
dti-2707	260	3	of	of	ADP
dti-2707	260	4	baicalein	baicalein	NOUN
dti-2707	260	5	dm	dm	X
dti-2707	260	6	is	be	AUX
dti-2707	260	7	the	the	DET
dti-2707	260	8	most	most	ADV
dti-2707	260	9	prevalent	prevalent	ADJ
dti-2707	260	10	endocrine	endocrine	ADJ
dti-2707	260	11	disorder	disorder	NOUN
dti-2707	260	12	in	in	ADP
dti-2707	260	13	the	the	DET
dti-2707	260	14	21st	21st	ADJ
dti-2707	260	15	century	century	NOUN
dti-2707	260	16	,	,	PUNCT
dti-2707	260	17	and	and	CCONJ
dti-2707	260	18	is	be	AUX
dti-2707	260	19	spreading	spread	VERB
dti-2707	260	20	all	all	ADV
dti-2707	260	21	over	over	ADP
dti-2707	260	22	the	the	DET
dti-2707	260	23	world	world	NOUN
dti-2707	260	24	.	.	PUNCT
dti-2707	261	1	diabetes	diabetes	NOUN
dti-2707	261	2	increases	increase	VERB
dti-2707	261	3	blood	blood	NOUN
dti-2707	261	4	sugar	sugar	NOUN
dti-2707	261	5	levels	level	NOUN
dti-2707	261	6	.	.	PUNCT
dti-2707	262	1	neglecting	neglect	VERB
dti-2707	262	2	to	to	PART
dti-2707	262	3	manage	manage	VERB
dti-2707	262	4	it	it	PRON
dti-2707	262	5	consistently	consistently	ADV
dti-2707	262	6	and	and	CCONJ
dti-2707	262	7	carefully	carefully	ADV
dti-2707	262	8	increases	increase	VERB
dti-2707	262	9	the	the	DET
dti-2707	262	10	risk	risk	NOUN
dti-2707	262	11	of	of	ADP
dti-2707	262	12	significant	significant	ADJ
dti-2707	262	13	adverse	adverse	ADJ
dti-2707	262	14	effects	effect	NOUN
dti-2707	262	15	,	,	PUNCT
dti-2707	262	16	including	include	VERB
dti-2707	262	17	stroke	stroke	NOUN
dti-2707	262	18	and	and	CCONJ
dti-2707	262	19	heart	heart	NOUN
dti-2707	262	20	failure	failure	NOUN
dti-2707	262	21	.	.	PUNCT
dti-2707	263	1	type	type	NOUN
dti-2707	263	2	1	1	NUM
dti-2707	263	3	,	,	PUNCT
dti-2707	263	4	type	type	NOUN
dti-2707	263	5	2	2	NUM
dti-2707	263	6	,	,	PUNCT
dti-2707	263	7	and	and	CCONJ
dti-2707	263	8	gestational	gestational	ADJ
dti-2707	263	9	diabetes	diabetes	NOUN
dti-2707	263	10	are	be	AUX
dti-2707	263	11	the	the	DET
dti-2707	263	12	three	three	NUM
dti-2707	263	13	most	most	ADV
dti-2707	263	14	prevalent	prevalent	ADJ
dti-2707	263	15	forms	form	NOUN
dti-2707	263	16	of	of	ADP
dti-2707	263	17	the	the	DET
dti-2707	263	18	disease	disease	NOUN
dti-2707	263	19	.	.	PUNCT
dti-2707	264	1	by	by	ADP
dti-2707	264	2	preventing	prevent	VERB
dti-2707	264	3	islet	islet	NOUN
dti-2707	264	4	cell	cell	NOUN
dti-2707	264	5	death	death	NOUN
dti-2707	264	6	,	,	PUNCT
dti-2707	264	7	baicalein	baicalein	NOUN
dti-2707	264	8	reduces	reduce	VERB
dti-2707	264	9	hyperglycemia	hyperglycemia	NOUN
dti-2707	264	10	,	,	PUNCT
dti-2707	264	11	improves	improve	VERB
dti-2707	264	12	glucose	glucose	NOUN
dti-2707	264	13	intolerance	intolerance	NOUN
dti-2707	264	14	,	,	PUNCT
dti-2707	264	15	and	and	CCONJ
dti-2707	264	16	encourages	encourage	VERB
dti-2707	264	17	insulin	insulin	NOUN
dti-2707	264	18	production	production	NOUN
dti-2707	264	19	(	(	PUNCT
dti-2707	264	20	118	118	NUM
dti-2707	264	21	)	)	PUNCT
dti-2707	264	22	.	.	PUNCT
dti-2707	265	1	baicalein	baicalein	PROPN
dti-2707	265	2	is	be	AUX
dti-2707	265	3	used	use	VERB
dti-2707	265	4	to	to	PART
dti-2707	265	5	treat	treat	VERB
dti-2707	265	6	diabetes	diabetes	NOUN
dti-2707	265	7	,	,	PUNCT
dti-2707	265	8	which	which	PRON
dti-2707	265	9	lowers	lower	VERB
dti-2707	265	10	total	total	ADJ
dti-2707	265	11	cholesterol	cholesterol	NOUN
dti-2707	265	12	,	,	PUNCT
dti-2707	265	13	plasma	plasma	NOUN
dti-2707	265	14	triglyceride	triglyceride	ADP
dti-2707	265	15	plasma	plasma	NOUN
dti-2707	265	16	levels	level	NOUN
dti-2707	265	17	along	along	ADP
dti-2707	265	18	with	with	ADP
dti-2707	265	19	sugar	sugar	NOUN
dti-2707	265	20	lowering	lower	VERB
dti-2707	265	21	effect	effect	NOUN
dti-2707	265	22	(	(	PUNCT
dti-2707	265	23	119	119	NUM
dti-2707	265	24	)	)	PUNCT
dti-2707	265	25	.	.	PUNCT
dti-2707	266	1	baicalein	baicalein	PROPN
dti-2707	266	2	additionally	additionally	ADV
dti-2707	266	3	showed	show	VERB
dti-2707	266	4	antihyperglycemic	antihyperglycemic	ADJ
dti-2707	266	5	effects	effect	NOUN
dti-2707	266	6	in	in	ADP
dti-2707	266	7	both	both	PRON
dti-2707	266	8	in	in	ADP
dti-2707	266	9	vivo	vivo	NOUN
dti-2707	266	10	and	and	CCONJ
dti-2707	266	11	in	in	ADP
dti-2707	266	12	vitro	vitro	X
dti-2707	266	13	models	model	NOUN
dti-2707	266	14	via	via	ADP
dti-2707	266	15	blocking	block	VERB
dti-2707	266	16	the	the	DET
dti-2707	266	17	α	α	NOUN
dti-2707	266	18	-	-	PUNCT
dti-2707	266	19	glucosidase	glucosidase	ADJ
dti-2707	266	20	action	action	NOUN
dti-2707	266	21	in	in	ADP
dti-2707	266	22	3t3	3t3	ADJ
dti-2707	266	23	-	-	PUNCT
dti-2707	266	24	l1	l1	NOUN
dti-2707	266	25	adipocyte	adipocyte	NOUN
dti-2707	266	26	cell	cell	NOUN
dti-2707	266	27	line	line	NOUN
dti-2707	266	28	.	.	PUNCT
dti-2707	267	1	the	the	DET
dti-2707	267	2	main	main	ADJ
dti-2707	267	3	function	function	NOUN
dti-2707	267	4	of	of	ADP
dti-2707	267	5	the	the	DET
dti-2707	267	6	enzyme	enzyme	NOUN
dti-2707	267	7	α	α	NOUN
dti-2707	267	8	-	-	NOUN
dti-2707	267	9	glucosidase	glucosidase	NOUN
dti-2707	267	10	is	be	AUX
dti-2707	267	11	to	to	PART
dti-2707	267	12	catalyze	catalyze	VERB
dti-2707	267	13	the	the	DET
dti-2707	267	14	breakdown	breakdown	NOUN
dti-2707	267	15	of	of	ADP
dti-2707	267	16	starches	starch	NOUN
dti-2707	267	17	and	and	CCONJ
dti-2707	267	18	carbs	carb	NOUN
dti-2707	267	19	in	in	ADP
dti-2707	267	20	food	food	NOUN
dti-2707	267	21	to	to	PART
dti-2707	267	22	produce	produce	VERB
dti-2707	267	23	glucose	glucose	NOUN
dti-2707	267	24	that	that	PRON
dti-2707	267	25	may	may	AUX
dti-2707	267	26	be	be	AUX
dti-2707	267	27	absorbed	absorb	VERB
dti-2707	267	28	through	through	ADP
dti-2707	267	29	the	the	DET
dti-2707	267	30	digestive	digestive	ADJ
dti-2707	267	31	tract	tract	NOUN
dti-2707	267	32	(	(	PUNCT
dti-2707	267	33	120	120	NUM
dti-2707	267	34	)	)	PUNCT
dti-2707	267	35	.	.	PUNCT
dti-2707	268	1	as	as	ADP
dti-2707	268	2	a	a	DET
dti-2707	268	3	result	result	NOUN
dti-2707	268	4	,	,	PUNCT
dti-2707	268	5	delaying	delay	VERB
dti-2707	268	6	the	the	DET
dti-2707	268	7	synthesis	synthesis	NOUN
dti-2707	268	8	of	of	ADP
dti-2707	268	9	glucose	glucose	NOUN
dti-2707	268	10	after	after	SCONJ
dti-2707	268	11	meal	meal	NOUN
dti-2707	268	12	digestion	digestion	NOUN
dti-2707	268	13	may	may	AUX
dti-2707	268	14	minimize	minimize	VERB
dti-2707	268	15	hyperglycemia	hyperglycemia	NOUN
dti-2707	268	16	.	.	PUNCT
dti-2707	269	1	it	it	PRON
dti-2707	269	2	was	be	AUX
dti-2707	269	3	discovered	discover	VERB
dti-2707	269	4	that	that	SCONJ
dti-2707	269	5	baicalein	baicalein	PROPN
dti-2707	269	6	had	have	VERB
dti-2707	269	7	α	α	VERB
dti-2707	269	8	-	-	PUNCT
dti-2707	269	9	glucosidase	glucosidase	ADJ
dti-2707	269	10	inhibitory	inhibitory	ADJ
dti-2707	269	11	effects	effect	NOUN
dti-2707	269	12	comparable	comparable	ADJ
dti-2707	269	13	to	to	ADP
dti-2707	269	14	those	those	PRON
dti-2707	269	15	of	of	ADP
dti-2707	269	16	the	the	DET
dti-2707	269	17	commonly	commonly	ADV
dti-2707	269	18	prescribed	prescribe	VERB
dti-2707	269	19	,	,	PUNCT
dti-2707	269	20	clinically	clinically	ADV
dti-2707	269	21	effective	effective	ADJ
dti-2707	269	22	α	α	PRON
dti-2707	269	23	-	-	PUNCT
dti-2707	269	24	glucosidase	glucosidase	ADJ
dti-2707	269	25	inhibitor	inhibitor	NOUN
dti-2707	269	26	,	,	PUNCT
dti-2707	269	27	acarbose	acarbose	X
dti-2707	269	28	(	(	PUNCT
dti-2707	269	29	120	120	NUM
dti-2707	269	30	)	)	PUNCT
dti-2707	269	31	.	.	PUNCT
dti-2707	270	1	the	the	DET
dti-2707	270	2	synergistic	synergistic	ADJ
dti-2707	270	3	impact	impact	NOUN
dti-2707	270	4	of	of	ADP
dti-2707	270	5	baicalein	baicalein	NOUN
dti-2707	270	6	and	and	CCONJ
dti-2707	270	7	acarbose	acarbose	NOUN
dti-2707	270	8	treatment	treatment	NOUN
dti-2707	270	9	is	be	AUX
dti-2707	270	10	reported	report	VERB
dti-2707	270	11	for	for	ADP
dti-2707	270	12	showing	show	VERB
dti-2707	270	13	reduced	reduce	VERB
dti-2707	270	14	harmful	harmful	ADJ
dti-2707	270	15	hepatic	hepatic	ADJ
dti-2707	270	16	side	side	NOUN
dti-2707	270	17	effects	effect	NOUN
dti-2707	270	18	associated	associate	VERB
dti-2707	270	19	with	with	ADP
dti-2707	270	20	using	use	VERB
dti-2707	270	21	high	high	ADJ
dti-2707	270	22	dosages	dosage	NOUN
dti-2707	270	23	of	of	ADP
dti-2707	270	24	the	the	DET
dti-2707	270	25	acarbose	acarbose	NOUN
dti-2707	270	26	alone	alone	ADJ
dti-2707	270	27	to	to	PART
dti-2707	270	28	treat	treat	VERB
dti-2707	270	29	diabetes	diabetes	NOUN
dti-2707	270	30	by	by	ADP
dti-2707	270	31	lowering	lower	VERB
dti-2707	270	32	the	the	DET
dti-2707	270	33	dosage	dosage	NOUN
dti-2707	270	34	from	from	ADP
dti-2707	270	35	high	high	ADJ
dti-2707	270	36	(	(	PUNCT
dti-2707	270	37	20	20	NUM
dti-2707	270	38	mg	mg	NUM
dti-2707	270	39	/	/	SYM
dti-2707	270	40	kg	kg	NOUN
dti-2707	270	41	)	)	PUNCT
dti-2707	270	42	to	to	PART
dti-2707	270	43	low	low	VERB
dti-2707	270	44	(	(	PUNCT
dti-2707	270	45	4	4	NUM
dti-2707	270	46	mg	mg	PROPN
dti-2707	270	47	/	/	SYM
dti-2707	270	48	kg	kg	PROPN
dti-2707	270	49	)	)	PUNCT
dti-2707	270	50	levels	level	NOUN
dti-2707	270	51	(	(	PUNCT
dti-2707	270	52	121	121	NUM
dti-2707	270	53	)	)	PUNCT
dti-2707	270	54	.	.	PUNCT
dti-2707	271	1	glycation	glycation	NOUN
dti-2707	271	2	of	of	ADP
dti-2707	271	3	bovine	bovine	ADJ
dti-2707	271	4	serum	serum	NOUN
dti-2707	271	5	albumin	albumin	PROPN
dti-2707	271	6	(	(	PUNCT
dti-2707	271	7	bsa	bsa	PROPN
dti-2707	271	8	)	)	PUNCT
dti-2707	271	9	is	be	AUX
dti-2707	271	10	a	a	DET
dti-2707	271	11	complicated	complicated	ADJ
dti-2707	271	12	chain	chain	NOUN
dti-2707	271	13	of	of	ADP
dti-2707	271	14	events	event	NOUN
dti-2707	271	15	wherein	wherein	ADJ
dti-2707	271	16	reducing	reduce	VERB
dti-2707	271	17	sugars	sugar	NOUN
dti-2707	271	18	like	like	ADP
dti-2707	271	19	glucose	glucose	NOUN
dti-2707	271	20	alter	alter	VERB
dti-2707	271	21	the	the	DET
dti-2707	271	22	structure	structure	NOUN
dti-2707	271	23	of	of	ADP
dti-2707	271	24	the	the	DET
dti-2707	271	25	protein	protein	NOUN
dti-2707	271	26	.	.	PUNCT
dti-2707	272	1	due	due	ADP
dti-2707	272	2	to	to	ADP
dti-2707	272	3	the	the	DET
dti-2707	272	4	excess	excess	ADJ
dti-2707	272	5	glucose	glucose	NOUN
dti-2707	272	6	molecules	molecule	NOUN
dti-2707	272	7	in	in	ADP
dti-2707	272	8	their	their	PRON
dti-2707	272	9	serum	serum	NOUN
dti-2707	272	10	,	,	PUNCT
dti-2707	272	11	diabetics	diabetic	NOUN
dti-2707	272	12	usually	usually	ADV
dti-2707	272	13	have	have	VERB
dti-2707	272	14	greater	great	ADJ
dti-2707	272	15	glycation	glycation	NOUN
dti-2707	272	16	rates	rate	NOUN
dti-2707	272	17	.	.	PUNCT
dti-2707	273	1	this	this	PRON
dti-2707	273	2	can	can	AUX
dti-2707	273	3	lead	lead	VERB
dti-2707	273	4	to	to	ADP
dti-2707	273	5	nonfunctional	nonfunctional	ADJ
dti-2707	273	6	proteins	protein	NOUN
dti-2707	273	7	and	and	CCONJ
dti-2707	273	8	further	far	ADV
dti-2707	273	9	activate	activate	VERB
dti-2707	273	10	several	several	ADJ
dti-2707	273	11	signaling	signal	VERB
dti-2707	273	12	pathways	pathway	NOUN
dti-2707	273	13	,	,	PUNCT
dti-2707	273	14	increasing	increase	VERB
dti-2707	273	15	the	the	DET
dti-2707	273	16	risk	risk	NOUN
dti-2707	273	17	of	of	ADP
dti-2707	273	18	beta	beta	NOUN
dti-2707	273	19	-	-	PUNCT
dti-2707	273	20	cell	cell	NOUN
dti-2707	273	21	damage	damage	NOUN
dti-2707	273	22	,	,	PUNCT
dti-2707	273	23	insulin	insulin	NOUN
dti-2707	273	24	resistance	resistance	NOUN
dti-2707	273	25	,	,	PUNCT
dti-2707	273	26	and	and	CCONJ
dti-2707	273	27	diabetes	diabetes	NOUN
dti-2707	273	28	complications	complication	NOUN
dti-2707	273	29	.	.	PUNCT
dti-2707	274	1	baicalein	baicalein	PROPN
dti-2707	274	2	also	also	ADV
dti-2707	274	3	has	have	VERB
dti-2707	274	4	the	the	DET
dti-2707	274	5	potential	potential	NOUN
dti-2707	274	6	to	to	PART
dti-2707	274	7	cure	cure	VERB
dti-2707	274	8	hyperglycemia	hyperglycemia	NOUN
dti-2707	274	9	by	by	ADP
dti-2707	274	10	reducing	reduce	VERB
dti-2707	274	11	bsa	bsa	NOUN
dti-2707	274	12	glycation	glycation	NOUN
dti-2707	274	13	(	(	PUNCT
dti-2707	274	14	122	122	NUM
dti-2707	274	15	)	)	PUNCT
dti-2707	274	16	.	.	PUNCT
dti-2707	275	1	baicalein	baicalein	PROPN
dti-2707	275	2	action	action	NOUN
dti-2707	275	3	as	as	ADP
dti-2707	275	4	an	an	DET
dti-2707	275	5	antiaging	antiage	VERB
dti-2707	275	6	agent	agent	NOUN
dti-2707	275	7	skin	skin	NOUN
dti-2707	275	8	aging	aging	NOUN
dti-2707	275	9	is	be	AUX
dti-2707	275	10	a	a	DET
dti-2707	275	11	natural	natural	ADJ
dti-2707	275	12	process	process	NOUN
dti-2707	275	13	that	that	PRON
dti-2707	275	14	is	be	AUX
dti-2707	275	15	defined	define	VERB
dti-2707	275	16	by	by	ADP
dti-2707	275	17	the	the	DET
dti-2707	275	18	skin	skin	NOUN
dti-2707	275	19	’s	’s	PART
dti-2707	275	20	progressive	progressive	ADJ
dti-2707	275	21	physiologic	physiologic	ADJ
dti-2707	275	22	and	and	CCONJ
dti-2707	275	23	anatomical	anatomical	ADJ
dti-2707	275	24	changes	change	NOUN
dti-2707	275	25	.	.	PUNCT
dti-2707	276	1	the	the	DET
dti-2707	276	2	dermis	dermis	NOUN
dti-2707	276	3	experiences	experience	VERB
dti-2707	276	4	striking	strike	VERB
dti-2707	276	5	alterations	alteration	NOUN
dti-2707	276	6	including	include	VERB
dti-2707	276	7	the	the	DET
dti-2707	276	8	huge	huge	ADJ
dti-2707	276	9	deposition	deposition	NOUN
dti-2707	276	10	of	of	ADP
dti-2707	276	11	irregular	irregular	ADJ
dti-2707	276	12	elastic	elastic	ADJ
dti-2707	276	13	fibers	fiber	NOUN
dti-2707	276	14	,	,	PUNCT
dti-2707	276	15	collagen	collagen	NOUN
dti-2707	276	16	deterioration	deterioration	NOUN
dti-2707	276	17	,	,	PUNCT
dti-2707	276	18	and	and	CCONJ
dti-2707	276	19	hyaluronic	hyaluronic	ADJ
dti-2707	276	20	acid	acid	NOUN
dti-2707	276	21	loss	loss	NOUN
dti-2707	276	22	.	.	PUNCT
dti-2707	277	1	skin	skin	NOUN
dti-2707	277	2	aging	aging	NOUN
dti-2707	277	3	is	be	AUX
dti-2707	277	4	caused	cause	VERB
dti-2707	277	5	by	by	ADP
dti-2707	277	6	a	a	DET
dti-2707	277	7	variety	variety	NOUN
dti-2707	277	8	of	of	ADP
dti-2707	277	9	extrinsic	extrinsic	ADJ
dti-2707	277	10	(	(	PUNCT
dti-2707	277	11	usually	usually	ADV
dti-2707	277	12	linked	link	VERB
dti-2707	277	13	to	to	ADP
dti-2707	277	14	aging	age	VERB
dti-2707	277	15	)	)	PUNCT
dti-2707	277	16	and	and	CCONJ
dti-2707	277	17	natural	natural	ADJ
dti-2707	277	18	(	(	PUNCT
dti-2707	277	19	mostly	mostly	ADV
dti-2707	277	20	genetically	genetically	ADV
dti-2707	277	21	determined	determine	VERB
dti-2707	277	22	)	)	PUNCT
dti-2707	277	23	factors	factor	NOUN
dti-2707	277	24	,	,	PUNCT
dti-2707	277	25	such	such	ADJ
dti-2707	277	26	as	as	ADP
dti-2707	277	27	exposure	exposure	NOUN
dti-2707	277	28	to	to	ADP
dti-2707	277	29	ultraviolet	ultraviolet	NOUN
dti-2707	277	30	(	(	PUNCT
dti-2707	277	31	uv	uv	NOUN
dti-2707	277	32	)	)	PUNCT
dti-2707	277	33	radiation	radiation	NOUN
dti-2707	277	34	,	,	PUNCT
dti-2707	277	35	high	high	ADJ
dti-2707	277	36	intake	intake	NOUN
dti-2707	277	37	of	of	ADP
dti-2707	277	38	alcohol	alcohol	NOUN
dti-2707	277	39	,	,	PUNCT
dti-2707	277	40	and	and	CCONJ
dti-2707	277	41	pollution	pollution	NOUN
dti-2707	277	42	.	.	PUNCT
dti-2707	278	1	uv	uv	NOUN
dti-2707	278	2	radiation	radiation	NOUN
dti-2707	278	3	is	be	AUX
dti-2707	278	4	the	the	DET
dti-2707	278	5	main	main	ADJ
dti-2707	278	6	cause	cause	NOUN
dti-2707	278	7	of	of	ADP
dti-2707	278	8	photoaging	photoage	VERB
dti-2707	278	9	in	in	ADP
dti-2707	278	10	human	human	ADJ
dti-2707	278	11	skin	skin	NOUN
dti-2707	278	12	(	(	PUNCT
dti-2707	278	13	123	123	NUM
dti-2707	278	14	)	)	PUNCT
dti-2707	278	15	.	.	PUNCT
dti-2707	279	1	baicalein	baicalein	PROPN
dti-2707	279	2	may	may	AUX
dti-2707	279	3	find	find	VERB
dti-2707	279	4	use	use	NOUN
dti-2707	279	5	in	in	ADP
dti-2707	279	6	skin	skin	NOUN
dti-2707	279	7	care	care	NOUN
dti-2707	279	8	products	product	NOUN
dti-2707	279	9	and	and	CCONJ
dti-2707	279	10	as	as	ADP
dti-2707	279	11	a	a	DET
dti-2707	279	12	photoprotective	photoprotective	ADJ
dti-2707	279	13	agent	agent	NOUN
dti-2707	279	14	.	.	PUNCT
dti-2707	280	1	uv	uv	NOUN
dti-2707	280	2	radiation	radiation	NOUN
dti-2707	280	3	significantly	significantly	ADV
dti-2707	280	4	raised	raise	VERB
dti-2707	280	5	the	the	DET
dti-2707	280	6	activities	activity	NOUN
dti-2707	280	7	of	of	ADP
dti-2707	280	8	mmp-1	mmp-1	NOUN
dti-2707	280	9	mrna	mrna	PROPN
dti-2707	280	10	(	(	PUNCT
dti-2707	280	11	123	123	NUM
dti-2707	280	12	)	)	PUNCT
dti-2707	280	13	,	,	PUNCT
dti-2707	280	14	while	while	SCONJ
dti-2707	280	15	baicalin	baicalin	NOUN
dti-2707	280	16	treatment	treatment	NOUN
dti-2707	280	17	inhibited	inhibit	VERB
dti-2707	280	18	this	this	DET
dti-2707	280	19	uv	uv	NOUN
dti-2707	280	20	radiation	radiation	NOUN
dti-2707	280	21	-	-	PUNCT
dti-2707	280	22	induced	induce	VERB
dti-2707	280	23	action	action	NOUN
dti-2707	280	24	of	of	ADP
dti-2707	280	25	mmp-1	mmp-1	PUNCT
dti-2707	280	26	and	and	CCONJ
dti-2707	280	27	resulted	result	VERB
dti-2707	280	28	in	in	ADP
dti-2707	280	29	the	the	DET
dti-2707	280	30	formation	formation	NOUN
dti-2707	280	31	of	of	ADP
dti-2707	280	32	procollagen	procollagen	NOUN
dti-2707	280	33	type	type	NOUN
dti-2707	280	34	1	1	NUM
dti-2707	280	35	.	.	PUNCT
dti-2707	280	36	rich	rich	ADJ
dti-2707	280	37	baicalein	baicalein	PROPN
dti-2707	280	38	inhibited	inhibit	VERB
dti-2707	280	39	collagen	collagen	NOUN
dti-2707	280	40	fiber	fiber	NOUN
dti-2707	280	41	loss	loss	NOUN
dti-2707	280	42	,	,	PUNCT
dti-2707	280	43	wrinkle	wrinkle	NOUN
dti-2707	280	44	formation	formation	NOUN
dti-2707	280	45	,	,	PUNCT
dti-2707	280	46	and	and	CCONJ
dti-2707	280	47	skin	skin	NOUN
dti-2707	280	48	thickness	thickness	NOUN
dti-2707	280	49	brought	bring	VERB
dti-2707	280	50	on	on	ADP
dti-2707	280	51	by	by	ADP
dti-2707	280	52	uv	uv	NOUN
dti-2707	280	53	radiation	radiation	NOUN
dti-2707	280	54	.	.	PUNCT
dti-2707	281	1	uv	uv	NOUN
dti-2707	281	2	causes	cause	VERB
dti-2707	281	3	high	high	ADJ
dti-2707	281	4	levels	level	NOUN
dti-2707	281	5	of	of	ADP
dti-2707	281	6	ros	ros	PROPN
dti-2707	281	7	to	to	PART
dti-2707	281	8	be	be	AUX
dti-2707	281	9	produced	produce	VERB
dti-2707	281	10	in	in	ADP
dti-2707	281	11	the	the	DET
dti-2707	281	12	skin	skin	NOUN
dti-2707	281	13	tissues	tissue	NOUN
dti-2707	281	14	.	.	PUNCT
dti-2707	282	1	this	this	PRON
dti-2707	282	2	can	can	AUX
dti-2707	282	3	cause	cause	VERB
dti-2707	282	4	increase	increase	NOUN
dti-2707	282	5	of	of	ADP
dti-2707	282	6	oxidative	oxidative	ADJ
dti-2707	282	7	stress	stress	NOUN
dti-2707	282	8	to	to	ADP
dti-2707	282	9	a	a	DET
dti-2707	282	10	variety	variety	NOUN
dti-2707	282	11	of	of	ADP
dti-2707	282	12	cellular	cellular	ADJ
dti-2707	282	13	macro	macro	NOUN
dti-2707	282	14	and	and	CCONJ
dti-2707	282	15	micro	micro	ADJ
dti-2707	282	16	molecules	molecule	NOUN
dti-2707	282	17	,	,	PUNCT
dti-2707	282	18	including	include	VERB
dti-2707	282	19	proteins	protein	NOUN
dti-2707	282	20	,	,	PUNCT
dti-2707	282	21	therapeutic	therapeutic	ADJ
dti-2707	282	22	insights	insight	NOUN
dti-2707	282	23	into	into	ADP
dti-2707	282	24	baicalein38	baicalein38	NOUN
dti-2707	282	25	©	©	ADP
dti-2707	282	26	2024	2024	NUM
dti-2707	282	27	the	the	DET
dti-2707	282	28	authors	author	NOUN
dti-2707	282	29	.	.	PUNCT
dti-2707	283	1	drug	drug	NOUN
dti-2707	283	2	target	target	NOUN
dti-2707	283	3	insights	insight	NOUN
dti-2707	283	4	issn	issn	VERB
dti-2707	283	5	1177	1177	NUM
dti-2707	283	6	-	-	SYM
dti-2707	283	7	3928	3928	NUM
dti-2707	283	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	VERB
dti-2707	283	9	nucleic	nucleic	ADJ
dti-2707	283	10	acids	acid	NOUN
dti-2707	283	11	,	,	PUNCT
dti-2707	283	12	and	and	CCONJ
dti-2707	283	13	cell	cell	NOUN
dti-2707	283	14	membranes	membrane	NOUN
dti-2707	283	15	.	.	PUNCT
dti-2707	284	1	ros	ros	PROPN
dti-2707	284	2	have	have	VERB
dti-2707	284	3	a	a	DET
dti-2707	284	4	major	major	ADJ
dti-2707	284	5	contribution	contribution	NOUN
dti-2707	284	6	in	in	ADP
dti-2707	284	7	both	both	CCONJ
dti-2707	284	8	the	the	DET
dti-2707	284	9	onset	onset	NOUN
dti-2707	284	10	and	and	CCONJ
dti-2707	284	11	development	development	NOUN
dti-2707	284	12	of	of	ADP
dti-2707	284	13	skin	skin	NOUN
dti-2707	284	14	aging	aging	NOUN
dti-2707	284	15	.	.	PUNCT
dti-2707	285	1	mda	mda	PROPN
dti-2707	285	2	is	be	AUX
dti-2707	285	3	a	a	DET
dti-2707	285	4	result	result	NOUN
dti-2707	285	5	of	of	ADP
dti-2707	285	6	lipid	lipid	NOUN
dti-2707	285	7	peroxidation	peroxidation	NOUN
dti-2707	285	8	whose	whose	DET
dti-2707	285	9	quantity	quantity	NOUN
dti-2707	285	10	reveals	reveal	VERB
dti-2707	285	11	the	the	DET
dti-2707	285	12	extent	extent	NOUN
dti-2707	285	13	of	of	ADP
dti-2707	285	14	oxidative	oxidative	ADJ
dti-2707	285	15	stress	stress	NOUN
dti-2707	285	16	on	on	ADP
dti-2707	285	17	cells	cell	NOUN
dti-2707	285	18	.	.	PUNCT
dti-2707	286	1	the	the	DET
dti-2707	286	2	antioxidant	antioxidant	ADJ
dti-2707	286	3	defense	defense	NOUN
dti-2707	286	4	of	of	ADP
dti-2707	286	5	the	the	DET
dti-2707	286	6	normal	normal	ADJ
dti-2707	286	7	cell	cell	NOUN
dti-2707	286	8	against	against	ADP
dti-2707	286	9	ros	ros	PROPN
dti-2707	286	10	is	be	AUX
dti-2707	286	11	carried	carry	VERB
dti-2707	286	12	out	out	ADP
dti-2707	286	13	by	by	ADP
dti-2707	286	14	sod	sod	NOUN
dti-2707	286	15	and	and	CCONJ
dti-2707	286	16	gsh	gsh	PROPN
dti-2707	286	17	-	-	PUNCT
dti-2707	286	18	px	px	PROPN
dti-2707	286	19	enzymes	enzyme	NOUN
dti-2707	286	20	(	(	PUNCT
dti-2707	286	21	125	125	NUM
dti-2707	286	22	)	)	PUNCT
dti-2707	286	23	.	.	PUNCT
dti-2707	287	1	the	the	DET
dti-2707	287	2	results	result	NOUN
dti-2707	287	3	demonstrate	demonstrate	VERB
dti-2707	287	4	that	that	SCONJ
dti-2707	287	5	uv	uv	NOUN
dti-2707	287	6	rays	ray	NOUN
dti-2707	287	7	cause	cause	VERB
dti-2707	287	8	oxidative	oxidative	ADJ
dti-2707	287	9	damage	damage	NOUN
dti-2707	287	10	and	and	CCONJ
dti-2707	287	11	slow	slow	VERB
dti-2707	287	12	down	down	ADP
dti-2707	287	13	the	the	DET
dti-2707	287	14	dermal	dermal	ADJ
dti-2707	287	15	tissue	tissue	NOUN
dti-2707	287	16	capacity	capacity	NOUN
dti-2707	287	17	to	to	PART
dti-2707	287	18	eliminate	eliminate	VERB
dti-2707	287	19	ros	ros	PROPN
dti-2707	287	20	.	.	PUNCT
dti-2707	288	1	it	it	PRON
dti-2707	288	2	was	be	AUX
dti-2707	288	3	also	also	ADV
dti-2707	288	4	revealed	reveal	VERB
dti-2707	288	5	that	that	SCONJ
dti-2707	288	6	uva	uva	PROPN
dti-2707	288	7	radiation	radiation	NOUN
dti-2707	288	8	considerably	considerably	ADV
dti-2707	288	9	elevated	elevate	VERB
dti-2707	288	10	mda	mda	PROPN
dti-2707	288	11	levels	level	NOUN
dti-2707	288	12	in	in	ADP
dti-2707	288	13	fibroblasts	fibroblast	NOUN
dti-2707	288	14	and	and	CCONJ
dti-2707	288	15	significantly	significantly	ADV
dti-2707	288	16	decreased	decrease	VERB
dti-2707	288	17	sod	sod	NOUN
dti-2707	288	18	and	and	CCONJ
dti-2707	288	19	gsh	gsh	PROPN
dti-2707	288	20	-	-	PUNCT
dti-2707	288	21	px	px	PROPN
dti-2707	288	22	activities	activity	NOUN
dti-2707	288	23	.	.	PUNCT
dti-2707	289	1	additionally	additionally	ADV
dti-2707	289	2	,	,	PUNCT
dti-2707	289	3	baicalin	baicalin	NOUN
dti-2707	289	4	therapy	therapy	NOUN
dti-2707	289	5	by	by	ADP
dti-2707	289	6	itself	itself	PRON
dti-2707	289	7	dramatically	dramatically	ADV
dti-2707	289	8	reduced	reduce	VERB
dti-2707	289	9	mda	mda	PROPN
dti-2707	289	10	levels	level	NOUN
dti-2707	289	11	in	in	ADP
dti-2707	289	12	fibroblasts	fibroblast	NOUN
dti-2707	289	13	and	and	CCONJ
dti-2707	289	14	increased	increase	VERB
dti-2707	289	15	sod	sod	NOUN
dti-2707	289	16	and	and	CCONJ
dti-2707	289	17	gsh	gsh	PROPN
dti-2707	289	18	-	-	PUNCT
dti-2707	289	19	px	px	PROPN
dti-2707	289	20	activity	activity	NOUN
dti-2707	289	21	(	(	PUNCT
dti-2707	289	22	125	125	NUM
dti-2707	289	23	)	)	PUNCT
dti-2707	289	24	.	.	PUNCT
dti-2707	290	1	pharmacokinetics	pharmacokinetic	NOUN
dti-2707	290	2	clinical	clinical	ADJ
dti-2707	290	3	and	and	CCONJ
dti-2707	290	4	toxicological	toxicological	ADJ
dti-2707	290	5	studies	study	NOUN
dti-2707	290	6	it	it	PRON
dti-2707	290	7	has	have	AUX
dti-2707	290	8	been	be	AUX
dti-2707	290	9	shown	show	VERB
dti-2707	290	10	that	that	SCONJ
dti-2707	290	11	baicalein	baicalein	NOUN
dti-2707	290	12	is	be	AUX
dti-2707	290	13	a	a	DET
dti-2707	290	14	unique	unique	ADJ
dti-2707	290	15	,	,	PUNCT
dti-2707	290	16	potentially	potentially	ADV
dti-2707	290	17	effective	effective	ADJ
dti-2707	290	18	medicinal	medicinal	ADJ
dti-2707	290	19	agent	agent	NOUN
dti-2707	290	20	for	for	ADP
dti-2707	290	21	treating	treat	VERB
dti-2707	290	22	a	a	DET
dti-2707	290	23	range	range	NOUN
dti-2707	290	24	of	of	ADP
dti-2707	290	25	illnesses	illness	NOUN
dti-2707	290	26	.	.	PUNCT
dti-2707	291	1	therefore	therefore	ADV
dti-2707	291	2	,	,	PUNCT
dti-2707	291	3	clinical	clinical	ADJ
dti-2707	291	4	trials	trial	NOUN
dti-2707	291	5	are	be	AUX
dti-2707	291	6	required	require	VERB
dti-2707	291	7	to	to	PART
dti-2707	291	8	ensure	ensure	VERB
dti-2707	291	9	the	the	DET
dti-2707	291	10	therapeutic	therapeutic	ADJ
dti-2707	291	11	role	role	NOUN
dti-2707	291	12	of	of	ADP
dti-2707	291	13	baicalein	baicalein	PROPN
dti-2707	291	14	.	.	PUNCT
dti-2707	292	1	several	several	ADJ
dti-2707	292	2	studies	study	NOUN
dti-2707	292	3	are	be	AUX
dti-2707	292	4	designed	design	VERB
dti-2707	292	5	by	by	ADP
dti-2707	292	6	various	various	ADJ
dti-2707	292	7	research	research	NOUN
dti-2707	292	8	groups	group	NOUN
dti-2707	292	9	for	for	ADP
dti-2707	292	10	the	the	DET
dti-2707	292	11	purpose	purpose	NOUN
dti-2707	292	12	.	.	PUNCT
dti-2707	293	1	two	two	NUM
dti-2707	293	2	phase	phase	NOUN
dti-2707	293	3	i	i	PRON
dti-2707	293	4	clinical	clinical	ADJ
dti-2707	293	5	trials	trial	NOUN
dti-2707	293	6	were	be	AUX
dti-2707	293	7	conducted	conduct	VERB
dti-2707	293	8	on	on	ADP
dti-2707	293	9	healthy	healthy	ADJ
dti-2707	293	10	adults	adult	NOUN
dti-2707	293	11	in	in	ADP
dti-2707	293	12	china	china	PROPN
dti-2707	293	13	to	to	PART
dti-2707	293	14	evaluate	evaluate	VERB
dti-2707	293	15	the	the	DET
dti-2707	293	16	safety	safety	NOUN
dti-2707	293	17	and	and	CCONJ
dti-2707	293	18	efficacy	efficacy	NOUN
dti-2707	293	19	using	use	VERB
dti-2707	293	20	chewable	chewable	PROPN
dti-2707	293	21	baicalein	baicalein	PROPN
dti-2707	293	22	pills	pill	NOUN
dti-2707	293	23	.	.	PUNCT
dti-2707	294	1	seventy	seventy	NUM
dti-2707	294	2	-	-	PUNCT
dti-2707	294	3	two	two	NUM
dti-2707	294	4	healthy	healthy	ADJ
dti-2707	294	5	chinese	chinese	ADJ
dti-2707	294	6	adults	adult	NOUN
dti-2707	294	7	participated	participate	VERB
dti-2707	294	8	in	in	ADP
dti-2707	294	9	a	a	DET
dti-2707	294	10	phase	phase	NOUN
dti-2707	294	11	i	i	PRON
dti-2707	294	12	(	(	PUNCT
dti-2707	294	13	2014	2014	NUM
dti-2707	294	14	)	)	PUNCT
dti-2707	294	15	random	random	ADJ
dti-2707	294	16	,	,	PUNCT
dti-2707	294	17	double	double	ADJ
dti-2707	294	18	-	-	PUNCT
dti-2707	294	19	blind	blind	ADJ
dti-2707	294	20	investigation	investigation	NOUN
dti-2707	294	21	to	to	PART
dti-2707	294	22	examine	examine	VERB
dti-2707	294	23	the	the	DET
dti-2707	294	24	pharmacokinetic	pharmacokinetic	ADJ
dti-2707	294	25	(	(	PUNCT
dti-2707	294	26	pk	pk	NOUN
dti-2707	294	27	)	)	PUNCT
dti-2707	294	28	characteristics	characteristic	NOUN
dti-2707	294	29	of	of	ADP
dti-2707	294	30	baicalein	baicalein	NOUN
dti-2707	294	31	using	use	VERB
dti-2707	294	32	a	a	DET
dti-2707	294	33	single	single	ADJ
dti-2707	294	34	-	-	PUNCT
dti-2707	294	35	dose	dose	NOUN
dti-2707	294	36	trial	trial	NOUN
dti-2707	294	37	(	(	PUNCT
dti-2707	294	38	100	100	NUM
dti-2707	294	39	-	-	SYM
dti-2707	294	40	2800	2800	NUM
dti-2707	294	41	mg	mg	NOUN
dti-2707	294	42	)	)	PUNCT
dti-2707	294	43	(	(	PUNCT
dti-2707	294	44	126	126	NUM
dti-2707	294	45	)	)	PUNCT
dti-2707	294	46	.	.	PUNCT
dti-2707	295	1	blood	blood	NOUN
dti-2707	295	2	,	,	PUNCT
dti-2707	295	3	urine	urine	NOUN
dti-2707	295	4	,	,	PUNCT
dti-2707	295	5	and	and	CCONJ
dti-2707	295	6	feces	fece	NOUN
dti-2707	295	7	samples	sample	NOUN
dti-2707	295	8	were	be	AUX
dti-2707	295	9	obtained	obtain	VERB
dti-2707	295	10	at	at	ADP
dti-2707	295	11	fixed	fix	VERB
dti-2707	295	12	schedules	schedule	NOUN
dti-2707	295	13	for	for	ADP
dti-2707	295	14	up	up	ADP
dti-2707	295	15	to	to	PART
dti-2707	295	16	48	48	NUM
dti-2707	295	17	hours	hour	NOUN
dti-2707	295	18	post	post	NOUN
dti-2707	295	19	drug	drug	NOUN
dti-2707	295	20	administration	administration	NOUN
dti-2707	295	21	.	.	PUNCT
dti-2707	296	1	after	after	ADP
dti-2707	296	2	that	that	PRON
dti-2707	296	3	,	,	PUNCT
dti-2707	296	4	baicalein	baicalein	PROPN
dti-2707	296	5	was	be	AUX
dti-2707	296	6	investigated	investigate	VERB
dti-2707	296	7	by	by	ADP
dti-2707	296	8	the	the	DET
dti-2707	296	9	spectrometric	spectrometric	ADJ
dti-2707	296	10	analysis	analysis	NOUN
dti-2707	296	11	of	of	ADP
dti-2707	296	12	samples	sample	NOUN
dti-2707	296	13	through	through	ADP
dti-2707	296	14	liquid	liquid	ADJ
dti-2707	296	15	chromatography	chromatography	NOUN
dti-2707	296	16	with	with	ADP
dti-2707	296	17	tandem	tandem	PROPN
dti-2707	296	18	mass	mass	PROPN
dti-2707	296	19	spectrometry	spectrometry	NOUN
dti-2707	296	20	(	(	PUNCT
dti-2707	296	21	lc	lc	PROPN
dti-2707	296	22	/	/	SYM
dti-2707	296	23	ms	ms	PROPN
dti-2707	296	24	/	/	SYM
dti-2707	296	25	ms	ms	PROPN
dti-2707	296	26	)	)	PUNCT
dti-2707	296	27	.	.	PUNCT
dti-2707	297	1	the	the	DET
dti-2707	297	2	pk	pk	PROPN
dti-2707	297	3	profile	profile	NOUN
dti-2707	297	4	of	of	ADP
dti-2707	297	5	baicalein	baicalein	NOUN
dti-2707	297	6	was	be	AUX
dti-2707	297	7	found	find	VERB
dti-2707	297	8	to	to	PART
dti-2707	297	9	be	be	AUX
dti-2707	297	10	multiphasic	multiphasic	NOUN
dti-2707	297	11	,	,	PUNCT
dti-2707	297	12	with	with	ADP
dti-2707	297	13	a	a	DET
dti-2707	297	14	median	median	ADJ
dti-2707	297	15	tmax	tmax	NOUN
dti-2707	297	16	of	of	ADP
dti-2707	297	17	0.75	0.75	NUM
dti-2707	297	18	-	-	SYM
dti-2707	297	19	3.5	3.5	NUM
dti-2707	297	20	hours	hour	NOUN
dti-2707	297	21	and	and	CCONJ
dti-2707	297	22	a	a	DET
dti-2707	297	23	t1/2	t1/2	NOUN
dti-2707	297	24	of	of	ADP
dti-2707	297	25	1.90	1.90	NUM
dti-2707	297	26	-	-	SYM
dti-2707	297	27	15.01	15.01	NUM
dti-2707	297	28	hours	hour	NOUN
dti-2707	297	29	.	.	PUNCT
dti-2707	298	1	the	the	DET
dti-2707	298	2	proportionality	proportionality	NOUN
dti-2707	298	3	coefficient	coefficient	NOUN
dti-2707	298	4	(	(	PUNCT
dti-2707	298	5	90	90	NUM
dti-2707	298	6	%	%	NOUN
dti-2707	298	7	ci	ci	NOUN
dti-2707	298	8	)	)	PUNCT
dti-2707	298	9	estimates	estimate	NOUN
dti-2707	298	10	for	for	ADP
dti-2707	298	11	cmax	cmax	NOUN
dti-2707	298	12	,	,	PUNCT
dti-2707	298	13	auc0	auc0	PROPN
dti-2707	298	14	-	-	PUNCT
dti-2707	298	15	t	t	PROPN
dti-2707	298	16	,	,	PUNCT
dti-2707	298	17	and	and	CCONJ
dti-2707	298	18	auc0	auc0	PROPN
dti-2707	298	19	were	be	AUX
dti-2707	298	20	0.83	0.83	NUM
dti-2707	298	21	(	(	PUNCT
dti-2707	298	22	0.70	0.70	NUM
dti-2707	298	23	-	-	SYM
dti-2707	298	24	0.96	0.96	NUM
dti-2707	298	25	)	)	PUNCT
dti-2707	298	26	,	,	PUNCT
dti-2707	298	27	0.91	0.91	NUM
dti-2707	298	28	(	(	PUNCT
dti-2707	298	29	0.81	0.81	NUM
dti-2707	298	30	-	-	SYM
dti-2707	298	31	1.00	1.00	NUM
dti-2707	298	32	)	)	PUNCT
dti-2707	298	33	,	,	PUNCT
dti-2707	298	34	and	and	CCONJ
dti-2707	298	35	0.92	0.92	NUM
dti-2707	298	36	(	(	PUNCT
dti-2707	298	37	0.82	0.82	NUM
dti-2707	298	38	-	-	SYM
dti-2707	298	39	1.02	1.02	NUM
dti-2707	298	40	)	)	PUNCT
dti-2707	298	41	,	,	PUNCT
dti-2707	298	42	in	in	ADP
dti-2707	298	43	that	that	DET
dti-2707	298	44	order	order	NOUN
dti-2707	298	45	.	.	PUNCT
dti-2707	299	1	the	the	DET
dti-2707	299	2	predefined	predefine	VERB
dti-2707	299	3	ranges	range	NOUN
dti-2707	299	4	of	of	ADP
dti-2707	299	5	0.89	0.89	NUM
dti-2707	299	6	-	-	SYM
dti-2707	299	7	1.11	1.11	NUM
dti-2707	299	8	,	,	PUNCT
dti-2707	299	9	0.93	0.93	NUM
dti-2707	299	10	-	-	PUNCT
dti-2707	299	11	1.07	1.07	NUM
dti-2707	299	12	,	,	PUNCT
dti-2707	299	13	and	and	CCONJ
dti-2707	299	14	0.93	0.93	NUM
dti-2707	299	15	-	-	PUNCT
dti-2707	299	16	1.07	1.07	NUM
dti-2707	299	17	,	,	PUNCT
dti-2707	299	18	respectively	respectively	ADV
dti-2707	299	19	,	,	PUNCT
dti-2707	299	20	encompass	encompass	VERB
dti-2707	299	21	all	all	DET
dti-2707	299	22	values	value	NOUN
dti-2707	299	23	.	.	PUNCT
dti-2707	300	1	it	it	PRON
dti-2707	300	2	was	be	AUX
dti-2707	300	3	unclear	unclear	ADJ
dti-2707	300	4	what	what	PRON
dti-2707	300	5	the	the	DET
dti-2707	300	6	dose	dose	NOUN
dti-2707	300	7	proportionality	proportionality	NOUN
dti-2707	300	8	was	be	AUX
dti-2707	300	9	for	for	ADP
dti-2707	300	10	a	a	DET
dti-2707	300	11	baicalein	baicalein	NOUN
dti-2707	300	12	dose	dose	NOUN
dti-2707	300	13	range	range	NOUN
dti-2707	300	14	of	of	ADP
dti-2707	300	15	1002800	1002800	NUM
dti-2707	300	16	mg	mg	PROPN
dti-2707	300	17	.	.	PUNCT
dti-2707	300	18	baicalein	baicalein	PROPN
dti-2707	300	19	excreted	excrete	VERB
dti-2707	300	20	in	in	ADP
dti-2707	300	21	urine	urine	NOUN
dti-2707	300	22	makes	make	VERB
dti-2707	300	23	up	up	ADP
dti-2707	300	24	1	1	NUM
dti-2707	300	25	%	%	NOUN
dti-2707	300	26	of	of	ADP
dti-2707	300	27	the	the	DET
dti-2707	300	28	total	total	NOUN
dti-2707	300	29	.	.	PUNCT
dti-2707	301	1	baicalein	baicalein	PROPN
dti-2707	301	2	was	be	AUX
dti-2707	301	3	eliminated	eliminate	VERB
dti-2707	301	4	as	as	ADP
dti-2707	301	5	a	a	DET
dti-2707	301	6	medication	medication	NOUN
dti-2707	301	7	in	in	ADP
dti-2707	301	8	approximately	approximately	ADV
dti-2707	301	9	27	27	NUM
dti-2707	301	10	%	%	NOUN
dti-2707	301	11	of	of	ADP
dti-2707	301	12	the	the	DET
dti-2707	301	13	feces	fece	NOUN
dti-2707	301	14	.	.	PUNCT
dti-2707	302	1	baicalein	baicalein	PROPN
dti-2707	302	2	’s	’s	PART
dti-2707	302	3	cmax	cmax	NOUN
dti-2707	302	4	and	and	CCONJ
dti-2707	302	5	cavg	cavg	NOUN
dti-2707	302	6	values	value	NOUN
dti-2707	302	7	at	at	ADP
dti-2707	302	8	800	800	NUM
dti-2707	302	9	mg	mg	PROPN
dti-2707	302	10	single	single	ADJ
dti-2707	302	11	dose	dose	NOUN
dti-2707	302	12	and	and	CCONJ
dti-2707	302	13	800	800	NUM
dti-2707	302	14	mg	mg	PROPN
dti-2707	302	15	multiple	multiple	ADJ
dti-2707	302	16	dose	dose	NOUN
dti-2707	302	17	,	,	PUNCT
dti-2707	302	18	respectively	respectively	ADV
dti-2707	302	19	,	,	PUNCT
dti-2707	302	20	were	be	AUX
dti-2707	302	21	higher	high	ADJ
dti-2707	302	22	than	than	ADP
dti-2707	302	23	the	the	DET
dti-2707	302	24	in	in	ADP
dti-2707	302	25	vitro	vitro	X
dti-2707	302	26	effective	effective	ADJ
dti-2707	302	27	concentration	concentration	NOUN
dti-2707	302	28	(	(	PUNCT
dti-2707	302	29	0.1	0.1	NUM
dti-2707	302	30	μm	μm	NUM
dti-2707	302	31	)	)	PUNCT
dti-2707	302	32	against	against	ADP
dti-2707	302	33	sars	sar	NOUN
dti-2707	302	34	-	-	PUNCT
dti-2707	302	35	cov-2	cov-2	PUNCT
dti-2707	302	36	(	(	PUNCT
dti-2707	302	37	127	127	NUM
dti-2707	302	38	)	)	PUNCT
dti-2707	302	39	.	.	PUNCT
dti-2707	303	1	baicalein	baicalein	PROPN
dti-2707	303	2	was	be	AUX
dti-2707	303	3	highly	highly	ADV
dti-2707	303	4	tolerable	tolerable	ADJ
dti-2707	303	5	.	.	PUNCT
dti-2707	304	1	eleven	eleven	NUM
dti-2707	304	2	adverse	adverse	ADJ
dti-2707	304	3	treatment	treatment	NOUN
dti-2707	304	4	-	-	PUNCT
dti-2707	304	5	related	relate	VERB
dti-2707	304	6	occurrences	occurrence	NOUN
dti-2707	304	7	were	be	AUX
dti-2707	304	8	detected	detect	VERB
dti-2707	304	9	;	;	PUNCT
dti-2707	304	10	all	all	PRON
dti-2707	304	11	were	be	AUX
dti-2707	304	12	considered	consider	VERB
dti-2707	304	13	“	"	PUNCT
dti-2707	304	14	minor	minor	ADJ
dti-2707	304	15	”	"	PUNCT
dti-2707	304	16	and	and	CCONJ
dti-2707	304	17	retreated	retreat	VERB
dti-2707	304	18	on	on	ADP
dti-2707	304	19	their	their	PRON
dti-2707	304	20	own	own	ADJ
dti-2707	304	21	.	.	PUNCT
dti-2707	305	1	there	there	PRON
dti-2707	305	2	were	be	VERB
dti-2707	305	3	no	no	DET
dti-2707	305	4	significant	significant	ADJ
dti-2707	305	5	adverse	adverse	ADJ
dti-2707	305	6	occurrences	occurrence	NOUN
dti-2707	305	7	.	.	PUNCT
dti-2707	306	1	as	as	ADP
dti-2707	306	2	a	a	DET
dti-2707	306	3	result	result	NOUN
dti-2707	306	4	,	,	PUNCT
dti-2707	306	5	healthy	healthy	ADJ
dti-2707	306	6	volunteers	volunteer	NOUN
dti-2707	306	7	tolerated	tolerate	VERB
dti-2707	306	8	single	single	ADJ
dti-2707	306	9	oral	oral	ADJ
dti-2707	306	10	dosages	dosage	NOUN
dti-2707	306	11	of	of	ADP
dti-2707	306	12	baicalein	baicalein	NOUN
dti-2707	306	13	of	of	ADP
dti-2707	306	14	100	100	NUM
dti-2707	306	15	-	-	SYM
dti-2707	306	16	2800	2800	NUM
dti-2707	306	17	mg	mg	NOUN
dti-2707	306	18	without	without	ADP
dti-2707	306	19	any	any	DET
dti-2707	306	20	adverse	adverse	ADJ
dti-2707	306	21	effects	effect	NOUN
dti-2707	306	22	(	(	PUNCT
dti-2707	306	23	127	127	NUM
dti-2707	306	24	)	)	PUNCT
dti-2707	306	25	.	.	PUNCT
dti-2707	307	1	the	the	DET
dti-2707	307	2	study	study	NOUN
dti-2707	307	3	by	by	ADP
dti-2707	307	4	li	li	PROPN
dti-2707	307	5	m	m	PROPN
dti-2707	307	6	,	,	PUNCT
dti-2707	307	7	shi	shi	PROPN
dti-2707	307	8	a	a	X
dti-2707	307	9	,	,	PUNCT
dti-2707	307	10	pang	pang	NOUN
dti-2707	307	11	h	h	NOUN
dti-2707	307	12	,	,	PUNCT
dti-2707	307	13	et	et	PROPN
dti-2707	307	14	al	al	PROPN
dti-2707	307	15	.	.	PROPN
dti-2707	307	16	published	publish	VERB
dti-2707	307	17	in	in	ADP
dti-2707	307	18	the	the	DET
dti-2707	307	19	journal	journal	NOUN
dti-2707	307	20	of	of	ADP
dti-2707	307	21	ethnopharmacology	ethnopharmacology	NOUN
dti-2707	307	22	in	in	ADP
dti-2707	307	23	2014	2014	NUM
dti-2707	307	24	investigated	investigate	VERB
dti-2707	307	25	the	the	DET
dti-2707	307	26	safety	safety	NOUN
dti-2707	307	27	,	,	PUNCT
dti-2707	307	28	tolerability	tolerability	NOUN
dti-2707	307	29	,	,	PUNCT
dti-2707	307	30	and	and	CCONJ
dti-2707	307	31	pharmacokinetics	pharmacokinetic	NOUN
dti-2707	307	32	of	of	ADP
dti-2707	307	33	a	a	DET
dti-2707	307	34	single	single	ADJ
dti-2707	307	35	ascending	ascend	VERB
dti-2707	307	36	dose	dose	NOUN
dti-2707	307	37	of	of	ADP
dti-2707	307	38	baicalein	baicalein	PROPN
dti-2707	307	39	chewable	chewable	NOUN
dti-2707	307	40	tablets	tablet	NOUN
dti-2707	307	41	in	in	ADP
dti-2707	307	42	healthy	healthy	ADJ
dti-2707	307	43	subjects	subject	NOUN
dti-2707	307	44	.	.	PUNCT
dti-2707	308	1	the	the	DET
dti-2707	308	2	research	research	NOUN
dti-2707	308	3	found	find	VERB
dti-2707	308	4	that	that	SCONJ
dti-2707	308	5	single	single	ADJ
dti-2707	308	6	oral	oral	ADJ
dti-2707	308	7	doses	dose	NOUN
dti-2707	308	8	of	of	ADP
dti-2707	308	9	100	100	NUM
dti-2707	308	10	-	-	SYM
dti-2707	308	11	2800	2800	NUM
dti-2707	308	12	mg	mg	NOUN
dti-2707	308	13	of	of	ADP
dti-2707	308	14	baicalein	baicalein	PROPN
dti-2707	308	15	were	be	AUX
dti-2707	308	16	safe	safe	ADJ
dti-2707	308	17	and	and	CCONJ
dti-2707	308	18	well	well	ADV
dti-2707	308	19	tolerated	tolerate	VERB
dti-2707	308	20	by	by	ADP
dti-2707	308	21	healthy	healthy	ADJ
dti-2707	308	22	individuals	individual	NOUN
dti-2707	308	23	,	,	PUNCT
dti-2707	308	24	with	with	ADP
dti-2707	308	25	no	no	DET
dti-2707	308	26	serious	serious	ADJ
dti-2707	308	27	adverse	adverse	ADJ
dti-2707	308	28	events	event	NOUN
dti-2707	308	29	occurring	occur	VERB
dti-2707	308	30	.	.	PUNCT
dti-2707	309	1	the	the	DET
dti-2707	309	2	study	study	NOUN
dti-2707	309	3	concluded	conclude	VERB
dti-2707	309	4	that	that	SCONJ
dti-2707	309	5	baicalein	baicalein	PROPN
dti-2707	309	6	chewable	chewable	NOUN
dti-2707	309	7	tablets	tablet	NOUN
dti-2707	309	8	were	be	AUX
dti-2707	309	9	generally	generally	ADV
dti-2707	309	10	safe	safe	ADJ
dti-2707	309	11	and	and	CCONJ
dti-2707	309	12	well	well	ADV
dti-2707	309	13	-	-	PUNCT
dti-2707	309	14	tolerated	tolerate	VERB
dti-2707	309	15	,	,	PUNCT
dti-2707	309	16	supporting	support	VERB
dti-2707	309	17	the	the	DET
dti-2707	309	18	further	further	ADJ
dti-2707	309	19	exploration	exploration	NOUN
dti-2707	309	20	of	of	ADP
dti-2707	309	21	baicalein	baicalein	NOUN
dti-2707	309	22	in	in	ADP
dti-2707	309	23	clinical	clinical	ADJ
dti-2707	309	24	studies	study	NOUN
dti-2707	309	25	due	due	ADP
dti-2707	309	26	to	to	ADP
dti-2707	309	27	its	its	PRON
dti-2707	309	28	favorable	favorable	ADJ
dti-2707	309	29	safety	safety	NOUN
dti-2707	309	30	profile	profile	NOUN
dti-2707	309	31	and	and	CCONJ
dti-2707	309	32	pharmacokinetic	pharmacokinetic	ADJ
dti-2707	309	33	properties	property	NOUN
dti-2707	309	34	(	(	PUNCT
dti-2707	309	35	128	128	NUM
dti-2707	309	36	)	)	PUNCT
dti-2707	309	37	.	.	PUNCT
dti-2707	310	1	baicalein	baicalein	PROPN
dti-2707	310	2	suppressed	suppress	VERB
dti-2707	310	3	the	the	DET
dti-2707	310	4	generation	generation	NOUN
dti-2707	310	5	of	of	ADP
dti-2707	310	6	mid	mid	ADJ
dti-2707	310	7	-	-	ADJ
dti-2707	310	8	late	late	ADJ
dti-2707	310	9	mrna	mrna	NOUN
dti-2707	310	10	,	,	PUNCT
dti-2707	310	11	hence	hence	ADV
dti-2707	310	12	suppressing	suppress	VERB
dti-2707	310	13	the	the	DET
dti-2707	310	14	h1n1	h1n1	NOUN
dti-2707	310	15	and	and	CCONJ
dti-2707	310	16	h3n2	h3n2	PROPN
dti-2707	310	17	influenza	influenza	NOUN
dti-2707	310	18	viruses	virus	NOUN
dti-2707	310	19	,	,	PUNCT
dti-2707	310	20	a	a	DET
dti-2707	310	21	/	/	SYM
dti-2707	310	22	fm1/1/47	fm1/1/47	ADJ
dti-2707	310	23	,	,	PUNCT
dti-2707	310	24	and	and	CCONJ
dti-2707	310	25	a/	a/	NOUN
dti-2707	310	26	beijing/32/92	beijing/32/92	NOUN
dti-2707	310	27	,	,	PUNCT
dti-2707	310	28	respectively	respectively	ADV
dti-2707	310	29	(	(	PUNCT
dti-2707	310	30	163	163	NUM
dti-2707	310	31	)	)	PUNCT
dti-2707	310	32	.	.	PUNCT
dti-2707	311	1	baicalein	baicalein	PROPN
dti-2707	311	2	and	and	CCONJ
dti-2707	311	3	its	its	PRON
dti-2707	311	4	metabolites	metabolite	NOUN
dti-2707	311	5	were	be	AUX
dti-2707	311	6	found	find	VERB
dti-2707	311	7	at	at	ADP
dti-2707	311	8	higher	high	ADJ
dti-2707	311	9	concentrations	concentration	NOUN
dti-2707	311	10	,	,	PUNCT
dti-2707	311	11	but	but	CCONJ
dti-2707	311	12	not	not	PART
dti-2707	311	13	in	in	ADP
dti-2707	311	14	a	a	DET
dti-2707	311	15	doseproportionate	doseproportionate	ADJ
dti-2707	311	16	way	way	NOUN
dti-2707	311	17	.	.	PUNCT
dti-2707	312	1	in	in	ADP
dti-2707	312	2	healthy	healthy	ADJ
dti-2707	312	3	chinese	chinese	ADJ
dti-2707	312	4	volunteers	volunteer	NOUN
dti-2707	312	5	,	,	PUNCT
dti-2707	312	6	baicalein	baicalein	NOUN
dti-2707	312	7	tablets	tablet	NOUN
dti-2707	312	8	within	within	ADP
dti-2707	312	9	the	the	DET
dti-2707	312	10	studied	study	VERB
dti-2707	312	11	dosage	dosage	NOUN
dti-2707	312	12	range	range	NOUN
dti-2707	312	13	were	be	AUX
dti-2707	312	14	well	well	ADV
dti-2707	312	15	-	-	PUNCT
dti-2707	312	16	tolerated	tolerate	VERB
dti-2707	312	17	and	and	CCONJ
dti-2707	312	18	safe	safe	ADJ
dti-2707	312	19	,	,	PUNCT
dti-2707	312	20	with	with	ADP
dti-2707	312	21	no	no	DET
dti-2707	312	22	severe	severe	ADJ
dti-2707	312	23	or	or	CCONJ
dti-2707	312	24	potentially	potentially	ADV
dti-2707	312	25	fatal	fatal	ADJ
dti-2707	312	26	side	side	NOUN
dti-2707	312	27	effects	effect	NOUN
dti-2707	312	28	(	(	PUNCT
dti-2707	312	29	128	128	NUM
dti-2707	312	30	)	)	PUNCT
dti-2707	312	31	.	.	PUNCT
dti-2707	313	1	in	in	ADP
dti-2707	313	2	order	order	NOUN
dti-2707	313	3	to	to	PART
dti-2707	313	4	assess	assess	VERB
dti-2707	313	5	the	the	DET
dti-2707	313	6	safety	safety	NOUN
dti-2707	313	7	and	and	CCONJ
dti-2707	313	8	efficacy	efficacy	NOUN
dti-2707	313	9	of	of	ADP
dti-2707	313	10	capecitabine	capecitabine	NOUN
dti-2707	313	11	(	(	PUNCT
dti-2707	313	12	cap	cap	NOUN
dti-2707	313	13	)	)	PUNCT
dti-2707	313	14	in	in	ADP
dti-2707	313	15	conjunction	conjunction	NOUN
dti-2707	313	16	with	with	ADP
dti-2707	313	17	phy906	phy906	PROPN
dti-2707	313	18	,	,	PUNCT
dti-2707	313	19	a	a	DET
dti-2707	313	20	combination	combination	NOUN
dti-2707	313	21	of	of	ADP
dti-2707	313	22	four	four	NUM
dti-2707	313	23	traditional	traditional	ADJ
dti-2707	313	24	chinese	chinese	ADJ
dti-2707	313	25	herbs	herb	NOUN
dti-2707	313	26	—	—	PUNCT
dti-2707	313	27	scutellaria	scutellaria	NOUN
dti-2707	313	28	baicalensis	baicalensis	NOUN
dti-2707	313	29	georgi	georgi	PROPN
dti-2707	313	30	,	,	PUNCT
dti-2707	313	31	glycyrrhiza	glycyrrhiza	PROPN
dti-2707	313	32	uralensis	uralensis	NOUN
dti-2707	313	33	fisch	fisch	PROPN
dti-2707	313	34	.	.	PUNCT
dti-2707	313	35	,	,	PUNCT
dti-2707	313	36	ziziphus	ziziphus	PROPN
dti-2707	313	37	jujuba	jujuba	PROPN
dti-2707	313	38	mill	mill	PROPN
dti-2707	313	39	.	.	PUNCT
dti-2707	313	40	,	,	PUNCT
dti-2707	313	41	and	and	CCONJ
dti-2707	313	42	paeonia	paeonia	NOUN
dti-2707	313	43	lactiflora	lactiflora	NOUN
dti-2707	313	44	pall.—in	pall.—in	PROPN
dti-2707	313	45	the	the	DET
dti-2707	313	46	treatment	treatment	NOUN
dti-2707	313	47	of	of	ADP
dti-2707	313	48	advanced	advanced	ADJ
dti-2707	313	49	pancreatic	pancreatic	ADJ
dti-2707	313	50	carcinoma	carcinoma	NOUN
dti-2707	313	51	(	(	PUNCT
dti-2707	313	52	apc	apc	PROPN
dti-2707	313	53	)	)	PUNCT
dti-2707	313	54	,	,	PUNCT
dti-2707	313	55	another	another	DET
dti-2707	313	56	study	study	NOUN
dti-2707	313	57	was	be	AUX
dti-2707	313	58	carried	carry	VERB
dti-2707	313	59	out	out	ADP
dti-2707	313	60	in	in	ADP
dti-2707	313	61	2006	2006	NUM
dti-2707	313	62	.	.	PUNCT
dti-2707	314	1	preclinical	preclinical	ADJ
dti-2707	314	2	studies	study	NOUN
dti-2707	314	3	indicate	indicate	VERB
dti-2707	314	4	that	that	SCONJ
dti-2707	314	5	phy906	phy906	PROPN
dti-2707	314	6	is	be	AUX
dti-2707	314	7	a	a	DET
dti-2707	314	8	potent	potent	ADJ
dti-2707	314	9	inhibitor	inhibitor	NOUN
dti-2707	314	10	of	of	ADP
dti-2707	314	11	nf	nf	NOUN
dti-2707	314	12	-	-	PUNCT
dti-2707	314	13	κb	κb	NOUN
dti-2707	314	14	and	and	CCONJ
dti-2707	314	15	that	that	SCONJ
dti-2707	314	16	it	it	PRON
dti-2707	314	17	works	work	VERB
dti-2707	314	18	in	in	ADP
dti-2707	314	19	concert	concert	NOUN
dti-2707	314	20	with	with	ADP
dti-2707	314	21	cap	cap	NOUN
dti-2707	314	22	to	to	PART
dti-2707	314	23	exhibit	exhibit	VERB
dti-2707	314	24	synergistic	synergistic	ADJ
dti-2707	314	25	antitumor	antitumor	NOUN
dti-2707	314	26	effects	effect	NOUN
dti-2707	314	27	in	in	ADP
dti-2707	314	28	panc-1	panc-1	NOUN
dti-2707	314	29	cell	cell	NOUN
dti-2707	314	30	lines	line	NOUN
dti-2707	314	31	.	.	PUNCT
dti-2707	315	1	phy906	phy906	PROPN
dti-2707	315	2	does	do	AUX
dti-2707	315	3	not	not	PART
dti-2707	315	4	alter	alter	VERB
dti-2707	315	5	the	the	DET
dti-2707	315	6	pk	pk	NOUN
dti-2707	315	7	of	of	ADP
dti-2707	315	8	cap	cap	NOUN
dti-2707	315	9	,	,	PUNCT
dti-2707	315	10	as	as	SCONJ
dti-2707	315	11	studies	study	NOUN
dti-2707	315	12	on	on	ADP
dti-2707	315	13	several	several	ADJ
dti-2707	315	14	tumor	tumor	NOUN
dti-2707	315	15	types	type	NOUN
dti-2707	315	16	have	have	AUX
dti-2707	315	17	shown	show	VERB
dti-2707	315	18	,	,	PUNCT
dti-2707	315	19	but	but	CCONJ
dti-2707	315	20	it	it	PRON
dti-2707	315	21	may	may	AUX
dti-2707	315	22	reduce	reduce	VERB
dti-2707	315	23	the	the	DET
dti-2707	315	24	gi	gi	NOUN
dti-2707	315	25	toxicities	toxicity	NOUN
dti-2707	315	26	associated	associate	VERB
dti-2707	315	27	with	with	ADP
dti-2707	315	28	chemotherapy	chemotherapy	NOUN
dti-2707	315	29	,	,	PUNCT
dti-2707	315	30	especially	especially	ADV
dti-2707	315	31	diarrhea	diarrhea	PROPN
dti-2707	315	32	.	.	PUNCT
dti-2707	316	1	these	these	DET
dti-2707	316	2	data	datum	NOUN
dti-2707	316	3	have	have	AUX
dti-2707	316	4	motivated	motivate	VERB
dti-2707	316	5	the	the	DET
dti-2707	316	6	phase	phase	NOUN
dti-2707	316	7	i	i	PRON
dti-2707	316	8	/	/	SYM
dti-2707	316	9	ii	ii	PROPN
dti-2707	316	10	study	study	NOUN
dti-2707	316	11	of	of	ADP
dti-2707	316	12	the	the	DET
dti-2707	316	13	safety	safety	NOUN
dti-2707	316	14	and	and	CCONJ
dti-2707	316	15	tolerability	tolerability	NOUN
dti-2707	316	16	of	of	ADP
dti-2707	316	17	a	a	DET
dti-2707	316	18	weekly	weekly	ADJ
dti-2707	316	19	(	(	PUNCT
dti-2707	316	20	7/7	7/7	NUM
dti-2707	316	21	)	)	PUNCT
dti-2707	316	22	dose	dose	NOUN
dti-2707	316	23	-	-	PUNCT
dti-2707	316	24	intense	intense	ADJ
dti-2707	316	25	schedule	schedule	NOUN
dti-2707	316	26	for	for	ADP
dti-2707	316	27	cap	cap	NOUN
dti-2707	316	28	plus	plus	CCONJ
dti-2707	316	29	phy906	phy906	PROPN
dti-2707	316	30	.	.	PUNCT
dti-2707	317	1	patients	patient	NOUN
dti-2707	317	2	with	with	ADP
dti-2707	317	3	advanced	advanced	ADJ
dti-2707	317	4	solid	solid	ADJ
dti-2707	317	5	tumors	tumor	NOUN
dti-2707	317	6	(	(	PUNCT
dti-2707	317	7	sts	sts	PROPN
dti-2707	317	8	)	)	PUNCT
dti-2707	317	9	who	who	PRON
dti-2707	317	10	did	do	AUX
dti-2707	317	11	not	not	PART
dti-2707	317	12	respond	respond	VERB
dti-2707	317	13	to	to	ADP
dti-2707	317	14	conventional	conventional	ADJ
dti-2707	317	15	therapy	therapy	NOUN
dti-2707	317	16	were	be	AUX
dti-2707	317	17	recruited	recruit	VERB
dti-2707	317	18	for	for	ADP
dti-2707	317	19	the	the	DET
dti-2707	317	20	phase	phase	NOUN
dti-2707	317	21	i	i	PRON
dti-2707	317	22	research	research	VERB
dti-2707	317	23	.	.	PUNCT
dti-2707	318	1	on	on	ADP
dti-2707	318	2	days	day	NOUN
dti-2707	318	3	1	1	NUM
dti-2707	318	4	-	-	SYM
dti-2707	318	5	4	4	NUM
dti-2707	318	6	,	,	PUNCT
dti-2707	318	7	patients	patient	NOUN
dti-2707	318	8	were	be	AUX
dti-2707	318	9	given	give	VERB
dti-2707	318	10	800	800	NUM
dti-2707	318	11	mg	mg	NOUN
dti-2707	318	12	of	of	ADP
dti-2707	318	13	phy906	phy906	PROPN
dti-2707	318	14	twice	twice	DET
dti-2707	318	15	a	a	DET
dti-2707	318	16	day	day	NOUN
dti-2707	318	17	,	,	PUNCT
dti-2707	318	18	and	and	CCONJ
dti-2707	318	19	for	for	ADP
dti-2707	318	20	14	14	NUM
dti-2707	318	21	days	day	NOUN
dti-2707	318	22	,	,	PUNCT
dti-2707	318	23	they	they	PRON
dti-2707	318	24	were	be	AUX
dti-2707	318	25	given	give	VERB
dti-2707	318	26	1,500	1,500	NUM
dti-2707	318	27	mg	mg	NOUN
dti-2707	318	28	/	/	SYM
dti-2707	318	29	m2	m2	PROPN
dti-2707	318	30	of	of	ADP
dti-2707	318	31	cap	cap	NOUN
dti-2707	318	32	every	every	DET
dti-2707	318	33	day	day	NOUN
dti-2707	318	34	.	.	PUNCT
dti-2707	319	1	patients	patient	NOUN
dti-2707	319	2	with	with	ADP
dti-2707	319	3	gemcitabinerefractory	gemcitabinerefractory	PROPN
dti-2707	319	4	apc	apc	PROPN
dti-2707	319	5	will	will	AUX
dti-2707	319	6	be	be	AUX
dti-2707	319	7	recruited	recruit	VERB
dti-2707	319	8	for	for	ADP
dti-2707	319	9	the	the	DET
dti-2707	319	10	phase	phase	NOUN
dti-2707	319	11	ii	ii	PROPN
dti-2707	319	12	research	research	NOUN
dti-2707	319	13	.	.	PUNCT
dti-2707	320	1	the	the	DET
dti-2707	320	2	study	study	NOUN
dti-2707	320	3	’s	’s	PART
dti-2707	320	4	findings	finding	NOUN
dti-2707	320	5	show	show	VERB
dti-2707	320	6	that	that	SCONJ
dti-2707	320	7	cap	cap	NOUN
dti-2707	320	8	and	and	CCONJ
dti-2707	320	9	phy906	phy906	PROPN
dti-2707	320	10	together	together	ADV
dti-2707	320	11	have	have	VERB
dti-2707	320	12	tolerable	tolerable	ADJ
dti-2707	320	13	toxicity	toxicity	NOUN
dti-2707	320	14	in	in	ADP
dti-2707	320	15	patients	patient	NOUN
dti-2707	320	16	with	with	ADP
dti-2707	320	17	st	st	PROPN
dti-2707	320	18	(	(	PUNCT
dti-2707	320	19	130	130	NUM
dti-2707	320	20	)	)	PUNCT
dti-2707	320	21	.	.	PUNCT
dti-2707	321	1	in	in	ADP
dti-2707	321	2	phase	phase	NOUN
dti-2707	321	3	i	i	PROPN
dti-2707	321	4	/	/	SYM
dti-2707	321	5	ii	ii	PROPN
dti-2707	321	6	clinical	clinical	ADJ
dti-2707	321	7	trials	trial	NOUN
dti-2707	321	8	oral	oral	ADJ
dti-2707	321	9	administration	administration	NOUN
dti-2707	321	10	of	of	ADP
dti-2707	321	11	baicalein	baicalein	PROPN
dti-2707	321	12	has	have	AUX
dti-2707	321	13	been	be	AUX
dti-2707	321	14	shown	show	VERB
dti-2707	321	15	to	to	PART
dti-2707	321	16	be	be	AUX
dti-2707	321	17	safe	safe	ADJ
dti-2707	321	18	for	for	ADP
dti-2707	321	19	humans	human	NOUN
dti-2707	321	20	(	(	PUNCT
dti-2707	321	21	130	130	NUM
dti-2707	321	22	)	)	PUNCT
dti-2707	321	23	.	.	PUNCT
dti-2707	322	1	however	however	ADV
dti-2707	322	2	,	,	PUNCT
dti-2707	322	3	more	more	ADV
dti-2707	322	4	detailed	detailed	ADJ
dti-2707	322	5	research	research	NOUN
dti-2707	322	6	on	on	ADP
dti-2707	322	7	baicalein	baicalein	PROPN
dti-2707	322	8	’s	’s	PART
dti-2707	322	9	therapeutic	therapeutic	ADJ
dti-2707	322	10	potential	potential	NOUN
dti-2707	322	11	in	in	ADP
dti-2707	322	12	patients	patient	NOUN
dti-2707	322	13	with	with	ADP
dti-2707	322	14	various	various	ADJ
dti-2707	322	15	diseases	disease	NOUN
dti-2707	322	16	is	be	AUX
dti-2707	322	17	required	require	VERB
dti-2707	322	18	.	.	PUNCT
dti-2707	323	1	nano	nano	NOUN
dti-2707	323	2	-	-	PUNCT
dti-2707	323	3	formulations	formulation	NOUN
dti-2707	323	4	of	of	ADP
dti-2707	323	5	baicalein	baicalein	PROPN
dti-2707	323	6	srivastava	srivastava	PROPN
dti-2707	323	7	et	et	PROPN
dti-2707	323	8	al	al	PROPN
dti-2707	323	9	created	create	VERB
dti-2707	323	10	baicalein	baicalein	NOUN
dti-2707	323	11	-	-	PUNCT
dti-2707	323	12	loaded	load	VERB
dti-2707	323	13	mixed	mixed	ADJ
dti-2707	323	14	micelles	micelle	NOUN
dti-2707	323	15	to	to	PART
dti-2707	323	16	improve	improve	VERB
dti-2707	323	17	the	the	DET
dti-2707	323	18	solubility	solubility	NOUN
dti-2707	323	19	and	and	CCONJ
dti-2707	323	20	bioavailability	bioavailability	NOUN
dti-2707	323	21	of	of	ADP
dti-2707	323	22	baicalein	baicalein	NOUN
dti-2707	323	23	oral	oral	ADJ
dti-2707	323	24	preparation	preparation	NOUN
dti-2707	323	25	to	to	PART
dti-2707	323	26	treat	treat	VERB
dti-2707	323	27	breast	breast	NOUN
dti-2707	323	28	cancer	cancer	NOUN
dti-2707	323	29	.	.	PUNCT
dti-2707	324	1	micelles	micelle	NOUN
dti-2707	324	2	encapsulating	encapsulate	VERB
dti-2707	324	3	baicalein	baicalein	NOUN
dti-2707	324	4	in	in	ADP
dti-2707	324	5	pluronic	pluronic	ADJ
dti-2707	324	6	f127	f127	PROPN
dti-2707	324	7	(	(	PUNCT
dti-2707	324	8	f127	f127	NUM
dti-2707	324	9	)	)	PUNCT
dti-2707	324	10	and	and	CCONJ
dti-2707	324	11	d	d	X
dti-2707	324	12	-	-	PUNCT
dti-2707	324	13	tocopherol	tocopherol	NOUN
dti-2707	324	14	polyethylene	polyethylene	NOUN
dti-2707	324	15	glycol	glycol	NOUN
dti-2707	324	16	1000	1000	NUM
dti-2707	324	17	succinate	succinate	NOUN
dti-2707	324	18	(	(	PUNCT
dti-2707	324	19	tpgs	tpgs	NOUN
dti-2707	324	20	)	)	PUNCT
dti-2707	324	21	were	be	AUX
dti-2707	324	22	investigated	investigate	VERB
dti-2707	324	23	for	for	ADP
dti-2707	324	24	their	their	PRON
dti-2707	324	25	anticancer	anticancer	NOUN
dti-2707	324	26	properties	property	NOUN
dti-2707	324	27	.	.	PUNCT
dti-2707	325	1	the	the	DET
dti-2707	325	2	micelles	micelle	NOUN
dti-2707	325	3	in	in	ADP
dti-2707	325	4	the	the	DET
dti-2707	325	5	optimal	optimal	ADJ
dti-2707	325	6	formulation	formulation	NOUN
dti-2707	325	7	exhibited	exhibit	VERB
dti-2707	325	8	a	a	DET
dti-2707	325	9	zeta	zeta	NOUN
dti-2707	325	10	potential	potential	NOUN
dti-2707	325	11	of	of	ADP
dti-2707	325	12	4.01	4.01	NUM
dti-2707	325	13	mv	mv	NOUN
dti-2707	325	14	and	and	CCONJ
dti-2707	325	15	a	a	DET
dti-2707	325	16	mean	mean	ADJ
dti-2707	325	17	particle	particle	NOUN
dti-2707	325	18	size	size	NOUN
dti-2707	325	19	of	of	ADP
dti-2707	325	20	25.04	25.04	NUM
dti-2707	325	21	nm	nm	NOUN
dti-2707	325	22	.	.	PUNCT
dti-2707	326	1	baicalein	baicalein	PROPN
dti-2707	326	2	was	be	AUX
dti-2707	326	3	released	release	VERB
dti-2707	326	4	from	from	ADP
dti-2707	326	5	micelles	micelle	NOUN
dti-2707	326	6	in	in	ADP
dti-2707	326	7	vitro	vitro	NOUN
dti-2707	326	8	with	with	ADP
dti-2707	326	9	a	a	DET
dti-2707	326	10	sustained	sustained	ADJ
dti-2707	326	11	release	release	NOUN
dti-2707	326	12	profile	profile	NOUN
dti-2707	326	13	at	at	ADP
dti-2707	326	14	ph	ph	PROPN
dti-2707	326	15	7.4	7.4	NUM
dti-2707	326	16	,	,	PUNCT
dti-2707	326	17	and	and	CCONJ
dti-2707	326	18	an	an	DET
dti-2707	326	19	83.43	83.43	NUM
dti-2707	326	20	%	%	NOUN
dti-2707	326	21	computed	compute	VERB
dti-2707	326	22	entrapment	entrapment	ADJ
dti-2707	326	23	efficiency	efficiency	NOUN
dti-2707	326	24	percentage	percentage	NOUN
dti-2707	326	25	was	be	AUX
dti-2707	326	26	obtained	obtain	VERB
dti-2707	326	27	.	.	PUNCT
dti-2707	327	1	in	in	ADP
dti-2707	327	2	vitro	vitro	X
dti-2707	327	3	cell	cell	NOUN
dti-2707	327	4	culture	culture	NOUN
dti-2707	327	5	studies	study	NOUN
dti-2707	327	6	showed	show	VERB
dti-2707	327	7	a	a	DET
dti-2707	327	8	significant	significant	ADJ
dti-2707	327	9	increase	increase	NOUN
dti-2707	327	10	in	in	ADP
dti-2707	327	11	the	the	DET
dti-2707	327	12	absorption	absorption	NOUN
dti-2707	327	13	and	and	CCONJ
dti-2707	327	14	cytotoxicity	cytotoxicity	NOUN
dti-2707	327	15	of	of	ADP
dti-2707	327	16	baicalein	baicalein	NOUN
dti-2707	327	17	formulation	formulation	NOUN
dti-2707	327	18	and	and	CCONJ
dti-2707	327	19	performance	performance	NOUN
dti-2707	327	20	evaluation	evaluation	NOUN
dti-2707	327	21	of	of	ADP
dti-2707	327	22	polymeric	polymeric	ADJ
dti-2707	327	23	in	in	ADP
dti-2707	327	24	-	-	PUNCT
dti-2707	327	25	loaded	load	VERB
dti-2707	327	26	micelles	micelle	NOUN
dti-2707	327	27	targeting	target	VERB
dti-2707	327	28	mdamb-231	mdamb-231	ADJ
dti-2707	327	29	cell	cell	NOUN
dti-2707	327	30	lines	line	NOUN
dti-2707	327	31	.	.	PUNCT
dti-2707	328	1	the	the	DET
dti-2707	328	2	cell	cell	NOUN
dti-2707	328	3	cycle	cycle	NOUN
dti-2707	328	4	analysis	analysis	NOUN
dti-2707	328	5	findings	finding	NOUN
dti-2707	328	6	demonstrated	demonstrate	VERB
dti-2707	328	7	that	that	SCONJ
dti-2707	328	8	cells	cell	NOUN
dti-2707	328	9	were	be	AUX
dti-2707	328	10	halted	halt	VERB
dti-2707	328	11	in	in	ADP
dti-2707	328	12	the	the	DET
dti-2707	328	13	g0	g0	PROPN
dti-2707	328	14	/	/	SYM
dti-2707	328	15	g1	g1	PROPN
dti-2707	328	16	phase	phase	NOUN
dti-2707	328	17	of	of	ADP
dti-2707	328	18	the	the	DET
dti-2707	328	19	cell	cell	NOUN
dti-2707	328	20	cycle	cycle	NOUN
dti-2707	328	21	and	and	CCONJ
dti-2707	328	22	that	that	PRON
dti-2707	328	23	baicalein	baicalein	NOUN
dti-2707	328	24	micelles	micelle	NOUN
dti-2707	328	25	had	have	VERB
dti-2707	328	26	a	a	DET
dti-2707	328	27	greater	great	ADJ
dti-2707	328	28	capacity	capacity	NOUN
dti-2707	328	29	to	to	PART
dti-2707	328	30	induce	induce	VERB
dti-2707	328	31	apoptosis	apoptosis	NOUN
dti-2707	328	32	than	than	SCONJ
dti-2707	328	33	did	do	AUX
dti-2707	328	34	baicalein	baicalein	VERB
dti-2707	328	35	in	in	ADP
dti-2707	328	36	its	its	PRON
dti-2707	328	37	free	free	ADJ
dti-2707	328	38	form	form	NOUN
dti-2707	328	39	.	.	PUNCT
dti-2707	329	1	the	the	DET
dti-2707	329	2	results	result	NOUN
dti-2707	329	3	of	of	ADP
dti-2707	329	4	the	the	DET
dti-2707	329	5	ros	ros	PROPN
dti-2707	329	6	and	and	CCONJ
dti-2707	329	7	mitochondrial	mitochondrial	ADJ
dti-2707	329	8	membrane	membrane	NOUN
dti-2707	329	9	potential	potential	ADJ
dti-2707	329	10	experiment	experiment	NOUN
dti-2707	329	11	demonstrate	demonstrate	VERB
dti-2707	329	12	that	that	SCONJ
dti-2707	329	13	the	the	DET
dti-2707	329	14	novel	novel	ADJ
dti-2707	329	15	formulation	formulation	NOUN
dti-2707	329	16	suppresses	suppress	VERB
dti-2707	329	17	cell	cell	NOUN
dti-2707	329	18	growth	growth	NOUN
dti-2707	329	19	through	through	ADP
dti-2707	329	20	the	the	DET
dti-2707	329	21	rosdependent	rosdependent	ADJ
dti-2707	329	22	mitochondrial	mitochondrial	ADJ
dti-2707	329	23	-	-	PUNCT
dti-2707	329	24	mediated	mediate	VERB
dti-2707	329	25	apoptotic	apoptotic	ADJ
dti-2707	329	26	pathway	pathway	NOUN
dti-2707	329	27	(	(	PUNCT
dti-2707	329	28	131	131	NUM
dti-2707	329	29	)	)	PUNCT
dti-2707	329	30	.	.	PUNCT
dti-2707	330	1	munjal	munjal	PROPN
dti-2707	330	2	et	et	PROPN
dti-2707	330	3	al	al	PROPN
dti-2707	330	4	drug	drug	PROPN
dti-2707	330	5	target	target	NOUN
dti-2707	330	6	insights	insight	NOUN
dti-2707	330	7	2024	2024	NUM
dti-2707	330	8	;	;	PUNCT
dti-2707	330	9	18	18	NUM
dti-2707	330	10	:	:	SYM
dti-2707	330	11	39	39	NUM
dti-2707	330	12	©	©	PROPN
dti-2707	330	13	2024	2024	NUM
dti-2707	330	14	the	the	DET
dti-2707	330	15	authors	author	NOUN
dti-2707	330	16	.	.	PUNCT
dti-2707	331	1	published	publish	VERB
dti-2707	331	2	by	by	ADP
dti-2707	331	3	aboutscience	aboutscience	NOUN
dti-2707	331	4	www.aboutscience.eu	www.aboutscience.eu	PROPN
dti-2707	331	5	majumdar	majumdar	PROPN
dti-2707	331	6	et	et	PROPN
dti-2707	331	7	al	al	PROPN
dti-2707	331	8	developed	develop	VERB
dti-2707	331	9	baicalein	baicalein	NOUN
dti-2707	331	10	-	-	PUNCT
dti-2707	331	11	loaded	load	VERB
dti-2707	331	12	nanoliposome	nanoliposome	NOUN
dti-2707	331	13	gel	gel	NOUN
dti-2707	331	14	formulation	formulation	NOUN
dti-2707	331	15	,	,	PUNCT
dti-2707	331	16	which	which	PRON
dti-2707	331	17	was	be	AUX
dti-2707	331	18	easy	easy	ADJ
dti-2707	331	19	to	to	PART
dti-2707	331	20	apply	apply	VERB
dti-2707	331	21	to	to	ADP
dti-2707	331	22	the	the	DET
dti-2707	331	23	skin	skin	NOUN
dti-2707	331	24	’s	’s	PART
dti-2707	331	25	surface	surface	NOUN
dti-2707	331	26	because	because	SCONJ
dti-2707	331	27	it	it	PRON
dti-2707	331	28	has	have	VERB
dti-2707	331	29	a	a	DET
dti-2707	331	30	high	high	ADJ
dti-2707	331	31	degree	degree	NOUN
dti-2707	331	32	of	of	ADP
dti-2707	331	33	homogeneity	homogeneity	NOUN
dti-2707	331	34	,	,	PUNCT
dti-2707	331	35	a	a	DET
dti-2707	331	36	ph	ph	NOUN
dti-2707	331	37	that	that	PRON
dti-2707	331	38	is	be	AUX
dti-2707	331	39	about	about	ADV
dti-2707	331	40	equivalent	equivalent	ADJ
dti-2707	331	41	to	to	ADP
dti-2707	331	42	that	that	PRON
dti-2707	331	43	of	of	ADP
dti-2707	331	44	the	the	DET
dti-2707	331	45	skin	skin	NOUN
dti-2707	331	46	,	,	PUNCT
dti-2707	331	47	and	and	CCONJ
dti-2707	331	48	an	an	DET
dti-2707	331	49	appropriate	appropriate	ADJ
dti-2707	331	50	thixotropic	thixotropic	NOUN
dti-2707	331	51	characteristic	characteristic	NOUN
dti-2707	331	52	.	.	PUNCT
dti-2707	332	1	baicalein	baicalein	PROPN
dti-2707	332	2	’s	’s	PART
dti-2707	332	3	release	release	NOUN
dti-2707	332	4	was	be	AUX
dti-2707	332	5	greatly	greatly	ADV
dti-2707	332	6	extended	extended	ADJ
dti-2707	332	7	and	and	CCONJ
dti-2707	332	8	concentration	concentration	NOUN
dti-2707	332	9	-	-	PUNCT
dti-2707	332	10	independent	independent	NOUN
dti-2707	332	11	after	after	ADP
dti-2707	332	12	the	the	DET
dti-2707	332	13	development	development	NOUN
dti-2707	332	14	of	of	ADP
dti-2707	332	15	nanoliposomal	nanoliposomal	ADJ
dti-2707	332	16	gel	gel	NOUN
dti-2707	332	17	.	.	PUNCT
dti-2707	333	1	in	in	ADP
dti-2707	333	2	contrast	contrast	NOUN
dti-2707	333	3	to	to	ADP
dti-2707	333	4	commercially	commercially	ADV
dti-2707	333	5	available	available	ADJ
dti-2707	333	6	formulations	formulation	NOUN
dti-2707	333	7	,	,	PUNCT
dti-2707	333	8	the	the	DET
dti-2707	333	9	nanoliposomes	nanoliposome	NOUN
dti-2707	333	10	loaded	load	VERB
dti-2707	333	11	with	with	ADP
dti-2707	333	12	baicalein	baicalein	NOUN
dti-2707	333	13	demonstrated	demonstrate	VERB
dti-2707	333	14	remarkable	remarkable	ADJ
dti-2707	333	15	anti	anti	ADJ
dti-2707	333	16	-	-	ADJ
dti-2707	333	17	inflammatory	inflammatory	ADJ
dti-2707	333	18	effectiveness	effectiveness	NOUN
dti-2707	333	19	throughout	throughout	ADP
dti-2707	333	20	testing	testing	NOUN
dti-2707	333	21	.	.	PUNCT
dti-2707	334	1	accordingly	accordingly	ADV
dti-2707	334	2	,	,	PUNCT
dti-2707	334	3	the	the	DET
dti-2707	334	4	engineered	engineer	VERB
dti-2707	334	5	nanoliposomal	nanoliposomal	ADJ
dti-2707	334	6	gel	gel	NOUN
dti-2707	334	7	filled	fill	VERB
dti-2707	334	8	with	with	ADP
dti-2707	334	9	baicalein	baicalein	NOUN
dti-2707	334	10	may	may	AUX
dti-2707	334	11	be	be	AUX
dti-2707	334	12	employed	employ	VERB
dti-2707	334	13	as	as	ADP
dti-2707	334	14	an	an	DET
dti-2707	334	15	effective	effective	ADJ
dti-2707	334	16	carrier	carrier	NOUN
dti-2707	334	17	for	for	ADP
dti-2707	334	18	baicalein	baicalein	PROPN
dti-2707	334	19	topical	topical	ADJ
dti-2707	334	20	administration	administration	NOUN
dti-2707	334	21	to	to	PART
dti-2707	334	22	suppress	suppress	VERB
dti-2707	334	23	inflammatory	inflammatory	ADJ
dti-2707	334	24	reactions	reaction	NOUN
dti-2707	334	25	(	(	PUNCT
dti-2707	334	26	132	132	NUM
dti-2707	334	27	)	)	PUNCT
dti-2707	334	28	.	.	PUNCT
dti-2707	335	1	the	the	DET
dti-2707	335	2	efficacy	efficacy	NOUN
dti-2707	335	3	of	of	ADP
dti-2707	335	4	baicalein	baicalein	NOUN
dti-2707	335	5	-	-	PUNCT
dti-2707	335	6	loaded	load	VERB
dti-2707	335	7	iron	iron	NOUN
dti-2707	335	8	oxide	oxide	NOUN
dti-2707	335	9	nanoparticles	nanoparticle	NOUN
dti-2707	335	10	(	(	PUNCT
dti-2707	335	11	nps	nps	PROPN
dti-2707	335	12	)	)	PUNCT
dti-2707	335	13	against	against	ADP
dti-2707	335	14	the	the	DET
dti-2707	335	15	triple	triple	ADJ
dti-2707	335	16	-	-	PUNCT
dti-2707	335	17	negative	negative	ADJ
dti-2707	335	18	breast	breast	NOUN
dti-2707	335	19	cancer	cancer	NOUN
dti-2707	335	20	(	(	PUNCT
dti-2707	335	21	tnbc	tnbc	ADJ
dti-2707	335	22	)	)	PUNCT
dti-2707	335	23	cell	cell	NOUN
dti-2707	335	24	line	line	NOUN
dti-2707	335	25	mda	mda	PROPN
dti-2707	335	26	-	-	PUNCT
dti-2707	335	27	mb-231	mb-231	PROPN
dti-2707	335	28	was	be	AUX
dti-2707	335	29	examined	examine	VERB
dti-2707	335	30	by	by	ADP
dti-2707	335	31	kavithaa	kavithaa	PROPN
dti-2707	335	32	et	et	PROPN
dti-2707	335	33	al	al	PROPN
dti-2707	335	34	.	.	PUNCT
dti-2707	335	35	using	use	VERB
dti-2707	335	36	an	an	DET
dti-2707	335	37	electron	electron	NOUN
dti-2707	335	38	microscope	microscope	NOUN
dti-2707	335	39	to	to	PART
dti-2707	335	40	analyze	analyze	VERB
dti-2707	335	41	a	a	DET
dti-2707	335	42	subset	subset	NOUN
dti-2707	335	43	of	of	ADP
dti-2707	335	44	cancer	cancer	NOUN
dti-2707	335	45	cells	cell	NOUN
dti-2707	335	46	,	,	PUNCT
dti-2707	335	47	it	it	PRON
dti-2707	335	48	was	be	AUX
dti-2707	335	49	revealed	reveal	VERB
dti-2707	335	50	that	that	SCONJ
dti-2707	335	51	the	the	DET
dti-2707	335	52	particles	particle	NOUN
dti-2707	335	53	were	be	AUX
dti-2707	335	54	absorbed	absorb	VERB
dti-2707	335	55	by	by	ADP
dti-2707	335	56	the	the	DET
dti-2707	335	57	various	various	ADJ
dti-2707	335	58	subcellular	subcellular	ADJ
dti-2707	335	59	components	component	NOUN
dti-2707	335	60	of	of	ADP
dti-2707	335	61	the	the	DET
dti-2707	335	62	cells	cell	NOUN
dti-2707	335	63	.	.	PUNCT
dti-2707	336	1	furthermore	furthermore	ADV
dti-2707	336	2	,	,	PUNCT
dti-2707	336	3	the	the	DET
dti-2707	336	4	assessment	assessment	NOUN
dti-2707	336	5	of	of	ADP
dti-2707	336	6	mitochondrial	mitochondrial	ADJ
dti-2707	336	7	membrane	membrane	NOUN
dti-2707	336	8	potential	potential	NOUN
dti-2707	336	9	was	be	AUX
dti-2707	336	10	conducted	conduct	VERB
dti-2707	336	11	using	use	VERB
dti-2707	336	12	flow	flow	NOUN
dti-2707	336	13	cytometry	cytometry	NOUN
dti-2707	336	14	employing	employ	VERB
dti-2707	336	15	jc-1	jc-1	NOUN
dti-2707	336	16	labeling	labeling	NOUN
dti-2707	336	17	.	.	PUNCT
dti-2707	337	1	the	the	DET
dti-2707	337	2	results	result	NOUN
dti-2707	337	3	indicated	indicate	VERB
dti-2707	337	4	the	the	DET
dti-2707	337	5	presence	presence	NOUN
dti-2707	337	6	of	of	ADP
dti-2707	337	7	significant	significant	ADJ
dti-2707	337	8	aggregates	aggregate	NOUN
dti-2707	337	9	in	in	ADP
dti-2707	337	10	cells	cell	NOUN
dti-2707	337	11	treated	treat	VERB
dti-2707	337	12	with	with	ADP
dti-2707	337	13	iron	iron	NOUN
dti-2707	337	14	oxide	oxide	NOUN
dti-2707	337	15	nps	nps	PROPN
dti-2707	337	16	loaded	load	VERB
dti-2707	337	17	with	with	ADP
dti-2707	337	18	baicalein	baicalein	PROPN
dti-2707	337	19	,	,	PUNCT
dti-2707	337	20	indicating	indicate	VERB
dti-2707	337	21	a	a	DET
dti-2707	337	22	considerable	considerable	ADJ
dti-2707	337	23	reduction	reduction	NOUN
dti-2707	337	24	in	in	ADP
dti-2707	337	25	mitochondrial	mitochondrial	ADJ
dti-2707	337	26	membrane	membrane	NOUN
dti-2707	337	27	potential	potential	NOUN
dti-2707	337	28	.	.	PUNCT
dti-2707	338	1	baicalein	baicalein	NOUN
dti-2707	338	2	-	-	PUNCT
dti-2707	338	3	loaded	load	VERB
dti-2707	338	4	iron	iron	NOUN
dti-2707	338	5	oxide	oxide	NOUN
dti-2707	338	6	nps	nps	PROPN
dti-2707	338	7	elevated	elevated	ADJ
dti-2707	338	8	apoptotic	apoptotic	ADJ
dti-2707	338	9	genes	gene	NOUN
dti-2707	338	10	such	such	ADJ
dti-2707	338	11	as	as	ADP
dti-2707	338	12	bad	bad	ADJ
dti-2707	338	13	,	,	PUNCT
dti-2707	338	14	bax	bax	NOUN
dti-2707	338	15	,	,	PUNCT
dti-2707	338	16	gadd45	gadd45	ADJ
dti-2707	338	17	,	,	PUNCT
dti-2707	338	18	and	and	CCONJ
dti-2707	338	19	poly(adp	poly(adp	NOUN
dti-2707	338	20	-	-	PUNCT
dti-2707	338	21	ribose	ribose	NOUN
dti-2707	338	22	)	)	PUNCT
dti-2707	338	23	polymerase	polymerase	NOUN
dti-2707	338	24	(	(	PUNCT
dti-2707	338	25	parp	parp	ADJ
dti-2707	338	26	)	)	PUNCT
dti-2707	338	27	cleavage	cleavage	NOUN
dti-2707	338	28	in	in	ADP
dti-2707	338	29	a	a	DET
dti-2707	338	30	dose	dose	NOUN
dti-2707	338	31	-	-	PUNCT
dti-2707	338	32	dependent	dependent	ADJ
dti-2707	338	33	manner	manner	NOUN
dti-2707	338	34	while	while	SCONJ
dti-2707	338	35	downregulating	downregulate	VERB
dti-2707	338	36	anti	anti	ADJ
dti-2707	338	37	-	-	ADJ
dti-2707	338	38	apoptotic	apoptotic	ADJ
dti-2707	338	39	genes	gene	NOUN
dti-2707	338	40	.	.	PUNCT
dti-2707	339	1	comprehensive	comprehensive	ADJ
dti-2707	339	2	kit	kit	NOUN
dti-2707	339	3	-	-	PUNCT
dti-2707	339	4	based	base	VERB
dti-2707	339	5	flow	flow	NOUN
dti-2707	339	6	cytometric	cytometric	ADJ
dti-2707	339	7	analysis	analysis	NOUN
dti-2707	339	8	confirms	confirm	VERB
dti-2707	339	9	that	that	SCONJ
dti-2707	339	10	nano	nano	NOUN
dti-2707	339	11	conjugates	conjugate	NOUN
dti-2707	339	12	may	may	AUX
dti-2707	339	13	clearly	clearly	ADV
dti-2707	339	14	induce	induce	VERB
dti-2707	339	15	apoptosis	apoptosis	NOUN
dti-2707	339	16	,	,	PUNCT
dti-2707	339	17	dna	dna	NOUN
dti-2707	339	18	damage	damage	NOUN
dti-2707	339	19	,	,	PUNCT
dti-2707	339	20	and	and	CCONJ
dti-2707	339	21	cell	cell	NOUN
dti-2707	339	22	cycle	cycle	NOUN
dti-2707	339	23	arrest	arrest	NOUN
dti-2707	339	24	,	,	PUNCT
dti-2707	339	25	as	as	ADV
dti-2707	339	26	well	well	ADV
dti-2707	339	27	as	as	ADP
dti-2707	339	28	reduce	reduce	VERB
dti-2707	339	29	the	the	DET
dti-2707	339	30	rate	rate	NOUN
dti-2707	339	31	of	of	ADP
dti-2707	339	32	cell	cell	NOUN
dti-2707	339	33	proliferation	proliferation	NOUN
dti-2707	339	34	in	in	ADP
dti-2707	339	35	tnbc	tnbc	ADJ
dti-2707	339	36	cells	cell	NOUN
dti-2707	339	37	(	(	PUNCT
dti-2707	339	38	133	133	NUM
dti-2707	339	39	)	)	PUNCT
dti-2707	339	40	.	.	PUNCT
dti-2707	340	1	li	li	PROPN
dti-2707	340	2	et	et	PROPN
dti-2707	340	3	al	al	PROPN
dti-2707	340	4	investigated	investigate	VERB
dti-2707	340	5	the	the	DET
dti-2707	340	6	releasing	releasing	NOUN
dti-2707	340	7	patterns	pattern	NOUN
dti-2707	340	8	and	and	CCONJ
dti-2707	340	9	loading	loading	NOUN
dti-2707	340	10	efficiencies	efficiency	NOUN
dti-2707	340	11	of	of	ADP
dti-2707	340	12	baicalein	baicalein	NOUN
dti-2707	340	13	(	(	PUNCT
dti-2707	340	14	be	be	AUX
dti-2707	340	15	)	)	PUNCT
dti-2707	340	16	and	and	CCONJ
dti-2707	340	17	baicalin	baicalin	NOUN
dti-2707	340	18	(	(	PUNCT
dti-2707	340	19	ba	ba	PROPN
dti-2707	340	20	)	)	PUNCT
dti-2707	340	21	enclosed	enclose	VERB
dti-2707	340	22	in	in	ADP
dti-2707	340	23	mesoporous	mesoporous	ADJ
dti-2707	340	24	silica	silica	NOUN
dti-2707	340	25	nanoparticles	nanoparticle	NOUN
dti-2707	340	26	(	(	PUNCT
dti-2707	340	27	msns	msns	NOUN
dti-2707	340	28	)	)	PUNCT
dti-2707	340	29	that	that	PRON
dti-2707	340	30	were	be	AUX
dti-2707	340	31	produced	produce	VERB
dti-2707	340	32	and	and	CCONJ
dti-2707	340	33	modified	modify	VERB
dti-2707	340	34	with	with	ADP
dti-2707	340	35	amines	amine	NOUN
dti-2707	340	36	(	(	PUNCT
dti-2707	340	37	nano	nano	NOUN
dti-2707	340	38	-	-	PUNCT
dti-2707	340	39	ba	ba	NOUN
dti-2707	340	40	and	and	CCONJ
dti-2707	340	41	nano	nano	NOUN
dti-2707	340	42	-	-	PUNCT
dti-2707	340	43	be	be	AUX
dti-2707	340	44	,	,	PUNCT
dti-2707	340	45	respectively	respectively	ADV
dti-2707	340	46	)	)	PUNCT
dti-2707	340	47	.	.	PUNCT
dti-2707	341	1	using	use	VERB
dti-2707	341	2	primary	primary	ADJ
dti-2707	341	3	human	human	ADJ
dti-2707	341	4	gingival	gingival	NOUN
dti-2707	341	5	epithelial	epithelial	ADJ
dti-2707	341	6	cells	cell	NOUN
dti-2707	341	7	(	(	PUNCT
dti-2707	341	8	hgecs	hgec	NOUN
dti-2707	341	9	)	)	PUNCT
dti-2707	341	10	,	,	PUNCT
dti-2707	341	11	the	the	DET
dti-2707	341	12	cytotoxicity	cytotoxicity	NOUN
dti-2707	341	13	of	of	ADP
dti-2707	341	14	nano	nano	NOUN
dti-2707	341	15	-	-	PUNCT
dti-2707	341	16	ba	ba	PROPN
dti-2707	341	17	and	and	CCONJ
dti-2707	341	18	nano	nano	NOUN
dti-2707	341	19	-	-	PUNCT
dti-2707	341	20	be	be	AUX
dti-2707	341	21	was	be	AUX
dti-2707	341	22	examined	examine	VERB
dti-2707	341	23	,	,	PUNCT
dti-2707	341	24	and	and	CCONJ
dti-2707	341	25	a	a	DET
dti-2707	341	26	transmission	transmission	NOUN
dti-2707	341	27	electron	electron	NOUN
dti-2707	341	28	microscope	microscope	NOUN
dti-2707	341	29	was	be	AUX
dti-2707	341	30	used	use	VERB
dti-2707	341	31	to	to	PART
dti-2707	341	32	observe	observe	VERB
dti-2707	341	33	the	the	DET
dti-2707	341	34	cells	cell	NOUN
dti-2707	341	35	’	'	PUNCT
dti-2707	341	36	uptake	uptake	NOUN
dti-2707	341	37	of	of	ADP
dti-2707	341	38	the	the	DET
dti-2707	341	39	compounds	compound	NOUN
dti-2707	341	40	.	.	PUNCT
dti-2707	342	1	their	their	PRON
dti-2707	342	2	anti	anti	ADJ
dti-2707	342	3	-	-	ADJ
dti-2707	342	4	inflammatory	inflammatory	ADJ
dti-2707	342	5	effects	effect	NOUN
dti-2707	342	6	in	in	ADP
dti-2707	342	7	il-1	il-1	ADV
dti-2707	342	8	-	-	PUNCT
dti-2707	342	9	treated	treat	VERB
dti-2707	342	10	hgecs	hgec	NOUN
dti-2707	342	11	were	be	AUX
dti-2707	342	12	measured	measure	VERB
dti-2707	342	13	using	use	VERB
dti-2707	342	14	the	the	DET
dti-2707	342	15	cytokine	cytokine	NOUN
dti-2707	342	16	array	array	NOUN
dti-2707	342	17	and	and	CCONJ
dti-2707	342	18	the	the	DET
dti-2707	342	19	enzyme	enzyme	NOUN
dti-2707	342	20	-	-	PUNCT
dti-2707	342	21	linked	link	VERB
dti-2707	342	22	immunosorbent	immunosorbent	ADJ
dti-2707	342	23	test	test	NOUN
dti-2707	342	24	.	.	PUNCT
dti-2707	343	1	this	this	DET
dti-2707	343	2	study	study	NOUN
dti-2707	343	3	shows	show	VERB
dti-2707	343	4	that	that	SCONJ
dti-2707	343	5	amine	amine	NOUN
dti-2707	343	6	-	-	PUNCT
dti-2707	343	7	modified	modify	VERB
dti-2707	343	8	msns	msns	NOUN
dti-2707	343	9	are	be	AUX
dti-2707	343	10	capable	capable	ADJ
dti-2707	343	11	of	of	ADP
dti-2707	343	12	encapsulating	encapsulate	VERB
dti-2707	343	13	ba	ba	PROPN
dti-2707	343	14	and	and	CCONJ
dti-2707	343	15	be	be	AUX
dti-2707	343	16	,	,	PUNCT
dti-2707	343	17	and	and	CCONJ
dti-2707	343	18	that	that	SCONJ
dti-2707	343	19	this	this	DET
dti-2707	343	20	nano	nano	NOUN
dti-2707	343	21	-	-	PUNCT
dti-2707	343	22	encapsulation	encapsulation	NOUN
dti-2707	343	23	greatly	greatly	ADV
dti-2707	343	24	increases	increase	VERB
dti-2707	343	25	the	the	DET
dti-2707	343	26	rate	rate	NOUN
dti-2707	343	27	of	of	ADP
dti-2707	343	28	drug	drug	NOUN
dti-2707	343	29	delivery	delivery	NOUN
dti-2707	343	30	and	and	CCONJ
dti-2707	343	31	prolongs	prolong	VERB
dti-2707	343	32	the	the	DET
dti-2707	343	33	release	release	NOUN
dti-2707	343	34	of	of	ADP
dti-2707	343	35	ba	ba	PROPN
dti-2707	343	36	and	and	CCONJ
dti-2707	343	37	be	be	AUX
dti-2707	343	38	for	for	ADP
dti-2707	343	39	up	up	ADP
dti-2707	343	40	to	to	PART
dti-2707	343	41	216	216	NUM
dti-2707	343	42	hours	hour	NOUN
dti-2707	343	43	.	.	PUNCT
dti-2707	344	1	furthermore	furthermore	ADV
dti-2707	344	2	,	,	PUNCT
dti-2707	344	3	when	when	SCONJ
dti-2707	344	4	exposed	expose	VERB
dti-2707	344	5	to	to	ADP
dti-2707	344	6	a	a	DET
dti-2707	344	7	solution	solution	NOUN
dti-2707	344	8	devoid	devoid	ADJ
dti-2707	344	9	of	of	ADP
dti-2707	344	10	nps	nps	PROPN
dti-2707	344	11	,	,	PUNCT
dti-2707	344	12	hgecs	hgec	NOUN
dti-2707	344	13	were	be	AUX
dti-2707	344	14	able	able	ADJ
dti-2707	344	15	to	to	PART
dti-2707	344	16	internalize	internalize	VERB
dti-2707	344	17	nano	nano	NOUN
dti-2707	344	18	-	-	PUNCT
dti-2707	344	19	ba	ba	NOUN
dti-2707	344	20	and	and	CCONJ
dti-2707	344	21	nano	nano	NOUN
dti-2707	344	22	-	-	PUNCT
dti-2707	344	23	be	be	AUX
dti-2707	344	24	and	and	CCONJ
dti-2707	344	25	maintain	maintain	VERB
dti-2707	344	26	them	they	PRON
dti-2707	344	27	inside	inside	ADP
dti-2707	344	28	the	the	DET
dti-2707	344	29	cells	cell	NOUN
dti-2707	344	30	for	for	ADP
dti-2707	344	31	at	at	ADV
dti-2707	344	32	least	least	ADV
dti-2707	344	33	24	24	NUM
dti-2707	344	34	hours	hour	NOUN
dti-2707	344	35	.	.	PUNCT
dti-2707	345	1	it	it	PRON
dti-2707	345	2	is	be	AUX
dti-2707	345	3	noteworthy	noteworthy	ADJ
dti-2707	345	4	that	that	SCONJ
dti-2707	345	5	il-1	il-1	ADV
dti-2707	345	6	-	-	PUNCT
dti-2707	345	7	induced	induce	VERB
dti-2707	345	8	expression	expression	NOUN
dti-2707	345	9	of	of	ADP
dti-2707	345	10	il-6	il-6	NOUN
dti-2707	345	11	and	and	CCONJ
dti-2707	345	12	il-8	il-8	NOUN
dti-2707	345	13	in	in	ADP
dti-2707	345	14	hgecs	hgec	NOUN
dti-2707	345	15	is	be	AUX
dti-2707	345	16	effectively	effectively	ADV
dti-2707	345	17	suppressed	suppress	VERB
dti-2707	345	18	by	by	ADP
dti-2707	345	19	pretreatment	pretreatment	NOUN
dti-2707	345	20	with	with	ADP
dti-2707	345	21	nano	nano	NOUN
dti-2707	345	22	-	-	PUNCT
dti-2707	345	23	be	be	AUX
dti-2707	345	24	.	.	PUNCT
dti-2707	345	25	to	to	PART
dti-2707	345	26	summarize	summarize	VERB
dti-2707	345	27	,	,	PUNCT
dti-2707	345	28	be	be	AUX
dti-2707	345	29	encapsulated	encapsulate	VERB
dti-2707	345	30	in	in	ADP
dti-2707	345	31	a	a	DET
dti-2707	345	32	np	np	NOUN
dti-2707	345	33	may	may	AUX
dti-2707	345	34	efficiently	efficiently	ADV
dti-2707	345	35	release	release	VERB
dti-2707	345	36	its	its	PRON
dti-2707	345	37	contents	content	NOUN
dti-2707	345	38	and	and	CCONJ
dti-2707	345	39	be	be	AUX
dti-2707	345	40	taken	take	VERB
dti-2707	345	41	up	up	ADP
dti-2707	345	42	by	by	ADP
dti-2707	345	43	cells	cell	NOUN
dti-2707	345	44	,	,	PUNCT
dti-2707	345	45	which	which	PRON
dti-2707	345	46	has	have	VERB
dti-2707	345	47	major	major	ADJ
dti-2707	345	48	anti	anti	ADJ
dti-2707	345	49	-	-	ADJ
dti-2707	345	50	inflammatory	inflammatory	ADJ
dti-2707	345	51	effects	effect	NOUN
dti-2707	345	52	(	(	PUNCT
dti-2707	345	53	134	134	NUM
dti-2707	345	54	)	)	PUNCT
dti-2707	345	55	.	.	PUNCT
dti-2707	346	1	researchers	researcher	NOUN
dti-2707	346	2	created	create	VERB
dti-2707	346	3	a	a	DET
dti-2707	346	4	ph	ph	ADJ
dti-2707	346	5	-	-	PUNCT
dti-2707	346	6	responsive	responsive	ADJ
dti-2707	346	7	drug	drug	NOUN
dti-2707	346	8	delivery	delivery	NOUN
dti-2707	346	9	system	system	NOUN
dti-2707	346	10	(	(	PUNCT
dti-2707	346	11	dds	dds	PROPN
dti-2707	346	12	)	)	PUNCT
dti-2707	346	13	encapsulating	encapsulate	VERB
dti-2707	346	14	baicalein	baicalein	NOUN
dti-2707	346	15	zeolite	zeolite	NOUN
dti-2707	346	16	imidazole	imidazole	NOUN
dti-2707	346	17	framework-8	framework-8	NUM
dti-2707	346	18	(	(	PUNCT
dti-2707	346	19	zif-8	zif-8	NUM
dti-2707	346	20	)	)	PUNCT
dti-2707	346	21	.	.	PUNCT
dti-2707	347	1	the	the	DET
dti-2707	347	2	synthesized	synthesize	VERB
dti-2707	347	3	nanocomposite	nanocomposite	NOUN
dti-2707	347	4	exhibited	exhibit	VERB
dti-2707	347	5	a	a	DET
dti-2707	347	6	drug	drug	NOUN
dti-2707	347	7	-	-	PUNCT
dti-2707	347	8	loading	loading	NOUN
dti-2707	347	9	capacity	capacity	NOUN
dti-2707	347	10	of	of	ADP
dti-2707	347	11	40.32	40.32	NUM
dti-2707	347	12	%	%	NOUN
dti-2707	347	13	.	.	PUNCT
dti-2707	348	1	the	the	DET
dti-2707	348	2	in	in	ADV
dti-2707	348	3	vitro	vitro	X
dti-2707	348	4	drug	drug	NOUN
dti-2707	348	5	release	release	NOUN
dti-2707	348	6	kinetics	kinetic	NOUN
dti-2707	348	7	from	from	ADP
dti-2707	348	8	the	the	DET
dti-2707	348	9	nanocomposite	nanocomposite	NOUN
dti-2707	348	10	showed	show	VERB
dti-2707	348	11	excellent	excellent	ADJ
dti-2707	348	12	stimuli	stimulus	NOUN
dti-2707	348	13	-	-	PUNCT
dti-2707	348	14	responsive	responsive	ADJ
dti-2707	348	15	drug	drug	NOUN
dti-2707	348	16	release	release	NOUN
dti-2707	348	17	capabilities	capability	NOUN
dti-2707	348	18	in	in	ADP
dti-2707	348	19	an	an	DET
dti-2707	348	20	acidic	acidic	ADJ
dti-2707	348	21	environment	environment	NOUN
dti-2707	348	22	.	.	PUNCT
dti-2707	349	1	the	the	DET
dti-2707	349	2	growth	growth	NOUN
dti-2707	349	3	of	of	ADP
dti-2707	349	4	e.	e.	PROPN
dti-2707	349	5	coli	coli	PROPN
dti-2707	349	6	,	,	PUNCT
dti-2707	349	7	s.	s.	PROPN
dti-2707	349	8	aureus	aureus	PROPN
dti-2707	349	9	,	,	PUNCT
dti-2707	349	10	p.	p.	NOUN
dti-2707	349	11	aeruginosa	aeruginosa	PROPN
dti-2707	349	12	,	,	PUNCT
dti-2707	349	13	and	and	CCONJ
dti-2707	349	14	staphylococcus	staphylococcus	NOUN
dti-2707	349	15	epidermidis	epidermidi	NOUN
dti-2707	349	16	was	be	AUX
dti-2707	349	17	significantly	significantly	ADV
dti-2707	349	18	inhibited	inhibit	VERB
dti-2707	349	19	by	by	ADP
dti-2707	349	20	the	the	DET
dti-2707	349	21	nanocomposite	nanocomposite	NOUN
dti-2707	349	22	.	.	PUNCT
dti-2707	350	1	the	the	DET
dti-2707	350	2	synergistic	synergistic	ADJ
dti-2707	350	3	effect	effect	NOUN
dti-2707	350	4	of	of	ADP
dti-2707	350	5	zinc	zinc	NOUN
dti-2707	350	6	(	(	PUNCT
dti-2707	350	7	ii	ii	NOUN
dti-2707	350	8	)	)	PUNCT
dti-2707	350	9	ions	ion	NOUN
dti-2707	350	10	and	and	CCONJ
dti-2707	350	11	baicalein	baicalein	NOUN
dti-2707	350	12	molecules	molecule	NOUN
dti-2707	350	13	was	be	AUX
dti-2707	350	14	demonstrated	demonstrate	VERB
dti-2707	350	15	to	to	PART
dti-2707	350	16	be	be	AUX
dti-2707	350	17	the	the	DET
dti-2707	350	18	antibacterial	antibacterial	ADJ
dti-2707	350	19	mechanism	mechanism	NOUN
dti-2707	350	20	of	of	ADP
dti-2707	350	21	the	the	DET
dti-2707	350	22	ba@zif-8	ba@zif-8	PROPN
dti-2707	350	23	nanocomposite	nanocomposite	NOUN
dti-2707	350	24	.	.	PUNCT
dti-2707	351	1	according	accord	VERB
dti-2707	351	2	to	to	ADP
dti-2707	351	3	in	in	ADP
dti-2707	351	4	vitro	vitro	X
dti-2707	351	5	biocompatibility	biocompatibility	NOUN
dti-2707	351	6	tests	test	NOUN
dti-2707	351	7	,	,	PUNCT
dti-2707	351	8	ba@zif-8	ba@zif-8	PROPN
dti-2707	351	9	did	do	AUX
dti-2707	351	10	not	not	PART
dti-2707	351	11	cause	cause	VERB
dti-2707	351	12	any	any	DET
dti-2707	351	13	cytotoxicity	cytotoxicity	NOUN
dti-2707	351	14	in	in	ADP
dti-2707	351	15	l929	l929	NOUN
dti-2707	351	16	fibroblast	fibroblast	ADJ
dti-2707	351	17	cells	cell	NOUN
dti-2707	351	18	.	.	PUNCT
dti-2707	352	1	the	the	DET
dti-2707	352	2	created	create	VERB
dti-2707	352	3	nanocomposite	nanocomposite	NOUN
dti-2707	352	4	dramatically	dramatically	ADV
dti-2707	352	5	enhanced	enhance	VERB
dti-2707	352	6	the	the	DET
dti-2707	352	7	number	number	NOUN
dti-2707	352	8	of	of	ADP
dti-2707	352	9	proliferating	proliferate	VERB
dti-2707	352	10	and	and	CCONJ
dti-2707	352	11	migrating	migrating	NOUN
dti-2707	352	12	cells	cell	NOUN
dti-2707	352	13	in	in	ADP
dti-2707	352	14	the	the	DET
dti-2707	352	15	wounded	wounded	ADJ
dti-2707	352	16	area	area	NOUN
dti-2707	352	17	,	,	PUNCT
dti-2707	352	18	according	accord	VERB
dti-2707	352	19	to	to	ADP
dti-2707	352	20	tests	test	NOUN
dti-2707	352	21	conducted	conduct	VERB
dti-2707	352	22	on	on	ADP
dti-2707	352	23	a	a	DET
dti-2707	352	24	scratch	scratch	NOUN
dti-2707	352	25	wound	wound	NOUN
dti-2707	352	26	.	.	PUNCT
dti-2707	353	1	according	accord	VERB
dti-2707	353	2	to	to	ADP
dti-2707	353	3	the	the	DET
dti-2707	353	4	findings	finding	NOUN
dti-2707	353	5	of	of	ADP
dti-2707	353	6	the	the	DET
dti-2707	353	7	ph	ph	ADJ
dti-2707	353	8	-	-	PUNCT
dti-2707	353	9	responsive	responsive	ADJ
dti-2707	353	10	drug	drug	NOUN
dti-2707	353	11	release	release	NOUN
dti-2707	353	12	mechanism	mechanism	NOUN
dti-2707	353	13	,	,	PUNCT
dti-2707	353	14	the	the	DET
dti-2707	353	15	synthesized	synthesize	VERB
dti-2707	353	16	nanocomposite	nanocomposite	NOUN
dti-2707	353	17	exhibited	exhibit	VERB
dti-2707	353	18	greater	great	ADJ
dti-2707	353	19	stability	stability	NOUN
dti-2707	353	20	at	at	ADP
dti-2707	353	21	a	a	DET
dti-2707	353	22	neutral	neutral	ADJ
dti-2707	353	23	ph	ph	NOUN
dti-2707	353	24	.	.	PUNCT
dti-2707	354	1	the	the	DET
dti-2707	354	2	nanocomposite	nanocomposite	NOUN
dti-2707	354	3	demonstrated	demonstrate	VERB
dti-2707	354	4	rapid	rapid	ADJ
dti-2707	354	5	baicalein	baicalein	NOUN
dti-2707	354	6	release	release	NOUN
dti-2707	354	7	(	(	PUNCT
dti-2707	354	8	65.8	65.8	NUM
dti-2707	354	9	%	%	NOUN
dti-2707	354	10	)	)	PUNCT
dti-2707	354	11	in	in	ADP
dti-2707	354	12	acidic	acidic	ADJ
dti-2707	354	13	conditions	condition	NOUN
dti-2707	354	14	,	,	PUNCT
dti-2707	354	15	indicating	indicate	VERB
dti-2707	354	16	that	that	SCONJ
dti-2707	354	17	it	it	PRON
dti-2707	354	18	is	be	AUX
dti-2707	354	19	a	a	DET
dti-2707	354	20	great	great	ADJ
dti-2707	354	21	choice	choice	NOUN
dti-2707	354	22	for	for	ADP
dti-2707	354	23	ph	ph	ADJ
dti-2707	354	24	-	-	PUNCT
dti-2707	354	25	responsive	responsive	ADJ
dti-2707	354	26	drug	drug	NOUN
dti-2707	354	27	delivery	delivery	NOUN
dti-2707	354	28	(	(	PUNCT
dti-2707	354	29	135	135	NUM
dti-2707	354	30	)	)	PUNCT
dti-2707	354	31	.	.	PUNCT
dti-2707	355	1	this	this	DET
dti-2707	355	2	investigation	investigation	NOUN
dti-2707	355	3	of	of	ADP
dti-2707	355	4	the	the	DET
dti-2707	355	5	anticancer	anticancer	NOUN
dti-2707	355	6	properties	property	NOUN
dti-2707	355	7	of	of	ADP
dti-2707	355	8	bsabaicalein	bsabaicalein	PROPN
dti-2707	355	9	@zn	@zn	NOUN
dti-2707	355	10	-	-	PUNCT
dti-2707	355	11	glu	glu	NOUN
dti-2707	355	12	nanostructure	nanostructure	NOUN
dti-2707	355	13	-	-	PUNCT
dti-2707	355	14	mediated	mediate	VERB
dti-2707	355	15	glurs	glur	NOUN
dti-2707	355	16	was	be	AUX
dti-2707	355	17	conducted	conduct	VERB
dti-2707	355	18	using	use	VERB
dti-2707	355	19	human	human	ADJ
dti-2707	355	20	glioblastoma	glioblastoma	NOUN
dti-2707	355	21	u87	u87	ADJ
dti-2707	355	22	cells	cell	NOUN
dti-2707	355	23	.	.	PUNCT
dti-2707	356	1	the	the	DET
dti-2707	356	2	transport	transport	NOUN
dti-2707	356	3	of	of	ADP
dti-2707	356	4	baicalein	baicalein	PROPN
dti-2707	356	5	active	active	ADJ
dti-2707	356	6	component	component	NOUN
dti-2707	356	7	was	be	AUX
dti-2707	356	8	studied	study	VERB
dti-2707	356	9	with	with	ADP
dti-2707	356	10	hybrid	hybrid	ADJ
dti-2707	356	11	nps	nps	PROPN
dti-2707	356	12	of	of	ADP
dti-2707	356	13	bsa	bsa	PROPN
dti-2707	356	14	-	-	PUNCT
dti-2707	356	15	ba@zn	ba@zn	PROPN
dti-2707	356	16	-	-	PUNCT
dti-2707	356	17	glu	glu	NOUN
dti-2707	356	18	.	.	PUNCT
dti-2707	357	1	bsa	bsa	PROPN
dti-2707	357	2	-	-	PUNCT
dti-2707	357	3	ba@zn	ba@zn	PROPN
dti-2707	357	4	-	-	PUNCT
dti-2707	357	5	glu	glu	PROPN
dti-2707	357	6	nps	nps	PROPN
dti-2707	357	7	were	be	AUX
dti-2707	357	8	effectively	effectively	ADV
dti-2707	357	9	synthesized	synthesize	VERB
dti-2707	357	10	in	in	ADP
dti-2707	357	11	a	a	DET
dti-2707	357	12	single	single	ADJ
dti-2707	357	13	reduction	reduction	NOUN
dti-2707	357	14	process	process	NOUN
dti-2707	357	15	.	.	PUNCT
dti-2707	358	1	the	the	DET
dti-2707	358	2	cytotoxic	cytotoxic	ADJ
dti-2707	358	3	efficacy	efficacy	NOUN
dti-2707	358	4	and	and	CCONJ
dti-2707	358	5	apoptotic	apoptotic	ADJ
dti-2707	358	6	rate	rate	NOUN
dti-2707	358	7	of	of	ADP
dti-2707	358	8	the	the	DET
dti-2707	358	9	nanostructures	nanostructure	NOUN
dti-2707	358	10	on	on	ADP
dti-2707	358	11	u87	u87	ADJ
dti-2707	358	12	glioblastoma	glioblastoma	NOUN
dti-2707	358	13	cells	cell	NOUN
dti-2707	358	14	were	be	AUX
dti-2707	358	15	assessed	assess	VERB
dti-2707	358	16	using	use	VERB
dti-2707	358	17	3-(4,5	3-(4,5	NOUN
dti-2707	358	18	-	-	PUNCT
dti-2707	358	19	dimethylthiazol	dimethylthiazol	VERB
dti-2707	358	20	-	-	PUNCT
dti-2707	358	21	a	a	DET
dti-2707	358	22	-	-	PUNCT
dti-2707	358	23	yl)-2,5	yl)-2,5	NOUN
dti-2707	358	24	diphenyltetrazolium	diphenyltetrazolium	NOUN
dti-2707	358	25	bromide	bromide	NOUN
dti-2707	358	26	(	(	PUNCT
dti-2707	358	27	mtt	mtt	NOUN
dti-2707	358	28	)	)	PUNCT
dti-2707	358	29	assays	assay	NOUN
dti-2707	358	30	and	and	CCONJ
dti-2707	358	31	flow	flow	NOUN
dti-2707	358	32	cytometry	cytometry	NOUN
dti-2707	358	33	,	,	PUNCT
dti-2707	358	34	respectively	respectively	ADV
dti-2707	358	35	.	.	PUNCT
dti-2707	359	1	the	the	DET
dti-2707	359	2	synthesized	synthesize	VERB
dti-2707	359	3	bsa	bsa	PROPN
dti-2707	359	4	-	-	PUNCT
dti-2707	359	5	ba@	ba@	PROPN
dti-2707	359	6	zn	zn	PROPN
dti-2707	359	7	-	-	PUNCT
dti-2707	359	8	glu	glu	NOUN
dti-2707	359	9	nanostructures	nanostructure	NOUN
dti-2707	359	10	,	,	PUNCT
dti-2707	359	11	with	with	ADP
dti-2707	359	12	diameters	diameter	NOUN
dti-2707	359	13	ranging	range	VERB
dti-2707	359	14	from	from	ADP
dti-2707	359	15	142.40	142.40	NUM
dti-2707	359	16	to	to	ADP
dti-2707	359	17	177.10	177.10	NUM
dti-2707	359	18	nm	nm	NOUN
dti-2707	359	19	and	and	CCONJ
dti-2707	359	20	zeta	zeta	NOUN
dti-2707	359	21	potentials	potential	VERB
dti-2707	359	22	between	between	ADP
dti-2707	359	23	10.57	10.57	NUM
dti-2707	359	24	and	and	CCONJ
dti-2707	359	25	35.77	35.77	NUM
dti-2707	359	26	mv	mv	NOUN
dti-2707	359	27	,	,	PUNCT
dti-2707	359	28	have	have	VERB
dti-2707	359	29	the	the	DET
dti-2707	359	30	potential	potential	NOUN
dti-2707	359	31	to	to	PART
dti-2707	359	32	extravasate	extravasate	VERB
dti-2707	359	33	into	into	ADP
dti-2707	359	34	cancer	cancer	NOUN
dti-2707	359	35	cells	cell	NOUN
dti-2707	359	36	.	.	PUNCT
dti-2707	360	1	the	the	DET
dti-2707	360	2	drug	drug	NOUN
dti-2707	360	3	release	release	NOUN
dti-2707	360	4	of	of	ADP
dti-2707	360	5	bsa	bsa	PROPN
dti-2707	360	6	-	-	PUNCT
dti-2707	360	7	ba@zn	ba@zn	PROPN
dti-2707	360	8	nps	nps	PROPN
dti-2707	360	9	was	be	AUX
dti-2707	360	10	both	both	PRON
dti-2707	360	11	ph	ph	ADJ
dti-2707	360	12	-	-	ADJ
dti-2707	360	13	dependent	dependent	ADJ
dti-2707	360	14	and	and	CCONJ
dti-2707	360	15	ph	ph	VERB
dti-2707	360	16	-	-	PUNCT
dti-2707	360	17	controlled	control	VERB
dti-2707	360	18	.	.	PUNCT
dti-2707	361	1	in	in	ADP
dti-2707	361	2	vitro	vitro	X
dti-2707	361	3	,	,	PUNCT
dti-2707	361	4	it	it	PRON
dti-2707	361	5	was	be	AUX
dti-2707	361	6	demonstrated	demonstrate	VERB
dti-2707	361	7	that	that	SCONJ
dti-2707	361	8	bsa	bsa	PROPN
dti-2707	361	9	-	-	PUNCT
dti-2707	361	10	ba@	ba@	PROPN
dti-2707	361	11	zn	zn	PROPN
dti-2707	361	12	-	-	PUNCT
dti-2707	361	13	glu	glu	PROPN
dti-2707	361	14	nps	nps	PROPN
dti-2707	361	15	significantly	significantly	ADV
dti-2707	361	16	reduced	reduce	VERB
dti-2707	361	17	cell	cell	NOUN
dti-2707	361	18	viability	viability	NOUN
dti-2707	361	19	and	and	CCONJ
dti-2707	361	20	increased	increase	VERB
dti-2707	361	21	apoptosis	apoptosis	NOUN
dti-2707	361	22	in	in	ADP
dti-2707	361	23	u87	u87	ADJ
dti-2707	361	24	cancer	cancer	NOUN
dti-2707	361	25	cells	cell	NOUN
dti-2707	361	26	.	.	PUNCT
dti-2707	362	1	a	a	DET
dti-2707	362	2	green	green	ADJ
dti-2707	362	3	manufacturing	manufacturing	NOUN
dti-2707	362	4	approach	approach	NOUN
dti-2707	362	5	was	be	AUX
dti-2707	362	6	used	use	VERB
dti-2707	362	7	to	to	PART
dti-2707	362	8	create	create	VERB
dti-2707	362	9	zn	zn	PROPN
dti-2707	362	10	nps	nps	PROPN
dti-2707	362	11	,	,	PUNCT
dti-2707	362	12	and	and	CCONJ
dti-2707	362	13	it	it	PRON
dti-2707	362	14	was	be	AUX
dti-2707	362	15	shown	show	VERB
dti-2707	362	16	that	that	SCONJ
dti-2707	362	17	these	these	DET
dti-2707	362	18	particles	particle	NOUN
dti-2707	362	19	had	have	VERB
dti-2707	362	20	a	a	DET
dti-2707	362	21	deadly	deadly	ADJ
dti-2707	362	22	effect	effect	NOUN
dti-2707	362	23	in	in	ADP
dti-2707	362	24	addition	addition	NOUN
dti-2707	362	25	to	to	ADP
dti-2707	362	26	increasing	increase	VERB
dti-2707	362	27	the	the	DET
dti-2707	362	28	uptake	uptake	NOUN
dti-2707	362	29	of	of	ADP
dti-2707	362	30	nps	nps	PROPN
dti-2707	362	31	by	by	ADP
dti-2707	362	32	cells	cell	NOUN
dti-2707	362	33	via	via	ADP
dti-2707	362	34	glu	glu	NOUN
dti-2707	362	35	receptors	receptor	NOUN
dti-2707	362	36	.	.	PUNCT
dti-2707	363	1	glu	glu	NOUN
dti-2707	363	2	conjugation	conjugation	NOUN
dti-2707	363	3	and	and	CCONJ
dti-2707	363	4	drug	drug	NOUN
dti-2707	363	5	delivery	delivery	NOUN
dti-2707	363	6	of	of	ADP
dti-2707	363	7	baicalein	baicalein	NOUN
dti-2707	363	8	were	be	AUX
dti-2707	363	9	achieved	achieve	VERB
dti-2707	363	10	through	through	ADP
dti-2707	363	11	the	the	DET
dti-2707	363	12	use	use	NOUN
dti-2707	363	13	of	of	ADP
dti-2707	363	14	bsa	bsa	PROPN
dti-2707	363	15	nps	nps	PROPN
dti-2707	363	16	as	as	ADP
dti-2707	363	17	a	a	DET
dti-2707	363	18	nano	nano	NOUN
dti-2707	363	19	-	-	PUNCT
dti-2707	363	20	platform	platform	NOUN
dti-2707	363	21	.	.	PUNCT
dti-2707	364	1	bsa	bsa	PROPN
dti-2707	364	2	-	-	PUNCT
dti-2707	364	3	ba@zn	ba@zn	PROPN
dti-2707	364	4	-	-	PUNCT
dti-2707	364	5	glu	glu	PROPN
dti-2707	364	6	nps	nps	PROPN
dti-2707	364	7	can	can	AUX
dti-2707	364	8	cause	cause	VERB
dti-2707	364	9	dose	dose	NOUN
dti-2707	364	10	-	-	PUNCT
dti-2707	364	11	dependent	dependent	ADJ
dti-2707	364	12	cytotoxicity	cytotoxicity	NOUN
dti-2707	364	13	and	and	CCONJ
dti-2707	364	14	death	death	NOUN
dti-2707	364	15	in	in	ADP
dti-2707	364	16	human	human	ADJ
dti-2707	364	17	brain	brain	NOUN
dti-2707	364	18	cancer	cancer	NOUN
dti-2707	364	19	cells	cell	NOUN
dti-2707	364	20	(	(	PUNCT
dti-2707	364	21	u87	u87	NOUN
dti-2707	364	22	)	)	PUNCT
dti-2707	364	23	.	.	PUNCT
dti-2707	365	1	finally	finally	ADV
dti-2707	365	2	,	,	PUNCT
dti-2707	365	3	future	future	ADJ
dti-2707	365	4	research	research	NOUN
dti-2707	365	5	on	on	ADP
dti-2707	365	6	targeted	target	VERB
dti-2707	365	7	medication	medication	NOUN
dti-2707	365	8	delivery	delivery	NOUN
dti-2707	365	9	in	in	ADP
dti-2707	365	10	vivo	vivo	NOUN
dti-2707	365	11	may	may	AUX
dti-2707	365	12	make	make	VERB
dti-2707	365	13	use	use	NOUN
dti-2707	365	14	of	of	ADP
dti-2707	365	15	this	this	DET
dti-2707	365	16	nanostructure	nanostructure	NOUN
dti-2707	365	17	.	.	PUNCT
dti-2707	366	1	it	it	PRON
dti-2707	366	2	may	may	AUX
dti-2707	366	3	also	also	ADV
dti-2707	366	4	be	be	AUX
dti-2707	366	5	paired	pair	VERB
dti-2707	366	6	with	with	ADP
dti-2707	366	7	other	other	ADJ
dti-2707	366	8	treatments	treatment	NOUN
dti-2707	366	9	,	,	PUNCT
dti-2707	366	10	such	such	ADJ
dti-2707	366	11	as	as	ADP
dti-2707	366	12	x	x	NOUN
dti-2707	366	13	-	-	NOUN
dti-2707	366	14	ray	ray	NOUN
dti-2707	366	15	irradiation	irradiation	NOUN
dti-2707	366	16	(	(	PUNCT
dti-2707	366	17	table	table	NOUN
dti-2707	366	18	3	3	NUM
dti-2707	366	19	)	)	PUNCT
dti-2707	366	20	(	(	PUNCT
dti-2707	366	21	136	136	NUM
dti-2707	366	22	)	)	PUNCT
dti-2707	366	23	.	.	PUNCT
dti-2707	367	1	patents	patent	NOUN
dti-2707	367	2	on	on	ADP
dti-2707	367	3	baicalein	baicalein	NOUN
dti-2707	367	4	the	the	DET
dti-2707	367	5	patents	patent	NOUN
dti-2707	367	6	related	relate	VERB
dti-2707	367	7	to	to	ADP
dti-2707	367	8	pharmacological	pharmacological	ADJ
dti-2707	367	9	activity	activity	NOUN
dti-2707	367	10	of	of	ADP
dti-2707	367	11	baicalein	baicalein	NOUN
dti-2707	367	12	have	have	AUX
dti-2707	367	13	been	be	AUX
dti-2707	367	14	tabulated	tabulate	VERB
dti-2707	367	15	in	in	ADP
dti-2707	367	16	table	table	NOUN
dti-2707	367	17	4	4	NUM
dti-2707	367	18	.	.	PUNCT
dti-2707	368	1	conclusion	conclusion	NOUN
dti-2707	368	2	this	this	DET
dti-2707	368	3	systematic	systematic	ADJ
dti-2707	368	4	review	review	NOUN
dti-2707	368	5	provides	provide	VERB
dti-2707	368	6	a	a	DET
dti-2707	368	7	new	new	ADJ
dti-2707	368	8	scientific	scientific	ADJ
dti-2707	368	9	and	and	CCONJ
dti-2707	368	10	modern	modern	ADJ
dti-2707	368	11	perspective	perspective	NOUN
dti-2707	368	12	on	on	ADP
dti-2707	368	13	the	the	DET
dti-2707	368	14	traditional	traditional	ADJ
dti-2707	368	15	chinese	chinese	ADJ
dti-2707	368	16	medicine	medicine	NOUN
dti-2707	368	17	baicalein	baicalein	NOUN
dti-2707	368	18	as	as	ADP
dti-2707	368	19	a	a	DET
dti-2707	368	20	possible	possible	ADJ
dti-2707	368	21	supplementary	supplementary	ADJ
dti-2707	368	22	therapy	therapy	NOUN
dti-2707	368	23	.	.	PUNCT
dti-2707	369	1	baicalein	baicalein	PROPN
dti-2707	369	2	contains	contain	VERB
dti-2707	369	3	anticancer	anticancer	NOUN
dti-2707	369	4	,	,	PUNCT
dti-2707	369	5	antimicrobial	antimicrobial	ADJ
dti-2707	369	6	,	,	PUNCT
dti-2707	369	7	antidiabetic	antidiabetic	ADJ
dti-2707	369	8	,	,	PUNCT
dti-2707	369	9	and	and	CCONJ
dti-2707	369	10	antiaging	antiage	VERB
dti-2707	369	11	properties	property	NOUN
dti-2707	369	12	in	in	ADP
dti-2707	369	13	addition	addition	NOUN
dti-2707	369	14	to	to	ADP
dti-2707	369	15	protective	protective	ADJ
dti-2707	369	16	effects	effect	NOUN
dti-2707	369	17	on	on	ADP
dti-2707	369	18	the	the	DET
dti-2707	369	19	brain	brain	NOUN
dti-2707	369	20	,	,	PUNCT
dti-2707	369	21	heart	heart	NOUN
dti-2707	369	22	,	,	PUNCT
dti-2707	369	23	lungs	lung	NOUN
dti-2707	369	24	,	,	PUNCT
dti-2707	369	25	stomach	stomach	NOUN
dti-2707	369	26	,	,	PUNCT
dti-2707	369	27	hepatic	hepatic	NOUN
dti-2707	369	28	,	,	PUNCT
dti-2707	369	29	and	and	CCONJ
dti-2707	369	30	renal	renal	ADJ
dti-2707	369	31	systems	system	NOUN
dti-2707	369	32	,	,	PUNCT
dti-2707	369	33	based	base	VERB
dti-2707	369	34	on	on	ADP
dti-2707	369	35	the	the	DET
dti-2707	369	36	published	publish	VERB
dti-2707	369	37	data	datum	NOUN
dti-2707	369	38	reviewed	review	VERB
dti-2707	369	39	.	.	PUNCT
dti-2707	370	1	repeatedly	repeatedly	ADV
dti-2707	370	2	administering	administer	VERB
dti-2707	370	3	baicalein	baicalein	NOUN
dti-2707	370	4	orally	orally	ADV
dti-2707	370	5	,	,	PUNCT
dti-2707	370	6	at	at	ADP
dti-2707	370	7	dosages	dosage	NOUN
dti-2707	370	8	ranging	range	VERB
dti-2707	370	9	from	from	ADP
dti-2707	370	10	200	200	NUM
dti-2707	370	11	to	to	PART
dti-2707	370	12	600	600	NUM
dti-2707	370	13	mg	mg	NUM
dti-2707	370	14	,	,	PUNCT
dti-2707	370	15	was	be	AUX
dti-2707	370	16	shown	show	VERB
dti-2707	370	17	to	to	PART
dti-2707	370	18	be	be	AUX
dti-2707	370	19	safe	safe	ADJ
dti-2707	370	20	and	and	CCONJ
dti-2707	370	21	well	well	ADV
dti-2707	370	22	-	-	PUNCT
dti-2707	370	23	tolerated	tolerate	VERB
dti-2707	370	24	by	by	ADP
dti-2707	370	25	healthy	healthy	ADJ
dti-2707	370	26	individuals	individual	NOUN
dti-2707	370	27	.	.	PUNCT
dti-2707	371	1	there	there	ADV
dti-2707	371	2	therapeutic	therapeutic	ADJ
dti-2707	371	3	insights	insight	NOUN
dti-2707	371	4	into	into	ADP
dti-2707	371	5	baicalein40	baicalein40	NOUN
dti-2707	371	6	©	©	ADP
dti-2707	371	7	2024	2024	NUM
dti-2707	371	8	the	the	DET
dti-2707	371	9	authors	author	NOUN
dti-2707	371	10	.	.	PUNCT
dti-2707	372	1	drug	drug	NOUN
dti-2707	372	2	target	target	NOUN
dti-2707	372	3	insights	insight	NOUN
dti-2707	372	4	issn	issn	VERB
dti-2707	372	5	1177	1177	NUM
dti-2707	372	6	-	-	SYM
dti-2707	372	7	3928	3928	NUM
dti-2707	372	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2707	372	9	table	table	NOUN
dti-2707	372	10	3	3	NUM
dti-2707	372	11	studies	study	NOUN
dti-2707	372	12	of	of	ADP
dti-2707	372	13	nano	nano	NOUN
dti-2707	372	14	-	-	PUNCT
dti-2707	372	15	formulated	formulate	VERB
dti-2707	372	16	baicalein	baicalein	NOUN
dti-2707	372	17	/	/	SYM
dti-2707	372	18	baicalin	baicalin	NOUN
dti-2707	372	19	in	in	ADP
dti-2707	372	20	several	several	ADJ
dti-2707	372	21	disorders	disorder	NOUN
dti-2707	372	22	s.	s.	PROPN
dti-2707	372	23	no	no	INTJ
dti-2707	372	24	.	.	PUNCT
dti-2707	373	1	disorder	disorder	NOUN
dti-2707	373	2	formulation	formulation	NOUN
dti-2707	373	3	combination	combination	NOUN
dti-2707	373	4	application	application	NOUN
dti-2707	373	5	outcome	outcome	NOUN
dti-2707	373	6	reference	reference	NOUN
dti-2707	373	7	1	1	NUM
dti-2707	373	8	.	.	PUNCT
dti-2707	374	1	diabetes	diabetes	NOUN
dti-2707	374	2	nlc	nlc	PROPN
dti-2707	374	3	no	no	INTJ
dti-2707	374	4	in	in	ADP
dti-2707	374	5	vitro	vitro	X
dti-2707	374	6	and	and	CCONJ
dti-2707	374	7	in	in	ADP
dti-2707	374	8	vivo	vivo	ADJ
dti-2707	374	9	b	b	PROPN
dti-2707	374	10	-	-	PUNCT
dti-2707	374	11	nlcs	nlcs	NOUN
dti-2707	374	12	possess	possess	VERB
dti-2707	374	13	favorable	favorable	ADJ
dti-2707	374	14	physical	physical	ADJ
dti-2707	374	15	stability	stability	NOUN
dti-2707	374	16	and	and	CCONJ
dti-2707	374	17	enhanced	enhanced	ADJ
dti-2707	374	18	capability	capability	NOUN
dti-2707	374	19	for	for	ADP
dti-2707	374	20	drug	drug	NOUN
dti-2707	374	21	retention	retention	NOUN
dti-2707	374	22	along	along	ADP
dti-2707	374	23	with	with	ADP
dti-2707	374	24	improved	improved	ADJ
dti-2707	374	25	antidiabetic	antidiabetic	ADJ
dti-2707	374	26	effectiveness	effectiveness	NOUN
dti-2707	374	27	(	(	PUNCT
dti-2707	374	28	137	137	NUM
dti-2707	374	29	)	)	PUNCT
dti-2707	374	30	selenium	selenium	NOUN
dti-2707	374	31	nps	nps	PROPN
dti-2707	374	32	naringenin	naringenin	PROPN
dti-2707	374	33	+	+	CCONJ
dti-2707	374	34	baicalin	baicalin	NOUN
dti-2707	374	35	in	in	ADP
dti-2707	374	36	vitro	vitro	X
dti-2707	374	37	and	and	CCONJ
dti-2707	374	38	in	in	ADP
dti-2707	374	39	vivo	vivo	NOUN
dti-2707	374	40	maintain	maintain	VERB
dti-2707	374	41	optimal	optimal	ADJ
dti-2707	374	42	blood	blood	NOUN
dti-2707	374	43	glucose	glucose	NOUN
dti-2707	374	44	levels	level	NOUN
dti-2707	374	45	by	by	ADP
dti-2707	374	46	enhancing	enhance	VERB
dti-2707	374	47	insulin	insulin	NOUN
dti-2707	374	48	sensitivity	sensitivity	NOUN
dti-2707	374	49	,	,	PUNCT
dti-2707	374	50	production	production	NOUN
dti-2707	374	51	,	,	PUNCT
dti-2707	374	52	and	and	CCONJ
dti-2707	374	53	mitigating	mitigate	VERB
dti-2707	374	54	the	the	DET
dti-2707	374	55	dysfunction	dysfunction	NOUN
dti-2707	374	56	of	of	ADP
dti-2707	374	57	pancreatic	pancreatic	ADJ
dti-2707	374	58	β	β	NOUN
dti-2707	374	59	-	-	NOUN
dti-2707	374	60	cells	cell	NOUN
dti-2707	374	61	in	in	ADP
dti-2707	374	62	t2	t2	NOUN
dti-2707	374	63	dm	dm	PROPN
dti-2707	374	64	(	(	PUNCT
dti-2707	374	65	138	138	NUM
dti-2707	374	66	)	)	SYM
dti-2707	374	67	2	2	NUM
dti-2707	374	68	breast	breast	NOUN
dti-2707	374	69	cancer	cancer	NOUN
dti-2707	374	70	iron	iron	NOUN
dti-2707	374	71	oxide	oxide	NOUN
dti-2707	374	72	nps	nps	PROPN
dti-2707	374	73	no	no	ADV
dti-2707	374	74	in	in	ADV
dti-2707	374	75	vitro	vitro	X
dti-2707	374	76	at	at	ADP
dti-2707	374	77	a	a	DET
dti-2707	374	78	very	very	ADV
dti-2707	374	79	low	low	ADJ
dti-2707	374	80	dose	dose	NOUN
dti-2707	374	81	,	,	PUNCT
dti-2707	374	82	it	it	PRON
dti-2707	374	83	inhibits	inhibit	VERB
dti-2707	374	84	antiapoptotic	antiapoptotic	ADJ
dti-2707	374	85	protein	protein	NOUN
dti-2707	374	86	and	and	CCONJ
dti-2707	374	87	increases	increase	VERB
dti-2707	374	88	apoptotic	apoptotic	ADJ
dti-2707	374	89	proteins	protein	NOUN
dti-2707	374	90	(	(	PUNCT
dti-2707	374	91	139	139	NUM
dti-2707	374	92	)	)	PUNCT
dti-2707	374	93	nanoemulsion	nanoemulsion	NOUN
dti-2707	374	94	paclitaxel	paclitaxel	NOUN
dti-2707	374	95	+	+	CCONJ
dti-2707	374	96	baicalein	baicalein	NOUN
dti-2707	374	97	in	in	ADP
dti-2707	374	98	vitro	vitro	X
dti-2707	374	99	and	and	CCONJ
dti-2707	374	100	in	in	ADP
dti-2707	374	101	vivo	vivo	NOUN
dti-2707	374	102	improved	improve	VERB
dti-2707	374	103	permeability	permeability	NOUN
dti-2707	374	104	and	and	CCONJ
dti-2707	374	105	retention	retention	NOUN
dti-2707	374	106	effects	effect	NOUN
dti-2707	374	107	(	(	PUNCT
dti-2707	374	108	140	140	NUM
dti-2707	374	109	)	)	PUNCT
dti-2707	374	110	3	3	NUM
dti-2707	374	111	.	.	PUNCT
dti-2707	374	112	human	human	ADJ
dti-2707	374	113	lung	lung	NOUN
dti-2707	374	114	cancer	cancer	NOUN
dti-2707	374	115	cells	cell	NOUN
dti-2707	374	116	nanoparticles	nanoparticle	NOUN
dti-2707	374	117	(	(	PUNCT
dti-2707	374	118	prodrug	prodrug	NOUN
dti-2707	374	119	)	)	PUNCT
dti-2707	374	120	paclitaxel	paclitaxel	NOUN
dti-2707	374	121	+	+	CCONJ
dti-2707	374	122	baicalein	baicalein	NOUN
dti-2707	374	123	in	in	ADP
dti-2707	374	124	vitro	vitro	X
dti-2707	374	125	and	and	CCONJ
dti-2707	374	126	in	in	ADP
dti-2707	374	127	vivo	vivo	NOUN
dti-2707	374	128	exhibited	exhibit	VERB
dti-2707	374	129	synergism	synergism	NOUN
dti-2707	374	130	and	and	CCONJ
dti-2707	374	131	anticancer	anticancer	NOUN
dti-2707	374	132	potential	potential	NOUN
dti-2707	374	133	and	and	CCONJ
dti-2707	374	134	reduction	reduction	NOUN
dti-2707	374	135	of	of	ADP
dti-2707	374	136	multidrug	multidrug	NOUN
dti-2707	374	137	resistance	resistance	NOUN
dti-2707	374	138	of	of	ADP
dti-2707	374	139	paclitaxel	paclitaxel	PROPN
dti-2707	374	140	occurs	occur	VERB
dti-2707	374	141	(	(	PUNCT
dti-2707	374	142	142	142	NUM
dti-2707	374	143	)	)	PUNCT
dti-2707	374	144	4	4	NUM
dti-2707	374	145	.	.	X
dti-2707	374	146	cervical	cervical	ADJ
dti-2707	374	147	tumor	tumor	NOUN
dti-2707	374	148	nanoliposomes	nanoliposome	VERB
dti-2707	374	149	no	no	ADV
dti-2707	374	150	in	in	ADV
dti-2707	374	151	vivo	vivo	NOUN
dti-2707	374	152	this	this	DET
dti-2707	374	153	formulation	formulation	NOUN
dti-2707	374	154	demonstrated	demonstrate	VERB
dti-2707	374	155	significant	significant	ADJ
dti-2707	374	156	antitumor	antitumor	PROPN
dti-2707	374	157	efficacy	efficacy	NOUN
dti-2707	374	158	(	(	PUNCT
dti-2707	374	159	142	142	NUM
dti-2707	374	160	)	)	PUNCT
dti-2707	374	161	5	5	NUM
dti-2707	374	162	.	.	PUNCT
dti-2707	375	1	cerebral	cerebral	ADJ
dti-2707	375	2	ischemia	ischemia	NOUN
dti-2707	375	3	sln	sln	PROPN
dti-2707	375	4	ox26	ox26	PROPN
dti-2707	375	5	antibody	antibody	NOUN
dti-2707	375	6	+	+	CCONJ
dti-2707	375	7	baicalin	baicalin	NOUN
dti-2707	375	8	in	in	ADP
dti-2707	375	9	vivo	vivo	NOUN
dti-2707	375	10	it	it	PRON
dti-2707	375	11	regulates	regulate	VERB
dti-2707	375	12	amino	amino	NOUN
dti-2707	375	13	acid	acid	NOUN
dti-2707	375	14	levels	level	NOUN
dti-2707	375	15	,	,	PUNCT
dti-2707	375	16	which	which	PRON
dti-2707	375	17	are	be	AUX
dti-2707	375	18	responsible	responsible	ADJ
dti-2707	375	19	for	for	ADP
dti-2707	375	20	the	the	DET
dti-2707	375	21	therapeutic	therapeutic	ADJ
dti-2707	375	22	effect	effect	NOUN
dti-2707	375	23	of	of	ADP
dti-2707	375	24	treating	treat	VERB
dti-2707	375	25	excitotoxic	excitotoxic	ADJ
dti-2707	375	26	neuronal	neuronal	ADJ
dti-2707	375	27	damage	damage	NOUN
dti-2707	375	28	(	(	PUNCT
dti-2707	375	29	143	143	NUM
dti-2707	375	30	)	)	PUNCT
dti-2707	375	31	nlc	nlc	PROPN
dti-2707	375	32	=	=	PROPN
dti-2707	375	33	nanostructured	nanostructure	VERB
dti-2707	375	34	lipid	lipid	NOUN
dti-2707	375	35	carriers	carrier	NOUN
dti-2707	375	36	;	;	PUNCT
dti-2707	375	37	np	np	NOUN
dti-2707	375	38	=	=	NOUN
dti-2707	375	39	nanoparticle	nanoparticle	NOUN
dti-2707	375	40	;	;	PUNCT
dti-2707	375	41	sln	sln	PROPN
dti-2707	375	42	=	=	PROPN
dti-2707	375	43	solid	solid	ADJ
dti-2707	375	44	lipid	lipid	NOUN
dti-2707	375	45	nanoparticles	nanoparticle	NOUN
dti-2707	375	46	;	;	PUNCT
dti-2707	376	1	t2	t2	NOUN
dti-2707	376	2	dm	dm	NOUN
dti-2707	376	3	=	=	PUNCT
dti-2707	376	4	type	type	NOUN
dti-2707	376	5	2	2	NUM
dti-2707	376	6	diabetes	diabetes	NOUN
dti-2707	376	7	mellitus	mellitus	NOUN
dti-2707	376	8	.	.	PUNCT
dti-2707	377	1	table	table	NOUN
dti-2707	377	2	4	4	NUM
dti-2707	377	3	patents	patent	NOUN
dti-2707	377	4	related	relate	VERB
dti-2707	377	5	to	to	PART
dti-2707	377	6	baicalein	baicalein	VERB
dti-2707	377	7	s.	s.	PROPN
dti-2707	377	8	no	no	INTJ
dti-2707	377	9	.	.	PUNCT
dti-2707	378	1	patent	patent	NOUN
dti-2707	378	2	number	number	NOUN
dti-2707	378	3	year	year	NOUN
dti-2707	378	4	of	of	ADP
dti-2707	378	5	publishing	publishing	NOUN
dti-2707	378	6	/	/	SYM
dti-2707	378	7	grant	grant	NOUN
dti-2707	378	8	details	detail	NOUN
dti-2707	378	9	of	of	ADP
dti-2707	378	10	patent	patent	NOUN
dti-2707	378	11	1	1	NUM
dti-2707	378	12	.	.	PUNCT
dti-2707	379	1	cn1411815a	cn1411815a	NOUN
dti-2707	379	2	2003	2003	NUM
dti-2707	379	3	the	the	DET
dti-2707	379	4	current	current	ADJ
dti-2707	379	5	innovation	innovation	NOUN
dti-2707	379	6	relates	relate	VERB
dti-2707	379	7	to	to	ADP
dti-2707	379	8	the	the	DET
dti-2707	379	9	preparation	preparation	NOUN
dti-2707	379	10	method	method	NOUN
dti-2707	379	11	for	for	ADP
dti-2707	379	12	baicalin	baicalin	NOUN
dti-2707	379	13	eye	eye	NOUN
dti-2707	379	14	drops	drop	NOUN
dti-2707	379	15	.	.	PUNCT
dti-2707	380	1	the	the	DET
dti-2707	380	2	root	root	NOUN
dti-2707	380	3	of	of	ADP
dti-2707	380	4	the	the	DET
dti-2707	380	5	natural	natural	ADJ
dti-2707	380	6	chinese	chinese	ADJ
dti-2707	380	7	medicinal	medicinal	ADJ
dti-2707	380	8	plant	plant	NOUN
dti-2707	380	9	scutellaria	scutellaria	NOUN
dti-2707	380	10	is	be	AUX
dti-2707	380	11	the	the	DET
dti-2707	380	12	source	source	NOUN
dti-2707	380	13	of	of	ADP
dti-2707	380	14	baicalin	baicalin	NOUN
dti-2707	380	15	,	,	PUNCT
dti-2707	380	16	the	the	DET
dti-2707	380	17	main	main	ADJ
dti-2707	380	18	active	active	ADJ
dti-2707	380	19	element	element	NOUN
dti-2707	380	20	in	in	ADP
dti-2707	380	21	the	the	DET
dti-2707	380	22	product	product	NOUN
dti-2707	380	23	.	.	PUNCT
dti-2707	381	1	it	it	PRON
dti-2707	381	2	exhibits	exhibit	VERB
dti-2707	381	3	a	a	DET
dti-2707	381	4	robust	robust	ADJ
dti-2707	381	5	therapeutic	therapeutic	ADJ
dti-2707	381	6	effect	effect	NOUN
dti-2707	381	7	in	in	ADP
dti-2707	381	8	the	the	DET
dti-2707	381	9	management	management	NOUN
dti-2707	381	10	of	of	ADP
dti-2707	381	11	pathogeninduced	pathogeninduce	VERB
dti-2707	381	12	ophthalmopathy	ophthalmopathy	NOUN
dti-2707	381	13	without	without	ADP
dti-2707	381	14	causing	cause	VERB
dti-2707	381	15	ocular	ocular	ADJ
dti-2707	381	16	discomfort	discomfort	NOUN
dti-2707	381	17	or	or	CCONJ
dti-2707	381	18	deleterious	deleterious	ADJ
dti-2707	381	19	side	side	NOUN
dti-2707	381	20	effects	effect	NOUN
dti-2707	381	21	.	.	PUNCT
dti-2707	382	1	2	2	X
dti-2707	382	2	.	.	X
dti-2707	382	3	cn103720650a	cn103720650a	NOUN
dti-2707	382	4	2014	2014	NUM
dti-2707	382	5	the	the	DET
dti-2707	382	6	innovation	innovation	NOUN
dti-2707	382	7	is	be	AUX
dti-2707	382	8	an	an	DET
dti-2707	382	9	injection	injection	NOUN
dti-2707	382	10	of	of	ADP
dti-2707	382	11	baicalin	baicalin	NOUN
dti-2707	382	12	that	that	PRON
dti-2707	382	13	has	have	VERB
dti-2707	382	14	anti	anti	ADJ
dti-2707	382	15	-	-	ADJ
dti-2707	382	16	influenza	influenza	ADJ
dti-2707	382	17	viral	viral	ADJ
dti-2707	382	18	properties	property	NOUN
dti-2707	382	19	.	.	PUNCT
dti-2707	383	1	baicalin	baicalin	NOUN
dti-2707	383	2	,	,	PUNCT
dti-2707	383	3	2.16	2.16	NUM
dti-2707	383	4	g	g	NOUN
dti-2707	383	5	of	of	ADP
dti-2707	383	6	disodium	disodium	NOUN
dti-2707	383	7	hydrogen	hydrogen	NOUN
dti-2707	383	8	phosphate	phosphate	NOUN
dti-2707	383	9	,	,	PUNCT
dti-2707	383	10	0.6	0.6	NUM
dti-2707	383	11	g	g	NOUN
dti-2707	383	12	of	of	ADP
dti-2707	383	13	sodium	sodium	NOUN
dti-2707	383	14	dihydrogen	dihydrogen	NOUN
dti-2707	383	15	phosphate	phosphate	NOUN
dti-2707	383	16	,	,	PUNCT
dti-2707	383	17	and	and	CCONJ
dti-2707	383	18	100	100	NUM
dti-2707	383	19	ml	ml	NOUN
dti-2707	383	20	of	of	ADP
dti-2707	383	21	injection	injection	NOUN
dti-2707	383	22	water	water	NOUN
dti-2707	383	23	make	make	VERB
dti-2707	383	24	up	up	ADP
dti-2707	383	25	this	this	DET
dti-2707	383	26	mixture	mixture	NOUN
dti-2707	383	27	.	.	PUNCT
dti-2707	384	1	the	the	DET
dti-2707	384	2	injection	injection	NOUN
dti-2707	384	3	is	be	AUX
dti-2707	384	4	sterilized	sterilize	VERB
dti-2707	384	5	by	by	ADP
dti-2707	384	6	applying	apply	VERB
dti-2707	384	7	high	high	ADJ
dti-2707	384	8	pressure	pressure	NOUN
dti-2707	384	9	while	while	SCONJ
dti-2707	384	10	keeping	keep	VERB
dti-2707	384	11	the	the	DET
dti-2707	384	12	sodium	sodium	NOUN
dti-2707	384	13	hydroxide	hydroxide	NOUN
dti-2707	384	14	ph	ph	NOUN
dti-2707	384	15	at	at	ADP
dti-2707	384	16	7.0	7.0	NUM
dti-2707	384	17	.	.	PUNCT
dti-2707	385	1	the	the	DET
dti-2707	385	2	medication	medication	NOUN
dti-2707	385	3	blocks	block	VERB
dti-2707	385	4	neuraminidase	neuraminidase	NOUN
dti-2707	385	5	action	action	NOUN
dti-2707	385	6	,	,	PUNCT
dti-2707	385	7	which	which	PRON
dti-2707	385	8	prevents	prevent	VERB
dti-2707	385	9	the	the	DET
dti-2707	385	10	virus	virus	NOUN
dti-2707	385	11	from	from	ADP
dti-2707	385	12	releasing	release	VERB
dti-2707	385	13	its	its	PRON
dti-2707	385	14	infection	infection	NOUN
dti-2707	385	15	.	.	PUNCT
dti-2707	386	1	it	it	PRON
dti-2707	386	2	is	be	AUX
dti-2707	386	3	highly	highly	ADV
dti-2707	386	4	bioavailable	bioavailable	ADJ
dti-2707	386	5	and	and	CCONJ
dti-2707	386	6	rarely	rarely	ADV
dti-2707	386	7	causes	cause	VERB
dti-2707	386	8	negative	negative	ADJ
dti-2707	386	9	side	side	NOUN
dti-2707	386	10	effects	effect	NOUN
dti-2707	386	11	.	.	PUNCT
dti-2707	387	1	3	3	X
dti-2707	387	2	.	.	X
dti-2707	387	3	cn101642426b	cn101642426b	PROPN
dti-2707	387	4	2009	2009	NUM
dti-2707	387	5	the	the	DET
dti-2707	387	6	innovation	innovation	NOUN
dti-2707	387	7	is	be	AUX
dti-2707	387	8	a	a	DET
dti-2707	387	9	technique	technique	NOUN
dti-2707	387	10	for	for	ADP
dti-2707	387	11	making	make	VERB
dti-2707	387	12	nanoscale	nanoscale	NOUN
dti-2707	387	13	eye	eye	NOUN
dti-2707	387	14	drops	drop	NOUN
dti-2707	387	15	of	of	ADP
dti-2707	387	16	the	the	DET
dti-2707	387	17	baicalein	baicalein	NOUN
dti-2707	387	18	adhesion	adhesion	NOUN
dti-2707	387	19	type	type	NOUN
dti-2707	387	20	.	.	PUNCT
dti-2707	388	1	baicalein	baicalein	PROPN
dti-2707	388	2	(	(	PUNCT
dti-2707	388	3	w	w	NOUN
dti-2707	388	4	/	/	SYM
dti-2707	388	5	w	w	NOUN
dti-2707	388	6	)	)	PUNCT
dti-2707	388	7	=	=	SYM
dti-2707	389	1	0.001%-3	0.001%-3	NUM
dti-2707	389	2	%	%	NOUN
dti-2707	389	3	,	,	PUNCT
dti-2707	389	4	lipid	lipid	NOUN
dti-2707	389	5	(	(	PUNCT
dti-2707	389	6	w	w	NOUN
dti-2707	389	7	/	/	SYM
dti-2707	389	8	w	w	NOUN
dti-2707	389	9	)	)	PUNCT
dti-2707	389	10	=	=	SYM
dti-2707	389	11	0.1%-20	0.1%-20	NOUN
dti-2707	389	12	%	%	NOUN
dti-2707	389	13	,	,	PUNCT
dti-2707	389	14	surfactant	surfactant	NOUN
dti-2707	389	15	(	(	PUNCT
dti-2707	389	16	w	w	NOUN
dti-2707	389	17	/	/	SYM
dti-2707	389	18	w	w	NOUN
dti-2707	389	19	)	)	PUNCT
dti-2707	389	20	=	=	SYM
dti-2707	389	21	0.1%10	0.1%10	NUM
dti-2707	389	22	%	%	NOUN
dti-2707	389	23	,	,	PUNCT
dti-2707	389	24	preservative	preservative	NOUN
dti-2707	389	25	(	(	PUNCT
dti-2707	389	26	w	w	NOUN
dti-2707	389	27	/	/	SYM
dti-2707	389	28	w	w	NOUN
dti-2707	389	29	)	)	PUNCT
dti-2707	389	30	=	=	SYM
dti-2707	390	1	0.001%-3	0.001%-3	NUM
dti-2707	390	2	%	%	NOUN
dti-2707	390	3	,	,	PUNCT
dti-2707	390	4	isotonic	isotonic	ADJ
dti-2707	390	5	regulator	regulator	NOUN
dti-2707	390	6	(	(	PUNCT
dti-2707	390	7	w	w	NOUN
dti-2707	390	8	/	/	SYM
dti-2707	390	9	w	w	NOUN
dti-2707	390	10	)	)	PUNCT
dti-2707	390	11	=	=	SYM
dti-2707	390	12	0.1%-10	0.1%-10	NUM
dti-2707	390	13	%	%	NOUN
dti-2707	390	14	,	,	PUNCT
dti-2707	390	15	penetration	penetration	NOUN
dti-2707	390	16	enhancer	enhancer	NOUN
dti-2707	390	17	(	(	PUNCT
dti-2707	390	18	w	w	NOUN
dti-2707	390	19	/	/	SYM
dti-2707	390	20	w	w	NOUN
dti-2707	390	21	)	)	PUNCT
dti-2707	390	22	=	=	SYM
dti-2707	390	23	0.005%-10	0.005%-10	NUM
dti-2707	390	24	%	%	NOUN
dti-2707	390	25	.	.	PUNCT
dti-2707	391	1	the	the	DET
dti-2707	391	2	remaining	remain	VERB
dti-2707	391	3	volume	volume	NOUN
dti-2707	391	4	of	of	ADP
dti-2707	391	5	deionized	deionize	VERB
dti-2707	391	6	water	water	NOUN
dti-2707	391	7	is	be	AUX
dti-2707	391	8	used	use	VERB
dti-2707	391	9	to	to	PART
dti-2707	391	10	create	create	VERB
dti-2707	391	11	the	the	DET
dti-2707	391	12	baicalin	baicalin	NOUN
dti-2707	391	13	adhesion	adhesion	NOUN
dti-2707	391	14	type	type	NOUN
dti-2707	391	15	nanoscale	nanoscale	NOUN
dti-2707	391	16	eye	eye	NOUN
dti-2707	391	17	drops	drop	VERB
dti-2707	391	18	,	,	PUNCT
dti-2707	391	19	with	with	SCONJ
dti-2707	391	20	the	the	DET
dti-2707	391	21	ph	ph	NOUN
dti-2707	391	22	being	be	AUX
dti-2707	391	23	kept	keep	VERB
dti-2707	391	24	between	between	ADP
dti-2707	391	25	5	5	NUM
dti-2707	391	26	and	and	CCONJ
dti-2707	391	27	9	9	NUM
dti-2707	391	28	.	.	NOUN
dti-2707	391	29	4	4	NUM
dti-2707	391	30	.	.	X
dti-2707	392	1	cn101856350a	cn101856350a	NOUN
dti-2707	392	2	2010	2010	NUM
dti-2707	392	3	the	the	DET
dti-2707	392	4	use	use	NOUN
dti-2707	392	5	of	of	ADP
dti-2707	392	6	baicalein	baicalein	NOUN
dti-2707	392	7	in	in	ADP
dti-2707	392	8	the	the	DET
dti-2707	392	9	preparation	preparation	NOUN
dti-2707	392	10	of	of	ADP
dti-2707	392	11	medications	medication	NOUN
dti-2707	392	12	for	for	ADP
dti-2707	392	13	the	the	DET
dti-2707	392	14	treatment	treatment	NOUN
dti-2707	392	15	and	and	CCONJ
dti-2707	392	16	prevention	prevention	NOUN
dti-2707	392	17	of	of	ADP
dti-2707	392	18	pd	pd	PROPN
dti-2707	392	19	is	be	AUX
dti-2707	392	20	disclosed	disclose	VERB
dti-2707	392	21	in	in	ADP
dti-2707	392	22	the	the	DET
dti-2707	392	23	invention	invention	NOUN
dti-2707	392	24	.	.	PUNCT
dti-2707	393	1	the	the	DET
dti-2707	393	2	formulation	formulation	NOUN
dti-2707	393	3	has	have	VERB
dti-2707	393	4	the	the	DET
dti-2707	393	5	ability	ability	NOUN
dti-2707	393	6	to	to	PART
dti-2707	393	7	improve	improve	VERB
dti-2707	393	8	and	and	CCONJ
dti-2707	393	9	treat	treat	VERB
dti-2707	393	10	pd	pd	NOUN
dti-2707	393	11	symptoms	symptom	NOUN
dti-2707	393	12	while	while	SCONJ
dti-2707	393	13	also	also	ADV
dti-2707	393	14	lowering	lower	VERB
dti-2707	393	15	the	the	DET
dti-2707	393	16	trembling	tremble	VERB
dti-2707	393	17	frequencies	frequency	NOUN
dti-2707	393	18	and	and	CCONJ
dti-2707	393	19	amplitudes	amplitude	NOUN
dti-2707	393	20	.	.	PUNCT
dti-2707	394	1	by	by	ADP
dti-2707	394	2	preventing	prevent	VERB
dti-2707	394	3	damage	damage	NOUN
dti-2707	394	4	to	to	ADP
dti-2707	394	5	dopaminergic	dopaminergic	ADJ
dti-2707	394	6	neurons	neuron	NOUN
dti-2707	394	7	,	,	PUNCT
dti-2707	394	8	the	the	DET
dti-2707	394	9	formulation	formulation	NOUN
dti-2707	394	10	can	can	AUX
dti-2707	394	11	effectively	effectively	ADV
dti-2707	394	12	prevent	prevent	VERB
dti-2707	394	13	and	and	CCONJ
dti-2707	394	14	treat	treat	VERB
dti-2707	394	15	pathological	pathological	ADJ
dti-2707	394	16	changes	change	NOUN
dti-2707	394	17	and	and	CCONJ
dti-2707	394	18	the	the	DET
dti-2707	394	19	development	development	NOUN
dti-2707	394	20	of	of	ADP
dti-2707	394	21	pd	pd	PROPN
dti-2707	394	22	.	.	PROPN
dti-2707	394	23	baicalein	baicalein	PROPN
dti-2707	394	24	,	,	PUNCT
dti-2707	394	25	on	on	ADP
dti-2707	394	26	the	the	DET
dti-2707	394	27	other	other	ADJ
dti-2707	394	28	hand	hand	NOUN
dti-2707	394	29	,	,	PUNCT
dti-2707	394	30	inhibits	inhibit	VERB
dti-2707	394	31	parkinson	parkinson	NOUN
dti-2707	394	32	’s	’s	PART
dti-2707	394	33	symptoms	symptom	NOUN
dti-2707	394	34	by	by	ADP
dti-2707	394	35	acting	act	VERB
dti-2707	394	36	on	on	ADP
dti-2707	394	37	nervous	nervous	ADJ
dti-2707	394	38	systems	system	NOUN
dti-2707	394	39	and	and	CCONJ
dti-2707	394	40	protects	protect	VERB
dti-2707	394	41	dopaminergic	dopaminergic	ADJ
dti-2707	394	42	neurons	neuron	NOUN
dti-2707	394	43	through	through	ADP
dti-2707	394	44	apoptosis	apoptosis	NOUN
dti-2707	394	45	resistance	resistance	NOUN
dti-2707	394	46	,	,	PUNCT
dti-2707	394	47	inflammatory	inflammatory	ADJ
dti-2707	394	48	resistance	resistance	NOUN
dti-2707	394	49	,	,	PUNCT
dti-2707	394	50	and	and	CCONJ
dti-2707	394	51	antioxidation	antioxidation	NOUN
dti-2707	394	52	.	.	PUNCT
dti-2707	395	1	5	5	X
dti-2707	395	2	.	.	X
dti-2707	395	3	cn101701245a	cn101701245a	VERB
dti-2707	395	4	2010	2010	NUM
dti-2707	395	5	the	the	DET
dti-2707	395	6	innovation	innovation	NOUN
dti-2707	395	7	offers	offer	VERB
dti-2707	395	8	a	a	DET
dti-2707	395	9	way	way	NOUN
dti-2707	395	10	to	to	PART
dti-2707	395	11	extract	extract	VERB
dti-2707	395	12	the	the	DET
dti-2707	395	13	major	major	ADJ
dti-2707	395	14	proteinase	proteinase	NOUN
dti-2707	395	15	inhibitor	inhibitor	NOUN
dti-2707	395	16	of	of	ADP
dti-2707	395	17	the	the	DET
dti-2707	395	18	sars	sars	PROPN
dti-2707	395	19	coronavirus	coronavirus	NOUN
dti-2707	395	20	from	from	ADP
dti-2707	395	21	a	a	DET
dti-2707	395	22	traditional	traditional	ADJ
dti-2707	395	23	chinese	chinese	ADJ
dti-2707	395	24	remedy	remedy	NOUN
dti-2707	395	25	.	.	PUNCT
dti-2707	396	1	the	the	DET
dti-2707	396	2	steps	step	NOUN
dti-2707	396	3	in	in	ADP
dti-2707	396	4	the	the	DET
dti-2707	396	5	procedure	procedure	NOUN
dti-2707	396	6	are	be	AUX
dti-2707	396	7	as	as	SCONJ
dti-2707	396	8	follows	follow	VERB
dti-2707	396	9	:	:	PUNCT
dti-2707	396	10	(	(	PUNCT
dti-2707	396	11	1	1	X
dti-2707	396	12	)	)	PUNCT
dti-2707	396	13	determining	determine	VERB
dti-2707	396	14	the	the	DET
dti-2707	396	15	exosomatic	exosomatic	ADJ
dti-2707	396	16	suppressive	suppressive	ADJ
dti-2707	396	17	activities	activity	NOUN
dti-2707	396	18	of	of	ADP
dti-2707	396	19	different	different	ADJ
dti-2707	396	20	extractives	extractive	NOUN
dti-2707	396	21	from	from	ADP
dti-2707	396	22	a	a	DET
dti-2707	396	23	single	single	ADJ
dti-2707	396	24	traditional	traditional	ADJ
dti-2707	396	25	chinese	chinese	ADJ
dti-2707	396	26	medicine	medicine	NOUN
dti-2707	396	27	that	that	PRON
dti-2707	396	28	are	be	AUX
dti-2707	396	29	main	main	ADJ
dti-2707	396	30	proteinase	proteinase	NOUN
dti-2707	396	31	inhibitors	inhibitor	NOUN
dti-2707	396	32	of	of	ADP
dti-2707	396	33	the	the	DET
dti-2707	396	34	sars	sars	PROPN
dti-2707	396	35	coronavirus	coronavirus	NOUN
dti-2707	396	36	;	;	PUNCT
dti-2707	396	37	(	(	PUNCT
dti-2707	396	38	2	2	X
dti-2707	396	39	)	)	PUNCT
dti-2707	396	40	choosing	choose	VERB
dti-2707	396	41	the	the	DET
dti-2707	396	42	extractive	extractive	NOUN
dti-2707	396	43	that	that	PRON
dti-2707	396	44	has	have	VERB
dti-2707	396	45	the	the	DET
dti-2707	396	46	highest	high	ADJ
dti-2707	396	47	exosomatic	exosomatic	ADJ
dti-2707	396	48	suppressive	suppressive	ADJ
dti-2707	396	49	activity	activity	NOUN
dti-2707	396	50	;	;	PUNCT
dti-2707	396	51	and	and	CCONJ
dti-2707	396	52	(	(	PUNCT
dti-2707	396	53	3	3	X
dti-2707	396	54	)	)	PUNCT
dti-2707	396	55	sorting	sort	VERB
dti-2707	396	56	and	and	CCONJ
dti-2707	396	57	choosing	choose	VERB
dti-2707	396	58	the	the	DET
dti-2707	396	59	extractives	extractive	NOUN
dti-2707	396	60	chosen	choose	VERB
dti-2707	396	61	in	in	ADP
dti-2707	396	62	step	step	NOUN
dti-2707	396	63	(	(	PUNCT
dti-2707	396	64	2	2	NUM
dti-2707	396	65	)	)	PUNCT
dti-2707	396	66	at	at	ADP
dti-2707	396	67	least	least	ADJ
dti-2707	396	68	once	once	ADV
dti-2707	396	69	.	.	PUNCT
dti-2707	397	1	the	the	DET
dti-2707	397	2	substance	substance	NOUN
dti-2707	397	3	that	that	SCONJ
dti-2707	397	4	the	the	DET
dti-2707	397	5	procedure	procedure	NOUN
dti-2707	397	6	separated	separate	VERB
dti-2707	397	7	has	have	AUX
dti-2707	397	8	exosomatic	exosomatic	ADJ
dti-2707	397	9	inhibitory	inhibitory	ADJ
dti-2707	397	10	actions	action	NOUN
dti-2707	397	11	on	on	ADP
dti-2707	397	12	the	the	DET
dti-2707	397	13	major	major	ADJ
dti-2707	397	14	proteinase	proteinase	NOUN
dti-2707	397	15	of	of	ADP
dti-2707	397	16	the	the	DET
dti-2707	397	17	sars	sars	PROPN
dti-2707	397	18	coronavirus	coronavirus	PROPN
dti-2707	397	19	,	,	PUNCT
dti-2707	397	20	making	make	VERB
dti-2707	397	21	it	it	PRON
dti-2707	397	22	a	a	DET
dti-2707	397	23	potentially	potentially	ADV
dti-2707	397	24	ideal	ideal	ADJ
dti-2707	397	25	medication	medication	NOUN
dti-2707	397	26	or	or	CCONJ
dti-2707	397	27	a	a	DET
dti-2707	397	28	viable	viable	ADJ
dti-2707	397	29	prodrug	prodrug	NOUN
dti-2707	397	30	for	for	ADP
dti-2707	397	31	commercialization	commercialization	NOUN
dti-2707	397	32	.	.	PUNCT
dti-2707	398	1	(	(	PUNCT
dti-2707	398	2	continued	continue	VERB
dti-2707	398	3	)	)	PUNCT
dti-2707	398	4	munjal	munjal	PROPN
dti-2707	398	5	et	et	PROPN
dti-2707	398	6	al	al	PROPN
dti-2707	398	7	drug	drug	PROPN
dti-2707	398	8	target	target	NOUN
dti-2707	398	9	insights	insight	NOUN
dti-2707	398	10	2024	2024	NUM
dti-2707	398	11	;	;	PUNCT
dti-2707	398	12	18	18	NUM
dti-2707	398	13	:	:	SYM
dti-2707	398	14	41	41	NUM
dti-2707	398	15	©	©	PROPN
dti-2707	398	16	2024	2024	NUM
dti-2707	398	17	the	the	DET
dti-2707	398	18	authors	author	NOUN
dti-2707	398	19	.	.	PUNCT
dti-2707	399	1	published	publish	VERB
dti-2707	399	2	by	by	ADP
dti-2707	399	3	aboutscience	aboutscience	NOUN
dti-2707	399	4	www.aboutscience.eu	www.aboutscience.eu	PROPN
dti-2707	399	5	s.	s.	PROPN
dti-2707	399	6	no	no	INTJ
dti-2707	399	7	.	.	PUNCT
dti-2707	400	1	patent	patent	NOUN
dti-2707	400	2	number	number	NOUN
dti-2707	400	3	year	year	NOUN
dti-2707	400	4	of	of	ADP
dti-2707	400	5	publishing	publishing	NOUN
dti-2707	400	6	/	/	SYM
dti-2707	400	7	grant	grant	NOUN
dti-2707	400	8	details	detail	NOUN
dti-2707	400	9	of	of	ADP
dti-2707	400	10	patent	patent	NOUN
dti-2707	400	11	6	6	NUM
dti-2707	400	12	.	.	PUNCT
dti-2707	400	13	cn102068452a	cn102068452a	NOUN
dti-2707	400	14	2011	2011	NUM
dti-2707	400	15	the	the	DET
dti-2707	400	16	invention	invention	NOUN
dti-2707	400	17	relates	relate	VERB
dti-2707	400	18	to	to	ADP
dti-2707	400	19	a	a	DET
dti-2707	400	20	pharmaceutical	pharmaceutical	ADJ
dti-2707	400	21	composition	composition	NOUN
dti-2707	400	22	with	with	ADP
dti-2707	400	23	a	a	DET
dti-2707	400	24	synergistic	synergistic	ADJ
dti-2707	400	25	antiviral	antiviral	ADJ
dti-2707	400	26	ratio	ratio	NOUN
dti-2707	400	27	of	of	ADP
dti-2707	400	28	20:1	20:1	NUM
dti-2707	400	29	to	to	ADP
dti-2707	400	30	1:10	1:10	NUM
dti-2707	400	31	for	for	ADP
dti-2707	400	32	baicalein	baicalein	NOUN
dti-2707	400	33	and	and	CCONJ
dti-2707	400	34	ribavirin	ribavirin	NOUN
dti-2707	400	35	.	.	PUNCT
dti-2707	401	1	it	it	PRON
dti-2707	401	2	lessens	lessen	VERB
dti-2707	401	3	the	the	DET
dti-2707	401	4	minimum	minimum	ADJ
dti-2707	401	5	medicine	medicine	NOUN
dti-2707	401	6	tolerance	tolerance	NOUN
dti-2707	401	7	as	as	ADV
dti-2707	401	8	well	well	ADV
dti-2707	401	9	as	as	ADP
dti-2707	401	10	the	the	DET
dti-2707	401	11	adverse	adverse	ADJ
dti-2707	401	12	effects	effect	NOUN
dti-2707	401	13	and	and	CCONJ
dti-2707	401	14	side	side	NOUN
dti-2707	401	15	effects	effect	NOUN
dti-2707	401	16	.	.	PUNCT
dti-2707	402	1	moreover	moreover	ADV
dti-2707	402	2	,	,	PUNCT
dti-2707	402	3	the	the	DET
dti-2707	402	4	antiviral	antiviral	ADJ
dti-2707	402	5	component	component	NOUN
dti-2707	402	6	works	work	VERB
dti-2707	402	7	by	by	ADP
dti-2707	402	8	inhibiting	inhibit	VERB
dti-2707	402	9	viral	viral	ADJ
dti-2707	402	10	replication	replication	NOUN
dti-2707	402	11	.	.	PUNCT
dti-2707	403	1	it	it	PRON
dti-2707	403	2	has	have	VERB
dti-2707	403	3	great	great	ADJ
dti-2707	403	4	advantages	advantage	NOUN
dti-2707	403	5	and	and	CCONJ
dti-2707	403	6	looks	look	VERB
dti-2707	403	7	to	to	PART
dti-2707	403	8	have	have	VERB
dti-2707	403	9	a	a	DET
dti-2707	403	10	bright	bright	ADJ
dti-2707	403	11	future	future	NOUN
dti-2707	403	12	in	in	ADP
dti-2707	403	13	treating	treat	VERB
dti-2707	403	14	and	and	CCONJ
dti-2707	403	15	preventing	prevent	VERB
dti-2707	403	16	influenza	influenza	ADJ
dti-2707	403	17	viruses	virus	NOUN
dti-2707	403	18	.	.	PUNCT
dti-2707	404	1	7	7	X
dti-2707	404	2	.	.	X
dti-2707	404	3	cn105560177a	cn105560177a	NOUN
dti-2707	404	4	2016	2016	NUM
dti-2707	404	5	the	the	DET
dti-2707	404	6	invention	invention	NOUN
dti-2707	404	7	discloses	disclose	VERB
dti-2707	404	8	the	the	DET
dti-2707	404	9	veterinary	veterinary	ADJ
dti-2707	404	10	mixed	mixed	ADJ
dti-2707	404	11	suspension	suspension	NOUN
dti-2707	404	12	containing	contain	VERB
dti-2707	404	13	amoxicillin	amoxicillin	NOUN
dti-2707	404	14	and	and	CCONJ
dti-2707	404	15	baicalein	baicalein	PROPN
dti-2707	404	16	,	,	PUNCT
dti-2707	404	17	as	as	ADV
dti-2707	404	18	well	well	ADV
dti-2707	404	19	as	as	ADP
dti-2707	404	20	the	the	DET
dti-2707	404	21	manufacturing	manufacturing	NOUN
dti-2707	404	22	process	process	NOUN
dti-2707	404	23	.	.	PUNCT
dti-2707	405	1	the	the	DET
dti-2707	405	2	suspension	suspension	NOUN
dti-2707	405	3	is	be	AUX
dti-2707	405	4	made	make	VERB
dti-2707	405	5	by	by	ADP
dti-2707	405	6	dispersing	disperse	VERB
dti-2707	405	7	the	the	DET
dti-2707	405	8	active	active	ADJ
dti-2707	405	9	components	component	NOUN
dti-2707	405	10	,	,	PUNCT
dti-2707	405	11	amoxicillin	amoxicillin	PROPN
dti-2707	405	12	and	and	CCONJ
dti-2707	405	13	baicalein	baicalein	PROPN
dti-2707	405	14	,	,	PUNCT
dti-2707	405	15	1:1	1:1	NUM
dti-2707	405	16	,	,	PUNCT
dti-2707	405	17	in	in	ADP
dti-2707	405	18	a	a	DET
dti-2707	405	19	dispersion	dispersion	NOUN
dti-2707	405	20	medium	medium	NOUN
dti-2707	405	21	.	.	PUNCT
dti-2707	406	1	the	the	DET
dti-2707	406	2	problems	problem	NOUN
dti-2707	406	3	of	of	ADP
dti-2707	406	4	amoxicillin	amoxicillin	PROPN
dti-2707	406	5	being	be	AUX
dti-2707	406	6	easily	easily	ADV
dti-2707	406	7	broken	break	VERB
dti-2707	406	8	down	down	ADP
dti-2707	406	9	in	in	ADP
dti-2707	406	10	an	an	DET
dti-2707	406	11	aqueous	aqueous	ADJ
dti-2707	406	12	solution	solution	NOUN
dti-2707	406	13	and	and	CCONJ
dti-2707	406	14	the	the	DET
dti-2707	406	15	medication	medication	NOUN
dti-2707	406	16	being	be	AUX
dti-2707	406	17	slowly	slowly	ADV
dti-2707	406	18	released	release	VERB
dti-2707	406	19	in	in	ADP
dti-2707	406	20	an	an	DET
dti-2707	406	21	oily	oily	ADV
dti-2707	406	22	mixed	mixed	ADJ
dti-2707	406	23	suspension	suspension	NOUN
dti-2707	406	24	are	be	AUX
dti-2707	406	25	both	both	PRON
dti-2707	406	26	solved	solve	VERB
dti-2707	406	27	for	for	ADP
dti-2707	406	28	time	time	NOUN
dti-2707	406	29	-	-	PUNCT
dti-2707	406	30	dependent	dependent	ADJ
dti-2707	406	31	antibiotics	antibiotic	NOUN
dti-2707	406	32	.	.	PUNCT
dti-2707	407	1	t	t	X
dti-2707	407	2	>	>	X
dti-2707	407	3	mic	mic	NOUN
dti-2707	407	4	is	be	AUX
dti-2707	407	5	prolonged	prolong	VERB
dti-2707	407	6	,	,	PUNCT
dti-2707	407	7	effective	effective	ADJ
dti-2707	407	8	acting	acting	NOUN
dti-2707	407	9	time	time	NOUN
dti-2707	407	10	is	be	AUX
dti-2707	407	11	prolonged	prolong	VERB
dti-2707	407	12	,	,	PUNCT
dti-2707	407	13	and	and	CCONJ
dti-2707	407	14	a	a	DET
dti-2707	407	15	user	user	NOUN
dti-2707	407	16	only	only	ADV
dti-2707	407	17	needs	need	VERB
dti-2707	407	18	to	to	PART
dti-2707	407	19	take	take	VERB
dti-2707	407	20	the	the	DET
dti-2707	407	21	medication	medication	NOUN
dti-2707	407	22	three	three	NUM
dti-2707	407	23	times	time	NOUN
dti-2707	407	24	consecutively	consecutively	ADV
dti-2707	407	25	at	at	ADP
dti-2707	407	26	intervals	interval	NOUN
dti-2707	407	27	of	of	ADP
dti-2707	407	28	12	12	NUM
dti-2707	407	29	hours	hour	NOUN
dti-2707	407	30	.	.	PUNCT
dti-2707	408	1	8	8	NUM
dti-2707	408	2	.	.	X
dti-2707	408	3	cn112007023a	cn112007023a	NOUN
dti-2707	408	4	2020	2020	NUM
dti-2707	408	5	according	accord	VERB
dti-2707	408	6	to	to	ADP
dti-2707	408	7	the	the	DET
dti-2707	408	8	invention	invention	NOUN
dti-2707	408	9	,	,	PUNCT
dti-2707	408	10	baicalein	baicalein	PROPN
dti-2707	408	11	alpha	alpha	PROPN
dti-2707	408	12	,	,	PUNCT
dti-2707	408	13	beta	beta	NOUN
dti-2707	408	14	,	,	PUNCT
dti-2707	408	15	or	or	CCONJ
dti-2707	408	16	(	(	PUNCT
dti-2707	408	17	beta	beta	NOUN
dti-2707	408	18	0	0	NUM
dti-2707	408	19	+	+	NOUN
dti-2707	408	20	beta	beta	ADJ
dti-2707	408	21	1	1	NUM
dti-2707	408	22	)	)	PUNCT
dti-2707	408	23	mixed	mixed	ADJ
dti-2707	408	24	crystal	crystal	NOUN
dti-2707	408	25	form	form	NOUN
dti-2707	408	26	can	can	AUX
dti-2707	408	27	be	be	AUX
dti-2707	408	28	used	use	VERB
dti-2707	408	29	for	for	ADP
dti-2707	408	30	preventing	prevent	VERB
dti-2707	408	31	and/or	and/or	CCONJ
dti-2707	408	32	treating	treat	VERB
dti-2707	408	33	obesity	obesity	NOUN
dti-2707	408	34	and	and	CCONJ
dti-2707	408	35	its	its	PRON
dti-2707	408	36	related	related	ADJ
dti-2707	408	37	conditions	condition	NOUN
dti-2707	408	38	.	.	PUNCT
dti-2707	409	1	more	more	ADV
dti-2707	409	2	precisely	precisely	ADV
dti-2707	409	3	,	,	PUNCT
dti-2707	409	4	to	to	ADP
dti-2707	409	5	the	the	DET
dti-2707	409	6	administration	administration	NOUN
dti-2707	409	7	of	of	ADP
dti-2707	409	8	a	a	DET
dti-2707	409	9	drug	drug	NOUN
dti-2707	409	10	in	in	ADP
dti-2707	409	11	the	the	DET
dti-2707	409	12	range	range	NOUN
dti-2707	409	13	of	of	ADP
dti-2707	409	14	0.001	0.001	NUM
dti-2707	409	15	-	-	SYM
dti-2707	409	16	2000	2000	NUM
dti-2707	409	17	mg	mg	PROPN
dti-2707	409	18	/	/	SYM
dti-2707	409	19	kg	kg	PROPN
dti-2707	409	20	/	/	SYM
dti-2707	409	21	day	day	NOUN
dti-2707	409	22	/	/	SYM
dti-2707	409	23	po	po	NOUN
dti-2707	409	24	as	as	ADP
dti-2707	409	25	an	an	DET
dti-2707	409	26	active	active	ADJ
dti-2707	409	27	element	element	NOUN
dti-2707	409	28	in	in	ADP
dti-2707	409	29	the	the	DET
dti-2707	409	30	management	management	NOUN
dti-2707	409	31	of	of	ADP
dti-2707	409	32	obesity	obesity	NOUN
dti-2707	409	33	and	and	CCONJ
dti-2707	409	34	its	its	PRON
dti-2707	409	35	by	by	NOUN
dti-2707	409	36	-	-	PUNCT
dti-2707	409	37	products	product	NOUN
dti-2707	409	38	,	,	PUNCT
dti-2707	409	39	including	include	VERB
dti-2707	409	40	hyperlipidemia	hyperlipidemia	NOUN
dti-2707	409	41	,	,	PUNCT
dti-2707	409	42	insulin	insulin	NOUN
dti-2707	409	43	resistance	resistance	NOUN
dti-2707	409	44	,	,	PUNCT
dti-2707	409	45	and	and	CCONJ
dti-2707	409	46	blood	blood	NOUN
dti-2707	409	47	sugar	sugar	NOUN
dti-2707	409	48	.	.	PUNCT
dti-2707	410	1	9	9	NUM
dti-2707	410	2	.	.	X
dti-2707	410	3	cn108653206b	cn108653206b	PROPN
dti-2707	410	4	2020	2020	NUM
dti-2707	411	1	the	the	DET
dti-2707	411	2	innovation	innovation	NOUN
dti-2707	411	3	,	,	PUNCT
dti-2707	411	4	which	which	PRON
dti-2707	411	5	falls	fall	VERB
dti-2707	411	6	under	under	ADP
dti-2707	411	7	the	the	DET
dti-2707	411	8	category	category	NOUN
dti-2707	411	9	of	of	ADP
dti-2707	411	10	pharmaceutical	pharmaceutical	ADJ
dti-2707	411	11	preparations	preparation	NOUN
dti-2707	411	12	,	,	PUNCT
dti-2707	411	13	describes	describe	VERB
dti-2707	411	14	how	how	SCONJ
dti-2707	411	15	to	to	PART
dti-2707	411	16	prepare	prepare	VERB
dti-2707	411	17	a	a	DET
dti-2707	411	18	baicalein	baicalein	NOUN
dti-2707	411	19	nanosuspension	nanosuspension	NOUN
dti-2707	411	20	.	.	PUNCT
dti-2707	412	1	the	the	DET
dti-2707	412	2	following	follow	VERB
dti-2707	412	3	elements	element	NOUN
dti-2707	412	4	comprise	comprise	VERB
dti-2707	412	5	the	the	DET
dti-2707	412	6	baicalein	baicalein	NOUN
dti-2707	412	7	nanosuspension	nanosuspension	NOUN
dti-2707	412	8	prescription	prescription	NOUN
dti-2707	412	9	,	,	PUNCT
dti-2707	412	10	expressed	express	VERB
dti-2707	412	11	as	as	ADP
dti-2707	412	12	a	a	DET
dti-2707	412	13	percentage	percentage	NOUN
dti-2707	412	14	by	by	ADP
dti-2707	412	15	mass	mass	ADJ
dti-2707	412	16	:	:	PUNCT
dti-2707	412	17	phospholipid	phospholipid	NOUN
dti-2707	412	18	(	(	PUNCT
dti-2707	412	19	0.05%-10	0.05%-10	NUM
dti-2707	412	20	%	%	NOUN
dti-2707	412	21	)	)	PUNCT
dti-2707	412	22	,	,	PUNCT
dti-2707	412	23	f-68	f-68	X
dti-2707	412	24	(	(	PUNCT
dti-2707	412	25	0.1	0.1	NUM
dti-2707	412	26	-	-	SYM
dti-2707	412	27	3	3	NUM
dti-2707	412	28	%	%	NOUN
dti-2707	412	29	)	)	PUNCT
dti-2707	412	30	,	,	PUNCT
dti-2707	412	31	glycerol	glycerol	NOUN
dti-2707	412	32	(	(	PUNCT
dti-2707	412	33	1%-10	1%-10	NUM
dti-2707	412	34	%	%	NOUN
dti-2707	412	35	)	)	PUNCT
dti-2707	412	36	,	,	PUNCT
dti-2707	412	37	and	and	CCONJ
dti-2707	412	38	the	the	DET
dti-2707	412	39	rest	rest	NOUN
dti-2707	412	40	water	water	NOUN
dti-2707	412	41	.	.	PUNCT
dti-2707	413	1	0.1%-2	0.1%-2	NOUN
dti-2707	413	2	%	%	NOUN
dti-2707	413	3	of	of	ADP
dti-2707	413	4	the	the	DET
dti-2707	413	5	phospholipid	phospholipid	NOUN
dti-2707	413	6	compound	compound	NOUN
dti-2707	413	7	is	be	AUX
dti-2707	413	8	called	call	VERB
dti-2707	413	9	baicalein	baicalein	PROPN
dti-2707	413	10	.	.	PUNCT
dti-2707	414	1	the	the	DET
dti-2707	414	2	invention	invention	NOUN
dti-2707	414	3	offers	offer	VERB
dti-2707	414	4	a	a	DET
dti-2707	414	5	low	low	ADJ
dti-2707	414	6	cost	cost	NOUN
dti-2707	414	7	and	and	CCONJ
dti-2707	414	8	energy	energy	NOUN
dti-2707	414	9	consumption	consumption	NOUN
dti-2707	414	10	,	,	PUNCT
dti-2707	414	11	excellent	excellent	ADJ
dti-2707	414	12	safety	safety	NOUN
dti-2707	414	13	,	,	PUNCT
dti-2707	414	14	enhanced	enhance	VERB
dti-2707	414	15	stability	stability	NOUN
dti-2707	414	16	,	,	PUNCT
dti-2707	414	17	better	well	ADJ
dti-2707	414	18	medication	medication	NOUN
dti-2707	414	19	loading	loading	NOUN
dti-2707	414	20	rate	rate	NOUN
dti-2707	414	21	,	,	PUNCT
dti-2707	414	22	and	and	CCONJ
dti-2707	414	23	a	a	DET
dti-2707	414	24	straightforward	straightforward	ADJ
dti-2707	414	25	and	and	CCONJ
dti-2707	414	26	convenient	convenient	ADJ
dti-2707	414	27	operation	operation	NOUN
dti-2707	414	28	.	.	PUNCT
dti-2707	415	1	10	10	NUM
dti-2707	415	2	.	.	PUNCT
dti-2707	415	3	cn112691102a	cn112691102a	VERB
dti-2707	415	4	2021	2021	NUM
dti-2707	415	5	the	the	DET
dti-2707	415	6	invention	invention	NOUN
dti-2707	415	7	describes	describe	VERB
dti-2707	415	8	using	use	VERB
dti-2707	415	9	baicalein	baicalein	NOUN
dti-2707	415	10	to	to	PART
dti-2707	415	11	make	make	VERB
dti-2707	415	12	a	a	DET
dti-2707	415	13	medication	medication	NOUN
dti-2707	415	14	that	that	PRON
dti-2707	415	15	treats	treat	VERB
dti-2707	415	16	and	and	CCONJ
dti-2707	415	17	prevents	prevent	VERB
dti-2707	415	18	pd	pd	PROPN
dti-2707	415	19	as	as	ADV
dti-2707	415	20	well	well	ADV
dti-2707	415	21	as	as	ADP
dti-2707	415	22	the	the	DET
dti-2707	415	23	depressive	depressive	ADJ
dti-2707	415	24	symptoms	symptom	NOUN
dti-2707	415	25	of	of	ADP
dti-2707	415	26	parkinson	parkinson	NOUN
dti-2707	415	27	’s	’s	PART
dti-2707	415	28	syndrome	syndrome	NOUN
dti-2707	415	29	.	.	PUNCT
dti-2707	416	1	the	the	DET
dti-2707	416	2	invention	invention	NOUN
dti-2707	416	3	finds	find	VERB
dti-2707	416	4	that	that	DET
dti-2707	416	5	baicalein	baicalein	NOUN
dti-2707	416	6	can	can	AUX
dti-2707	416	7	clearly	clearly	ADV
dti-2707	416	8	increase	increase	VERB
dti-2707	416	9	the	the	DET
dti-2707	416	10	levels	level	NOUN
dti-2707	416	11	of	of	ADP
dti-2707	416	12	neurotransmitters	neurotransmitter	NOUN
dti-2707	416	13	like	like	ADP
dti-2707	416	14	da	da	PROPN
dti-2707	416	15	,	,	PUNCT
dti-2707	416	16	ne	ne	PROPN
dti-2707	416	17	,	,	PUNCT
dti-2707	416	18	and	and	CCONJ
dti-2707	416	19	5	5	NUM
dti-2707	416	20	-	-	SYM
dti-2707	416	21	ht	ht	NOUN
dti-2707	416	22	in	in	ADP
dti-2707	416	23	the	the	DET
dti-2707	416	24	brain	brain	NOUN
dti-2707	416	25	and	and	CCONJ
dti-2707	416	26	metabolites	metabolite	NOUN
dti-2707	416	27	thereof	thereof	ADV
dti-2707	416	28	,	,	PUNCT
dti-2707	416	29	decrease	decrease	VERB
dti-2707	416	30	the	the	DET
dti-2707	416	31	level	level	NOUN
dti-2707	416	32	of	of	ADP
dti-2707	416	33	neuroinflammation	neuroinflammation	NOUN
dti-2707	416	34	factors	factor	NOUN
dti-2707	416	35	in	in	ADP
dti-2707	416	36	blood	blood	NOUN
dti-2707	416	37	plasma	plasma	NOUN
dti-2707	416	38	,	,	PUNCT
dti-2707	416	39	and	and	CCONJ
dti-2707	416	40	improve	improve	VERB
dti-2707	416	41	the	the	DET
dti-2707	416	42	symptoms	symptom	NOUN
dti-2707	416	43	of	of	ADP
dti-2707	416	44	a	a	DET
dti-2707	416	45	rotenone	rotenone	NOUN
dti-2707	416	46	-	-	PUNCT
dti-2707	416	47	induced	induce	VERB
dti-2707	416	48	depression	depression	NOUN
dti-2707	416	49	mood	mood	NOUN
dti-2707	416	50	model	model	NOUN
dti-2707	416	51	of	of	ADP
dti-2707	416	52	a	a	DET
dti-2707	416	53	pd	pd	PROPN
dti-2707	416	54	/	/	SYM
dti-2707	416	55	parkinson	parkinson	NOUN
dti-2707	416	56	syndrome	syndrome	NOUN
dti-2707	416	57	mouse	mouse	NOUN
dti-2707	416	58	.	.	PUNCT
dti-2707	417	1	consequently	consequently	ADV
dti-2707	417	2	,	,	PUNCT
dti-2707	417	3	baicalein	baicalein	PROPN
dti-2707	417	4	can	can	AUX
dti-2707	417	5	be	be	AUX
dti-2707	417	6	utilized	utilize	VERB
dti-2707	417	7	to	to	PART
dti-2707	417	8	make	make	VERB
dti-2707	417	9	medications	medication	NOUN
dti-2707	417	10	that	that	PRON
dti-2707	417	11	prevent	prevent	VERB
dti-2707	417	12	and	and	CCONJ
dti-2707	417	13	treat	treat	VERB
dti-2707	417	14	pd	pd	INTJ
dti-2707	417	15	as	as	ADV
dti-2707	417	16	well	well	ADV
dti-2707	417	17	as	as	ADP
dti-2707	417	18	the	the	DET
dti-2707	417	19	symptoms	symptom	NOUN
dti-2707	417	20	of	of	ADP
dti-2707	417	21	depression	depression	NOUN
dti-2707	417	22	associated	associate	VERB
dti-2707	417	23	with	with	ADP
dti-2707	417	24	the	the	DET
dti-2707	417	25	condition	condition	NOUN
dti-2707	417	26	.	.	PUNCT
dti-2707	418	1	11	11	NUM
dti-2707	418	2	.	.	PUNCT
dti-2707	419	1	cn113244216a	cn113244216a	NOUN
dti-2707	419	2	2021	2021	NUM
dti-2707	419	3	the	the	DET
dti-2707	419	4	innovation	innovation	NOUN
dti-2707	419	5	reveals	reveal	VERB
dti-2707	419	6	the	the	DET
dti-2707	419	7	use	use	NOUN
dti-2707	419	8	of	of	ADP
dti-2707	419	9	baicalein	baicalein	NOUN
dti-2707	419	10	in	in	ADP
dti-2707	419	11	the	the	DET
dti-2707	419	12	development	development	NOUN
dti-2707	419	13	of	of	ADP
dti-2707	419	14	a	a	DET
dti-2707	419	15	medication	medication	NOUN
dti-2707	419	16	to	to	PART
dti-2707	419	17	suppress	suppress	VERB
dti-2707	419	18	a	a	DET
dti-2707	419	19	novel	novel	ADJ
dti-2707	419	20	coronavirus	coronavirus	NOUN
dti-2707	419	21	and	and	CCONJ
dti-2707	419	22	reveals	reveal	VERB
dti-2707	419	23	that	that	SCONJ
dti-2707	419	24	baicalein	baicalein	NOUN
dti-2707	419	25	and	and	CCONJ
dti-2707	419	26	sars	sar	NOUN
dti-2707	419	27	-	-	PUNCT
dti-2707	419	28	cov-2mpro	cov-2mpro	NOUN
dti-2707	419	29	can	can	AUX
dti-2707	419	30	be	be	AUX
dti-2707	419	31	coupled	couple	VERB
dti-2707	419	32	,	,	PUNCT
dti-2707	419	33	also	also	ADV
dti-2707	419	34	preventing	prevent	VERB
dti-2707	419	35	sars	sar	NOUN
dti-2707	419	36	-	-	PUNCT
dti-2707	419	37	cov-2mpro	cov-2mpro	NOUN
dti-2707	419	38	from	from	ADP
dti-2707	419	39	functioning	function	VERB
dti-2707	419	40	as	as	ADP
dti-2707	419	41	an	an	DET
dti-2707	419	42	enzyme	enzyme	NOUN
dti-2707	419	43	in	in	ADP
dti-2707	419	44	vitro	vitro	VERB
dti-2707	419	45	.	.	PUNCT
dti-2707	420	1	the	the	DET
dti-2707	420	2	protease	protease	NOUN
dti-2707	420	3	activity	activity	NOUN
dti-2707	420	4	,	,	PUNCT
dti-2707	420	5	which	which	PRON
dti-2707	420	6	impedes	impede	VERB
dti-2707	420	7	the	the	DET
dti-2707	420	8	new	new	ADJ
dti-2707	420	9	coronavirus	coronavirus	NOUN
dti-2707	420	10	’s	’s	PART
dti-2707	420	11	ability	ability	NOUN
dti-2707	420	12	to	to	PART
dti-2707	420	13	replicate	replicate	VERB
dti-2707	420	14	,	,	PUNCT
dti-2707	420	15	has	have	AUX
dti-2707	420	16	promising	promise	VERB
dti-2707	420	17	applications	application	NOUN
dti-2707	420	18	in	in	ADP
dti-2707	420	19	the	the	DET
dti-2707	420	20	field	field	NOUN
dti-2707	420	21	of	of	ADP
dti-2707	420	22	creating	create	VERB
dti-2707	420	23	new	new	ADJ
dti-2707	420	24	coronavirus	coronavirus	NOUN
dti-2707	420	25	drugs	drug	NOUN
dti-2707	420	26	.	.	PUNCT
dti-2707	421	1	12	12	NUM
dti-2707	421	2	.	.	PUNCT
dti-2707	422	1	wo2021159570a1	wo2021159570a1	NOUN
dti-2707	422	2	2021	2021	NUM
dti-2707	422	3	this	this	DET
dti-2707	422	4	invention	invention	NOUN
dti-2707	422	5	involves	involve	VERB
dti-2707	422	6	using	use	VERB
dti-2707	422	7	baicalein	baicalein	NOUN
dti-2707	422	8	to	to	PART
dti-2707	422	9	make	make	VERB
dti-2707	422	10	a	a	DET
dti-2707	422	11	drug	drug	NOUN
dti-2707	422	12	that	that	PRON
dti-2707	422	13	will	will	AUX
dti-2707	422	14	either	either	CCONJ
dti-2707	422	15	treat	treat	VERB
dti-2707	422	16	or	or	CCONJ
dti-2707	422	17	prevent	prevent	VERB
dti-2707	422	18	a	a	DET
dti-2707	422	19	disease	disease	NOUN
dti-2707	422	20	caused	cause	VERB
dti-2707	422	21	by	by	ADP
dti-2707	422	22	a	a	DET
dti-2707	422	23	novel	novel	ADJ
dti-2707	422	24	coronavirus	coronavirus	NOUN
dti-2707	422	25	infection	infection	NOUN
dti-2707	422	26	.	.	PUNCT
dti-2707	423	1	the	the	DET
dti-2707	423	2	invention	invention	NOUN
dti-2707	423	3	in	in	ADP
dti-2707	423	4	question	question	NOUN
dti-2707	423	5	pertains	pertain	NOUN
dti-2707	423	6	specifically	specifically	ADV
dti-2707	423	7	to	to	ADP
dti-2707	423	8	the	the	DET
dti-2707	423	9	use	use	NOUN
dti-2707	423	10	of	of	ADP
dti-2707	423	11	baicalein	baicalein	NOUN
dti-2707	423	12	and	and	CCONJ
dti-2707	423	13	a	a	DET
dti-2707	423	14	pharmaceutical	pharmaceutical	ADJ
dti-2707	423	15	composition	composition	NOUN
dti-2707	423	16	containing	contain	VERB
dti-2707	423	17	baicalein	baicalein	NOUN
dti-2707	423	18	in	in	ADP
dti-2707	423	19	the	the	DET
dti-2707	423	20	preparation	preparation	NOUN
dti-2707	423	21	of	of	ADP
dti-2707	423	22	a	a	DET
dti-2707	423	23	drug	drug	NOUN
dti-2707	423	24	intended	intend	VERB
dti-2707	423	25	to	to	PART
dti-2707	423	26	prevent	prevent	VERB
dti-2707	423	27	and/or	and/or	CCONJ
dti-2707	423	28	treat	treat	VERB
dti-2707	423	29	diseases	disease	NOUN
dti-2707	423	30	caused	cause	VERB
dti-2707	423	31	by	by	ADP
dti-2707	423	32	novel	novel	ADJ
dti-2707	423	33	coronavirus	coronavirus	NOUN
dti-2707	423	34	infections	infection	NOUN
dti-2707	423	35	(	(	PUNCT
dti-2707	423	36	sars	sar	NOUN
dti-2707	423	37	-	-	PUNCT
dti-2707	423	38	cov-2	cov-2	NOUN
dti-2707	423	39	)	)	PUNCT
dti-2707	423	40	.	.	PUNCT
dti-2707	424	1	these	these	DET
dti-2707	424	2	infections	infection	NOUN
dti-2707	424	3	can	can	AUX
dti-2707	424	4	range	range	VERB
dti-2707	424	5	in	in	ADP
dti-2707	424	6	severity	severity	NOUN
dti-2707	424	7	from	from	ADP
dti-2707	424	8	mild	mild	ADJ
dti-2707	424	9	to	to	ADP
dti-2707	424	10	severe	severe	ADJ
dti-2707	424	11	,	,	PUNCT
dti-2707	424	12	and	and	CCONJ
dti-2707	424	13	they	they	PRON
dti-2707	424	14	include	include	VERB
dti-2707	424	15	novel	novel	ADJ
dti-2707	424	16	coronavirus	coronavirus	NOUN
dti-2707	424	17	pneumonia	pneumonia	NOUN
dti-2707	424	18	.	.	PUNCT
dti-2707	425	1	13	13	NUM
dti-2707	425	2	.	.	PUNCT
dti-2707	426	1	cn113925861a	cn113925861a	VERB
dti-2707	426	2	2022	2022	NUM
dti-2707	426	3	the	the	DET
dti-2707	426	4	invention	invention	NOUN
dti-2707	426	5	describes	describe	VERB
dti-2707	426	6	the	the	DET
dti-2707	426	7	use	use	NOUN
dti-2707	426	8	of	of	ADP
dti-2707	426	9	a	a	DET
dti-2707	426	10	scutellaria	scutellaria	NOUN
dti-2707	426	11	flavone	flavone	NOUN
dti-2707	426	12	active	active	ADJ
dti-2707	426	13	ingredient	ingredient	NOUN
dti-2707	426	14	and	and	CCONJ
dti-2707	426	15	its	its	PRON
dti-2707	426	16	preparation	preparation	NOUN
dti-2707	426	17	in	in	ADP
dti-2707	426	18	the	the	DET
dti-2707	426	19	manufacturing	manufacturing	NOUN
dti-2707	426	20	of	of	ADP
dti-2707	426	21	a	a	DET
dti-2707	426	22	medication	medication	NOUN
dti-2707	426	23	intended	intend	VERB
dti-2707	426	24	to	to	PART
dti-2707	426	25	cure	cure	VERB
dti-2707	426	26	or	or	CCONJ
dti-2707	426	27	prevent	prevent	VERB
dti-2707	426	28	inflammatory	inflammatory	ADJ
dti-2707	426	29	storm	storm	NOUN
dti-2707	426	30	.	.	PUNCT
dti-2707	427	1	wogonin	wogonin	PROPN
dti-2707	427	2	,	,	PUNCT
dti-2707	427	3	oroxylin	oroxylin	PROPN
dti-2707	427	4	a	a	X
dti-2707	427	5	,	,	PUNCT
dti-2707	427	6	and	and	CCONJ
dti-2707	427	7	baicalein	baicalein	NOUN
dti-2707	427	8	are	be	AUX
dti-2707	427	9	the	the	DET
dti-2707	427	10	components	component	NOUN
dti-2707	427	11	from	from	ADP
dti-2707	427	12	which	which	PRON
dti-2707	427	13	the	the	DET
dti-2707	427	14	active	active	ADJ
dti-2707	427	15	ingredient	ingredient	NOUN
dti-2707	427	16	of	of	ADP
dti-2707	427	17	baicalein	baicalein	NOUN
dti-2707	427	18	is	be	AUX
dti-2707	427	19	chosen	choose	VERB
dti-2707	427	20	.	.	PUNCT
dti-2707	428	1	reducing	reduce	VERB
dti-2707	428	2	the	the	DET
dti-2707	428	3	frequency	frequency	NOUN
dti-2707	428	4	of	of	ADP
dti-2707	428	5	inflammatory	inflammatory	ADJ
dti-2707	428	6	storms	storm	NOUN
dti-2707	428	7	,	,	PUNCT
dti-2707	428	8	particularly	particularly	ADV
dti-2707	428	9	in	in	ADP
dti-2707	428	10	patients	patient	NOUN
dti-2707	428	11	who	who	PRON
dti-2707	428	12	are	be	AUX
dti-2707	428	13	severely	severely	ADV
dti-2707	428	14	ill	ill	ADJ
dti-2707	428	15	,	,	PUNCT
dti-2707	428	16	helps	help	VERB
dti-2707	428	17	to	to	PART
dti-2707	428	18	lessen	lessen	VERB
dti-2707	428	19	organ	organ	NOUN
dti-2707	428	20	damage	damage	NOUN
dti-2707	428	21	and	and	CCONJ
dti-2707	428	22	halt	halt	VERB
dti-2707	428	23	the	the	DET
dti-2707	428	24	disease	disease	NOUN
dti-2707	428	25	’s	’s	PART
dti-2707	428	26	course	course	NOUN
dti-2707	428	27	.	.	PUNCT
dti-2707	429	1	the	the	DET
dti-2707	429	2	innovation	innovation	NOUN
dti-2707	429	3	finds	find	VERB
dti-2707	429	4	that	that	DET
dti-2707	429	5	wogonin	wogonin	PROPN
dti-2707	429	6	,	,	PUNCT
dti-2707	429	7	baicalein	baicalein	PROPN
dti-2707	429	8	,	,	PUNCT
dti-2707	429	9	and	and	CCONJ
dti-2707	429	10	oroxylin	oroxylin	PROPN
dti-2707	429	11	a	a	DET
dti-2707	429	12	all	all	PRON
dti-2707	429	13	operate	operate	VERB
dti-2707	429	14	to	to	ADP
dti-2707	429	15	varying	vary	VERB
dti-2707	429	16	degrees	degree	NOUN
dti-2707	429	17	to	to	PART
dti-2707	429	18	block	block	VERB
dti-2707	429	19	the	the	DET
dti-2707	429	20	mouse	mouse	NOUN
dti-2707	429	21	cytokine	cytokine	NOUN
dti-2707	429	22	storm	storm	NOUN
dti-2707	429	23	.	.	PUNCT
dti-2707	430	1	lung	lung	NOUN
dti-2707	430	2	damage	damage	NOUN
dti-2707	430	3	and	and	CCONJ
dti-2707	430	4	inflammatory	inflammatory	ADJ
dti-2707	430	5	cell	cell	NOUN
dti-2707	430	6	infiltration	infiltration	NOUN
dti-2707	430	7	brought	bring	VERB
dti-2707	430	8	on	on	ADP
dti-2707	430	9	by	by	ADP
dti-2707	430	10	an	an	DET
dti-2707	430	11	inflammatory	inflammatory	ADJ
dti-2707	430	12	storm	storm	NOUN
dti-2707	430	13	can	can	AUX
dti-2707	430	14	be	be	AUX
dti-2707	430	15	lessened	lessen	VERB
dti-2707	430	16	by	by	ADP
dti-2707	430	17	baicalein	baicalein	PROPN
dti-2707	430	18	.	.	PUNCT
dti-2707	431	1	thus	thus	ADV
dti-2707	431	2	,	,	PUNCT
dti-2707	431	3	the	the	DET
dti-2707	431	4	medication	medication	NOUN
dti-2707	431	5	for	for	ADP
dti-2707	431	6	both	both	CCONJ
dti-2707	431	7	preventing	prevent	VERB
dti-2707	431	8	and	and	CCONJ
dti-2707	431	9	treating	treat	VERB
dti-2707	431	10	the	the	DET
dti-2707	431	11	inflammatory	inflammatory	ADJ
dti-2707	431	12	storm	storm	NOUN
dti-2707	431	13	can	can	AUX
dti-2707	431	14	be	be	AUX
dti-2707	431	15	made	make	VERB
dti-2707	431	16	using	use	VERB
dti-2707	431	17	the	the	DET
dti-2707	431	18	active	active	ADJ
dti-2707	431	19	ingredient	ingredient	NOUN
dti-2707	431	20	of	of	ADP
dti-2707	431	21	baicalein	baicalein	PROPN
dti-2707	431	22	.	.	PUNCT
dti-2707	432	1	da	da	NOUN
dti-2707	432	2	=	=	PUNCT
dti-2707	432	3	dopamine	dopamine	NOUN
dti-2707	432	4	;	;	PUNCT
dti-2707	432	5	mic	mic	ADJ
dti-2707	432	6	=	=	SYM
dti-2707	432	7	minimum	minimum	ADJ
dti-2707	432	8	inhibitory	inhibitory	ADJ
dti-2707	432	9	concentration	concentration	NOUN
dti-2707	432	10	;	;	PUNCT
dti-2707	432	11	ne	ne	X
dti-2707	432	12	=	=	SYM
dti-2707	432	13	norepinephrine	norepinephrine	NOUN
dti-2707	432	14	;	;	PUNCT
dti-2707	432	15	pd	pd	PROPN
dti-2707	432	16	=	=	PUNCT
dti-2707	432	17	parkinson	parkinson	NOUN
dti-2707	432	18	’s	’s	PART
dti-2707	432	19	disease	disease	NOUN
dti-2707	432	20	;	;	PUNCT
dti-2707	432	21	sars	sar	NOUN
dti-2707	432	22	-	-	PUNCT
dti-2707	432	23	cov	cov	NOUN
dti-2707	432	24	=	=	SYM
dti-2707	432	25	severe	severe	ADJ
dti-2707	432	26	acute	acute	ADJ
dti-2707	432	27	respiratory	respiratory	ADJ
dti-2707	432	28	syndrome	syndrome	NOUN
dti-2707	432	29	coronavirus	coronavirus	NOUN
dti-2707	432	30	.	.	PUNCT
dti-2707	433	1	table	table	NOUN
dti-2707	433	2	4	4	NUM
dti-2707	433	3	(	(	PUNCT
dti-2707	433	4	continued	continued	ADJ
dti-2707	433	5	)	)	PUNCT
dti-2707	433	6	therapeutic	therapeutic	ADJ
dti-2707	433	7	insights	insight	NOUN
dti-2707	433	8	into	into	ADP
dti-2707	433	9	baicalein42	baicalein42	NOUN
dti-2707	433	10	©	©	ADP
dti-2707	433	11	2024	2024	NUM
dti-2707	433	12	the	the	DET
dti-2707	433	13	authors	author	NOUN
dti-2707	433	14	.	.	PUNCT
dti-2707	434	1	drug	drug	NOUN
dti-2707	434	2	target	target	NOUN
dti-2707	434	3	insights	insight	NOUN
dti-2707	434	4	issn	issn	VERB
dti-2707	434	5	1177	1177	NUM
dti-2707	434	6	-	-	SYM
dti-2707	434	7	3928	3928	NUM
dti-2707	434	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2707	434	9	was	be	AUX
dti-2707	434	10	no	no	DET
dti-2707	434	11	impairment	impairment	NOUN
dti-2707	434	12	seen	see	VERB
dti-2707	434	13	in	in	ADP
dti-2707	434	14	liver	liver	NOUN
dti-2707	434	15	and	and	CCONJ
dti-2707	434	16	renal	renal	ADJ
dti-2707	434	17	function	function	NOUN
dti-2707	434	18	;	;	PUNCT
dti-2707	434	19	however	however	ADV
dti-2707	434	20	,	,	PUNCT
dti-2707	434	21	it	it	PRON
dti-2707	434	22	may	may	AUX
dti-2707	434	23	affect	affect	VERB
dti-2707	434	24	the	the	DET
dti-2707	434	25	metabolism	metabolism	NOUN
dti-2707	434	26	of	of	ADP
dti-2707	434	27	triglycerides	triglyceride	NOUN
dti-2707	434	28	.	.	PUNCT
dti-2707	435	1	baicalein	baicalein	PROPN
dti-2707	435	2	is	be	AUX
dti-2707	435	3	rapidly	rapidly	ADV
dti-2707	435	4	and	and	CCONJ
dti-2707	435	5	extensively	extensively	ADV
dti-2707	435	6	metabolized	metabolize	VERB
dti-2707	435	7	in	in	ADP
dti-2707	435	8	the	the	DET
dti-2707	435	9	body	body	NOUN
dti-2707	435	10	,	,	PUNCT
dti-2707	435	11	resulting	result	VERB
dti-2707	435	12	in	in	ADP
dti-2707	435	13	the	the	DET
dti-2707	435	14	production	production	NOUN
dti-2707	435	15	of	of	ADP
dti-2707	435	16	several	several	ADJ
dti-2707	435	17	metabolites	metabolite	NOUN
dti-2707	435	18	.	.	PUNCT
dti-2707	436	1	out	out	ADP
dti-2707	436	2	of	of	ADP
dti-2707	436	3	the	the	DET
dti-2707	436	4	seven	seven	NUM
dti-2707	436	5	metabolites	metabolite	NOUN
dti-2707	436	6	,	,	PUNCT
dti-2707	436	7	7	7	NUM
dti-2707	436	8	-	-	PUNCT
dti-2707	436	9	bs	bs	PROPN
dti-2707	436	10	and	and	CCONJ
dti-2707	436	11	bgg	bgg	PROPN
dti-2707	436	12	exhibited	exhibit	VERB
dti-2707	436	13	a	a	DET
dti-2707	436	14	significantly	significantly	ADV
dti-2707	436	15	larger	large	ADJ
dti-2707	436	16	amount	amount	NOUN
dti-2707	436	17	in	in	ADP
dti-2707	436	18	the	the	DET
dti-2707	436	19	plasma	plasma	NOUN
dti-2707	436	20	.	.	PUNCT
dti-2707	437	1	the	the	DET
dti-2707	437	2	scientific	scientific	ADJ
dti-2707	437	3	literature	literature	NOUN
dti-2707	437	4	has	have	AUX
dti-2707	437	5	shown	show	VERB
dti-2707	437	6	the	the	DET
dti-2707	437	7	antiviral	antiviral	ADJ
dti-2707	437	8	activity	activity	NOUN
dti-2707	437	9	of	of	ADP
dti-2707	437	10	baicalein	baicalein	NOUN
dti-2707	437	11	and	and	CCONJ
dti-2707	437	12	baicalin	baicalin	NOUN
dti-2707	437	13	(	(	PUNCT
dti-2707	437	14	7	7	NUM
dti-2707	437	15	-	-	NUM
dti-2707	437	16	bg	bg	NOUN
dti-2707	437	17	)	)	PUNCT
dti-2707	437	18	.	.	PUNCT
dti-2707	438	1	there	there	PRON
dti-2707	438	2	are	be	VERB
dti-2707	438	3	direct	direct	ADJ
dti-2707	438	4	and	and	CCONJ
dti-2707	438	5	indirect	indirect	ADJ
dti-2707	438	6	consequences	consequence	NOUN
dti-2707	438	7	among	among	ADP
dti-2707	438	8	them	they	PRON
dti-2707	438	9	.	.	PUNCT
dti-2707	439	1	it	it	PRON
dti-2707	439	2	is	be	AUX
dti-2707	439	3	critical	critical	ADJ
dti-2707	439	4	to	to	PART
dti-2707	439	5	know	know	VERB
dti-2707	439	6	each	each	DET
dti-2707	439	7	mode	mode	NOUN
dti-2707	439	8	of	of	ADP
dti-2707	439	9	action	action	NOUN
dti-2707	439	10	in	in	ADP
dti-2707	439	11	order	order	NOUN
dti-2707	439	12	to	to	PART
dti-2707	439	13	maximize	maximize	VERB
dti-2707	439	14	this	this	DET
dti-2707	439	15	flavonoid	flavonoid	NOUN
dti-2707	439	16	’s	’s	PART
dti-2707	439	17	efficacy	efficacy	NOUN
dti-2707	439	18	in	in	ADP
dti-2707	439	19	treating	treat	VERB
dti-2707	439	20	diseases	disease	NOUN
dti-2707	439	21	.	.	PUNCT
dti-2707	440	1	there	there	PRON
dti-2707	440	2	are	be	VERB
dti-2707	440	3	direct	direct	ADJ
dti-2707	440	4	and	and	CCONJ
dti-2707	440	5	indirect	indirect	ADJ
dti-2707	440	6	consequences	consequence	NOUN
dti-2707	440	7	among	among	ADP
dti-2707	440	8	them	they	PRON
dti-2707	440	9	.	.	PUNCT
dti-2707	441	1	clinical	clinical	ADJ
dti-2707	441	2	research	research	NOUN
dti-2707	441	3	on	on	ADP
dti-2707	441	4	this	this	DET
dti-2707	441	5	natural	natural	ADJ
dti-2707	441	6	substance	substance	NOUN
dti-2707	441	7	’s	’s	PART
dti-2707	441	8	efficacy	efficacy	NOUN
dti-2707	441	9	,	,	PUNCT
dti-2707	441	10	however	however	ADV
dti-2707	441	11	,	,	PUNCT
dti-2707	441	12	did	do	AUX
dti-2707	441	13	not	not	PART
dti-2707	441	14	provide	provide	VERB
dti-2707	441	15	enough	enough	ADJ
dti-2707	441	16	information	information	NOUN
dti-2707	441	17	.	.	PUNCT
dti-2707	442	1	consequently	consequently	ADV
dti-2707	442	2	,	,	PUNCT
dti-2707	442	3	additional	additional	ADJ
dti-2707	442	4	evidence	evidence	NOUN
dti-2707	442	5	-	-	PUNCT
dti-2707	442	6	based	base	VERB
dti-2707	442	7	clinical	clinical	ADJ
dti-2707	442	8	trials	trial	NOUN
dti-2707	442	9	are	be	AUX
dti-2707	442	10	required	require	VERB
dti-2707	442	11	to	to	PART
dti-2707	442	12	verify	verify	VERB
dti-2707	442	13	the	the	DET
dti-2707	442	14	safety	safety	NOUN
dti-2707	442	15	and	and	CCONJ
dti-2707	442	16	effectiveness	effectiveness	NOUN
dti-2707	442	17	of	of	ADP
dti-2707	442	18	baicalein	baicalein	NOUN
dti-2707	442	19	as	as	ADP
dti-2707	442	20	a	a	DET
dti-2707	442	21	potential	potential	ADJ
dti-2707	442	22	therapeutic	therapeutic	ADJ
dti-2707	442	23	agent	agent	NOUN
dti-2707	442	24	for	for	ADP
dti-2707	442	25	a	a	DET
dti-2707	442	26	range	range	NOUN
dti-2707	442	27	of	of	ADP
dti-2707	442	28	human	human	ADJ
dti-2707	442	29	illnesses	illness	NOUN
dti-2707	442	30	and	and	CCONJ
dti-2707	442	31	for	for	ADP
dti-2707	442	32	the	the	DET
dti-2707	442	33	good	good	NOUN
dti-2707	442	34	of	of	ADP
dti-2707	442	35	humanity	humanity	NOUN
dti-2707	442	36	.	.	PUNCT
dti-2707	443	1	acknowledgment	acknowledgment	NOUN
dti-2707	443	2	the	the	DET
dti-2707	443	3	images	image	NOUN
dti-2707	443	4	were	be	AUX
dti-2707	443	5	created	create	VERB
dti-2707	443	6	using	use	VERB
dti-2707	443	7	biorender	biorend	ADJ
dti-2707	443	8	software	software	NOUN
dti-2707	443	9	.	.	PUNCT
dti-2707	444	1	disclosures	disclosure	VERB
dti-2707	444	2	conflict	conflict	NOUN
dti-2707	444	3	of	of	ADP
dti-2707	444	4	interest	interest	NOUN
dti-2707	444	5	:	:	PUNCT
dti-2707	444	6	the	the	DET
dti-2707	444	7	authors	author	NOUN
dti-2707	444	8	declare	declare	VERB
dti-2707	444	9	no	no	DET
dti-2707	444	10	conflict	conflict	NOUN
dti-2707	444	11	of	of	ADP
dti-2707	444	12	interest	interest	NOUN
dti-2707	444	13	.	.	PUNCT
dti-2707	445	1	financial	financial	ADJ
dti-2707	445	2	support	support	NOUN
dti-2707	445	3	:	:	PUNCT
dti-2707	445	4	nil	nil	ADJ
dti-2707	445	5	author	author	NOUN
dti-2707	445	6	contributions	contribution	NOUN
dti-2707	445	7	:	:	PUNCT
dti-2707	445	8	kavita	kavita	PROPN
dti-2707	445	9	munjal	munjal	PROPN
dti-2707	445	10	,	,	PUNCT
dti-2707	445	11	yashgoel	yashgoel	PROPN
dti-2707	445	12	,	,	PUNCT
dti-2707	445	13	vinod	vinod	PROPN
dti-2707	445	14	kumar	kumar	PROPN
dti-2707	445	15	gauttam	gauttam	PROPN
dti-2707	445	16	:	:	PUNCT
dti-2707	445	17	conceptualization	conceptualization	NOUN
dti-2707	445	18	,	,	PUNCT
dti-2707	445	19	methodology	methodology	NOUN
dti-2707	445	20	,	,	PUNCT
dti-2707	445	21	investigation	investigation	NOUN
dti-2707	445	22	,	,	PUNCT
dti-2707	445	23	data	data	NOUN
dti-2707	445	24	collection	collection	NOUN
dti-2707	445	25	,	,	PUNCT
dti-2707	445	26	and	and	CCONJ
dti-2707	445	27	writing	writing	NOUN
dti-2707	445	28	—	—	PUNCT
dti-2707	445	29	original	original	ADJ
dti-2707	445	30	manuscript	manuscript	NOUN
dti-2707	445	31	.	.	PUNCT
dti-2707	446	1	hitesh	hitesh	PROPN
dti-2707	446	2	chopra	chopra	PROPN
dti-2707	446	3	,	,	PUNCT
dti-2707	446	4	madhav	madhav	PROPN
dti-2707	446	5	singla	singla	PROPN
dti-2707	446	6	,	,	PUNCT
dti-2707	446	7	smriti	smriti	PROPN
dti-2707	446	8	,	,	PUNCT
dti-2707	446	9	saurabh	saurabh	PROPN
dti-2707	446	10	gupta	gupta	PROPN
dti-2707	446	11	,	,	PUNCT
dti-2707	446	12	rohit	rohit	PROPN
dti-2707	446	13	sharma	sharma	PROPN
dti-2707	446	14	:	:	PUNCT
dti-2707	446	15	editing	editing	NOUN
dti-2707	446	16	and	and	CCONJ
dti-2707	446	17	proofreading	proofreading	NOUN
dti-2707	446	18	.	.	PUNCT
dti-2707	447	1	hitesh	hitesh	PROPN
dti-2707	447	2	chopra	chopra	PROPN
dti-2707	447	3	,	,	PUNCT
dti-2707	447	4	rohit	rohit	PROPN
dti-2707	447	5	sharma	sharma	PROPN
dti-2707	447	6	:	:	PUNCT
dti-2707	447	7	supervision	supervision	NOUN
dti-2707	447	8	.	.	PUNCT
dti-2707	448	1	all	all	DET
dti-2707	448	2	authors	author	NOUN
dti-2707	448	3	approved	approve	VERB
dti-2707	448	4	the	the	DET
dti-2707	448	5	submission	submission	NOUN
dti-2707	448	6	of	of	ADP
dti-2707	448	7	the	the	DET
dti-2707	448	8	final	final	ADJ
dti-2707	448	9	manuscript	manuscript	NOUN
dti-2707	448	10	.	.	PUNCT
dti-2707	449	1	references	reference	NOUN
dti-2707	449	2	1	1	NUM
dti-2707	449	3	.	.	PUNCT
dti-2707	450	1	liang	liang	PROPN
dti-2707	450	2	w	w	PROPN
dti-2707	450	3	,	,	PUNCT
dti-2707	450	4	huang	huang	PROPN
dti-2707	450	5	x	x	PROPN
dti-2707	450	6	,	,	PUNCT
dti-2707	450	7	chen	chen	PROPN
dti-2707	450	8	w.	w.	PROPN
dti-2707	450	9	the	the	DET
dti-2707	450	10	effects	effect	NOUN
dti-2707	450	11	of	of	ADP
dti-2707	450	12	baicalin	baicalin	NOUN
dti-2707	450	13	and	and	CCONJ
dti-2707	450	14	baicalein	baicalein	NOUN
dti-2707	450	15	on	on	ADP
dti-2707	450	16	cerebral	cerebral	ADJ
dti-2707	450	17	ischemia	ischemia	NOUN
dti-2707	450	18	:	:	PUNCT
dti-2707	450	19	a	a	DET
dti-2707	450	20	review	review	NOUN
dti-2707	450	21	.	.	PUNCT
dti-2707	451	1	aging	age	VERB
dti-2707	451	2	dis	dis	PROPN
dti-2707	451	3	.	.	PUNCT
dti-2707	452	1	2017;8(6):850	2017;8(6):850	PROPN
dti-2707	452	2	-	-	SYM
dti-2707	452	3	867	867	NUM
dti-2707	452	4	.	.	PUNCT
dti-2707	453	1	crossref	crossref	PROPN
dti-2707	453	2	pubmed	pubmed	PROPN
dti-2707	453	3	2	2	PROPN
dti-2707	453	4	.	.	PUNCT
dti-2707	454	1	li	li	PROPN
dti-2707	454	2	-	-	PROPN
dti-2707	454	3	weber	weber	PROPN
dti-2707	454	4	m.	m.	NOUN
dti-2707	454	5	new	new	ADJ
dti-2707	454	6	therapeutic	therapeutic	ADJ
dti-2707	454	7	aspects	aspect	NOUN
dti-2707	454	8	of	of	ADP
dti-2707	454	9	flavones	flavone	NOUN
dti-2707	454	10	:	:	PUNCT
dti-2707	454	11	the	the	DET
dti-2707	454	12	anticancer	anticancer	NOUN
dti-2707	454	13	properties	property	NOUN
dti-2707	454	14	of	of	ADP
dti-2707	454	15	scutellaria	scutellaria	NOUN
dti-2707	454	16	and	and	CCONJ
dti-2707	454	17	its	its	PRON
dti-2707	454	18	main	main	ADJ
dti-2707	454	19	active	active	ADJ
dti-2707	454	20	constituents	constituent	NOUN
dti-2707	454	21	wogonin	wogonin	PROPN
dti-2707	454	22	,	,	PUNCT
dti-2707	454	23	baicalein	baicalein	NOUN
dti-2707	454	24	and	and	CCONJ
dti-2707	454	25	baicalin	baicalin	NOUN
dti-2707	454	26	.	.	PUNCT
dti-2707	455	1	cancer	cancer	NOUN
dti-2707	455	2	treat	treat	PROPN
dti-2707	455	3	rev	rev	VERB
dti-2707	455	4	.	.	PROPN
dti-2707	455	5	2009	2009	NUM
dti-2707	455	6	;	;	PUNCT
dti-2707	455	7	35(1):57	35(1):57	NUM
dti-2707	455	8	-	-	SYM
dti-2707	455	9	68	68	NUM
dti-2707	455	10	.	.	PUNCT
dti-2707	456	1	crossref	crossref	PROPN
dti-2707	456	2	pubmed	pubmed	PROPN
dti-2707	456	3	3	3	PROPN
dti-2707	456	4	.	.	PUNCT
dti-2707	457	1	nik	nik	PROPN
dti-2707	457	2	salleh	salleh	PROPN
dti-2707	457	3	nnh	nnh	PROPN
dti-2707	457	4	,	,	PUNCT
dti-2707	457	5	othman	othman	PROPN
dti-2707	457	6	fa	fa	PROPN
dti-2707	457	7	,	,	PUNCT
dti-2707	457	8	kamarudin	kamarudin	NOUN
dti-2707	457	9	na	na	PROPN
dti-2707	457	10	,	,	PUNCT
dti-2707	457	11	tan	tan	PROPN
dti-2707	457	12	sc	sc	PROPN
dti-2707	457	13	.	.	PUNCT
dti-2707	458	1	the	the	DET
dti-2707	458	2	biological	biological	ADJ
dti-2707	458	3	activities	activity	NOUN
dti-2707	458	4	and	and	CCONJ
dti-2707	458	5	therapeutic	therapeutic	ADJ
dti-2707	458	6	potentials	potential	NOUN
dti-2707	458	7	of	of	ADP
dti-2707	458	8	baicalein	baicalein	NOUN
dti-2707	458	9	extracted	extract	VERB
dti-2707	458	10	from	from	ADP
dti-2707	458	11	oroxylum	oroxylum	PROPN
dti-2707	458	12	indicum	indicum	NOUN
dti-2707	458	13	:	:	PUNCT
dti-2707	458	14	a	a	DET
dti-2707	458	15	systematic	systematic	ADJ
dti-2707	458	16	review	review	NOUN
dti-2707	458	17	.	.	PUNCT
dti-2707	459	1	molecules	molecule	NOUN
dti-2707	459	2	.	.	PUNCT
dti-2707	460	1	2020	2020	NUM
dti-2707	460	2	;	;	PUNCT
dti-2707	461	1	25(23):5677	25(23):5677	NUM
dti-2707	461	2	.	.	PUNCT
dti-2707	462	1	crossref	crossref	PROPN
dti-2707	462	2	pubmed	pubmed	PROPN
dti-2707	462	3	4	4	PROPN
dti-2707	462	4	.	.	PUNCT
dti-2707	462	5	rossi	rossi	PROPN
dti-2707	462	6	m	m	PROPN
dti-2707	462	7	,	,	PUNCT
dti-2707	462	8	meyer	meyer	PROPN
dti-2707	462	9	r	r	PROPN
dti-2707	462	10	,	,	PUNCT
dti-2707	462	11	constantinou	constantinou	NOUN
dti-2707	462	12	p	p	NOUN
dti-2707	462	13	,	,	PUNCT
dti-2707	462	14	et	et	PROPN
dti-2707	462	15	al	al	PROPN
dti-2707	462	16	.	.	PUNCT
dti-2707	463	1	molecular	molecular	ADJ
dti-2707	463	2	structure	structure	NOUN
dti-2707	463	3	and	and	CCONJ
dti-2707	463	4	activity	activity	NOUN
dti-2707	463	5	toward	toward	ADP
dti-2707	463	6	dna	dna	NOUN
dti-2707	463	7	of	of	ADP
dti-2707	463	8	baicalein	baicalein	PROPN
dti-2707	463	9	,	,	PUNCT
dti-2707	463	10	a	a	DET
dti-2707	463	11	flavone	flavone	NOUN
dti-2707	463	12	constituent	constituent	NOUN
dti-2707	463	13	of	of	ADP
dti-2707	463	14	the	the	DET
dti-2707	463	15	asian	asian	ADJ
dti-2707	463	16	herbal	herbal	ADJ
dti-2707	463	17	medicine	medicine	NOUN
dti-2707	463	18	“	"	PUNCT
dti-2707	463	19	sho	sho	X
dti-2707	463	20	-	-	PUNCT
dti-2707	463	21	saiko	saiko	NOUN
dti-2707	463	22	-	-	PUNCT
dti-2707	463	23	to	to	ADP
dti-2707	463	24	”	"	PUNCT
dti-2707	463	25	.	.	PUNCT
dti-2707	464	1	j	j	PROPN
dti-2707	464	2	nat	nat	PROPN
dti-2707	464	3	prod	prod	NOUN
dti-2707	464	4	.	.	PUNCT
dti-2707	465	1	2001;64(1):26	2001;64(1):26	NUM
dti-2707	465	2	-	-	SYM
dti-2707	465	3	31	31	NUM
dti-2707	465	4	.	.	PUNCT
dti-2707	466	1	crossref	crossref	PROPN
dti-2707	466	2	pubmed	pubmed	PROPN
dti-2707	466	3	5	5	PROPN
dti-2707	466	4	.	.	PUNCT
dti-2707	467	1	gao	gao	PROPN
dti-2707	467	2	y	y	PROPN
dti-2707	467	3	,	,	PUNCT
dti-2707	467	4	snyder	snyder	PROPN
dti-2707	467	5	sa	sa	PROPN
dti-2707	467	6	,	,	PUNCT
dti-2707	467	7	smith	smith	PROPN
dti-2707	467	8	jn	jn	PROPN
dti-2707	467	9	,	,	PUNCT
dti-2707	467	10	chen	chen	PROPN
dti-2707	467	11	yc	yc	PROPN
dti-2707	467	12	.	.	PUNCT
dti-2707	468	1	anticancer	anticancer	NOUN
dti-2707	468	2	properties	property	NOUN
dti-2707	468	3	of	of	ADP
dti-2707	468	4	baicalein	baicalein	PROPN
dti-2707	468	5	:	:	PUNCT
dti-2707	468	6	a	a	DET
dti-2707	468	7	review	review	NOUN
dti-2707	468	8	.	.	PUNCT
dti-2707	469	1	med	med	ADJ
dti-2707	469	2	chem	chem	NOUN
dti-2707	469	3	res	re	NOUN
dti-2707	469	4	.	.	PUNCT
dti-2707	470	1	2016;25(8):1515	2016;25(8):1515	PROPN
dti-2707	470	2	-	-	PUNCT
dti-2707	470	3	1523	1523	NUM
dti-2707	470	4	.	.	PUNCT
dti-2707	471	1	crossref	crossref	PROPN
dti-2707	471	2	pubmed	pubmed	PROPN
dti-2707	471	3	6	6	NUM
dti-2707	471	4	.	.	PUNCT
dti-2707	472	1	adin	adin	PROPN
dti-2707	472	2	sn	sn	PROPN
dti-2707	472	3	,	,	PUNCT
dti-2707	472	4	gupta	gupta	PROPN
dti-2707	472	5	i	i	PRON
dti-2707	472	6	,	,	PUNCT
dti-2707	472	7	ahad	ahad	PROPN
dti-2707	472	8	a	a	PROPN
dti-2707	472	9	,	,	PUNCT
dti-2707	472	10	aqil	aqil	PROPN
dti-2707	472	11	m	m	PROPN
dti-2707	472	12	,	,	PUNCT
dti-2707	472	13	mujeeb	mujeeb	PROPN
dti-2707	472	14	m.	m.	PROPN
dti-2707	472	15	a	a	DET
dti-2707	472	16	developed	develop	VERB
dti-2707	472	17	highperformance	highperformance	NOUN
dti-2707	472	18	thin	thin	ADJ
dti-2707	472	19	-	-	PUNCT
dti-2707	472	20	layer	layer	NOUN
dti-2707	472	21	chromatography	chromatography	NOUN
dti-2707	472	22	method	method	NOUN
dti-2707	472	23	for	for	ADP
dti-2707	472	24	the	the	DET
dti-2707	472	25	determination	determination	NOUN
dti-2707	472	26	of	of	ADP
dti-2707	472	27	baicalin	baicalin	NOUN
dti-2707	472	28	in	in	ADP
dti-2707	472	29	oroxylum	oroxylum	PROPN
dti-2707	472	30	indicum	indicum	PROPN
dti-2707	472	31	l.	l.	PROPN
dti-2707	472	32	and	and	CCONJ
dti-2707	472	33	its	its	PRON
dti-2707	472	34	antioxidant	antioxidant	ADJ
dti-2707	472	35	activity	activity	NOUN
dti-2707	472	36	.	.	PUNCT
dti-2707	473	1	j	j	PROPN
dti-2707	473	2	planar	planar	PROPN
dti-2707	473	3	chromatogr	chromatogr	PROPN
dti-2707	473	4	mod	mod	PROPN
dti-2707	473	5	tlc	tlc	PROPN
dti-2707	473	6	.	.	PUNCT
dti-2707	474	1	2022;35(4):383	2022;35(4):383	NUM
dti-2707	474	2	-	-	PUNCT
dti-2707	474	3	393	393	NUM
dti-2707	474	4	.	.	PUNCT
dti-2707	475	1	crossref	crossref	PROPN
dti-2707	475	2	7	7	NUM
dti-2707	475	3	.	.	PUNCT
dti-2707	475	4	rojsanga	rojsanga	ADV
dti-2707	475	5	p	p	X
dti-2707	475	6	,	,	PUNCT
dti-2707	475	7	bunsupa	bunsupa	PROPN
dti-2707	475	8	s	s	PROPN
dti-2707	475	9	,	,	PUNCT
dti-2707	475	10	sithisarn	sithisarn	PROPN
dti-2707	475	11	p.	p.	PROPN
dti-2707	475	12	flavones	flavone	NOUN
dti-2707	475	13	contents	content	NOUN
dti-2707	475	14	in	in	ADP
dti-2707	475	15	extracts	extract	NOUN
dti-2707	475	16	from	from	ADP
dti-2707	475	17	oroxylum	oroxylum	PROPN
dti-2707	475	18	indicum	indicum	NOUN
dti-2707	475	19	seeds	seed	NOUN
dti-2707	475	20	and	and	CCONJ
dti-2707	475	21	plant	plant	NOUN
dti-2707	475	22	tissue	tissue	NOUN
dti-2707	475	23	cultures	culture	NOUN
dti-2707	475	24	.	.	PUNCT
dti-2707	476	1	molecules	molecule	NOUN
dti-2707	476	2	.	.	PUNCT
dti-2707	477	1	2020;25(7):1545	2020;25(7):1545	NUM
dti-2707	477	2	.	.	PUNCT
dti-2707	478	1	crossref	crossref	PROPN
dti-2707	478	2	pubmed	pubmed	PROPN
dti-2707	478	3	8	8	PROPN
dti-2707	478	4	.	.	PUNCT
dti-2707	478	5	yu	yu	PROPN
dti-2707	479	1	h	h	PROPN
dti-2707	479	2	,	,	PUNCT
dti-2707	479	3	han	han	PROPN
dti-2707	479	4	y	y	PROPN
dti-2707	479	5	,	,	PUNCT
dti-2707	479	6	liu	liu	PROPN
dti-2707	479	7	c	c	PROPN
dti-2707	479	8	,	,	PUNCT
dti-2707	479	9	et	et	PROPN
dti-2707	479	10	al	al	PROPN
dti-2707	479	11	.	.	PUNCT
dti-2707	479	12	preparation	preparation	NOUN
dti-2707	479	13	of	of	ADP
dti-2707	479	14	baicalein	baicalein	NOUN
dti-2707	479	15	from	from	ADP
dti-2707	479	16	baicalin	baicalin	NOUN
dti-2707	479	17	using	use	VERB
dti-2707	479	18	a	a	DET
dti-2707	479	19	baicalin	baicalin	NOUN
dti-2707	479	20	-	-	PUNCT
dti-2707	479	21	β	β	NOUN
dti-2707	479	22	-	-	ADJ
dti-2707	479	23	d	d	NOUN
dti-2707	479	24	-	-	NOUN
dti-2707	479	25	glucuronidase	glucuronidase	NOUN
dti-2707	479	26	from	from	ADP
dti-2707	479	27	aspergillus	aspergillus	NOUN
dti-2707	479	28	niger	niger	NOUN
dti-2707	479	29	b.48	b.48	NOUN
dti-2707	479	30	strain	strain	NOUN
dti-2707	479	31	.	.	PUNCT
dti-2707	480	1	process	process	NOUN
dti-2707	480	2	biochem	biochem	NOUN
dti-2707	480	3	.	.	PUNCT
dti-2707	481	1	2020;97:168	2020;97:168	NUM
dti-2707	481	2	-	-	SYM
dti-2707	481	3	175	175	NUM
dti-2707	481	4	.	.	PUNCT
dti-2707	482	1	crossref	crossref	PROPN
dti-2707	482	2	9	9	NUM
dti-2707	482	3	.	.	PUNCT
dti-2707	483	1	wang	wang	PROPN
dti-2707	483	2	h	h	PROPN
dti-2707	483	3	,	,	PUNCT
dti-2707	483	4	ma	ma	PROPN
dti-2707	483	5	x	x	PROPN
dti-2707	483	6	,	,	PUNCT
dti-2707	483	7	cheng	cheng	PROPN
dti-2707	483	8	q	q	PROPN
dti-2707	483	9	,	,	PUNCT
dti-2707	483	10	wang	wang	PROPN
dti-2707	483	11	l	l	PROPN
dti-2707	483	12	,	,	PUNCT
dti-2707	483	13	zhang	zhang	PROPN
dti-2707	483	14	l.	l.	PROPN
dti-2707	483	15	deep	deep	PROPN
dti-2707	483	16	eutectic	eutectic	ADJ
dti-2707	483	17	solvent	solvent	NOUN
dti-2707	483	18	-	-	PUNCT
dti-2707	483	19	based	base	VERB
dti-2707	483	20	ultrahigh	ultrahigh	ADJ
dti-2707	483	21	pressure	pressure	NOUN
dti-2707	483	22	extraction	extraction	NOUN
dti-2707	483	23	of	of	ADP
dti-2707	483	24	baicalin	baicalin	NOUN
dti-2707	483	25	from	from	ADP
dti-2707	483	26	scutellaria	scutellaria	PROPN
dti-2707	483	27	baicalensis	baicalensis	NOUN
dti-2707	483	28	georgi	georgi	PROPN
dti-2707	483	29	.	.	PUNCT
dti-2707	484	1	molecules	molecule	NOUN
dti-2707	484	2	.	.	PUNCT
dti-2707	485	1	2018;23(12):3233	2018;23(12):3233	X
dti-2707	485	2	.	.	X
dti-2707	485	3	crossref	crossref	PROPN
dti-2707	485	4	pubmed	pubmed	PROPN
dti-2707	485	5	10	10	PROPN
dti-2707	485	6	.	.	PUNCT
dti-2707	486	1	li	li	PROPN
dti-2707	486	2	hb	hb	PROPN
dti-2707	486	3	,	,	PUNCT
dti-2707	486	4	jiang	jiang	PROPN
dti-2707	486	5	y	y	PROPN
dti-2707	486	6	,	,	PUNCT
dti-2707	486	7	chen	chen	PROPN
dti-2707	486	8	f.	f.	PROPN
dti-2707	486	9	separation	separation	PROPN
dti-2707	486	10	methods	method	NOUN
dti-2707	486	11	used	use	VERB
dti-2707	486	12	for	for	ADP
dti-2707	486	13	scutellaria	scutellaria	NOUN
dti-2707	486	14	baicalensis	baicalensis	NOUN
dti-2707	486	15	active	active	ADJ
dti-2707	486	16	components	component	NOUN
dti-2707	486	17	.	.	PUNCT
dti-2707	487	1	j	j	PROPN
dti-2707	487	2	chromatogr	chromatogr	PROPN
dti-2707	487	3	b	b	PROPN
dti-2707	487	4	analyt	analyt	PROPN
dti-2707	487	5	technol	technol	PROPN
dti-2707	487	6	biomed	biome	VERB
dti-2707	487	7	life	life	NOUN
dti-2707	487	8	sci	sci	PROPN
dti-2707	487	9	.	.	PUNCT
dti-2707	488	1	2004;812(1	2004;812(1	AUX
dti-2707	488	2	-	-	PUNCT
dti-2707	488	3	2):277	2):277	NUM
dti-2707	488	4	-	-	PUNCT
dti-2707	488	5	290	290	NUM
dti-2707	488	6	.	.	PUNCT
dti-2707	489	1	crossref	crossref	PROPN
dti-2707	489	2	pubmed	pubmed	PROPN
dti-2707	489	3	11	11	NUM
dti-2707	489	4	.	.	PUNCT
dti-2707	490	1	de	de	PROPN
dti-2707	490	2	oliveira	oliveira	PROPN
dti-2707	490	3	mr	mr	PROPN
dti-2707	490	4	,	,	PUNCT
dti-2707	490	5	nabavi	nabavi	PROPN
dti-2707	490	6	sf	sf	PROPN
dti-2707	490	7	,	,	PUNCT
dti-2707	490	8	habtemariam	habtemariam	PROPN
dti-2707	490	9	s	s	PROPN
dti-2707	490	10	,	,	PUNCT
dti-2707	490	11	erdogan	erdogan	ADJ
dti-2707	490	12	orhan	orhan	PROPN
dti-2707	490	13	i	i	PROPN
dti-2707	490	14	,	,	PUNCT
dti-2707	490	15	daglia	daglia	PROPN
dti-2707	490	16	m	m	PROPN
dti-2707	490	17	,	,	PUNCT
dti-2707	490	18	nabavi	nabavi	PROPN
dti-2707	490	19	sm	sm	NOUN
dti-2707	490	20	.	.	PUNCT
dti-2707	491	1	the	the	DET
dti-2707	491	2	effects	effect	NOUN
dti-2707	491	3	of	of	ADP
dti-2707	491	4	baicalein	baicalein	NOUN
dti-2707	491	5	and	and	CCONJ
dti-2707	491	6	baicalin	baicalin	NOUN
dti-2707	491	7	on	on	ADP
dti-2707	491	8	mitochondrial	mitochondrial	ADJ
dti-2707	491	9	function	function	NOUN
dti-2707	491	10	and	and	CCONJ
dti-2707	491	11	dynamics	dynamic	NOUN
dti-2707	491	12	:	:	PUNCT
dti-2707	491	13	a	a	DET
dti-2707	491	14	review	review	NOUN
dti-2707	491	15	.	.	PUNCT
dti-2707	492	1	pharmacol	pharmacol	PROPN
dti-2707	492	2	res	re	NOUN
dti-2707	492	3	.	.	PUNCT
dti-2707	493	1	2015;100:296	2015;100:296	NUM
dti-2707	493	2	-	-	SYM
dti-2707	493	3	308	308	NUM
dti-2707	493	4	.	.	PUNCT
dti-2707	494	1	crossref	crossref	PROPN
dti-2707	494	2	pubmed	pubmed	PROPN
dti-2707	494	3	12	12	NUM
dti-2707	494	4	.	.	PUNCT
dti-2707	495	1	jelić	jelić	PROPN
dti-2707	495	2	d	d	NOUN
dti-2707	495	3	,	,	PUNCT
dti-2707	495	4	lower	lower	ADV
dti-2707	495	5	-	-	PUNCT
dti-2707	495	6	nedza	nedza	NOUN
dti-2707	495	7	ad	ad	NOUN
dti-2707	495	8	,	,	PUNCT
dti-2707	495	9	brantner	brantner	NOUN
dti-2707	495	10	ah	ah	INTJ
dti-2707	495	11	,	,	PUNCT
dti-2707	495	12	et	et	PROPN
dti-2707	495	13	al	al	PROPN
dti-2707	495	14	.	.	PROPN
dti-2707	495	15	baicalein	baicalein	PROPN
dti-2707	495	16	and	and	CCONJ
dti-2707	495	17	baicalein	baicalein	PROPN
dti-2707	495	18	inhibit	inhibit	NOUN
dti-2707	495	19	src	src	PROPN
dti-2707	495	20	tyrosine	tyrosine	PROPN
dti-2707	495	21	kinase	kinase	PROPN
dti-2707	495	22	and	and	CCONJ
dti-2707	495	23	production	production	NOUN
dti-2707	495	24	of	of	ADP
dti-2707	495	25	il-6	il-6	NUM
dti-2707	495	26	.	.	PUNCT
dti-2707	496	1	j	j	PROPN
dti-2707	496	2	chem	chem	PROPN
dti-2707	496	3	.	.	PUNCT
dti-2707	497	1	2016;2510621	2016;2510621	NUM
dti-2707	497	2	.	.	PUNCT
dti-2707	497	3	crossref	crossref	PROPN
dti-2707	497	4	13	13	NUM
dti-2707	497	5	.	.	PUNCT
dti-2707	498	1	li	li	PROPN
dti-2707	498	2	l	l	PROPN
dti-2707	498	3	,	,	PUNCT
dti-2707	498	4	liu	liu	PROPN
dti-2707	498	5	wy	wy	PROPN
dti-2707	498	6	,	,	PUNCT
dti-2707	498	7	feng	feng	PROPN
dti-2707	498	8	f	f	PROPN
dti-2707	498	9	,	,	PUNCT
dti-2707	498	10	wu	wu	PROPN
dti-2707	498	11	cy	cy	PROPN
dti-2707	498	12	,	,	PUNCT
dti-2707	498	13	xie	xie	PROPN
dti-2707	498	14	n.	n.	PROPN
dti-2707	498	15	synthesis	synthesis	NOUN
dti-2707	498	16	and	and	CCONJ
dti-2707	498	17	in	in	ADP
dti-2707	498	18	vitro	vitro	X
dti-2707	498	19	cytotoxicity	cytotoxicity	NOUN
dti-2707	498	20	evaluation	evaluation	NOUN
dti-2707	498	21	of	of	ADP
dti-2707	498	22	baicalein	baicalein	NOUN
dti-2707	498	23	amino	amino	NOUN
dti-2707	498	24	acid	acid	NOUN
dti-2707	498	25	derivatives	derivative	NOUN
dti-2707	498	26	.	.	PUNCT
dti-2707	499	1	chin	chin	PROPN
dti-2707	499	2	j	j	PROPN
dti-2707	499	3	nat	nat	PROPN
dti-2707	499	4	med	me	VERB
dti-2707	499	5	.	.	PUNCT
dti-2707	500	1	2013;11(3):284	2013;11(3):284	NUM
dti-2707	500	2	-	-	SYM
dti-2707	500	3	288	288	NUM
dti-2707	500	4	.	.	PUNCT
dti-2707	501	1	crossref	crossref	PROPN
dti-2707	501	2	pubmed	pubmed	PROPN
dti-2707	501	3	14	14	PROPN
dti-2707	501	4	.	.	PUNCT
dti-2707	502	1	huang	huang	PROPN
dti-2707	502	2	wh	wh	PROPN
dti-2707	502	3	,	,	PUNCT
dti-2707	502	4	lee	lee	PROPN
dti-2707	502	5	ar	ar	PROPN
dti-2707	502	6	,	,	PUNCT
dti-2707	502	7	chien	chien	PROPN
dti-2707	502	8	py	py	PROPN
dti-2707	502	9	,	,	PUNCT
dti-2707	502	10	chou	chou	PROPN
dti-2707	502	11	tc	tc	PROPN
dti-2707	502	12	.	.	PUNCT
dti-2707	502	13	synthesis	synthesis	NOUN
dti-2707	502	14	of	of	ADP
dti-2707	502	15	baicalein	baicalein	NOUN
dti-2707	502	16	derivatives	derivative	NOUN
dti-2707	502	17	as	as	ADP
dti-2707	502	18	potential	potential	ADJ
dti-2707	502	19	anti	anti	ADJ
dti-2707	502	20	-	-	ADJ
dti-2707	502	21	aggregatory	aggregatory	ADJ
dti-2707	502	22	and	and	CCONJ
dti-2707	502	23	anti	anti	ADJ
dti-2707	502	24	-	-	ADJ
dti-2707	502	25	inflammatory	inflammatory	ADJ
dti-2707	502	26	agents	agent	NOUN
dti-2707	502	27	.	.	PUNCT
dti-2707	503	1	j	j	PROPN
dti-2707	503	2	pharm	pharm	PROPN
dti-2707	503	3	pharmacol	pharmacol	PROPN
dti-2707	503	4	.	.	PUNCT
dti-2707	504	1	2005;57(2):219	2005;57(2):219	NUM
dti-2707	504	2	-	-	PUNCT
dti-2707	504	3	225	225	NUM
dti-2707	504	4	.	.	PUNCT
dti-2707	505	1	crossref	crossref	PROPN
dti-2707	505	2	pubmed	pubmed	PROPN
dti-2707	505	3	15	15	PROPN
dti-2707	505	4	.	.	PUNCT
dti-2707	506	1	suski	suski	PROPN
dti-2707	506	2	jm	jm	PROPN
dti-2707	506	3	,	,	PUNCT
dti-2707	506	4	braun	braun	PROPN
dti-2707	506	5	m	m	PROPN
dti-2707	506	6	,	,	PUNCT
dti-2707	506	7	strmiska	strmiska	ADJ
dti-2707	506	8	v	v	NOUN
dti-2707	506	9	,	,	PUNCT
dti-2707	506	10	sicinski	sicinski	PROPN
dti-2707	506	11	p.	p.	NOUN
dti-2707	506	12	targeting	target	VERB
dti-2707	506	13	cell	cell	NOUN
dti-2707	506	14	-	-	PUNCT
dti-2707	506	15	cycle	cycle	NOUN
dti-2707	506	16	machinery	machinery	NOUN
dti-2707	506	17	in	in	ADP
dti-2707	506	18	cancer	cancer	NOUN
dti-2707	506	19	.	.	PUNCT
dti-2707	507	1	cancer	cancer	NOUN
dti-2707	507	2	cell	cell	NOUN
dti-2707	507	3	.	.	PUNCT
dti-2707	508	1	2021;39(6):759	2021;39(6):759	NUM
dti-2707	508	2	-	-	PUNCT
dti-2707	508	3	778	778	NUM
dti-2707	508	4	.	.	PUNCT
dti-2707	509	1	crossref	crossref	PROPN
dti-2707	509	2	pubmed	pubmed	PROPN
dti-2707	509	3	16	16	NUM
dti-2707	509	4	.	.	PUNCT
dti-2707	510	1	cheng	cheng	PROPN
dti-2707	510	2	yh	yh	PROPN
dti-2707	510	3	,	,	PUNCT
dti-2707	510	4	li	li	PROPN
dti-2707	510	5	la	la	PROPN
dti-2707	510	6	,	,	PUNCT
dti-2707	510	7	lin	lin	PROPN
dti-2707	510	8	p	p	PROPN
dti-2707	510	9	,	,	PUNCT
dti-2707	510	10	et	et	PROPN
dti-2707	510	11	al	al	PROPN
dti-2707	510	12	.	.	PROPN
dti-2707	510	13	baicalein	baicalein	PROPN
dti-2707	510	14	induces	induce	VERB
dti-2707	510	15	g1	g1	PROPN
dti-2707	510	16	arrest	arrest	NOUN
dti-2707	510	17	in	in	ADP
dti-2707	510	18	oral	oral	ADJ
dti-2707	510	19	cancer	cancer	NOUN
dti-2707	510	20	cells	cell	NOUN
dti-2707	510	21	by	by	ADP
dti-2707	510	22	enhancing	enhance	VERB
dti-2707	510	23	the	the	DET
dti-2707	510	24	degradation	degradation	NOUN
dti-2707	510	25	of	of	ADP
dti-2707	510	26	cyclin	cyclin	NOUN
dti-2707	510	27	d1	d1	PROPN
dti-2707	510	28	and	and	CCONJ
dti-2707	510	29	activating	activate	VERB
dti-2707	510	30	ahr	ahr	PROPN
dti-2707	510	31	to	to	PART
dti-2707	510	32	decrease	decrease	VERB
dti-2707	510	33	rb	rb	DET
dti-2707	510	34	phosphorylation	phosphorylation	NOUN
dti-2707	510	35	.	.	PUNCT
dti-2707	511	1	toxicol	toxicol	PROPN
dti-2707	511	2	appl	appl	PROPN
dti-2707	511	3	pharmacol	pharmacol	PROPN
dti-2707	511	4	.	.	PUNCT
dti-2707	512	1	2012;263(3):360	2012;263(3):360	NUM
dti-2707	512	2	-	-	SYM
dti-2707	512	3	367	367	NUM
dti-2707	512	4	.	.	PUNCT
dti-2707	513	1	crossref	crossref	PROPN
dti-2707	513	2	pubmed	pubmed	PROPN
dti-2707	513	3	17	17	NUM
dti-2707	513	4	.	.	PUNCT
dti-2707	514	1	siegel	siegel	PROPN
dti-2707	514	2	rl	rl	PROPN
dti-2707	514	3	,	,	PUNCT
dti-2707	514	4	giaquinto	giaquinto	NOUN
dti-2707	514	5	an	an	DET
dti-2707	514	6	,	,	PUNCT
dti-2707	514	7	jemal	jemal	ADJ
dti-2707	514	8	a.	a.	NOUN
dti-2707	514	9	cancer	cancer	NOUN
dti-2707	514	10	statistics	statistic	NOUN
dti-2707	514	11	,	,	PUNCT
dti-2707	514	12	2024	2024	NUM
dti-2707	514	13	.	.	PUNCT
dti-2707	515	1	ca	can	AUX
dti-2707	515	2	cancer	cancer	PROPN
dti-2707	515	3	j	j	PROPN
dti-2707	515	4	clin	clin	PROPN
dti-2707	515	5	.	.	PUNCT
dti-2707	516	1	2024;74(1):12	2024;74(1):12	NUM
dti-2707	516	2	-	-	SYM
dti-2707	516	3	49	49	NUM
dti-2707	516	4	.	.	PUNCT
dti-2707	517	1	crossref	crossref	PROPN
dti-2707	517	2	pubmed	pubmed	PROPN
dti-2707	517	3	18	18	NUM
dti-2707	517	4	.	.	PUNCT
dti-2707	518	1	lee	lee	PROPN
dti-2707	518	2	hz	hz	PROPN
dti-2707	518	3	,	,	PUNCT
dti-2707	518	4	leung	leung	PROPN
dti-2707	518	5	hw	hw	PROPN
dti-2707	518	6	,	,	PUNCT
dti-2707	518	7	lai	lai	PROPN
dti-2707	518	8	my	my	PRON
dti-2707	518	9	,	,	PUNCT
dti-2707	518	10	wu	wu	PROPN
dti-2707	518	11	ch	ch	PROPN
dti-2707	518	12	.	.	PROPN
dti-2707	518	13	baicalein	baicalein	PROPN
dti-2707	519	1	induced	induce	VERB
dti-2707	519	2	cell	cell	NOUN
dti-2707	519	3	cycle	cycle	NOUN
dti-2707	519	4	arrest	arrest	NOUN
dti-2707	519	5	and	and	CCONJ
dti-2707	519	6	apoptosis	apoptosis	NOUN
dti-2707	519	7	in	in	ADP
dti-2707	519	8	human	human	ADJ
dti-2707	519	9	lung	lung	NOUN
dti-2707	519	10	squamous	squamous	ADJ
dti-2707	519	11	carcinoma	carcinoma	NOUN
dti-2707	519	12	ch27	ch27	PROPN
dti-2707	519	13	cells	cell	NOUN
dti-2707	519	14	.	.	PUNCT
dti-2707	520	1	anticancer	anticancer	NOUN
dti-2707	520	2	res	re	NOUN
dti-2707	520	3	.	.	PUNCT
dti-2707	521	1	2005;25(2a):959	2005;25(2a):959	NOUN
dti-2707	521	2	-	-	SYM
dti-2707	521	3	964	964	NUM
dti-2707	521	4	.	.	PUNCT
dti-2707	522	1	pubmed	pubmed	PROPN
dti-2707	522	2	19	19	NUM
dti-2707	522	3	.	.	PUNCT
dti-2707	523	1	arzanova	arzanova	PROPN
dti-2707	523	2	e	e	NOUN
dti-2707	523	3	,	,	PUNCT
dti-2707	523	4	mayrovitz	mayrovitz	PROPN
dti-2707	523	5	hn	hn	PROPN
dti-2707	523	6	.	.	PUNCT
dti-2707	524	1	the	the	DET
dti-2707	524	2	epidemiology	epidemiology	NOUN
dti-2707	524	3	of	of	ADP
dti-2707	524	4	breast	breast	NOUN
dti-2707	524	5	cancer	cancer	NOUN
dti-2707	524	6	.	.	PUNCT
dti-2707	525	1	in	in	ADP
dti-2707	525	2	:	:	PUNCT
dti-2707	525	3	mayrovitz	mayrovitz	PROPN
dti-2707	525	4	hn	hn	PROPN
dti-2707	525	5	,	,	PUNCT
dti-2707	525	6	ed	ed	NOUN
dti-2707	525	7	.	.	PUNCT
dti-2707	525	8	breast	breast	NOUN
dti-2707	525	9	cancer	cancer	NOUN
dti-2707	525	10	[	[	X
dti-2707	525	11	internet	internet	NOUN
dti-2707	525	12	brisbane	brisbane	NOUN
dti-2707	525	13	(	(	PUNCT
dti-2707	525	14	au	au	PROPN
dti-2707	525	15	):	):	PUNCT
dti-2707	525	16	exon	exon	NOUN
dti-2707	525	17	publications	publication	NOUN
dti-2707	525	18	.	.	PUNCT
dti-2707	526	1	2022	2022	NUM
dti-2707	526	2	aug	aug	PROPN
dti-2707	526	3	6	6	NUM
dti-2707	526	4	:	:	PUNCT
dti-2707	526	5	chap	chap	NOUN
dti-2707	526	6	1	1	NUM
dti-2707	526	7	.	.	PUNCT
dti-2707	527	1	crossref	crossref	PROPN
dti-2707	527	2	20	20	NUM
dti-2707	527	3	.	.	PUNCT
dti-2707	528	1	wang	wang	PROPN
dti-2707	528	2	cz	cz	PROPN
dti-2707	528	3	,	,	PUNCT
dti-2707	528	4	li	li	PROPN
dti-2707	528	5	xl	xl	PROPN
dti-2707	528	6	,	,	PUNCT
dti-2707	528	7	wang	wang	PROPN
dti-2707	528	8	qf	qf	PROPN
dti-2707	528	9	,	,	PUNCT
dti-2707	528	10	mehendale	mehendale	PROPN
dti-2707	528	11	sr	sr	PROPN
dti-2707	528	12	,	,	PUNCT
dti-2707	528	13	yuan	yuan	PROPN
dti-2707	528	14	cs	cs	PROPN
dti-2707	528	15	.	.	PROPN
dti-2707	528	16	selective	selective	ADJ
dti-2707	528	17	fraction	fraction	NOUN
dti-2707	528	18	of	of	ADP
dti-2707	528	19	scutellaria	scutellaria	NOUN
dti-2707	528	20	baicalensis	baicalensis	NOUN
dti-2707	528	21	and	and	CCONJ
dti-2707	528	22	its	its	PRON
dti-2707	528	23	chemopreventive	chemopreventive	ADJ
dti-2707	528	24	effects	effect	NOUN
dti-2707	528	25	on	on	ADP
dti-2707	528	26	mcf-7	mcf-7	NOUN
dti-2707	528	27	human	human	ADJ
dti-2707	528	28	breast	breast	NOUN
dti-2707	528	29	cancer	cancer	NOUN
dti-2707	528	30	cells	cell	NOUN
dti-2707	528	31	.	.	PUNCT
dti-2707	529	1	phytomedicine	phytomedicine	NOUN
dti-2707	529	2	.	.	PUNCT
dti-2707	530	1	2010;17(1):63	2010;17(1):63	X
dti-2707	530	2	-	-	SYM
dti-2707	530	3	68	68	NUM
dti-2707	530	4	.	.	PUNCT
dti-2707	531	1	crossref	crossref	PROPN
dti-2707	531	2	pubmed	pubmed	PROPN
dti-2707	531	3	21	21	NUM
dti-2707	531	4	.	.	PUNCT
dti-2707	532	1	sekiguchi	sekiguchi	PROPN
dti-2707	532	2	m	m	PROPN
dti-2707	532	3	,	,	PUNCT
dti-2707	532	4	oda	oda	PROPN
dti-2707	533	1	i	i	PROPN
dti-2707	533	2	,	,	PUNCT
dti-2707	533	3	matsuda	matsuda	PROPN
dti-2707	533	4	t	t	PROPN
dti-2707	533	5	,	,	PUNCT
dti-2707	533	6	saito	saito	PROPN
dti-2707	533	7	y.	y.	PROPN
dti-2707	533	8	epidemiological	epidemiological	ADJ
dti-2707	533	9	trends	trend	NOUN
dti-2707	533	10	and	and	CCONJ
dti-2707	533	11	future	future	ADJ
dti-2707	533	12	perspectives	perspective	NOUN
dti-2707	533	13	of	of	ADP
dti-2707	533	14	gastric	gastric	ADJ
dti-2707	533	15	cancer	cancer	NOUN
dti-2707	533	16	in	in	ADP
dti-2707	533	17	eastern	eastern	PROPN
dti-2707	533	18	asia	asia	PROPN
dti-2707	533	19	.	.	PUNCT
dti-2707	534	1	digestion	digestion	NOUN
dti-2707	534	2	.	.	PUNCT
dti-2707	535	1	2022;103(1):22	2022;103(1):22	NUM
dti-2707	535	2	-	-	PUNCT
dti-2707	535	3	28	28	NUM
dti-2707	535	4	.	.	PUNCT
dti-2707	536	1	crossref	crossref	PROPN
dti-2707	536	2	pubmed	pubmed	PROPN
dti-2707	536	3	22	22	NUM
dti-2707	536	4	.	.	PUNCT
dti-2707	537	1	mu	mu	PROPN
dti-2707	537	2	j	j	PROPN
dti-2707	537	3	,	,	PUNCT
dti-2707	537	4	liu	liu	PROPN
dti-2707	537	5	t	t	PROPN
dti-2707	537	6	,	,	PUNCT
dti-2707	537	7	jiang	jiang	PROPN
dti-2707	537	8	l	l	PROPN
dti-2707	537	9	,	,	PUNCT
dti-2707	537	10	et	et	PROPN
dti-2707	537	11	al	al	PROPN
dti-2707	537	12	.	.	PUNCT
dti-2707	538	1	the	the	DET
dti-2707	538	2	traditional	traditional	ADJ
dti-2707	538	3	chinese	chinese	ADJ
dti-2707	538	4	medicine	medicine	NOUN
dti-2707	538	5	baicalein	baicalein	NOUN
dti-2707	538	6	potently	potently	ADV
dti-2707	538	7	inhibits	inhibit	VERB
dti-2707	538	8	gastric	gastric	ADJ
dti-2707	538	9	cancer	cancer	NOUN
dti-2707	538	10	cells	cell	NOUN
dti-2707	538	11	.	.	PUNCT
dti-2707	539	1	j	j	PROPN
dti-2707	539	2	cancer	cancer	NOUN
dti-2707	539	3	.	.	PUNCT
dti-2707	540	1	2016	2016	NUM
dti-2707	540	2	;	;	PUNCT
dti-2707	540	3	7(4):453	7(4):453	NUM
dti-2707	540	4	-	-	SYM
dti-2707	540	5	461	461	NUM
dti-2707	540	6	.	.	PUNCT
dti-2707	541	1	crossref	crossref	PROPN
dti-2707	541	2	pubmed	pubmed	PROPN
dti-2707	541	3	23	23	NUM
dti-2707	541	4	.	.	PUNCT
dti-2707	542	1	zheng	zheng	PROPN
dti-2707	542	2	,	,	PUNCT
dti-2707	542	3	yh	yh	PROPN
dti-2707	542	4	,	,	PUNCT
dti-2707	542	5	yin	yin	PROPN
dti-2707	542	6	,	,	PUNCT
dti-2707	542	7	lh	lh	PROPN
dti-2707	542	8	,	,	PUNCT
dti-2707	542	9	grahn	grahn	VERB
dti-2707	542	10	th	th	NUM
dti-2707	542	11	,	,	PUNCT
dti-2707	542	12	ye	ye	PROPN
dti-2707	542	13	af	af	PROPN
dti-2707	542	14	,	,	PUNCT
dti-2707	542	15	zhao	zhao	PROPN
dti-2707	542	16	yr	yr	PROPN
dti-2707	542	17	,	,	PUNCT
dti-2707	542	18	&	&	CCONJ
dti-2707	542	19	zhang	zhang	PROPN
dti-2707	542	20	qy	qy	PROPN
dti-2707	542	21	.	.	PROPN
dti-2707	542	22	anticancer	anticancer	NOUN
dti-2707	542	23	effects	effect	NOUN
dti-2707	542	24	of	of	ADP
dti-2707	542	25	baicalein	baicalein	NOUN
dti-2707	542	26	on	on	ADP
dti-2707	542	27	hepatocellular	hepatocellular	ADJ
dti-2707	542	28	carcinoma	carcinoma	NOUN
dti-2707	542	29	cells	cell	NOUN
dti-2707	542	30	.	.	PUNCT
dti-2707	543	1	phytother	phytother	PROPN
dti-2707	543	2	res	re	NOUN
dti-2707	543	3	.	.	PUNCT
dti-2707	544	1	2014;28(9),1	2014;28(9),1	NUM
dti-2707	545	1	342	342	NUM
dti-2707	545	2	-	-	SYM
dti-2707	545	3	1348	1348	NUM
dti-2707	545	4	.	.	PUNCT
dti-2707	546	1	crossref	crossref	PROPN
dti-2707	546	2	24	24	NUM
dti-2707	546	3	.	.	PUNCT
dti-2707	547	1	rawla	rawla	PROPN
dti-2707	547	2	p	p	PROPN
dti-2707	547	3	,	,	PUNCT
dti-2707	547	4	sunkara	sunkara	PROPN
dti-2707	547	5	t	t	PROPN
dti-2707	547	6	,	,	PUNCT
dti-2707	547	7	gaduputi	gaduputi	PROPN
dti-2707	547	8	v.	v.	ADP
dti-2707	547	9	epidemiology	epidemiology	NOUN
dti-2707	547	10	of	of	ADP
dti-2707	547	11	pancreatic	pancreatic	ADJ
dti-2707	547	12	cancer	cancer	NOUN
dti-2707	547	13	:	:	PUNCT
dti-2707	548	1	global	global	ADJ
dti-2707	548	2	trends	trend	NOUN
dti-2707	548	3	,	,	PUNCT
dti-2707	548	4	etiology	etiology	NOUN
dti-2707	548	5	and	and	CCONJ
dti-2707	548	6	risk	risk	NOUN
dti-2707	548	7	factors	factor	NOUN
dti-2707	548	8	.	.	PUNCT
dti-2707	549	1	world	world	PROPN
dti-2707	549	2	j	j	PROPN
dti-2707	549	3	oncol	oncol	PROPN
dti-2707	549	4	.	.	PUNCT
dti-2707	550	1	2019;10(1):10	2019;10(1):10	X
dti-2707	550	2	-	-	SYM
dti-2707	550	3	27	27	NUM
dti-2707	550	4	.	.	PUNCT
dti-2707	551	1	crossref	crossref	PROPN
dti-2707	551	2	pubmed	pubmed	PROPN
dti-2707	551	3	25	25	NUM
dti-2707	551	4	.	.	PUNCT
dti-2707	552	1	takahashi	takahashi	PROPN
dti-2707	552	2	h	h	PROPN
dti-2707	552	3	,	,	PUNCT
dti-2707	552	4	chen	chen	PROPN
dti-2707	552	5	mc	mc	PROPN
dti-2707	552	6	,	,	PUNCT
dti-2707	552	7	pham	pham	PROPN
dti-2707	552	8	h	h	PROPN
dti-2707	552	9	,	,	PUNCT
dti-2707	552	10	et	et	PROPN
dti-2707	552	11	al	al	PROPN
dti-2707	552	12	.	.	PROPN
dti-2707	552	13	baicalein	baicalein	PROPN
dti-2707	552	14	,	,	PUNCT
dti-2707	552	15	a	a	DET
dti-2707	552	16	component	component	NOUN
dti-2707	552	17	of	of	ADP
dti-2707	552	18	scutellaria	scutellaria	NOUN
dti-2707	552	19	baicalensis	baicalensis	NOUN
dti-2707	552	20	,	,	PUNCT
dti-2707	552	21	induces	induce	VERB
dti-2707	552	22	apoptosis	apoptosis	NOUN
dti-2707	552	23	by	by	ADP
dti-2707	552	24	mcl-1	mcl-1	VERB
dti-2707	552	25	downregulation	downregulation	NOUN
dti-2707	552	26	in	in	ADP
dti-2707	552	27	human	human	ADJ
dti-2707	552	28	pancreatic	pancreatic	ADJ
dti-2707	552	29	cancer	cancer	NOUN
dti-2707	552	30	cells	cell	NOUN
dti-2707	552	31	.	.	PUNCT
dti-2707	553	1	biochim	biochim	PROPN
dti-2707	553	2	biophys	biophy	NOUN
dti-2707	553	3	acta	acta	PROPN
dti-2707	553	4	.	.	PUNCT
dti-2707	554	1	2011;1813(8):1465	2011;1813(8):1465	NUM
dti-2707	554	2	-	-	SYM
dti-2707	554	3	1474	1474	NUM
dti-2707	554	4	.	.	PUNCT
dti-2707	555	1	crossref	crossref	PROPN
dti-2707	555	2	pubmed	pubmed	PROPN
dti-2707	555	3	26	26	NUM
dti-2707	555	4	.	.	PUNCT
dti-2707	556	1	tong	tong	PROPN
dti-2707	556	2	wg	wg	PROPN
dti-2707	556	3	,	,	PUNCT
dti-2707	556	4	ding	ding	PROPN
dti-2707	556	5	xz	xz	PROPN
dti-2707	556	6	,	,	PUNCT
dti-2707	556	7	witt	witt	PROPN
dti-2707	556	8	rc	rc	PROPN
dti-2707	556	9	,	,	PUNCT
dti-2707	556	10	adrian	adrian	PROPN
dti-2707	556	11	te	te	PROPN
dti-2707	556	12	.	.	PUNCT
dti-2707	557	1	lipoxygenase	lipoxygenase	NOUN
dti-2707	557	2	inhibitors	inhibitor	NOUN
dti-2707	557	3	attenuate	attenuate	VERB
dti-2707	557	4	growth	growth	NOUN
dti-2707	557	5	of	of	ADP
dti-2707	557	6	human	human	ADJ
dti-2707	557	7	pancreatic	pancreatic	ADJ
dti-2707	557	8	cancer	cancer	NOUN
dti-2707	557	9	xenografts	xenograft	NOUN
dti-2707	557	10	and	and	CCONJ
dti-2707	557	11	induce	induce	VERB
dti-2707	557	12	apoptosis	apoptosis	NOUN
dti-2707	557	13	through	through	ADP
dti-2707	557	14	the	the	DET
dti-2707	557	15	mitochondrial	mitochondrial	ADJ
dti-2707	557	16	pathway	pathway	NOUN
dti-2707	557	17	.	.	PUNCT
dti-2707	558	1	mol	mol	ADP
dti-2707	558	2	cancer	cancer	NOUN
dti-2707	558	3	ther	ther	ADV
dti-2707	558	4	.	.	PUNCT
dti-2707	559	1	2002;1(11):929	2002;1(11):929	NOUN
dti-2707	559	2	-	-	SYM
dti-2707	559	3	935	935	NUM
dti-2707	559	4	.	.	PUNCT
dti-2707	560	1	pubmed	pubmed	PROPN
dti-2707	560	2	https://doi.org/10.14336/ad.2017.0829	https://doi.org/10.14336/ad.2017.0829	PROPN
dti-2707	560	3	https://www.ncbi.nlm.nih.gov/pubmed/29344420	https://www.ncbi.nlm.nih.gov/pubmed/29344420	ADP
dti-2707	560	4	https://doi.org/10.1016/j.ctrv.2008.09.005	https://doi.org/10.1016/j.ctrv.2008.09.005	PROPN
dti-2707	560	5	https://www.ncbi.nlm.nih.gov/pubmed/19004559	https://www.ncbi.nlm.nih.gov/pubmed/19004559	NUM
dti-2707	560	6	https://doi.org/10.3390/molecules25235677	https://doi.org/10.3390/molecules25235677	PROPN
dti-2707	561	1	https://www.ncbi.nlm.nih.gov/pubmed/33276419	https://www.ncbi.nlm.nih.gov/pubmed/33276419	PROPN
dti-2707	561	2	https://doi.org/10.1021/np000068s	https://doi.org/10.1021/np000068s	NOUN
dti-2707	561	3	https://www.ncbi.nlm.nih.gov/pubmed/11170661	https://www.ncbi.nlm.nih.gov/pubmed/11170661	PRON
dti-2707	561	4	https://doi.org/10.1007/s00044-016-1607-x	https://doi.org/10.1007/s00044-016-1607-x	PROPN
dti-2707	561	5	https://www.ncbi.nlm.nih.gov/pubmed/28008217	https://www.ncbi.nlm.nih.gov/pubmed/28008217	NUM
dti-2707	561	6	https://doi.org/10.1007/s00764-022-00182-4	https://doi.org/10.1007/s00764-022-00182-4	NUM
dti-2707	561	7	https://doi.org/10.3390/molecules25071545	https://doi.org/10.3390/molecules25071545	NOUN
dti-2707	561	8	https://www.ncbi.nlm.nih.gov/pubmed/32231034	https://www.ncbi.nlm.nih.gov/pubmed/32231034	PUNCT
dti-2707	561	9	https://doi.org/10.1016/j.procbio.2020.05.030	https://doi.org/10.1016/j.procbio.2020.05.030	PROPN
dti-2707	561	10	https://doi.org/10.3390/molecules23123233	https://doi.org/10.3390/molecules23123233	PROPN
dti-2707	561	11	https://www.ncbi.nlm.nih.gov/pubmed/30544548	https://www.ncbi.nlm.nih.gov/pubmed/30544548	PROPN
dti-2707	561	12	https://doi.org/10.1016/s1570-0232(04)00545-8	https://doi.org/10.1016/s1570-0232(04)00545-8	PROPN
dti-2707	561	13	https://www.ncbi.nlm.nih.gov/pubmed/15556504	https://www.ncbi.nlm.nih.gov/pubmed/15556504	ADP
dti-2707	561	14	https://doi.org/10.1016/j.phrs.2015.08.021	https://doi.org/10.1016/j.phrs.2015.08.021	PROPN
dti-2707	561	15	https://www.ncbi.nlm.nih.gov/pubmed/26318266	https://www.ncbi.nlm.nih.gov/pubmed/26318266	X
dti-2707	561	16	https://doi.org/10.1155/2016/2510621	https://doi.org/10.1155/2016/2510621	NOUN
dti-2707	561	17	https://doi.org/10.1016/s1875-5364(13)60030-8	https://doi.org/10.1016/s1875-5364(13)60030-8	VERB
dti-2707	561	18	https://www.ncbi.nlm.nih.gov/pubmed/23725843	https://www.ncbi.nlm.nih.gov/pubmed/23725843	NUM
dti-2707	561	19	https://doi.org/10.1211/0022357055371	https://doi.org/10.1211/0022357055371	PUNCT
dti-2707	561	20	https://www.ncbi.nlm.nih.gov/pubmed/15720786	https://www.ncbi.nlm.nih.gov/pubmed/15720786	NUM
dti-2707	561	21	https://doi.org/10.1016/j.ccell.2021.03.010	https://doi.org/10.1016/j.ccell.2021.03.010	NOUN
dti-2707	561	22	https://www.ncbi.nlm.nih.gov/pubmed/33891890	https://www.ncbi.nlm.nih.gov/pubmed/33891890	NUM
dti-2707	561	23	https://doi.org/10.1016/j.taap.2012.07.010	https://doi.org/10.1016/j.taap.2012.07.010	PROPN
dti-2707	561	24	https://www.ncbi.nlm.nih.gov/pubmed/22820424	https://www.ncbi.nlm.nih.gov/pubmed/22820424	X
dti-2707	561	25	https://doi.org/10.3322/caac.21820	https://doi.org/10.3322/caac.21820	NOUN
dti-2707	561	26	https://www.ncbi.nlm.nih.gov/pubmed/38230766	https://www.ncbi.nlm.nih.gov/pubmed/38230766	ADP
dti-2707	561	27	https://www.ncbi.nlm.nih.gov/pubmed/15868934	https://www.ncbi.nlm.nih.gov/pubmed/15868934	NUM
dti-2707	562	1	https://doi.org/10.36255/exon-publications-breast-cancer-epidemiology	https://doi.org/10.36255/exon-publications-breast-cancer-epidemiology	PROPN
dti-2707	562	2	https://doi.org/10.1016/j.phymed.2009.07.003	https://doi.org/10.1016/j.phymed.2009.07.003	PROPN
dti-2707	562	3	https://www.ncbi.nlm.nih.gov/pubmed/19836937	https://www.ncbi.nlm.nih.gov/pubmed/19836937	X
dti-2707	562	4	https://doi.org/10.1159/000518483	https://doi.org/10.1159/000518483	NOUN
dti-2707	562	5	https://www.ncbi.nlm.nih.gov/pubmed/34515086	https://www.ncbi.nlm.nih.gov/pubmed/34515086	X
dti-2707	562	6	https://doi.org/10.7150/jca.13548	https://doi.org/10.7150/jca.13548	ADV
dti-2707	562	7	https://www.ncbi.nlm.nih.gov/pubmed/26918059	https://www.ncbi.nlm.nih.gov/pubmed/26918059	X
dti-2707	562	8	https://doi.org/10.1002/ptr.5135	https://doi.org/10.1002/ptr.5135	INTJ
dti-2707	562	9	https://doi.org/10.14740/wjon1166	https://doi.org/10.14740/wjon1166	PROPN
dti-2707	562	10	https://www.ncbi.nlm.nih.gov/pubmed/30834048	https://www.ncbi.nlm.nih.gov/pubmed/30834048	PROPN
dti-2707	562	11	https://doi.org/10.1016/j.bbamcr.2011.05.003	https://doi.org/10.1016/j.bbamcr.2011.05.003	NOUN
dti-2707	562	12	https://www.ncbi.nlm.nih.gov/pubmed/21596068	https://www.ncbi.nlm.nih.gov/pubmed/21596068	ADJ
dti-2707	562	13	https://www.ncbi.nlm.nih.gov/pubmed/12481414	https://www.ncbi.nlm.nih.gov/pubmed/12481414	NUM
dti-2707	562	14	munjal	munjal	PROPN
dti-2707	562	15	et	et	PROPN
dti-2707	562	16	al	al	PROPN
dti-2707	562	17	drug	drug	NOUN
dti-2707	562	18	target	target	NOUN
dti-2707	562	19	insights	insight	NOUN
dti-2707	562	20	2024	2024	NUM
dti-2707	562	21	;	;	PUNCT
dti-2707	562	22	18	18	NUM
dti-2707	562	23	:	:	SYM
dti-2707	562	24	43	43	NUM
dti-2707	562	25	©	©	ADP
dti-2707	562	26	2024	2024	NUM
dti-2707	562	27	the	the	DET
dti-2707	562	28	authors	author	NOUN
dti-2707	562	29	.	.	PUNCT
dti-2707	563	1	published	publish	VERB
dti-2707	563	2	by	by	ADP
dti-2707	563	3	aboutscience	aboutscience	NOUN
dti-2707	563	4	www.aboutscience.eu	www.aboutscience.eu	PROPN
dti-2707	563	5	27	27	NUM
dti-2707	563	6	.	.	PUNCT
dti-2707	564	1	doleman	doleman	PROPN
dti-2707	564	2	b	b	PROPN
dti-2707	564	3	,	,	PUNCT
dti-2707	564	4	mills	mills	PROPN
dti-2707	564	5	kt	kt	PROPN
dti-2707	564	6	,	,	PUNCT
dti-2707	564	7	lim	lim	PROPN
dti-2707	564	8	s	s	PROPN
dti-2707	564	9	,	,	PUNCT
dti-2707	564	10	zelhart	zelhart	PROPN
dti-2707	564	11	md	md	PROPN
dti-2707	564	12	,	,	PUNCT
dti-2707	564	13	gagliardi	gagliardi	PROPN
dti-2707	564	14	g.	g.	PROPN
dti-2707	564	15	body	body	PROPN
dti-2707	564	16	mass	mass	PROPN
dti-2707	564	17	index	index	NOUN
dti-2707	564	18	and	and	CCONJ
dti-2707	564	19	colorectal	colorectal	ADJ
dti-2707	564	20	cancer	cancer	NOUN
dti-2707	564	21	prognosis	prognosis	NOUN
dti-2707	564	22	:	:	PUNCT
dti-2707	564	23	a	a	DET
dti-2707	564	24	systematic	systematic	ADJ
dti-2707	564	25	review	review	NOUN
dti-2707	564	26	and	and	CCONJ
dti-2707	564	27	meta	meta	ADJ
dti-2707	564	28	-	-	PUNCT
dti-2707	564	29	analysis	analysis	NOUN
dti-2707	564	30	.	.	PUNCT
dti-2707	565	1	tech	tech	NOUN
dti-2707	565	2	coloproctol	coloproctol	NOUN
dti-2707	565	3	.	.	PUNCT
dti-2707	566	1	2016;20(8):517	2016;20(8):517	PROPN
dti-2707	566	2	-	-	SYM
dti-2707	566	3	535	535	NUM
dti-2707	566	4	.	.	PUNCT
dti-2707	567	1	crossref	crossref	PROPN
dti-2707	567	2	pubmed	pubmed	PROPN
dti-2707	567	3	28	28	PROPN
dti-2707	567	4	.	.	PUNCT
dti-2707	568	1	phan	phan	PROPN
dti-2707	568	2	t	t	PROPN
dti-2707	568	3	,	,	PUNCT
dti-2707	568	4	nguyen	nguyen	PROPN
dti-2707	568	5	vh	vh	PROPN
dti-2707	568	6	,	,	PUNCT
dti-2707	568	7	a’lincourt	a’lincourt	PROPN
dti-2707	568	8	salazar	salazar	PROPN
dti-2707	568	9	m	m	PROPN
dti-2707	568	10	,	,	PUNCT
dti-2707	568	11	et	et	PROPN
dti-2707	568	12	al	al	PROPN
dti-2707	568	13	.	.	PROPN
dti-2707	569	1	inhibition	inhibition	NOUN
dti-2707	569	2	of	of	ADP
dti-2707	569	3	autophagy	autophagy	NOUN
dti-2707	569	4	amplifies	amplify	VERB
dti-2707	569	5	baicalein	baicalein	NOUN
dti-2707	569	6	-	-	PUNCT
dti-2707	569	7	induced	induce	VERB
dti-2707	569	8	apoptosis	apoptosis	NOUN
dti-2707	569	9	in	in	ADP
dti-2707	569	10	human	human	ADJ
dti-2707	569	11	colorectal	colorectal	ADJ
dti-2707	569	12	cancer	cancer	NOUN
dti-2707	569	13	.	.	PUNCT
dti-2707	570	1	mol	mol	ADP
dti-2707	570	2	ther	ther	PROPN
dti-2707	570	3	oncolytics	oncolytic	NOUN
dti-2707	570	4	.	.	PUNCT
dti-2707	571	1	2020;19:1	2020;19:1	NUM
dti-2707	571	2	-	-	SYM
dti-2707	571	3	7	7	NUM
dti-2707	571	4	.	.	PUNCT
dti-2707	572	1	crossref	crossref	PROPN
dti-2707	572	2	pubmed	pubmed	PROPN
dti-2707	572	3	29	29	NUM
dti-2707	572	4	.	.	PUNCT
dti-2707	573	1	pidgeon	pidgeon	PROPN
dti-2707	573	2	gp	gp	PROPN
dti-2707	573	3	,	,	PUNCT
dti-2707	573	4	kandouz	kandouz	PROPN
dti-2707	573	5	m	m	PROPN
dti-2707	573	6	,	,	PUNCT
dti-2707	573	7	meram	meram	PROPN
dti-2707	573	8	a	a	PRON
dti-2707	573	9	,	,	PUNCT
dti-2707	573	10	honn	honn	PROPN
dti-2707	573	11	kv	kv	PROPN
dti-2707	573	12	.	.	PUNCT
dti-2707	574	1	mechanisms	mechanism	NOUN
dti-2707	574	2	controlling	control	VERB
dti-2707	574	3	cell	cell	NOUN
dti-2707	574	4	cycle	cycle	NOUN
dti-2707	574	5	arrest	arrest	NOUN
dti-2707	574	6	and	and	CCONJ
dti-2707	574	7	induction	induction	NOUN
dti-2707	574	8	of	of	ADP
dti-2707	574	9	apoptosis	apoptosis	NOUN
dti-2707	574	10	after	after	ADP
dti-2707	574	11	12	12	NUM
dti-2707	574	12	-	-	PUNCT
dti-2707	574	13	lipoxygenase	lipoxygenase	NOUN
dti-2707	574	14	inhibition	inhibition	NOUN
dti-2707	574	15	in	in	ADP
dti-2707	574	16	prostate	prostate	NOUN
dti-2707	574	17	cancer	cancer	NOUN
dti-2707	574	18	cells	cell	NOUN
dti-2707	574	19	.	.	PUNCT
dti-2707	575	1	cancer	cancer	NOUN
dti-2707	575	2	res	re	NOUN
dti-2707	575	3	.	.	PUNCT
dti-2707	576	1	2002;62(9):2721	2002;62(9):2721	NUM
dti-2707	576	2	-	-	PUNCT
dti-2707	576	3	2727	2727	NUM
dti-2707	576	4	.	.	PUNCT
dti-2707	577	1	pubmed	pubmed	PROPN
dti-2707	577	2	30	30	NUM
dti-2707	577	3	.	.	PUNCT
dti-2707	578	1	dianatinasab	dianatinasab	PROPN
dti-2707	578	2	m	m	PROPN
dti-2707	578	3	,	,	PUNCT
dti-2707	578	4	forozani	forozani	ADV
dti-2707	578	5	e	e	NOUN
dti-2707	578	6	,	,	PUNCT
dti-2707	578	7	akbari	akbari	PROPN
dti-2707	578	8	a	a	PROPN
dti-2707	578	9	,	,	PUNCT
dti-2707	578	10	et	et	PROPN
dti-2707	578	11	al	al	PROPN
dti-2707	578	12	.	.	PUNCT
dti-2707	579	1	dietary	dietary	ADJ
dti-2707	579	2	patterns	pattern	NOUN
dti-2707	579	3	and	and	CCONJ
dti-2707	579	4	risk	risk	NOUN
dti-2707	579	5	of	of	ADP
dti-2707	579	6	bladder	bladder	NOUN
dti-2707	579	7	cancer	cancer	NOUN
dti-2707	579	8	:	:	PUNCT
dti-2707	579	9	a	a	DET
dti-2707	579	10	systematic	systematic	ADJ
dti-2707	579	11	review	review	NOUN
dti-2707	579	12	and	and	CCONJ
dti-2707	579	13	meta	meta	VERB
dti-2707	579	14	analysis	analysis	NOUN
dti-2707	579	15	.	.	PUNCT
dti-2707	580	1	bmc	bmc	ADJ
dti-2707	580	2	public	public	ADJ
dti-2707	580	3	health	health	NOUN
dti-2707	580	4	.	.	PUNCT
dti-2707	581	1	2022;22(1):73	2022;22(1):73	NUM
dti-2707	581	2	.	.	PUNCT
dti-2707	582	1	crossref	crossref	PROPN
dti-2707	582	2	pubmed	pubmed	PROPN
dti-2707	582	3	31	31	NUM
dti-2707	582	4	.	.	PUNCT
dti-2707	583	1	chao	chao	PROPN
dti-2707	583	2	ji	ji	PROPN
dti-2707	583	3	,	,	PUNCT
dti-2707	583	4	su	su	PROPN
dti-2707	583	5	wc	wc	PROPN
dti-2707	583	6	,	,	PUNCT
dti-2707	583	7	liu	liu	PROPN
dti-2707	583	8	hf	hf	PROPN
dti-2707	583	9	.	.	PUNCT
dti-2707	583	10	baicalein	baicalein	PROPN
dti-2707	583	11	induces	induce	VERB
dti-2707	583	12	cancer	cancer	NOUN
dti-2707	583	13	cell	cell	NOUN
dti-2707	583	14	death	death	NOUN
dti-2707	583	15	and	and	CCONJ
dti-2707	583	16	proliferation	proliferation	NOUN
dti-2707	583	17	retardation	retardation	NOUN
dti-2707	583	18	by	by	ADP
dti-2707	583	19	the	the	DET
dti-2707	583	20	inhibition	inhibition	NOUN
dti-2707	583	21	of	of	ADP
dti-2707	583	22	cdc2	cdc2	PROPN
dti-2707	583	23	kinase	kinase	PROPN
dti-2707	583	24	and	and	CCONJ
dti-2707	583	25	survivin	survivin	PROPN
dti-2707	583	26	associated	associate	VERB
dti-2707	583	27	with	with	ADP
dti-2707	583	28	opposite	opposite	ADJ
dti-2707	583	29	role	role	NOUN
dti-2707	583	30	of	of	ADP
dti-2707	583	31	p38	p38	NOUN
dti-2707	583	32	mitogen	mitogen	NOUN
dti-2707	583	33	-	-	PUNCT
dti-2707	583	34	activated	activate	VERB
dti-2707	583	35	protein	protein	NOUN
dti-2707	583	36	kinase	kinase	NOUN
dti-2707	583	37	and	and	CCONJ
dti-2707	583	38	akt	akt	PROPN
dti-2707	583	39	.	.	PUNCT
dti-2707	584	1	mol	mol	ADP
dti-2707	584	2	cancer	cancer	NOUN
dti-2707	584	3	ther	ther	ADV
dti-2707	584	4	.	.	PUNCT
dti-2707	585	1	2007;6(11):30393048	2007;6(11):30393048	NUM
dti-2707	585	2	.	.	PUNCT
dti-2707	586	1	crossref	crossref	PROPN
dti-2707	586	2	pubmed	pubmed	PROPN
dti-2707	586	3	32	32	NUM
dti-2707	586	4	.	.	PUNCT
dti-2707	587	1	wu	wu	PROPN
dti-2707	587	2	j	j	PROPN
dti-2707	587	3	,	,	PUNCT
dti-2707	587	4	zhou	zhou	PROPN
dti-2707	587	5	t	t	PROPN
dti-2707	587	6	,	,	PUNCT
dti-2707	587	7	wang	wang	PROPN
dti-2707	587	8	y	y	PROPN
dti-2707	587	9	,	,	PUNCT
dti-2707	587	10	jiang	jiang	PROPN
dti-2707	587	11	y	y	PROPN
dti-2707	587	12	,	,	PUNCT
dti-2707	587	13	wang	wang	PROPN
dti-2707	587	14	y.	y.	PROPN
dti-2707	587	15	mechanisms	mechanism	NOUN
dti-2707	587	16	and	and	CCONJ
dti-2707	587	17	advances	advance	NOUN
dti-2707	587	18	in	in	ADP
dti-2707	587	19	anti	anti	ADJ
dti-2707	587	20	-	-	ADJ
dti-2707	587	21	ovarian	ovarian	ADJ
dti-2707	587	22	cancer	cancer	NOUN
dti-2707	587	23	with	with	ADP
dti-2707	587	24	natural	natural	ADJ
dti-2707	587	25	plants	plant	NOUN
dti-2707	587	26	component	component	NOUN
dti-2707	587	27	.	.	PUNCT
dti-2707	588	1	molecules	molecule	NOUN
dti-2707	588	2	.	.	PUNCT
dti-2707	589	1	2021;26(19):5949	2021;26(19):5949	NUM
dti-2707	589	2	.	.	X
dti-2707	590	1	crossref	crossref	PROPN
dti-2707	590	2	pubmed	pubmed	PROPN
dti-2707	590	3	33	33	NUM
dti-2707	590	4	.	.	PUNCT
dti-2707	591	1	liu	liu	PROPN
dti-2707	591	2	h	h	PROPN
dti-2707	591	3	,	,	PUNCT
dti-2707	591	4	dong	dong	PROPN
dti-2707	591	5	y	y	PROPN
dti-2707	591	6	,	,	PUNCT
dti-2707	591	7	gao	gao	PROPN
dti-2707	591	8	y	y	PROPN
dti-2707	591	9	,	,	PUNCT
dti-2707	591	10	et	et	PROPN
dti-2707	591	11	al	al	PROPN
dti-2707	591	12	.	.	PUNCT
dti-2707	592	1	the	the	DET
dti-2707	592	2	fascinating	fascinating	ADJ
dti-2707	592	3	effects	effect	NOUN
dti-2707	592	4	of	of	ADP
dti-2707	592	5	baicalein	baicalein	NOUN
dti-2707	592	6	on	on	ADP
dti-2707	592	7	cancer	cancer	NOUN
dti-2707	592	8	:	:	PUNCT
dti-2707	592	9	a	a	DET
dti-2707	592	10	review	review	NOUN
dti-2707	592	11	.	.	PUNCT
dti-2707	593	1	int	int	PROPN
dti-2707	593	2	j	j	PROPN
dti-2707	593	3	mol	mol	ADP
dti-2707	593	4	sci	sci	PROPN
dti-2707	593	5	.	.	PUNCT
dti-2707	594	1	2016;17(10):1681	2016;17(10):1681	X
dti-2707	594	2	.	.	PUNCT
dti-2707	594	3	crossref	crossref	PROPN
dti-2707	594	4	pubmed	pubmed	PROPN
dti-2707	594	5	34	34	NUM
dti-2707	594	6	.	.	PUNCT
dti-2707	595	1	chen	chen	PROPN
dti-2707	595	2	j	j	PROPN
dti-2707	595	3	,	,	PUNCT
dti-2707	595	4	li	li	PROPN
dti-2707	595	5	z	z	PROPN
dti-2707	595	6	,	,	PUNCT
dti-2707	595	7	chen	chen	PROPN
dti-2707	595	8	ay	ay	PROPN
dti-2707	595	9	,	,	PUNCT
dti-2707	595	10	et	et	PROPN
dti-2707	595	11	al	al	PROPN
dti-2707	595	12	.	.	PROPN
dti-2707	595	13	inhibitory	inhibitory	ADJ
dti-2707	595	14	effect	effect	NOUN
dti-2707	595	15	of	of	ADP
dti-2707	595	16	baicalin	baicalin	NOUN
dti-2707	595	17	and	and	CCONJ
dti-2707	595	18	baicalein	baicalein	NOUN
dti-2707	595	19	on	on	ADP
dti-2707	595	20	ovarian	ovarian	ADJ
dti-2707	595	21	cancer	cancer	NOUN
dti-2707	595	22	cells	cell	NOUN
dti-2707	595	23	.	.	PUNCT
dti-2707	596	1	int	int	PROPN
dti-2707	596	2	j	j	PROPN
dti-2707	596	3	mol	mol	ADP
dti-2707	596	4	sci	sci	PROPN
dti-2707	596	5	.	.	PUNCT
dti-2707	597	1	2013;14(3	2013;14(3	NUM
dti-2707	597	2	):	):	PUNCT
dti-2707	597	3	6012	6012	NUM
dti-2707	597	4	-	-	SYM
dti-2707	597	5	6025	6025	NUM
dti-2707	597	6	.	.	PUNCT
dti-2707	598	1	crossref	crossref	PROPN
dti-2707	598	2	pubmed	pubmed	PROPN
dti-2707	598	3	35	35	NUM
dti-2707	598	4	.	.	PUNCT
dti-2707	599	1	yan	yan	PROPN
dti-2707	599	2	h	h	PROPN
dti-2707	599	3	,	,	PUNCT
dti-2707	599	4	xin	xin	PROPN
dti-2707	599	5	s	s	PROPN
dti-2707	599	6	,	,	PUNCT
dti-2707	599	7	wang	wang	PROPN
dti-2707	599	8	h	h	PROPN
dti-2707	599	9	,	,	PUNCT
dti-2707	599	10	ma	ma	PROPN
dti-2707	599	11	j	j	PROPN
dti-2707	599	12	,	,	PUNCT
dti-2707	599	13	zhang	zhang	PROPN
dti-2707	599	14	h	h	PROPN
dti-2707	599	15	,	,	PUNCT
dti-2707	599	16	wei	wei	PROPN
dti-2707	599	17	h.	h.	PROPN
dti-2707	599	18	baicalein	baicalein	PROPN
dti-2707	599	19	inhibits	inhibit	VERB
dti-2707	599	20	mmp-2	mmp-2	PRON
dti-2707	599	21	expression	expression	NOUN
dti-2707	599	22	in	in	ADP
dti-2707	599	23	human	human	ADJ
dti-2707	599	24	ovarian	ovarian	ADJ
dti-2707	599	25	cancer	cancer	NOUN
dti-2707	599	26	cells	cell	NOUN
dti-2707	599	27	by	by	ADP
dti-2707	599	28	suppressing	suppress	VERB
dti-2707	599	29	the	the	DET
dti-2707	599	30	p38	p38	NOUN
dti-2707	599	31	mapk	mapk	NOUN
dti-2707	599	32	-	-	PUNCT
dti-2707	599	33	dependent	dependent	ADJ
dti-2707	599	34	nf	nf	ADJ
dti-2707	599	35	-	-	PUNCT
dti-2707	599	36	κb	κb	NOUN
dti-2707	599	37	signaling	signal	VERB
dti-2707	599	38	pathway	pathway	NOUN
dti-2707	599	39	.	.	PUNCT
dti-2707	600	1	anticancer	anticancer	NOUN
dti-2707	600	2	drugs	drug	NOUN
dti-2707	600	3	.	.	PUNCT
dti-2707	601	1	2015;26(6):649	2015;26(6):649	NUM
dti-2707	601	2	-	-	SYM
dti-2707	601	3	656	656	NUM
dti-2707	601	4	.	.	PUNCT
dti-2707	602	1	crossref	crossref	PROPN
dti-2707	602	2	pubmed	pubmed	PROPN
dti-2707	602	3	36	36	NUM
dti-2707	602	4	.	.	PUNCT
dti-2707	603	1	sanapour	sanapour	PROPN
dti-2707	603	2	n	n	CCONJ
dti-2707	603	3	,	,	PUNCT
dti-2707	603	4	malakoti	malakoti	PROPN
dti-2707	604	1	f	f	X
dti-2707	604	2	,	,	PUNCT
dti-2707	604	3	shanebandi	shanebandi	PROPN
dti-2707	604	4	d	d	PROPN
dti-2707	604	5	,	,	PUNCT
dti-2707	604	6	et	et	PROPN
dti-2707	604	7	al	al	PROPN
dti-2707	604	8	.	.	PUNCT
dti-2707	605	1	thymoquinone	thymoquinone	NOUN
dti-2707	605	2	augments	augment	VERB
dti-2707	605	3	methotrexate	methotrexate	NOUN
dti-2707	605	4	-	-	PUNCT
dti-2707	605	5	induced	induce	VERB
dti-2707	605	6	apoptosis	apoptosis	NOUN
dti-2707	605	7	on	on	ADP
dti-2707	605	8	osteosarcoma	osteosarcoma	ADJ
dti-2707	605	9	cells	cell	NOUN
dti-2707	605	10	.	.	PUNCT
dti-2707	606	1	drug	drug	NOUN
dti-2707	606	2	res	re	NOUN
dti-2707	606	3	(	(	PUNCT
dti-2707	606	4	stuttg	stuttg	ADJ
dti-2707	606	5	)	)	PUNCT
dti-2707	606	6	.	.	PUNCT
dti-2707	607	1	2022;72(4):220	2022;72(4):220	NUM
dti-2707	607	2	-	-	PUNCT
dti-2707	607	3	225	225	NUM
dti-2707	607	4	.	.	PUNCT
dti-2707	608	1	crossref	crossref	PROPN
dti-2707	608	2	pubmed	pubmed	PROPN
dti-2707	608	3	37	37	NUM
dti-2707	608	4	.	.	PUNCT
dti-2707	609	1	ye	ye	PRON
dti-2707	609	2	f	f	PROPN
dti-2707	609	3	,	,	PUNCT
dti-2707	609	4	wang	wang	PROPN
dti-2707	609	5	h	h	PROPN
dti-2707	609	6	,	,	PUNCT
dti-2707	609	7	zhang	zhang	PROPN
dti-2707	609	8	l	l	PROPN
dti-2707	609	9	,	,	PUNCT
dti-2707	609	10	zou	zou	PROPN
dti-2707	609	11	y	y	PROPN
dti-2707	609	12	,	,	PUNCT
dti-2707	609	13	han	han	PROPN
dti-2707	609	14	h	h	PROPN
dti-2707	609	15	,	,	PUNCT
dti-2707	609	16	huang	huang	PROPN
dti-2707	609	17	j.	j.	PROPN
dti-2707	609	18	baicalein	baicalein	PROPN
dti-2707	609	19	induces	induce	VERB
dti-2707	609	20	human	human	ADJ
dti-2707	609	21	osteosarcoma	osteosarcoma	ADJ
dti-2707	609	22	cell	cell	NOUN
dti-2707	609	23	line	line	NOUN
dti-2707	609	24	mg-63	mg-63	NOUN
dti-2707	609	25	apoptosis	apoptosis	NOUN
dti-2707	609	26	via	via	ADP
dti-2707	609	27	ros	ros	PROPN
dti-2707	609	28	-	-	PUNCT
dti-2707	609	29	induced	induce	VERB
dti-2707	609	30	bnip3	bnip3	NOUN
dti-2707	609	31	expression	expression	NOUN
dti-2707	609	32	.	.	PUNCT
dti-2707	610	1	tumour	tumour	PROPN
dti-2707	610	2	biol	biol	PROPN
dti-2707	610	3	.	.	PUNCT
dti-2707	611	1	2015;36(6):4731	2015;36(6):4731	NUM
dti-2707	611	2	-	-	SYM
dti-2707	611	3	4740	4740	NUM
dti-2707	611	4	.	.	PUNCT
dti-2707	612	1	crossref	crossref	PROPN
dti-2707	612	2	pubmed	pubmed	PROPN
dti-2707	612	3	38	38	NUM
dti-2707	612	4	.	.	PUNCT
dti-2707	613	1	verma	verma	PROPN
dti-2707	613	2	s	s	PROPN
dti-2707	613	3	,	,	PUNCT
dti-2707	613	4	gupta	gupta	PROPN
dti-2707	613	5	s	s	PART
dti-2707	613	6	,	,	PUNCT
dti-2707	613	7	das	das	PROPN
dti-2707	613	8	r	r	PROPN
dti-2707	613	9	,	,	PUNCT
dti-2707	613	10	et	et	PROPN
dti-2707	613	11	al	al	PROPN
dti-2707	613	12	.	.	PUNCT
dti-2707	614	1	unravelling	unravel	VERB
dti-2707	614	2	the	the	DET
dti-2707	614	3	approaches	approach	NOUN
dti-2707	614	4	to	to	PART
dti-2707	614	5	treat	treat	VERB
dti-2707	614	6	osteoarthritis	osteoarthritis	NOUN
dti-2707	614	7	:	:	PUNCT
dti-2707	614	8	a	a	DET
dti-2707	614	9	focus	focus	NOUN
dti-2707	614	10	on	on	ADP
dti-2707	614	11	the	the	DET
dti-2707	614	12	potential	potential	NOUN
dti-2707	614	13	of	of	ADP
dti-2707	614	14	medicinal	medicinal	ADJ
dti-2707	614	15	plants	plant	NOUN
dti-2707	614	16	.	.	PUNCT
dti-2707	615	1	pharmacognosy	pharmacognosy	NOUN
dti-2707	615	2	res	re	NOUN
dti-2707	615	3	.	.	PUNCT
dti-2707	616	1	2023;15(1):13	2023;15(1):13	X
dti-2707	616	2	-	-	SYM
dti-2707	616	3	25	25	NUM
dti-2707	616	4	.	.	PUNCT
dti-2707	617	1	crossref	crossref	PROPN
dti-2707	617	2	39	39	NUM
dti-2707	617	3	.	.	PUNCT
dti-2707	618	1	zhang	zhang	PROPN
dti-2707	618	2	y	y	PROPN
dti-2707	618	3	,	,	PUNCT
dti-2707	618	4	song	song	PROPN
dti-2707	618	5	l	l	PROPN
dti-2707	618	6	,	,	PUNCT
dti-2707	618	7	cai	cai	PROPN
dti-2707	618	8	l	l	PROPN
dti-2707	618	9	,	,	PUNCT
dti-2707	618	10	wei	wei	PROPN
dti-2707	618	11	r	r	PROPN
dti-2707	618	12	,	,	PUNCT
dti-2707	618	13	hu	hu	PROPN
dti-2707	618	14	h	h	PROPN
dti-2707	618	15	,	,	PUNCT
dti-2707	618	16	jin	jin	PROPN
dti-2707	618	17	w.	w.	PROPN
dti-2707	618	18	effects	effect	NOUN
dti-2707	618	19	of	of	ADP
dti-2707	618	20	baicalein	baicalein	NOUN
dti-2707	618	21	on	on	ADP
dti-2707	618	22	apoptosis	apoptosis	NOUN
dti-2707	618	23	,	,	PUNCT
dti-2707	618	24	cell	cell	NOUN
dti-2707	618	25	cycle	cycle	NOUN
dti-2707	618	26	arrest	arrest	NOUN
dti-2707	618	27	,	,	PUNCT
dti-2707	618	28	migration	migration	NOUN
dti-2707	618	29	and	and	CCONJ
dti-2707	618	30	invasion	invasion	NOUN
dti-2707	618	31	of	of	ADP
dti-2707	618	32	osteosarcoma	osteosarcoma	ADJ
dti-2707	618	33	cells	cell	NOUN
dti-2707	618	34	.	.	PUNCT
dti-2707	619	1	food	food	NOUN
dti-2707	619	2	chem	chem	NOUN
dti-2707	619	3	toxicol	toxicol	NOUN
dti-2707	619	4	.	.	PUNCT
dti-2707	620	1	2013;53:325	2013;53:325	NUM
dti-2707	620	2	-	-	PUNCT
dti-2707	620	3	333	333	NUM
dti-2707	620	4	.	.	PUNCT
dti-2707	621	1	crossref	crossref	PROPN
dti-2707	621	2	pubmed	pubmed	PROPN
dti-2707	621	3	40	40	NUM
dti-2707	621	4	.	.	PUNCT
dti-2707	622	1	qiu	qiu	PROPN
dti-2707	622	2	c	c	PROPN
dti-2707	622	3	,	,	PUNCT
dti-2707	622	4	kivipelto	kivipelto	PROPN
dti-2707	622	5	m	m	PROPN
dti-2707	622	6	,	,	PUNCT
dti-2707	622	7	von	von	PROPN
dti-2707	622	8	strauss	strauss	PROPN
dti-2707	622	9	e.	e.	PROPN
dti-2707	622	10	epidemiology	epidemiology	PROPN
dti-2707	622	11	of	of	ADP
dti-2707	622	12	alzheimer	alzheimer	PROPN
dti-2707	622	13	’s	’s	PART
dti-2707	622	14	disease	disease	NOUN
dti-2707	622	15	:	:	PUNCT
dti-2707	622	16	occurrence	occurrence	NOUN
dti-2707	622	17	,	,	PUNCT
dti-2707	622	18	determinants	determinant	NOUN
dti-2707	622	19	,	,	PUNCT
dti-2707	622	20	and	and	CCONJ
dti-2707	622	21	strategies	strategy	NOUN
dti-2707	622	22	toward	toward	ADP
dti-2707	622	23	intervention	intervention	NOUN
dti-2707	622	24	.	.	PUNCT
dti-2707	623	1	dialogues	dialogue	NOUN
dti-2707	623	2	clin	clin	PROPN
dti-2707	623	3	neurosci	neurosci	PROPN
dti-2707	623	4	.	.	PUNCT
dti-2707	624	1	2009;11(2):111	2009;11(2):111	NUM
dti-2707	624	2	-	-	SYM
dti-2707	624	3	128	128	NUM
dti-2707	624	4	.	.	PUNCT
dti-2707	625	1	crossref	crossref	PROPN
dti-2707	625	2	pubmed	pubmed	PROPN
dti-2707	625	3	41	41	NUM
dti-2707	625	4	.	.	PUNCT
dti-2707	626	1	malik	malik	PROPN
dti-2707	626	2	j	j	PROPN
dti-2707	626	3	,	,	PUNCT
dti-2707	626	4	munjal	munjal	PROPN
dti-2707	626	5	k	k	X
dti-2707	626	6	,	,	PUNCT
dti-2707	626	7	deshmukh	deshmukh	PROPN
dti-2707	626	8	r.	r.	PROPN
dti-2707	626	9	attenuating	attenuate	VERB
dti-2707	626	10	effect	effect	NOUN
dti-2707	626	11	of	of	ADP
dti-2707	626	12	standardized	standardized	ADJ
dti-2707	626	13	lyophilized	lyophilized	ADJ
dti-2707	626	14	cinnamomum	cinnamomum	ADJ
dti-2707	626	15	zeylanicum	zeylanicum	NOUN
dti-2707	626	16	bark	bark	NOUN
dti-2707	626	17	extract	extract	NOUN
dti-2707	626	18	against	against	ADP
dti-2707	626	19	streptozotocin	streptozotocin	NOUN
dti-2707	626	20	-	-	PUNCT
dti-2707	626	21	induced	induce	VERB
dti-2707	626	22	experimental	experimental	ADJ
dti-2707	626	23	dementia	dementia	NOUN
dti-2707	626	24	of	of	ADP
dti-2707	626	25	alzheimer	alzheimer	PROPN
dti-2707	626	26	’s	’s	PART
dti-2707	626	27	type	type	NOUN
dti-2707	626	28	.	.	PUNCT
dti-2707	627	1	j	j	PROPN
dti-2707	627	2	basic	basic	ADJ
dti-2707	627	3	clin	clin	PROPN
dti-2707	627	4	physiol	physiol	PROPN
dti-2707	627	5	pharmacol	pharmacol	PROPN
dti-2707	627	6	.	.	PUNCT
dti-2707	628	1	2015;26(3):275	2015;26(3):275	NUM
dti-2707	628	2	-	-	PUNCT
dti-2707	628	3	285	285	NUM
dti-2707	628	4	.	.	PUNCT
dti-2707	629	1	crossref	crossref	PROPN
dti-2707	629	2	pubmed	pubmed	PROPN
dti-2707	629	3	42	42	NUM
dti-2707	629	4	.	.	PUNCT
dti-2707	630	1	choi	choi	PROPN
dti-2707	630	2	rc	rc	PROPN
dti-2707	630	3	,	,	PUNCT
dti-2707	630	4	zhu	zhu	PROPN
dti-2707	630	5	jt	jt	PROPN
dti-2707	630	6	,	,	PUNCT
dti-2707	630	7	yung	yung	PROPN
dti-2707	630	8	aw	aw	INTJ
dti-2707	630	9	,	,	PUNCT
dti-2707	630	10	et	et	PROPN
dti-2707	630	11	al	al	PROPN
dti-2707	630	12	.	.	PROPN
dti-2707	630	13	synergistic	synergistic	ADJ
dti-2707	630	14	action	action	NOUN
dti-2707	630	15	of	of	ADP
dti-2707	630	16	flavonoids	flavonoid	NOUN
dti-2707	630	17	,	,	PUNCT
dti-2707	630	18	baicalein	baicalein	PROPN
dti-2707	630	19	,	,	PUNCT
dti-2707	630	20	and	and	CCONJ
dti-2707	630	21	daidzein	daidzein	ADJ
dti-2707	630	22	in	in	ADP
dti-2707	630	23	estrogenic	estrogenic	NOUN
dti-2707	630	24	and	and	CCONJ
dti-2707	630	25	neuroprotective	neuroprotective	ADJ
dti-2707	630	26	effects	effect	NOUN
dti-2707	630	27	:	:	PUNCT
dti-2707	630	28	a	a	DET
dti-2707	630	29	development	development	NOUN
dti-2707	630	30	of	of	ADP
dti-2707	630	31	potential	potential	ADJ
dti-2707	630	32	health	health	NOUN
dti-2707	630	33	products	product	NOUN
dti-2707	630	34	and	and	CCONJ
dti-2707	630	35	therapeutic	therapeutic	ADJ
dti-2707	630	36	drugs	drug	NOUN
dti-2707	630	37	against	against	ADP
dti-2707	630	38	alzheimer	alzheimer	PROPN
dti-2707	630	39	’s	’s	PART
dti-2707	630	40	disease	disease	NOUN
dti-2707	630	41	.	.	PUNCT
dti-2707	631	1	evid	evid	PROPN
dti-2707	631	2	based	base	VERB
dti-2707	631	3	complement	complement	PROPN
dti-2707	631	4	alternat	alternat	NOUN
dti-2707	631	5	med	me	VERB
dti-2707	631	6	.	.	PUNCT
dti-2707	632	1	2013;2013:635694	2013;2013:635694	NUM
dti-2707	632	2	.	.	PUNCT
dti-2707	633	1	crossref	crossref	PROPN
dti-2707	633	2	pubmed	pubmed	PROPN
dti-2707	633	3	43	43	NUM
dti-2707	633	4	.	.	PUNCT
dti-2707	634	1	zhang	zhang	PROPN
dti-2707	634	2	s	s	PROPN
dti-2707	634	3	-	-	PUNCT
dti-2707	634	4	q	q	ADJ
dti-2707	634	5	,	,	PUNCT
dti-2707	634	6	obregon	obregon	PROPN
dti-2707	634	7	d	d	PROPN
dti-2707	634	8	,	,	PUNCT
dti-2707	634	9	ehrhart	ehrhart	PROPN
dti-2707	634	10	j	j	PROPN
dti-2707	634	11	,	,	PUNCT
dti-2707	634	12	et	et	PROPN
dti-2707	634	13	al	al	PROPN
dti-2707	634	14	.	.	PROPN
dti-2707	634	15	baicalein	baicalein	PROPN
dti-2707	634	16	reduces	reduce	VERB
dti-2707	634	17	β	β	NOUN
dti-2707	634	18	-	-	NOUN
dti-2707	634	19	amyloid	amyloid	NOUN
dti-2707	634	20	and	and	CCONJ
dti-2707	634	21	promotes	promote	VERB
dti-2707	634	22	nonamyloidogenic	nonamyloidogenic	ADJ
dti-2707	634	23	amyloid	amyloid	NOUN
dti-2707	634	24	precursor	precursor	NOUN
dti-2707	634	25	protein	protein	NOUN
dti-2707	634	26	processing	processing	NOUN
dti-2707	634	27	in	in	ADP
dti-2707	634	28	an	an	DET
dti-2707	634	29	alzheimer	alzheimer	NOUN
dti-2707	634	30	’s	’s	PART
dti-2707	634	31	disease	disease	NOUN
dti-2707	634	32	transgenic	transgenic	NOUN
dti-2707	634	33	mouse	mouse	NOUN
dti-2707	634	34	model	model	NOUN
dti-2707	634	35	.	.	PUNCT
dti-2707	635	1	j	j	PROPN
dti-2707	635	2	neurosci	neurosci	PROPN
dti-2707	635	3	res	re	NOUN
dti-2707	635	4	.	.	PUNCT
dti-2707	636	1	2013;91(9):1239	2013;91(9):1239	NUM
dti-2707	636	2	-	-	SYM
dti-2707	636	3	1246	1246	NUM
dti-2707	636	4	.	.	PUNCT
dti-2707	637	1	crossref	crossref	PROPN
dti-2707	637	2	pubmed	pubmed	PROPN
dti-2707	637	3	44	44	NUM
dti-2707	637	4	.	.	PUNCT
dti-2707	638	1	zhu	zhu	PROPN
dti-2707	638	2	jt	jt	PROPN
dti-2707	638	3	,	,	PUNCT
dti-2707	638	4	choi	choi	PROPN
dti-2707	638	5	rc	rc	PROPN
dti-2707	638	6	,	,	PUNCT
dti-2707	638	7	chu	chu	PROPN
dti-2707	638	8	gk	gk	PROPN
dti-2707	638	9	,	,	PUNCT
dti-2707	638	10	et	et	PROPN
dti-2707	638	11	al	al	PROPN
dti-2707	638	12	.	.	PUNCT
dti-2707	639	1	flavonoids	flavonoid	NOUN
dti-2707	639	2	possess	possess	VERB
dti-2707	639	3	neuroprotective	neuroprotective	ADJ
dti-2707	639	4	effects	effect	NOUN
dti-2707	639	5	on	on	ADP
dti-2707	639	6	cultured	cultured	ADJ
dti-2707	639	7	pheochromocytoma	pheochromocytoma	NOUN
dti-2707	639	8	pc12	pc12	PROPN
dti-2707	639	9	cells	cell	NOUN
dti-2707	639	10	:	:	PUNCT
dti-2707	639	11	a	a	DET
dti-2707	639	12	comparison	comparison	NOUN
dti-2707	639	13	of	of	ADP
dti-2707	639	14	different	different	ADJ
dti-2707	639	15	flavonoids	flavonoid	NOUN
dti-2707	639	16	in	in	ADP
dti-2707	639	17	activating	activate	VERB
dti-2707	639	18	estrogenic	estrogenic	ADJ
dti-2707	639	19	effect	effect	NOUN
dti-2707	639	20	and	and	CCONJ
dti-2707	639	21	in	in	ADP
dti-2707	639	22	preventing	prevent	VERB
dti-2707	639	23	beta	beta	NOUN
dti-2707	639	24	-	-	PUNCT
dti-2707	639	25	amyloid	amyloid	NOUN
dti-2707	639	26	-	-	PUNCT
dti-2707	639	27	induced	induce	VERB
dti-2707	639	28	cell	cell	NOUN
dti-2707	639	29	death	death	NOUN
dti-2707	639	30	.	.	PUNCT
dti-2707	640	1	j	j	PROPN
dti-2707	640	2	agric	agric	PROPN
dti-2707	640	3	food	food	PROPN
dti-2707	640	4	chem	chem	NOUN
dti-2707	640	5	.	.	PUNCT
dti-2707	641	1	2007;55(6):2438	2007;55(6):2438	NUM
dti-2707	641	2	-	-	SYM
dti-2707	641	3	2445	2445	NUM
dti-2707	641	4	.	.	PUNCT
dti-2707	642	1	crossref	crossref	PROPN
dti-2707	642	2	pubmed	pubmed	PROPN
dti-2707	642	3	45	45	NUM
dti-2707	642	4	.	.	PUNCT
dti-2707	643	1	patil	patil	PROPN
dti-2707	643	2	rr	rr	PROPN
dti-2707	643	3	.	.	PUNCT
dti-2707	644	1	epidemiology	epidemiology	NOUN
dti-2707	644	2	of	of	ADP
dti-2707	644	3	parkinson	parkinson	NOUN
dti-2707	644	4	’s	’s	PART
dti-2707	644	5	disease	disease	NOUN
dti-2707	644	6	—	—	PUNCT
dti-2707	644	7	current	current	ADJ
dti-2707	644	8	understanding	understanding	NOUN
dti-2707	644	9	of	of	ADP
dti-2707	644	10	causation	causation	NOUN
dti-2707	644	11	and	and	CCONJ
dti-2707	644	12	risk	risk	NOUN
dti-2707	644	13	factors	factor	NOUN
dti-2707	644	14	.	.	PUNCT
dti-2707	645	1	in	in	ADP
dti-2707	645	2	:	:	PUNCT
dti-2707	645	3	arjunan	arjunan	PROPN
dti-2707	645	4	sp	sp	PROPN
dti-2707	645	5	,	,	PUNCT
dti-2707	645	6	kumar	kumar	PROPN
dti-2707	645	7	dk	dk	PROPN
dti-2707	645	8	,	,	PUNCT
dti-2707	645	9	eds	ed	NOUN
dti-2707	645	10	.	.	PUNCT
dti-2707	646	1	techniques	technique	NOUN
dti-2707	646	2	for	for	ADP
dti-2707	646	3	assessment	assessment	NOUN
dti-2707	646	4	of	of	ADP
dti-2707	646	5	parkinsonism	parkinsonism	NOUN
dti-2707	646	6	for	for	ADP
dti-2707	646	7	diagnosis	diagnosis	NOUN
dti-2707	646	8	and	and	CCONJ
dti-2707	646	9	rehabilitation	rehabilitation	NOUN
dti-2707	646	10	.	.	PUNCT
dti-2707	647	1	springer	springer	NOUN
dti-2707	647	2	singapore	singapore	PROPN
dti-2707	647	3	2022	2022	NUM
dti-2707	647	4	;	;	PUNCT
dti-2707	647	5	31	31	NUM
dti-2707	647	6	-	-	SYM
dti-2707	647	7	48	48	NUM
dti-2707	647	8	.	.	PUNCT
dti-2707	647	9	46	46	NUM
dti-2707	647	10	.	.	PUNCT
dti-2707	648	1	spillantini	spillantini	PROPN
dti-2707	648	2	mg	mg	PROPN
dti-2707	648	3	,	,	PUNCT
dti-2707	648	4	schmidt	schmidt	PROPN
dti-2707	648	5	ml	ml	PROPN
dti-2707	648	6	,	,	PUNCT
dti-2707	648	7	lee	lee	PROPN
dti-2707	648	8	vm	vm	PROPN
dti-2707	648	9	,	,	PUNCT
dti-2707	648	10	trojanowski	trojanowski	PROPN
dti-2707	648	11	jq	jq	PROPN
dti-2707	648	12	,	,	PUNCT
dti-2707	648	13	jakes	jakes	PROPN
dti-2707	648	14	r	r	PROPN
dti-2707	648	15	,	,	PUNCT
dti-2707	648	16	goedert	goedert	PROPN
dti-2707	648	17	m.	m.	NOUN
dti-2707	648	18	alpha	alpha	PROPN
dti-2707	648	19	-	-	PUNCT
dti-2707	648	20	synuclein	synuclein	NOUN
dti-2707	648	21	in	in	ADP
dti-2707	648	22	lewy	lewy	PROPN
dti-2707	648	23	bodies	body	NOUN
dti-2707	648	24	.	.	PUNCT
dti-2707	649	1	nature	nature	NOUN
dti-2707	649	2	.	.	PUNCT
dti-2707	650	1	1997	1997	NUM
dti-2707	650	2	;	;	PUNCT
dti-2707	650	3	388(6645):839	388(6645):839	X
dti-2707	650	4	-	-	SYM
dti-2707	650	5	840	840	NUM
dti-2707	650	6	.	.	PUNCT
dti-2707	651	1	crossref	crossref	PROPN
dti-2707	651	2	pubmed	pubmed	PROPN
dti-2707	651	3	47	47	NUM
dti-2707	651	4	.	.	PUNCT
dti-2707	652	1	glabe	glabe	PROPN
dti-2707	652	2	cg	cg	PROPN
dti-2707	652	3	,	,	PUNCT
dti-2707	652	4	kayed	kaye	VERB
dti-2707	652	5	r.	r.	PROPN
dti-2707	652	6	common	common	ADJ
dti-2707	652	7	structure	structure	NOUN
dti-2707	652	8	and	and	CCONJ
dti-2707	652	9	toxic	toxic	ADJ
dti-2707	652	10	function	function	NOUN
dti-2707	652	11	of	of	ADP
dti-2707	652	12	amyloid	amyloid	NOUN
dti-2707	652	13	oligomers	oligomer	NOUN
dti-2707	652	14	implies	imply	VERB
dti-2707	652	15	a	a	DET
dti-2707	652	16	common	common	ADJ
dti-2707	652	17	mechanism	mechanism	NOUN
dti-2707	652	18	of	of	ADP
dti-2707	652	19	pathogenesis	pathogenesis	NOUN
dti-2707	652	20	.	.	PUNCT
dti-2707	653	1	neurology	neurology	NOUN
dti-2707	653	2	.	.	PUNCT
dti-2707	654	1	2006;66(2)(suppl	2006;66(2)(suppl	NUM
dti-2707	654	2	1):s74	1):s74	NUM
dti-2707	654	3	-	-	PUNCT
dti-2707	654	4	s78	s78	NOUN
dti-2707	654	5	.	.	PUNCT
dti-2707	655	1	crossref	crossref	PROPN
dti-2707	655	2	pubmed	pubmed	PROPN
dti-2707	655	3	48	48	NUM
dti-2707	655	4	.	.	PUNCT
dti-2707	656	1	zhu	zhu	PROPN
dti-2707	656	2	m	m	PROPN
dti-2707	656	3	,	,	PUNCT
dti-2707	656	4	rajamani	rajamani	PROPN
dti-2707	656	5	s	s	PROPN
dti-2707	656	6	,	,	PUNCT
dti-2707	656	7	kaylor	kaylor	PROPN
dti-2707	656	8	j	j	PROPN
dti-2707	656	9	,	,	PUNCT
dti-2707	656	10	han	han	PROPN
dti-2707	656	11	s	s	PROPN
dti-2707	656	12	,	,	PUNCT
dti-2707	656	13	zhou	zhou	PROPN
dti-2707	656	14	f	f	PROPN
dti-2707	656	15	,	,	PUNCT
dti-2707	656	16	fink	fink	PROPN
dti-2707	656	17	al	al	PROPN
dti-2707	656	18	.	.	PUNCT
dti-2707	657	1	the	the	DET
dti-2707	657	2	flavonoid	flavonoid	PROPN
dti-2707	657	3	baicalein	baicalein	PROPN
dti-2707	657	4	inhibits	inhibit	VERB
dti-2707	657	5	fibrillation	fibrillation	NOUN
dti-2707	657	6	of	of	ADP
dti-2707	657	7	alpha	alpha	NOUN
dti-2707	657	8	-	-	PUNCT
dti-2707	657	9	synuclein	synuclein	NOUN
dti-2707	657	10	and	and	CCONJ
dti-2707	657	11	disaggregates	disaggregate	VERB
dti-2707	657	12	existing	exist	VERB
dti-2707	657	13	fibrils	fibril	NOUN
dti-2707	657	14	.	.	PUNCT
dti-2707	658	1	j	j	PROPN
dti-2707	658	2	biol	biol	PROPN
dti-2707	658	3	chem	chem	NOUN
dti-2707	658	4	.	.	PUNCT
dti-2707	659	1	2004;279(26):2684626857	2004;279(26):2684626857	NUM
dti-2707	659	2	.	.	PUNCT
dti-2707	659	3	crossref	crossref	PROPN
dti-2707	659	4	pubmed	pubmed	PROPN
dti-2707	659	5	49	49	NUM
dti-2707	659	6	.	.	PUNCT
dti-2707	660	1	suk	suk	PROPN
dti-2707	660	2	k	k	PROPN
dti-2707	660	3	,	,	PUNCT
dti-2707	660	4	lee	lee	PROPN
dti-2707	660	5	h	h	PROPN
dti-2707	660	6	,	,	PUNCT
dti-2707	660	7	kang	kang	PROPN
dti-2707	660	8	ss	ss	PROPN
dti-2707	660	9	,	,	PUNCT
dti-2707	660	10	cho	cho	PROPN
dti-2707	660	11	gj	gj	PROPN
dti-2707	660	12	,	,	PUNCT
dti-2707	660	13	choi	choi	PROPN
dti-2707	660	14	ws	ws	PROPN
dti-2707	660	15	.	.	PUNCT
dti-2707	661	1	flavonoid	flavonoid	PROPN
dti-2707	661	2	baicalein	baicalein	PROPN
dti-2707	661	3	attenuates	attenuate	VERB
dti-2707	661	4	activation	activation	NOUN
dti-2707	661	5	-	-	PUNCT
dti-2707	661	6	induced	induce	VERB
dti-2707	661	7	cell	cell	NOUN
dti-2707	661	8	death	death	NOUN
dti-2707	661	9	of	of	ADP
dti-2707	661	10	brain	brain	NOUN
dti-2707	661	11	microglia	microglia	NOUN
dti-2707	661	12	.	.	PUNCT
dti-2707	662	1	j	j	PROPN
dti-2707	662	2	pharmacol	pharmacol	PROPN
dti-2707	662	3	exp	exp	NOUN
dti-2707	662	4	ther	ther	ADV
dti-2707	662	5	.	.	PUNCT
dti-2707	663	1	2003;305(2):638	2003;305(2):638	NOUN
dti-2707	663	2	-	-	SYM
dti-2707	663	3	645	645	NUM
dti-2707	663	4	.	.	PUNCT
dti-2707	664	1	crossref	crossref	PROPN
dti-2707	664	2	pubmed	pubmed	PROPN
dti-2707	664	3	50	50	NUM
dti-2707	664	4	.	.	PUNCT
dti-2707	665	1	feigin	feigin	PROPN
dti-2707	665	2	vl	vl	PROPN
dti-2707	665	3	,	,	PUNCT
dti-2707	665	4	brainin	brainin	NOUN
dti-2707	665	5	m	m	PROPN
dti-2707	665	6	,	,	PUNCT
dti-2707	665	7	norrving	norrve	VERB
dti-2707	665	8	b	b	NUM
dti-2707	665	9	,	,	PUNCT
dti-2707	665	10	et	et	PROPN
dti-2707	665	11	al	al	PROPN
dti-2707	665	12	.	.	PROPN
dti-2707	666	1	world	world	PROPN
dti-2707	666	2	stroke	stroke	PROPN
dti-2707	666	3	organization	organization	PROPN
dti-2707	666	4	(	(	PUNCT
dti-2707	666	5	wso	wso	PROPN
dti-2707	666	6	):	):	PUNCT
dti-2707	666	7	global	global	ADJ
dti-2707	666	8	stroke	stroke	NOUN
dti-2707	666	9	fact	fact	NOUN
dti-2707	666	10	sheet	sheet	NOUN
dti-2707	666	11	2022	2022	NUM
dti-2707	666	12	.	.	PUNCT
dti-2707	667	1	int	int	NOUN
dti-2707	667	2	j	j	PROPN
dti-2707	667	3	stroke	stroke	NOUN
dti-2707	667	4	.	.	PUNCT
dti-2707	668	1	2022;17(1):18	2022;17(1):18	NUM
dti-2707	668	2	-	-	SYM
dti-2707	668	3	29	29	NUM
dti-2707	668	4	.	.	PUNCT
dti-2707	669	1	crossref	crossref	PROPN
dti-2707	669	2	pubmed	pubmed	PROPN
dti-2707	669	3	51	51	NUM
dti-2707	669	4	.	.	PUNCT
dti-2707	670	1	singh	singh	PROPN
dti-2707	670	2	g	g	PROPN
dti-2707	670	3	,	,	PUNCT
dti-2707	670	4	sharma	sharma	PROPN
dti-2707	670	5	m	m	PROPN
dti-2707	670	6	,	,	PUNCT
dti-2707	670	7	kumar	kumar	PROPN
dti-2707	670	8	ga	ga	PROPN
dti-2707	670	9	,	,	PUNCT
dti-2707	670	10	et	et	PROPN
dti-2707	670	11	al	al	PROPN
dti-2707	670	12	;	;	PUNCT
dti-2707	670	13	india	india	PROPN
dti-2707	670	14	state	state	NOUN
dti-2707	670	15	-	-	PUNCT
dti-2707	670	16	level	level	NOUN
dti-2707	670	17	disease	disease	NOUN
dti-2707	670	18	burden	burden	NOUN
dti-2707	670	19	initiative	initiative	NOUN
dti-2707	670	20	neurological	neurological	ADJ
dti-2707	670	21	disorders	disorder	NOUN
dti-2707	670	22	collaborators	collaborator	NOUN
dti-2707	670	23	.	.	PUNCT
dti-2707	671	1	the	the	DET
dti-2707	671	2	burden	burden	NOUN
dti-2707	671	3	of	of	ADP
dti-2707	671	4	neurological	neurological	ADJ
dti-2707	671	5	disorders	disorder	NOUN
dti-2707	671	6	across	across	ADP
dti-2707	671	7	the	the	DET
dti-2707	671	8	states	state	NOUN
dti-2707	671	9	of	of	ADP
dti-2707	671	10	india	india	PROPN
dti-2707	671	11	:	:	PUNCT
dti-2707	671	12	the	the	DET
dti-2707	671	13	global	global	ADJ
dti-2707	671	14	burden	burden	NOUN
dti-2707	671	15	of	of	ADP
dti-2707	671	16	disease	disease	NOUN
dti-2707	671	17	study	study	NOUN
dti-2707	671	18	1990	1990	NUM
dti-2707	671	19	-	-	SYM
dti-2707	671	20	2019	2019	NUM
dti-2707	671	21	.	.	PUNCT
dti-2707	672	1	lancet	lancet	NOUN
dti-2707	672	2	glob	glob	PROPN
dti-2707	672	3	health	health	NOUN
dti-2707	672	4	.	.	PUNCT
dti-2707	673	1	2021;9(8):e1129	2021;9(8):e1129	NUM
dti-2707	673	2	-	-	PUNCT
dti-2707	673	3	e1144	e1144	PROPN
dti-2707	673	4	.	.	PUNCT
dti-2707	674	1	crossref	crossref	PROPN
dti-2707	674	2	pubmed	pubmed	PROPN
dti-2707	674	3	52	52	NUM
dti-2707	674	4	.	.	PUNCT
dti-2707	675	1	zhou	zhou	PROPN
dti-2707	675	2	p	p	PROPN
dti-2707	675	3	,	,	PUNCT
dti-2707	675	4	iadecola	iadecola	PROPN
dti-2707	675	5	c.	c.	PROPN
dti-2707	675	6	inos	inos	PROPN
dti-2707	675	7	and	and	CCONJ
dti-2707	675	8	cox-2	cox-2	ADV
dti-2707	675	9	in	in	ADP
dti-2707	675	10	ischemic	ischemic	ADJ
dti-2707	675	11	stroke	stroke	NOUN
dti-2707	675	12	.	.	PUNCT
dti-2707	676	1	in	in	ADP
dti-2707	676	2	:	:	PUNCT
dti-2707	676	3	lajtha	lajtha	PROPN
dti-2707	676	4	a	a	PROPN
dti-2707	676	5	,	,	PUNCT
dti-2707	676	6	chan	chan	PROPN
dti-2707	676	7	ph	ph	PROPN
dti-2707	676	8	,	,	PUNCT
dti-2707	676	9	eds	ed	NOUN
dti-2707	676	10	.	.	PUNCT
dti-2707	676	11	handbook	handbook	NOUN
dti-2707	676	12	of	of	ADP
dti-2707	676	13	neurochemistry	neurochemistry	NOUN
dti-2707	676	14	and	and	CCONJ
dti-2707	676	15	molecular	molecular	ADJ
dti-2707	676	16	neurobiology	neurobiology	NOUN
dti-2707	676	17	:	:	PUNCT
dti-2707	676	18	acute	acute	ADJ
dti-2707	676	19	ischemic	ischemic	ADJ
dti-2707	676	20	injury	injury	NOUN
dti-2707	676	21	and	and	CCONJ
dti-2707	676	22	repair	repair	NOUN
dti-2707	676	23	in	in	ADP
dti-2707	676	24	the	the	DET
dti-2707	676	25	nervous	nervous	ADJ
dti-2707	676	26	system	system	NOUN
dti-2707	676	27	.	.	PUNCT
dti-2707	677	1	new	new	PROPN
dti-2707	677	2	york	york	PROPN
dti-2707	677	3	,	,	PUNCT
dti-2707	677	4	ny	ny	PROPN
dti-2707	677	5	:	:	PUNCT
dti-2707	677	6	springer	springer	NOUN
dti-2707	677	7	us	we	PRON
dti-2707	677	8	2007	2007	NUM
dti-2707	677	9	;	;	PUNCT
dti-2707	677	10	33	33	NUM
dti-2707	677	11	-	-	SYM
dti-2707	677	12	45	45	NUM
dti-2707	677	13	.	.	PUNCT
dti-2707	677	14	53	53	NUM
dti-2707	677	15	.	.	PUNCT
dti-2707	678	1	yuan	yuan	PROPN
dti-2707	678	2	y	y	PROPN
dti-2707	678	3	,	,	PUNCT
dti-2707	678	4	men	men	PROPN
dti-2707	678	5	w	w	PROPN
dti-2707	678	6	,	,	PUNCT
dti-2707	678	7	shan	shan	ADJ
dti-2707	678	8	x	x	NOUN
dti-2707	678	9	,	,	PUNCT
dti-2707	678	10	et	et	PROPN
dti-2707	678	11	al	al	PROPN
dti-2707	678	12	.	.	PROPN
dti-2707	678	13	baicalein	baicalein	PROPN
dti-2707	678	14	exerts	exert	VERB
dti-2707	678	15	neuroprotective	neuroprotective	ADJ
dti-2707	678	16	effect	effect	NOUN
dti-2707	678	17	against	against	ADP
dti-2707	678	18	ischaemic	ischaemic	ADJ
dti-2707	678	19	/	/	SYM
dti-2707	678	20	reperfusion	reperfusion	NOUN
dti-2707	678	21	injury	injury	NOUN
dti-2707	678	22	via	via	ADP
dti-2707	678	23	alteration	alteration	NOUN
dti-2707	678	24	of	of	ADP
dti-2707	678	25	nf	nf	NOUN
dti-2707	678	26	-	-	PUNCT
dti-2707	678	27	kb	kb	NOUN
dti-2707	678	28	and	and	CCONJ
dti-2707	678	29	lox	lox	NOUN
dti-2707	678	30	and	and	CCONJ
dti-2707	678	31	ampk	ampk	NOUN
dti-2707	678	32	/	/	SYM
dti-2707	678	33	nrf2	nrf2	NOUN
dti-2707	678	34	pathway	pathway	NOUN
dti-2707	678	35	.	.	PUNCT
dti-2707	679	1	inflammopharmacology	inflammopharmacology	NOUN
dti-2707	679	2	.	.	PUNCT
dti-2707	680	1	2020;28(5):1327	2020;28(5):1327	NUM
dti-2707	680	2	-	-	PUNCT
dti-2707	680	3	1341	1341	NUM
dti-2707	680	4	.	.	PUNCT
dti-2707	681	1	crossref	crossref	PROPN
dti-2707	681	2	pubmed	pubmed	PROPN
dti-2707	681	3	54	54	NUM
dti-2707	681	4	.	.	PUNCT
dti-2707	682	1	chen	chen	PROPN
dti-2707	682	2	w	w	PROPN
dti-2707	682	3	,	,	PUNCT
dti-2707	682	4	teng	teng	PROPN
dti-2707	682	5	x	x	X
dti-2707	682	6	,	,	PUNCT
dti-2707	682	7	ding	ding	NOUN
dti-2707	682	8	h	h	NOUN
dti-2707	682	9	,	,	PUNCT
dti-2707	682	10	et	et	PROPN
dti-2707	682	11	al	al	PROPN
dti-2707	682	12	.	.	PROPN
dti-2707	682	13	nrf2	nrf2	PROPN
dti-2707	682	14	protects	protect	VERB
dti-2707	682	15	against	against	ADP
dti-2707	682	16	cerebral	cerebral	ADJ
dti-2707	682	17	ischemia	ischemia	NOUN
dti-2707	682	18	-	-	PUNCT
dti-2707	682	19	reperfusion	reperfusion	NOUN
dti-2707	682	20	injury	injury	NOUN
dti-2707	682	21	by	by	ADP
dti-2707	682	22	suppressing	suppress	VERB
dti-2707	682	23	programmed	program	VERB
dti-2707	682	24	necrosis	necrosis	NOUN
dti-2707	682	25	and	and	CCONJ
dti-2707	682	26	inflammatory	inflammatory	ADJ
dti-2707	682	27	signaling	signal	VERB
dti-2707	682	28	pathways	pathway	NOUN
dti-2707	682	29	.	.	PUNCT
dti-2707	683	1	ann	ann	PROPN
dti-2707	683	2	transl	transl	PROPN
dti-2707	683	3	med	med	PROPN
dti-2707	683	4	.	.	PUNCT
dti-2707	684	1	2022;10(6):285	2022;10(6):285	PROPN
dti-2707	684	2	.	.	PUNCT
dti-2707	685	1	crossref	crossref	PROPN
dti-2707	685	2	pubmed	pubmed	PROPN
dti-2707	685	3	55	55	NUM
dti-2707	685	4	.	.	PUNCT
dti-2707	686	1	vaibhav	vaibhav	PROPN
dti-2707	686	2	k	k	PROPN
dti-2707	686	3	,	,	PUNCT
dti-2707	686	4	shrivastava	shrivastava	PROPN
dti-2707	686	5	p	p	PROPN
dti-2707	686	6	,	,	PUNCT
dti-2707	686	7	javed	javed	ADJ
dti-2707	686	8	h	h	NOUN
dti-2707	686	9	,	,	PUNCT
dti-2707	686	10	et	et	PROPN
dti-2707	686	11	al	al	PROPN
dti-2707	686	12	.	.	PROPN
dti-2707	686	13	piperine	piperine	PROPN
dti-2707	686	14	suppresses	suppress	VERB
dti-2707	686	15	cerebral	cerebral	ADJ
dti-2707	686	16	ischemia	ischemia	NOUN
dti-2707	686	17	-	-	PUNCT
dti-2707	686	18	reperfusion	reperfusion	NOUN
dti-2707	686	19	-	-	PUNCT
dti-2707	686	20	induced	induce	VERB
dti-2707	686	21	inflammation	inflammation	NOUN
dti-2707	686	22	through	through	ADP
dti-2707	686	23	the	the	DET
dti-2707	686	24	repression	repression	NOUN
dti-2707	686	25	of	of	ADP
dti-2707	686	26	cox-2	cox-2	NOUN
dti-2707	686	27	,	,	PUNCT
dti-2707	686	28	nos-2	nos-2	X
dti-2707	686	29	,	,	PUNCT
dti-2707	686	30	and	and	CCONJ
dti-2707	686	31	nf	nf	X
dti-2707	686	32	-	-	PUNCT
dti-2707	686	33	κb	κb	NOUN
dti-2707	686	34	in	in	ADP
dti-2707	686	35	middle	middle	ADJ
dti-2707	686	36	cerebral	cerebral	ADJ
dti-2707	686	37	artery	artery	NOUN
dti-2707	686	38	occlusion	occlusion	NOUN
dti-2707	686	39	rat	rat	NOUN
dti-2707	686	40	model	model	NOUN
dti-2707	686	41	.	.	PUNCT
dti-2707	687	1	mol	mol	ADP
dti-2707	687	2	cell	cell	NOUN
dti-2707	687	3	biochem	biochem	NOUN
dti-2707	687	4	.	.	PUNCT
dti-2707	688	1	2012;367(1	2012;367(1	NOUN
dti-2707	688	2	-	-	SYM
dti-2707	688	3	2	2	NUM
dti-2707	688	4	):	):	PUNCT
dti-2707	688	5	73	73	NUM
dti-2707	688	6	-	-	SYM
dti-2707	688	7	84	84	NUM
dti-2707	688	8	.	.	PUNCT
dti-2707	689	1	crossref	crossref	PROPN
dti-2707	689	2	pubmed	pubmed	PROPN
dti-2707	689	3	56	56	NUM
dti-2707	689	4	.	.	PUNCT
dti-2707	690	1	pitkänen	pitkänen	PROPN
dti-2707	690	2	a	a	PRON
dti-2707	690	3	,	,	PUNCT
dti-2707	690	4	mcintosh	mcintosh	PROPN
dti-2707	690	5	tk	tk	PROPN
dti-2707	690	6	.	.	PROPN
dti-2707	690	7	animal	animal	NOUN
dti-2707	690	8	models	model	NOUN
dti-2707	690	9	of	of	ADP
dti-2707	690	10	post	post	ADJ
dti-2707	690	11	-	-	ADJ
dti-2707	690	12	traumatic	traumatic	ADJ
dti-2707	690	13	epilepsy	epilepsy	NOUN
dti-2707	690	14	.	.	PUNCT
dti-2707	691	1	j	j	PROPN
dti-2707	691	2	neurotrauma	neurotrauma	PROPN
dti-2707	691	3	.	.	PUNCT
dti-2707	692	1	2006;23(2):241	2006;23(2):241	PROPN
dti-2707	692	2	-	-	PUNCT
dti-2707	692	3	261	261	NUM
dti-2707	692	4	.	.	PUNCT
dti-2707	693	1	crossref	crossref	PROPN
dti-2707	693	2	pubmed	pubmed	PROPN
dti-2707	693	3	57	57	NUM
dti-2707	693	4	.	.	PUNCT
dti-2707	694	1	li	li	PROPN
dti-2707	694	2	q	q	PROPN
dti-2707	694	3	,	,	PUNCT
dti-2707	694	4	li	li	PROPN
dti-2707	694	5	qq	qq	PROPN
dti-2707	694	6	,	,	PUNCT
dti-2707	694	7	jia	jia	PROPN
dti-2707	694	8	jn	jn	PROPN
dti-2707	694	9	,	,	PUNCT
dti-2707	694	10	et	et	PROPN
dti-2707	694	11	al	al	PROPN
dti-2707	694	12	.	.	PROPN
dti-2707	694	13	baicalein	baicalein	PROPN
dti-2707	694	14	exerts	exert	VERB
dti-2707	694	15	neuroprotective	neuroprotective	ADJ
dti-2707	694	16	effects	effect	NOUN
dti-2707	694	17	in	in	ADP
dti-2707	694	18	fecl3	fecl3	ADV
dti-2707	694	19	-	-	PUNCT
dti-2707	694	20	induced	induce	VERB
dti-2707	694	21	posttraumatic	posttraumatic	ADJ
dti-2707	694	22	epileptic	epileptic	ADJ
dti-2707	694	23	seizures	seizure	NOUN
dti-2707	694	24	via	via	ADP
dti-2707	694	25	suppressing	suppress	VERB
dti-2707	694	26	ferroptosis	ferroptosis	NOUN
dti-2707	694	27	.	.	PUNCT
dti-2707	695	1	front	front	ADJ
dti-2707	695	2	pharmacol	pharmacol	PROPN
dti-2707	695	3	.	.	PUNCT
dti-2707	696	1	2019;10:638	2019;10:638	NOUN
dti-2707	696	2	.	.	PUNCT
dti-2707	697	1	crossref	crossref	PROPN
dti-2707	697	2	pubmed	pubmed	PROPN
dti-2707	697	3	58	58	NUM
dti-2707	697	4	.	.	PUNCT
dti-2707	698	1	li	li	PROPN
dti-2707	698	2	y	y	PROPN
dti-2707	698	3	,	,	PUNCT
dti-2707	698	4	chen	chen	PROPN
dti-2707	698	5	q	q	PROPN
dti-2707	698	6	,	,	PUNCT
dti-2707	698	7	ran	run	VERB
dti-2707	698	8	d	d	PROPN
dti-2707	698	9	,	,	PUNCT
dti-2707	698	10	et	et	PROPN
dti-2707	698	11	al	al	PROPN
dti-2707	698	12	.	.	PROPN
dti-2707	699	1	changes	change	NOUN
dti-2707	699	2	in	in	ADP
dti-2707	699	3	the	the	DET
dti-2707	699	4	levels	level	NOUN
dti-2707	699	5	of	of	ADP
dti-2707	699	6	12/15	12/15	NUM
dti-2707	699	7	-	-	PUNCT
dti-2707	699	8	lipoxygenase	lipoxygenase	NOUN
dti-2707	699	9	,	,	PUNCT
dti-2707	699	10	apoptosis	apoptosis	NOUN
dti-2707	699	11	-	-	PUNCT
dti-2707	699	12	related	relate	VERB
dti-2707	699	13	proteins	protein	NOUN
dti-2707	699	14	and	and	CCONJ
dti-2707	699	15	inflammatory	inflammatory	ADJ
dti-2707	699	16	factors	factor	NOUN
dti-2707	699	17	in	in	ADP
dti-2707	699	18	the	the	DET
dti-2707	699	19	cortex	cortex	NOUN
dti-2707	699	20	of	of	ADP
dti-2707	699	21	diabetic	diabetic	ADJ
dti-2707	699	22	rats	rat	NOUN
dti-2707	699	23	and	and	CCONJ
dti-2707	699	24	the	the	DET
dti-2707	699	25	neuroprotection	neuroprotection	NOUN
dti-2707	699	26	of	of	ADP
dti-2707	699	27	baicalein	baicalein	PROPN
dti-2707	699	28	.	.	PUNCT
dti-2707	700	1	free	free	ADJ
dti-2707	700	2	radic	radic	ADJ
dti-2707	700	3	biol	biol	PROPN
dti-2707	700	4	med	me	VERB
dti-2707	700	5	.	.	PUNCT
dti-2707	701	1	2019;134:239	2019;134:239	NUM
dti-2707	701	2	-	-	SYM
dti-2707	701	3	247	247	NUM
dti-2707	701	4	.	.	PUNCT
dti-2707	702	1	crossref	crossref	PROPN
dti-2707	702	2	pubmed	pubmed	PROPN
dti-2707	702	3	59	59	NUM
dti-2707	702	4	.	.	PUNCT
dti-2707	703	1	the	the	DET
dti-2707	703	2	lancet	lancet	PROPN
dti-2707	703	3	.	.	PUNCT
dti-2707	704	1	gbd	gbd	PROPN
dti-2707	704	2	2017	2017	NUM
dti-2707	704	3	:	:	PUNCT
dti-2707	704	4	a	a	DET
dti-2707	704	5	fragile	fragile	ADJ
dti-2707	704	6	world	world	NOUN
dti-2707	704	7	.	.	PUNCT
dti-2707	705	1	lancet	lancet	PROPN
dti-2707	705	2	.	.	PUNCT
dti-2707	706	1	2018;392	2018;392	NUM
dti-2707	706	2	(	(	PUNCT
dti-2707	706	3	10159):1683	10159):1683	NOUN
dti-2707	706	4	.	.	PUNCT
dti-2707	707	1	crossref	crossref	PROPN
dti-2707	707	2	pubmed	pubmed	PROPN
dti-2707	707	3	60	60	PROPN
dti-2707	707	4	.	.	PUNCT
dti-2707	708	1	dharmage	dharmage	PROPN
dti-2707	708	2	sc	sc	PROPN
dti-2707	708	3	,	,	PUNCT
dti-2707	708	4	perret	perret	PROPN
dti-2707	708	5	jl	jl	PROPN
dti-2707	708	6	,	,	PUNCT
dti-2707	708	7	custovic	custovic	ADJ
dti-2707	708	8	a.	a.	NOUN
dti-2707	708	9	epidemiology	epidemiology	NOUN
dti-2707	708	10	of	of	ADP
dti-2707	708	11	asthma	asthma	NOUN
dti-2707	708	12	in	in	ADP
dti-2707	708	13	children	child	NOUN
dti-2707	708	14	and	and	CCONJ
dti-2707	708	15	adults	adult	NOUN
dti-2707	708	16	.	.	PUNCT
dti-2707	709	1	front	front	ADJ
dti-2707	709	2	pediatr	pediatr	NOUN
dti-2707	709	3	.	.	PUNCT
dti-2707	710	1	2019;7:246	2019;7:246	PROPN
dti-2707	710	2	.	.	PUNCT
dti-2707	711	1	crossref	crossref	PROPN
dti-2707	711	2	pubmed	pubmed	PROPN
dti-2707	711	3	61	61	NUM
dti-2707	711	4	.	.	PUNCT
dti-2707	712	1	quirt	quirt	PROPN
dti-2707	712	2	j	j	PROPN
dti-2707	712	3	,	,	PUNCT
dti-2707	712	4	hildebrand	hildebrand	PROPN
dti-2707	712	5	kj	kj	PROPN
dti-2707	712	6	,	,	PUNCT
dti-2707	712	7	mazza	mazza	PROPN
dti-2707	712	8	j	j	PROPN
dti-2707	712	9	,	,	PUNCT
dti-2707	712	10	noya	noya	PROPN
dti-2707	712	11	f	f	PROPN
dti-2707	712	12	,	,	PUNCT
dti-2707	712	13	kim	kim	PROPN
dti-2707	712	14	h.	h.	PROPN
dti-2707	712	15	asthma	asthma	PROPN
dti-2707	712	16	.	.	PUNCT
dti-2707	713	1	allergy	allergy	PROPN
dti-2707	713	2	asthma	asthma	PROPN
dti-2707	713	3	clin	clin	PROPN
dti-2707	713	4	immunol	immunol	NOUN
dti-2707	713	5	.	.	PUNCT
dti-2707	714	1	2018;14(s2)(suppl	2018;14(s2)(suppl	ADJ
dti-2707	714	2	2):50	2):50	NUM
dti-2707	714	3	.	.	PUNCT
dti-2707	715	1	crossref	crossref	PROPN
dti-2707	715	2	pubmed	pubmed	PROPN
dti-2707	715	3	https://doi.org/10.1007/s10151-016-1498-3	https://doi.org/10.1007/s10151-016-1498-3	PROPN
dti-2707	715	4	https://www.ncbi.nlm.nih.gov/pubmed/27343117	https://www.ncbi.nlm.nih.gov/pubmed/27343117	NUM
dti-2707	715	5	https://doi.org/10.1016/j.omto.2020.08.016	https://doi.org/10.1016/j.omto.2020.08.016	PROPN
dti-2707	715	6	https://www.ncbi.nlm.nih.gov/pubmed/33024814	https://www.ncbi.nlm.nih.gov/pubmed/33024814	NUM
dti-2707	715	7	https://www.ncbi.nlm.nih.gov/pubmed/11980674	https://www.ncbi.nlm.nih.gov/pubmed/11980674	NUM
dti-2707	715	8	https://doi.org/10.1186/s12889-022-12516-2	https://doi.org/10.1186/s12889-022-12516-2	NUM
dti-2707	715	9	https://www.ncbi.nlm.nih.gov/pubmed/35016647	https://www.ncbi.nlm.nih.gov/pubmed/35016647	NUM
dti-2707	715	10	https://doi.org/10.1158/1535-7163.mct-07-0281	https://doi.org/10.1158/1535-7163.mct-07-0281	PROPN
dti-2707	715	11	https://www.ncbi.nlm.nih.gov/pubmed/18025287	https://www.ncbi.nlm.nih.gov/pubmed/18025287	NUM
dti-2707	715	12	https://doi.org/10.3390/molecules26195949	https://doi.org/10.3390/molecules26195949	NOUN
dti-2707	715	13	https://www.ncbi.nlm.nih.gov/pubmed/34641493	https://www.ncbi.nlm.nih.gov/pubmed/34641493	NUM
dti-2707	716	1	https://doi.org/10.3390/ijms17101681	https://doi.org/10.3390/ijms17101681	PROPN
dti-2707	716	2	https://www.ncbi.nlm.nih.gov/pubmed/27735841	https://www.ncbi.nlm.nih.gov/pubmed/27735841	NUM
dti-2707	716	3	https://doi.org/10.3390/ijms14036012	https://doi.org/10.3390/ijms14036012	NOUN
dti-2707	716	4	https://www.ncbi.nlm.nih.gov/pubmed/23502466	https://www.ncbi.nlm.nih.gov/pubmed/23502466	PUNCT
dti-2707	716	5	https://doi.org/10.1097/cad.0000000000000230	https://doi.org/10.1097/cad.0000000000000230	PROPN
dti-2707	716	6	https://www.ncbi.nlm.nih.gov/pubmed/25811965	https://www.ncbi.nlm.nih.gov/pubmed/25811965	PRON
dti-2707	716	7	https://doi.org/10.1055/a-1775-7908	https://doi.org/10.1055/a-1775-7908	PROPN
dti-2707	716	8	https://www.ncbi.nlm.nih.gov/pubmed/35385883	https://www.ncbi.nlm.nih.gov/pubmed/35385883	ADP
dti-2707	716	9	https://doi.org/10.1007/s13277-015-3122-y	https://doi.org/10.1007/s13277-015-3122-y	PROPN
dti-2707	716	10	https://www.ncbi.nlm.nih.gov/pubmed/25618603	https://www.ncbi.nlm.nih.gov/pubmed/25618603	NUM
dti-2707	716	11	https://doi.org/10.5530/097484900001	https://doi.org/10.5530/097484900001	X
dti-2707	716	12	https://doi.org/10.1016/j.fct.2012.12.019	https://doi.org/10.1016/j.fct.2012.12.019	PROPN
dti-2707	716	13	https://www.ncbi.nlm.nih.gov/pubmed/23266503	https://www.ncbi.nlm.nih.gov/pubmed/23266503	NUM
dti-2707	716	14	https://doi.org/10.31887/dcns.2009.11.2/cqiu	https://doi.org/10.31887/dcns.2009.11.2/cqiu	NUM
dti-2707	716	15	https://www.ncbi.nlm.nih.gov/pubmed/19585947	https://www.ncbi.nlm.nih.gov/pubmed/19585947	NUM
dti-2707	716	16	https://doi.org/10.1515/jbcpp-2014-0012	https://doi.org/10.1515/jbcpp-2014-0012	PROPN
dti-2707	716	17	https://www.ncbi.nlm.nih.gov/pubmed/25301673	https://www.ncbi.nlm.nih.gov/pubmed/25301673	ADP
dti-2707	716	18	https://doi.org/10.1155/2013/635694	https://doi.org/10.1155/2013/635694	PROPN
dti-2707	716	19	https://www.ncbi.nlm.nih.gov/pubmed/24058373	https://www.ncbi.nlm.nih.gov/pubmed/24058373	NUM
dti-2707	716	20	https://doi.org/10.1002/jnr.23244	https://doi.org/10.1002/jnr.23244	PROPN
dti-2707	716	21	https://www.ncbi.nlm.nih.gov/pubmed/23686791	https://www.ncbi.nlm.nih.gov/pubmed/23686791	X
dti-2707	716	22	https://doi.org/10.1021/jf063299z	https://doi.org/10.1021/jf063299z	PROPN
dti-2707	716	23	https://www.ncbi.nlm.nih.gov/pubmed/17323972	https://www.ncbi.nlm.nih.gov/pubmed/17323972	NUM
dti-2707	716	24	https://doi.org/10.1038/42166	https://doi.org/10.1038/42166	ADP
dti-2707	716	25	https://www.ncbi.nlm.nih.gov/pubmed/9278044	https://www.ncbi.nlm.nih.gov/pubmed/9278044	NUM
dti-2707	716	26	https://doi.org/10.1212/01.wnl.0000192103.24796.42	https://doi.org/10.1212/01.wnl.0000192103.24796.42	NOUN
dti-2707	716	27	https://www.ncbi.nlm.nih.gov/pubmed/16432151	https://www.ncbi.nlm.nih.gov/pubmed/16432151	NUM
dti-2707	716	28	https://doi.org/10.1074/jbc.m403129200	https://doi.org/10.1074/jbc.m403129200	X
dti-2707	716	29	https://www.ncbi.nlm.nih.gov/pubmed/15096521	https://www.ncbi.nlm.nih.gov/pubmed/15096521	NUM
dti-2707	716	30	https://doi.org/10.1124/jpet.102.047373	https://doi.org/10.1124/jpet.102.047373	NOUN
dti-2707	716	31	https://www.ncbi.nlm.nih.gov/pubmed/12606597	https://www.ncbi.nlm.nih.gov/pubmed/12606597	NOUN
dti-2707	716	32	https://doi.org/10.1177/17474930211065917	https://doi.org/10.1177/17474930211065917	NOUN
dti-2707	716	33	https://www.ncbi.nlm.nih.gov/pubmed/34986727	https://www.ncbi.nlm.nih.gov/pubmed/34986727	NUM
dti-2707	717	1	https://doi.org/10.1016/s2214-109x(21)00164-9	https://doi.org/10.1016/s2214-109x(21)00164-9	ADJ
dti-2707	717	2	https://www.ncbi.nlm.nih.gov/pubmed/34273302	https://www.ncbi.nlm.nih.gov/pubmed/34273302	NUM
dti-2707	717	3	https://doi.org/10.1007/s10787-020-00714-6	https://doi.org/10.1007/s10787-020-00714-6	PROPN
dti-2707	717	4	https://www.ncbi.nlm.nih.gov/pubmed/32418004	https://www.ncbi.nlm.nih.gov/pubmed/32418004	PROPN
dti-2707	717	5	https://doi.org/10.21037/atm-22-604	https://doi.org/10.21037/atm-22-604	VERB
dti-2707	717	6	https://www.ncbi.nlm.nih.gov/pubmed/35434015	https://www.ncbi.nlm.nih.gov/pubmed/35434015	NUM
dti-2707	717	7	https://doi.org/10.1007/s11010-012-1321-z	https://doi.org/10.1007/s11010-012-1321-z	NOUN
dti-2707	717	8	https://www.ncbi.nlm.nih.gov/pubmed/22669728	https://www.ncbi.nlm.nih.gov/pubmed/22669728	PROPN
dti-2707	717	9	https://doi.org/10.1089/neu.2006.23.241	https://doi.org/10.1089/neu.2006.23.241	PROPN
dti-2707	717	10	tps://www.ncbi.nlm.nih.gov/pubmed/16503807	tps://www.ncbi.nlm.nih.gov/pubmed/16503807	VERB
dti-2707	717	11	https://doi.org/10.3389/fphar.2019.00638	https://doi.org/10.3389/fphar.2019.00638	PROPN
dti-2707	717	12	https://www.ncbi.nlm.nih.gov/pubmed/31231224	https://www.ncbi.nlm.nih.gov/pubmed/31231224	X
dti-2707	717	13	https://doi.org/10.1016/j.freeradbiomed.2019.01.019	https://doi.org/10.1016/j.freeradbiomed.2019.01.019	PROPN
dti-2707	717	14	https://www.ncbi.nlm.nih.gov/pubmed/30659940	https://www.ncbi.nlm.nih.gov/pubmed/30659940	NUM
dti-2707	717	15	https://doi.org/10.1016/s0140-6736(18)32858-7	https://doi.org/10.1016/s0140-6736(18)32858-7	PROPN
dti-2707	717	16	https://www.ncbi.nlm.nih.gov/pubmed/30415747	https://www.ncbi.nlm.nih.gov/pubmed/30415747	X
dti-2707	717	17	https://doi.org/10.3389/fped.2019.00246	https://doi.org/10.3389/fped.2019.00246	PROPN
dti-2707	717	18	https://www.ncbi.nlm.nih.gov/pubmed/31275909	https://www.ncbi.nlm.nih.gov/pubmed/31275909	NUM
dti-2707	717	19	https://doi.org/10.1186/s13223-018-0279-0	https://doi.org/10.1186/s13223-018-0279-0	NUM
dti-2707	717	20	https://www.ncbi.nlm.nih.gov/pubmed/30275843	https://www.ncbi.nlm.nih.gov/pubmed/30275843	NUM
dti-2707	717	21	therapeutic	therapeutic	ADJ
dti-2707	717	22	insights	insight	NOUN
dti-2707	717	23	into	into	ADP
dti-2707	717	24	baicalein44	baicalein44	NOUN
dti-2707	717	25	©	©	ADP
dti-2707	717	26	2024	2024	NUM
dti-2707	717	27	the	the	DET
dti-2707	717	28	authors	author	NOUN
dti-2707	717	29	.	.	PUNCT
dti-2707	718	1	drug	drug	NOUN
dti-2707	718	2	target	target	NOUN
dti-2707	718	3	insights	insight	NOUN
dti-2707	718	4	issn	issn	VERB
dti-2707	718	5	1177	1177	NUM
dti-2707	718	6	-	-	SYM
dti-2707	718	7	3928	3928	NUM
dti-2707	718	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	VERB
dti-2707	718	9	62	62	NUM
dti-2707	718	10	.	.	PUNCT
dti-2707	719	1	alsharairi	alsharairi	PROPN
dti-2707	719	2	na	na	PROPN
dti-2707	719	3	.	.	PROPN
dti-2707	719	4	scutellaria	scutellaria	PROPN
dti-2707	719	5	baicalensis	baicalensis	NOUN
dti-2707	719	6	and	and	CCONJ
dti-2707	719	7	their	their	PRON
dti-2707	719	8	natural	natural	ADJ
dti-2707	719	9	flavone	flavone	NOUN
dti-2707	719	10	compounds	compound	NOUN
dti-2707	719	11	as	as	ADP
dti-2707	719	12	potential	potential	ADJ
dti-2707	719	13	medicinal	medicinal	ADJ
dti-2707	719	14	drugs	drug	NOUN
dti-2707	719	15	for	for	ADP
dti-2707	719	16	the	the	DET
dti-2707	719	17	treatment	treatment	NOUN
dti-2707	719	18	of	of	ADP
dti-2707	719	19	nicotine	nicotine	NOUN
dti-2707	719	20	-	-	PUNCT
dti-2707	719	21	induced	induce	VERB
dti-2707	719	22	non	non	ADJ
dti-2707	719	23	-	-	ADJ
dti-2707	719	24	small	small	ADJ
dti-2707	719	25	-	-	PUNCT
dti-2707	719	26	cell	cell	NOUN
dti-2707	719	27	lung	lung	NOUN
dti-2707	719	28	cancer	cancer	NOUN
dti-2707	719	29	and	and	CCONJ
dti-2707	719	30	asthma	asthma	NOUN
dti-2707	719	31	.	.	PUNCT
dti-2707	720	1	int	int	PROPN
dti-2707	721	1	j	j	PROPN
dti-2707	721	2	environ	environ	PROPN
dti-2707	721	3	res	re	VERB
dti-2707	721	4	public	public	ADJ
dti-2707	721	5	health	health	NOUN
dti-2707	721	6	.	.	PUNCT
dti-2707	722	1	2021;18(10):5243	2021;18(10):5243	X
dti-2707	722	2	.	.	PUNCT
dti-2707	723	1	crossref	crossref	PROPN
dti-2707	723	2	pubmed	pubmed	PROPN
dti-2707	723	3	63	63	NUM
dti-2707	723	4	.	.	PUNCT
dti-2707	724	1	xu	xu	PROPN
dti-2707	724	2	t	t	PROPN
dti-2707	724	3	,	,	PUNCT
dti-2707	724	4	ge	ge	PROPN
dti-2707	724	5	x	x	PROPN
dti-2707	724	6	,	,	PUNCT
dti-2707	724	7	lu	lu	PROPN
dti-2707	724	8	c	c	NOUN
dti-2707	724	9	,	,	PUNCT
dti-2707	724	10	et	et	PROPN
dti-2707	724	11	al	al	PROPN
dti-2707	724	12	.	.	PROPN
dti-2707	724	13	baicalein	baicalein	PROPN
dti-2707	724	14	attenuates	attenuate	VERB
dti-2707	724	15	ova	ova	ADV
dti-2707	724	16	-	-	PUNCT
dti-2707	724	17	induced	induce	VERB
dti-2707	724	18	allergic	allergic	ADJ
dti-2707	724	19	airway	airway	NOUN
dti-2707	724	20	inflammation	inflammation	NOUN
dti-2707	724	21	through	through	ADP
dti-2707	724	22	the	the	DET
dti-2707	724	23	inhibition	inhibition	NOUN
dti-2707	724	24	of	of	ADP
dti-2707	724	25	the	the	DET
dti-2707	724	26	nf	nf	NOUN
dti-2707	724	27	-	-	PUNCT
dti-2707	724	28	κb	κb	NOUN
dti-2707	724	29	signaling	signal	VERB
dti-2707	724	30	pathway	pathway	NOUN
dti-2707	724	31	.	.	PUNCT
dti-2707	725	1	aging	age	VERB
dti-2707	725	2	(	(	PUNCT
dti-2707	725	3	albany	albany	PROPN
dti-2707	725	4	ny	ny	PROPN
dti-2707	725	5	)	)	PUNCT
dti-2707	725	6	.	.	PUNCT
dti-2707	726	1	2019;11(21):9310	2019;11(21):9310	X
dti-2707	726	2	-	-	NOUN
dti-2707	726	3	9327	9327	NUM
dti-2707	726	4	.	.	PUNCT
dti-2707	727	1	crossref	crossref	PROPN
dti-2707	727	2	pubmed	pubmed	PROPN
dti-2707	727	3	64	64	NUM
dti-2707	727	4	.	.	PUNCT
dti-2707	728	1	westergren	westergren	PROPN
dti-2707	728	2	-	-	PUNCT
dti-2707	728	3	thorsson	thorsson	PROPN
dti-2707	728	4	g	g	PROPN
dti-2707	728	5	,	,	PUNCT
dti-2707	728	6	larsen	larsen	PROPN
dti-2707	728	7	k	k	PROPN
dti-2707	728	8	,	,	PUNCT
dti-2707	728	9	nihlberg	nihlberg	PROPN
dti-2707	728	10	k	k	PROPN
dti-2707	728	11	,	,	PUNCT
dti-2707	728	12	et	et	PROPN
dti-2707	728	13	al	al	PROPN
dti-2707	728	14	.	.	PUNCT
dti-2707	728	15	pathological	pathological	ADJ
dti-2707	728	16	airway	airway	NOUN
dti-2707	728	17	remodelling	remodelle	VERB
dti-2707	728	18	in	in	ADP
dti-2707	728	19	inflammation	inflammation	NOUN
dti-2707	728	20	.	.	PUNCT
dti-2707	729	1	clin	clin	PROPN
dti-2707	729	2	respir	respir	VERB
dti-2707	729	3	j.	j.	PROPN
dti-2707	729	4	2010;4(s1	2010;4(s1	NUM
dti-2707	729	5	)	)	PUNCT
dti-2707	729	6	(	(	PUNCT
dti-2707	729	7	suppl	suppl	PROPN
dti-2707	729	8	1):1	1):1	NUM
dti-2707	729	9	-	-	SYM
dti-2707	729	10	8	8	NUM
dti-2707	729	11	.	.	PUNCT
dti-2707	730	1	crossref	crossref	PROPN
dti-2707	730	2	pubmed	pubmed	PROPN
dti-2707	730	3	65	65	NUM
dti-2707	730	4	.	.	PUNCT
dti-2707	731	1	sampsonas	sampsonas	PROPN
dti-2707	731	2	f	f	PROPN
dti-2707	731	3	,	,	PUNCT
dti-2707	731	4	kaparianos	kaparianos	PROPN
dti-2707	731	5	a	a	PRON
dti-2707	731	6	,	,	PUNCT
dti-2707	731	7	lykouras	lykouras	X
dti-2707	731	8	d	d	PROPN
dti-2707	731	9	,	,	PUNCT
dti-2707	731	10	karkoulias	karkoulias	PROPN
dti-2707	731	11	k	k	PROPN
dti-2707	731	12	,	,	PUNCT
dti-2707	731	13	spiropoulos	spiropoulos	PROPN
dti-2707	731	14	k.	k.	PROPN
dti-2707	731	15	dna	dna	PROPN
dti-2707	731	16	sequence	sequence	NOUN
dti-2707	731	17	variations	variation	NOUN
dti-2707	731	18	of	of	ADP
dti-2707	731	19	metalloproteinases	metalloproteinase	NOUN
dti-2707	731	20	:	:	PUNCT
dti-2707	731	21	their	their	PRON
dti-2707	731	22	role	role	NOUN
dti-2707	731	23	in	in	ADP
dti-2707	731	24	asthma	asthma	NOUN
dti-2707	731	25	and	and	CCONJ
dti-2707	731	26	copd	copd	PROPN
dti-2707	731	27	.	.	PUNCT
dti-2707	732	1	postgrad	postgrad	PROPN
dti-2707	732	2	med	med	PROPN
dti-2707	732	3	j.	j.	PROPN
dti-2707	732	4	2007;83	2007;83	PROPN
dti-2707	732	5	(	(	PUNCT
dti-2707	732	6	978):244	978):244	NUM
dti-2707	732	7	-	-	PUNCT
dti-2707	732	8	250	250	NUM
dti-2707	732	9	.	.	PUNCT
dti-2707	733	1	crossref	crossref	PROPN
dti-2707	733	2	pubmed	pubmed	PROPN
dti-2707	733	3	66	66	NUM
dti-2707	733	4	.	.	PUNCT
dti-2707	734	1	bakhtiyari	bakhtiyari	PROPN
dti-2707	734	2	m	m	PROPN
dti-2707	734	3	,	,	PUNCT
dti-2707	734	4	kazemian	kazemian	PROPN
dti-2707	734	5	e	e	PROPN
dti-2707	734	6	,	,	PUNCT
dti-2707	734	7	kabir	kabir	PROPN
dti-2707	734	8	k	k	PROPN
dti-2707	734	9	,	,	PUNCT
dti-2707	734	10	et	et	PROPN
dti-2707	734	11	al	al	PROPN
dti-2707	734	12	.	.	PROPN
dti-2707	734	13	contribution	contribution	NOUN
dti-2707	734	14	of	of	ADP
dti-2707	734	15	obesity	obesity	NOUN
dti-2707	734	16	and	and	CCONJ
dti-2707	734	17	cardiometabolic	cardiometabolic	NOUN
dti-2707	734	18	risk	risk	NOUN
dti-2707	734	19	factors	factor	NOUN
dti-2707	734	20	in	in	ADP
dti-2707	734	21	developing	develop	VERB
dti-2707	734	22	cardiovascular	cardiovascular	ADJ
dti-2707	734	23	disease	disease	NOUN
dti-2707	734	24	:	:	PUNCT
dti-2707	734	25	a	a	DET
dti-2707	734	26	population	population	NOUN
dti-2707	734	27	-	-	PUNCT
dti-2707	734	28	based	base	VERB
dti-2707	734	29	cohort	cohort	NOUN
dti-2707	734	30	study	study	NOUN
dti-2707	734	31	.	.	PUNCT
dti-2707	735	1	sci	sci	PROPN
dti-2707	735	2	rep	rep	PROPN
dti-2707	735	3	.	.	PROPN
dti-2707	735	4	2022;12(1):1544	2022;12(1):1544	NUM
dti-2707	735	5	.	.	PUNCT
dti-2707	736	1	crossref	crossref	PROPN
dti-2707	736	2	pubmed	pubmed	PROPN
dti-2707	736	3	67	67	NUM
dti-2707	736	4	.	.	PUNCT
dti-2707	737	1	gaziano	gaziano	PROPN
dti-2707	737	2	ta	ta	PROPN
dti-2707	737	3	,	,	PUNCT
dti-2707	737	4	bitton	bitton	PROPN
dti-2707	737	5	a	a	PROPN
dti-2707	737	6	,	,	PUNCT
dti-2707	737	7	anand	anand	PROPN
dti-2707	737	8	s	s	PROPN
dti-2707	737	9	,	,	PUNCT
dti-2707	737	10	abrahams	abrahams	NOUN
dti-2707	737	11	-	-	PUNCT
dti-2707	737	12	gessel	gessel	NOUN
dti-2707	737	13	s	s	PROPN
dti-2707	737	14	,	,	PUNCT
dti-2707	737	15	murphy	murphy	PROPN
dti-2707	737	16	a.	a.	NOUN
dti-2707	737	17	growing	grow	VERB
dti-2707	737	18	epidemic	epidemic	NOUN
dti-2707	737	19	of	of	ADP
dti-2707	737	20	coronary	coronary	ADJ
dti-2707	737	21	heart	heart	NOUN
dti-2707	737	22	disease	disease	NOUN
dti-2707	737	23	in	in	ADP
dti-2707	737	24	lowand	lowand	ADJ
dti-2707	737	25	middle	middle	ADJ
dti-2707	737	26	-	-	PUNCT
dti-2707	737	27	income	income	NOUN
dti-2707	737	28	countries	country	NOUN
dti-2707	737	29	.	.	PUNCT
dti-2707	738	1	curr	curr	PROPN
dti-2707	738	2	probl	probl	PROPN
dti-2707	738	3	cardiol	cardiol	NOUN
dti-2707	738	4	.	.	PUNCT
dti-2707	739	1	2010;35(2):72	2010;35(2):72	NUM
dti-2707	739	2	-	-	SYM
dti-2707	739	3	115	115	NUM
dti-2707	739	4	.	.	PUNCT
dti-2707	740	1	crossref	crossref	PROPN
dti-2707	740	2	pubmed	pubmed	PROPN
dti-2707	740	3	68	68	NUM
dti-2707	740	4	.	.	PUNCT
dti-2707	741	1	sharma	sharma	PROPN
dti-2707	741	2	a	a	PROPN
dti-2707	741	3	,	,	PUNCT
dti-2707	741	4	et	et	PROPN
dti-2707	741	5	al	al	PROPN
dti-2707	741	6	.	.	PROPN
dti-2707	741	7	combination	combination	NOUN
dti-2707	741	8	effect	effect	NOUN
dti-2707	741	9	of	of	ADP
dti-2707	741	10	spirulina	spirulina	PROPN
dti-2707	741	11	fusiformis	fusiformis	PROPN
dti-2707	741	12	with	with	ADP
dti-2707	741	13	rutin	rutin	NOUN
dti-2707	741	14	or	or	CCONJ
dti-2707	741	15	chlorogenic	chlorogenic	ADJ
dti-2707	741	16	acid	acid	NOUN
dti-2707	741	17	in	in	ADP
dti-2707	741	18	lipopolysaccharide	lipopolysaccharide	ADV
dti-2707	741	19	-	-	PUNCT
dti-2707	741	20	induced	induce	VERB
dti-2707	741	21	septic	septic	ADJ
dti-2707	741	22	cardiac	cardiac	ADJ
dti-2707	741	23	inflammation	inflammation	NOUN
dti-2707	741	24	in	in	ADP
dti-2707	741	25	experimental	experimental	ADJ
dti-2707	741	26	diabetic	diabetic	ADJ
dti-2707	741	27	rat	rat	NOUN
dti-2707	741	28	model	model	NOUN
dti-2707	741	29	.	.	PUNCT
dti-2707	742	1	pharmacogn	pharmacogn	VERB
dti-2707	742	2	mag	mag	PROPN
dti-2707	742	3	.	.	PUNCT
dti-2707	743	1	2021;17(6):257	2021;17(6):257	NOUN
dti-2707	743	2	-	-	SYM
dti-2707	743	3	267	267	NUM
dti-2707	743	4	.	.	PUNCT
dti-2707	744	1	crossref	crossref	PROPN
dti-2707	744	2	69	69	NUM
dti-2707	744	3	.	.	PUNCT
dti-2707	745	1	satyavert	satyavert	PROPN
dti-2707	745	2	gs	gs	PROPN
dti-2707	745	3	,	,	PUNCT
dti-2707	745	4	gupta	gupta	PROPN
dti-2707	745	5	s	s	PROPN
dti-2707	745	6	,	,	PUNCT
dti-2707	745	7	choudhury	choudhury	PROPN
dti-2707	745	8	h	h	PROPN
dti-2707	745	9	,	,	PUNCT
dti-2707	745	10	et	et	PROPN
dti-2707	745	11	al	al	PROPN
dti-2707	745	12	.	.	PUNCT
dti-2707	745	13	pharmacokinetics	pharmacokinetic	NOUN
dti-2707	745	14	and	and	CCONJ
dti-2707	745	15	tissue	tissue	NOUN
dti-2707	745	16	distribution	distribution	NOUN
dti-2707	745	17	of	of	ADP
dti-2707	745	18	hydrazinocurcumin	hydrazinocurcumin	PROPN
dti-2707	745	19	in	in	ADP
dti-2707	745	20	rats	rat	NOUN
dti-2707	745	21	.	.	PUNCT
dti-2707	746	1	pharmacol	pharmacol	PROPN
dti-2707	746	2	rep	rep	PROPN
dti-2707	746	3	.	.	PROPN
dti-2707	746	4	2021;73(6):1734	2021;73(6):1734	NUM
dti-2707	746	5	-	-	SYM
dti-2707	746	6	1743	1743	NUM
dti-2707	746	7	.	.	PUNCT
dti-2707	747	1	crossref	crossref	PROPN
dti-2707	747	2	pubmed	pubmed	PROPN
dti-2707	747	3	70	70	PROPN
dti-2707	747	4	.	.	PUNCT
dti-2707	748	1	al	al	PROPN
dti-2707	748	2	-	-	PUNCT
dti-2707	748	3	makki	makki	PROPN
dti-2707	748	4	a	a	PRON
dti-2707	748	5	,	,	PUNCT
dti-2707	748	6	dipette	dipette	PROPN
dti-2707	748	7	d	d	PROPN
dti-2707	748	8	,	,	PUNCT
dti-2707	748	9	whelton	whelton	PROPN
dti-2707	748	10	pk	pk	PROPN
dti-2707	748	11	,	,	PUNCT
dti-2707	748	12	et	et	PROPN
dti-2707	748	13	al	al	PROPN
dti-2707	748	14	.	.	PUNCT
dti-2707	748	15	hypertension	hypertension	NOUN
dti-2707	748	16	pharmacological	pharmacological	NOUN
dti-2707	748	17	treatment	treatment	NOUN
dti-2707	748	18	in	in	ADP
dti-2707	748	19	adults	adult	NOUN
dti-2707	748	20	:	:	PUNCT
dti-2707	748	21	a	a	DET
dti-2707	748	22	world	world	NOUN
dti-2707	748	23	health	health	NOUN
dti-2707	748	24	organization	organization	PROPN
dti-2707	748	25	guideline	guideline	PROPN
dti-2707	748	26	executive	executive	PROPN
dti-2707	748	27	summary	summary	NOUN
dti-2707	748	28	.	.	PUNCT
dti-2707	749	1	hypertension	hypertension	NOUN
dti-2707	749	2	.	.	PUNCT
dti-2707	750	1	2022;79(1	2022;79(1	NUM
dti-2707	750	2	):	):	PUNCT
dti-2707	750	3	293	293	NUM
dti-2707	750	4	-	-	SYM
dti-2707	750	5	301	301	NUM
dti-2707	750	6	.	.	PUNCT
dti-2707	751	1	crossref	crossref	PROPN
dti-2707	751	2	pubmed	pubmed	PROPN
dti-2707	751	3	71	71	NUM
dti-2707	751	4	.	.	PUNCT
dti-2707	752	1	wu	wu	PROPN
dti-2707	752	2	d	d	PROPN
dti-2707	752	3	,	,	PUNCT
dti-2707	752	4	ding	ding	NOUN
dti-2707	752	5	l	l	NOUN
dti-2707	752	6	,	,	PUNCT
dti-2707	752	7	tang	tang	PROPN
dti-2707	752	8	x	x	PROPN
dti-2707	752	9	,	,	PUNCT
dti-2707	752	10	wang	wang	PROPN
dti-2707	752	11	w	w	PROPN
dti-2707	752	12	,	,	PUNCT
dti-2707	752	13	chen	chen	PROPN
dti-2707	752	14	y	y	PROPN
dti-2707	752	15	,	,	PUNCT
dti-2707	752	16	zhang	zhang	PROPN
dti-2707	752	17	t.	t.	PROPN
dti-2707	752	18	baicalin	baicalin	PROPN
dti-2707	752	19	protects	protect	VERB
dti-2707	752	20	against	against	ADP
dti-2707	752	21	hypertension	hypertension	NOUN
dti-2707	752	22	-	-	PUNCT
dti-2707	752	23	associated	associate	VERB
dti-2707	752	24	intestinal	intestinal	ADJ
dti-2707	752	25	barrier	barrier	NOUN
dti-2707	752	26	impairment	impairment	NOUN
dti-2707	752	27	in	in	ADP
dti-2707	752	28	part	part	NOUN
dti-2707	752	29	through	through	ADP
dti-2707	752	30	enhanced	enhance	VERB
dti-2707	752	31	microbial	microbial	ADJ
dti-2707	752	32	production	production	NOUN
dti-2707	752	33	of	of	ADP
dti-2707	752	34	short	short	ADJ
dti-2707	752	35	-	-	PUNCT
dti-2707	752	36	chain	chain	NOUN
dti-2707	752	37	fatty	fatty	NOUN
dti-2707	752	38	acids	acid	NOUN
dti-2707	752	39	.	.	PUNCT
dti-2707	753	1	front	front	ADJ
dti-2707	753	2	pharmacol	pharmacol	PROPN
dti-2707	753	3	.	.	PUNCT
dti-2707	754	1	2019;10:1271	2019;10:1271	NUM
dti-2707	754	2	.	.	PUNCT
dti-2707	755	1	crossref	crossref	PROPN
dti-2707	755	2	pubmed	pubmed	PROPN
dti-2707	755	3	72	72	PROPN
dti-2707	755	4	.	.	PUNCT
dti-2707	756	1	li	li	PROPN
dti-2707	756	2	m	m	PROPN
dti-2707	756	3	,	,	PUNCT
dti-2707	756	4	ren	ren	PROPN
dti-2707	756	5	c.	c.	PROPN
dti-2707	756	6	exploring	explore	VERB
dti-2707	756	7	the	the	DET
dti-2707	756	8	protective	protective	ADJ
dti-2707	756	9	mechanism	mechanism	NOUN
dti-2707	756	10	of	of	ADP
dti-2707	756	11	baicalin	baicalin	NOUN
dti-2707	756	12	in	in	ADP
dti-2707	756	13	treatment	treatment	NOUN
dti-2707	756	14	of	of	ADP
dti-2707	756	15	atherosclerosis	atherosclerosis	NOUN
dti-2707	756	16	using	use	VERB
dti-2707	756	17	endothelial	endothelial	ADJ
dti-2707	756	18	cells	cell	NOUN
dti-2707	756	19	deregulation	deregulation	NOUN
dti-2707	756	20	model	model	NOUN
dti-2707	756	21	and	and	CCONJ
dti-2707	756	22	network	network	NOUN
dti-2707	756	23	pharmacology	pharmacology	NOUN
dti-2707	756	24	.	.	PUNCT
dti-2707	757	1	bmc	bmc	PROPN
dti-2707	757	2	complement	complement	PROPN
dti-2707	757	3	med	me	VERB
dti-2707	757	4	ther	ther	ADV
dti-2707	757	5	.	.	PUNCT
dti-2707	758	1	2022	2022	NUM
dti-2707	758	2	oct	oct	PROPN
dti-2707	758	3	3;22(1):257	3;22(1):257	PROPN
dti-2707	758	4	.	.	PUNCT
dti-2707	759	1	crossref	crossref	PROPN
dti-2707	759	2	pubmed	pubmed	PROPN
dti-2707	759	3	73	73	NUM
dti-2707	759	4	.	.	PUNCT
dti-2707	760	1	sampaio	sampaio	PROPN
dti-2707	760	2	wo	will	AUX
dti-2707	760	3	,	,	PUNCT
dti-2707	760	4	souza	souza	PROPN
dti-2707	760	5	dos	do	VERB
dti-2707	760	6	santos	santos	PROPN
dti-2707	760	7	ra	ra	PROPN
dti-2707	760	8	,	,	PUNCT
dti-2707	760	9	faria	faria	PROPN
dti-2707	760	10	-	-	PROPN
dti-2707	760	11	silva	silva	PROPN
dti-2707	760	12	r	r	PROPN
dti-2707	760	13	,	,	PUNCT
dti-2707	760	14	da	da	PROPN
dti-2707	760	15	mata	mata	PROPN
dti-2707	760	16	machado	machado	PROPN
dti-2707	760	17	lt	lt	PROPN
dti-2707	760	18	,	,	PUNCT
dti-2707	760	19	schiffrin	schiffrin	PROPN
dti-2707	760	20	el	el	PROPN
dti-2707	760	21	,	,	PUNCT
dti-2707	760	22	touyz	touyz	PROPN
dti-2707	760	23	rm	rm	PROPN
dti-2707	760	24	.	.	PUNCT
dti-2707	761	1	angiotensin-(1	angiotensin-(1	PROPN
dti-2707	761	2	-	-	PUNCT
dti-2707	761	3	7	7	NUM
dti-2707	761	4	)	)	PUNCT
dti-2707	761	5	through	through	ADP
dti-2707	761	6	receptor	receptor	NOUN
dti-2707	761	7	mas	mas	PROPN
dti-2707	761	8	mediates	mediates	PROPN
dti-2707	761	9	endothelial	endothelial	ADJ
dti-2707	761	10	nitric	nitric	ADJ
dti-2707	761	11	oxide	oxide	NOUN
dti-2707	761	12	synthase	synthase	NOUN
dti-2707	761	13	activation	activation	NOUN
dti-2707	761	14	via	via	ADP
dti-2707	761	15	akt	akt	PROPN
dti-2707	761	16	-	-	PUNCT
dti-2707	761	17	dependent	dependent	ADJ
dti-2707	761	18	pathways	pathway	NOUN
dti-2707	761	19	.	.	PUNCT
dti-2707	762	1	hypertension	hypertension	NOUN
dti-2707	762	2	.	.	PUNCT
dti-2707	763	1	2007;49(1):185	2007;49(1):185	NUM
dti-2707	763	2	-	-	SYM
dti-2707	763	3	192	192	NUM
dti-2707	763	4	.	.	PUNCT
dti-2707	764	1	crossref	crossref	PROPN
dti-2707	764	2	pubmed	pubmed	PROPN
dti-2707	764	3	74	74	NUM
dti-2707	764	4	.	.	PUNCT
dti-2707	765	1	alshehri	alshehri	PROPN
dti-2707	765	2	b	b	PROPN
dti-2707	765	3	,	,	PUNCT
dti-2707	765	4	vijayakumar	vijayakumar	PROPN
dti-2707	765	5	r	r	PROPN
dti-2707	765	6	,	,	PUNCT
dti-2707	765	7	senthilkumar	senthilkumar	PROPN
dti-2707	765	8	s	s	PROPN
dti-2707	765	9	,	,	PUNCT
dti-2707	765	10	et	et	PROPN
dti-2707	765	11	al	al	PROPN
dti-2707	765	12	.	.	PUNCT
dti-2707	766	1	therapeutic	therapeutic	ADJ
dti-2707	766	2	potential	potential	NOUN
dti-2707	766	3	of	of	ADP
dti-2707	766	4	nitric	nitric	ADJ
dti-2707	766	5	oxide	oxide	NOUN
dti-2707	766	6	synthase	synthase	NOUN
dti-2707	766	7	inhibitor	inhibitor	NOUN
dti-2707	766	8	from	from	ADP
dti-2707	766	9	natural	natural	ADJ
dti-2707	766	10	sources	source	NOUN
dti-2707	766	11	for	for	ADP
dti-2707	766	12	the	the	DET
dti-2707	766	13	treatment	treatment	NOUN
dti-2707	766	14	of	of	ADP
dti-2707	766	15	ischemic	ischemic	ADJ
dti-2707	766	16	stroke	stroke	NOUN
dti-2707	766	17	.	.	PUNCT
dti-2707	767	1	saudi	saudi	PROPN
dti-2707	767	2	j	j	PROPN
dti-2707	767	3	biol	biol	PROPN
dti-2707	767	4	sci	sci	PROPN
dti-2707	767	5	.	.	PUNCT
dti-2707	768	1	2022;29(2):984	2022;29(2):984	NUM
dti-2707	768	2	-	-	PUNCT
dti-2707	768	3	991	991	NUM
dti-2707	768	4	.	.	PUNCT
dti-2707	769	1	crossref	crossref	PROPN
dti-2707	769	2	pubmed	pubmed	PROPN
dti-2707	769	3	75	75	NUM
dti-2707	769	4	.	.	PUNCT
dti-2707	770	1	huang	huang	PROPN
dti-2707	770	2	p	p	PROPN
dti-2707	770	3	,	,	PUNCT
dti-2707	770	4	gao	gao	PROPN
dti-2707	770	5	jw	jw	PROPN
dti-2707	770	6	,	,	PUNCT
dti-2707	770	7	shi	shi	PROPN
dti-2707	770	8	z	z	PROPN
dti-2707	770	9	,	,	PUNCT
dti-2707	770	10	et	et	PROPN
dti-2707	770	11	al	al	PROPN
dti-2707	770	12	.	.	PUNCT
dti-2707	771	1	a	a	DET
dti-2707	771	2	novel	novel	ADJ
dti-2707	771	3	uplc	uplc	ADJ
dti-2707	771	4	-	-	PUNCT
dti-2707	771	5	ms	ms	PROPN
dti-2707	771	6	/	/	SYM
dti-2707	771	7	ms	ms	PROPN
dti-2707	771	8	method	method	NOUN
dti-2707	771	9	for	for	ADP
dti-2707	771	10	simultaneous	simultaneous	ADJ
dti-2707	771	11	quantification	quantification	NOUN
dti-2707	771	12	of	of	ADP
dti-2707	771	13	rhein	rhein	NOUN
dti-2707	771	14	,	,	PUNCT
dti-2707	771	15	emodin	emodin	PROPN
dti-2707	771	16	,	,	PUNCT
dti-2707	771	17	berberine	berberine	NOUN
dti-2707	771	18	and	and	CCONJ
dti-2707	771	19	baicalin	baicalin	NOUN
dti-2707	771	20	in	in	ADP
dti-2707	771	21	rat	rat	NOUN
dti-2707	771	22	plasma	plasma	NOUN
dti-2707	771	23	and	and	CCONJ
dti-2707	771	24	its	its	PRON
dti-2707	771	25	application	application	NOUN
dti-2707	771	26	in	in	ADP
dti-2707	771	27	a	a	DET
dti-2707	771	28	pharmacokinetic	pharmacokinetic	ADJ
dti-2707	771	29	study	study	NOUN
dti-2707	771	30	.	.	PUNCT
dti-2707	772	1	bioanalysis	bioanalysis	NOUN
dti-2707	772	2	.	.	PUNCT
dti-2707	773	1	2012;4(10):1205	2012;4(10):1205	NUM
dti-2707	773	2	-	-	SYM
dti-2707	773	3	1213	1213	NUM
dti-2707	773	4	.	.	PUNCT
dti-2707	774	1	crossref	crossref	PROPN
dti-2707	774	2	pubmed	pubmed	PROPN
dti-2707	774	3	76	76	NUM
dti-2707	774	4	.	.	PUNCT
dti-2707	775	1	xin	xin	PROPN
dti-2707	775	2	l	l	PROPN
dti-2707	775	3	,	,	PUNCT
dti-2707	775	4	gao	gao	PROPN
dti-2707	775	5	j	j	PROPN
dti-2707	775	6	,	,	PUNCT
dti-2707	775	7	lin	lin	PROPN
dti-2707	775	8	h	h	PROPN
dti-2707	775	9	,	,	PUNCT
dti-2707	775	10	qu	qu	PROPN
dti-2707	775	11	y	y	PROPN
dti-2707	775	12	,	,	PUNCT
dti-2707	775	13	shang	shang	PROPN
dti-2707	775	14	c	c	PROPN
dti-2707	775	15	,	,	PUNCT
dti-2707	775	16	wang	wang	PROPN
dti-2707	775	17	y	y	PROPN
dti-2707	775	18	,	,	PUNCT
dti-2707	775	19	lu	lu	PROPN
dti-2707	775	20	y	y	PROPN
dti-2707	775	21	,	,	PUNCT
dti-2707	775	22	cui	cui	NOUN
dti-2707	775	23	x.	x.	NOUN
dti-2707	775	24	regulatory	regulatory	ADJ
dti-2707	775	25	mechanisms	mechanism	NOUN
dti-2707	775	26	of	of	ADP
dti-2707	775	27	baicalin	baicalin	NOUN
dti-2707	775	28	in	in	ADP
dti-2707	775	29	cardiovascular	cardiovascular	ADJ
dti-2707	775	30	diseases	disease	NOUN
dti-2707	775	31	:	:	PUNCT
dti-2707	775	32	a	a	DET
dti-2707	775	33	review	review	NOUN
dti-2707	775	34	.	.	PUNCT
dti-2707	776	1	frontiers	frontier	NOUN
dti-2707	776	2	in	in	ADP
dti-2707	776	3	pharmacology	pharmacology	NOUN
dti-2707	776	4	.	.	PUNCT
dti-2707	777	1	2020	2020	NUM
dti-2707	777	2	;	;	PUNCT
dti-2707	778	1	2;11:583200	2;11:583200	NUM
dti-2707	778	2	.	.	PUNCT
dti-2707	779	1	crossref	crossref	PROPN
dti-2707	779	2	77	77	NUM
dti-2707	779	3	.	.	PUNCT
dti-2707	780	1	wencker	wencker	PROPN
dti-2707	780	2	d	d	PROPN
dti-2707	780	3	,	,	PUNCT
dti-2707	780	4	chandra	chandra	PROPN
dti-2707	780	5	m	m	PROPN
dti-2707	780	6	,	,	PUNCT
dti-2707	780	7	nguyen	nguyen	PROPN
dti-2707	780	8	k	k	PROPN
dti-2707	780	9	,	,	PUNCT
dti-2707	780	10	et	et	PROPN
dti-2707	780	11	al	al	PROPN
dti-2707	780	12	.	.	PUNCT
dti-2707	781	1	a	a	DET
dti-2707	781	2	mechanistic	mechanistic	ADJ
dti-2707	781	3	role	role	NOUN
dti-2707	781	4	for	for	ADP
dti-2707	781	5	cardiac	cardiac	ADJ
dti-2707	781	6	myocyte	myocyte	NOUN
dti-2707	781	7	apoptosis	apoptosis	NOUN
dti-2707	781	8	in	in	ADP
dti-2707	781	9	heart	heart	NOUN
dti-2707	781	10	failure	failure	NOUN
dti-2707	781	11	.	.	PUNCT
dti-2707	782	1	j	j	PROPN
dti-2707	782	2	clin	clin	PROPN
dti-2707	782	3	invest	invest	PROPN
dti-2707	782	4	.	.	PUNCT
dti-2707	783	1	2003;111(10):1497	2003;111(10):1497	NUM
dti-2707	783	2	-	-	SYM
dti-2707	783	3	1504	1504	NUM
dti-2707	783	4	.	.	PUNCT
dti-2707	784	1	crossref	crossref	PROPN
dti-2707	784	2	pubmed	pubmed	PROPN
dti-2707	784	3	78	78	NUM
dti-2707	784	4	.	.	PUNCT
dti-2707	785	1	zhang	zhang	PROPN
dti-2707	785	2	k	k	PROPN
dti-2707	785	3	,	,	PUNCT
dti-2707	785	4	lu	lu	PROPN
dti-2707	785	5	j	j	PROPN
dti-2707	785	6	,	,	PUNCT
dti-2707	785	7	mori	mori	PROPN
dti-2707	785	8	t	t	PROPN
dti-2707	785	9	,	,	PUNCT
dti-2707	785	10	et	et	PROPN
dti-2707	785	11	al	al	PROPN
dti-2707	785	12	.	.	PROPN
dti-2707	785	13	baicalin	baicalin	PROPN
dti-2707	785	14	increases	increase	NOUN
dti-2707	785	15	vegf	vegf	NOUN
dti-2707	785	16	expression	expression	NOUN
dti-2707	785	17	and	and	CCONJ
dti-2707	785	18	angiogenesis	angiogenesis	NOUN
dti-2707	785	19	by	by	ADP
dti-2707	785	20	activating	activate	VERB
dti-2707	785	21	the	the	DET
dti-2707	785	22	err{α}/pgc-1{α	err{α}/pgc-1{α	NOUN
dti-2707	785	23	}	}	PUNCT
dti-2707	785	24	pathway	pathway	NOUN
dti-2707	785	25	.	.	PUNCT
dti-2707	786	1	cardiovasc	cardiovasc	PROPN
dti-2707	786	2	res	res	PROPN
dti-2707	786	3	.	.	PUNCT
dti-2707	787	1	2011;89(2):426	2011;89(2):426	NUM
dti-2707	787	2	-	-	SYM
dti-2707	787	3	435	435	NUM
dti-2707	787	4	.	.	PUNCT
dti-2707	788	1	crossref	crossref	PROPN
dti-2707	788	2	pubmed	pubmed	PROPN
dti-2707	788	3	79	79	NUM
dti-2707	788	4	.	.	PUNCT
dti-2707	789	1	pang	pang	PROPN
dti-2707	789	2	h	h	PROPN
dti-2707	789	3	,	,	PUNCT
dti-2707	789	4	wu	wu	PROPN
dti-2707	789	5	t	t	PROPN
dti-2707	789	6	,	,	PUNCT
dti-2707	789	7	peng	peng	PROPN
dti-2707	789	8	z	z	PROPN
dti-2707	789	9	,	,	PUNCT
dti-2707	789	10	tan	tan	PROPN
dti-2707	789	11	q	q	PROPN
dti-2707	789	12	,	,	PUNCT
dti-2707	789	13	peng	peng	PROPN
dti-2707	789	14	x	x	PROPN
dti-2707	789	15	,	,	PUNCT
dti-2707	789	16	zhan	zhan	PROPN
dti-2707	789	17	z	z	PROPN
dti-2707	789	18	,	,	PUNCT
dti-2707	789	19	song	song	PROPN
dti-2707	789	20	l	l	PROPN
dti-2707	789	21	,	,	PUNCT
dti-2707	789	22	wei	wei	PROPN
dti-2707	789	23	b.	b.	PROPN
dti-2707	789	24	baicalin	baicalin	PROPN
dti-2707	789	25	induces	induce	VERB
dti-2707	789	26	apoptosis	apoptosis	NOUN
dti-2707	789	27	and	and	CCONJ
dti-2707	789	28	autophagy	autophagy	NOUN
dti-2707	789	29	in	in	ADP
dti-2707	789	30	human	human	ADJ
dti-2707	789	31	osteosarcoma	osteosarcoma	ADJ
dti-2707	789	32	cells	cell	NOUN
dti-2707	789	33	by	by	ADP
dti-2707	789	34	increasing	increase	VERB
dti-2707	789	35	ros	ro	NOUN
dti-2707	789	36	to	to	PART
dti-2707	789	37	inhibit	inhibit	VERB
dti-2707	789	38	pi3k	pi3k	PROPN
dti-2707	789	39	/	/	SYM
dti-2707	789	40	akt	akt	PROPN
dti-2707	789	41	/	/	SYM
dti-2707	789	42	mtor	mtor	PROPN
dti-2707	789	43	,	,	PUNCT
dti-2707	789	44	erk1/2	erk1/2	PROPN
dti-2707	789	45	and	and	CCONJ
dti-2707	789	46	β	β	NOUN
dti-2707	789	47	-	-	ADJ
dti-2707	789	48	catenin	catenin	ADJ
dti-2707	789	49	signaling	signal	VERB
dti-2707	789	50	pathways	pathway	NOUN
dti-2707	789	51	.	.	PUNCT
dti-2707	790	1	journal	journal	NOUN
dti-2707	790	2	of	of	ADP
dti-2707	790	3	bone	bone	NOUN
dti-2707	790	4	oncology	oncology	NOUN
dti-2707	790	5	.	.	PUNCT
dti-2707	791	1	2022	2022	NUM
dti-2707	791	2	;	;	PUNCT
dti-2707	792	1	1;33:100415	1;33:100415	NUM
dti-2707	792	2	.	.	PUNCT
dti-2707	793	1	crossref	crossref	PROPN
dti-2707	793	2	pubmed	pubmed	PROPN
dti-2707	793	3	80	80	NUM
dti-2707	793	4	.	.	PUNCT
dti-2707	794	1	sung	sung	PROPN
dti-2707	794	2	jj	jj	PROPN
dti-2707	794	3	,	,	PUNCT
dti-2707	794	4	kuipers	kuipers	PROPN
dti-2707	794	5	ej	ej	PROPN
dti-2707	794	6	,	,	PUNCT
dti-2707	794	7	el	el	PROPN
dti-2707	794	8	-	-	PUNCT
dti-2707	794	9	serag	serag	PROPN
dti-2707	794	10	hb	hb	PROPN
dti-2707	794	11	.	.	PUNCT
dti-2707	795	1	systematic	systematic	PROPN
dti-2707	795	2	review	review	PROPN
dti-2707	795	3	:	:	PUNCT
dti-2707	795	4	the	the	DET
dti-2707	795	5	global	global	ADJ
dti-2707	795	6	incidence	incidence	NOUN
dti-2707	795	7	and	and	CCONJ
dti-2707	795	8	prevalence	prevalence	NOUN
dti-2707	795	9	of	of	ADP
dti-2707	795	10	peptic	peptic	ADJ
dti-2707	795	11	ulcer	ulcer	NOUN
dti-2707	795	12	disease	disease	NOUN
dti-2707	795	13	.	.	PUNCT
dti-2707	796	1	aliment	aliment	NOUN
dti-2707	796	2	pharmacol	pharmacol	VERB
dti-2707	796	3	ther	ther	ADV
dti-2707	796	4	.	.	PUNCT
dti-2707	797	1	2009;29(9):938	2009;29(9):938	NUM
dti-2707	797	2	-	-	PUNCT
dti-2707	797	3	946	946	NUM
dti-2707	797	4	.	.	PUNCT
dti-2707	798	1	crossref	crossref	PROPN
dti-2707	798	2	pubmed	pubmed	PROPN
dti-2707	798	3	81	81	NUM
dti-2707	798	4	.	.	PUNCT
dti-2707	799	1	cheng	cheng	PROPN
dti-2707	799	2	hc	hc	PROPN
dti-2707	799	3	,	,	PUNCT
dti-2707	799	4	gleason	gleason	PROPN
dti-2707	799	5	em	em	PRON
dti-2707	799	6	,	,	PUNCT
dti-2707	799	7	nathan	nathan	PROPN
dti-2707	799	8	ba	ba	PROPN
dti-2707	799	9	,	,	PUNCT
dti-2707	799	10	lachmann	lachmann	PROPN
dti-2707	799	11	pj	pj	PROPN
dti-2707	799	12	,	,	PUNCT
dti-2707	799	13	woodward	woodward	PROPN
dti-2707	799	14	jk	jk	PROPN
dti-2707	799	15	.	.	PUNCT
dti-2707	800	1	effects	effect	NOUN
dti-2707	800	2	of	of	ADP
dti-2707	800	3	clonidine	clonidine	NOUN
dti-2707	800	4	on	on	ADP
dti-2707	800	5	gastric	gastric	ADJ
dti-2707	800	6	acid	acid	NOUN
dti-2707	800	7	secretion	secretion	NOUN
dti-2707	800	8	in	in	ADP
dti-2707	800	9	the	the	DET
dti-2707	800	10	rat	rat	NOUN
dti-2707	800	11	.	.	PUNCT
dti-2707	801	1	j	j	PROPN
dti-2707	801	2	pharmacol	pharmacol	PROPN
dti-2707	801	3	exp	exp	NOUN
dti-2707	801	4	ther	ther	ADV
dti-2707	801	5	.	.	PUNCT
dti-2707	802	1	1981;217(1):121	1981;217(1):121	NUM
dti-2707	802	2	-	-	SYM
dti-2707	802	3	126	126	NUM
dti-2707	802	4	.	.	PUNCT
dti-2707	803	1	pubmed	pubmed	PROPN
dti-2707	803	2	82	82	NUM
dti-2707	803	3	.	.	PUNCT
dti-2707	804	1	dijoseph	dijoseph	PROPN
dti-2707	804	2	jf	jf	PROPN
dti-2707	804	3	,	,	PUNCT
dti-2707	804	4	eash	eash	VERB
dti-2707	804	5	jr	jr	PROPN
dti-2707	804	6	,	,	PUNCT
dti-2707	804	7	mir	mir	PROPN
dti-2707	804	8	gn	gn	PROPN
dti-2707	804	9	.	.	PROPN
dti-2707	804	10	gastric	gastric	ADJ
dti-2707	804	11	antisecretory	antisecretory	NOUN
dti-2707	804	12	and	and	CCONJ
dti-2707	804	13	antiulcer	antiulcer	NOUN
dti-2707	804	14	effects	effect	NOUN
dti-2707	804	15	of	of	ADP
dti-2707	804	16	whr1582a	whr1582a	PROPN
dti-2707	804	17	,	,	PUNCT
dti-2707	804	18	a	a	DET
dti-2707	804	19	compound	compound	NOUN
dti-2707	804	20	exerting	exert	VERB
dti-2707	804	21	alpha-2	alpha-2	NUM
dti-2707	804	22	adrenoceptor	adrenoceptor	NOUN
dti-2707	804	23	agonist	agonist	NOUN
dti-2707	804	24	activity	activity	NOUN
dti-2707	804	25	.	.	PUNCT
dti-2707	805	1	j	j	PROPN
dti-2707	805	2	pharmacol	pharmacol	PROPN
dti-2707	805	3	exp	exp	NOUN
dti-2707	805	4	ther	ther	ADV
dti-2707	805	5	.	.	PUNCT
dti-2707	806	1	1987;241(1	1987;241(1	NUM
dti-2707	806	2	):	):	PUNCT
dti-2707	806	3	97	97	NUM
dti-2707	806	4	-	-	SYM
dti-2707	806	5	102	102	NUM
dti-2707	806	6	.	.	PUNCT
dti-2707	807	1	pubmed	pubmed	PROPN
dti-2707	807	2	83	83	NUM
dti-2707	807	3	.	.	PUNCT
dti-2707	808	1	ribeiro	ribeiro	PROPN
dti-2707	808	2	ars	ars	PROPN
dti-2707	808	3	,	,	PUNCT
dti-2707	808	4	do	do	VERB
dti-2707	808	5	nascimento	nascimento	PROPN
dti-2707	808	6	valença	valença	PROPN
dti-2707	808	7	jd	jd	PROPN
dti-2707	808	8	,	,	PUNCT
dti-2707	808	9	da	da	PROPN
dti-2707	808	10	silva	silva	PROPN
dti-2707	808	11	santos	santos	PROPN
dti-2707	808	12	j	j	PROPN
dti-2707	808	13	,	,	PUNCT
dti-2707	808	14	et	et	PROPN
dti-2707	808	15	al	al	PROPN
dti-2707	808	16	.	.	PUNCT
dti-2707	809	1	the	the	DET
dti-2707	809	2	effects	effect	NOUN
dti-2707	809	3	of	of	ADP
dti-2707	809	4	baicalein	baicalein	NOUN
dti-2707	809	5	on	on	ADP
dti-2707	809	6	gastric	gastric	ADJ
dti-2707	809	7	mucosal	mucosal	NOUN
dti-2707	809	8	ulcerations	ulceration	NOUN
dti-2707	809	9	in	in	ADP
dti-2707	809	10	mice	mouse	NOUN
dti-2707	809	11	:	:	PUNCT
dti-2707	809	12	protective	protective	ADJ
dti-2707	809	13	pathways	pathway	NOUN
dti-2707	809	14	and	and	CCONJ
dti-2707	809	15	anti	anti	ADJ
dti-2707	809	16	-	-	ADJ
dti-2707	809	17	secretory	secretory	ADJ
dti-2707	809	18	mechanisms	mechanism	NOUN
dti-2707	809	19	.	.	PUNCT
dti-2707	810	1	chem	chem	NOUN
dti-2707	810	2	biol	biol	PROPN
dti-2707	810	3	interact	interact	VERB
dti-2707	810	4	.	.	PUNCT
dti-2707	811	1	2016;260:33	2016;260:33	NUM
dti-2707	811	2	-	-	SYM
dti-2707	811	3	41	41	NUM
dti-2707	811	4	.	.	PUNCT
dti-2707	812	1	crossref	crossref	PROPN
dti-2707	812	2	pubmed	pubmed	PROPN
dti-2707	812	3	84	84	NUM
dti-2707	812	4	.	.	PUNCT
dti-2707	813	1	yang	yang	PROPN
dti-2707	813	2	h	h	PROPN
dti-2707	813	3	,	,	PUNCT
dti-2707	813	4	lu	lu	PROPN
dti-2707	813	5	y	y	PROPN
dti-2707	813	6	,	,	PUNCT
dti-2707	813	7	zeng	zeng	PROPN
dti-2707	813	8	xf	xf	PROPN
dti-2707	813	9	,	,	PUNCT
dti-2707	813	10	et	et	PROPN
dti-2707	813	11	al	al	PROPN
dti-2707	813	12	.	.	PROPN
dti-2707	813	13	antichronic	antichronic	ADJ
dti-2707	813	14	gastric	gastric	ADJ
dti-2707	813	15	ulcer	ulcer	NOUN
dti-2707	813	16	effect	effect	NOUN
dti-2707	813	17	of	of	ADP
dti-2707	813	18	zinc	zinc	NOUN
dti-2707	813	19	-	-	PUNCT
dti-2707	813	20	baicalin	baicalin	NOUN
dti-2707	813	21	complex	complex	NOUN
dti-2707	813	22	on	on	ADP
dti-2707	813	23	the	the	DET
dti-2707	813	24	acetic	acetic	ADJ
dti-2707	813	25	acid	acid	NOUN
dti-2707	813	26	-	-	PUNCT
dti-2707	813	27	induced	induce	VERB
dti-2707	813	28	chronic	chronic	ADJ
dti-2707	813	29	gastric	gastric	ADJ
dti-2707	813	30	ulcer	ulcer	NOUN
dti-2707	813	31	rat	rat	NOUN
dti-2707	813	32	model	model	NOUN
dti-2707	813	33	.	.	PUNCT
dti-2707	814	1	gastroenterol	gastroenterol	NOUN
dti-2707	814	2	res	re	NOUN
dti-2707	814	3	pract	pract	NOUN
dti-2707	814	4	.	.	PUNCT
dti-2707	815	1	2018;2018:1275486	2018;2018:1275486	NUM
dti-2707	815	2	.	.	PUNCT
dti-2707	816	1	crossref	crossref	PROPN
dti-2707	816	2	pubmed	pubmed	PROPN
dti-2707	816	3	85	85	NUM
dti-2707	816	4	.	.	PUNCT
dti-2707	817	1	riazi	riazi	PROPN
dti-2707	817	2	k	k	PROPN
dti-2707	817	3	,	,	PUNCT
dti-2707	817	4	azhari	azhari	PROPN
dti-2707	817	5	h	h	NOUN
dti-2707	817	6	,	,	PUNCT
dti-2707	817	7	charette	charette	PROPN
dti-2707	817	8	jh	jh	PROPN
dti-2707	817	9	,	,	PUNCT
dti-2707	817	10	et	et	PROPN
dti-2707	817	11	al	al	PROPN
dti-2707	817	12	.	.	PUNCT
dti-2707	818	1	the	the	DET
dti-2707	818	2	prevalence	prevalence	NOUN
dti-2707	818	3	and	and	CCONJ
dti-2707	818	4	incidence	incidence	NOUN
dti-2707	818	5	of	of	ADP
dti-2707	818	6	nafld	nafld	ADJ
dti-2707	818	7	worldwide	worldwide	ADV
dti-2707	818	8	:	:	PUNCT
dti-2707	818	9	a	a	DET
dti-2707	818	10	systematic	systematic	ADJ
dti-2707	818	11	review	review	NOUN
dti-2707	818	12	and	and	CCONJ
dti-2707	818	13	metaanalysis	metaanalysis	NOUN
dti-2707	818	14	.	.	PUNCT
dti-2707	819	1	lancet	lancet	NOUN
dti-2707	819	2	gastroenterol	gastroenterol	NOUN
dti-2707	819	3	hepatol	hepatol	ADJ
dti-2707	819	4	.	.	PUNCT
dti-2707	820	1	2022;7(9):851	2022;7(9):851	X
dti-2707	820	2	-	-	SYM
dti-2707	820	3	861	861	NUM
dti-2707	820	4	.	.	PUNCT
dti-2707	821	1	crossref	crossref	PROPN
dti-2707	821	2	pubmed	pubmed	PROPN
dti-2707	821	3	86	86	NUM
dti-2707	821	4	.	.	PUNCT
dti-2707	822	1	huh	huh	INTJ
dti-2707	823	1	y	y	PROPN
dti-2707	823	2	,	,	PUNCT
dti-2707	823	3	cho	cho	PROPN
dti-2707	823	4	yj	yj	PROPN
dti-2707	823	5	,	,	PUNCT
dti-2707	823	6	nam	nam	PROPN
dti-2707	823	7	ge	ge	PROPN
dti-2707	823	8	.	.	PUNCT
dti-2707	824	1	recent	recent	ADJ
dti-2707	824	2	epidemiology	epidemiology	NOUN
dti-2707	824	3	and	and	CCONJ
dti-2707	824	4	risk	risk	NOUN
dti-2707	824	5	factors	factor	NOUN
dti-2707	824	6	of	of	ADP
dti-2707	824	7	nonalcoholic	nonalcoholic	ADJ
dti-2707	824	8	fatty	fatty	NOUN
dti-2707	824	9	liver	liver	NOUN
dti-2707	824	10	disease	disease	NOUN
dti-2707	824	11	.	.	PUNCT
dti-2707	825	1	j	j	PROPN
dti-2707	825	2	obes	obes	PROPN
dti-2707	825	3	metab	metab	NOUN
dti-2707	825	4	syndr	syndr	NOUN
dti-2707	825	5	.	.	PUNCT
dti-2707	826	1	2022;31(1):17	2022;31(1):17	NUM
dti-2707	826	2	-	-	SYM
dti-2707	826	3	27	27	NUM
dti-2707	826	4	.	.	PUNCT
dti-2707	827	1	crossref	crossref	PROPN
dti-2707	827	2	pubmed	pubmed	PROPN
dti-2707	827	3	87	87	NUM
dti-2707	827	4	.	.	PUNCT
dti-2707	828	1	maurice	maurice	PROPN
dti-2707	828	2	j	j	PROPN
dti-2707	828	3	,	,	PUNCT
dti-2707	828	4	manousou	manousou	PROPN
dti-2707	828	5	p.	p.	PROPN
dti-2707	828	6	non	non	ADJ
dti-2707	828	7	-	-	ADJ
dti-2707	828	8	alcoholic	alcoholic	ADJ
dti-2707	828	9	fatty	fatty	NOUN
dti-2707	828	10	liver	liver	NOUN
dti-2707	828	11	disease	disease	NOUN
dti-2707	828	12	.	.	PUNCT
dti-2707	829	1	clin	clin	PROPN
dti-2707	829	2	med	med	PROPN
dti-2707	829	3	(	(	PUNCT
dti-2707	829	4	lond	lond	PROPN
dti-2707	829	5	)	)	PUNCT
dti-2707	829	6	.	.	PUNCT
dti-2707	830	1	2018;18(3):245	2018;18(3):245	NUM
dti-2707	830	2	-	-	PUNCT
dti-2707	830	3	250	250	NUM
dti-2707	830	4	.	.	PUNCT
dti-2707	831	1	crossref	crossref	PROPN
dti-2707	831	2	pubmed	pubmed	PROPN
dti-2707	831	3	88	88	NUM
dti-2707	831	4	.	.	PUNCT
dti-2707	832	1	yang	yang	PROPN
dti-2707	832	2	jy	jy	PROPN
dti-2707	832	3	,	,	PUNCT
dti-2707	832	4	li	li	PROPN
dti-2707	832	5	m	m	PROPN
dti-2707	832	6	,	,	PUNCT
dti-2707	832	7	zhang	zhang	PROPN
dti-2707	832	8	cl	cl	PROPN
dti-2707	832	9	,	,	PUNCT
dti-2707	832	10	liu	liu	PROPN
dti-2707	832	11	d.	d.	PROPN
dti-2707	832	12	pharmacological	pharmacological	NOUN
dti-2707	832	13	properties	property	NOUN
dti-2707	832	14	of	of	ADP
dti-2707	832	15	baicalin	baicalin	NOUN
dti-2707	832	16	on	on	ADP
dti-2707	832	17	liver	liver	NOUN
dti-2707	832	18	diseases	disease	NOUN
dti-2707	832	19	:	:	PUNCT
dti-2707	832	20	a	a	DET
dti-2707	832	21	narrative	narrative	NOUN
dti-2707	832	22	review	review	NOUN
dti-2707	832	23	.	.	PUNCT
dti-2707	833	1	pharmacol	pharmacol	PROPN
dti-2707	833	2	rep	rep	PROPN
dti-2707	833	3	.	.	PROPN
dti-2707	833	4	2021;73(5):1230	2021;73(5):1230	NUM
dti-2707	833	5	-	-	SYM
dti-2707	833	6	1239	1239	NUM
dti-2707	833	7	.	.	PUNCT
dti-2707	834	1	crossref	crossref	PROPN
dti-2707	834	2	pubmed	pubmed	PROPN
dti-2707	834	3	89	89	PROPN
dti-2707	834	4	.	.	PUNCT
dti-2707	835	1	ma	ma	PROPN
dti-2707	835	2	y	y	PROPN
dti-2707	835	3	,	,	PUNCT
dti-2707	835	4	yang	yang	PROPN
dti-2707	835	5	f	f	PROPN
dti-2707	835	6	,	,	PUNCT
dti-2707	835	7	wang	wang	PROPN
dti-2707	835	8	y	y	PROPN
dti-2707	835	9	,	,	PUNCT
dti-2707	835	10	et	et	PROPN
dti-2707	835	11	al	al	PROPN
dti-2707	835	12	.	.	PROPN
dti-2707	835	13	camkkβ	camkkβ	PROPN
dti-2707	835	14	is	be	AUX
dti-2707	835	15	involved	involve	VERB
dti-2707	835	16	in	in	ADP
dti-2707	835	17	ampactivated	ampactivate	VERB
dti-2707	835	18	protein	protein	NOUN
dti-2707	835	19	kinase	kinase	NOUN
dti-2707	835	20	activation	activation	NOUN
dti-2707	835	21	by	by	ADP
dti-2707	835	22	baicalin	baicalin	NOUN
dti-2707	835	23	in	in	ADP
dti-2707	835	24	lkb1	lkb1	PROPN
dti-2707	835	25	deficient	deficient	ADJ
dti-2707	835	26	cell	cell	NOUN
dti-2707	835	27	lines	line	NOUN
dti-2707	835	28	.	.	PUNCT
dti-2707	836	1	plos	plos	PROPN
dti-2707	836	2	one	one	NUM
dti-2707	836	3	.	.	PUNCT
dti-2707	837	1	2012;7(10):e47900	2012;7(10):e47900	NUM
dti-2707	837	2	.	.	PUNCT
dti-2707	838	1	crossref	crossref	PROPN
dti-2707	838	2	pubmed	pubmed	PROPN
dti-2707	838	3	90	90	NUM
dti-2707	838	4	.	.	PUNCT
dti-2707	839	1	guo	guo	PROPN
dti-2707	839	2	hx	hx	PROPN
dti-2707	839	3	,	,	PUNCT
dti-2707	839	4	liu	liu	PROPN
dti-2707	839	5	dh	dh	PROPN
dti-2707	839	6	,	,	PUNCT
dti-2707	839	7	ma	ma	PROPN
dti-2707	839	8	y	y	PROPN
dti-2707	839	9	,	,	PUNCT
dti-2707	839	10	et	et	PROPN
dti-2707	839	11	al	al	PROPN
dti-2707	839	12	.	.	PUNCT
dti-2707	840	1	long	long	ADJ
dti-2707	840	2	-	-	PUNCT
dti-2707	840	3	term	term	NOUN
dti-2707	840	4	baicalin	baicalin	NOUN
dti-2707	840	5	administration	administration	NOUN
dti-2707	840	6	ameliorates	ameliorate	VERB
dti-2707	840	7	metabolic	metabolic	NOUN
dti-2707	840	8	disorders	disorder	NOUN
dti-2707	840	9	and	and	CCONJ
dti-2707	840	10	hepatic	hepatic	ADJ
dti-2707	840	11	steatosis	steatosis	NOUN
dti-2707	840	12	in	in	ADP
dti-2707	840	13	rats	rat	NOUN
dti-2707	840	14	given	give	VERB
dti-2707	840	15	a	a	DET
dti-2707	840	16	high	high	ADJ
dti-2707	840	17	-	-	PUNCT
dti-2707	840	18	fat	fat	NOUN
dti-2707	840	19	diet	diet	NOUN
dti-2707	840	20	.	.	PUNCT
dti-2707	841	1	acta	acta	PROPN
dti-2707	841	2	pharmacol	pharmacol	PROPN
dti-2707	841	3	sin	sin	NOUN
dti-2707	841	4	.	.	PUNCT
dti-2707	842	1	2009;30(11):15051512	2009;30(11):15051512	X
dti-2707	842	2	.	.	PUNCT
dti-2707	843	1	crossref	crossref	PROPN
dti-2707	843	2	pubmed	pubmed	PROPN
dti-2707	843	3	91	91	NUM
dti-2707	843	4	.	.	PUNCT
dti-2707	844	1	zhong	zhong	PROPN
dti-2707	844	2	x	x	PROPN
dti-2707	844	3	,	,	PUNCT
dti-2707	844	4	liu	liu	PROPN
dti-2707	844	5	h.	h.	PROPN
dti-2707	844	6	baicalin	baicalin	PROPN
dti-2707	844	7	attenuates	attenuate	NOUN
dti-2707	844	8	diet	diet	NOUN
dti-2707	844	9	induced	induce	VERB
dti-2707	844	10	nonalcoholic	nonalcoholic	NOUN
dti-2707	844	11	steatohepatitis	steatohepatitis	NOUN
dti-2707	844	12	by	by	ADP
dti-2707	844	13	inhibiting	inhibit	VERB
dti-2707	844	14	inflammation	inflammation	NOUN
dti-2707	844	15	and	and	CCONJ
dti-2707	844	16	oxidative	oxidative	ADJ
dti-2707	844	17	stress	stress	NOUN
dti-2707	844	18	via	via	ADP
dti-2707	844	19	suppressing	suppress	VERB
dti-2707	844	20	jnk	jnk	NOUN
dti-2707	844	21	signaling	signal	VERB
dti-2707	844	22	pathways	pathway	NOUN
dti-2707	844	23	.	.	PUNCT
dti-2707	845	1	biomed	biome	VERB
dti-2707	845	2	pharmacother	pharmacother	ADJ
dti-2707	845	3	.	.	PUNCT
dti-2707	846	1	2018;98:111	2018;98:111	PROPN
dti-2707	846	2	-	-	SYM
dti-2707	846	3	117	117	NUM
dti-2707	846	4	.	.	PUNCT
dti-2707	847	1	crossref	crossref	PROPN
dti-2707	847	2	pubmed	pubmed	PROPN
dti-2707	847	3	92	92	NUM
dti-2707	847	4	.	.	PUNCT
dti-2707	848	1	wu	wu	PROPN
dti-2707	848	2	t	t	PROPN
dti-2707	848	3	,	,	PUNCT
dti-2707	848	4	liu	liu	PROPN
dti-2707	848	5	t	t	PROPN
dti-2707	848	6	,	,	PUNCT
dti-2707	848	7	xing	xing	PROPN
dti-2707	848	8	l	l	PROPN
dti-2707	848	9	,	,	PUNCT
dti-2707	848	10	ji	ji	PROPN
dti-2707	848	11	g.	g.	PROPN
dti-2707	848	12	baicalin	baicalin	PROPN
dti-2707	848	13	and	and	CCONJ
dti-2707	848	14	puerarin	puerarin	NOUN
dti-2707	848	15	reverse	reverse	ADJ
dti-2707	848	16	epithelial	epithelial	ADJ
dti-2707	848	17	-	-	PUNCT
dti-2707	848	18	mesenchymal	mesenchymal	ADJ
dti-2707	848	19	transition	transition	NOUN
dti-2707	848	20	via	via	ADP
dti-2707	848	21	the	the	DET
dti-2707	848	22	tgf	tgf	PROPN
dti-2707	848	23	-	-	PUNCT
dti-2707	848	24	β1	β1	PROPN
dti-2707	848	25	/	/	SYM
dti-2707	848	26	smad3	smad3	NOUN
dti-2707	848	27	pathway	pathway	NOUN
dti-2707	848	28	in	in	ADP
dti-2707	848	29	vitro	vitro	X
dti-2707	848	30	.	.	PUNCT
dti-2707	849	1	exp	exp	NOUN
dti-2707	849	2	ther	ther	PROPN
dti-2707	849	3	med	me	VERB
dti-2707	849	4	.	.	PUNCT
dti-2707	850	1	2018;16(3):1968	2018;16(3):1968	NUM
dti-2707	850	2	-	-	SYM
dti-2707	850	3	1974	1974	NUM
dti-2707	850	4	.	.	PUNCT
dti-2707	851	1	crossref	crossref	PROPN
dti-2707	851	2	pubmed	pubmed	PROPN
dti-2707	851	3	93	93	NUM
dti-2707	851	4	.	.	PUNCT
dti-2707	852	1	fang	fang	PROPN
dti-2707	852	2	p	p	PROPN
dti-2707	852	3	,	,	PUNCT
dti-2707	852	4	sun	sun	PROPN
dti-2707	852	5	y	y	PROPN
dti-2707	852	6	,	,	PUNCT
dti-2707	852	7	gu	gu	NOUN
dti-2707	852	8	x	x	PROPN
dti-2707	852	9	,	,	PUNCT
dti-2707	852	10	et	et	PROPN
dti-2707	852	11	al	al	PROPN
dti-2707	852	12	.	.	PROPN
dti-2707	852	13	baicalin	baicalin	PROPN
dti-2707	852	14	ameliorates	ameliorate	VERB
dti-2707	852	15	hepatic	hepatic	ADJ
dti-2707	852	16	insulin	insulin	NOUN
dti-2707	852	17	resistance	resistance	NOUN
dti-2707	852	18	and	and	CCONJ
dti-2707	852	19	gluconeogenic	gluconeogenic	ADJ
dti-2707	852	20	activity	activity	NOUN
dti-2707	852	21	through	through	ADP
dti-2707	852	22	inhibition	inhibition	NOUN
dti-2707	852	23	of	of	ADP
dti-2707	852	24	p38	p38	NOUN
dti-2707	852	25	mapk	mapk	NOUN
dti-2707	852	26	/	/	SYM
dti-2707	852	27	pgc-1α	pgc-1α	NOUN
dti-2707	852	28	pathway	pathway	NOUN
dti-2707	852	29	.	.	PUNCT
dti-2707	853	1	phytomedicine	phytomedicine	NOUN
dti-2707	853	2	.	.	PUNCT
dti-2707	854	1	2019;64:153074	2019;64:153074	NUM
dti-2707	854	2	.	.	PUNCT
dti-2707	855	1	crossref	crossref	PROPN
dti-2707	855	2	pubmed	pubmed	PROPN
dti-2707	855	3	94	94	PROPN
dti-2707	855	4	.	.	PUNCT
dti-2707	856	1	lv	lv	PROPN
dti-2707	856	2	jc	jc	PROPN
dti-2707	856	3	,	,	PUNCT
dti-2707	856	4	zhang	zhang	PROPN
dti-2707	856	5	lx	lx	PROPN
dti-2707	856	6	.	.	PUNCT
dti-2707	857	1	prevalence	prevalence	NOUN
dti-2707	857	2	and	and	CCONJ
dti-2707	857	3	disease	disease	NOUN
dti-2707	857	4	burden	burden	NOUN
dti-2707	857	5	of	of	ADP
dti-2707	857	6	chronic	chronic	ADJ
dti-2707	857	7	kidney	kidney	NOUN
dti-2707	857	8	disease	disease	NOUN
dti-2707	857	9	.	.	PUNCT
dti-2707	858	1	adv	adv	PROPN
dti-2707	858	2	exp	exp	NOUN
dti-2707	858	3	med	med	ADJ
dti-2707	858	4	biol	biol	NOUN
dti-2707	858	5	.	.	PUNCT
dti-2707	859	1	2019;1165:3	2019;1165:3	NUM
dti-2707	859	2	-	-	SYM
dti-2707	859	3	15	15	NUM
dti-2707	859	4	.	.	PUNCT
dti-2707	860	1	crossref	crossref	PROPN
dti-2707	860	2	pubmed	pubmed	PROPN
dti-2707	860	3	95	95	PROPN
dti-2707	860	4	.	.	PUNCT
dti-2707	861	1	basile	basile	PROPN
dti-2707	861	2	dp	dp	PROPN
dti-2707	861	3	,	,	PUNCT
dti-2707	861	4	anderson	anderson	PROPN
dti-2707	861	5	md	md	PROPN
dti-2707	861	6	,	,	PUNCT
dti-2707	861	7	sutton	sutton	PROPN
dti-2707	861	8	ta	ta	PROPN
dti-2707	861	9	.	.	PUNCT
dti-2707	862	1	pathophysiology	pathophysiology	PROPN
dti-2707	862	2	of	of	ADP
dti-2707	862	3	acute	acute	PROPN
dti-2707	862	4	kidney	kidney	NOUN
dti-2707	862	5	injury	injury	NOUN
dti-2707	862	6	.	.	PUNCT
dti-2707	863	1	compr	compr	PROPN
dti-2707	863	2	physiol	physiol	PROPN
dti-2707	863	3	.	.	PUNCT
dti-2707	864	1	2012;2(2):1303	2012;2(2):1303	NUM
dti-2707	864	2	-	-	SYM
dti-2707	864	3	1353	1353	NUM
dti-2707	864	4	.	.	PUNCT
dti-2707	865	1	crossref	crossref	PROPN
dti-2707	865	2	pubmed	pubmed	PROPN
dti-2707	865	3	96	96	PROPN
dti-2707	865	4	.	.	PUNCT
dti-2707	866	1	gauttam	gauttam	PROPN
dti-2707	866	2	v	v	PROPN
dti-2707	866	3	,	,	PUNCT
dti-2707	866	4	munjal	munjal	ADJ
dti-2707	866	5	k	k	NOUN
dti-2707	866	6	,	,	PUNCT
dti-2707	866	7	mujwar	mujwar	NOUN
dti-2707	866	8	s	s	PROPN
dti-2707	866	9	,	,	PUNCT
dti-2707	866	10	sawale	sawale	PROPN
dti-2707	866	11	j	j	PROPN
dti-2707	866	12	,	,	PUNCT
dti-2707	866	13	rohilla	rohilla	NOUN
dti-2707	866	14	m	m	PROPN
dti-2707	866	15	,	,	PUNCT
dti-2707	866	16	gupta	gupta	PROPN
dti-2707	866	17	s.	s.	PROPN
dti-2707	866	18	comparative	comparative	PROPN
dti-2707	866	19	study	study	NOUN
dti-2707	866	20	of	of	ADP
dti-2707	866	21	developed	develop	VERB
dti-2707	866	22	formulation	formulation	NOUN
dti-2707	866	23	and	and	CCONJ
dti-2707	866	24	market	market	NOUN
dti-2707	866	25	formulation	formulation	NOUN
dti-2707	866	26	for	for	ADP
dti-2707	866	27	antidiabetic	antidiabetic	ADJ
dti-2707	866	28	potential	potential	NOUN
dti-2707	866	29	in	in	ADP
dti-2707	866	30	alloxan	alloxan	NOUN
dti-2707	866	31	-	-	PUNCT
dti-2707	866	32	induced	induce	VERB
dti-2707	866	33	diabetic	diabetic	ADJ
dti-2707	866	34	wistar	wistar	PROPN
dti-2707	866	35	rats	rat	NOUN
dti-2707	866	36	.	.	PUNCT
dti-2707	867	1	j	j	PROPN
dti-2707	867	2	young	young	ADJ
dti-2707	867	3	pharm	pharm	NOUN
dti-2707	867	4	.	.	PUNCT
dti-2707	868	1	2022;14(4):387	2022;14(4):387	NUM
dti-2707	868	2	-	-	SYM
dti-2707	868	3	393	393	NUM
dti-2707	868	4	.	.	PUNCT
dti-2707	869	1	crossref	crossref	PROPN
dti-2707	869	2	97	97	NUM
dti-2707	869	3	.	.	PUNCT
dti-2707	870	1	ahad	ahad	PROPN
dti-2707	870	2	a	a	PROPN
dti-2707	870	3	,	,	PUNCT
dti-2707	870	4	mujeeb	mujeeb	PROPN
dti-2707	870	5	m	m	PROPN
dti-2707	870	6	,	,	PUNCT
dti-2707	870	7	ahsan	ahsan	PROPN
dti-2707	870	8	h	h	PROPN
dti-2707	870	9	,	,	PUNCT
dti-2707	870	10	siddiqui	siddiqui	PROPN
dti-2707	870	11	wa	wa	PROPN
dti-2707	870	12	.	.	PROPN
dti-2707	870	13	prophylactic	prophylactic	ADJ
dti-2707	870	14	effect	effect	NOUN
dti-2707	870	15	of	of	ADP
dti-2707	870	16	baicalein	baicalein	NOUN
dti-2707	870	17	against	against	ADP
dti-2707	870	18	renal	renal	ADJ
dti-2707	870	19	dysfunction	dysfunction	NOUN
dti-2707	870	20	in	in	ADP
dti-2707	870	21	type	type	NOUN
dti-2707	870	22	2	2	NUM
dti-2707	870	23	diabetic	diabetic	ADJ
dti-2707	870	24	rats	rat	NOUN
dti-2707	870	25	.	.	PUNCT
dti-2707	871	1	biochimie	biochimie	PROPN
dti-2707	871	2	.	.	PUNCT
dti-2707	872	1	2014;106:101	2014;106:101	NUM
dti-2707	872	2	-	-	SYM
dti-2707	872	3	110	110	NUM
dti-2707	872	4	.	.	PUNCT
dti-2707	873	1	crossref	crossref	PROPN
dti-2707	873	2	pubmed	pubmed	PROPN
dti-2707	873	3	https://doi.org/10.3390/ijerph18105243	https://doi.org/10.3390/ijerph18105243	PROPN
dti-2707	873	4	https://www.ncbi.nlm.nih.gov/pubmed/34069141	https://www.ncbi.nlm.nih.gov/pubmed/34069141	PROPN
dti-2707	873	5	https://doi.org/10.18632/aging.102371	https://doi.org/10.18632/aging.102371	PROPN
dti-2707	873	6	https://www.ncbi.nlm.nih.gov/pubmed/31692453	https://www.ncbi.nlm.nih.gov/pubmed/31692453	NUM
dti-2707	873	7	https://doi.org/10.1111/j.1752-699x.2010.00190.x	https://doi.org/10.1111/j.1752-699x.2010.00190.x	NOUN
dti-2707	873	8	https://www.ncbi.nlm.nih.gov/pubmed/20500603	https://www.ncbi.nlm.nih.gov/pubmed/20500603	NUM
dti-2707	873	9	https://doi.org/10.1136/pgmj.2006.052100	https://doi.org/10.1136/pgmj.2006.052100	PROPN
dti-2707	873	10	https://www.ncbi.nlm.nih.gov/pubmed/17403951	https://www.ncbi.nlm.nih.gov/pubmed/17403951	PROPN
dti-2707	873	11	https://doi.org/10.1038/s41598-022-05536-w	https://doi.org/10.1038/s41598-022-05536-w	PROPN
dti-2707	873	12	https://www.ncbi.nlm.nih.gov/pubmed/35091663	https://www.ncbi.nlm.nih.gov/pubmed/35091663	ADP
dti-2707	873	13	https://doi.org/10.1016/j.cpcardiol.2009.10.002	https://doi.org/10.1016/j.cpcardiol.2009.10.002	X
dti-2707	873	14	https://www.ncbi.nlm.nih.gov/pubmed/20109979	https://www.ncbi.nlm.nih.gov/pubmed/20109979	NUM
dti-2707	873	15	https://doi.org/10.4103/pm.pm_179_21	https://doi.org/10.4103/pm.pm_179_21	NOUN
dti-2707	873	16	https://doi.org/10.1007/s43440-021-00312-5	https://doi.org/10.1007/s43440-021-00312-5	NUM
dti-2707	873	17	https://www.ncbi.nlm.nih.gov/pubmed/34283375	https://www.ncbi.nlm.nih.gov/pubmed/34283375	NUM
dti-2707	873	18	https://doi.org/10.1161/hypertensionaha.121.18192	https://doi.org/10.1161/hypertensionaha.121.18192	NOUN
dti-2707	873	19	https://www.ncbi.nlm.nih.gov/pubmed/34775787	https://www.ncbi.nlm.nih.gov/pubmed/34775787	NUM
dti-2707	873	20	https://doi.org/10.3389/fphar.2019.01271	https://doi.org/10.3389/fphar.2019.01271	PROPN
dti-2707	873	21	https://www.ncbi.nlm.nih.gov/pubmed/31719823	https://www.ncbi.nlm.nih.gov/pubmed/31719823	NUM
dti-2707	873	22	https://doi.org/10.1186/s12906-022-03738-3	https://doi.org/10.1186/s12906-022-03738-3	NUM
dti-2707	873	23	https://pubmed.ncbi.nlm.nih.gov/36192741/	https://pubmed.ncbi.nlm.nih.gov/36192741/	PROPN
dti-2707	873	24	https://doi.org/10.1161/01.hyp.0000251865.35728.2f	https://doi.org/10.1161/01.hyp.0000251865.35728.2f	X
dti-2707	873	25	https://www.ncbi.nlm.nih.gov/pubmed/17116756	https://www.ncbi.nlm.nih.gov/pubmed/17116756	NUM
dti-2707	873	26	https://doi.org/10.1016/j.sjbs.2021.10.003	https://doi.org/10.1016/j.sjbs.2021.10.003	NUM
dti-2707	873	27	https://www.ncbi.nlm.nih.gov/pubmed/35197767	https://www.ncbi.nlm.nih.gov/pubmed/35197767	NUM
dti-2707	873	28	https://doi.org/10.4155/bio.12.81	https://doi.org/10.4155/bio.12.81	NOUN
dti-2707	873	29	https://www.ncbi.nlm.nih.gov/pubmed/22651564	https://www.ncbi.nlm.nih.gov/pubmed/22651564	ADP
dti-2707	873	30	https://doi.org/10.3389/fphar.2020.583200	https://doi.org/10.3389/fphar.2020.583200	PROPN
dti-2707	873	31	https://doi.org/10.1172/jci17664	https://doi.org/10.1172/jci17664	VERB
dti-2707	873	32	https://www.ncbi.nlm.nih.gov/pubmed/12750399	https://www.ncbi.nlm.nih.gov/pubmed/12750399	NOUN
dti-2707	873	33	https://doi.org/10.1093/cvr/cvq296	https://doi.org/10.1093/cvr/cvq296	X
dti-2707	873	34	https://www.ncbi.nlm.nih.gov/pubmed/20851810	https://www.ncbi.nlm.nih.gov/pubmed/20851810	PUNCT
dti-2707	873	35	https://doi.org/10.1016/j.jbo.2022.100415	https://doi.org/10.1016/j.jbo.2022.100415	X
dti-2707	873	36	https://pubmed.ncbi.nlm.nih.gov/35573641/	https://pubmed.ncbi.nlm.nih.gov/35573641/	PROPN
dti-2707	873	37	https://doi.org/10.1111/j.1365-2036.2009.03960.x	https://doi.org/10.1111/j.1365-2036.2009.03960.x	VERB
dti-2707	873	38	https://www.ncbi.nlm.nih.gov/pubmed/19220208	https://www.ncbi.nlm.nih.gov/pubmed/19220208	NUM
dti-2707	873	39	https://www.ncbi.nlm.nih.gov/pubmed/7205646	https://www.ncbi.nlm.nih.gov/pubmed/7205646	NUM
dti-2707	873	40	https://www.ncbi.nlm.nih.gov/pubmed/2883297	https://www.ncbi.nlm.nih.gov/pubmed/2883297	NUM
dti-2707	873	41	https://doi.org/10.1016/j.cbi.2016.10.016	https://doi.org/10.1016/j.cbi.2016.10.016	PRON
dti-2707	873	42	https://www.ncbi.nlm.nih.gov/pubmed/27780710	https://www.ncbi.nlm.nih.gov/pubmed/27780710	ADJ
dti-2707	873	43	https://doi.org/10.1155/2018/1275486	https://doi.org/10.1155/2018/1275486	NOUN
dti-2707	873	44	https://www.ncbi.nlm.nih.gov/pubmed/30510570	https://www.ncbi.nlm.nih.gov/pubmed/30510570	NUM
dti-2707	873	45	https://doi.org/10.1016/s2468-1253(22)00165-0	https://doi.org/10.1016/s2468-1253(22)00165-0	NOUN
dti-2707	873	46	https://www.ncbi.nlm.nih.gov/pubmed/35798021	https://www.ncbi.nlm.nih.gov/pubmed/35798021	NUM
dti-2707	873	47	https://doi.org/10.7570/jomes22021	https://doi.org/10.7570/jomes22021	VERB
dti-2707	873	48	https://www.ncbi.nlm.nih.gov/pubmed/35332111	https://www.ncbi.nlm.nih.gov/pubmed/35332111	PROPN
dti-2707	873	49	https://doi.org/10.7861/clinmedicine.18-3-245	https://doi.org/10.7861/clinmedicine.18-3-245	PROPN
dti-2707	873	50	https://www.ncbi.nlm.nih.gov/pubmed/29858436	https://www.ncbi.nlm.nih.gov/pubmed/29858436	PRON
dti-2707	873	51	https://doi.org/10.1007/s43440-021-00227-1	https://doi.org/10.1007/s43440-021-00227-1	NOUN
dti-2707	873	52	https://www.ncbi.nlm.nih.gov/pubmed/33595821	https://www.ncbi.nlm.nih.gov/pubmed/33595821	VERB
dti-2707	873	53	https://doi.org/10.1371/journal.pone.0047900	https://doi.org/10.1371/journal.pone.0047900	ADJ
dti-2707	873	54	https://www.ncbi.nlm.nih.gov/pubmed/23110126	https://www.ncbi.nlm.nih.gov/pubmed/23110126	NOUN
dti-2707	874	1	https://doi.org/10.1038/aps.2009.150	https://doi.org/10.1038/aps.2009.150	PROPN
dti-2707	875	1	https://www.ncbi.nlm.nih.gov/pubmed/19890358	https://www.ncbi.nlm.nih.gov/pubmed/19890358	PUNCT
dti-2707	876	1	https://doi.org/10.1016/j.biopha.2017.12.026	https://doi.org/10.1016/j.biopha.2017.12.026	PROPN
dti-2707	876	2	https://www.ncbi.nlm.nih.gov/pubmed/29247950	https://www.ncbi.nlm.nih.gov/pubmed/29247950	PROPN
dti-2707	876	3	https://doi.org/10.3892/etm.2018.6400	https://doi.org/10.3892/etm.2018.6400	VERB
dti-2707	876	4	https://www.ncbi.nlm.nih.gov/pubmed/30186426	https://www.ncbi.nlm.nih.gov/pubmed/30186426	X
dti-2707	876	5	https://doi.org/10.1016/j.phymed.2019.153074	https://doi.org/10.1016/j.phymed.2019.153074	PROPN
dti-2707	876	6	https://www.ncbi.nlm.nih.gov/pubmed/31473580	https://www.ncbi.nlm.nih.gov/pubmed/31473580	PUNCT
dti-2707	876	7	https://doi.org/10.1007/978-981-13-8871-2_1	https://doi.org/10.1007/978-981-13-8871-2_1	ADP
dti-2707	876	8	https://www.ncbi.nlm.nih.gov/pubmed/31399958	https://www.ncbi.nlm.nih.gov/pubmed/31399958	X
dti-2707	876	9	https://doi.org/10.1002/cphy.c110041	https://doi.org/10.1002/cphy.c110041	NOUN
dti-2707	876	10	https://www.ncbi.nlm.nih.gov/pubmed/23798302	https://www.ncbi.nlm.nih.gov/pubmed/23798302	NUM
dti-2707	876	11	https://doi.org/10.5530/jyp.2022.14.78	https://doi.org/10.5530/jyp.2022.14.78	X
dti-2707	876	12	https://doi.org/10.1016/j.biochi.2014.08.006	https://doi.org/10.1016/j.biochi.2014.08.006	PROPN
dti-2707	876	13	https://www.ncbi.nlm.nih.gov/pubmed/25151412	https://www.ncbi.nlm.nih.gov/pubmed/25151412	PUNCT
dti-2707	876	14	munjal	munjal	PROPN
dti-2707	876	15	et	et	PROPN
dti-2707	876	16	al	al	PROPN
dti-2707	876	17	drug	drug	NOUN
dti-2707	876	18	target	target	NOUN
dti-2707	876	19	insights	insight	NOUN
dti-2707	876	20	2024	2024	NUM
dti-2707	876	21	;	;	PUNCT
dti-2707	876	22	18	18	NUM
dti-2707	876	23	:	:	SYM
dti-2707	876	24	45	45	NUM
dti-2707	876	25	©	©	PROPN
dti-2707	876	26	2024	2024	NUM
dti-2707	876	27	the	the	DET
dti-2707	876	28	authors	author	NOUN
dti-2707	876	29	.	.	PUNCT
dti-2707	877	1	published	publish	VERB
dti-2707	877	2	by	by	ADP
dti-2707	877	3	aboutscience	aboutscience	NOUN
dti-2707	877	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2707	877	5	98	98	NUM
dti-2707	877	6	.	.	PUNCT
dti-2707	878	1	yang	yang	PROPN
dti-2707	878	2	m	m	PROPN
dti-2707	878	3	,	,	PUNCT
dti-2707	878	4	kan	kan	PROPN
dti-2707	878	5	l	l	PROPN
dti-2707	878	6	,	,	PUNCT
dti-2707	878	7	wu	wu	PROPN
dti-2707	878	8	l	l	PROPN
dti-2707	878	9	,	,	PUNCT
dti-2707	878	10	zhu	zhu	PROPN
dti-2707	878	11	y	y	PROPN
dti-2707	878	12	,	,	PUNCT
dti-2707	878	13	wang	wang	PROPN
dti-2707	878	14	q.	q.	PROPN
dti-2707	878	15	effect	effect	NOUN
dti-2707	878	16	of	of	ADP
dti-2707	878	17	baicalin	baicalin	NOUN
dti-2707	878	18	on	on	ADP
dti-2707	878	19	renal	renal	ADJ
dti-2707	878	20	function	function	NOUN
dti-2707	878	21	in	in	ADP
dti-2707	878	22	patients	patient	NOUN
dti-2707	878	23	with	with	ADP
dti-2707	878	24	diabetic	diabetic	ADJ
dti-2707	878	25	nephropathy	nephropathy	NOUN
dti-2707	878	26	and	and	CCONJ
dti-2707	878	27	its	its	PRON
dti-2707	878	28	therapeutic	therapeutic	ADJ
dti-2707	878	29	mechanism	mechanism	NOUN
dti-2707	878	30	.	.	PUNCT
dti-2707	879	1	exp	exp	NOUN
dti-2707	879	2	ther	ther	PROPN
dti-2707	879	3	med	me	VERB
dti-2707	879	4	.	.	PUNCT
dti-2707	880	1	2019;17(3):2071	2019;17(3):2071	NUM
dti-2707	880	2	-	-	SYM
dti-2707	880	3	2076	2076	NUM
dti-2707	880	4	.	.	PUNCT
dti-2707	881	1	crossref	crossref	PROPN
dti-2707	881	2	pubmed	pubmed	PROPN
dti-2707	881	3	99	99	NUM
dti-2707	881	4	.	.	PUNCT
dti-2707	882	1	haye	haye	VERB
dti-2707	882	2	a	a	DET
dti-2707	882	3	,	,	PUNCT
dti-2707	882	4	ansari	ansari	PROPN
dti-2707	882	5	ma	ma	PROPN
dti-2707	882	6	,	,	PUNCT
dti-2707	882	7	saini	saini	PROPN
dti-2707	882	8	a	a	PROPN
dti-2707	882	9	,	,	PUNCT
dti-2707	882	10	et	et	PROPN
dti-2707	882	11	al	al	PROPN
dti-2707	882	12	.	.	PUNCT
dti-2707	882	13	polyherbal	polyherbal	ADJ
dti-2707	882	14	formulation	formulation	NOUN
dti-2707	882	15	improves	improve	VERB
dti-2707	882	16	glucose	glucose	NOUN
dti-2707	882	17	-	-	PUNCT
dti-2707	882	18	lipid	lipid	NOUN
dti-2707	882	19	metabolism	metabolism	NOUN
dti-2707	882	20	and	and	CCONJ
dti-2707	882	21	prevent	prevent	VERB
dti-2707	882	22	hepatotoxicity	hepatotoxicity	NOUN
dti-2707	882	23	in	in	ADP
dti-2707	882	24	streptozotocin	streptozotocin	NOUN
dti-2707	882	25	-	-	PUNCT
dti-2707	882	26	induced	induce	VERB
dti-2707	882	27	diabetic	diabetic	ADJ
dti-2707	882	28	rats	rat	NOUN
dti-2707	882	29	:	:	PUNCT
dti-2707	882	30	plausible	plausible	ADJ
dti-2707	882	31	role	role	NOUN
dti-2707	882	32	of	of	ADP
dti-2707	882	33	irspi3k	irspi3k	PROPN
dti-2707	882	34	-	-	PUNCT
dti-2707	882	35	akt	akt	PROPN
dti-2707	882	36	-	-	PUNCT
dti-2707	882	37	glut2	glut2	NOUN
dti-2707	882	38	signaling	signal	VERB
dti-2707	882	39	.	.	PUNCT
dti-2707	883	1	pharmacogn	pharmacogn	PROPN
dti-2707	883	2	mag	mag	PROPN
dti-2707	883	3	.	.	PUNCT
dti-2707	884	1	2022;18(77):52	2022;18(77):52	NUM
dti-2707	884	2	.	.	PUNCT
dti-2707	885	1	crossref	crossref	PROPN
dti-2707	885	2	100	100	NUM
dti-2707	885	3	.	.	PUNCT
dti-2707	885	4	hu	hu	PROPN
dti-2707	886	1	z	z	PROPN
dti-2707	886	2	,	,	PUNCT
dti-2707	886	3	guan	guan	PROPN
dti-2707	886	4	y	y	PROPN
dti-2707	886	5	,	,	PUNCT
dti-2707	886	6	hu	hu	PROPN
dti-2707	886	7	w	w	PROPN
dti-2707	886	8	,	,	PUNCT
dti-2707	886	9	xu	xu	PROPN
dti-2707	886	10	z	z	X
dti-2707	886	11	,	,	PUNCT
dti-2707	886	12	ishfaq	ishfaq	NOUN
dti-2707	886	13	m.	m.	NOUN
dti-2707	886	14	an	an	DET
dti-2707	886	15	overview	overview	NOUN
dti-2707	886	16	of	of	ADP
dti-2707	886	17	pharmacological	pharmacological	ADJ
dti-2707	886	18	activities	activity	NOUN
dti-2707	886	19	of	of	ADP
dti-2707	886	20	baicalin	baicalin	NOUN
dti-2707	886	21	and	and	CCONJ
dti-2707	886	22	its	its	PRON
dti-2707	886	23	aglycone	aglycone	NOUN
dti-2707	886	24	baicalein	baicalein	NOUN
dti-2707	886	25	:	:	PUNCT
dti-2707	886	26	new	new	ADJ
dti-2707	886	27	insights	insight	NOUN
dti-2707	886	28	into	into	ADP
dti-2707	886	29	molecular	molecular	ADJ
dti-2707	886	30	mechanisms	mechanism	NOUN
dti-2707	886	31	and	and	CCONJ
dti-2707	886	32	signaling	signal	VERB
dti-2707	886	33	pathways	pathway	NOUN
dti-2707	886	34	.	.	PUNCT
dti-2707	887	1	iran	iran	PROPN
dti-2707	887	2	j	j	PROPN
dti-2707	887	3	basic	basic	ADJ
dti-2707	887	4	med	med	PROPN
dti-2707	887	5	sci	sci	PROPN
dti-2707	887	6	.	.	PUNCT
dti-2707	887	7	2022;25(1):14	2022;25(1):14	PROPN
dti-2707	887	8	-	-	SYM
dti-2707	887	9	26	26	NUM
dti-2707	887	10	.	.	PUNCT
dti-2707	888	1	pubmed	pubmed	PROPN
dti-2707	888	2	101	101	NUM
dti-2707	888	3	.	.	PUNCT
dti-2707	889	1	piao	piao	PROPN
dti-2707	889	2	xl	xl	PROPN
dti-2707	889	3	,	,	PUNCT
dti-2707	889	4	cho	cho	PROPN
dti-2707	889	5	ej	ej	PROPN
dti-2707	889	6	,	,	PUNCT
dti-2707	889	7	jang	jang	PROPN
dti-2707	889	8	mh	mh	PROPN
dti-2707	889	9	.	.	PUNCT
dti-2707	890	1	cytoprotective	cytoprotective	ADJ
dti-2707	890	2	effect	effect	NOUN
dti-2707	890	3	of	of	ADP
dti-2707	890	4	baicalein	baicalein	NOUN
dti-2707	890	5	against	against	ADP
dti-2707	890	6	peroxynitrite	peroxynitrite	ADV
dti-2707	890	7	-	-	PUNCT
dti-2707	890	8	induced	induce	VERB
dti-2707	890	9	toxicity	toxicity	NOUN
dti-2707	890	10	in	in	ADP
dti-2707	890	11	llc	llc	PROPN
dti-2707	890	12	-	-	PUNCT
dti-2707	890	13	pk(1	pk(1	PROPN
dti-2707	890	14	)	)	PUNCT
dti-2707	890	15	cells	cell	NOUN
dti-2707	890	16	.	.	PUNCT
dti-2707	891	1	food	food	NOUN
dti-2707	891	2	chem	chem	NOUN
dti-2707	891	3	toxicol	toxicol	NOUN
dti-2707	891	4	.	.	PUNCT
dti-2707	892	1	2008;46(5):1576	2008;46(5):1576	NUM
dti-2707	892	2	-	-	PUNCT
dti-2707	892	3	1581	1581	NUM
dti-2707	892	4	.	.	PUNCT
dti-2707	893	1	crossref	crossref	PROPN
dti-2707	893	2	pubmed	pubmed	PROPN
dti-2707	893	3	102	102	NUM
dti-2707	893	4	.	.	PUNCT
dti-2707	894	1	sahu	sahu	PROPN
dti-2707	894	2	bd	bd	PROPN
dti-2707	894	3	,	,	PUNCT
dti-2707	894	4	mahesh	mahesh	PROPN
dti-2707	894	5	kumar	kumar	PROPN
dti-2707	894	6	j	j	PROPN
dti-2707	894	7	,	,	PUNCT
dti-2707	894	8	sistla	sistla	PROPN
dti-2707	894	9	r.	r.	PROPN
dti-2707	894	10	baicalein	baicalein	PROPN
dti-2707	894	11	,	,	PUNCT
dti-2707	894	12	a	a	DET
dti-2707	894	13	bioflavonoid	bioflavonoid	NOUN
dti-2707	894	14	,	,	PUNCT
dti-2707	894	15	prevents	prevent	VERB
dti-2707	894	16	cisplatin	cisplatin	NOUN
dti-2707	894	17	-	-	PUNCT
dti-2707	894	18	induced	induce	VERB
dti-2707	894	19	acute	acute	NOUN
dti-2707	894	20	kidney	kidney	NOUN
dti-2707	894	21	injury	injury	NOUN
dti-2707	894	22	by	by	ADP
dti-2707	894	23	up	up	ADV
dti-2707	894	24	-	-	PUNCT
dti-2707	894	25	regulating	regulate	VERB
dti-2707	894	26	antioxidant	antioxidant	NOUN
dti-2707	894	27	defenses	defense	NOUN
dti-2707	894	28	and	and	CCONJ
dti-2707	894	29	down	down	ADV
dti-2707	894	30	-	-	PUNCT
dti-2707	894	31	regulating	regulate	VERB
dti-2707	894	32	the	the	DET
dti-2707	894	33	mapks	mapks	NOUN
dti-2707	894	34	and	and	CCONJ
dti-2707	894	35	nf	nf	ADJ
dti-2707	894	36	-	-	PUNCT
dti-2707	894	37	κb	κb	NOUN
dti-2707	894	38	pathways	pathway	NOUN
dti-2707	894	39	.	.	PUNCT
dti-2707	895	1	plos	plos	PROPN
dti-2707	895	2	one	one	NUM
dti-2707	895	3	.	.	PUNCT
dti-2707	896	1	2015;10(7):e0134139	2015;10(7):e0134139	NUM
dti-2707	896	2	.	.	PUNCT
dti-2707	896	3	crossref	crossref	PROPN
dti-2707	896	4	pubmed	pubmed	PROPN
dti-2707	896	5	103	103	NUM
dti-2707	896	6	.	.	PUNCT
dti-2707	897	1	kirtane	kirtane	PROPN
dti-2707	897	2	ar	ar	PROPN
dti-2707	897	3	,	,	PUNCT
dti-2707	897	4	verma	verma	PROPN
dti-2707	897	5	m	m	PROPN
dti-2707	897	6	,	,	PUNCT
dti-2707	897	7	karandikar	karandikar	PROPN
dti-2707	897	8	p	p	X
dti-2707	897	9	,	,	PUNCT
dti-2707	897	10	furin	furin	PROPN
dti-2707	897	11	j	j	PROPN
dti-2707	897	12	,	,	PUNCT
dti-2707	897	13	langer	langer	PROPN
dti-2707	897	14	r	r	PROPN
dti-2707	897	15	,	,	PUNCT
dti-2707	897	16	traverso	traverso	PROPN
dti-2707	897	17	g.	g.	PROPN
dti-2707	897	18	nanotechnology	nanotechnology	PROPN
dti-2707	897	19	approaches	approach	VERB
dti-2707	897	20	for	for	ADP
dti-2707	897	21	global	global	ADJ
dti-2707	897	22	infectious	infectious	ADJ
dti-2707	897	23	diseases	disease	NOUN
dti-2707	897	24	.	.	PUNCT
dti-2707	898	1	nat	nat	PROPN
dti-2707	898	2	nanotechnol	nanotechnol	NOUN
dti-2707	898	3	.	.	PUNCT
dti-2707	899	1	2021;16(4):369	2021;16(4):369	NUM
dti-2707	899	2	-	-	PUNCT
dti-2707	899	3	384	384	NUM
dti-2707	899	4	.	.	PUNCT
dti-2707	899	5	crossref	crossref	PROPN
dti-2707	899	6	pubmed	pubmed	PROPN
dti-2707	899	7	104	104	PROPN
dti-2707	899	8	.	.	PUNCT
dti-2707	900	1	fair	fair	PROPN
dti-2707	900	2	rj	rj	PROPN
dti-2707	900	3	,	,	PUNCT
dti-2707	900	4	tor	tor	PROPN
dti-2707	900	5	y.	y.	NOUN
dti-2707	900	6	antibiotics	antibiotic	NOUN
dti-2707	900	7	and	and	CCONJ
dti-2707	900	8	bacterial	bacterial	ADJ
dti-2707	900	9	resistance	resistance	NOUN
dti-2707	900	10	in	in	ADP
dti-2707	900	11	the	the	DET
dti-2707	900	12	21st	21st	ADJ
dti-2707	900	13	century	century	NOUN
dti-2707	900	14	.	.	PUNCT
dti-2707	901	1	perspect	perspect	VERB
dti-2707	901	2	medicin	medicin	PROPN
dti-2707	901	3	chem	chem	NOUN
dti-2707	901	4	.	.	PUNCT
dti-2707	902	1	2014;6:25	2014;6:25	NOUN
dti-2707	902	2	-	-	SYM
dti-2707	902	3	64	64	NUM
dti-2707	902	4	.	.	PUNCT
dti-2707	903	1	crossref	crossref	PROPN
dti-2707	903	2	pubmed	pubmed	PROPN
dti-2707	903	3	105	105	NUM
dti-2707	903	4	.	.	PUNCT
dti-2707	904	1	aghazadeh	aghazadeh	PROPN
dti-2707	904	2	m	m	PROPN
dti-2707	904	3	,	,	PUNCT
dti-2707	904	4	zahedi	zahedi	PROPN
dti-2707	904	5	bialvaei	bialvaei	NOUN
dti-2707	904	6	a	a	PRON
dti-2707	904	7	,	,	PUNCT
dti-2707	904	8	aghazadeh	aghazadeh	NOUN
dti-2707	904	9	m	m	PROPN
dti-2707	904	10	,	,	PUNCT
dti-2707	905	1	et	et	PROPN
dti-2707	905	2	al	al	PROPN
dti-2707	905	3	.	.	PUNCT
dti-2707	905	4	survey	survey	NOUN
dti-2707	905	5	of	of	ADP
dti-2707	905	6	the	the	DET
dti-2707	905	7	antibiofilm	antibiofilm	NOUN
dti-2707	905	8	and	and	CCONJ
dti-2707	905	9	antimicrobial	antimicrobial	ADJ
dti-2707	905	10	effects	effect	NOUN
dti-2707	905	11	of	of	ADP
dti-2707	905	12	zingiber	zingiber	NOUN
dti-2707	905	13	officinale	officinale	PROPN
dti-2707	905	14	(	(	PUNCT
dti-2707	905	15	in	in	ADP
dti-2707	905	16	vitro	vitro	X
dti-2707	905	17	study	study	NOUN
dti-2707	905	18	)	)	PUNCT
dti-2707	905	19	.	.	PUNCT
dti-2707	906	1	jundishapur	jundishapur	PROPN
dti-2707	906	2	j	j	PROPN
dti-2707	906	3	microbiol	microbiol	PROPN
dti-2707	906	4	.	.	PUNCT
dti-2707	907	1	2016;9(2):e30167	2016;9(2):e30167	ADJ
dti-2707	907	2	.	.	PUNCT
dti-2707	908	1	crossref	crossref	PROPN
dti-2707	908	2	pubmed	pubmed	PROPN
dti-2707	908	3	106	106	NUM
dti-2707	908	4	.	.	PUNCT
dti-2707	909	1	li	li	PROPN
dti-2707	909	2	c	c	PROPN
dti-2707	909	3	,	,	PUNCT
dti-2707	909	4	huang	huang	PROPN
dti-2707	909	5	p	p	PROPN
dti-2707	909	6	,	,	PUNCT
dti-2707	909	7	wong	wong	PROPN
dti-2707	909	8	k	k	PROPN
dti-2707	909	9	,	,	PUNCT
dti-2707	909	10	et	et	PROPN
dti-2707	909	11	al	al	PROPN
dti-2707	909	12	.	.	PROPN
dti-2707	909	13	coptisine	coptisine	NOUN
dti-2707	909	14	-	-	PUNCT
dti-2707	909	15	induced	induce	VERB
dti-2707	909	16	inhibition	inhibition	NOUN
dti-2707	909	17	of	of	ADP
dti-2707	909	18	helicobacter	helicobacter	NOUN
dti-2707	909	19	pylori	pylori	NOUN
dti-2707	909	20	:	:	PUNCT
dti-2707	909	21	elucidation	elucidation	NOUN
dti-2707	909	22	of	of	ADP
dti-2707	909	23	specific	specific	ADJ
dti-2707	909	24	mechanisms	mechanism	NOUN
dti-2707	909	25	by	by	ADP
dti-2707	909	26	probing	probe	VERB
dti-2707	909	27	urease	urease	VERB
dti-2707	909	28	active	active	ADJ
dti-2707	909	29	site	site	NOUN
dti-2707	909	30	and	and	CCONJ
dti-2707	909	31	its	its	PRON
dti-2707	909	32	maturation	maturation	NOUN
dti-2707	909	33	process	process	NOUN
dti-2707	909	34	.	.	PUNCT
dti-2707	910	1	j	j	PROPN
dti-2707	910	2	enzyme	enzyme	NOUN
dti-2707	910	3	inhib	inhib	VERB
dti-2707	910	4	med	med	ADJ
dti-2707	910	5	chem	chem	NOUN
dti-2707	910	6	.	.	PUNCT
dti-2707	911	1	2018;33(1):1362	2018;33(1):1362	NUM
dti-2707	911	2	-	-	PUNCT
dti-2707	911	3	1375	1375	NUM
dti-2707	911	4	.	.	PUNCT
dti-2707	912	1	crossref	crossref	PROPN
dti-2707	912	2	pubmed	pubmed	PROPN
dti-2707	912	3	107	107	PROPN
dti-2707	912	4	.	.	PUNCT
dti-2707	913	1	guo	guo	PROPN
dti-2707	913	2	m	m	PROPN
dti-2707	913	3	,	,	PUNCT
dti-2707	913	4	zhang	zhang	PROPN
dti-2707	913	5	n	n	PROPN
dti-2707	913	6	,	,	PUNCT
dti-2707	913	7	li	li	PROPN
dti-2707	913	8	d	d	PROPN
dti-2707	913	9	,	,	PUNCT
dti-2707	913	10	et	et	PROPN
dti-2707	913	11	al	al	PROPN
dti-2707	913	12	.	.	PROPN
dti-2707	913	13	baicalin	baicalin	PROPN
dti-2707	913	14	plays	play	VERB
dti-2707	913	15	an	an	DET
dti-2707	913	16	anti	anti	ADJ
dti-2707	913	17	-	-	ADJ
dti-2707	913	18	inflammatory	inflammatory	ADJ
dti-2707	913	19	role	role	NOUN
dti-2707	913	20	through	through	ADP
dti-2707	913	21	reducing	reduce	VERB
dti-2707	913	22	nuclear	nuclear	ADJ
dti-2707	913	23	factor	factor	NOUN
dti-2707	913	24	-	-	PUNCT
dti-2707	913	25	κb	κb	NOUN
dti-2707	913	26	and	and	CCONJ
dti-2707	913	27	p38	p38	NOUN
dti-2707	913	28	phosphorylation	phosphorylation	NOUN
dti-2707	913	29	in	in	ADP
dti-2707	913	30	s.	s.	PROPN
dti-2707	913	31	aureus	aureus	PROPN
dti-2707	913	32	-	-	PUNCT
dti-2707	913	33	induced	induce	VERB
dti-2707	913	34	mastitis	mastitis	NOUN
dti-2707	913	35	.	.	PUNCT
dti-2707	914	1	int	int	PROPN
dti-2707	914	2	immunopharmacol	immunopharmacol	PROPN
dti-2707	914	3	.	.	PUNCT
dti-2707	915	1	2013;16(2):125	2013;16(2):125	NUM
dti-2707	915	2	-	-	PUNCT
dti-2707	915	3	130	130	NUM
dti-2707	915	4	.	.	PUNCT
dti-2707	916	1	crossref	crossref	PROPN
dti-2707	916	2	pubmed	pubmed	PROPN
dti-2707	916	3	108	108	NUM
dti-2707	916	4	.	.	PUNCT
dti-2707	917	1	ozma	ozma	PROPN
dti-2707	917	2	ma	ma	PROPN
dti-2707	917	3	,	,	PUNCT
dti-2707	917	4	khodadadi	khodadadi	PROPN
dti-2707	917	5	e	e	PROPN
dti-2707	917	6	,	,	PUNCT
dti-2707	917	7	pakdel	pakdel	PROPN
dti-2707	917	8	f	f	PROPN
dti-2707	917	9	,	,	PUNCT
dti-2707	917	10	et	et	PROPN
dti-2707	917	11	al	al	PROPN
dti-2707	917	12	.	.	PROPN
dti-2707	917	13	baicalin	baicalin	PROPN
dti-2707	917	14	,	,	PUNCT
dti-2707	917	15	a	a	DET
dti-2707	917	16	natural	natural	ADJ
dti-2707	917	17	antimicrobial	antimicrobial	ADJ
dti-2707	917	18	and	and	CCONJ
dti-2707	917	19	anti	anti	ADJ
dti-2707	917	20	-	-	ADJ
dti-2707	917	21	biofilm	biofilm	ADJ
dti-2707	917	22	agent	agent	NOUN
dti-2707	917	23	.	.	PUNCT
dti-2707	918	1	j	j	PROPN
dti-2707	918	2	herb	herb	PROPN
dti-2707	918	3	med	me	VERB
dti-2707	918	4	.	.	PUNCT
dti-2707	919	1	2021;27:100432	2021;27:100432	X
dti-2707	919	2	.	.	PUNCT
dti-2707	919	3	crossref	crossref	PROPN
dti-2707	919	4	109	109	NUM
dti-2707	919	5	.	.	PUNCT
dti-2707	920	1	luo	luo	PROPN
dti-2707	920	2	j	j	PROPN
dti-2707	920	3	,	,	PUNCT
dti-2707	920	4	dong	dong	PROPN
dti-2707	920	5	b	b	PROPN
dti-2707	920	6	,	,	PUNCT
dti-2707	920	7	wang	wang	PROPN
dti-2707	920	8	k	k	PROPN
dti-2707	920	9	,	,	PUNCT
dti-2707	920	10	et	et	PROPN
dti-2707	920	11	al	al	PROPN
dti-2707	920	12	.	.	PROPN
dti-2707	920	13	baicalin	baicalin	PROPN
dti-2707	920	14	inhibits	inhibit	VERB
dti-2707	920	15	biofilm	biofilm	NOUN
dti-2707	920	16	formation	formation	NOUN
dti-2707	920	17	,	,	PUNCT
dti-2707	920	18	attenuates	attenuate	VERB
dti-2707	920	19	the	the	DET
dti-2707	920	20	quorum	quorum	NOUN
dti-2707	920	21	sensing	sensing	NOUN
dti-2707	920	22	-	-	PUNCT
dti-2707	920	23	controlled	control	VERB
dti-2707	920	24	virulence	virulence	NOUN
dti-2707	920	25	and	and	CCONJ
dti-2707	920	26	enhances	enhance	VERB
dti-2707	920	27	pseudomonas	pseudomona	NOUN
dti-2707	920	28	aeruginosa	aeruginosa	NOUN
dti-2707	920	29	clearance	clearance	NOUN
dti-2707	920	30	in	in	ADP
dti-2707	920	31	a	a	DET
dti-2707	920	32	mouse	mouse	NOUN
dti-2707	920	33	peritoneal	peritoneal	ADJ
dti-2707	920	34	implant	implant	ADJ
dti-2707	920	35	infection	infection	NOUN
dti-2707	920	36	model	model	NOUN
dti-2707	920	37	.	.	PUNCT
dti-2707	921	1	plos	plos	PROPN
dti-2707	921	2	one	one	NUM
dti-2707	921	3	.	.	PUNCT
dti-2707	922	1	2017;12(4	2017;12(4	X
dti-2707	922	2	):	):	PUNCT
dti-2707	922	3	e0176883	e0176883	NOUN
dti-2707	922	4	.	.	PUNCT
dti-2707	923	1	crossref	crossref	PROPN
dti-2707	923	2	pubmed	pubmed	PROPN
dti-2707	923	3	110	110	NUM
dti-2707	923	4	.	.	PUNCT
dti-2707	924	1	chen	chen	PROPN
dti-2707	924	2	y	y	PROPN
dti-2707	924	3	,	,	PUNCT
dti-2707	924	4	liu	liu	PROPN
dti-2707	924	5	t	t	PROPN
dti-2707	924	6	,	,	PUNCT
dti-2707	924	7	wang	wang	PROPN
dti-2707	924	8	k	k	PROPN
dti-2707	924	9	,	,	PUNCT
dti-2707	924	10	et	et	PROPN
dti-2707	924	11	al	al	PROPN
dti-2707	924	12	.	.	PROPN
dti-2707	924	13	baicalein	baicalein	PROPN
dti-2707	924	14	inhibits	inhibit	VERB
dti-2707	924	15	staphylococcus	staphylococcus	NOUN
dti-2707	924	16	aureus	aureus	NOUN
dti-2707	924	17	biofilm	biofilm	NOUN
dti-2707	924	18	formation	formation	NOUN
dti-2707	924	19	and	and	CCONJ
dti-2707	924	20	the	the	DET
dti-2707	924	21	quorum	quorum	NOUN
dti-2707	924	22	sensing	sense	VERB
dti-2707	924	23	system	system	NOUN
dti-2707	924	24	in	in	ADP
dti-2707	924	25	vitro	vitro	X
dti-2707	924	26	.	.	PUNCT
dti-2707	925	1	plos	plos	PROPN
dti-2707	925	2	one	one	NUM
dti-2707	925	3	.	.	PUNCT
dti-2707	926	1	2016;11(4):e0153468	2016;11(4):e0153468	X
dti-2707	926	2	.	.	PUNCT
dti-2707	926	3	crossref	crossref	PROPN
dti-2707	926	4	pubmed	pubmed	PROPN
dti-2707	926	5	111	111	NUM
dti-2707	926	6	.	.	PUNCT
dti-2707	927	1	li	li	PROPN
dti-2707	927	2	k	k	PROPN
dti-2707	927	3	,	,	PUNCT
dti-2707	927	4	liang	liang	PROPN
dti-2707	927	5	y	y	PROPN
dti-2707	927	6	,	,	PUNCT
dti-2707	927	7	cheng	cheng	PROPN
dti-2707	927	8	a	a	PROPN
dti-2707	927	9	,	,	PUNCT
dti-2707	927	10	et	et	PROPN
dti-2707	927	11	al	al	PROPN
dti-2707	927	12	.	.	PUNCT
dti-2707	927	13	antiviral	antiviral	ADJ
dti-2707	927	14	properties	property	NOUN
dti-2707	927	15	of	of	ADP
dti-2707	927	16	baicalin	baicalin	NOUN
dti-2707	927	17	:	:	PUNCT
dti-2707	927	18	a	a	DET
dti-2707	927	19	concise	concise	ADJ
dti-2707	927	20	review	review	NOUN
dti-2707	927	21	.	.	PUNCT
dti-2707	928	1	rev	rev	PROPN
dti-2707	928	2	bras	bras	PROPN
dti-2707	928	3	farmacogn	farmacogn	VERB
dti-2707	928	4	.	.	PUNCT
dti-2707	929	1	2021;31(4):408	2021;31(4):408	NUM
dti-2707	929	2	-	-	SYM
dti-2707	929	3	419	419	NUM
dti-2707	929	4	.	.	PUNCT
dti-2707	930	1	crossref	crossref	PROPN
dti-2707	930	2	pubmed	pubmed	PROPN
dti-2707	930	3	112	112	NUM
dti-2707	930	4	.	.	PUNCT
dti-2707	931	1	su	su	PROPN
dti-2707	931	2	y	y	PROPN
dti-2707	931	3	,	,	PUNCT
dti-2707	931	4	xiang	xiang	PROPN
dti-2707	931	5	y.	y.	PROPN
dti-2707	931	6	clinical	clinical	PROPN
dti-2707	931	7	efficacy	efficacy	PROPN
dti-2707	931	8	of	of	ADP
dti-2707	931	9	baicalin	baicalin	NOUN
dti-2707	931	10	combined	combine	VERB
dti-2707	931	11	with	with	ADP
dti-2707	931	12	antivirals	antiviral	NOUN
dti-2707	931	13	in	in	ADP
dti-2707	931	14	the	the	DET
dti-2707	931	15	treatment	treatment	NOUN
dti-2707	931	16	of	of	ADP
dti-2707	931	17	severe	severe	ADJ
dti-2707	931	18	influenza	influenza	NOUN
dti-2707	931	19	a	a	DET
dti-2707	931	20	hin1	hin1	PROPN
dti-2707	931	21	influenza	influenza	NOUN
dti-2707	931	22	.	.	PUNCT
dti-2707	932	1	chin	chin	PROPN
dti-2707	932	2	hosp	hosp	PROPN
dti-2707	932	3	pharm	pharm	PROPN
dti-2707	932	4	j.	j.	PROPN
dti-2707	932	5	2014;34:306	2014;34:306	PROPN
dti-2707	932	6	-	-	SYM
dti-2707	932	7	308	308	NUM
dti-2707	932	8	.	.	NOUN
dti-2707	932	9	113	113	NUM
dti-2707	932	10	.	.	PUNCT
dti-2707	933	1	jenks	jenks	PROPN
dti-2707	933	2	jd	jd	PROPN
dti-2707	933	3	,	,	PUNCT
dti-2707	933	4	cornely	cornely	ADV
dti-2707	933	5	oa	oa	PROPN
dti-2707	933	6	,	,	PUNCT
dti-2707	933	7	chen	chen	PROPN
dti-2707	933	8	sc	sc	PROPN
dti-2707	933	9	,	,	PUNCT
dti-2707	933	10	thompson	thompson	PROPN
dti-2707	933	11	gr	gr	PROPN
dti-2707	933	12	iii	iii	PROPN
dti-2707	933	13	,	,	PUNCT
dti-2707	933	14	hoenigl	hoenigl	PROPN
dti-2707	933	15	m.	m.	PROPN
dti-2707	933	16	breakthrough	breakthrough	VERB
dti-2707	933	17	invasive	invasive	ADJ
dti-2707	933	18	fungal	fungal	ADJ
dti-2707	933	19	infections	infection	NOUN
dti-2707	933	20	:	:	PUNCT
dti-2707	933	21	who	who	PRON
dti-2707	933	22	is	be	AUX
dti-2707	933	23	at	at	ADP
dti-2707	933	24	risk	risk	NOUN
dti-2707	933	25	?	?	PUNCT
dti-2707	934	1	mycoses	mycose	NOUN
dti-2707	934	2	.	.	PUNCT
dti-2707	935	1	2020;63(10):1021	2020;63(10):1021	NUM
dti-2707	935	2	-	-	SYM
dti-2707	935	3	1032	1032	NUM
dti-2707	935	4	.	.	PUNCT
dti-2707	936	1	crossref	crossref	PROPN
dti-2707	936	2	pubmed	pubmed	PROPN
dti-2707	936	3	114	114	NUM
dti-2707	936	4	.	.	PUNCT
dti-2707	937	1	campoy	campoy	PROPN
dti-2707	937	2	s	s	NOUN
dti-2707	937	3	,	,	PUNCT
dti-2707	937	4	adrio	adrio	PROPN
dti-2707	937	5	jl	jl	PROPN
dti-2707	937	6	.	.	PUNCT
dti-2707	937	7	antifungals	antifungal	NOUN
dti-2707	937	8	.	.	PUNCT
dti-2707	938	1	biochem	biochem	PROPN
dti-2707	938	2	pharmacol	pharmacol	PROPN
dti-2707	938	3	.	.	PROPN
dti-2707	939	1	2017	2017	NUM
dti-2707	939	2	;	;	PUNCT
dti-2707	940	1	133:86	133:86	NUM
dti-2707	940	2	-	-	SYM
dti-2707	940	3	96	96	NUM
dti-2707	940	4	.	.	PUNCT
dti-2707	941	1	crossref	crossref	PROPN
dti-2707	941	2	pubmed	pubmed	PROPN
dti-2707	941	3	115	115	PROPN
dti-2707	941	4	.	.	PUNCT
dti-2707	942	1	li	li	PROPN
dti-2707	942	2	l	l	PROPN
dti-2707	942	3	,	,	PUNCT
dti-2707	942	4	lu	lu	PROPN
dti-2707	942	5	h	h	NOUN
dti-2707	942	6	,	,	PUNCT
dti-2707	942	7	zhang	zhang	PROPN
dti-2707	942	8	x	x	PROPN
dti-2707	942	9	,	,	PUNCT
dti-2707	942	10	et	et	PROPN
dti-2707	942	11	al	al	PROPN
dti-2707	942	12	.	.	PROPN
dti-2707	942	13	baicalein	baicalein	PROPN
dti-2707	942	14	acts	act	NOUN
dti-2707	942	15	against	against	ADP
dti-2707	942	16	candida	candida	NOUN
dti-2707	942	17	albicans	albican	NOUN
dti-2707	942	18	by	by	ADP
dti-2707	942	19	targeting	target	VERB
dti-2707	942	20	eno1	eno1	NOUN
dti-2707	942	21	and	and	CCONJ
dti-2707	942	22	inhibiting	inhibit	VERB
dti-2707	942	23	glycolysis	glycolysis	NOUN
dti-2707	942	24	.	.	PUNCT
dti-2707	943	1	microbiol	microbiol	PROPN
dti-2707	943	2	spectr	spectr	PROPN
dti-2707	943	3	.	.	PUNCT
dti-2707	944	1	2022;10(4):e0208522	2022;10(4):e0208522	X
dti-2707	944	2	.	.	PUNCT
dti-2707	945	1	crossref	crossref	PROPN
dti-2707	945	2	pubmed	pubmed	PROPN
dti-2707	945	3	116	116	PROPN
dti-2707	945	4	.	.	PUNCT
dti-2707	946	1	zhu	zhu	PROPN
dti-2707	946	2	y	y	PROPN
dti-2707	946	3	,	,	PUNCT
dti-2707	946	4	peng	peng	PROPN
dti-2707	946	5	x	x	PROPN
dti-2707	946	6	,	,	PUNCT
dti-2707	946	7	zhang	zhang	PROPN
dti-2707	946	8	y	y	PROPN
dti-2707	946	9	,	,	PUNCT
dti-2707	946	10	lin	lin	PROPN
dti-2707	946	11	j	j	PROPN
dti-2707	946	12	,	,	PUNCT
dti-2707	946	13	zhao	zhao	PROPN
dti-2707	946	14	g.	g.	PROPN
dti-2707	946	15	baicalein	baicalein	PROPN
dti-2707	946	16	protects	protect	VERB
dti-2707	946	17	against	against	ADP
dti-2707	946	18	aspergillus	aspergillus	NOUN
dti-2707	946	19	fumigatus	fumigatus	NOUN
dti-2707	946	20	keratitis	keratitis	NOUN
dti-2707	946	21	by	by	ADP
dti-2707	946	22	reducing	reduce	VERB
dti-2707	946	23	fungal	fungal	ADJ
dti-2707	946	24	load	load	NOUN
dti-2707	946	25	and	and	CCONJ
dti-2707	946	26	inhibiting	inhibit	VERB
dti-2707	946	27	tslp	tslp	NOUN
dti-2707	946	28	-	-	PUNCT
dti-2707	946	29	induced	induce	VERB
dti-2707	946	30	inflammatory	inflammatory	ADJ
dti-2707	946	31	response	response	NOUN
dti-2707	946	32	.	.	PUNCT
dti-2707	947	1	invest	invest	VERB
dti-2707	947	2	ophthalmol	ophthalmol	PROPN
dti-2707	947	3	vis	vis	X
dti-2707	947	4	sci	sci	PROPN
dti-2707	947	5	.	.	PUNCT
dti-2707	948	1	2021;62(6):26	2021;62(6):26	X
dti-2707	948	2	.	.	PUNCT
dti-2707	948	3	crossref	crossref	PROPN
dti-2707	948	4	pubmed	pubmed	PROPN
dti-2707	948	5	117	117	PROPN
dti-2707	948	6	.	.	PUNCT
dti-2707	949	1	wang	wang	PROPN
dti-2707	949	2	t	t	PROPN
dti-2707	949	3	,	,	PUNCT
dti-2707	949	4	shi	shi	PROPN
dti-2707	949	5	g	g	PROPN
dti-2707	949	6	,	,	PUNCT
dti-2707	949	7	shao	shao	PROPN
dti-2707	949	8	j	j	PROPN
dti-2707	949	9	,	,	PUNCT
dti-2707	949	10	et	et	PROPN
dti-2707	949	11	al	al	PROPN
dti-2707	949	12	.	.	PROPN
dti-2707	950	1	in	in	ADP
dti-2707	950	2	vitro	vitro	X
dti-2707	950	3	antifungal	antifungal	ADJ
dti-2707	950	4	activity	activity	NOUN
dti-2707	950	5	of	of	ADP
dti-2707	950	6	baicalin	baicalin	NOUN
dti-2707	950	7	against	against	ADP
dti-2707	950	8	candida	candida	NOUN
dti-2707	950	9	albicans	albican	NOUN
dti-2707	950	10	biofilms	biofilm	NOUN
dti-2707	950	11	via	via	ADP
dti-2707	950	12	apoptotic	apoptotic	ADJ
dti-2707	950	13	induction	induction	NOUN
dti-2707	950	14	.	.	PUNCT
dti-2707	951	1	microb	microb	PROPN
dti-2707	951	2	pathog	pathog	PROPN
dti-2707	951	3	.	.	PUNCT
dti-2707	952	1	2015;87:21	2015;87:21	NUM
dti-2707	952	2	-	-	SYM
dti-2707	952	3	29	29	NUM
dti-2707	952	4	.	.	PUNCT
dti-2707	953	1	crossref	crossref	PROPN
dti-2707	953	2	pubmed	pubmed	PROPN
dti-2707	953	3	118	118	NUM
dti-2707	953	4	.	.	PUNCT
dti-2707	954	1	singh	singh	PROPN
dti-2707	954	2	j	j	PROPN
dti-2707	954	3	,	,	PUNCT
dti-2707	954	4	kakkar	kakkar	PROPN
dti-2707	954	5	p.	p.	NOUN
dti-2707	954	6	modulation	modulation	NOUN
dti-2707	954	7	of	of	ADP
dti-2707	954	8	liver	liver	NOUN
dti-2707	954	9	function	function	NOUN
dti-2707	954	10	,	,	PUNCT
dti-2707	954	11	antioxidant	antioxidant	ADJ
dti-2707	954	12	responses	response	NOUN
dti-2707	954	13	,	,	PUNCT
dti-2707	954	14	insulin	insulin	NOUN
dti-2707	954	15	resistance	resistance	NOUN
dti-2707	954	16	and	and	CCONJ
dti-2707	954	17	glucose	glucose	NOUN
dti-2707	954	18	transport	transport	NOUN
dti-2707	954	19	by	by	ADP
dti-2707	954	20	oroxylum	oroxylum	PROPN
dti-2707	954	21	indicum	indicum	NOUN
dti-2707	954	22	stem	stem	NOUN
dti-2707	954	23	bark	bark	NOUN
dti-2707	954	24	in	in	ADP
dti-2707	954	25	stz	stz	VERB
dti-2707	954	26	induced	induce	VERB
dti-2707	954	27	diabetic	diabetic	ADJ
dti-2707	954	28	rats	rat	NOUN
dti-2707	954	29	.	.	PUNCT
dti-2707	955	1	food	food	NOUN
dti-2707	955	2	chem	chem	NOUN
dti-2707	955	3	toxicol	toxicol	NOUN
dti-2707	955	4	.	.	PUNCT
dti-2707	956	1	2013;62:722	2013;62:722	NOUN
dti-2707	956	2	-	-	SYM
dti-2707	956	3	731	731	NUM
dti-2707	956	4	.	.	PUNCT
dti-2707	957	1	crossref	crossref	PROPN
dti-2707	957	2	pubmed	pubmed	PROPN
dti-2707	957	3	119	119	NUM
dti-2707	957	4	.	.	PUNCT
dti-2707	958	1	fu	fu	PROPN
dti-2707	958	2	y	y	PROPN
dti-2707	958	3	,	,	PUNCT
dti-2707	958	4	luo	luo	PROPN
dti-2707	958	5	j	j	PROPN
dti-2707	958	6	,	,	PUNCT
dti-2707	958	7	jia	jia	PROPN
dti-2707	958	8	z	z	PROPN
dti-2707	958	9	,	,	PUNCT
dti-2707	958	10	et	et	PROPN
dti-2707	958	11	al	al	PROPN
dti-2707	958	12	.	.	PROPN
dti-2707	958	13	baicalein	baicalein	PROPN
dti-2707	958	14	protects	protect	VERB
dti-2707	958	15	against	against	ADP
dti-2707	958	16	type	type	NOUN
dti-2707	958	17	2	2	NUM
dti-2707	958	18	diabetes	diabetes	NOUN
dti-2707	958	19	via	via	ADP
dti-2707	958	20	promoting	promote	VERB
dti-2707	958	21	islet	islet	NOUN
dti-2707	958	22	β	β	NOUN
dti-2707	958	23	-	-	NOUN
dti-2707	958	24	cell	cell	NOUN
dti-2707	958	25	function	function	NOUN
dti-2707	958	26	in	in	ADP
dti-2707	958	27	obese	obese	ADJ
dti-2707	958	28	diabetic	diabetic	ADJ
dti-2707	958	29	mice	mouse	NOUN
dti-2707	958	30	.	.	PUNCT
dti-2707	959	1	int	int	NOUN
dti-2707	959	2	j	j	PROPN
dti-2707	959	3	endocrinol	endocrinol	NOUN
dti-2707	959	4	.	.	PUNCT
dti-2707	960	1	2014;2014:846742	2014;2014:846742	NUM
dti-2707	960	2	.	.	PUNCT
dti-2707	961	1	crossref	crossref	PROPN
dti-2707	961	2	pubmed	pubmed	PROPN
dti-2707	961	3	120	120	NUM
dti-2707	961	4	.	.	PUNCT
dti-2707	961	5	alqahtani	alqahtani	PROPN
dti-2707	961	6	as	as	ADP
dti-2707	961	7	,	,	PUNCT
dti-2707	961	8	hidayathulla	hidayathulla	NOUN
dti-2707	961	9	s	s	PROPN
dti-2707	961	10	,	,	PUNCT
dti-2707	961	11	rehman	rehman	PROPN
dti-2707	961	12	mt	mt	PROPN
dti-2707	961	13	,	,	PUNCT
dti-2707	961	14	et	et	PROPN
dti-2707	961	15	al	al	PROPN
dti-2707	961	16	.	.	PUNCT
dti-2707	961	17	alpha	alpha	NOUN
dti-2707	961	18	-	-	PUNCT
dti-2707	961	19	amylase	amylase	NOUN
dti-2707	961	20	and	and	CCONJ
dti-2707	961	21	alpha	alpha	NOUN
dti-2707	961	22	-	-	PUNCT
dti-2707	961	23	glucosidase	glucosidase	ADJ
dti-2707	961	24	enzyme	enzyme	NOUN
dti-2707	961	25	inhibition	inhibition	NOUN
dti-2707	961	26	and	and	CCONJ
dti-2707	961	27	antioxidant	antioxidant	ADJ
dti-2707	961	28	potential	potential	NOUN
dti-2707	961	29	of	of	ADP
dti-2707	961	30	3	3	NUM
dti-2707	961	31	-	-	PUNCT
dti-2707	961	32	oxolupenal	oxolupenal	ADJ
dti-2707	961	33	and	and	CCONJ
dti-2707	961	34	katononic	katononic	ADJ
dti-2707	961	35	acid	acid	NOUN
dti-2707	961	36	isolated	isolate	VERB
dti-2707	961	37	from	from	ADP
dti-2707	961	38	nuxia	nuxia	NOUN
dti-2707	961	39	oppositifolia	oppositifolia	NOUN
dti-2707	961	40	.	.	PUNCT
dti-2707	962	1	biomolecules	biomolecule	NOUN
dti-2707	962	2	.	.	PUNCT
dti-2707	963	1	2019;10(1):61	2019;10(1):61	X
dti-2707	963	2	.	.	PUNCT
dti-2707	963	3	crossref	crossref	PROPN
dti-2707	963	4	pubmed	pubmed	PROPN
dti-2707	963	5	121	121	NUM
dti-2707	963	6	.	.	PUNCT
dti-2707	964	1	sun	sun	PROPN
dti-2707	964	2	w	w	PROPN
dti-2707	964	3	,	,	PUNCT
dti-2707	964	4	sang	sing	VERB
dti-2707	964	5	y	y	PROPN
dti-2707	964	6	,	,	PUNCT
dti-2707	964	7	zhang	zhang	PROPN
dti-2707	964	8	b	b	PROPN
dti-2707	964	9	,	,	PUNCT
dti-2707	964	10	et	et	PROPN
dti-2707	964	11	al	al	PROPN
dti-2707	964	12	.	.	PUNCT
dti-2707	965	1	synergistic	synergistic	ADJ
dti-2707	965	2	effects	effect	NOUN
dti-2707	965	3	of	of	ADP
dti-2707	965	4	acarbose	acarbose	NOUN
dti-2707	965	5	and	and	CCONJ
dti-2707	965	6	an	an	DET
dti-2707	965	7	oroxylum	oroxylum	ADJ
dti-2707	965	8	indicum	indicum	NOUN
dti-2707	965	9	seed	seed	NOUN
dti-2707	965	10	extract	extract	NOUN
dti-2707	965	11	in	in	ADP
dti-2707	965	12	streptozotocin	streptozotocin	PROPN
dti-2707	965	13	and	and	CCONJ
dti-2707	965	14	high	high	ADJ
dti-2707	965	15	-	-	PUNCT
dti-2707	965	16	fat	fat	ADJ
dti-2707	965	17	-	-	PUNCT
dti-2707	965	18	diet	diet	NOUN
dti-2707	965	19	induced	induce	VERB
dti-2707	965	20	prediabetic	prediabetic	ADJ
dti-2707	965	21	mice	mouse	NOUN
dti-2707	965	22	.	.	PUNCT
dti-2707	965	23	biomed	biome	VERB
dti-2707	965	24	pharmacother	pharmacother	ADJ
dti-2707	965	25	.	.	PUNCT
dti-2707	966	1	2017;87:160	2017;87:160	VERB
dti-2707	966	2	-	-	SYM
dti-2707	966	3	170	170	NUM
dti-2707	966	4	.	.	PUNCT
dti-2707	967	1	crossref	crossref	PROPN
dti-2707	967	2	pubmed	pubmed	PROPN
dti-2707	967	3	122	122	NUM
dti-2707	967	4	.	.	PUNCT
dti-2707	968	1	vlassara	vlassara	PROPN
dti-2707	968	2	h	h	PROPN
dti-2707	968	3	,	,	PUNCT
dti-2707	968	4	uribarri	uribarri	PROPN
dti-2707	968	5	j.	j.	PROPN
dti-2707	968	6	advanced	advanced	PROPN
dti-2707	968	7	glycation	glycation	NOUN
dti-2707	968	8	end	end	NOUN
dti-2707	968	9	products	product	NOUN
dti-2707	968	10	(	(	PUNCT
dti-2707	968	11	age	age	NOUN
dti-2707	968	12	)	)	PUNCT
dti-2707	968	13	and	and	CCONJ
dti-2707	968	14	diabetes	diabetes	NOUN
dti-2707	968	15	:	:	PUNCT
dti-2707	968	16	cause	cause	NOUN
dti-2707	968	17	,	,	PUNCT
dti-2707	968	18	effect	effect	NOUN
dti-2707	968	19	,	,	PUNCT
dti-2707	968	20	or	or	CCONJ
dti-2707	968	21	both	both	PRON
dti-2707	968	22	?	?	PUNCT
dti-2707	969	1	curr	curr	PROPN
dti-2707	969	2	diab	diab	PROPN
dti-2707	969	3	rep	rep	PROPN
dti-2707	969	4	.	.	PROPN
dti-2707	969	5	2014;14(1):453	2014;14(1):453	NUM
dti-2707	969	6	.	.	PUNCT
dti-2707	970	1	crossref	crossref	PROPN
dti-2707	970	2	pubmed	pubmed	PROPN
dti-2707	970	3	123	123	NUM
dti-2707	970	4	.	.	PUNCT
dti-2707	971	1	min	min	PROPN
dti-2707	971	2	w	w	PROPN
dti-2707	971	3	,	,	PUNCT
dti-2707	971	4	liu	liu	PROPN
dti-2707	971	5	x	x	PROPN
dti-2707	971	6	,	,	PUNCT
dti-2707	971	7	qian	qian	PROPN
dti-2707	971	8	q	q	PROPN
dti-2707	971	9	,	,	PUNCT
dti-2707	971	10	et	et	PROPN
dti-2707	971	11	al	al	PROPN
dti-2707	971	12	.	.	PUNCT
dti-2707	971	13	effects	effect	NOUN
dti-2707	971	14	of	of	ADP
dti-2707	971	15	baicalin	baicalin	NOUN
dti-2707	971	16	against	against	ADP
dti-2707	971	17	uvainduced	uvainduced	ADJ
dti-2707	971	18	photoaging	photoaging	NOUN
dti-2707	971	19	in	in	ADP
dti-2707	971	20	skin	skin	NOUN
dti-2707	971	21	fibroblasts	fibroblast	NOUN
dti-2707	971	22	.	.	PUNCT
dti-2707	972	1	am	be	AUX
dti-2707	972	2	j	j	PROPN
dti-2707	972	3	chin	chin	PROPN
dti-2707	972	4	med	med	PROPN
dti-2707	972	5	.	.	PUNCT
dti-2707	973	1	2014;42(3):709	2014;42(3):709	NUM
dti-2707	973	2	-	-	PUNCT
dti-2707	973	3	727	727	NUM
dti-2707	973	4	.	.	PUNCT
dti-2707	974	1	crossref	crossref	PROPN
dti-2707	974	2	pubmed	pubmed	PROPN
dti-2707	974	3	124	124	NUM
dti-2707	974	4	.	.	PUNCT
dti-2707	975	1	yun	yun	PROPN
dti-2707	975	2	m	m	PROPN
dti-2707	975	3	-	-	PROPN
dti-2707	975	4	y	y	PROPN
dti-2707	975	5	,	,	PUNCT
dti-2707	975	6	won	win	VERB
dti-2707	975	7	e	e	PROPN
dti-2707	975	8	-	-	PROPN
dti-2707	975	9	y	y	PROPN
dti-2707	975	10	,	,	PUNCT
dti-2707	975	11	lee	lee	PROPN
dti-2707	975	12	j	j	PROPN
dti-2707	975	13	-	-	PROPN
dti-2707	975	14	h	h	PROPN
dti-2707	975	15	,	,	PUNCT
dti-2707	975	16	jung	jung	PROPN
dti-2707	975	17	j	j	PROPN
dti-2707	975	18	-	-	PROPN
dti-2707	975	19	i	i	PROPN
dti-2707	975	20	,	,	PUNCT
dti-2707	975	21	choi	choi	NOUN
dti-2707	975	22	h	h	PROPN
dti-2707	975	23	-	-	PUNCT
dti-2707	975	24	j.	j.	PROPN
dti-2707	975	25	bioconversion	bioconversion	PROPN
dti-2707	975	26	from	from	ADP
dti-2707	975	27	scutellaria	scutellaria	NOUN
dti-2707	975	28	baicalensis	baicalensis	NOUN
dti-2707	975	29	(	(	PUNCT
dti-2707	975	30	baicalin	baicalin	NOUN
dti-2707	975	31	)	)	PUNCT
dti-2707	975	32	fermented	ferment	VERB
dti-2707	975	33	with	with	ADP
dti-2707	975	34	leatiporus	leatiporus	NOUN
dti-2707	975	35	sulphureus	sulphureus	ADV
dti-2707	975	36	into	into	ADP
dti-2707	975	37	enriched	enrich	VERB
dti-2707	975	38	-	-	PUNCT
dti-2707	975	39	baicalein	baicalein	NOUN
dti-2707	975	40	and	and	CCONJ
dti-2707	975	41	anti	anti	ADJ
dti-2707	975	42	wrinkle	wrinkle	NOUN
dti-2707	975	43	effects	effect	NOUN
dti-2707	975	44	.	.	PUNCT
dti-2707	976	1	pharmacogn	pharmacogn	PROPN
dti-2707	976	2	mag	mag	PROPN
dti-2707	976	3	.	.	PUNCT
dti-2707	977	1	2018;14(57):s453	2018;14(57):s453	NUM
dti-2707	977	2	-	-	SYM
dti-2707	977	3	457	457	NUM
dti-2707	977	4	.	.	PUNCT
dti-2707	978	1	online	online	ADP
dti-2707	978	2	125	125	NUM
dti-2707	978	3	.	.	PUNCT
dti-2707	978	4	bossi	bossi	PROPN
dti-2707	978	5	o	o	PROPN
dti-2707	978	6	,	,	PUNCT
dti-2707	978	7	gartsbein	gartsbein	ADJ
dti-2707	978	8	m	m	PROPN
dti-2707	978	9	,	,	PUNCT
dti-2707	978	10	leitges	leitge	NOUN
dti-2707	978	11	m	m	PROPN
dti-2707	978	12	,	,	PUNCT
dti-2707	978	13	kuroki	kuroki	PROPN
dti-2707	978	14	t	t	PROPN
dti-2707	978	15	,	,	PUNCT
dti-2707	978	16	grossman	grossman	PROPN
dti-2707	978	17	s	s	PROPN
dti-2707	978	18	,	,	PUNCT
dti-2707	978	19	tennenbaum	tennenbaum	ADJ
dti-2707	978	20	t.	t.	NOUN
dti-2707	978	21	uv	uv	NOUN
dti-2707	978	22	irradiation	irradiation	NOUN
dti-2707	978	23	increases	increase	VERB
dti-2707	978	24	ros	ros	PROPN
dti-2707	978	25	production	production	NOUN
dti-2707	978	26	via	via	ADP
dti-2707	978	27	pkcdelta	pkcdelta	NOUN
dti-2707	978	28	signaling	signal	VERB
dti-2707	978	29	in	in	ADP
dti-2707	978	30	primary	primary	ADJ
dti-2707	978	31	murine	murine	ADJ
dti-2707	978	32	fibroblasts	fibroblast	NOUN
dti-2707	978	33	.	.	PUNCT
dti-2707	979	1	j	j	PROPN
dti-2707	979	2	cell	cell	PROPN
dti-2707	979	3	biochem	biochem	PROPN
dti-2707	979	4	.	.	PUNCT
dti-2707	980	1	2008;105(1):194	2008;105(1):194	NUM
dti-2707	980	2	-	-	PUNCT
dti-2707	980	3	207	207	NUM
dti-2707	980	4	.	.	PUNCT
dti-2707	981	1	crossref	crossref	PROPN
dti-2707	981	2	pubmed	pubmed	PROPN
dti-2707	981	3	126	126	PROPN
dti-2707	981	4	.	.	PUNCT
dti-2707	982	1	dong	dong	PROPN
dti-2707	982	2	r	r	PROPN
dti-2707	982	3	,	,	PUNCT
dti-2707	982	4	li	li	PROPN
dti-2707	982	5	l	l	PROPN
dti-2707	982	6	,	,	PUNCT
dti-2707	982	7	gao	gao	PROPN
dti-2707	982	8	h	h	PROPN
dti-2707	982	9	,	,	PUNCT
dti-2707	982	10	et	et	PROPN
dti-2707	982	11	al	al	PROPN
dti-2707	982	12	.	.	PROPN
dti-2707	982	13	safety	safety	PROPN
dti-2707	982	14	,	,	PUNCT
dti-2707	982	15	tolerability	tolerability	NOUN
dti-2707	982	16	,	,	PUNCT
dti-2707	982	17	pharmacokinetics	pharmacokinetic	NOUN
dti-2707	982	18	,	,	PUNCT
dti-2707	982	19	and	and	CCONJ
dti-2707	982	20	food	food	NOUN
dti-2707	982	21	effect	effect	NOUN
dti-2707	982	22	of	of	ADP
dti-2707	982	23	baicalein	baicalein	NOUN
dti-2707	982	24	tablets	tablet	NOUN
dti-2707	982	25	in	in	ADP
dti-2707	982	26	healthy	healthy	ADJ
dti-2707	982	27	chinese	chinese	ADJ
dti-2707	982	28	subjects	subject	NOUN
dti-2707	982	29	:	:	PUNCT
dti-2707	982	30	a	a	DET
dti-2707	982	31	single	single	ADJ
dti-2707	982	32	-	-	PUNCT
dti-2707	982	33	center	center	NOUN
dti-2707	982	34	,	,	PUNCT
dti-2707	982	35	randomized	randomize	VERB
dti-2707	982	36	,	,	PUNCT
dti-2707	982	37	double	double	ADJ
dti-2707	982	38	-	-	PUNCT
dti-2707	982	39	blind	blind	ADJ
dti-2707	982	40	,	,	PUNCT
dti-2707	982	41	placebo	placebo	NOUN
dti-2707	982	42	-	-	PUNCT
dti-2707	982	43	controlled	control	VERB
dti-2707	982	44	,	,	PUNCT
dti-2707	982	45	single	single	ADJ
dti-2707	982	46	-	-	PUNCT
dti-2707	982	47	dose	dose	VERB
dti-2707	982	48	phase	phase	NOUN
dti-2707	982	49	i	i	PRON
dti-2707	982	50	study	study	VERB
dti-2707	982	51	.	.	PUNCT
dti-2707	983	1	j	j	PROPN
dti-2707	983	2	ethnopharmacol	ethnopharmacol	PROPN
dti-2707	983	3	.	.	PUNCT
dti-2707	984	1	2021;274:114052	2021;274:114052	X
dti-2707	984	2	.	.	PUNCT
dti-2707	985	1	crossref	crossref	PROPN
dti-2707	985	2	pubmed	pubmed	PROPN
dti-2707	985	3	127	127	NUM
dti-2707	985	4	.	.	PUNCT
dti-2707	986	1	song	song	PROPN
dti-2707	986	2	j	j	PROPN
dti-2707	986	3	,	,	PUNCT
dti-2707	986	4	zhang	zhang	PROPN
dti-2707	986	5	l	l	PROPN
dti-2707	986	6	,	,	PUNCT
dti-2707	986	7	xu	xu	PROPN
dti-2707	986	8	y	y	PROPN
dti-2707	986	9	,	,	PUNCT
dti-2707	986	10	et	et	PROPN
dti-2707	986	11	al	al	PROPN
dti-2707	986	12	.	.	PUNCT
dti-2707	987	1	the	the	DET
dti-2707	987	2	comprehensive	comprehensive	ADJ
dti-2707	987	3	study	study	NOUN
dti-2707	987	4	on	on	ADP
dti-2707	987	5	the	the	DET
dti-2707	987	6	therapeutic	therapeutic	ADJ
dti-2707	987	7	effects	effect	NOUN
dti-2707	987	8	of	of	ADP
dti-2707	987	9	baicalein	baicalein	NOUN
dti-2707	987	10	for	for	ADP
dti-2707	987	11	the	the	DET
dti-2707	987	12	treatment	treatment	NOUN
dti-2707	987	13	of	of	ADP
dti-2707	987	14	covid-19	covid-19	PROPN
dti-2707	987	15	in	in	ADP
dti-2707	987	16	vivo	vivo	NOUN
dti-2707	987	17	and	and	CCONJ
dti-2707	987	18	in	in	ADP
dti-2707	987	19	vitro	vitro	X
dti-2707	987	20	.	.	PUNCT
dti-2707	988	1	biochem	biochem	PROPN
dti-2707	988	2	pharmacol	pharmacol	PROPN
dti-2707	988	3	.	.	PUNCT
dti-2707	989	1	2021;183:114302	2021;183:114302	NUM
dti-2707	989	2	.	.	PUNCT
dti-2707	990	1	crossref	crossref	PROPN
dti-2707	990	2	pubmed	pubmed	PROPN
dti-2707	990	3	128	128	NUM
dti-2707	990	4	.	.	PUNCT
dti-2707	991	1	li	li	PROPN
dti-2707	991	2	m	m	PROPN
dti-2707	991	3	,	,	PUNCT
dti-2707	991	4	shi	shi	PROPN
dti-2707	991	5	a	a	X
dti-2707	991	6	,	,	PUNCT
dti-2707	991	7	pang	pang	NOUN
dti-2707	991	8	h	h	NOUN
dti-2707	991	9	,	,	PUNCT
dti-2707	991	10	et	et	PROPN
dti-2707	991	11	al	al	PROPN
dti-2707	991	12	.	.	PROPN
dti-2707	991	13	safety	safety	PROPN
dti-2707	991	14	,	,	PUNCT
dti-2707	991	15	tolerability	tolerability	NOUN
dti-2707	991	16	,	,	PUNCT
dti-2707	991	17	and	and	CCONJ
dti-2707	991	18	pharmacokinetics	pharmacokinetic	NOUN
dti-2707	991	19	of	of	ADP
dti-2707	991	20	a	a	DET
dti-2707	991	21	single	single	ADJ
dti-2707	991	22	ascending	ascend	VERB
dti-2707	991	23	dose	dose	NOUN
dti-2707	991	24	of	of	ADP
dti-2707	991	25	baicalein	baicalein	PROPN
dti-2707	991	26	chewable	chewable	NOUN
dti-2707	991	27	tablets	tablet	NOUN
dti-2707	991	28	in	in	ADP
dti-2707	991	29	healthy	healthy	ADJ
dti-2707	991	30	subjects	subject	NOUN
dti-2707	991	31	.	.	PUNCT
dti-2707	992	1	j	j	PROPN
dti-2707	992	2	ethnopharmacol	ethnopharmacol	PROPN
dti-2707	992	3	.	.	PUNCT
dti-2707	993	1	2014;156:210	2014;156:210	PROPN
dti-2707	993	2	-	-	PUNCT
dti-2707	993	3	215	215	NUM
dti-2707	993	4	.	.	PUNCT
dti-2707	994	1	crossref	crossref	PROPN
dti-2707	994	2	pubmed	pubmed	PROPN
dti-2707	994	3	129	129	NUM
dti-2707	994	4	.	.	PUNCT
dti-2707	995	1	tyagi	tyagi	PROPN
dti-2707	995	2	s	s	PROPN
dti-2707	995	3	,	,	PUNCT
dti-2707	995	4	raghvendra	raghvendra	PROPN
dti-2707	995	5	,	,	PUNCT
dti-2707	995	6	sing	sing	VERB
dti-2707	995	7	u	u	NOUN
dti-2707	995	8	,	,	PUNCT
dti-2707	995	9	et	et	PROPN
dti-2707	995	10	al	al	PROPN
dti-2707	995	11	.	.	PUNCT
dti-2707	995	12	applications	application	NOUN
dti-2707	995	13	of	of	ADP
dti-2707	995	14	metabolomics	metabolomic	NOUN
dti-2707	995	15	—	—	PUNCT
dti-2707	995	16	a	a	DET
dti-2707	995	17	systematic	systematic	ADJ
dti-2707	995	18	study	study	NOUN
dti-2707	995	19	of	of	ADP
dti-2707	995	20	the	the	DET
dti-2707	995	21	unique	unique	ADJ
dti-2707	995	22	chemical	chemical	NOUN
dti-2707	995	23	fingerprints	fingerprint	NOUN
dti-2707	995	24	:	:	PUNCT
dti-2707	995	25	an	an	DET
dti-2707	995	26	overview	overview	NOUN
dti-2707	995	27	.	.	PUNCT
dti-2707	996	1	international	international	ADJ
dti-2707	996	2	journal	journal	PROPN
dti-2707	996	3	of	of	ADP
dti-2707	996	4	pharmaceutical	pharmaceutical	PROPN
dti-2707	996	5	sciences	sciences	PROPN
dti-2707	996	6	review	review	NOUN
dti-2707	996	7	and	and	CCONJ
dti-2707	996	8	research	research	NOUN
dti-2707	996	9	2010;3:83	2010;3:83	NOUN
dti-2707	996	10	-	-	SYM
dti-2707	996	11	86	86	NUM
dti-2707	996	12	online	online	ADV
dti-2707	996	13	(	(	PUNCT
dti-2707	996	14	accessed	access	VERB
dti-2707	996	15	october	october	PROPN
dti-2707	996	16	2023	2023	NUM
dti-2707	996	17	)	)	PUNCT
dti-2707	996	18	130	130	NUM
dti-2707	996	19	.	.	PUNCT
dti-2707	997	1	hoimes	hoimes	PROPN
dti-2707	997	2	cj	cj	PROPN
dti-2707	997	3	,	,	PUNCT
dti-2707	997	4	lamb	lamb	PROPN
dti-2707	997	5	l	l	PROPN
dti-2707	997	6	,	,	PUNCT
dti-2707	997	7	ruta	ruta	PROPN
dti-2707	997	8	s	s	PROPN
dti-2707	997	9	,	,	PUNCT
dti-2707	997	10	et	et	PROPN
dti-2707	997	11	al	al	PROPN
dti-2707	997	12	.	.	PUNCT
dti-2707	998	1	a	a	DET
dti-2707	998	2	phase	phase	NOUN
dti-2707	998	3	i	i	PRON
dti-2707	998	4	/	/	SYM
dti-2707	998	5	ii	ii	PROPN
dti-2707	998	6	study	study	NOUN
dti-2707	998	7	of	of	ADP
dti-2707	998	8	phy906	phy906	PROPN
dti-2707	998	9	plus	plus	CCONJ
dti-2707	998	10	capecitabine	capecitabine	NOUN
dti-2707	998	11	(	(	PUNCT
dti-2707	998	12	cap	cap	NOUN
dti-2707	998	13	)	)	PUNCT
dti-2707	998	14	in	in	ADP
dti-2707	998	15	patients	patient	NOUN
dti-2707	998	16	(	(	PUNCT
dti-2707	998	17	pts	pt	NOUN
dti-2707	998	18	)	)	PUNCT
dti-2707	998	19	with	with	ADP
dti-2707	998	20	advanced	advanced	ADJ
dti-2707	998	21	pancreatic	pancreatic	ADJ
dti-2707	998	22	cancer	cancer	NOUN
dti-2707	998	23	(	(	PUNCT
dti-2707	998	24	apc	apc	PROPN
dti-2707	998	25	)	)	PUNCT
dti-2707	998	26	.	.	PUNCT
dti-2707	999	1	j	j	PROPN
dti-2707	999	2	clin	clin	PROPN
dti-2707	999	3	oncol	oncol	PROPN
dti-2707	999	4	.	.	PUNCT
dti-2707	1000	1	2008;26(15_suppl):15538	2008;26(15_suppl):15538	NUM
dti-2707	1000	2	.	.	PUNCT
dti-2707	1001	1	crossref	crossref	PROPN
dti-2707	1001	2	131	131	NUM
dti-2707	1001	3	.	.	PUNCT
dti-2707	1002	1	srivastava	srivastava	PROPN
dti-2707	1002	2	s	s	PROPN
dti-2707	1002	3	,	,	PUNCT
dti-2707	1002	4	kumar	kumar	PROPN
dti-2707	1002	5	a	a	PROPN
dti-2707	1002	6	,	,	PUNCT
dti-2707	1002	7	yadav	yadav	PROPN
dti-2707	1002	8	pk	pk	PROPN
dti-2707	1002	9	,	,	PUNCT
dti-2707	1002	10	et	et	PROPN
dti-2707	1002	11	al	al	PROPN
dti-2707	1002	12	.	.	PUNCT
dti-2707	1002	13	formulation	formulation	NOUN
dti-2707	1002	14	and	and	CCONJ
dti-2707	1002	15	performance	performance	NOUN
dti-2707	1002	16	evaluation	evaluation	NOUN
dti-2707	1002	17	of	of	ADP
dti-2707	1002	18	polymeric	polymeric	ADJ
dti-2707	1002	19	mixed	mixed	ADJ
dti-2707	1002	20	micelles	micelle	NOUN
dti-2707	1002	21	encapsulated	encapsulate	VERB
dti-2707	1002	22	with	with	ADP
dti-2707	1002	23	baicalein	baicalein	NOUN
dti-2707	1002	24	for	for	ADP
dti-2707	1002	25	breast	breast	NOUN
dti-2707	1002	26	cancer	cancer	NOUN
dti-2707	1002	27	treatment	treatment	NOUN
dti-2707	1002	28	.	.	PUNCT
dti-2707	1003	1	drug	drug	PROPN
dti-2707	1003	2	dev	dev	PROPN
dti-2707	1003	3	ind	ind	PROPN
dti-2707	1003	4	pharm	pharm	PROPN
dti-2707	1003	5	.	.	PUNCT
dti-2707	1004	1	2021;47(9):1512	2021;47(9):1512	NUM
dti-2707	1004	2	-	-	SYM
dti-2707	1004	3	1522	1522	NUM
dti-2707	1004	4	.	.	PUNCT
dti-2707	1005	1	crossref	crossref	PROPN
dti-2707	1005	2	pubmed	pubmed	PROPN
dti-2707	1005	3	132	132	NUM
dti-2707	1005	4	.	.	PUNCT
dti-2707	1006	1	majumdar	majumdar	PROPN
dti-2707	1006	2	s	s	PROPN
dti-2707	1006	3	,	,	PUNCT
dti-2707	1006	4	dey	dey	PROPN
dti-2707	1006	5	s	s	PART
dti-2707	1006	6	,	,	PUNCT
dti-2707	1006	7	ganguly	ganguly	NOUN
dti-2707	1006	8	d	d	PROPN
dti-2707	1006	9	,	,	PUNCT
dti-2707	1006	10	mazumder	mazumder	PROPN
dti-2707	1006	11	r.	r.	PROPN
dti-2707	1006	12	enhanced	enhance	VERB
dti-2707	1006	13	topical	topical	ADJ
dti-2707	1006	14	permeability	permeability	NOUN
dti-2707	1006	15	of	of	ADP
dti-2707	1006	16	natural	natural	ADJ
dti-2707	1006	17	flavonoid	flavonoid	NOUN
dti-2707	1006	18	baicalein	baicalein	NOUN
dti-2707	1006	19	through	through	ADP
dti-2707	1006	20	nano	nano	NOUN
dti-2707	1006	21	https://doi.org/10.3892/etm.2019.7181	https://doi.org/10.3892/etm.2019.7181	NOUN
dti-2707	1006	22	https://www.ncbi.nlm.nih.gov/pubmed/30867693	https://www.ncbi.nlm.nih.gov/pubmed/30867693	PRON
dti-2707	1006	23	https://doi.org/10.4103/pm.pm_318_21	https://doi.org/10.4103/pm.pm_318_21	NOUN
dti-2707	1006	24	https://www.ncbi.nlm.nih.gov/pubmed/35656442	https://www.ncbi.nlm.nih.gov/pubmed/35656442	NUM
dti-2707	1006	25	https://doi.org/10.1016/j.fct.2007.12.023	https://doi.org/10.1016/j.fct.2007.12.023	NOUN
dti-2707	1006	26	https://www.ncbi.nlm.nih.gov/pubmed/18299170	https://www.ncbi.nlm.nih.gov/pubmed/18299170	PUNCT
dti-2707	1006	27	https://doi.org/10.1371/journal.pone.0134139	https://doi.org/10.1371/journal.pone.0134139	ADJ
dti-2707	1006	28	https://www.ncbi.nlm.nih.gov/pubmed/26222683	https://www.ncbi.nlm.nih.gov/pubmed/26222683	NUM
dti-2707	1006	29	https://doi.org/10.1038/s41565-021-00866-8	https://doi.org/10.1038/s41565-021-00866-8	NUM
dti-2707	1006	30	https://www.ncbi.nlm.nih.gov/pubmed/33753915	https://www.ncbi.nlm.nih.gov/pubmed/33753915	X
dti-2707	1006	31	https://doi.org/10.4137/pmc.s14459	https://doi.org/10.4137/pmc.s14459	X
dti-2707	1006	32	https://www.ncbi.nlm.nih.gov/pubmed/25232278	https://www.ncbi.nlm.nih.gov/pubmed/25232278	X
dti-2707	1006	33	https://doi.org/10.5812/jjm.30167	https://doi.org/10.5812/jjm.30167	ADV
dti-2707	1006	34	https://www.ncbi.nlm.nih.gov/pubmed/27127591	https://www.ncbi.nlm.nih.gov/pubmed/27127591	NOUN
dti-2707	1006	35	https://doi.org/10.1080/14756366.2018.1501044	https://doi.org/10.1080/14756366.2018.1501044	X
dti-2707	1006	36	https://www.ncbi.nlm.nih.gov/pubmed/30191728	https://www.ncbi.nlm.nih.gov/pubmed/30191728	VERB
dti-2707	1006	37	https://doi.org/10.1016/j.intimp.2013.03.006	https://doi.org/10.1016/j.intimp.2013.03.006	NOUN
dti-2707	1006	38	https://www.ncbi.nlm.nih.gov/pubmed/23523628	https://www.ncbi.nlm.nih.gov/pubmed/23523628	PRON
dti-2707	1006	39	https://doi.org/10.1016/j.hermed.2021.100432	https://doi.org/10.1016/j.hermed.2021.100432	PROPN
dti-2707	1006	40	https://doi.org/10.1371/journal.pone.0176883	https://doi.org/10.1371/journal.pone.0176883	ADV
dti-2707	1006	41	https://www.ncbi.nlm.nih.gov/pubmed/28453568	https://www.ncbi.nlm.nih.gov/pubmed/28453568	NOUN
dti-2707	1006	42	https://doi.org/10.1371/journal.pone.0153468	https://doi.org/10.1371/journal.pone.0153468	NOUN
dti-2707	1006	43	https://www.ncbi.nlm.nih.gov/pubmed/27128436	https://www.ncbi.nlm.nih.gov/pubmed/27128436	NUM
dti-2707	1006	44	https://doi.org/10.1007/s43450-021-00182-1	https://doi.org/10.1007/s43450-021-00182-1	NUM
dti-2707	1007	1	https://www.ncbi.nlm.nih.gov/pubmed/34642508	https://www.ncbi.nlm.nih.gov/pubmed/34642508	NUM
dti-2707	1007	2	https://doi.org/10.1111/myc.13148	https://doi.org/10.1111/myc.13148	PROPN
dti-2707	1007	3	https://www.ncbi.nlm.nih.gov/pubmed/32744334	https://www.ncbi.nlm.nih.gov/pubmed/32744334	ADP
dti-2707	1007	4	https://doi.org/10.1016/j.bcp.2016.11.019	https://doi.org/10.1016/j.bcp.2016.11.019	PROPN
dti-2707	1007	5	https://www.ncbi.nlm.nih.gov/pubmed/27884742	https://www.ncbi.nlm.nih.gov/pubmed/27884742	ADV
dti-2707	1007	6	https://doi.org/10.1128/spectrum.02085-22	https://doi.org/10.1128/spectrum.02085-22	PROPN
dti-2707	1007	7	https://www.ncbi.nlm.nih.gov/pubmed/35900099	https://www.ncbi.nlm.nih.gov/pubmed/35900099	PRON
dti-2707	1007	8	https://doi.org/10.1167/iovs.62.6.26	https://doi.org/10.1167/iovs.62.6.26	PROPN
dti-2707	1007	9	https://www.ncbi.nlm.nih.gov/pubmed/34038512	https://www.ncbi.nlm.nih.gov/pubmed/34038512	NUM
dti-2707	1007	10	https://doi.org/10.1016/j.micpath.2015.07.006	https://doi.org/10.1016/j.micpath.2015.07.006	PROPN
dti-2707	1007	11	https://www.ncbi.nlm.nih.gov/pubmed/26169236	https://www.ncbi.nlm.nih.gov/pubmed/26169236	ADP
dti-2707	1007	12	https://doi.org/10.1016/j.fct.2013.09.035	https://doi.org/10.1016/j.fct.2013.09.035	PROPN
dti-2707	1007	13	https://www.ncbi.nlm.nih.gov/pubmed/24140466	https://www.ncbi.nlm.nih.gov/pubmed/24140466	NUM
dti-2707	1007	14	https://doi.org/10.1155/2014/846742	https://doi.org/10.1155/2014/846742	PROPN
dti-2707	1007	15	https://www.ncbi.nlm.nih.gov/pubmed/25147566	https://www.ncbi.nlm.nih.gov/pubmed/25147566	X
dti-2707	1007	16	https://doi.org/10.3390/biom10010061	https://doi.org/10.3390/biom10010061	NOUN
dti-2707	1007	17	https://www.ncbi.nlm.nih.gov/pubmed/31905962	https://www.ncbi.nlm.nih.gov/pubmed/31905962	NUM
dti-2707	1007	18	https://doi.org/10.1016/j.biopha.2016.12.096	https://doi.org/10.1016/j.biopha.2016.12.096	NOUN
dti-2707	1007	19	https://www.ncbi.nlm.nih.gov/pubmed/28056420	https://www.ncbi.nlm.nih.gov/pubmed/28056420	NUM
dti-2707	1007	20	https://doi.org/10.1007/s11892-013-0453-1	https://doi.org/10.1007/s11892-013-0453-1	PROPN
dti-2707	1007	21	https://www.ncbi.nlm.nih.gov/pubmed/24292971	https://www.ncbi.nlm.nih.gov/pubmed/24292971	NUM
dti-2707	1007	22	https://doi.org/10.1142/s0192415x14500463	https://doi.org/10.1142/s0192415x14500463	NUM
dti-2707	1007	23	https://www.ncbi.nlm.nih.gov/pubmed/24871661	https://www.ncbi.nlm.nih.gov/pubmed/24871661	NUM
dti-2707	1007	24	https://phcog.com/article/sites/default/files/phcogmag1457453-2990838_081828.pdf	https://phcog.com/article/sites/default/files/phcogmag1457453-2990838_081828.pdf	PROPN
dti-2707	1007	25	https://doi.org/10.1002/jcb.21817	https://doi.org/10.1002/jcb.21817	PROPN
dti-2707	1007	26	https://www.ncbi.nlm.nih.gov/pubmed/18523985	https://www.ncbi.nlm.nih.gov/pubmed/18523985	X
dti-2707	1007	27	https://doi.org/10.1016/j.jep.2021.114052	https://doi.org/10.1016/j.jep.2021.114052	PROPN
dti-2707	1007	28	https://www.ncbi.nlm.nih.gov/pubmed/33753147	https://www.ncbi.nlm.nih.gov/pubmed/33753147	X
dti-2707	1008	1	https://doi.org/10.1016/j.bcp.2020.114302	https://doi.org/10.1016/j.bcp.2020.114302	PUNCT
dti-2707	1009	1	https://www.ncbi.nlm.nih.gov/pubmed/33121927	https://www.ncbi.nlm.nih.gov/pubmed/33121927	INTJ
dti-2707	1010	1	https://doi.org/10.1016/j.jep.2014.08.031	https://doi.org/10.1016/j.jep.2014.08.031	AUX
dti-2707	1010	2	https://www.ncbi.nlm.nih.gov/pubmed/25219601	https://www.ncbi.nlm.nih.gov/pubmed/25219601	PRON
dti-2707	1010	3	https://docslib.org/doc/2205314/applications-of-metabolomics-a-systematic-study-of-the-unique-chemical-fingerprints-an-overview	https://docslib.org/doc/2205314/applications-of-metabolomics-a-systematic-study-of-the-unique-chemical-fingerprints-an-overview	VERB
dti-2707	1010	4	https://doi.org/10.1200/jco.2008.26.15_suppl.15538	https://doi.org/10.1200/jco.2008.26.15_suppl.15538	NOUN
dti-2707	1010	5	https://doi.org/10.1080/03639045.2021.2007394	https://doi.org/10.1080/03639045.2021.2007394	NOUN
dti-2707	1011	1	https://www.ncbi.nlm.nih.gov/pubmed/34781796	https://www.ncbi.nlm.nih.gov/pubmed/34781796	PROPN
dti-2707	1011	2	therapeutic	therapeutic	ADJ
dti-2707	1011	3	insights	insight	NOUN
dti-2707	1011	4	into	into	ADP
dti-2707	1011	5	baicalein46	baicalein46	NOUN
dti-2707	1011	6	©	©	PROPN
dti-2707	1011	7	2024	2024	NUM
dti-2707	1012	1	the	the	DET
dti-2707	1012	2	authors	author	NOUN
dti-2707	1012	3	.	.	PUNCT
dti-2707	1013	1	drug	drug	NOUN
dti-2707	1013	2	target	target	NOUN
dti-2707	1013	3	insights	insight	NOUN
dti-2707	1013	4	issn	issn	VERB
dti-2707	1013	5	1177	1177	NUM
dti-2707	1013	6	-	-	SYM
dti-2707	1013	7	3928	3928	NUM
dti-2707	1013	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2707	1013	9	liposomal	liposomal	ADJ
dti-2707	1013	10	gel	gel	NOUN
dti-2707	1013	11	:	:	PUNCT
dti-2707	1013	12	in	in	ADP
dti-2707	1013	13	vitro	vitro	X
dti-2707	1013	14	and	and	CCONJ
dti-2707	1013	15	in	in	ADP
dti-2707	1013	16	vivo	vivo	ADJ
dti-2707	1013	17	investigation	investigation	NOUN
dti-2707	1013	18	.	.	PUNCT
dti-2707	1014	1	j	j	PROPN
dti-2707	1014	2	drug	drug	PROPN
dti-2707	1014	3	deliv	deliv	VERB
dti-2707	1014	4	sci	sci	PROPN
dti-2707	1014	5	technol	technol	NOUN
dti-2707	1014	6	.	.	PUNCT
dti-2707	1015	1	2020;57:101666	2020;57:101666	NUM
dti-2707	1015	2	.	.	PUNCT
dti-2707	1016	1	crossref	crossref	PROPN
dti-2707	1016	2	133	133	NUM
dti-2707	1016	3	.	.	PUNCT
dti-2707	1017	1	kavithaa	kavithaa	PROPN
dti-2707	1017	2	k	k	PROPN
dti-2707	1017	3	,	,	PUNCT
dti-2707	1017	4	sumathi	sumathi	PROPN
dti-2707	1017	5	s	s	PROPN
dti-2707	1017	6	,	,	PUNCT
dti-2707	1017	7	padma	padma	PROPN
dti-2707	1017	8	p.	p.	NOUN
dti-2707	1017	9	intracellular	intracellular	ADJ
dti-2707	1017	10	uptake	uptake	NOUN
dti-2707	1017	11	of	of	ADP
dti-2707	1017	12	pegfunctionalized	pegfunctionalize	VERB
dti-2707	1017	13	baicalein	baicalein	NOUN
dti-2707	1017	14	loaded	load	VERB
dti-2707	1017	15	iron	iron	NOUN
dti-2707	1017	16	oxide	oxide	NOUN
dti-2707	1017	17	nanoparticles	nanoparticle	NOUN
dti-2707	1017	18	regulates	regulate	VERB
dti-2707	1017	19	apoptotic	apoptotic	ADJ
dti-2707	1017	20	genes	gene	NOUN
dti-2707	1017	21	in	in	ADP
dti-2707	1017	22	triple	triple	ADJ
dti-2707	1017	23	negative	negative	ADJ
dti-2707	1017	24	breast	breast	NOUN
dti-2707	1017	25	cancer	cancer	NOUN
dti-2707	1017	26	cells	cell	NOUN
dti-2707	1017	27	:	:	PUNCT
dti-2707	1017	28	mitochondrial	mitochondrial	ADJ
dti-2707	1017	29	pathway	pathway	NOUN
dti-2707	1017	30	targeted	target	VERB
dti-2707	1017	31	therapy	therapy	NOUN
dti-2707	1017	32	for	for	ADP
dti-2707	1017	33	breast	breast	NOUN
dti-2707	1017	34	cancer	cancer	NOUN
dti-2707	1017	35	.	.	PUNCT
dti-2707	1018	1	j	j	PROPN
dti-2707	1018	2	cluster	cluster	PROPN
dti-2707	1018	3	sci	sci	PROPN
dti-2707	1018	4	.	.	PUNCT
dti-2707	1019	1	2017;28(4):2057	2017;28(4):2057	NUM
dti-2707	1019	2	-	-	PUNCT
dti-2707	1019	3	2073	2073	NUM
dti-2707	1019	4	.	.	PUNCT
dti-2707	1020	1	crossref	crossref	PROPN
dti-2707	1020	2	134	134	NUM
dti-2707	1020	3	.	.	PUNCT
dti-2707	1021	1	li	li	PROPN
dti-2707	1021	2	x	x	PROPN
dti-2707	1021	3	,	,	PUNCT
dti-2707	1021	4	luo	luo	PROPN
dti-2707	1021	5	w	w	PROPN
dti-2707	1021	6	,	,	PUNCT
dti-2707	1021	7	ng	ng	PROPN
dti-2707	1021	8	tw	tw	PROPN
dti-2707	1021	9	,	,	PUNCT
dti-2707	1021	10	et	et	PROPN
dti-2707	1021	11	al	al	PROPN
dti-2707	1021	12	.	.	PROPN
dti-2707	1021	13	nanoparticle	nanoparticle	NOUN
dti-2707	1021	14	-	-	PUNCT
dti-2707	1021	15	encapsulated	encapsulate	VERB
dti-2707	1021	16	baicalein	baicalein	NOUN
dti-2707	1021	17	markedly	markedly	ADV
dti-2707	1021	18	modulates	modulate	NOUN
dti-2707	1021	19	pro	pro	ADJ
dti-2707	1021	20	-	-	ADJ
dti-2707	1021	21	inflammatory	inflammatory	ADJ
dti-2707	1021	22	response	response	NOUN
dti-2707	1021	23	in	in	ADP
dti-2707	1021	24	gingival	gingival	ADJ
dti-2707	1021	25	epithelial	epithelial	ADJ
dti-2707	1021	26	cells	cell	NOUN
dti-2707	1021	27	.	.	PUNCT
dti-2707	1022	1	nanoscale	nanoscale	PROPN
dti-2707	1022	2	.	.	PUNCT
dti-2707	1023	1	2017;9(35):12897	2017;9(35):12897	PROPN
dti-2707	1023	2	-	-	SYM
dti-2707	1023	3	12907	12907	NUM
dti-2707	1023	4	.	.	PUNCT
dti-2707	1024	1	crossref	crossref	PROPN
dti-2707	1024	2	pubmed	pubmed	PROPN
dti-2707	1024	3	135	135	PROPN
dti-2707	1024	4	.	.	PUNCT
dti-2707	1025	1	yang	yang	PROPN
dti-2707	1025	2	j	j	PROPN
dti-2707	1025	3	,	,	PUNCT
dti-2707	1025	4	chen	chen	PROPN
dti-2707	1025	5	a	a	PROPN
dti-2707	1025	6	,	,	PUNCT
dti-2707	1025	7	he	he	PRON
dti-2707	1025	8	x	x	PROPN
dti-2707	1025	9	,	,	PUNCT
dti-2707	1025	10	lu	lu	PROPN
dti-2707	1025	11	s.	s.	PROPN
dti-2707	1025	12	fabrication	fabrication	PROPN
dti-2707	1025	13	of	of	ADP
dti-2707	1025	14	baicalein	baicalein	NOUN
dti-2707	1025	15	-	-	PUNCT
dti-2707	1025	16	encapsulated	encapsulate	VERB
dti-2707	1025	17	zeolitic	zeolitic	ADJ
dti-2707	1025	18	imidazole	imidazole	NOUN
dti-2707	1025	19	framework	framework	NOUN
dti-2707	1025	20	as	as	ADP
dti-2707	1025	21	a	a	DET
dti-2707	1025	22	novel	novel	NOUN
dti-2707	1025	23	nanocomposited	nanocomposite	VERB
dti-2707	1025	24	wound	wound	NOUN
dti-2707	1025	25	closure	closure	NOUN
dti-2707	1025	26	material	material	NOUN
dti-2707	1025	27	to	to	PART
dti-2707	1025	28	persuade	persuade	VERB
dti-2707	1025	29	ph	ph	ADJ
dti-2707	1025	30	-	-	ADJ
dti-2707	1025	31	responsive	responsive	ADJ
dti-2707	1025	32	healing	healing	NOUN
dti-2707	1025	33	efficacy	efficacy	NOUN
dti-2707	1025	34	in	in	ADP
dti-2707	1025	35	post	post	ADJ
dti-2707	1025	36	-	-	ADJ
dti-2707	1025	37	caesarean	caesarean	ADJ
dti-2707	1025	38	section	section	NOUN
dti-2707	1025	39	wound	wound	NOUN
dti-2707	1025	40	care	care	NOUN
dti-2707	1025	41	.	.	PUNCT
dti-2707	1026	1	int	int	NOUN
dti-2707	1026	2	wound	wound	NOUN
dti-2707	1026	3	j.	j.	PROPN
dti-2707	1026	4	2023;20(6):1921	2023;20(6):1921	PROPN
dti-2707	1026	5	-	-	PUNCT
dti-2707	1026	6	1933	1933	NUM
dti-2707	1026	7	.	.	PUNCT
dti-2707	1027	1	crossref	crossref	PROPN
dti-2707	1027	2	pubmed	pubmed	PROPN
dti-2707	1027	3	136	136	NUM
dti-2707	1027	4	.	.	PUNCT
dti-2707	1028	1	gharbavi	gharbavi	PROPN
dti-2707	1028	2	m	m	PROPN
dti-2707	1028	3	,	,	PUNCT
dti-2707	1028	4	johari	johari	PROPN
dti-2707	1028	5	b	b	NUM
dti-2707	1028	6	,	,	PUNCT
dti-2707	1028	7	ghorbani	ghorbani	ADJ
dti-2707	1028	8	r	r	NOUN
dti-2707	1028	9	,	,	PUNCT
dti-2707	1028	10	madanchi	madanchi	PROPN
dti-2707	1028	11	h	h	NOUN
dti-2707	1028	12	,	,	PUNCT
dti-2707	1028	13	sharafi	sharafi	PROPN
dti-2707	1028	14	a.	a.	NOUN
dti-2707	1028	15	green	green	PROPN
dti-2707	1028	16	synthesis	synthesis	NOUN
dti-2707	1028	17	of	of	ADP
dti-2707	1028	18	zn	zn	PROPN
dti-2707	1028	19	nanoparticles	nanoparticle	NOUN
dti-2707	1028	20	and	and	CCONJ
dti-2707	1028	21	in	in	ADP
dti-2707	1028	22	situ	situ	NOUN
dti-2707	1028	23	hybridized	hybridize	VERB
dti-2707	1028	24	with	with	ADP
dti-2707	1028	25	bsa	bsa	PROPN
dti-2707	1028	26	nanoparticles	nanoparticle	NOUN
dti-2707	1028	27	for	for	ADP
dti-2707	1028	28	baicalein	baicalein	NOUN
dti-2707	1028	29	targeted	target	VERB
dti-2707	1028	30	delivery	delivery	NOUN
dti-2707	1028	31	mediated	mediate	VERB
dti-2707	1028	32	with	with	ADP
dti-2707	1028	33	glutamate	glutamate	ADJ
dti-2707	1028	34	receptors	receptor	NOUN
dti-2707	1028	35	to	to	ADP
dti-2707	1028	36	u87	u87	NOUN
dti-2707	1028	37	-	-	PUNCT
dti-2707	1028	38	mg	mg	PROPN
dti-2707	1028	39	cancer	cancer	NOUN
dti-2707	1028	40	cell	cell	NOUN
dti-2707	1028	41	lines	line	NOUN
dti-2707	1028	42	.	.	PUNCT
dti-2707	1029	1	appl	appl	NOUN
dti-2707	1029	2	organomet	organomet	VERB
dti-2707	1029	3	chem	chem	NOUN
dti-2707	1029	4	.	.	PUNCT
dti-2707	1030	1	2023;37(1):e6926	2023;37(1):e6926	X
dti-2707	1030	2	.	.	PUNCT
dti-2707	1031	1	crossref	crossref	PROPN
dti-2707	1031	2	137	137	NUM
dti-2707	1031	3	.	.	PUNCT
dti-2707	1032	1	shi	shi	PROPN
dti-2707	1032	2	f	f	PROPN
dti-2707	1032	3	,	,	PUNCT
dti-2707	1032	4	wei	wei	PROPN
dti-2707	1032	5	z	z	PROPN
dti-2707	1032	6	,	,	PUNCT
dti-2707	1032	7	zhao	zhao	PROPN
dti-2707	1032	8	y	y	PROPN
dti-2707	1032	9	,	,	PUNCT
dti-2707	1032	10	xu	xu	PROPN
dti-2707	1032	11	x.	x.	PROPN
dti-2707	1032	12	nanostructured	nanostructure	VERB
dti-2707	1032	13	lipid	lipid	NOUN
dti-2707	1032	14	carriers	carrier	NOUN
dti-2707	1032	15	loaded	load	VERB
dti-2707	1032	16	with	with	ADP
dti-2707	1032	17	baicalin	baicalin	NOUN
dti-2707	1032	18	:	:	PUNCT
dti-2707	1032	19	an	an	DET
dti-2707	1032	20	efficient	efficient	ADJ
dti-2707	1032	21	carrier	carrier	NOUN
dti-2707	1032	22	for	for	ADP
dti-2707	1032	23	enhanced	enhanced	ADJ
dti-2707	1032	24	antidiabetic	antidiabetic	ADJ
dti-2707	1032	25	effects	effect	NOUN
dti-2707	1032	26	.	.	PUNCT
dti-2707	1033	1	pharmacogn	pharmacogn	VERB
dti-2707	1033	2	mag	mag	INTJ
dti-2707	1033	3	.	.	PUNCT
dti-2707	1034	1	2016;12(47):198	2016;12(47):198	NUM
dti-2707	1034	2	-	-	PUNCT
dti-2707	1034	3	202	202	NUM
dti-2707	1034	4	.	.	PUNCT
dti-2707	1035	1	crossref	crossref	PROPN
dti-2707	1035	2	pubmed	pubmed	PROPN
dti-2707	1035	3	138	138	NUM
dti-2707	1035	4	.	.	PUNCT
dti-2707	1036	1	abdel	abdel	PROPN
dti-2707	1036	2	maksoud	maksoud	PROPN
dti-2707	1036	3	ha	ha	PROPN
dti-2707	1036	4	,	,	PUNCT
dti-2707	1036	5	abou	abou	PROPN
dti-2707	1036	6	zaid	zaid	PROPN
dti-2707	1036	7	oar	oar	PROPN
dti-2707	1036	8	,	,	PUNCT
dti-2707	1036	9	elharrif	elharrif	VERB
dti-2707	1036	10	mg	mg	PROPN
dti-2707	1036	11	,	,	PUNCT
dti-2707	1036	12	omnia	omnia	PROPN
dti-2707	1036	13	ma	ma	PROPN
dti-2707	1036	14	,	,	PUNCT
dti-2707	1036	15	alaa	alaa	PROPN
dti-2707	1036	16	ea	ea	PROPN
dti-2707	1036	17	.	.	PUNCT
dti-2707	1036	18	selenium	selenium	NOUN
dti-2707	1036	19	cleome	cleome	VERB
dti-2707	1036	20	droserifolia	droserifolia	PROPN
dti-2707	1036	21	nanoparticles	nanoparticle	NOUN
dti-2707	1036	22	(	(	PUNCT
dti-2707	1036	23	se	se	ADJ
dti-2707	1036	24	-	-	NOUN
dti-2707	1036	25	cnps	cnps	ADJ
dti-2707	1036	26	)	)	PUNCT
dti-2707	1036	27	and	and	CCONJ
dti-2707	1036	28	it	it	PRON
dti-2707	1036	29	's	be	AUX
dti-2707	1036	30	ameliorative	ameliorative	ADJ
dti-2707	1036	31	effects	effect	NOUN
dti-2707	1036	32	in	in	ADP
dti-2707	1036	33	experimentally	experimentally	ADV
dti-2707	1036	34	induced	induced	ADJ
dti-2707	1036	35	diabetes	diabetes	NOUN
dti-2707	1036	36	mellitus	mellitus	NOUN
dti-2707	1036	37	.	.	PUNCT
dti-2707	1037	1	clin	clin	PROPN
dti-2707	1037	2	nutr	nutr	PROPN
dti-2707	1037	3	espen	espen	PROPN
dti-2707	1037	4	.	.	PROPN
dti-2707	1037	5	2020	2020	NUM
dti-2707	1037	6	dec;40:383	dec;40:383	NOUN
dti-2707	1037	7	-	-	SYM
dti-2707	1037	8	391	391	NUM
dti-2707	1037	9	.	.	PUNCT
dti-2707	1038	1	crossref	crossref	PROPN
dti-2707	1038	2	pubmed	pubmed	PROPN
dti-2707	1038	3	139	139	NUM
dti-2707	1038	4	.	.	PUNCT
dti-2707	1039	1	kavithaa	kavithaa	PROPN
dti-2707	1039	2	k	k	PROPN
dti-2707	1039	3	,	,	PUNCT
dti-2707	1039	4	paulpandi	paulpandi	PROPN
dti-2707	1039	5	m	m	PROPN
dti-2707	1039	6	,	,	PUNCT
dti-2707	1039	7	padma	padma	PROPN
dti-2707	1039	8	pr	pr	NOUN
dti-2707	1039	9	,	,	PUNCT
dti-2707	1039	10	sumathi	sumathi	PROPN
dti-2707	1039	11	s.	s.	PROPN
dti-2707	1039	12	induction	induction	NOUN
dti-2707	1039	13	of	of	ADP
dti-2707	1039	14	intrinsic	intrinsic	ADJ
dti-2707	1039	15	apoptotic	apoptotic	ADJ
dti-2707	1039	16	pathway	pathway	NOUN
dti-2707	1039	17	and	and	CCONJ
dti-2707	1039	18	cell	cell	NOUN
dti-2707	1039	19	cycle	cycle	NOUN
dti-2707	1039	20	arrest	arrest	NOUN
dti-2707	1039	21	via	via	ADP
dti-2707	1039	22	baicalein	baicalein	PROPN
dti-2707	1039	23	loaded	load	VERB
dti-2707	1039	24	iron	iron	NOUN
dti-2707	1039	25	oxide	oxide	NOUN
dti-2707	1039	26	nanoparticles	nanoparticle	NOUN
dti-2707	1039	27	as	as	ADP
dti-2707	1039	28	a	a	DET
dti-2707	1039	29	competent	competent	ADJ
dti-2707	1039	30	nano	nano	NOUN
dti-2707	1039	31	mediated	mediate	VERB
dti-2707	1039	32	system	system	NOUN
dti-2707	1039	33	for	for	ADP
dti-2707	1039	34	triple	triple	ADJ
dti-2707	1039	35	negative	negative	ADJ
dti-2707	1039	36	breast	breast	NOUN
dti-2707	1039	37	cancer	cancer	NOUN
dti-2707	1039	38	therapy	therapy	NOUN
dti-2707	1039	39	.	.	PUNCT
dti-2707	1040	1	rsc	rsc	PROPN
dti-2707	1040	2	adv	adv	PROPN
dti-2707	1040	3	.	.	PUNCT
dti-2707	1041	1	2016;6(69):64531	2016;6(69):64531	NUM
dti-2707	1041	2	-	-	PUNCT
dti-2707	1041	3	64543	64543	NUM
dti-2707	1041	4	.	.	PUNCT
dti-2707	1042	1	crossref	crossref	PROPN
dti-2707	1042	2	140	140	NUM
dti-2707	1042	3	.	.	PUNCT
dti-2707	1043	1	yadav	yadav	PROPN
dti-2707	1043	2	pk	pk	PROPN
dti-2707	1043	3	,	,	PUNCT
dti-2707	1043	4	saklani	saklani	ADJ
dti-2707	1043	5	r	r	NOUN
dti-2707	1043	6	,	,	PUNCT
dti-2707	1043	7	tiwari	tiwari	PROPN
dti-2707	1043	8	ak	ak	PROPN
dti-2707	1043	9	,	,	PUNCT
dti-2707	1043	10	et	et	PROPN
dti-2707	1043	11	al	al	PROPN
dti-2707	1043	12	.	.	PROPN
dti-2707	1043	13	ratiometric	ratiometric	PROPN
dti-2707	1043	14	codelivery	codelivery	NOUN
dti-2707	1043	15	of	of	ADP
dti-2707	1043	16	paclitaxel	paclitaxel	PROPN
dti-2707	1043	17	and	and	CCONJ
dti-2707	1043	18	baicalein	baicalein	PROPN
dti-2707	1043	19	loaded	load	VERB
dti-2707	1043	20	nanoemulsion	nanoemulsion	NOUN
dti-2707	1043	21	for	for	ADP
dti-2707	1043	22	enhancement	enhancement	NOUN
dti-2707	1043	23	of	of	ADP
dti-2707	1043	24	breast	breast	NOUN
dti-2707	1043	25	cancer	cancer	NOUN
dti-2707	1043	26	treatment	treatment	NOUN
dti-2707	1043	27	.	.	PUNCT
dti-2707	1044	1	int	int	PROPN
dti-2707	1044	2	j	j	PROPN
dti-2707	1044	3	pharm	pharm	PROPN
dti-2707	1044	4	.	.	PUNCT
dti-2707	1045	1	2023;643:123209	2023;643:123209	NOUN
dti-2707	1045	2	.	.	PUNCT
dti-2707	1046	1	crossref	crossref	PROPN
dti-2707	1046	2	pubmed	pubmed	PROPN
dti-2707	1046	3	141	141	NUM
dti-2707	1046	4	.	.	PUNCT
dti-2707	1047	1	wang	wang	PROPN
dti-2707	1047	2	w	w	PROPN
dti-2707	1047	3	,	,	PUNCT
dti-2707	1047	4	xi	xi	PROPN
dti-2707	1047	5	m	m	PROPN
dti-2707	1047	6	,	,	PUNCT
dti-2707	1047	7	duan	duan	PROPN
dti-2707	1047	8	x	x	PROPN
dti-2707	1047	9	,	,	PUNCT
dti-2707	1047	10	wang	wang	PROPN
dti-2707	1047	11	y	y	PROPN
dti-2707	1047	12	,	,	PUNCT
dti-2707	1047	13	kong	kong	PROPN
dti-2707	1047	14	f.	f.	PROPN
dti-2707	1047	15	delivery	delivery	PROPN
dti-2707	1047	16	of	of	ADP
dti-2707	1047	17	baicalein	baicalein	PROPN
dti-2707	1047	18	and	and	CCONJ
dti-2707	1047	19	paclitaxel	paclitaxel	PROPN
dti-2707	1047	20	using	use	VERB
dti-2707	1047	21	self	self	NOUN
dti-2707	1047	22	-	-	PUNCT
dti-2707	1047	23	assembled	assemble	VERB
dti-2707	1047	24	nanoparticles	nanoparticle	NOUN
dti-2707	1047	25	:	:	PUNCT
dti-2707	1047	26	synergistic	synergistic	ADJ
dti-2707	1047	27	antitumor	antitumor	PROPN
dti-2707	1047	28	effect	effect	NOUN
dti-2707	1047	29	in	in	ADP
dti-2707	1047	30	vitro	vitro	X
dti-2707	1047	31	and	and	CCONJ
dti-2707	1047	32	in	in	ADP
dti-2707	1047	33	vivo	vivo	NOUN
dti-2707	1047	34	.	.	PUNCT
dti-2707	1048	1	int	int	NOUN
dti-2707	1048	2	j	j	PROPN
dti-2707	1048	3	nanomedicine	nanomedicine	PROPN
dti-2707	1048	4	.	.	PUNCT
dti-2707	1049	1	2015;10:3737	2015;10:3737	NUM
dti-2707	1049	2	-	-	SYM
dti-2707	1049	3	3750	3750	NUM
dti-2707	1049	4	.	.	PUNCT
dti-2707	1050	1	pubmed	pubmed	PROPN
dti-2707	1050	2	142	142	NUM
dti-2707	1050	3	.	.	PUNCT
dti-2707	1051	1	li	li	PROPN
dti-2707	1051	2	k	k	PROPN
dti-2707	1051	3	,	,	PUNCT
dti-2707	1051	4	zhang	zhang	PROPN
dti-2707	1051	5	h	h	PROPN
dti-2707	1051	6	,	,	PUNCT
dti-2707	1051	7	gao	gao	PROPN
dti-2707	1051	8	l	l	PROPN
dti-2707	1051	9	,	,	PUNCT
dti-2707	1051	10	et	et	PROPN
dti-2707	1051	11	al	al	PROPN
dti-2707	1051	12	.	.	PUNCT
dti-2707	1051	13	preparation	preparation	NOUN
dti-2707	1051	14	and	and	CCONJ
dti-2707	1051	15	characterization	characterization	NOUN
dti-2707	1051	16	of	of	ADP
dti-2707	1051	17	baicalein	baicalein	NOUN
dti-2707	1051	18	-	-	PUNCT
dti-2707	1051	19	loaded	load	VERB
dti-2707	1051	20	nanoliposomes	nanoliposome	NOUN
dti-2707	1051	21	for	for	ADP
dti-2707	1051	22	antitumor	antitumor	PROPN
dti-2707	1051	23	therapy	therapy	NOUN
dti-2707	1051	24	.	.	PUNCT
dti-2707	1052	1	j	j	PROPN
dti-2707	1052	2	nanomater	nanomater	PROPN
dti-2707	1052	3	.	.	PUNCT
dti-2707	1052	4	2016;2861915	2016;2861915	NUM
dti-2707	1052	5	.	.	PUNCT
dti-2707	1053	1	crossref	crossref	PROPN
dti-2707	1053	2	143	143	NUM
dti-2707	1053	3	.	.	PUNCT
dti-2707	1054	1	liu	liu	PROPN
dti-2707	1054	2	z	z	PROPN
dti-2707	1054	3	,	,	PUNCT
dti-2707	1054	4	zhang	zhang	PROPN
dti-2707	1054	5	l	l	PROPN
dti-2707	1054	6	,	,	PUNCT
dti-2707	1054	7	he	he	PRON
dti-2707	1054	8	q	q	AUX
dti-2707	1054	9	,	,	PUNCT
dti-2707	1054	10	et	et	PROPN
dti-2707	1054	11	al	al	PROPN
dti-2707	1054	12	.	.	PROPN
dti-2707	1054	13	effect	effect	NOUN
dti-2707	1054	14	of	of	ADP
dti-2707	1054	15	baicalin	baicalin	NOUN
dti-2707	1054	16	-	-	PUNCT
dti-2707	1054	17	loaded	load	VERB
dti-2707	1054	18	pegylated	pegylated	ADJ
dti-2707	1054	19	cationic	cationic	ADJ
dti-2707	1054	20	solid	solid	ADJ
dti-2707	1054	21	lipid	lipid	NOUN
dti-2707	1054	22	nanoparticles	nanoparticle	NOUN
dti-2707	1054	23	modified	modify	VERB
dti-2707	1054	24	by	by	ADP
dti-2707	1054	25	ox26	ox26	PROPN
dti-2707	1054	26	antibody	antibody	NOUN
dti-2707	1054	27	on	on	ADP
dti-2707	1054	28	regulating	regulate	VERB
dti-2707	1054	29	the	the	DET
dti-2707	1054	30	levels	level	NOUN
dti-2707	1054	31	of	of	ADP
dti-2707	1054	32	baicalin	baicalin	NOUN
dti-2707	1054	33	and	and	CCONJ
dti-2707	1054	34	amino	amino	ADJ
dti-2707	1054	35	acids	acid	NOUN
dti-2707	1054	36	during	during	ADP
dti-2707	1054	37	cerebral	cerebral	ADJ
dti-2707	1054	38	ischemia	ischemia	NOUN
dti-2707	1054	39	-	-	PUNCT
dti-2707	1054	40	reperfusion	reperfusion	NOUN
dti-2707	1054	41	in	in	ADP
dti-2707	1054	42	rats	rat	NOUN
dti-2707	1054	43	.	.	PUNCT
dti-2707	1055	1	int	int	NOUN
dti-2707	1055	2	j	j	PROPN
dti-2707	1055	3	pharm	pharm	PROPN
dti-2707	1055	4	.	.	PUNCT
dti-2707	1056	1	2015;489	2015;489	NUM
dti-2707	1056	2	(	(	PUNCT
dti-2707	1056	3	1	1	NUM
dti-2707	1056	4	-	-	PUNCT
dti-2707	1056	5	2):131	2):131	NUM
dti-2707	1056	6	-	-	PUNCT
dti-2707	1056	7	138	138	NUM
dti-2707	1056	8	.	.	PUNCT
dti-2707	1057	1	crossref	crossref	PROPN
dti-2707	1057	2	pubmed	pubmed	PROPN
dti-2707	1057	3	https://doi.org/10.1016/j.jddst.2020.101666	https://doi.org/10.1016/j.jddst.2020.101666	PROPN
dti-2707	1057	4	https://doi.org/10.1007/s10876-017-1204-2	https://doi.org/10.1007/s10876-017-1204-2	NUM
dti-2707	1057	5	https://doi.org/10.1039/c7nr02546	https://doi.org/10.1039/c7nr02546	NOUN
dti-2707	1057	6	g	g	NOUN
dti-2707	1057	7	https://www.ncbi.nlm.nih.gov/pubmed/28650029	https://www.ncbi.nlm.nih.gov/pubmed/28650029	NUM
dti-2707	1057	8	https://doi.org/10.1111/iwj.14052	https://doi.org/10.1111/iwj.14052	PROPN
dti-2707	1057	9	https://www.ncbi.nlm.nih.gov/pubmed/36572003	https://www.ncbi.nlm.nih.gov/pubmed/36572003	PUNCT
dti-2707	1057	10	https://doi.org/10.1002/aoc.6926	https://doi.org/10.1002/aoc.6926	PROPN
dti-2707	1057	11	https://doi.org/10.4103/0973-1296.186347	https://doi.org/10.4103/0973-1296.186347	PROPN
dti-2707	1057	12	https://www.ncbi.nlm.nih.gov/pubmed/27601850	https://www.ncbi.nlm.nih.gov/pubmed/27601850	X
dti-2707	1058	1	https://doi.org/10.1016/j.clnesp.2020.07.016	https://doi.org/10.1016/j.clnesp.2020.07.016	PROPN
dti-2707	1058	2	https://pubmed.ncbi.nlm.nih.gov/33183567/	https://pubmed.ncbi.nlm.nih.gov/33183567/	PROPN
dti-2707	1058	3	https://doi.org/10.1039/c6ra11658b	https://doi.org/10.1039/c6ra11658b	PROPN
dti-2707	1058	4	https://doi.org/10.1016/j.ijpharm.2023.123209	https://doi.org/10.1016/j.ijpharm.2023.123209	NOUN
dti-2707	1058	5	https://www.ncbi.nlm.nih.gov/pubmed/37422142	https://www.ncbi.nlm.nih.gov/pubmed/37422142	PROPN
dti-2707	1058	6	https://www.ncbi.nlm.nih.gov/pubmed/26045664	https://www.ncbi.nlm.nih.gov/pubmed/26045664	X
dti-2707	1058	7	https://doi.org/10.1155/2016/2861915	https://doi.org/10.1155/2016/2861915	PROPN
dti-2707	1058	8	https://doi.org/10.1016/j.ijpharm.2015.04.049	https://doi.org/10.1016/j.ijpharm.2015.04.049	NOUN
dti-2707	1058	9	https://www.ncbi.nlm.nih.gov/pubmed/25895718	https://www.ncbi.nlm.nih.gov/pubmed/25895718	NOUN